1 orlistat hsa04916 Melanogenesis 5579_5578_5566_81029_1387_107 6 + 0.037090956947261 0.245318725577717 2 orlistat hsa04120 Ubiquitin mediated proteolysis 9063_4281_8945_23759_330_22888_326_8651 8 + 0.0103215320093284 0.187851882569777 3 orlistat hsa05010 Alzheimer's disease 775_2902_779_6390_317_3709_4035_487_517 9 + 0.00129953453817571 0.0394192143246632 4 orlistat hsa04310 Wnt signaling pathway 6425_8945_5579_5578_4088_5566_81029_3725_1387_5516 10 + 0.0199457917764641 0.243201055166699 5 orlistat hsa05016 Huntington's disease 5432_2902_4899_6648_7052_1639_6390_317_246721_10540_9001_1387_10126_517 14 + 0.0278200736560103 0.243201055166699 6 orlistat hsa03420 Nucleotide excision repair 5111 1 + 0.0377413423965719 0.245318725577717 7 orlistat hsa04740 Olfactory transduction 26211_7932_5566_135948_2979_5592 6 + 5.61566142238143e-15 5.1102518943671e-13 8 orlistat hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8329_8294_8342_8341_3123_3126_3127_3125_8969_8370_718_8332_8359_8330_8331_8336_554313_6738_121504_3018_85235_3119_3111_1511 34 + 0.00497712755624379 0.113229651904546 9 orlistat hsa04110 Cell cycle 995_1647_5111_4088_7040_1870_1387 7 + 0.0259622605718311 0.243201055166699 10 orlistat hsa05221 Acute myeloid leukemia 861_6655 2 + 0.0293979297454252 0.243201055166699 11 orlistat hsa04530 Tight junction 29895_5579_5578_998_6709_2036_88_3996_5516 9 + 0.0283739001602148 0.243201055166699 12 orlistat hsa04150 mTOR signaling pathway 6794 1 + 0.0177103855262332 0.243201055166699 13 orlistat hsa05012 Parkinson's disease 9627_6390_317_517 4 + 0.000195730215626766 0.00890572481101785 14 orlistat hsa04620 Toll-like receptor signaling pathway 3592_1432_3576_3441_7099_3725 6 + 0.0365378432550878 0.245318725577717 15 orlistat hsa04120 Ubiquitin mediated proteolysis 23327_10277_996_4281_10075_7328_11060_23759_5371_4193_672_26091_83737_8454_26272_9820_7329_27338_23221_7327_9040 21 - 0.0226543724123308 0.191532421304251 16 orlistat hsa05010 Alzheimer's disease 55851_2597_3710_2904_5663_51806_5664_6622_348_4842_4843_776_5533_5532_3709_489_23236_5594_4713_642502_6391_4137_1537_808_823_805_801_517 28 - 0.0142836433570177 0.166047354025331 17 orlistat hsa04080 Neuroactive ligand-receptor interaction 623_151_2901_152_2904_2908_5724_134_5644_6870_2488_1813_624_3360_799_3953_3972_4986_5646_7068_1909_2911_2918_5025_148_6915_146_7067_5733_3269_3358_9170_1812_5734_2558_4160_6755_2740_8811_10800_680 41 - 0.0034976005355354 0.0650553699609584 18 orlistat hsa04742 Taste transduction 2785_346562_5566_3710_6340 5 - 0.0221988816835997 0.191532421304251 19 orlistat hsa05016 Huntington's disease 246721_2904_5432_1537_6648_5434_7157_1639_6667_10488_64446_7416_23236_1175_581_548644_163_4713_642502_6391_3092_5978_1387_293_517 25 - 0.00106029065179554 0.0328690102056617 20 orlistat hsa03420 Nucleotide excision repair 5983_6117_5111_5985 4 - 0.046003418294576 0.285221193426371 21 orlistat hsa04740 Olfactory transduction 51806_5592_56656_26211_5566_135948_2978_808_805_801_816 11 - 5.91466509381143e-26 5.50063853724463e-24 22 orlistat hsa04340 Hedgehog signaling pathway 7479_5566_7472_7480_6469 5 - 0.0164639321770689 0.170127299163045 23 orlistat hsa04630 Jak-STAT signaling pathway 3581_3561_3566_2057_3953_1271_6654_10379_3440_5293_50615_3451_50616_3977_3976_8835_3597_1489_1387_3569 20 - 0.00236367630627485 0.0549554741208903 24 orlistat hsa04062 Chemokine signaling pathway 113_156_5580_5293_7852_5880_10235_2309_3579_2783_5829_5566_7410_1398_6362_4793_6367_2785_108_2185_23236_115_6352_5594_5579_6654_6464_6358_6359_3845_7409_5970_8976 33 - 0.0300274554070249 0.228914570415456 25 orlistat hsa05012 Parkinson's disease 4713_7327_5413_7314_6391_7054_1537_7416_65018_6531_6622_293_517_642502 14 - 0.00032900349918696 0.0152986627121936 26 orlistat hsa04260 Cardiac muscle contraction 776_781_782_783_1537_4624_481_4635_7171_7137_10368 11 - 0.0388963171821295 0.258382678424146 27 orlistat hsa04060 Cytokine-cytokine receptor interaction 3597_5155_8742_8741_7852_7850_1489_1896_959_1271_3554_3579_2057_3451_4049_3953_4982_3977_3976_8718_6362_6367_3581_23495_8743_3624_8200_4254_1956_7040_91_6352_268_8794_8795_3561_3566_944_3569_3440_6358_6359_50615_50616_7423_7422_1435_51330 48 - 0.0319988109182896 0.228914570415456 28 orlistat hsa03010 Ribosome 440589_6192_6233_6187_6142_6141_6234_9045_439992_6160_6159_6129_6189 13 - 0.0141422015450258 0.166047354025331 29 orlistat hsa03050 Proteasome 9491_5689_5702 3 - 0.00794931659272342 0.123214407187213 30 fluorocurarine hsa04740 Olfactory transduction 8387_81697_26212_56656_8388 5 + 0.0198881161878468 0.725916240856408 31 fluorocurarine hsa05322 Systemic lupus erythematosus 2903_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 12 + 0.00569684942698343 0.41587000816979 32 fluorocurarine hsa04512 ECM-receptor interaction 1278_1284_7059_1302_3690_3371_1292 7 + 0.0312123357426658 0.759500169738201 33 fluorocurarine hsa04740 Olfactory transduction 4991 1 - 0.000575084618898805 0.0408310079418152 34 moxonidine hsa05214 Glioma 5154_5578 2 + 0.0180406635724886 0.0691614321521407 35 moxonidine hsa04070 Phosphatidylinositol signaling system 8526_5578 2 + 0.0239945355414357 0.0691614321521407 36 moxonidine hsa04080 Neuroactive ligand-receptor interaction 2688_1442_2689 3 + 0.0449450463632359 0.0837150037631633 37 moxonidine hsa05200 Pathways in cancer 2260_5578_5154_7042 4 + 0.0190590611292972 0.0691614321521407 38 moxonidine hsa05131 Shigellosis 7430_5578 2 + 0.0137214813830822 0.0691614321521407 39 moxonidine hsa05130 Pathogenic Escherichia coli infection 7430_5578 2 + 0.0137214813830822 0.0691614321521407 40 moxonidine hsa05212 Pancreatic cancer 2260_5154 2 + 0.0319206609932957 0.0691614321521407 41 moxonidine hsa05215 Prostate cancer 2260_5154 2 + 0.031278481526646 0.0691614321521407 42 moxonidine hsa04530 Tight junction 4619_5578_5516 3 + 0.00898821413993621 0.0691614321521407 43 moxonidine hsa04664 Fc epsilon RI signaling pathway 8398_5578 2 + 0.025740769003202 0.0691614321521407 44 moxonidine hsa04370 VEGF signaling pathway 8398_5578 2 + 0.0245709374949867 0.0691614321521407 45 moxonidine hsa05218 Melanoma 2260_5154 2 + 0.0211992044533351 0.0691614321521407 46 moxonidine hsa04350 TGF-beta signaling pathway 5516_7042 2 + 0.0306415794091915 0.0691614321521407 47 moxonidine hsa04630 Jak-STAT signaling pathway 2688_1442_2689 3 + 0.0124769352890242 0.0691614321521407 48 moxonidine hsa04810 Regulation of actin cytoskeleton 2260_7430_5154 3 + 0.0304856616668224 0.0691614321521407 49 moxonidine hsa04010 MAPK signaling pathway 8398_782_5578_5154_8912_4763_7042_2260 8 + 1.54619862641083e-06 6.03017464300224e-05 50 moxonidine hsa04540 Gap junction 5154_5578 2 + 0.0345414267547491 0.0709008233386955 51 moxonidine hsa04260 Cardiac muscle contraction 782_4635 2 + 0.0281474781446568 0.0691614321521407 52 moxonidine hsa04060 Cytokine-cytokine receptor interaction 2689_2688_5154_7042 4 + 0.00865830466038985 0.0691614321521407 53 moxonidine hsa04912 GnRH signaling pathway 8398_5578 2 + 0.0450773097186264 0.0837150037631633 54 moxonidine hsa04730 Long-term depression 5578_8398_5516 3 + 0.00149353607434549 0.0291239534497371 55 moxonidine hsa05322 Systemic lupus erythematosus 8343_8339_8347_8346_8344 5 - 0.0083764419676824 0.309928352804249 56 terazosin hsa04070 Phosphatidylinositol signaling system 23533_3710_5579_51806_5578_3631_3708_23236 8 + 0.0245825925906723 0.352408865302675 57 terazosin hsa04740 Olfactory transduction 51806_26212 2 + 1.37497806115624e-05 0.00107248288770187 58 terazosin hsa04664 Fc epsilon RI signaling pathway 23533_10000_5579_5581_5599_5578_5600_5603 8 + 0.029588801453865 0.352408865302675 59 terazosin hsa04720 Long-term potentiation 51806_3710_5579_2904_5578_6196_3708_27330_23236 9 + 0.00853987754473327 0.218964036429169 60 terazosin hsa04540 Gap junction 3710_5579_5578_2983_5598_1813_5155_115_3708_23236 10 + 0.0112289249450856 0.218964036429169 61 terazosin hsa05012 Parkinson's disease 1339 1 + 0.0316264366297272 0.352408865302675 62 terazosin hsa04912 GnRH signaling pathway 4214_3710_5579_5578_5599_5598_5603_2002_115_3708_51806_5600_2185_2796_23236 15 + 0.000194126398284924 0.00757092953311204 63 terazosin hsa04730 Long-term depression 3710_5579_5578_2983_3708_23236_5516 7 + 0.04524492550796 0.44113802370261 64 terazosin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3111 22 - 1.05309584585865e-12 5.79202715222258e-11 65 terazosin hsa04330 Notch signaling pathway 196403_1488_4854_5664 4 - 0.0174879846986542 0.48091957921299 66 cefalonium hsa04670 Leukocyte transendothelial migration 5829_7430 2 + 0.0435427579761828 0.389830318292949 67 alsterpaullone hsa05214 Glioma 818_1026_4193_5578 4 + 0.0147092160620159 0.389405613532079 68 alsterpaullone hsa05131 Shigellosis 7278_113457_5578 3 + 0.0469972292193889 0.389405613532079 69 alsterpaullone hsa05130 Pathogenic Escherichia coli infection 7278_113457_5578 3 + 0.0469972292193889 0.389405613532079 70 alsterpaullone hsa05322 Systemic lupus erythematosus 8358_85235_8968_3013_3113_8969_8332_8330_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357 19 + 6.48385143471485e-13 3.76063383213461e-11 71 alsterpaullone hsa04012 ErbB signaling pathway 818_1026_56924_5578 4 + 0.0361931085644046 0.389405613532079 72 alsterpaullone hsa04540 Gap junction 7278_5578_113457_112 4 + 0.0441072027722856 0.389405613532079 73 alsterpaullone hsa04270 Vascular smooth muscle contraction 9138_5578_3778_59_112 5 + 0.0268953261857075 0.389405613532079 74 alsterpaullone hsa04916 Melanogenesis 2033_4286_4157_2535_5613_7855_5616_5894_3845_6934_112_8324_1385_1387_8321_107_8323_8322 18 - 0.0303482819757461 0.0806397206784111 75 alsterpaullone hsa05332 Graft-versus-host disease 355 1 - 0.000365990874415824 0.00179142901687745 76 alsterpaullone hsa04650 Natural killer cell mediated cytotoxicity 8503_6850_5295_5290_5291_10451_836_3459_3845_4277_4276_10725_673_5533_5532_5894_5534_8795_3460_6655_6654_355_7409_4772 24 - 0.0110815491912035 0.0332446475736105 77 alsterpaullone hsa04120 Ubiquitin mediated proteolysis 10277_9817_8554_7328_23759_331_996_11059_22954_55958_7324_7326_4281_51366_7321_7322_22888_51343_6477_51433_26091_83737_8925_55236_26232_8065_329_23291_10401_997_64750_10054_672_8454_8453_8452_8451_8945_8697_7320_7337_868_25898_4734_55120_6502_7323_11065_3093_51588_10393_27338_11060_7189_51465_57154_63893 57 - 0.0499622937413237 0.127126839197402 78 alsterpaullone hsa04640 Hematopoietic cell lineage 3589_3554_960_1604_2057 5 - 8.71505604086266e-06 6.75416843166856e-05 79 alsterpaullone hsa03320 PPAR signaling pathway 7316_1962_6256_2181_8310_5467_1376_6257_28965 9 - 0.0107200361480109 0.0332321120588338 80 alsterpaullone hsa05010 Alzheimer's disease 5533_836_1327_841_8772_5534_317_9451_5663_5532_3708_3709_509_7132_355 15 - 3.27382709297393e-08 6.08931839293151e-07 81 alsterpaullone hsa04080 Neuroactive ligand-receptor interaction 5029_4889_5618_4157_7068_2908_5025_4886_5031_2150_136_9568_2690_9170 14 - 6.66844917599916e-16 3.10082886683961e-14 82 alsterpaullone hsa04742 Taste transduction 5613_5616_112 3 - 0.000437167209199499 0.00203282752277767 83 alsterpaullone hsa05320 Autoimmune thyroid disease 355 1 - 1.53340358655209e-05 0.000101861809678103 84 alsterpaullone hsa04612 Antigen processing and presentation 4800_4801_4802_3306_1385_3304_3312_3303 8 - 0.000231801261096187 0.00134734483012159 85 alsterpaullone hsa04670 Leukocyte transendothelial migration 24146_1364_8503_1432_5829_5295_6387_5290_9475_10451_1365_7430_4636_394_7409_6093_9080_5908_5291_643752 20 - 0.00904260640694063 0.0300343712801957 86 alsterpaullone hsa05016 Huntington's disease 4899_1327_317_246721_23186_7019_6874_6908_5433_5430_836_6667_2033_509_7419_3708_548644_51164_841_1385_1387_9519 22 - 3.04404693539965e-06 2.83096364992167e-05 87 alsterpaullone hsa04740 Olfactory transduction 5613_5616 2 - 8.62688651864611e-42 8.02300446234088e-40 88 alsterpaullone hsa04514 Cell adhesion molecules (CAMs) 24146_965_214_4685_4897_9080_1364_1365_5792_6693_25945_5817 12 - 2.67679767772373e-06 2.76602426698119e-05 89 alsterpaullone hsa04510 Focal adhesion 8503_595_1302_5295_331_5154_5290_9475_10451_4636_394_4659_5501_5728_2324_5829_7057_23396_1399_1398_5908_329_5063_1793_3480_673_5894_6093_5291_4233_1729_6655_6654_2002_7424_7409_7422_643752 38 - 0.0044476666829623 0.0165453200606198 90 alsterpaullone hsa05322 Systemic lupus erythematosus 6738_3014 2 - 2.26270689199004e-14 7.01439136516912e-13 91 alsterpaullone hsa05340 Primary immunodeficiency 64421 1 - 0.00128481115187103 0.00519510596191329 92 alsterpaullone hsa04530 Tight junction 5520_64398_4636_9223_24146_5728_5583_5581_93643_51776_55844_8777_9080_5519_22800_9218_5515_5516_7082_1364_1457_3845_1365 23 - 0.00798440495017224 0.0275018392728155 93 alsterpaullone hsa05110 Vibrio cholerae infection 7082_30001_5613_5616_526_528_23545 7 - 0.0126155803410688 0.0366640303662312 94 alsterpaullone hsa04512 ECM-receptor interaction 960_1605_7057_1302_3161 5 - 1.24603375146437e-05 8.91393376047588e-05 95 alsterpaullone hsa04062 Chemokine signaling pathway 3717_1147_5295_8503_5290_9475_6387_112_2309_3551_5829_1399_1398_7409_5908_408_673_5894_6093_5291_107_5613_6655_6654_5616_10451_6772_7074_3845_5970_8976_643752 32 - 0.00102555897001247 0.00433531746414362 96 alsterpaullone hsa04810 Regulation of actin cytoskeleton 8503_10672_5295_5154_5290_9475_10451_4636_23396_10458_4659_5501_3985_5829_8394_7430_1399_1398_2263_5962_2261_2264_324_5063_1793_673_22800_5894_2245_6093_5291_200576_8874_1729_6655_6654_5305_7074_3845_54434_7409_8976 42 - 0.00595604806668005 0.0213043257769709 97 alsterpaullone hsa05012 Parkinson's disease 2861_7326_836_1327_7314_317_51465_509_27429_7419 10 - 1.86457992730968e-07 2.47722761771143e-06 98 alsterpaullone hsa04260 Cardiac muscle contraction 10479_1327_481 3 - 9.4489093032586e-07 1.09843570650381e-05 99 alsterpaullone hsa04060 Cytokine-cytokine receptor interaction 55540_5154_6387_9180_90_7132_657_27242_3554_2057_2324_3459_3572_3588_4982_23529_3589_3625_4055_91_655_92_4233_7048_5618_3460_355_7424_7422_8795_51330_2690 32 - 7.90665777570645e-08 1.2255319552345e-06 100 alsterpaullone hsa03010 Ribosome 6139_51187_6125_6168_6141_9349_6233 7 - 5.59983049591234e-06 4.73440214654407e-05 101 alsterpaullone hsa04020 Calcium signaling pathway 8912_8877_5613_56848_5616_3707_5533_5532_3708_3709_136_5534_5025_7419_490_107 16 - 2.35262889778075e-08 5.46986218734024e-07 102 alsterpaullone hsa03050 Proteasome 5706_23198 2 - 0.000339227561191021 0.00175267573282028 103 alsterpaullone hsa04912 GnRH signaling pathway 4215_4216_1432_468_5613_6655_6654_5616_3709_2002_3708_5606_3845_6416_112_5894_107 17 - 0.0102029715932796 0.0327198744198277 104 alsterpaullone hsa05330 Allograft rejection 355 1 - 0.000851230132754479 0.00376973344505555 105 alsterpaullone hsa04730 Long-term depression 10672_673_5519_3708_3709_5894_3480_3845_5515_5516 10 - 0.0236745105705196 0.0647567495017154 106 alsterpaullone hsa04270 Vascular smooth muscle contraction 5583_5581_5613_5616_3709_673_10672_3708_9826_5894_136_112_6093_9475_4659_107_5501 17 - 0.00275930204500222 0.0106922954243836 107 alsterpaullone hsa04940 Type I diabetes mellitus 355 1 - 0.000142041344807458 0.00088065633780624 108 alsterpaullone hsa02010 ABC transporters 23461_5826_23457_9619 4 - 0.0149728586123995 0.0421962379076713 109 alsterpaullone hsa04610 Complement and coagulation cascades 1604_2152_7035_5104_5329 5 - 0.000270692549053188 0.00148084747423215 110 ketorolac hsa05332 Graft-versus-host disease 3824_3119_3123_3126_3127_941_355_3125 8 + 0.000116310286521302 0.00284089811546206 111 ketorolac hsa05320 Autoimmune thyroid disease 3119_3123_3126_3127_941_355_3125 7 + 0.00215561947819726 0.0221720860614575 112 ketorolac hsa04740 Olfactory transduction 26211 1 + 0.000118370754810919 0.00284089811546206 113 ketorolac hsa05322 Systemic lupus erythematosus 3119_3123_941_3126_3127_3125_8358_8968_3013_8350_8351_8352_8353_8354_8355_8356_8357 17 + 7.49531366985214e-06 0.000539662584229354 114 ketorolac hsa05310 Asthma 2205_3119_3123_3126_3127_3125 6 + 0.00067245303811065 0.00968332374879336 115 ketorolac hsa04010 MAPK signaling pathway 2261_10000_5598_9254_4763_8817_355_5607_10912_2249_5058_2260_2247_5971_4149 15 + 0.0359860376551232 0.323874338896109 116 ketorolac hsa05330 Allograft rejection 3119_3123_3126_3127_941_355_3125 7 + 0.000373303022626405 0.00671945440727529 117 ketorolac hsa04940 Type I diabetes mellitus 3119_3123_3126_3127_941_355_3125 7 + 0.000815264306983154 0.00978317168379785 118 ketorolac hsa04070 Phosphatidylinositol signaling system 5296_8394_3707_3633_51763 5 - 0.0449966426598141 0.448408008816638 119 ketorolac hsa05131 Shigellosis 347733_7280_9181_7430_9475 5 - 0.0152933469790407 0.282926919112253 120 ketorolac hsa05130 Pathogenic Escherichia coli infection 347733_7280_9181_7430_9475 5 - 0.0152933469790407 0.282926919112253 121 ketorolac hsa04360 Axon guidance 6405_4233_2049_219699_9475_22885_10507 7 - 0.0484765414936906 0.448408008816638 122 ketorolac hsa04370 VEGF signaling pathway 5829_5296_8681_100137049_5600 5 - 0.0470209782429307 0.448408008816638 123 ketorolac hsa05218 Melanoma 4286_5296_1029_8074_1956_4233 6 - 0.0103262837527968 0.282926919112253 124 ketorolac hsa04810 Regulation of actin cytoskeleton 5829_10672_2909_3693_8394_8074_54961_9475_5296_1956_7430_324_3655 13 - 0.00393343729042938 0.282926919112253 125 ketorolac hsa04730 Long-term depression 10672_8681_100137049_5518_2911 5 - 0.0356700118956331 0.448408008816638 126 0316684-0000 hsa04740 Olfactory transduction 818 1 + 0.000815804059158409 0.0489482435495045 127 0316684-0000 hsa04912 GnRH signaling pathway 5598_2767_818_8681_5600_3725_100137049 7 + 0.0292391418259061 0.877174254777183 128 0316684-0000 hsa05332 Graft-versus-host disease 3119_3105_3106_3126_3127_3125_3135_3123_649853 9 - 0.000944432649419904 0.0207775182872379 129 0316684-0000 hsa04080 Neuroactive ligand-receptor interaction 9568_5618_7068 3 - 0.00136666728757501 0.0240533442613202 130 0316684-0000 hsa05320 Autoimmune thyroid disease 3119_3105_3106_3126_3127_3125_3135_3123_649853 9 - 0.00384093459331957 0.048286034887446 131 0316684-0000 hsa04612 Antigen processing and presentation 4802_3119_3123_3106_3126_3127_3125_3135_6890_3308_3105_821_649853 13 - 0.0019013631899899 0.0278866601198519 132 0316684-0000 hsa05131 Shigellosis 7280_5578_347733_999_60_7430_7534 7 - 0.0397031434635914 0.332132861928492 133 0316684-0000 hsa05130 Pathogenic Escherichia coli infection 7280_5578_347733_999_60_7430_7534 7 - 0.0397031434635914 0.332132861928492 134 0316684-0000 hsa04740 Olfactory transduction 219464 1 - 4.60076359724408e-08 4.04867196557479e-06 135 0316684-0000 hsa05322 Systemic lupus erythematosus 85235_3119_3123_3126_3127_3014_3125_8332_8969_8331_8336_8329_9555_8330 14 - 0.0415166077410615 0.332132861928492 136 0316684-0000 hsa05310 Asthma 3123_3126_3127_3119_3125 5 - 0.0305198306182683 0.332132861928492 137 0316684-0000 hsa05012 Parkinson's disease 7419_7327 2 - 0.0490424813998452 0.359644863598865 138 0316684-0000 hsa05330 Allograft rejection 3119_3105_3106_3126_3127_3125_3135_3123_649853 9 - 0.000506744340938562 0.0148645006675312 139 0316684-0000 hsa04940 Type I diabetes mellitus 3382_3119_3105_3106_3126_3127_3125_3135_3123_649853 10 - 0.000332142257392727 0.01461425932528 140 Prestwick-972 hsa05322 Systemic lupus erythematosus 717_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 12 + 1.39128202657333e-07 7.23466653818132e-06 141 Prestwick-972 hsa04070 Phosphatidylinositol signaling system 8394_8821_3710_5298_3631 5 - 0.00343281510501482 0.138818343247432 142 Prestwick-972 hsa04810 Regulation of actin cytoskeleton 8394_5155_5881_1956_7430_324_3675 7 - 0.0235229532690784 0.324866244718629 143 Prestwick-972 hsa05213 Endometrial cancer 2309_1956_6934_324 4 - 0.00523842804707291 0.138818343247432 144 Prestwick-972 hsa05210 Colorectal cancer 5881_1956_324_6934 4 - 0.0245182071485758 0.324866244718629 145 lincomycin hsa04740 Olfactory transduction 81797_4991 2 + 0.00333877318652638 0.240391669429899 146 lincomycin hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 - 0.00741265012561229 0.101618009922728 147 lincomycin hsa04070 Phosphatidylinositol signaling system 3636_8394_3633_3707 4 - 0.0463516218406881 0.27347456886006 148 lincomycin hsa04640 Hematopoietic cell lineage 1436_2057_3123_3126_3570_3127_3125 7 - 0.00104100262838038 0.0614191550744424 149 lincomycin hsa05320 Autoimmune thyroid disease 3123_3126_3127_3125 4 - 0.0155560009529606 0.152967342704113 150 lincomycin hsa05014 Amyotrophic lateral sclerosis (ALS) 11261_5606_5600_5603 4 - 0.0184732959629547 0.155703494544904 151 lincomycin hsa04514 Cell adhesion molecules (CAMs) 2734_3123_3126_3127_3125_26047 6 - 0.0314058378988712 0.228711212752631 152 lincomycin hsa05310 Asthma 3123_3126_3127_3125 4 - 0.00246417042161937 0.0726930274377714 153 lincomycin hsa04620 Toll-like receptor signaling pathway 3665_5606_5600_5603_7187 5 - 0.0348881510978589 0.228711212752631 154 lincomycin hsa05330 Allograft rejection 3123_3126_3127_3125 4 - 0.00535653461421439 0.101618009922728 155 lincomycin hsa04940 Type I diabetes mellitus 3123_3126_3127_3125 4 - 0.00861169575616341 0.101618009922728 156 griseofulvin hsa04740 Olfactory transduction 5593 1 + 0.0156721489551127 0.376131574922705 157 griseofulvin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_6737_8359_8294_8367_554313_121504 15 + 1.10055005997771e-07 5.28264028789301e-06 158 griseofulvin hsa04080 Neuroactive ligand-receptor interaction 2911_5618_4889_2917 4 - 0.00151578479092905 0.0314525344117778 159 griseofulvin hsa04740 Olfactory transduction 219464 1 - 6.21879700698028e-09 3.86591361926565e-07 160 griseofulvin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8345_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 31 - 9.31545450425458e-09 3.86591361926565e-07 161 griseofulvin hsa04060 Cytokine-cytokine receptor interaction 7852_5618_7422_2057 4 - 0.00108677656044586 0.0300674848390021 162 dilazep hsa04740 Olfactory transduction 8387_8388 2 + 0.0132402210736511 0.397206632209533 163 dilazep hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8349_8329_8294_121504_8343_8347_8346_8344_8339_8969_8968_8370_8358_8359_8330_8331_8336_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_720_721 41 + 1.21969929882644e-29 7.31819579295864e-28 164 dilazep hsa04080 Neuroactive ligand-receptor interaction 2911_5618_2917_4886_136_1909 6 - 0.0323086656343934 0.523400383277173 165 dilazep hsa04740 Olfactory transduction 157_409_816 3 - 4.78153811584526e-06 0.000387304587383466 166 dilazep hsa05322 Systemic lupus erythematosus 6738 1 - 0.00717591527285474 0.280254334720124 167 dilazep hsa04210 Apoptosis 3556_8503_651610_841_596_5575_5295_472_51135_8837_1677 11 - 0.0176766411751555 0.357951983796899 168 dilazep hsa05012 Parkinson's disease 7419 1 - 0.0103797901748194 0.280254334720124 169 riluzole hsa05214 Glioma 7039_2475_10000_816 4 + 0.0476184665372907 0.422018066597533 170 riluzole hsa04660 T cell receptor signaling pathway 10000_5588_915_4775_7535_925 6 + 0.0275627834465927 0.420841864546784 171 riluzole hsa04740 Olfactory transduction 3000_816 2 + 0.0375022123370983 0.420841864546784 172 riluzole hsa05322 Systemic lupus erythematosus 3119_3013_8358_6738_8968_8350_8351_8352_8353_8354_8355_8356_8357 13 + 1.36011873498381e-05 0.000884077177739476 173 riluzole hsa05340 Primary immunodeficiency 7535_915_925 3 + 0.0388469413427801 0.420841864546784 174 riluzole hsa05221 Acute myeloid leukemia 861_5371_2475_10000 4 + 0.0359045873180303 0.420841864546784 175 riluzole hsa04012 ErbB signaling pathway 7039_2475_10000_1399_816 5 + 0.0356604300277015 0.420841864546784 176 riluzole hsa05332 Graft-versus-host disease 3105_3106_3107_3135_3133_649853 6 - 0.0244318548716292 0.289691993477889 177 riluzole hsa04080 Neuroactive ligand-receptor interaction 3953_64106_2901_7067 4 - 0.0108006846213062 0.224114205892104 178 riluzole hsa04740 Olfactory transduction 109_5568 2 - 2.06035693711423e-06 8.55048128902406e-05 179 riluzole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 30 - 5.25728459627542e-10 4.3635462149086e-08 180 riluzole hsa04210 Apoptosis 8503_5568_841_581_598_5575_331_51135_208 9 - 0.049911265486357 0.441268073092175 181 riluzole hsa04540 Gap junction 7280_5568_347733_6655_113457_2776_3708_5607_109_112_7278 11 - 0.00975628556815573 0.224114205892104 182 riluzole hsa05012 Parkinson's disease 509 1 - 0.0226303440101511 0.289691993477889 183 riluzole hsa05330 Allograft rejection 3105_3106_3107_3135_3133_649853 6 - 0.0164432270320524 0.27295756873207 184 riluzole hsa04940 Type I diabetes mellitus 3105_3106_3107_3135_3133_649853 6 - 0.029257040746971 0.303541797749824 185 sulfamethoxazole hsa05332 Graft-versus-host disease 3123_3126_3127_3119_3125 5 + 0.000298904639389937 0.00292926546602138 186 sulfamethoxazole hsa04640 Hematopoietic cell lineage 3123_3126_3127_3125 4 + 0.0279993801920438 0.191968613999501 187 sulfamethoxazole hsa05320 Autoimmune thyroid disease 3119_7253_3123_3126_3127_3125 6 + 9.43473242905578e-05 0.00154100629674578 188 sulfamethoxazole hsa04612 Antigen processing and presentation 3123_3126_3127_3119_3125 5 + 0.00667807621446487 0.0545376224181298 189 sulfamethoxazole hsa04514 Cell adhesion molecules (CAMs) 3123_3126_3127_3119_3125 5 + 0.0313418145305308 0.191968613999501 190 sulfamethoxazole hsa05322 Systemic lupus erythematosus 3123_3126_3127_3119_3125 5 + 0.0404141486245161 0.220032586955699 191 sulfamethoxazole hsa05310 Asthma 3123_3126_3127_3119_3125 5 + 7.1406348520931e-05 0.00154100629674578 192 sulfamethoxazole hsa05330 Allograft rejection 3123_3126_3127_3119_3125 5 + 0.000195295930086096 0.00239237514355468 193 sulfamethoxazole hsa04940 Type I diabetes mellitus 3382_3119_3123_3126_3127_3125 6 + 3.65103012508858e-05 0.00154100629674578 194 sulfamethoxazole hsa04080 Neuroactive ligand-receptor interaction 2740_5618_2908_7068 4 - 0.000771660839321402 0.0320239248318382 195 sulfamethoxazole hsa05200 Pathways in cancer 8030_598_5295_331_5154_332_5899_1488_4149_6789_9134_1613_2263_1398_367_2260_1017_4842_324_581_3480_999_998_7042_91_3725_2271_841_6655_208_7184 31 - 0.040162728973524 0.332716540548888 196 sulfamethoxazole hsa05131 Shigellosis 7280_347733_999_998_9475_60_7430_7534_2017 9 - 0.0135332390672737 0.208883760959051 197 sulfamethoxazole hsa05130 Pathogenic Escherichia coli infection 7280_347733_999_998_9475_60_7430_7534_2017 9 - 0.0135332390672737 0.208883760959051 198 sulfamethoxazole hsa04740 Olfactory transduction 818_157_409 3 - 2.35324309289451e-07 1.95319176710244e-05 199 sulfamethoxazole hsa05322 Systemic lupus erythematosus 8337 1 - 0.00228192981698678 0.0631333916033009 200 sulfamethoxazole hsa05212 Pancreatic cancer 9134_3480_6655_5295_5154_208_2263_367_1385_2260_1017_7184 12 - 0.0176167027314862 0.208883760959051 201 sulfamethoxazole hsa04110 Cell cycle 995_472_5001_1017_51343_5934_4173_699_9134_996_7042_7534_651610_4616 14 - 0.0380622014047742 0.332716540548888 202 sulfamethoxazole hsa05215 Prostate cancer 9134_3480_6655_5295_5154_208_2263_367_1385_2260_1017_7184 12 - 0.0166489849456511 0.208883760959051 203 sulfamethoxazole hsa04210 Apoptosis 5534_3552_841_581_598_5295_331_472_51135_208_651610 11 - 0.049497788870748 0.332716540548888 204 sulfamethoxazole hsa03010 Ribosome 6181 1 - 0.0318064831927735 0.329992263125025 205 cloxacillin hsa05332 Graft-versus-host disease 3123_3107_3126_3127_3125 5 + 0.00525109651029279 0.0865917693549523 206 cloxacillin hsa04640 Hematopoietic cell lineage 3590_2812_3123_3126_3127_3125_3684 7 + 0.00750427241438381 0.0865917693549523 207 cloxacillin hsa05320 Autoimmune thyroid disease 3449_3123_3107_3126_3127_3125 6 + 0.00285778548477827 0.0865917693549523 208 cloxacillin hsa04612 Antigen processing and presentation 3449_3123_3107_3126_3127_3125 6 + 0.027048742857688 0.210379111115351 209 cloxacillin hsa04740 Olfactory transduction 26212_9635 2 + 0.00653144968216864 0.0865917693549523 210 cloxacillin hsa05310 Asthma 3123_3126_3127_3125 4 + 0.00865917693549523 0.0865917693549523 211 cloxacillin hsa04010 MAPK signaling pathway 208 1 + 0.0156296547830204 0.136759479351428 212 cloxacillin hsa05330 Allograft rejection 3123_3107_3126_3127_3125 5 + 0.00356194447501522 0.0865917693549523 213 cloxacillin hsa04940 Type I diabetes mellitus 3123_3107_3126_3127_3125 5 + 0.00627910058541217 0.0865917693549523 214 cloxacillin hsa05322 Systemic lupus erythematosus 85235_8348_8969_8332_8330_8331_8329_8336 8 - 0.000275274133623172 0.0112862394785501 215 pentoxifylline hsa05332 Graft-versus-host disease 3123_3107_3126_3127_3125_356_355 7 + 0.00234568439378044 0.0347161290279505 216 pentoxifylline hsa04070 Phosphatidylinositol signaling system 8871_5728_5578_3709_3631_8821_23236 7 + 0.0380443567181328 0.286839338204987 217 pentoxifylline hsa05320 Autoimmune thyroid disease 1081_3123_3107_3126_3127_3125_356_355 8 + 0.00204253972002419 0.0347161290279505 218 pentoxifylline hsa05131 Shigellosis 9076_5578_7278_113457_10382_2017 6 + 0.0297470888115859 0.27516057150717 219 pentoxifylline hsa05130 Pathogenic Escherichia coli infection 9076_5578_7278_113457_10382_2017 6 + 0.0297470888115859 0.27516057150717 220 pentoxifylline hsa04740 Olfactory transduction 5568_26692 2 + 6.14593217902631e-05 0.00227399490623973 221 pentoxifylline hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_55766_8294_8367_554313_8368_121504_8342 20 + 3.86629491307741e-06 0.000286105823567728 222 pentoxifylline hsa05310 Asthma 3123_3126_3127_3125 4 + 0.0387620727304037 0.286839338204987 223 pentoxifylline hsa04912 GnRH signaling pathway 5568_1081_5578_5599_2002_2798_3709_2796_23236 9 + 0.0444098271933092 0.298757019300444 224 pentoxifylline hsa05330 Allograft rejection 3123_3107_3126_3127_3125_356_355 7 + 0.00141140223633384 0.0347161290279505 225 pentoxifylline hsa04940 Type I diabetes mellitus 3123_3107_3126_3127_3125_356_355 7 + 0.00296267104339252 0.0365396095351744 226 pentoxifylline hsa03020 RNA polymerase 246721_5439_548644 3 - 0.00613493913449081 0.331286713262504 227 meclofenamic acid hsa04740 Olfactory transduction 26212_26692_26664_818_5132_816 6 + 5.11551452295401e-05 0.00212293852702591 228 meclofenamic acid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2213_3119_2215_3013_3014 29 + 1.4808718564845e-07 1.22912364088214e-05 229 meclofenamic acid hsa03440 Homologous recombination 8940_10111 2 - 0.0340014567433217 0.663028406494773 230 meclofenamic acid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504 14 - 3.10261712352789e-10 1.21002067817588e-08 231 tiapride hsa05010 Alzheimer's disease 489_5534 2 - 0.0130634031477195 0.523086367239375 232 tiapride hsa04080 Neuroactive ligand-receptor interaction 2911_2901_2908_1081_2917 5 - 0.0193735691570139 0.523086367239375 233 tiapride hsa04740 Olfactory transduction 5568_816 2 - 9.53601306217582e-07 7.72417058036241e-05 234 tiapride hsa04940 Type I diabetes mellitus 3382_3105_3106_3107_3135_649853 6 - 0.0348434022687093 0.617979006311251 235 tinidazole hsa05320 Autoimmune thyroid disease 3586_3105_3106_3107_3135_649853 6 + 0.0427469624878685 0.454186476433603 236 tinidazole hsa04660 T cell receptor signaling pathway 10298_3586_208_29851_56924_5293_4776_27040_4772_5534_2534 11 + 0.02085013673773 0.303272720757995 237 tinidazole hsa04740 Olfactory transduction 81697_5593_157_1179_4991 5 + 0.000892493816895862 0.0379309872180741 238 tinidazole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8370_3586_718_8368_8366_8290_3014_8359_8294_8367_554313_121504_8354_8364 19 + 8.61599215349047e-05 0.0073235933304669 239 tinidazole hsa04370 VEGF signaling pathway 9261_208_5293_4776_8681_4772_5534_100137049 8 + 0.0315801065070613 0.383472721871459 240 tinidazole hsa05330 Allograft rejection 3586_3105_3106_3107_3135_649853 6 + 0.0115135940195913 0.303272720757995 241 tinidazole hsa04730 Long-term depression 5593_2775_5519_5330_3709_8681_100137049_23236 8 + 0.0214074861711526 0.303272720757995 242 tinidazole hsa04940 Type I diabetes mellitus 3105_3106_3107_2571_3135_649853 6 + 0.0208458731368503 0.303272720757995 243 tinidazole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 6.7856424645374e-06 0.000393567262943169 244 guaifenesin hsa05332 Graft-versus-host disease 3553_3126_3127_3123_3125 5 + 0.0208214318569247 0.372936023008617 245 guaifenesin hsa04640 Hematopoietic cell lineage 3553_3123_3126_3127_3125_1378_3674 7 + 0.0402207625234111 0.442428387757522 246 guaifenesin hsa05320 Autoimmune thyroid disease 3123_3451_3126_3127_3125 5 + 0.0461615069788049 0.444304504670997 247 guaifenesin hsa04740 Olfactory transduction 1179_26476_9635_816 4 + 0.00597419745216453 0.16876198439578 248 guaifenesin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_3123_3126_3127_3125_8370_718_717_8359_554313_121504_720_721 22 + 4.03557625527596e-08 3.10739371656249e-06 249 guaifenesin hsa04360 Axon guidance 2044_10298_10154_1943_1946_998_8482_5534_10505_3897 10 + 0.0290599498448273 0.372936023008617 250 guaifenesin hsa05310 Asthma 3123_3126_3127_3125 4 + 0.0270390784559717 0.372936023008617 251 guaifenesin hsa04940 Type I diabetes mellitus 3553_3126_2572_3127_3125_3123 6 + 0.00657514224918625 0.16876198439578 252 guaifenesin hsa05016 Huntington's disease 246721_7419_4695_7052_5439_27113_5468_548644_23236 9 - 0.0446752398702981 0.661193550080412 253 guaifenesin hsa05322 Systemic lupus erythematosus 85235_3013_6737_8330_8969_8332_88_8331_8329_8351_8336 11 - 0.000737483392153488 0.0545737710193581 254 guaifenesin hsa04360 Axon guidance 5362_1969_56924_64221_4772_6092_27289_10507_3983 9 - 0.00429844715672861 0.159042544798959 255 guaifenesin hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0344598907057705 0.637507978056754 256 guaifenesin hsa04912 GnRH signaling pathway 50487_6655_1839_107_5338_4323_23236 7 - 0.0149483819557824 0.368726754909299 257 thiamazole hsa05332 Graft-versus-host disease 3126_3108_3127_3123_3125 5 + 0.0157625034079357 0.191033188498459 258 thiamazole hsa05320 Autoimmune thyroid disease 3126_3108_3127_3123_3125 5 + 0.0356550006484153 0.305048338880886 259 thiamazole hsa04520 Adherens junction 4008_998_10580_91_2260_1387_2064 7 + 0.0198476039998399 0.191033188498459 260 thiamazole hsa04740 Olfactory transduction 7932 1 + 8.1067281429372e-05 0.00312109033503082 261 thiamazole hsa04514 Cell adhesion molecules (CAMs) 214_3108_3123_3126_3127_3696_3125_23308_1462 9 + 0.0470998010257898 0.362668467898581 262 thiamazole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504_3108 19 + 8.66531214942352e-07 6.67229035505611e-05 263 thiamazole hsa04370 VEGF signaling pathway 5293_998_8681_4772_5600_5534_100137049 7 + 0.0166541622530609 0.191033188498459 264 thiamazole hsa05310 Asthma 3123_3125_3108_3127_3126 5 + 0.00453248401242614 0.116333756318938 265 thiamazole hsa05330 Allograft rejection 3126_3108_3127_3123_3125 5 + 0.0109517096810688 0.191033188498459 266 thiamazole hsa04940 Type I diabetes mellitus 3126_3108_3127_3123_3125 5 + 0.0186247996069907 0.191033188498459 267 thiamazole hsa04740 Olfactory transduction 393046 1 - 0.00247112864017181 0.0852539380859274 268 thiamazole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8370_94239_8366_8364_8368_8359_8294_8367_554313_121504_8337 16 - 6.15707379785781e-07 4.24838092052189e-05 269 lithocholic acid hsa05320 Autoimmune thyroid disease 3451_3448_3126_3113_3127_3125_3123 7 + 0.0199440882697908 0.408853809530711 270 lithocholic acid hsa04740 Olfactory transduction 2978_23538_1179_816 4 + 0.000106087837101151 0.00434960132114719 271 lithocholic acid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113_720_721 32 + 1.85096968940301e-11 1.51779514531047e-09 272 lithocholic acid hsa05310 Asthma 3123_3113_3127_3126_3125_8288 6 + 0.0056138495286691 0.153445220450289 273 lithocholic acid hsa04512 ECM-receptor interaction 1278_948_3690_3371_1277_5649_3679_51206_3674 9 + 0.0395644519596694 0.51297113100887 274 lithocholic acid hsa05330 Allograft rejection 3126_3113_3127_3123_3125 5 + 0.0467355213163969 0.51297113100887 275 lithocholic acid hsa04940 Type I diabetes mellitus 3123_2572_3127_3126_3125_3113 6 + 0.0266948999795363 0.437796359664395 276 lithocholic acid hsa03440 Homologous recombination 5890_7516_8438_6742 4 - 0.023926836899826 0.466573319546607 277 lithocholic acid hsa04080 Neuroactive ligand-receptor interaction 64106_2561_1909 3 - 0.0372764425420693 0.500942228836044 278 lithocholic acid hsa05200 Pathways in cancer 5914_405_6655_3551 4 - 0.0146720174367302 0.381472453354985 279 lithocholic acid hsa04740 Olfactory transduction 51806 1 - 2.57093396381897e-05 0.0010026642458894 280 lithocholic acid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_81_8969_8370_8332_8359_8330_8331_8336_554313_8351_85235_3013 24 - 3.40003788675548e-09 2.65202955166927e-07 281 lithocholic acid hsa04060 Cytokine-cytokine receptor interaction 3589_1271_3594 3 - 0.0385340176027726 0.500942228836044 282 nalidixic acid hsa05214 Glioma 23533_5578_4193_818_1956_3845 6 + 0.0116477025159056 0.100549420053376 283 nalidixic acid hsa05332 Graft-versus-host disease 3804_3126_3127_941_3123_3125 6 + 0.00166117143738494 0.0323928430290063 284 nalidixic acid hsa05320 Autoimmune thyroid disease 3451_3449_3123_3126_3127_941_3125 7 + 0.00104654860947367 0.0315739808540705 285 nalidixic acid hsa04612 Antigen processing and presentation 3451_3449_3123_3126_3127_3125_6891_6892_3804 9 + 0.00121438387900271 0.0315739808540705 286 nalidixic acid hsa04740 Olfactory transduction 818_9635 2 + 0.00331297633894781 0.0516824308875858 287 nalidixic acid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_9103_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504_941 20 + 1.36709043368569e-08 1.06633053827484e-06 288 nalidixic acid hsa04012 ErbB signaling pathway 23533_10298_5578_2549_818_1956_3845 7 + 0.0128909512888943 0.100549420053376 289 nalidixic acid hsa05310 Asthma 3123_3126_3127_3125 4 + 0.0123817687678885 0.100549420053376 290 nalidixic acid hsa05223 Non-small cell lung cancer 23533_6257_1956_3845_5578 5 + 0.0204576735988595 0.145063503701004 291 nalidixic acid hsa04912 GnRH signaling pathway 5578_5598_818_108_1956_3845_5320 7 + 0.0345813961068836 0.224779074694743 292 nalidixic acid hsa05330 Allograft rejection 3123_941_3126_3127_3125 5 + 0.00554927536458604 0.0721405797396185 293 nalidixic acid hsa04940 Type I diabetes mellitus 3123_941_3126_3127_3125 5 + 0.00965744097227326 0.100549420053376 294 nalidixic acid hsa04070 Phosphatidylinositol signaling system 8871_8503_8394_8396_5290_3631_3708_23236 8 - 0.00517918203404108 0.147067527047561 295 nalidixic acid hsa05211 Renal cell carcinoma 8503_208_5155_5290_3725_4233 6 - 0.0377219643567555 0.381934889112149 296 nalidixic acid hsa04662 B cell receptor signaling pathway 8503_6850_208_5290_7410_3725 6 - 0.0440940191529154 0.396846172376239 297 nalidixic acid hsa04740 Olfactory transduction 5568 1 - 8.27565837499917e-05 0.00670328328374933 298 nalidixic acid hsa04510 Focal adhesion 8503_596_208_2909_3693_5155_6464_5290_1277_2002_7410_3725_4638_4233_3675 15 - 0.00544694544620595 0.147067527047561 299 nalidixic acid hsa04810 Regulation of actin cytoskeleton 8503_8394_2909_3693_5155_54961_7410_7430_5290_2263_4638_8396_8976_3675 14 - 0.0213242411010602 0.36702870876976 300 nalidixic acid hsa04912 GnRH signaling pathway 5568_1081_5598_2002_3708_113_3725_23236 8 - 0.0317185303875101 0.36702870876976 301 nalidixic acid hsa05210 Colorectal cancer 8503_596_208_1856_5290_3725_4233 7 - 0.0258088133184902 0.36702870876976 302 nalidixic acid hsa05222 Small cell lung cancer 8503_4149_596_208_5290_8554_3675 7 - 0.0286453913043484 0.36702870876976 303 metaraminol hsa04742 Taste transduction 51764_3745_50835_773 4 + 0.0421685828872511 0.857427852040772 304 metaraminol hsa04740 Olfactory transduction 81696_81797 2 + 0.0133326779101021 0.813293352516228 305 metaraminol hsa04730 Long-term depression 3708_8681_100137049_773_6261 5 + 0.0288718918391558 0.857427852040772 306 metaraminol hsa04070 Phosphatidylinositol signaling system 8394_3633_5290_3631_3708_5335_23236 7 - 0.0495916490033412 0.652956711877326 307 metaraminol hsa04740 Olfactory transduction 5568 1 - 3.90680950319789e-06 0.000154318975376317 308 metaraminol hsa04514 Cell adhesion molecules (CAMs) 5817 1 - 0.0455625490193181 0.652956711877326 309 metaraminol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 30 - 1.08780669863316e-11 8.59367291920196e-10 310 metaraminol hsa04060 Cytokine-cytokine receptor interaction 8792_8744_3552_7042 4 - 0.0268556394602305 0.652956711877326 311 metaraminol hsa04270 Vascular smooth muscle contraction 5568_5583_5581_10672_2776_9475_3708_6093_4638_23236 10 - 0.0388551667802783 0.652956711877326 312 cefamandole hsa04060 Cytokine-cytokine receptor interaction 1435_3568_5155_4254_3572_7852_7042_6372 8 + 0.0288560424996396 0.894537317488828 313 cefamandole hsa05220 Chronic myeloid leukemia 5605_861_1488_7042 4 + 0.0214818039951352 0.894537317488828 314 terbutaline hsa04740 Olfactory transduction 219464_26212_7932_157_26707_393046 6 + 9.18106976508588e-06 0.000381014395251064 315 terbutaline hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013 34 + 3.29216213655704e-09 2.73249457334234e-07 316 terbutaline hsa04530 Tight junction 5010_3996_998 3 + 0.0497095910071516 1 317 terbutaline hsa03440 Homologous recombination 8940_5425_7156_5424_675_5888_10111 7 - 0.000890099334232675 0.0347138740350743 318 terbutaline hsa04080 Neuroactive ligand-receptor interaction 2846_7434_7068_1909 4 - 0.014910345237924 0.214995244736829 319 terbutaline hsa04740 Olfactory transduction 818_5567_157_409 4 - 0.000104382544850428 0.00814183849833338 320 terbutaline hsa04514 Cell adhesion molecules (CAMs) 5817 1 - 0.0218404174424233 0.214995244736829 321 terbutaline hsa04530 Tight junction 7525 1 - 0.0220507943319825 0.214995244736829 322 terbutaline hsa04630 Jak-STAT signaling pathway 3460 1 - 0.0106554982458209 0.207782215793508 323 terbutaline hsa05012 Parkinson's disease 836 1 - 0.021934576259444 0.214995244736829 324 terbutaline hsa04060 Cytokine-cytokine receptor interaction 3579_4233_3460 3 - 0.00269065874381101 0.0699571273390863 325 nortriptyline hsa04740 Olfactory transduction 26211 1 + 8.72043599175699e-05 0.00680194007357045 326 nortriptyline hsa05322 Systemic lupus erythematosus 3013_3111_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 12 + 0.00455028872699296 0.177461260352725 327 nortriptyline hsa03450 Non-homologous end-joining 27343_27434_2547 3 + 0.0161237564160506 0.419217666817316 328 nortriptyline hsa04080 Neuroactive ligand-receptor interaction 1131 1 - 0.00521555775400963 0.118219309090885 329 nortriptyline hsa04740 Olfactory transduction 219464 1 - 0.000120191673883656 0.0040865169120443 330 nortriptyline hsa04510 Focal adhesion 9475 1 - 0.0227720119959706 0.3871242039315 331 nortriptyline hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3012_3013 34 - 4.77140472311029e-18 3.244555211715e-16 332 piromidic acid hsa04910 Insulin signaling pathway 2475_5568_208_5140_6009_23265 6 + 0.0424483179232323 0.454803406320346 333 piromidic acid hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_4741_5879_317 4 + 0.0213836878414693 0.31723376859563 334 piromidic acid hsa04740 Olfactory transduction 5568 1 + 0.0159373867586351 0.31723376859563 335 piromidic acid hsa04210 Apoptosis 317_5568_3553_843_208 5 + 0.0253787014876504 0.31723376859563 336 piromidic acid hsa05221 Acute myeloid leukemia 861_208_2475_5914 4 + 0.02508538015623 0.31723376859563 337 piromidic acid hsa04620 Toll-like receptor signaling pathway 3593_3553_3448_3663_208_3576_5879 7 + 0.00315041193287855 0.236280894965891 338 piromidic acid hsa04940 Type I diabetes mellitus 3593_3553_3119_2571 4 + 0.0100391671482187 0.31723376859563 339 piromidic acid hsa04080 Neuroactive ligand-receptor interaction 5618_7067_2908_3354_135_9568_5644 7 - 0.0131221937278755 0.209955099646008 340 piromidic acid hsa04740 Olfactory transduction 219464_5613_393046 3 - 7.29370368515553e-08 5.83496294812442e-06 341 piromidic acid hsa04710 Circadian rhythm - mammal 8553_1408_5187_9572 4 - 0.0181421685213375 0.2418955802845 342 piromidic acid hsa04210 Apoptosis 651610_581_7157_5613_5575_5295_331_23052_472_5534_8837_1677_8794 13 - 0.011454753053223 0.209955099646008 343 piromidic acid hsa05012 Parkinson's disease 7419 1 - 0.003445640046597 0.13782560186388 344 piromidic acid hsa04060 Cytokine-cytokine receptor interaction 5618_2057_3594_3601_3572_7042_8794 7 - 0.00986888816511254 0.209955099646008 345 theobromine hsa04512 ECM-receptor interaction 3690_7057_1277 3 + 0.0498215804023981 0.468858236681595 346 theobromine hsa04062 Chemokine signaling pathway 6349_6348_728830_414062_10235_6093 6 + 0.0116266042429829 0.468858236681595 347 theobromine hsa04060 Cytokine-cytokine receptor interaction 1436_6348_8742_8741_10913_1950 6 + 0.0422249472569448 0.468858236681595 348 theobromine hsa05211 Renal cell carcinoma 5296_6655_2271_5781_7422 5 - 0.0358306567618607 0.508795326018422 349 theobromine hsa04662 B cell receptor signaling pathway 3551_5296_10892_6655_8519_7410 6 - 0.0123718957039507 0.292801531660167 350 theobromine hsa04080 Neuroactive ligand-receptor interaction 7067 1 - 0.0338230844910151 0.508795326018422 351 theobromine hsa04740 Olfactory transduction 157 1 - 0.0017188876247026 0.122041021353885 352 theobromine hsa04370 VEGF signaling pathway 5296_9261_8398_6714_7422 5 - 0.0450610299397069 0.533222187619865 353 theobromine hsa05220 Chronic myeloid leukemia 3551_5296_6655_4193_867_5781 6 - 0.0123718957039507 0.292801531660167 354 Prestwick-864 hsa05332 Graft-versus-host disease 3107_3553_3112_3119 4 + 0.00529572061547169 0.111210132924906 355 Prestwick-864 hsa05320 Autoimmune thyroid disease 3107_3446_3112_3119 4 + 0.011259927600338 0.177343859705323 356 Prestwick-864 hsa04612 Antigen processing and presentation 3107_3119_3805_3446_3112_3310 6 + 0.00336961316942114 0.106142814836766 357 Prestwick-864 hsa04740 Olfactory transduction 8392 1 + 0.0322369934570227 0.290132941113204 358 Prestwick-864 hsa04710 Circadian rhythm - mammal 1408_5187 2 + 0.0215917486311949 0.259884269679823 359 Prestwick-864 hsa05330 Allograft rejection 3107_3112_3119 3 + 0.0247508828266498 0.259884269679823 360 Prestwick-864 hsa04940 Type I diabetes mellitus 3553_3107_3382_3112_3119 5 + 0.00088671628773087 0.0558631261270448 361 Prestwick-864 hsa05332 Graft-versus-host disease 3108_3119_3105_3106_3135_355_649853 7 - 0.0177267359735208 0.318334767778124 362 Prestwick-864 hsa04080 Neuroactive ligand-receptor interaction 1812_7067_5025_135_2149_9170 6 - 0.0189484980820312 0.318334767778124 363 Prestwick-864 hsa05320 Autoimmune thyroid disease 3108_3119_3105_3106_3135_355_649853 7 - 0.0474811873312593 0.569774247975112 364 Prestwick-864 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3012_8368_8335_8359_8294_8367_554313_121504_3119_3108 18 - 0.00475093585995396 0.312975517877571 365 Prestwick-864 hsa03010 Ribosome 6234 1 - 0.0466395914997293 0.569774247975112 366 Prestwick-864 hsa05330 Allograft rejection 3108_3119_3105_3106_3135_355_649853 7 - 0.0113241600682666 0.317076481911465 367 Prestwick-864 hsa04940 Type I diabetes mellitus 3108_3119_3105_3106_2571_3135_355_649853 8 - 0.00745179804470407 0.312975517877571 368 roxithromycin hsa04740 Olfactory transduction 1179_5568_9635_442194 4 + 0.0372355284342816 0.92934310848794 369 roxithromycin hsa04080 Neuroactive ligand-receptor interaction 5029_5618_2908_152_2149 5 - 0.000604691712580176 0.0183423152815987 370 roxithromycin hsa04740 Olfactory transduction 801_808_805 3 - 1.03218025522512e-08 9.39284032254859e-07 371 roxithromycin hsa05322 Systemic lupus erythematosus 55506_8329_8343_8347_8346_8344_8339_3123_3126_3127_3125_8969_8968_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3014_9555 30 - 1.36706924469918e-06 6.22016506338127e-05 372 roxithromycin hsa04260 Cardiac muscle contraction 776 1 - 0.0443279098544826 0.806767959351583 373 roxithromycin hsa03010 Ribosome 9349 1 - 0.015003644920909 0.34133292195068 374 procyclidine hsa04310 Wnt signaling pathway 4088_5880_4772_23236 4 + 0.0366644628963505 0.702825612338271 375 procyclidine hsa04360 Axon guidance 5880_4772_1944_5365 4 + 0.0231598663398557 0.702825612338271 376 procyclidine hsa04080 Neuroactive ligand-receptor interaction 1909_7433 2 - 0.000791952602120473 0.0328660329879996 377 procyclidine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344 19 - 0.000205538914525041 0.0170597299055784 378 benzthiazide hsa05332 Graft-versus-host disease 5551_3126_3127_3123_3125 5 + 5.4646138468963e-05 0.000870963754040639 379 benzthiazide hsa04640 Hematopoietic cell lineage 3690_3123_3126_3570_3127_3125 6 + 0.000163869198613295 0.0012781797491837 380 benzthiazide hsa05320 Autoimmune thyroid disease 5551_3126_3127_3123_3125 5 + 0.000151263129896548 0.0012781797491837 381 benzthiazide hsa04612 Antigen processing and presentation 3123_3126_3127_3125 4 + 0.00910098408305991 0.0443672974049171 382 benzthiazide hsa04514 Cell adhesion molecules (CAMs) 23308_3123_3126_3127_3125 5 + 0.00760276256508722 0.0423582485769145 383 benzthiazide hsa05322 Systemic lupus erythematosus 3123_3126_3127_3125 4 + 0.0416483805792317 0.162428684259004 384 benzthiazide hsa05310 Asthma 3123_3126_3127_3125 4 + 0.000214370891768348 0.00139341079649426 385 benzthiazide hsa04512 ECM-receptor interaction 3690_961_1302 3 + 0.0413842575572347 0.162428684259004 386 benzthiazide hsa05330 Allograft rejection 5551_3126_3127_3123_3125 5 + 3.52564784652195e-05 0.000870963754040639 387 benzthiazide hsa04940 Type I diabetes mellitus 5551_3126_3127_3123_3125 5 + 6.69972118492799e-05 0.000870963754040639 388 benzthiazide hsa05332 Graft-versus-host disease 3135_3105_3106_649853_3123 5 - 0.0255426544464699 0.319283180580874 389 benzthiazide hsa04080 Neuroactive ligand-receptor interaction 1081 1 - 0.00173399389603568 0.065024771101338 390 benzthiazide hsa05320 Autoimmune thyroid disease 1081_3105_3106_3135_3123_649853 6 - 0.0183853279667698 0.319283180580874 391 benzthiazide hsa04612 Antigen processing and presentation 4800_3123_3106_3135_3105_811_3305_649853 8 - 0.0226536408002395 0.319283180580874 392 benzthiazide hsa04740 Olfactory transduction 409 1 - 1.74630222583385e-05 0.00130972666937539 393 benzthiazide hsa04630 Jak-STAT signaling pathway 9180 1 - 0.0466766731678079 0.437593810948199 394 benzthiazide hsa05330 Allograft rejection 3135_3105_3106_649853_3123 5 - 0.0179852033512085 0.319283180580874 395 benzthiazide hsa04940 Type I diabetes mellitus 3135_3105_3106_649853_3123 5 - 0.0299817768583351 0.321233323482162 396 cefsulodin hsa04640 Hematopoietic cell lineage 2814_3575_3123_3126_3127_3125_924 7 + 0.0327015519913155 0.469841241071084 397 cefsulodin hsa05010 Alzheimer's disease 5533 1 + 0.0321129216193618 0.469841241071084 398 cefsulodin hsa05320 Autoimmune thyroid disease 3123_3446_3126_3127_3125 5 + 0.039251024326608 0.469841241071084 399 cefsulodin hsa04740 Olfactory transduction 81696_8390_81797 3 + 0.00194163061733938 0.0698987022242177 400 cefsulodin hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8366_8368_9103_8360_8362_8294_3123_3126_3127_3125_8370_8359_554313_121504_83740_729 23 + 3.95879266086562e-09 2.85033071582325e-07 401 cefsulodin hsa05310 Asthma 3123_3126_3127_3125 4 + 0.0233739382505593 0.469841241071084 402 cefsulodin hsa05330 Allograft rejection 3123_3126_3127_3125 4 + 0.0461975897644554 0.469841241071084 403 cefsulodin hsa03440 Homologous recombination 5890_7156_10111_25788_8940 5 - 0.0223034999576025 0.370238099296202 404 cefsulodin hsa04080 Neuroactive ligand-receptor interaction 3953_5618_4158_1081 4 - 0.00562627462386441 0.233490396890373 405 cefsulodin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3014_720_721 36 - 4.41514593586954e-13 3.66457112677172e-11 406 cefsulodin hsa04210 Apoptosis 651610_581_5576_5575_5534_472_598_8737_8837_1677_8794 11 - 0.0165979770197365 0.370238099296202 407 cefsulodin hsa03022 Basal transcription factors 2969_10629_6875_51616_6872_728198 6 - 0.0186833600637029 0.370238099296202 408 spectinomycin hsa04740 Olfactory transduction 157 1 + 0.0159373867586351 0.796869337931755 409 spectinomycin hsa05211 Renal cell carcinoma 5228_6655_5295_998_5290_5291_5605_405_5781_1398_3725_7042_673_7422 14 - 0.0404332775857071 0.365320437629299 410 spectinomycin hsa04080 Neuroactive ligand-receptor interaction 5029_5618_4157_7068_64106_5025_136_7433_9170 9 - 0.000179535623834294 0.00798933526062608 411 spectinomycin hsa04740 Olfactory transduction 810_219464_5567_409 4 - 1.69882630500614e-12 1.51195541145546e-10 412 spectinomycin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235_9555 31 - 0.000609579281787574 0.018084185359698 413 spectinomycin hsa05221 Acute myeloid leukemia 6932_5970_6655_5295_5290_673_5605_6934_11040_5914_5291_6198 12 - 0.0410472401830673 0.365320437629299 414 spectinomycin hsa04530 Tight junction 5519_8531_60_998_50855 5 - 0.013165357415249 0.29292920248929 415 spectinomycin hsa05216 Thyroid cancer 6932_8030_7157_673_5605_7175_6934_6257 8 - 0.0205694189388416 0.305113047592817 416 spectinomycin hsa04060 Cytokine-cytokine receptor interaction 5618_3566_3459_5154_6358_3572_657_4982_7422_7042_91_3597_8792_6359_51330_659 16 - 0.0292348300361539 0.365320437629299 417 spectinomycin hsa03010 Ribosome 6187_9349_6234 3 - 0.017506894688377 0.305113047592817 418 spectinomycin hsa05210 Colorectal cancer 324_581_7157_6655_5295_7042_5290_673_6932_5601_6934_3725_91_8324_2956_5291 16 - 0.0373115360744024 0.365320437629299 419 theophylline hsa04514 Cell adhesion molecules (CAMs) 933_4099_923_25945_5817 5 + 0.0153342586073427 0.255570976789045 420 theophylline hsa05322 Systemic lupus erythematosus 9103_720_721_8343_8339_8347_8346_8344 8 + 0.000189093382995268 0.0094546691497634 421 theophylline hsa04530 Tight junction 5584_9223_5519_84612_208_93643 6 + 0.00386954023226521 0.0967385058066303 422 theophylline hsa04730 Long-term depression 5519_2775_1392 3 + 0.0425401049070785 0.425401049070785 423 theophylline hsa04610 Complement and coagulation cascades 721_720_2153 3 + 0.0397235417961322 0.425401049070785 424 theophylline hsa04310 Wnt signaling pathway 6477_6932_5881_79718_6934_5602_3725_6093_23236 9 - 0.0475461861512328 0.758837440995594 425 theophylline hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_8359_8294_8367_121504_8368_8351_6738 17 - 2.64967169217538e-06 0.000182827346760101 426 theophylline hsa05221 Acute myeloid leukemia 6932_6654_5371_6934_11040 5 - 0.0335058527460626 0.758837440995594 427 theophylline hsa05210 Colorectal cancer 6654_6932_5881_6934_5602_3725 6 - 0.0407788728609465 0.758837440995594 428 etidronic acid hsa05332 Graft-versus-host disease 3553_3107_5551_3811_3802 5 + 0.000818292253426197 0.0374977215445502 429 etidronic acid hsa04650 Natural killer cell mediated cytotoxicity 3811_3448_3107_3802_5880_5551 6 + 0.0261749746805303 0.28055473973181 430 etidronic acid hsa04080 Neuroactive ligand-receptor interaction 151_2911_1269_3360_3062_2688_2689_3269_1442 9 + 0.038294549416664 0.28055473973181 431 etidronic acid hsa05320 Autoimmune thyroid disease 959_958_3107_5551_3448 5 + 0.00212769668996456 0.0411354693393148 432 etidronic acid hsa04062 Chemokine signaling pathway 1237_3579_5880_998_6368_2829_6363 7 + 0.0386972054802496 0.28055473973181 433 etidronic acid hsa04060 Cytokine-cytokine receptor interaction 959_958_1237_3553_3448_6368_2688_2829_6363_3579_83729_2689 12 + 0.00129302488084656 0.0374977215445502 434 etidronic acid hsa05330 Allograft rejection 959_958_3107_5551 4 + 0.00416275701221173 0.0603599766770701 435 etidronic acid hsa04940 Type I diabetes mellitus 3553_3107_5551 3 + 0.0375198516827131 0.28055473973181 436 etidronic acid hsa04740 Olfactory transduction 109 1 - 8.72043599175699e-05 0.00654032699381774 437 etidronic acid hsa04210 Apoptosis 651610_581_208_5575_472_5534_8837_1677 8 - 0.012864661484593 0.482424805672237 438 etidronic acid hsa04530 Tight junction 9076_24146_5581_208_998_4619_2036_84612_55870_9223 10 - 0.0282789122441525 0.503647001628479 439 etidronic acid hsa04115 p53 signaling pathway 5366_581_7057_472_10912_651610 6 - 0.0335764667752319 0.503647001628479 440 etidronic acid hsa03020 RNA polymerase 246721_5439_548644_10622 4 - 0.0207512615611589 0.503647001628479 441 ciprofibrate hsa05131 Shigellosis 7278_6093_7430_113457 4 + 0.0284449811948861 0.457136840457445 442 ciprofibrate hsa05130 Pathogenic Escherichia coli infection 7278_6093_7430_113457 4 + 0.0284449811948861 0.457136840457445 443 ciprofibrate hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_718_8332_8359_8330_8331_8336_554313_121504_85235 22 + 7.76760259238036e-13 4.2721814258092e-11 444 ciprofibrate hsa05221 Acute myeloid leukemia 5914_862_5467_11040 4 + 0.0332463156696324 0.457136840457445 445 ciprofibrate hsa04080 Neuroactive ligand-receptor interaction 5618_152_1081_7068_64106_7067_2150 7 - 0.00981492303504582 0.366868244208175 446 ciprofibrate hsa04740 Olfactory transduction 801_109_805_808 4 - 3.30407194758729e-07 2.74237971649745e-05 447 ciprofibrate hsa05012 Parkinson's disease 7314_842_4712 3 - 0.0497570090706287 0.766437446654449 448 ciprofibrate hsa04060 Cytokine-cytokine receptor interaction 5618_3566_2057_2324_3572_4982_7422_8795 8 - 0.0212357646826966 0.440642117165954 449 ciprofibrate hsa05213 Endometrial cancer 2309_5594_999_5290_673_6934_324_2064_842 9 - 0.013260297983428 0.366868244208175 450 AR-A014418 hsa05322 Systemic lupus erythematosus 3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 11 + 1.29498820353344e-07 3.75546579024698e-06 451 AR-A014418 hsa04740 Olfactory transduction 818 1 - 0.0226573265175533 0.58324224893747 452 AR-A014418 hsa04140 Regulation of autophagy 8408_9706_23710 3 - 0.024488495607471 0.58324224893747 453 AR-A014418 hsa04010 MAPK signaling pathway 784_8517_4217_6654_2005_3306_3304_3727_3303_8569 10 - 0.0273394804189439 0.58324224893747 454 methanthelinium bromide hsa05016 Huntington's disease 4899_6390_5439_246721_7416_548644_23236 7 + 0.0177362585771087 0.325164740580326 455 methanthelinium bromide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8367_8370_8366_8368_8359_8294_554313_121504_8364 14 + 3.052764428942e-08 1.6790204359181e-06 456 methanthelinium bromide hsa03020 RNA polymerase 246721_5439_548644 3 + 0.00935317502841688 0.257212313281464 457 methanthelinium bromide hsa05211 Renal cell carcinoma 5605_7039_2271_4233_3725 5 - 0.025810415034544 0.453716798650127 458 methanthelinium bromide hsa04080 Neuroactive ligand-receptor interaction 1909 1 - 0.0471367785257881 0.453716798650127 459 methanthelinium bromide hsa05014 Amyotrophic lateral sclerosis (ALS) 836_834_5603_581 4 - 0.0410424189093408 0.453716798650127 460 methanthelinium bromide hsa04740 Olfactory transduction 157 1 - 0.0036347581295683 0.265337343458486 461 methanthelinium bromide hsa05210 Colorectal cancer 4233_3725_836_6934_581 5 - 0.0441445892186706 0.453716798650127 462 nicardipine hsa04740 Olfactory transduction 818_5137_1258_1179 4 + 0.000411370502502468 0.0312641581901876 463 nicardipine hsa04740 Olfactory transduction 157 1 - 0.000801931692988083 0.0553332868161777 464 nicardipine hsa04912 GnRH signaling pathway 8398_5599_50487_113_3725_6714_23236 7 - 0.0282412966091268 0.974324733014875 465 chloramphenicol hsa05332 Graft-versus-host disease 3135_3117_3553_3119 4 + 0.00801659228640122 0.256530953164839 466 chloramphenicol hsa04740 Olfactory transduction 816 1 + 0.0154966916135747 0.33059608775626 467 chloramphenicol hsa04720 Long-term potentiation 816_814_3710_2776 4 + 0.0477717735187001 0.436770500742401 468 chloramphenicol hsa03450 Non-homologous end-joining 3981_10111 2 + 0.0304459463276677 0.429380963681862 469 chloramphenicol hsa04912 GnRH signaling pathway 5338_2776_5609_3710_816 5 + 0.0461252704362909 0.436770500742401 470 chloramphenicol hsa05330 Allograft rejection 3135_3117_3119 3 + 0.0335453877876455 0.429380963681862 471 chloramphenicol hsa04940 Type I diabetes mellitus 3135_3117_2572_3119_3553 5 + 0.00150630313038677 0.0964034003447533 472 chloramphenicol hsa05322 Systemic lupus erythematosus 85235_8330_8969_3014_8332_88_8331_8329_8336 9 - 0.000547286486090064 0.0311953297071337 473 chloramphenicol hsa05219 Bladder cancer 1956_3845_4193 3 - 0.0310195261798149 0.453965120500418 474 chloramphenicol hsa04540 Gap junction 2697_1956_3845_107_7082 5 - 0.0169395655670362 0.453965120500418 475 CAY-10397 hsa05219 Bladder cancer 4318_1956 2 + 0.0402966914964459 0.745296183554575 476 CAY-10397 hsa04710 Circadian rhythm - mammal 9572_8863 2 - 0.0309631804174427 1 477 estriol hsa04740 Olfactory transduction 1179 1 + 2.54266473218401e-05 0.00104249254019544 478 estriol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3109_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 26 + 1.18720662171136e-10 9.73509429803315e-09 479 estriol hsa04210 Apoptosis 10000_581_596_5293_472_5532_651610 7 + 0.046487730236847 0.762398775884291 480 estriol hsa04630 Jak-STAT signaling pathway 53832_3449_2057_3953_3589_3568_894_5293_1270_200734_5781_9180_3976_10000 14 + 0.00200234946281018 0.0547308853168116 481 estriol hsa05210 Colorectal cancer 10000_581_5599_596_5293_5880_11211 7 + 0.0364007578003422 0.746215534907015 482 estriol hsa04080 Neuroactive ligand-receptor interaction 5031_9170 2 - 0.00161011558012229 0.0652096809949527 483 estriol hsa04740 Olfactory transduction 5613_5616 2 - 9.548595867783e-06 0.000773436265290423 484 estriol hsa05012 Parkinson's disease 517 1 - 0.0318777574805456 0.645524588981048 485 estriol hsa04020 Calcium signaling pathway 5613_5616 2 - 0.0263852081742524 0.645524588981048 486 lidoflazine hsa05010 Alzheimer's disease 3709_1339 2 + 0.000490822915260173 0.014070256904125 487 lidoflazine hsa04612 Antigen processing and presentation 6891 1 + 0.0206311562857426 0.354855888114773 488 lidoflazine hsa05016 Huntington's disease 9586_1339 2 + 0.000236503158681759 0.0101696358233156 489 lidoflazine hsa04740 Olfactory transduction 8387_219464_5616_8388 4 + 5.26617185135605e-08 4.5289077921662e-06 490 lidoflazine hsa05012 Parkinson's disease 1339_7318 2 + 0.00601899372106216 0.129408365002836 491 lidoflazine hsa04740 Olfactory transduction 109 1 - 0.00740105119142981 0.451464122677218 492 propantheline bromide hsa04740 Olfactory transduction 816 1 + 0.000575084618898805 0.0402559233229164 493 propantheline bromide hsa04080 Neuroactive ligand-receptor interaction 4889_5618_1081_7068_5025_5031_2150_9170 8 - 0.0278246154254869 0.468801924369701 494 propantheline bromide hsa05200 Pathways in cancer 4088_598_5295_9618_1613_5605_5335_5336_3673_3675_4149_6789_405_5900_324_1398_1017_7475_9134_613_999_4233_842_2271_5594_6655_5602_6772_7157_355_7423_5914_5970 33 - 0.0361233747266731 0.468801924369701 495 propantheline bromide hsa04210 Apoptosis 651610_3552_7157_598_11261_5295_8795_472_355_8837_5970_9020_842 13 - 0.0126082222736601 0.290864025037957 496 propantheline bromide hsa04370 VEGF signaling pathway 7867_9261_1432_5594_5829_11261_5295_5605_4775_5335_5336_842 12 - 0.0125592895111086 0.290864025037957 497 propantheline bromide hsa05110 Vibrio cholerae infection 60_11015_5336_10945_115_528_5335_523_375 9 - 0.0377196950642288 0.468801924369701 498 propantheline bromide hsa05223 Non-small cell lung cancer 2309_842_6789_6655_5295_5605_7157_5335_5336_5594 10 - 0.00625113901770294 0.290864025037957 499 propantheline bromide hsa05213 Endometrial cancer 2309_5594_7157_6655_5295_999_5605_324_842 9 - 0.0133730586224348 0.290864025037957 500 cycloserine hsa04510 Focal adhesion 1278_10319_5578_3690_3371_4633_1284_23396_4638_3674_3082 11 + 0.0236906219022247 0.78720068015391 501 cycloserine hsa04512 ECM-receptor interaction 1278_10319_1284_3690_3371_3674 6 + 0.0244571581878988 0.78720068015391 502 cycloserine hsa04730 Long-term depression 2911_10842_5578_5320_23236 5 + 0.0405128053141744 0.78720068015391 503 cycloserine hsa04640 Hematopoietic cell lineage 3554 1 - 0.0311015103947807 0.32267817034585 504 cycloserine hsa05010 Alzheimer's disease 355_5534_6868_2776_509 5 - 0.0254530131056178 0.32267817034585 505 cycloserine hsa04080 Neuroactive ligand-receptor interaction 5618_4157_7068 3 - 1.78216762335012e-05 0.0014791991273806 506 cycloserine hsa04514 Cell adhesion molecules (CAMs) 999_9019 2 - 0.00599524452989631 0.124401323995348 507 cycloserine hsa04530 Tight junction 5519_5583_998 3 - 0.0183526251927378 0.304653578199447 508 cycloserine hsa04260 Cardiac muscle contraction 7171 1 - 0.0297403331343677 0.32267817034585 509 cycloserine hsa04060 Cytokine-cytokine receptor interaction 5618_3554_3601_657_355_659 6 - 0.000880103762762788 0.0365243061546557 510 cycloserine hsa04020 Calcium signaling pathway 56848_490_2776_5534 4 - 0.00535013697719679 0.124401323995348 511 nadide hsa04740 Olfactory transduction 26539_4993_816 3 + 0.00739817378736089 0.389243271878784 512 nadide hsa04920 Adipocytokine signaling pathway 5599_8471_1375_5781_9021_4793 6 + 0.016218469661616 0.389243271878784 513 nadide hsa04512 ECM-receptor interaction 22798_2812_1605_3908_3679_3691 6 + 0.0402215696075937 0.449526141088794 514 nadide hsa04630 Jak-STAT signaling pathway 6778_3594_3589_200734_50616_5781_8554_8651_81848_9021 10 + 0.0264519112198803 0.421104487617429 515 nadide hsa04930 Type II diabetes mellitus 8651_8471_5599_9021 4 + 0.0476383562059503 0.449526141088794 516 nadide hsa05330 Allograft rejection 3117_958_3107_3111 4 + 0.0292433671956548 0.421104487617429 517 nadide hsa05222 Small cell lung cancer 22798_596_6502_3908_330_331_8554 7 + 0.0153029188846087 0.389243271878784 518 nadide hsa04070 Phosphatidylinositol signaling system 3628_8394_3633_5290_23396_3705 6 - 0.0259884939067378 0.222346003424312 519 nadide hsa05211 Renal cell carcinoma 2271_208_6655_5155_5290_201163_7423_7042 8 - 0.0016221191857608 0.0624515886517908 520 nadide hsa04740 Olfactory transduction 5613_5566_5616 3 - 0.0105543185168637 0.162536505159701 521 nadide hsa05212 Pancreatic cancer 208_6655_5155_5290_6934_2263 6 - 0.0481307060725716 0.296277578927069 522 nadide hsa05215 Prostate cancer 208_6655_5155_5290_6934_2263 6 - 0.0461137249635828 0.296277578927069 523 nadide hsa04210 Apoptosis 5613_5566_5534_5616_5290_208_8837_7186 8 - 0.00540513550496691 0.138731811294151 524 nadide hsa05221 Acute myeloid leukemia 861_208_6655_6934_5290 5 - 0.0318711429255057 0.245407800526394 525 nadide hsa04664 Fc epsilon RI signaling pathway 208_6655_5290_8681_5606_9846_100137049 7 - 0.00970241119274542 0.162536505159701 526 nadide hsa04150 mTOR signaling pathway 208_9470_7423_6196_5290 5 - 0.0204299555840231 0.222346003424312 527 nadide hsa04010 MAPK signaling pathway 5155_1326_100137049_5613_6655_5534_5616_4763_5598_208_6196_23162_5606_7042_8681_2263_3164_9344_5566_7186 20 - 0.000185354388463096 0.0142722879116584 528 nadide hsa04912 GnRH signaling pathway 5598_6655_5616_5606_8681_5613_100137049_5566 8 - 0.0151916100215395 0.194958995276424 529 nadide hsa05220 Chronic myeloid leukemia 861_208_6655_5290_9846_7042 6 - 0.0246381796729976 0.222346003424312 530 phenoxybenzamine hsa04120 Ubiquitin mediated proteolysis 23759_4193_8452 3 + 0.0354182930099873 0.425019516119848 531 phenoxybenzamine hsa05010 Alzheimer's disease 355_2081_4695_9451 4 + 0.0192444220665103 0.404132863396716 532 phenoxybenzamine hsa05016 Huntington's disease 1639_1211_4695_10126_27113 5 + 0.0342836937482114 0.425019516119848 533 phenoxybenzamine hsa04740 Olfactory transduction 2979_2774_8392 3 + 4.92830971680446e-08 4.13978016211575e-06 534 phenoxybenzamine hsa04360 Axon guidance 1949_27289_1969 3 + 0.048312320081743 0.434160243168852 535 phenoxybenzamine hsa05219 Bladder cancer 1026_11186_1029_3576_1612_4193_5228_1950_7422 9 + 0.00409445913708062 0.171967283757386 536 phenoxybenzamine hsa04115 p53 signaling pathway 1647_27113_5366_1029_4193_63970_355_1026_10912_8795 10 + 0.0314923507617527 0.425019516119848 537 phenoxybenzamine hsa04062 Chemokine signaling pathway 3576_5293_113_10850 4 + 0.0106623570694838 0.298545997945546 538 phenoxybenzamine hsa05012 Parkinson's disease 2861_4695_5413 3 + 0.0498605457196859 0.434160243168852 539 phenoxybenzamine hsa04070 Phosphatidylinositol signaling system 8867_8503_8760_5578_8394_5305_5295_3633_5287_3631_5331_5332_51763_5728_8821_1606_3707_23236 18 - 0.0346906462791953 0.301808622628999 540 phenoxybenzamine hsa05010 Alzheimer's disease 4714_5331_5594_841_2776_5530_5533_5532_5332_489_5664_102_23236 13 - 0.0308643705476505 0.298355581960622 541 phenoxybenzamine hsa04080 Neuroactive ligand-receptor interaction 5029_5028_1269_1812_4889_3953_1131_7068_5618_4886_5031_3354_56288_2692_2690 15 - 0.000753078969537306 0.0193170631228228 542 phenoxybenzamine hsa04742 Taste transduction 2778 1 - 0.0182980352475077 0.198991133316646 543 phenoxybenzamine hsa05016 Huntington's disease 4714_841_7052_2776_5331_5978_7416_55567_5332_1385_6874_23236 12 - 0.0102451135047949 0.127332124988165 544 phenoxybenzamine hsa04740 Olfactory transduction 818_26212_409 3 - 1.32393231816885e-17 1.1518211168069e-15 545 phenoxybenzamine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 34 - 0.00444992789381945 0.0774287453524584 546 phenoxybenzamine hsa04110 Cell cycle 890_51343_983_701_11200_699_51433_1017_1031_7531_7533_995_996_9134_8379_8556_7043_9700_8243_5347_4173_6502_5933_7027_7465 25 - 0.04905344261653 0.329094213502821 547 phenoxybenzamine hsa05012 Parkinson's disease 4714_2861_7326_7327_7416 5 - 0.000888140833233231 0.0193170631228228 548 phenoxybenzamine hsa04260 Cardiac muscle contraction 27092 1 - 0.000527498473164905 0.0193170631228228 549 phenoxybenzamine hsa04060 Cytokine-cytokine receptor interaction 5618_3554_9180_2057_3455_3953_5155_8742_8741_4254_7852_657_6387_4982_7046_7043_7424_2690_659 19 - 0.00641232873183902 0.0929787666116658 550 phenoxybenzamine hsa03010 Ribosome 140801_6125_6168_439992_6129_6189 6 - 0.0491749974199618 0.329094213502821 551 phenoxybenzamine hsa04610 Complement and coagulation cascades 5265_5328_5329 3 - 0.0425994665649959 0.329094213502821 552 ronidazole hsa04740 Olfactory transduction 810_81285 2 + 0.000185912623237151 0.0152448351054464 553 ronidazole hsa04514 Cell adhesion molecules (CAMs) 9076_9074_3688_8174_4099_3107_3111_933_923_26047 10 + 0.0351484046960778 0.718546165200679 554 ronidazole hsa04510 Focal adhesion 23533_3688_2335_2318_596_331_5155_1277_5649_1284_5880_5923_6714_1291_3082 15 + 0.0139602875304425 0.572371788748143 555 ronidazole hsa04360 Axon guidance 2045_80031_5365_22854_5880_1944_219699_3688_27289_10507 10 + 0.0323036271913155 0.718546165200679 556 ronidazole hsa05222 Small cell lung cancer 23533_3688_2335_1284_596_331_5915 7 + 0.043813790561017 0.718546165200679 557 ronidazole hsa05211 Renal cell carcinoma 5228_5295_998_5290_5605_5781_3725_7422 8 - 0.0200056542828499 0.200056542828499 558 ronidazole hsa04080 Neuroactive ligand-receptor interaction 64106_1909 2 - 0.00159064046941066 0.0636256187764264 559 ronidazole hsa05131 Shigellosis 7278_999_113457_998_7100_7534_9475 7 - 0.0169952069960828 0.194230937098089 560 ronidazole hsa05130 Pathogenic Escherichia coli infection 7278_999_113457_998_7100_7534_9475 7 - 0.0169952069960828 0.194230937098089 561 ronidazole hsa04740 Olfactory transduction 109 1 - 1.11251726077966e-06 8.90013808623728e-05 562 ronidazole hsa05219 Bladder cancer 5228_11186_999_7057_4193_5605_7422 7 - 0.00437778596810208 0.116740959149389 563 ronidazole hsa03022 Basal transcription factors 2967_10629_6884_6875_51616_728198 6 - 0.00915585645497098 0.146493703279536 564 ronidazole hsa04060 Cytokine-cytokine receptor interaction 91_7422_2057 3 - 0.00770518185602598 0.146493703279536 565 lorglumide hsa05332 Graft-versus-host disease 57292_3123_3107_3126_3127_941_3125 7 + 0.00503103667532718 0.134160978008725 566 lorglumide hsa04650 Natural killer cell mediated cytotoxicity 57292_3451_3449_962_2207_4068_3806_8743_3107_7410_80328_4772_2534 13 + 0.0237388279763101 0.211011804233868 567 lorglumide hsa04120 Ubiquitin mediated proteolysis 22888 1 + 0.0331521195028717 0.265216956022974 568 lorglumide hsa04640 Hematopoietic cell lineage 1436_2814_3815_3123_2812_3126_3127_3125_7066_933 10 + 0.00953268884639346 0.177150254143148 569 lorglumide hsa05320 Autoimmune thyroid disease 3451_3449_3123_3107_3126_3127_3125_941 8 + 0.00475244778613895 0.134160978008725 570 lorglumide hsa04612 Antigen processing and presentation 57292_3451_3449_3123_3806_3126_3127_3125_3107 9 + 0.0393083452766486 0.285878874739263 571 lorglumide hsa04740 Olfactory transduction 26539 1 + 7.4969624475374e-07 5.99756995802992e-05 572 lorglumide hsa04514 Cell adhesion molecules (CAMs) 3123_4099_3107_3126_3127_3125_6693_10666_57863_941_933_5817_1462 13 + 0.0132862690607361 0.177150254143148 573 lorglumide hsa05310 Asthma 3123_3125_3126_3127_2207 5 + 0.0170053001095268 0.194346286966021 574 lorglumide hsa05330 Allograft rejection 3123_3107_3126_3127_941_3125 6 + 0.0115135940195913 0.177150254143148 575 lorglumide hsa04940 Type I diabetes mellitus 3123_3107_3126_3127_941_3125 6 + 0.0208458731368503 0.208458731368503 576 lorglumide hsa04130 SNARE interactions in vesicular transport 8773_6804_9570_8675_8417_6844 6 - 0.0402220058169029 0.874828626517638 577 lorglumide hsa04080 Neuroactive ligand-receptor interaction 5028_1081_3953_1131_2908_2925_2149 7 - 0.0227633230104164 0.660136367302076 578 lorglumide hsa04740 Olfactory transduction 818_5613_5616_157 4 - 1.43320970144091e-06 0.000124689244025359 579 lorglumide hsa04912 GnRH signaling pathway 2778_5331_1432_1081_5613_1839_5616_5602_818_3709_5603_3725_10746_8398_23236 15 - 0.00557158971618542 0.242364152654066 580 enoxacin hsa04640 Hematopoietic cell lineage 3590_916_3552_1435 4 + 0.0166897990510792 0.458969473904678 581 enoxacin hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_3725_3579 3 + 0.0455532533225359 0.501085786547895 582 enoxacin hsa04920 Adipocytokine signaling pathway 5599_6794_8471_4793 4 + 0.00714266711133993 0.392846691123696 583 enoxacin hsa04912 GnRH signaling pathway 5599_3725_5568_5320 4 + 0.0327181107841322 0.501085786547895 584 enoxacin hsa04270 Vascular smooth muscle contraction 800_5568_5320_1909 4 + 0.0426898940329679 0.501085786547895 585 enoxacin hsa04740 Olfactory transduction 26212_157_4991 3 - 8.4087506598431e-05 0.00630656299488232 586 enoxacin hsa04514 Cell adhesion molecules (CAMs) 24146 1 - 0.0471003354120219 0.67997374607064 587 enoxacin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 0.00768285325429644 0.288106997036116 588 enoxacin hsa05212 Pancreatic cancer 2308_842_3551_5296_5155_4193_1956_3845_6934 9 - 0.0216276791697469 0.405518984432754 589 enoxacin hsa05215 Prostate cancer 2308_842_3551_5296_5155_4193_1956_3845_6934 9 - 0.0203670840037158 0.405518984432754 590 bephenium hydroxynaphthoate hsa05332 Graft-versus-host disease 3824_3123_3107_3126_3127_3125 6 + 0.0232285657325744 0.445450744366222 591 bephenium hydroxynaphthoate hsa04664 Fc epsilon RI signaling pathway 23533_2207_5599_3937_5605_7410_8681_5600_100137049 9 + 0.0210966316989417 0.445450744366222 592 bephenium hydroxynaphthoate hsa05310 Asthma 3123_3125_3126_3127_2207 5 + 0.0220477637556522 0.445450744366222 593 bephenium hydroxynaphthoate hsa05012 Parkinson's disease 7345 1 + 0.0222605715450198 0.445450744366222 594 bephenium hydroxynaphthoate hsa05330 Allograft rejection 3123_3107_3126_3127_3125 5 + 0.0483985801917107 0.645314402556143 595 bephenium hydroxynaphthoate hsa04940 Type I diabetes mellitus 3126_3107_2572_3127_3125_3123 6 + 0.0278406715228889 0.445450744366222 596 bephenium hydroxynaphthoate hsa03440 Homologous recombination 5890_7516_5893_8940_6742 5 - 0.0408204333882527 0.489845200659032 597 bephenium hydroxynaphthoate hsa04080 Neuroactive ligand-receptor interaction 7067_7433 2 - 3.94778412568049e-05 0.00165806933278581 598 bephenium hydroxynaphthoate hsa04740 Olfactory transduction 5613_26212_5616 3 - 2.24148422669653e-07 1.88284675042509e-05 599 bephenium hydroxynaphthoate hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_8368_8359_8294_8367_8351_8970_121504_9555 18 - 0.00977128801657871 0.164157638678522 600 bephenium hydroxynaphthoate hsa04210 Apoptosis 3556_3553_472_596_5296_5613_5616_5533_5534_8737_8837_651610 12 - 0.0166212387678688 0.232697342750163 601 bephenium hydroxynaphthoate hsa05012 Parkinson's disease 7416 1 - 0.00494850196349657 0.138558054977904 602 bephenium hydroxynaphthoate hsa04060 Cytokine-cytokine receptor interaction 3556_3553_3594_5155_3572_7422 6 - 0.00773587139995242 0.162453299399001 603 clioquinol hsa05131 Shigellosis 7278_113457_7430_10382_9181_6093 6 + 0.0234814172329369 0.324043557814529 604 clioquinol hsa05130 Pathogenic Escherichia coli infection 7278_113457_7430_10382_9181_6093 6 + 0.0234814172329369 0.324043557814529 605 clioquinol hsa04740 Olfactory transduction 8383 1 + 1.77773088306882e-05 0.00122663430931749 606 clioquinol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_8294_720_721_121504_8367 16 + 0.000204027518807024 0.00703894939884233 607 clioquinol hsa04540 Gap junction 7082_1813_7278_6654_5155_113457_1956_10382_23236 9 + 0.0110274423154187 0.25363117325463 608 clioquinol hsa04640 Hematopoietic cell lineage 2057 1 - 0.0438935406364502 0.433794739908313 609 clioquinol hsa05010 Alzheimer's disease 5331_4137_23236 3 - 0.00733532323205827 0.217614589217729 610 clioquinol hsa04080 Neuroactive ligand-receptor interaction 4889_4157_1813_5021_2925_3354 6 - 0.00419205217009937 0.186546321569422 611 clioquinol hsa05016 Huntington's disease 5331_1385_246721_161_23236 5 - 0.0340706743399889 0.410109088846717 612 clioquinol hsa04740 Olfactory transduction 5613_26212_5616 3 - 4.84334736903734e-08 4.31057915844323e-06 613 clioquinol hsa04514 Cell adhesion molecules (CAMs) 3135_3113_25945 3 - 0.04874098201217 0.433794739908313 614 clioquinol hsa05322 Systemic lupus erythematosus 6738_3113_9555 3 - 0.0368637383233004 0.410109088846717 615 clioquinol hsa04540 Gap junction 2778_5331_5155_1813_5613_6655_5616_113457_115_5607_3845_7278_23236 13 - 0.023160961130259 0.347682339630175 616 clioquinol hsa04060 Cytokine-cytokine receptor interaction 7046_2057_3594_23529_5155_7852_6387_655 8 - 0.021162072473533 0.347682339630175 617 clioquinol hsa04912 GnRH signaling pathway 2778_4214_1432_2002_5613_6655_1839_5616_115_3845_5600_3725_5331_23236 14 - 0.0234392588514725 0.347682339630175 618 brinzolamide hsa04740 Olfactory transduction 7932_1179_4991 3 + 0.000978771100104198 0.0376826873540116 619 brinzolamide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3117_8368_3014_8359_8294_8367_554313_121504 16 + 0.000121639494254064 0.00936624105756293 620 brinzolamide hsa04210 Apoptosis 3556_3554_3553_581_5575_330_9941_5534 8 + 0.0183183117150455 0.470170000686168 621 brinzolamide hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_8336 7 - 0.00567022073231764 0.21546838782807 622 verteporfin hsa05322 Systemic lupus erythematosus 3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 11 + 3.21761503477008e-05 0.00151227906634194 623 verteporfin hsa04940 Type I diabetes mellitus 3558_3382_2571 3 + 0.0375198516827131 0.881716514543758 624 verteporfin hsa04120 Ubiquitin mediated proteolysis 8651_23221_8945 3 - 0.000388203973659206 0.00695222313717934 625 verteporfin hsa04080 Neuroactive ligand-receptor interaction 146_4889_5618_7442_1131_4886_5031_2150_1909_2690 10 - 0.000130950928018493 0.0037102762938573 626 verteporfin hsa05016 Huntington's disease 5331_246721_27113_5439_6667_3092_548644 7 - 0.000773871703785742 0.00939701354596972 627 verteporfin hsa04740 Olfactory transduction 818_801_109_805_808 5 - 5.31066211574131e-13 4.51406279838011e-11 628 verteporfin hsa04514 Cell adhesion molecules (CAMs) 9076_2734_214_4897_6382_3655_9019_24146_3123_3106_3107_50848_3897_999_3135_3688_23705_4685_3685_1364_5792_3105_4950_1001_5817 25 - 0.0338983196112382 0.192090477797016 629 verteporfin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8348_8329_8294_8343_8347_8346_8344_3123_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235_3014 29 - 0.00763665374144828 0.0649115568023104 630 verteporfin hsa04360 Axon guidance 23654_6387_10512_2050_1948_1969_1946_1945_10507_8829_3897_54910_5361_55558_10725_219699_4775_6091_10500_6092_4233_7869_3688_2042_2043_5364_2041_6405_5881_2049_3985 31 - 0.000595238653791543 0.00843254759538019 631 verteporfin hsa04110 Cell cycle 7040_7042 2 - 0.00040895430218702 0.00695222313717934 632 verteporfin hsa04530 Tight junction 9076_24146_9223_1364_2017_50848_4950 7 - 0.0268645625276971 0.175652908834943 633 verteporfin hsa04350 TGF-beta signaling pathway 659_4091_7059_4052_9372_3625_7057_6667_657_1874_652_7040_7042_91_90_92_7048_653 18 - 0.0335371407958481 0.192090477797016 634 verteporfin hsa04512 ECM-receptor interaction 3913_3915_7059_960_3912_3911_961_3691_3688_1605_3909_3914_7057_375790_3685_6382_3673_3655_3339_1289_2335 21 - 0.00299488362918743 0.0282850120534368 635 verteporfin hsa05012 Parkinson's disease 2861 1 - 1.18257267394408e-05 0.000502593386426234 636 verteporfin hsa03010 Ribosome 6125_284393_389342 3 - 0.00871952996996435 0.0673781861315427 637 verteporfin hsa05210 Colorectal cancer 6934_5295_5881_7855_8324_7976_8321_8323_8322_324_3480_6932_1956_7040_8312_7042_91_3725_4233_7048_5602_2535 22 - 0.00111612138923341 0.011858789760605 638 verteporfin hsa05217 Basal cell carcinoma 6934_324_2535_5727_6932_652_7477_8312_7855_8324_7976_8321_8323_8322 14 - 0.0144378040121833 0.102267778419632 639 trifluridine hsa05332 Graft-versus-host disease 3119_3123_3458_3126_3127_3125_355 7 + 0.0002508524302697 0.00371261596799156 640 trifluridine hsa05320 Autoimmune thyroid disease 3119_3123_3126_3127_3125_355 6 + 0.0041534896993991 0.0384197797194417 641 trifluridine hsa04740 Olfactory transduction 5137 1 + 0.000835389899918386 0.0103031420989934 642 trifluridine hsa04514 Cell adhesion molecules (CAMs) 3383_3119_3123_3126_3127_3125_23308_26047 8 + 0.0318801579422382 0.196594307310469 643 trifluridine hsa05322 Systemic lupus erythematosus 3119_3123_3458_3126_3127_3125_8348_8337_8343_8339_8347_8346_8344 13 + 0.00022438095236069 0.00371261596799156 644 trifluridine hsa04360 Axon guidance 9353_1949_2048_5880_7869_3985_10505_27289_64218 9 + 0.0107894445887405 0.0887132110629774 645 trifluridine hsa04110 Cell cycle 995_1647_1026_9134_4088_4193_472_8556 8 + 0.0176837808982392 0.125675374350825 646 trifluridine hsa04210 Apoptosis 10000_598_317_472_355_8794 6 + 0.0371900347676985 0.211697120985361 647 trifluridine hsa04115 p53 signaling pathway 1647_1026_5366_9134_317_4193_5268_472_355_9540 10 + 3.54399667874778e-05 0.0019445257201425 648 trifluridine hsa05310 Asthma 3123_3126_3127_3119_3125 5 + 0.00196303589292388 0.0207520937251953 649 trifluridine hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0495514670803739 0.261914897424833 650 trifluridine hsa05330 Allograft rejection 3119_3123_3458_3126_3127_3125_355 7 + 0.000144797504496153 0.00357167177757177 651 trifluridine hsa04940 Type I diabetes mellitus 3119_3123_3458_3126_3127_2571_355_3125 8 + 5.25547491930406e-05 0.0019445257201425 652 trifluridine hsa05220 Chronic myeloid leukemia 1026_10000_4088_598_4193_861 6 + 0.0186814745656632 0.125675374350825 653 trifluridine hsa04080 Neuroactive ligand-receptor interaction 5029 1 - 0.000791935447598857 0.0269258052183611 654 trifluridine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8343_8347_8346_8344_8339_3123_3126_3127_3125_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3014 42 - 2.03611689795759e-21 1.38455949061116e-19 655 trifluridine hsa04110 Cell cycle 995_890_5347_991_891_699_701_9184_996_1869_1031_7465 12 - 0.0042084474404754 0.0953914753174424 656 trifluridine hsa05310 Asthma 3123_3126_3127_3125 4 - 0.0390566424955683 0.379407384242663 657 trifluridine hsa04630 Jak-STAT signaling pathway 9655 1 - 0.0322573084680917 0.365582829305039 658 trifluridine hsa04062 Chemokine signaling pathway 7409 1 - 0.00740860606552904 0.125946303113994 659 trifluridine hsa04020 Calcium signaling pathway 2064 1 - 0.0107189449162534 0.145777650861046 660 tetracycline hsa04210 Apoptosis 3556_208_5616_5290_472_5613_651610 7 + 0.0039597863307453 0.13463273524534 661 tetracycline hsa04062 Chemokine signaling pathway 1234_157_5829_5613_3576_5616_6358_2931_5290_208_6359 11 + 0.00375903066830018 0.13463273524534 662 tetracycline hsa05211 Renal cell carcinoma 3725_405_5293_7422 4 - 0.00413101891530836 0.168522978964054 663 tetracycline hsa04662 B cell receptor signaling pathway 3725_5293_4793 3 - 0.0296556290092785 0.396066707686347 664 tetracycline hsa05200 Pathways in cancer 4088_5293_405_7422_6934_3725_2247_4842 8 - 0.00886963047179233 0.168522978964054 665 tetracycline hsa04520 Adherens junction 4088_8976_6934 3 - 0.0347426936566971 0.396066707686347 666 tetracycline hsa04350 TGF-beta signaling pathway 4088_655_6667 3 - 0.0425732867802632 0.4044462244125 667 tetracycline hsa05210 Colorectal cancer 4088_3725_5293_6934 4 - 0.00694520188597614 0.168522978964054 668 dihydroergotamine hsa05332 Graft-versus-host disease 3119_3123_3126_3127_3125_5551 6 + 0.0098680602776065 0.13682362952657 669 dihydroergotamine hsa05320 Autoimmune thyroid disease 1081_3119_3123_3126_3127_3125_5551 7 + 0.00797332347862502 0.13682362952657 670 dihydroergotamine hsa04740 Olfactory transduction 5137_51806_23538_4991 4 + 0.0011280508650593 0.060611438515404 671 dihydroergotamine hsa04514 Cell adhesion molecules (CAMs) 3383_3119_3123_3126_3127_3696_3125_23308_57863_947_26285_5817 12 + 0.0138345889209777 0.156133217822463 672 dihydroergotamine hsa05310 Asthma 3123_3126_3127_3119_3125 5 + 0.0103916680653091 0.13682362952657 673 dihydroergotamine hsa04912 GnRH signaling pathway 4214_1432_5579_1081_51806_5598_6655_1956_4323 9 + 0.0464989055048697 0.459176691860588 674 dihydroergotamine hsa05330 Allograft rejection 3593_3119_3123_3126_3127_3125_5551 7 + 0.00153446679785833 0.060611438515404 675 dihydroergotamine hsa04940 Type I diabetes mellitus 3593_3119_3123_3126_3127_3125_5551 7 + 0.00321178676313015 0.084577051429094 676 dihydroergotamine hsa04740 Olfactory transduction 219464 1 - 0.00512843229948771 0.369247125563115 677 dihydroergotamine hsa04710 Circadian rhythm - mammal 9572_1408 2 - 0.0361333110108867 1 678 acenocoumarol hsa05010 Alzheimer's disease 5330_4698 2 + 0.0497880748635736 1 679 acenocoumarol hsa04740 Olfactory transduction 26476_8390_81797_23538 4 + 0.00113192641778871 0.0510353164757604 680 acenocoumarol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_88_8294_8367_554313_121504 15 + 0.00124476381648196 0.0510353164757604 681 acenocoumarol hsa04210 Apoptosis 472_5576_8837_651610_5534 5 - 0.0420674025199269 0.869392985411823 682 acenocoumarol hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0264751420612323 0.869392985411823 683 acenocoumarol hsa05210 Colorectal cancer 91_3725_8321_8312_6934 5 - 0.0344509413194465 0.869392985411823 684 triamcinolone hsa05211 Renal cell carcinoma 2271_405_3082_10000_7039 5 + 0.0424838366483386 0.585429380822016 685 triamcinolone hsa05200 Pathways in cancer 51176_836_10319_861_10000_3576_5371_405_51384_5900_2271_5467_7039_2260_2950_3674_3082 17 + 0.00763832703530031 0.290256427341412 686 triamcinolone hsa04740 Olfactory transduction 26529 1 + 0.0011974113001081 0.0910032588082156 687 triamcinolone hsa04510 Focal adhesion 10000_10319_7148_3690_2909_1277_29780_824_55742_3674_3082 11 + 0.0236906219022247 0.450121816142269 688 triamcinolone hsa05221 Acute myeloid leukemia 861_5371_10000_5467_51176 5 + 0.0211857463228968 0.450121816142269 689 triamcinolone hsa04060 Cytokine-cytokine receptor interaction 655 1 - 0.0325585142740777 1 690 dihydrostreptomycin hsa04912 GnRH signaling pathway 5598_8681_1839_100137049_816 5 + 0.0173894290933509 0.817303167387492 691 dihydrostreptomycin hsa04540 Gap junction 7280_3710_347733_7278_2767_113457 6 - 0.0366996275458333 1 692 pindolol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 1.08305301233164e-06 6.71492867645617e-05 693 pindolol hsa04710 Circadian rhythm - mammal 4862_8863 2 + 0.0297918576794478 0.615698392041921 694 pindolol hsa04010 MAPK signaling pathway 786_9344_782_8823_5566_4763_5156_356_4208_8913_7042_2260_2261 13 + 0.00224088913603774 0.0694675632171699 695 pindolol hsa04740 Olfactory transduction 5566 1 - 0.0228488206154537 1 696 cefotaxime hsa05332 Graft-versus-host disease 3109_3119_3123_3107_3126_3127_940_3125_5551 9 + 0.00029410855576389 0.00471998771313776 697 cefotaxime hsa05320 Autoimmune thyroid disease 3109_3119_3123_3107_3126_3127_940_3125_5551_7038 10 + 0.00033714197950984 0.00471998771313776 698 cefotaxime hsa04612 Antigen processing and presentation 4261_3109_3119_3123_3107_3126_3127_3125_6891_811 10 + 0.0103476726988679 0.0965782785227671 699 cefotaxime hsa05014 Amyotrophic lateral sclerosis (ALS) 836_4741_5630_5533_10452_5600_4842 7 + 0.0184961457757052 0.144255344439536 700 cefotaxime hsa04740 Olfactory transduction 5568 1 + 1.18028827655497e-06 4.95721076153087e-05 701 cefotaxime hsa04514 Cell adhesion molecules (CAMs) 3109_3119_3683_3123_29851_3107_3126_3127_940_3125_5797_6383_6693_26285 14 + 0.00619852609898901 0.0650845240393846 702 cefotaxime hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8347_8346_8344_3109_3123_3126_3127_3125_8370_8359_554313_121504_8339_3119_940 26 + 1.67959398126713e-08 1.41085894426439e-06 703 cefotaxime hsa05310 Asthma 3596_3119_3123_3126_3127_3125_3109 7 + 0.000899544251093808 0.0107945310131257 704 cefotaxime hsa05012 Parkinson's disease 836 1 + 0.0318777574805456 0.223144302363819 705 cefotaxime hsa04912 GnRH signaling pathway 5319_5568_6655_1839_3709_3708_3972_5600_112_4323_23236 11 + 0.0188905808194631 0.144255344439536 706 cefotaxime hsa05330 Allograft rejection 3109_3119_3123_3107_3126_3127_940_3125_5551 9 + 0.000153571075883438 0.0032249925935522 707 cefotaxime hsa04940 Type I diabetes mellitus 3109_3119_2572_3107_3126_3127_940_3125_5551_3123 10 + 8.94041831450747e-05 0.00250331712806209 708 cefotaxime hsa04740 Olfactory transduction 109 1 - 0.0318206650307395 1 709 thioproperazine hsa04210 Apoptosis 842_5296_5613_331_5616_208_8837 7 + 0.00967266562070605 0.254713528011926 710 thioproperazine hsa04664 Fc epsilon RI signaling pathway 5609_5581_5296_208_50487_8681_100137049_2534 8 + 0.00137130324944217 0.108332956705931 711 thioproperazine hsa04370 VEGF signaling pathway 842_5296_208_50487_8681_100137049 6 + 0.0168006878480494 0.331813584998976 712 thioproperazine hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0439410874161466 0.459415411627845 713 thioproperazine hsa04912 GnRH signaling pathway 2778_100137049_5613_50487_5616_8681_5609_816 8 + 0.00808925642101914 0.254713528011926 714 thioproperazine hsa04270 Vascular smooth muscle contraction 2778_5581_5613_50487_5616_8681_100137049 7 + 0.0356424595328557 0.459415411627845 715 thioproperazine hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 - 0.0101973353280545 0.144166916718291 716 thioproperazine hsa04640 Hematopoietic cell lineage 3123_3675_3126_3127_3125 5 - 0.0280129832711864 0.213598997442796 717 thioproperazine hsa05320 Autoimmune thyroid disease 3123_3126_3127_3125 4 - 0.0211067960121662 0.213598997442796 718 thioproperazine hsa05322 Systemic lupus erythematosus 85235_3123_3126_3127_3125_8332_8969_8331_8336_8329_8330 11 - 0.000141928926192817 0.00865766449776184 719 thioproperazine hsa04115 p53 signaling pathway 55367_51512_10912_8795 4 - 0.0464113521161884 0.314565831009721 720 thioproperazine hsa05310 Asthma 3123_3126_3127_3125 4 - 0.00344211597480815 0.104984537231649 721 thioproperazine hsa05330 Allograft rejection 3123_3126_3127_3125 4 - 0.00740625581252465 0.144166916718291 722 thioproperazine hsa05222 Small cell lung cancer 598_3912_5293_8554_3675 5 - 0.0268805634458654 0.213598997442796 723 thioproperazine hsa04940 Type I diabetes mellitus 3123_3126_3127_3125 4 - 0.0118169603867452 0.144166916718291 724 picotamide hsa04514 Cell adhesion molecules (CAMs) 5010_965_958_3113_3133_6693_5817 7 + 0.0111739680313502 0.466572247210115 725 picotamide hsa05322 Systemic lupus erythematosus 958_718_3113_720_721_8341_8340 7 + 0.0158160083800039 0.466572247210115 726 picotamide hsa05340 Primary immunodeficiency 958_3561_3718 3 + 0.027557032747388 0.494794469867771 727 picotamide hsa05330 Allograft rejection 958_3113_3133 3 + 0.0335453877876455 0.494794469867771 728 picotamide hsa05220 Chronic myeloid leukemia 861_6777_4193_9846 4 + 0.0477717735187001 0.514138368020413 729 picotamide hsa05131 Shigellosis 7278_6093_7430_113457 4 - 0.0221521422634581 0.398738560742246 730 picotamide hsa05130 Pathogenic Escherichia coli infection 7278_6093_7430_113457 4 - 0.0221521422634581 0.398738560742246 731 picotamide hsa04270 Vascular smooth muscle contraction 5581_4660_8681_4637_1909_6093_100137049 7 - 0.00706290067342133 0.381396636364752 732 pirenzepine hsa04740 Olfactory transduction 1179 1 + 0.00167624308094183 0.127394474151579 733 pirenzepine hsa04514 Cell adhesion molecules (CAMs) 214_9672_3683_3107_23308_57863_6383 7 + 0.0462339940349503 0.348879696784099 734 pirenzepine hsa05322 Systemic lupus erythematosus 85235_717_8330_8332_8969_8331_8329_8336_8354 9 + 0.00938086064520765 0.214217537260697 735 pirenzepine hsa04360 Axon guidance 9901_1944_9475_5880_3985_6092_27289 7 + 0.0419745009017241 0.348879696784099 736 pirenzepine hsa04664 Fc epsilon RI signaling pathway 6655_8681_100137049_2205_5880 5 + 0.0457073281457915 0.348879696784099 737 pirenzepine hsa04912 GnRH signaling pathway 2778_3710_100137049_6655_1839_8681_5337_2796 8 + 0.00558463916183177 0.212216288149607 738 pirenzepine hsa04730 Long-term depression 2778_8681_100137049_3710_2775 5 + 0.0316767459086199 0.348879696784099 739 pirenzepine hsa04270 Vascular smooth muscle contraction 2778_3710_3778_9475_8681_800_100137049 7 + 0.0264969083790568 0.348879696784099 740 pirenzepine hsa05220 Chronic myeloid leukemia 2122_861_6655_5925_7042_1488 6 + 0.0112746072242472 0.214217537260697 741 pirenzepine hsa04520 Adherens junction 51701_4088_117178_5792_6934_2260 6 - 0.0292171430180212 0.761294585799982 742 pirenzepine hsa04740 Olfactory transduction 818 1 - 0.000583676048585479 0.0402736473523981 743 chlortalidone hsa05010 Alzheimer's disease 51806_3708_776 3 + 0.00257575529548825 0.109181607407925 744 chlortalidone hsa05016 Huntington's disease 7052_3092_246721_3708 4 + 0.00385346849675029 0.109181607407925 745 chlortalidone hsa04740 Olfactory transduction 51806_8390_8383_26664_5137_4991_26539_1258 8 + 1.6130213265381e-05 0.00137106812755739 746 chlortalidone hsa04110 Cell cycle 995_1029 2 + 0.0173330802893729 0.368327956149174 747 chlortalidone hsa04512 ECM-receptor interaction 1278_10319_3688_1281_22798_948_3690_1289_3908_7057_3371_7060_1277 13 + 0.0234139440147153 0.39803704825016 748 chlortalidone hsa05210 Colorectal cancer 10000 1 + 0.0298537328030145 0.422927881376039 749 chlortalidone hsa03440 Homologous recombination 5425_5892_10111 3 - 0.0405401272607534 0.699317195247996 750 chlortalidone hsa04520 Adherens junction 117178_5795_6934_91_2260_8976 6 - 0.0196944790008547 0.553302223322302 751 chlortalidone hsa04740 Olfactory transduction 810_157 2 - 0.00670492565086955 0.462639869909999 752 chlortalidone hsa04512 ECM-receptor interaction 8515_3691_1289_5649_3688_3675 6 - 0.0240566184053175 0.553302223322302 753 furosemide hsa04640 Hematopoietic cell lineage 1436_3563_2811_3690_3126_1438_926_3655_931_3674 10 + 0.0358213507756513 0.565977342255291 754 furosemide hsa04740 Olfactory transduction 26211_5593_7932_5137_9635_816 6 + 0.000187513879944791 0.0148135965156385 755 furosemide hsa05322 Systemic lupus erythematosus 717_3113_3126_8358_6738_8968_3013_8350_8351_8352_8353_8354_8355_8356_8357 15 + 0.0286712043400928 0.565977342255291 756 furosemide hsa04512 ECM-receptor interaction 1278_2811_22798_3690_3694_3371_3918_5649_6383_3655_3339_1291_3674 13 + 0.00160896362637166 0.0635540632416806 757 furosemide hsa03010 Ribosome 6192 1 + 0.044473573892531 0.585568722918325 758 furosemide hsa04020 Calcium signaling pathway 2911_6262_773_2905_2902_3709_3360_6261_5724_5330_1956_487_135_488_5137_814_816_6870 18 + 0.0249056623340904 0.565977342255291 759 furosemide hsa05211 Renal cell carcinoma 8503_2549_5290_201163_3845_3725 6 - 0.0300463923178324 0.570881454038816 760 furosemide hsa04740 Olfactory transduction 818 1 - 0.000186170689714814 0.0141489724183259 761 furosemide hsa05322 Systemic lupus erythematosus 474382_474381_85235_83740_8330_8332_8969_8331_8329_8336 10 - 0.0267712347473879 0.570881454038816 762 furosemide hsa04060 Cytokine-cytokine receptor interaction 2324 1 - 0.00524508628662485 0.199313278891744 763 furosemide hsa04020 Calcium signaling pathway 818 1 - 0.0469806607755803 0.714106043788821 764 ketotifen hsa05332 Graft-versus-host disease 57292_3553_3119_3126_3113_3127_3111_3125_3134_355_3123 11 + 0.000708860162630118 0.0196117978327666 765 ketotifen hsa05320 Autoimmune thyroid disease 1081_3119_3126_3113_3127_3111_3125_3134_355_3123 10 + 0.00931185286132138 0.110411969641382 766 ketotifen hsa04910 Insulin signaling pathway 23433_9021_5139 3 + 0.0261838967433558 0.238006414488396 767 ketotifen hsa04740 Olfactory transduction 818 1 + 4.36952240028361e-11 3.6267035922354e-09 768 ketotifen hsa04514 Cell adhesion molecules (CAMs) 9076_965_3383_3119_3123_3126_3127_3111_3125_5818_3134_57502_5817_6383_923_25945_3113_26047_1462 19 + 0.00898113716396041 0.110411969641382 769 ketotifen hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_9103_8294_8343_8347_8346_8344_3123_3126_3127_3125_8370_8359_554313_121504_8339_3119_2215_3113_3111 28 + 1.73598294694127e-05 0.000720432922980627 770 ketotifen hsa04012 ErbB signaling pathway 818 1 + 0.0303275141445367 0.238006414488396 771 ketotifen hsa05310 Asthma 3119_3123_3113_3127_3111_3126_3125 7 + 0.0109953771135122 0.114077037552689 772 ketotifen hsa04062 Chemokine signaling pathway 1230_6772_6773_108_2931_23236 6 + 0.0315430187876188 0.238006414488396 773 ketotifen hsa04260 Cardiac muscle contraction 782 1 + 0.0450779626626652 0.303907634732133 774 ketotifen hsa03010 Ribosome 6189_439992 2 + 0.0475999909821413 0.303907634732133 775 ketotifen hsa05330 Allograft rejection 3119_3113_3126_3127_3111_3125_3134_355_3123 9 + 0.00380369166875095 0.0631412817012658 776 ketotifen hsa04940 Type I diabetes mellitus 3553_3119_3113_3126_3127_3111_3125_3134_355_3123 10 + 0.00301626268173389 0.0625874506459782 777 bambuterol hsa05332 Graft-versus-host disease 3113_3107_3126_3127_940_3125_356_355_5551_3123_3558 11 + 0.00390665520043518 0.0585998280065277 778 bambuterol hsa05010 Alzheimer's disease 775_355_3709_4023_776 5 + 0.00278959737177066 0.0502127526918719 779 bambuterol hsa05320 Autoimmune thyroid disease 3113_3107_3126_3127_940_3125_356_355_5551_3123_7038_3558 12 + 0.0104258889277932 0.117291250437673 780 bambuterol hsa05016 Huntington's disease 246721_1211_1639_9001_5468_161 6 + 0.00547338107143974 0.0703720423470824 781 bambuterol hsa04740 Olfactory transduction 390892_8390_1179_26531_4991_816 6 + 4.5047196018737e-09 4.05424764168633e-07 782 bambuterol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113_940 31 + 7.86956013495933e-05 0.0035413020607317 783 bambuterol hsa04530 Tight junction 5519_5865_6714_23136_4626 5 + 0.032024274662509 0.32024274662509 784 bambuterol hsa05330 Allograft rejection 3113_3107_3126_3127_940_3558_356_355_5551_3123_3125 11 + 0.00203170668198756 0.0457134003447201 785 bambuterol hsa04940 Type I diabetes mellitus 3382_2572_3107_3126_3127_940_3558_356_355_5551_3123_3125_3113 13 + 0.000700486857073183 0.0210146057121955 786 bambuterol hsa04740 Olfactory transduction 818_810 2 - 0.00080646418441803 0.0500007794339179 787 naloxone hsa04740 Olfactory transduction 51806_7932 2 + 0.0371654414393294 0.87511518698492 788 naloxone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_2215_8370_2214_8368_8366_942_8359_8294_8367_554313_121504_8364 17 + 1.64766440704878e-08 1.00507528829976e-06 789 naloxone hsa05332 Graft-versus-host disease 3135_3105_3106_3107_649853 5 - 0.0485407761531934 0.451007866020838 790 naloxone hsa04080 Neuroactive ligand-receptor interaction 9568_1269 2 - 0.00158991380498484 0.0635965521993936 791 naloxone hsa05016 Huntington's disease 5331_23236 2 - 0.0267560191454203 0.399063665681338 792 naloxone hsa04740 Olfactory transduction 818_26212_5566 3 - 5.85357452030186e-05 0.00468285961624149 793 naloxone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 0.00847994790637562 0.169598958127512 794 naloxone hsa04060 Cytokine-cytokine receptor interaction 1956_6358_6359 3 - 0.00528909104798404 0.141042427946241 795 naloxone hsa04912 GnRH signaling pathway 5331_3710_5599_5566_818_1956_3845_5600_5606_23236 10 - 0.0345941440775965 0.399063665681338 796 naloxone hsa05330 Allograft rejection 3135_3105_3106_3107_649853 5 - 0.0349180707471171 0.399063665681338 797 apomorphine hsa03450 Non-homologous end-joining 27343_7518 2 + 0.010640026982633 0.42560107930532 798 apomorphine hsa04740 Olfactory transduction 818 1 - 0.0113627622120339 0.346564247467034 799 apomorphine hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_8336 7 - 0.0246198678538507 0.500603979694964 800 apomorphine hsa03020 RNA polymerase 246721_5439_548644_661 4 - 0.00331769473706251 0.202379378960813 801 practolol hsa04640 Hematopoietic cell lineage 2323_3581_3554_2812_4254_7850_920_1378_931 9 + 0.0430802111460512 0.73236358948287 802 practolol hsa04520 Adherens junction 4089_998_5797_1956_5787_88_3643_2241_2534_25945 10 + 0.00824959305749939 0.350607704943724 803 practolol hsa04740 Olfactory transduction 56656_1258_390892 3 + 1.97959226772412e-05 0.0016826534275655 804 practolol hsa04062 Chemokine signaling pathway 998_6347_23236 3 + 0.0369045954269357 0.73236358948287 805 practolol hsa05012 Parkinson's disease 5413 1 + 0.0220127284880991 0.623693973829475 806 practolol hsa04080 Neuroactive ligand-receptor interaction 7434_1812_1909 3 - 0.0075776773456705 0.299318255153985 807 practolol hsa04740 Olfactory transduction 810 1 - 1.18028827655497e-06 9.32427738478426e-05 808 practolol hsa04514 Cell adhesion molecules (CAMs) 3119 1 - 0.0316064560646451 0.832303343035654 809 alfuzosin hsa05332 Graft-versus-host disease 3123_355_3126_3127_3125 5 + 0.0467058362214471 0.540453247705316 810 alfuzosin hsa05016 Huntington's disease 4695_6648 2 + 0.026224911353101 0.354036303266863 811 alfuzosin hsa04740 Olfactory transduction 26659_23538_7932_5568_1179 5 + 0.00122026774127741 0.0494208435217351 812 alfuzosin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3123_3126_3127_3125_8969_8370_717_8332_8359_8330_8331_8336_554313_121504_85235 26 + 9.87391267411336e-09 7.99786926603182e-07 813 alfuzosin hsa05310 Asthma 3123_3126_3127_8288_3125 5 + 0.0148578506386133 0.290333664989428 814 alfuzosin hsa05330 Allograft rejection 3593_3123_3126_3127_3125_355 6 + 0.00982739457770144 0.265339653597939 815 alfuzosin hsa04940 Type I diabetes mellitus 3593_3123_3126_3127_3125_355 6 + 0.0179218311721869 0.290333664989428 816 alfuzosin hsa04740 Olfactory transduction 157 1 - 2.08110988442571e-08 1.78975450060611e-06 817 alfuzosin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8329_8294_8969_8370_8332_8359_8330_8331_8336_6737_121504_85235_3119 23 - 2.33913167700386e-05 0.00100582662111166 818 alfuzosin hsa05012 Parkinson's disease 4714_836 2 - 0.0348796945942801 0.999884578369363 819 trimethobenzamide hsa05332 Graft-versus-host disease 3824_3126_3113_3127_3125_3123 6 + 0.0216858982228861 0.327353464861848 820 trimethobenzamide hsa05010 Alzheimer's disease 5532_5664 2 + 0.0180787293570809 0.327353464861848 821 trimethobenzamide hsa04612 Antigen processing and presentation 3824_3440_3123_3806_3126_3127_3125_8302_920_3113 10 + 0.0245515098646386 0.327353464861848 822 trimethobenzamide hsa04740 Olfactory transduction 5593_8390_1179 3 + 1.97235727878532e-05 0.000788942911514128 823 trimethobenzamide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_9103_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113_8970 32 + 1.58286041578222e-11 1.26628833262578e-09 824 trimethobenzamide hsa05310 Asthma 3123_3126_3127_3113_3125 5 + 0.0207477693342463 0.327353464861848 825 trimethobenzamide hsa05330 Allograft rejection 3126_3113_3127_3123_3125 5 + 0.045753858480635 0.522901239778686 826 trimethobenzamide hsa04070 Phosphatidylinositol signaling system 8394_5333_3707 3 - 0.024729149190664 0.49458298381328 827 trimethobenzamide hsa05211 Renal cell carcinoma 3725_8453_7042 3 - 0.0215951021958999 0.49458298381328 828 tolnaftate hsa04080 Neuroactive ligand-receptor interaction 623_2901_1131_5030_2150_134_2696_2357_2149 9 + 0.0150429626327057 0.327184437261349 829 tolnaftate hsa04740 Olfactory transduction 5568 1 + 1.30488914272695e-11 1.13525355417245e-09 830 tolnaftate hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_94239_8366_8368_8294_121504_8367_8968_8370_8358_8359_8330_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 27 + 0.000118897079640419 0.00517202296435823 831 tolnaftate hsa04115 p53 signaling pathway 5366_9134_983_4194_581_7057_4193_472_355_1017_8795 11 + 0.0293683077906961 0.511008555558112 832 tolnaftate hsa04020 Calcium signaling pathway 623_1131_5568_2149 4 + 0.00386589498569559 0.112110954585172 833 tolnaftate hsa04510 Focal adhesion 5829_5155_3909_55742_1291_3675 6 - 0.019397965116772 0.38795930233544 834 tolnaftate hsa05322 Systemic lupus erythematosus 8343_8339_8347_8346_8344 5 - 0.0166831315642104 0.38795930233544 835 khellin hsa04740 Olfactory transduction 26212_3000 2 + 0.0032529999698632 0.214697998010971 836 khellin hsa04810 Regulation of actin cytoskeleton 2335 1 + 0.0322948502485783 1 837 metronidazole hsa04080 Neuroactive ligand-receptor interaction 23566_799_4142 3 + 0.0272514801648266 0.7176223110071 838 metronidazole hsa04740 Olfactory transduction 2979 1 + 1.16842750029456e-05 0.000461528862616351 839 metronidazole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_9103_88_8329_8294_8969_8370_8332_8359_8330_8331_8336_8337_554313_121504_85235_3014 25 + 1.99487606889027e-09 1.57595209442331e-07 840 metronidazole hsa05016 Huntington's disease 1213_246721_6648_4698_5439_548644 6 - 0.0240306559027284 0.540689757811389 841 metronidazole hsa04115 p53 signaling pathway 472_651610_3732 3 - 0.0495373109155703 0.743059663733554 842 metronidazole hsa03020 RNA polymerase 246721_5439_548644 3 - 0.00571995866419287 0.257398139888679 843 niclosamide hsa04740 Olfactory transduction 26211_393046 2 + 4.38915246910069e-06 0.000168982370060377 844 niclosamide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8349_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_8970 27 + 8.8992787480595e-09 6.85244463600581e-07 845 niclosamide hsa04710 Circadian rhythm - mammal 8553_5187_9572 3 + 0.0322097000767904 0.496029381182572 846 niclosamide hsa04115 p53 signaling pathway 1647_1026_5366_581_1029_6477_472_651610_8795 9 + 0.00778589306300581 0.182026882075884 847 niclosamide hsa04010 MAPK signaling pathway 2872_50487_3164_10125_51776_11221_2260_4214_468_5971_5532_4609_3727_4791_1647_1848_1843_2317_1649_1846_5598_2353_7042 23 + 0.00945594192601993 0.182026882075884 848 niclosamide hsa04080 Neuroactive ligand-receptor interaction 2690_5031_1813 3 - 0.0382034584416199 1 849 niclosamide hsa05200 Pathways in cancer 6934_5154_5336_5888_1050_4824_5371_355_652_2261_112399_9134_898_4254_6932_8453_8554_91_3725_2956_2122_6502_5979_7186 24 - 0.00296347162615299 0.237077730092239 850 niclosamide hsa04010 MAPK signaling pathway 784_91_2261_9064_5154_4137_4776_7786_355_2122_5600_3306_3725_3304_3305_3303_7186 17 - 0.0359060887042608 1 851 4-hydroxyphenazone hsa04740 Olfactory transduction 26211 1 + 7.92319515438566e-06 0.000554623660806996 852 4-hydroxyphenazone hsa04740 Olfactory transduction 157 1 - 0.0318206650307395 0.697743753957983 853 4-hydroxyphenazone hsa04210 Apoptosis 5296_3556_5575_5534 4 - 0.0497118044851575 0.697743753957983 854 4-hydroxyphenazone hsa04062 Chemokine signaling pathway 7454_2786_157_5296_6358_6359_23236 7 - 0.0297171063208284 0.697743753957983 855 4-hydroxyphenazone hsa05210 Colorectal cancer 4088_5296_4437_8312_3725 5 - 0.0104010777140959 0.697743753957983 856 tolazoline hsa04740 Olfactory transduction 8390 1 + 0.000118370754810919 0.004379717928004 857 tolazoline hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3113 22 + 5.36355919898885e-09 3.96903380725175e-07 858 tolazoline hsa04062 Chemokine signaling pathway 107 1 + 0.0323705031324765 0.598854307950815 859 tolazoline hsa04940 Type I diabetes mellitus 3113_3107_3382_356_2571 5 + 0.0159649633358731 0.393802428951536 860 tolazoline hsa05211 Renal cell carcinoma 2271_5291_5605_8453_5781_1398_3725 7 - 0.0220622968272129 0.506228791864065 861 tolazoline hsa04080 Neuroactive ligand-receptor interaction 5021_7068_1909 3 - 0.0269988688994168 0.506228791864065 862 tolazoline hsa04310 Wnt signaling pathway 5663_4041_51701_10725_11261_818_5528_4775_5519_3725_6885 11 - 0.0495559802824667 0.568395877336465 863 tolazoline hsa04740 Olfactory transduction 818 1 - 1.72827151558826e-05 0.000661336467947321 864 tolazoline hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_8294_720_721_6738_121504_9555_8367 18 - 1.76356391452619e-05 0.000661336467947321 865 lidocaine hsa03320 PPAR signaling pathway 5170_51703_5465_5467_23305_8309 6 + 0.0399548649403558 0.353794761312079 866 lidocaine hsa05200 Pathways in cancer 652671_356_5599_208_6655_6789_5371_4193_1438_2252_8817_5925_51384_7170_5467_2263_836_2260_7475_861 20 + 0.0213012705899455 0.33229982120315 867 lidocaine hsa04740 Olfactory transduction 5566_8390_9635 3 + 0.00203733576237952 0.0595963818799801 868 lidocaine hsa05212 Pancreatic cancer 5170_208_6655_4193_5925_2263_2260 7 + 0.0400409879784477 0.353794761312079 869 lidocaine hsa05215 Prostate cancer 5170_208_6655_4193_5925_2263_2260 7 + 0.0381582221493438 0.353794761312079 870 lidocaine hsa05221 Acute myeloid leukemia 861_208_6655_5371_5467_652671 6 + 0.0203549573467708 0.33229982120315 871 lidocaine hsa05218 Melanoma 208_4193_8817_5925_2260_2252 6 + 0.0421753916107872 0.353794761312079 872 lidocaine hsa04920 Adipocytokine signaling pathway 3717_51703_3953_208_5599_5465_32_23305_4852 9 + 0.000877635280488945 0.0595963818799801 873 lidocaine hsa05223 Non-small cell lung cancer 6789_208_6655_5170_5925 5 + 0.0453583027323178 0.353794761312079 874 lidocaine hsa04010 MAPK signaling pathway 836_51701_57551_9479_3553_1852_5599_208_6655_6789_786_8817_356_4763_776_1432_5566_2263_2260_2252 20 + 0.00229216853384539 0.0595963818799801 875 lidocaine hsa05016 Huntington's disease 5432_246721_5439_6667_9001_55567_548644 7 - 0.0153635007599264 0.330315266338418 876 lidocaine hsa03020 RNA polymerase 5432_246721_5439_548644 4 - 0.000912998187375775 0.0392589220571583 877 ivermectin hsa04740 Olfactory transduction 9635 1 + 5.64421303468359e-05 0.00208835882283293 878 ivermectin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8348_8294_121504_8352_8968_8370_717_8358_8359_554313_8350_8351_7124_8353_8354_8355_8356_8357_3013_3113 29 + 3.11498007383902e-13 2.30508525464087e-11 879 ivermectin hsa04650 Natural killer cell mediated cytotoxicity 8794 1 - 0.0316606306145226 0.497147596000787 880 ivermectin hsa04080 Neuroactive ligand-receptor interaction 3953_3354 2 - 0.00232304054464138 0.0596247073124621 881 ivermectin hsa04740 Olfactory transduction 818_5613_5616 3 - 8.38325555265798e-05 0.00322755338777332 882 ivermectin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3021_3020_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344 21 - 5.11387889431861e-06 0.000393768674862533 883 ivermectin hsa04340 Hedgehog signaling pathway 5613_5616_1454_652_653_4036 6 - 0.0475071172829188 0.523299186945347 884 ivermectin hsa05216 Thyroid cancer 10342_5979_6256_6934 4 - 0.0475726533586679 0.523299186945347 885 ivermectin hsa04912 GnRH signaling pathway 2002_5613_5616_2776_5608_818_5600_113_5338_107 10 - 0.0322823114286225 0.497147596000787 886 diazoxide hsa05332 Graft-versus-host disease 3804_3126_3127_3123_3125 5 + 0.00134138552291637 0.047919369675679 887 diazoxide hsa05320 Autoimmune thyroid disease 3123_3126_3127_3125 4 + 0.0177156314930497 0.149373307719817 888 diazoxide hsa04612 Antigen processing and presentation 3123_3126_3127_3125_6892_3804 6 + 0.00649561889851091 0.0831439219009397 889 diazoxide hsa05131 Shigellosis 7100_7278_7430_113457 4 + 0.0210056213980993 0.149373307719817 890 diazoxide hsa05130 Pathogenic Escherichia coli infection 7100_7278_7430_113457 4 + 0.0210056213980993 0.149373307719817 891 diazoxide hsa04514 Cell adhesion molecules (CAMs) 965_3123_3126_3127_3125_23308 6 + 0.036977232469467 0.236654287804589 892 diazoxide hsa05322 Systemic lupus erythematosus 3123_3126_3127_3125_8343_8339_8347_8346_8344 9 + 0.00149748030236497 0.047919369675679 893 diazoxide hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1839_6868_5600_5781 4 + 0.0428496241930544 0.249306904395953 894 diazoxide hsa05310 Asthma 3123_3126_3127_3125 4 + 0.00284015748837922 0.0605900264187567 895 diazoxide hsa05330 Allograft rejection 3123_3126_3127_3125 4 + 0.00614785732182475 0.0831439219009397 896 diazoxide hsa04940 Type I diabetes mellitus 3123_3126_3127_3125 4 + 0.00985297810004026 0.105098433067096 897 diazoxide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_8294_8367_554313_121504 15 - 6.28855453994955e-07 3.01850617917578e-05 898 disulfiram hsa04612 Antigen processing and presentation 972_3105_3106_3135_3310_3304_3303_649853 8 + 0.0229659391750879 0.787455968092389 899 disulfiram hsa05200 Pathways in cancer 4286_2271_596_6789_6502_5295_5979_7188_405_1956_367_2247 12 - 0.00444824398649546 0.289135859122205 900 disulfiram hsa04740 Olfactory transduction 409 1 - 0.0471055774427457 0.362813072651127 901 disulfiram hsa04360 Axon guidance 3984_2050_1949_10507_3985 5 - 0.0486611823873638 0.362813072651127 902 disulfiram hsa05212 Pancreatic cancer 367_1956_5295_596 4 - 0.0468236178681976 0.362813072651127 903 disulfiram hsa05215 Prostate cancer 367_1956_5295_596 4 - 0.0453034047526261 0.362813072651127 904 disulfiram hsa05218 Melanoma 2247_1956_5295_4286 4 - 0.0237635213943009 0.362813072651127 905 disulfiram hsa03022 Basal transcription factors 51616_2969_728198 3 - 0.0202574864896167 0.362813072651127 906 disulfiram hsa05222 Small cell lung cancer 7188_6502_5295_596 4 - 0.0423476204459379 0.362813072651127 907 atropine oxide hsa04514 Cell adhesion molecules (CAMs) 5010_23308_26285_923_5817 5 + 0.0360292182557465 0.882715847265789 908 atropine oxide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504 14 + 1.74093388169057e-08 8.53057602028379e-07 909 chlorphenamine hsa04920 Adipocytokine signaling pathway 3953_32_8660_1375_5781_4793 6 + 0.000533954826439806 0.0261637864955505 910 chlorphenamine hsa05332 Graft-versus-host disease 3106_3107_3552 3 - 0.0461022528096869 0.885819602600191 911 chlorphenamine hsa04810 Regulation of actin cytoskeleton 5296_8396_3693_5154_7074_324_3984_2909_3675 9 - 0.0212062003200876 0.885819602600191 912 isoconazole hsa04662 B cell receptor signaling pathway 11025_208_6655_2353_3725 5 + 0.0338998598838338 0.290907832202217 913 isoconazole hsa04660 T cell receptor signaling pathway 1326_5063_208_6655_3725_2353_2534 7 + 0.0163011482006964 0.273106113864525 914 isoconazole hsa04510 Focal adhesion 29895_5063_1311_208_6655_1277_29780_3725_3676_2909_2534 11 + 0.00990342353551083 0.273106113864525 915 isoconazole hsa05322 Systemic lupus erythematosus 3013_3111_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 12 + 0.000202922213183696 0.0152191659887772 916 isoconazole hsa04710 Circadian rhythm - mammal 9572_1408 2 + 0.043596172223849 0.290907832202217 917 isoconazole hsa04340 Hedgehog signaling pathway 656_7474_5568_353500 4 + 0.0480096267840612 0.290907832202217 918 isoconazole hsa04012 ErbB signaling pathway 5063_208_6655_1839_818_3725 6 + 0.018207074257635 0.273106113864525 919 isoconazole hsa04010 MAPK signaling pathway 1326_782_1843_208_6655_1649_1846_2353_4763_5568_3725_3310_3164 13 + 0.0139039559051335 0.273106113864525 920 isoconazole hsa04060 Cytokine-cytokine receptor interaction 83729 1 + 0.0325585142740777 0.290907832202217 921 isoconazole hsa04912 GnRH signaling pathway 5568_1081_6655_1839_818_3725 6 + 0.0434517686853339 0.290907832202217 922 isoconazole hsa05210 Colorectal cancer 2353_208_6655_8326_3725 5 + 0.0499099767851536 0.290907832202217 923 isoconazole hsa04080 Neuroactive ligand-receptor interaction 2561_5618_2925 3 - 0.036981655837768 0.899886958719021 924 isoconazole hsa04740 Olfactory transduction 157 1 - 3.93862979777865e-05 0.00287519975237841 925 isoconazole hsa03020 RNA polymerase 5433_246721_5439_548644_84172 5 - 0.0055215352225216 0.201536035622038 926 clindamycin hsa04740 Olfactory transduction 816 1 + 0.000808163090172309 0.0307101974265477 927 clindamycin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3113_8359_8294_8367_554313_121504 15 + 1.41840753764046e-05 0.00107798972860675 928 clindamycin hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0482277937016223 0.79460669418943 929 clindamycin hsa04740 Olfactory transduction 5613_5616 2 - 0.0135634843951604 0.393341047459652 930 clindamycin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 1.49661093418476e-05 0.000868034341827161 931 nicergoline hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 + 0.0243687324274519 0.231294027296852 932 nicergoline hsa04070 Phosphatidylinositol signaling system 8867_8396_27124_5290_3707 5 + 0.0456355950734548 0.358484252577455 933 nicergoline hsa04640 Hematopoietic cell lineage 1435_3123_3126_3127_3125_920 6 + 0.0246713629116642 0.231294027296852 934 nicergoline hsa05320 Autoimmune thyroid disease 958_3126_3127_3123_3125 5 + 0.0126763780713322 0.190145671069983 935 nicergoline hsa04740 Olfactory transduction 157 1 + 0.00180505677094514 0.0451264192736285 936 nicergoline hsa04514 Cell adhesion molecules (CAMs) 958_214_3123_3126_3127_3125_920_26285 8 + 0.021496017579804 0.231294027296852 937 nicergoline hsa05310 Asthma 958_3125_3126_3127_3123 5 + 0.00140436381159848 0.0451264192736285 938 nicergoline hsa05330 Allograft rejection 958_3126_3127_3123_3125 5 + 0.00356194447501522 0.0667864589065354 939 nicergoline hsa04940 Type I diabetes mellitus 3382_3126_2572_3127_3125_3123 6 + 0.00120656476064509 0.0451264192736285 940 nicergoline hsa04080 Neuroactive ligand-receptor interaction 5618_2908 2 - 0.026406033544296 0.326922373720963 941 nicergoline hsa05016 Huntington's disease 1213 1 - 0.032231783324602 0.326922373720963 942 nicergoline hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_834_1616_5533_5606_4842 6 - 0.0119701889984213 0.26445574444476 943 nicergoline hsa04740 Olfactory transduction 109 1 - 0.000122422770861356 0.00869201673115627 944 nicergoline hsa04210 Apoptosis 3556_1147_3551_5296_5533_8717_8795 7 - 0.0289482860935362 0.326922373720963 945 nicergoline hsa05221 Acute myeloid leukemia 1147_3551_5296_5371_6934_6198 6 - 0.0148989151799865 0.26445574444476 946 nicergoline hsa05222 Small cell lung cancer 5728_4149_1147_3551_5296_3912_4842_3675 8 - 0.00849221372973574 0.26445574444476 947 gallamine triethiodide hsa04080 Neuroactive ligand-receptor interaction 64106_2925 2 - 0.0378255183296843 0.868738387566432 948 gallamine triethiodide hsa04740 Olfactory transduction 818 1 - 0.000177274446048212 0.0111682901010374 949 aminophenazone hsa05332 Graft-versus-host disease 3123_3107_3126_3127_3125 5 + 0.00144217712522106 0.0257818722076932 950 aminophenazone hsa04640 Hematopoietic cell lineage 933_3123_3126_3127_3125 5 + 0.0243632921813132 0.176074284397676 951 aminophenazone hsa05320 Autoimmune thyroid disease 3451_3123_3107_3126_3127_3125 6 + 0.000616738161506409 0.0257818722076932 952 aminophenazone hsa04612 Antigen processing and presentation 3451_3123_3107_3126_3127_3125_3305 7 + 0.00162411662206741 0.0257818722076932 953 aminophenazone hsa04514 Cell adhesion molecules (CAMs) 3123_4099_3107_3126_3127_3125_4359_933 8 + 0.00392033878030771 0.0414435813918244 954 aminophenazone hsa04510 Focal adhesion 10000_2335_3381_858_1277_1293_55742_1291_3082 9 + 0.0150493411887946 0.13920640599635 955 aminophenazone hsa05218 Melanoma 8817_1021_10000_3082 4 + 0.0450423964438452 0.277761444737045 956 aminophenazone hsa05310 Asthma 3123_3126_3127_3125 4 + 0.00301256711510248 0.0371549944195973 957 aminophenazone hsa04512 ECM-receptor interaction 1293_1277_1291_2335_3381 5 + 0.0214521771267811 0.176074284397676 958 aminophenazone hsa04630 Jak-STAT signaling pathway 3451_10000_1271_6773_10253_10252_4352 7 + 0.0261732044374923 0.176074284397676 959 aminophenazone hsa05330 Allograft rejection 3123_3107_3126_3127_3125 5 + 0.000958627578074284 0.0257818722076932 960 aminophenazone hsa04940 Type I diabetes mellitus 3123_3107_3126_3127_3125 5 + 0.0017420183924117 0.0257818722076932 961 aminophenazone hsa04650 Natural killer cell mediated cytotoxicity 3133 1 - 0.0457041628589215 0.667280777740254 962 aminophenazone hsa04080 Neuroactive ligand-receptor interaction 2561_2149 2 - 0.0048930280774295 0.0892977624130884 963 aminophenazone hsa04740 Olfactory transduction 818_5613_5566_5616 4 - 0.000805547200223186 0.0294024728081463 964 aminophenazone hsa04340 Hedgehog signaling pathway 5613_5566_5616_1454_655_652_653_7477 8 - 0.00376461540835229 0.0892977624130884 965 aminophenazone hsa04060 Cytokine-cytokine receptor interaction 655 1 - 0.000551590922967909 0.0294024728081463 966 levobunolol hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 + 0.0299963009279617 0.342814867748134 967 levobunolol hsa04640 Hematopoietic cell lineage 1435_3123_3126_3127_3125_3590_925 7 + 0.0105227836662301 0.296910713943784 968 levobunolol hsa05320 Autoimmune thyroid disease 7038_3123_3126_3127_3125 5 + 0.0163849815392718 0.296910713943784 969 levobunolol hsa04612 Antigen processing and presentation 3123_3806_3126_3127_3125_6891_925 7 + 0.0117377080555342 0.296910713943784 970 levobunolol hsa04740 Olfactory transduction 810_51806_1179 3 + 0.0203202685316042 0.296910713943784 971 levobunolol hsa05310 Asthma 3123_3126_3127_3125 4 + 0.0108179213384683 0.296910713943784 972 levobunolol hsa05330 Allograft rejection 3123_3126_3127_3125 4 + 0.0222683035457838 0.296910713943784 973 levobunolol hsa04940 Type I diabetes mellitus 3123_3126_3127_3125 4 + 0.0343843377017923 0.343843377017923 974 levobunolol hsa05131 Shigellosis 7278_7430_113457 3 - 0.0268418898586403 0.420522941118698 975 levobunolol hsa05130 Pathogenic Escherichia coli infection 7278_7430_113457 3 - 0.0268418898586403 0.420522941118698 976 levobunolol hsa05322 Systemic lupus erythematosus 85235_8969_8332_8330_8331_8336_8329 7 - 0.00133963375773045 0.0629627866133312 977 timolol hsa05332 Graft-versus-host disease 3811_3113_3458_3107_3126_3127_3125_356_3123_3802 10 + 0.00102469934273249 0.0283500151489322 978 timolol hsa04740 Olfactory transduction 8387_9635_8388 3 + 1.09068526857435e-07 9.0526877291671e-06 979 timolol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_2904_8368_554313_8294_3123_3458_8366_3126_3127_3125_8370_8359_8335_121504_3113_720_721 24 + 0.000104874631946294 0.0043522972257712 980 timolol hsa05212 Pancreatic cancer 6716 1 + 0.0439545824375125 0.447837816488277 981 timolol hsa04530 Tight junction 5588_5581 2 + 0.0182292116004203 0.243101488127234 982 timolol hsa05310 Asthma 2207_3123_3126_3127_3125_3113 6 + 0.0205025351432607 0.243101488127234 983 timolol hsa05012 Parkinson's disease 6392_7416_651820 3 + 0.0485607270890903 0.447837816488277 984 timolol hsa05330 Allograft rejection 3113_3458_3107_3126_3127_3125_356_3123 8 + 0.00611119391272796 0.101445818951284 985 timolol hsa04940 Type I diabetes mellitus 3382_3113_3458_3107_3126_3127_3125_356_3123 9 + 0.00438863564213431 0.0910641895742869 986 timolol hsa04070 Phosphatidylinositol signaling system 8394_8871_8396_23236 4 - 0.0455501891839163 0.555712308043779 987 timolol hsa04740 Olfactory transduction 816 1 - 0.0233250572769127 0.474276164630558 988 timolol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 3.96608786363022e-07 2.41931359681443e-05 989 timolol hsa04115 p53 signaling pathway 472_651610_3732_27113 4 - 0.0342640910639839 0.522527388725754 990 timolol hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0162007840488729 0.474276164630558 991 molsidomine hsa04740 Olfactory transduction 26212 1 + 0.0154966916135747 0.441655710986879 992 molsidomine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 5.61003223575876e-07 3.19771837438249e-05 993 molsidomine hsa04930 Type II diabetes mellitus 775_776_773 3 + 0.0499055424293142 0.94820530615697 994 molsidomine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 25 - 3.91566054985411e-11 2.66264917390079e-09 995 molsidomine hsa04710 Circadian rhythm - mammal 1454_9572_1408 3 - 0.0114644117119601 0.389789998206643 996 dirithromycin hsa04740 Olfactory transduction 5593 1 + 0.0228488206154537 0.61691815661725 997 dirithromycin hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0157101398278764 0.61691815661725 998 dirithromycin hsa04130 SNARE interactions in vesicular transport 9570_8417_6844_10652 4 - 0.0151076392405634 0.626129527415462 999 dirithromycin hsa05222 Small cell lung cancer 208_3909_9618_5925_6502_3655 6 - 0.0186904336541929 0.626129527415462 1000 dosulepin hsa05322 Systemic lupus erythematosus 3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 11 + 0.00015548878302664 0.00948481576462504 1001 dosulepin hsa04710 Circadian rhythm - mammal 8553_1408 2 + 0.0312587547138942 0.953392018773773 1002 dosulepin hsa04740 Olfactory transduction 157 1 - 3.93862979777865e-05 0.00307213124226735 1003 dosulepin hsa05322 Systemic lupus erythematosus 3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 11 - 0.0213972573950465 0.834493038406813 1004 budesonide hsa05200 Pathways in cancer 6513_10000_5599_5155_54205_5371_998_867_83439_3576_1029_5602_5915_4791 14 + 0.0487180568868304 0.853026663566937 1005 budesonide hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_534_3576_998_5602 5 + 0.0356700118956331 0.853026663566937 1006 budesonide hsa04920 Adipocytokine signaling pathway 5599_6513_10000_5563_5602 5 + 0.0291483785109738 0.853026663566937 1007 budesonide hsa05214 Glioma 5154_5594_208_6655_5295_6464_4193_5291_5925_3845_3480_1869 12 - 0.0161753242449503 0.159955984200064 1008 budesonide hsa04662 B cell receptor signaling pathway 5594_6850_3551_10725_208_6655_5295_5291_5533_5881_3845_3725_8519_4793 14 - 0.0085382334058403 0.159955984200064 1009 budesonide hsa05010 Alzheimer's disease 5594_642502_6391_5533_22926_5664_23236 7 - 0.0492681518085804 0.228013709938569 1010 budesonide hsa04080 Neuroactive ligand-receptor interaction 2901_1909_7068_1131_9170 5 - 8.00814667629893e-05 0.00712725054190605 1011 budesonide hsa04910 Insulin signaling pathway 2872_5594_3551_5599_5576_6655_5295_6464_5140_5291_2002_5564_208_23265_3845_51763_5509_8651_5792 19 - 0.048017807726807 0.228013709938569 1012 budesonide hsa05016 Huntington's disease 5432_642502_6391_3092_1385_23236_163 7 - 0.0289275356513975 0.174224468157257 1013 budesonide hsa05212 Pancreatic cancer 5594_3551_596_3480_6655_5295_5154_4193_5925_3845_208_1869_1385_2260_5291 15 - 0.015374934005461 0.159955984200064 1014 budesonide hsa05215 Prostate cancer 5594_3551_596_3480_6655_5295_5154_4193_5925_3845_208_1869_1385_2260_5291 15 - 0.0144798214880882 0.159955984200064 1015 budesonide hsa04664 Fc epsilon RI signaling pathway 1432_6850_5581_5599_208_6655_5295_5291_5881_3845_5603_5608_5594 13 - 0.0287695239087257 0.174224468157257 1016 budesonide hsa04370 VEGF signaling pathway 9261_1432_5594_10725_208_5295_998_5291_5533_5881_3845_5603 12 - 0.0461333535918779 0.228013709938569 1017 budesonide hsa05218 Melanoma 5594_3480_5295_4193_5154_5925_3845_2257_208_1869_2260_5291_4233 13 - 0.0126967550160072 0.159955984200064 1018 budesonide hsa05223 Non-small cell lung cancer 11186_5594_6789_208_6655_5295_5291_5925_3845_1869 10 - 0.0293636744085264 0.174224468157257 1019 budesonide hsa04010 MAPK signaling pathway 9261_9344_2872_5154_5881_5058_5603_3164_5608_3552_3551_6789_10746_2260_408_4214_208_2005_998_5533_5536_3725_4791_784_1432_5594_5599_6655_2002_1843_3845_27092_2257 33 - 0.0492043941328673 0.228013709938569 1020 budesonide hsa05012 Parkinson's disease 642502_6391 2 - 0.00199988203134101 0.0604356962221695 1021 budesonide hsa04060 Cytokine-cytokine receptor interaction 3552_2057_23529_8742_8741_5154_9180_4254_4233_8795 10 - 0.0106249813061324 0.159955984200064 1022 budesonide hsa03010 Ribosome 6187_440589 2 - 0.0241557790718324 0.174224468157257 1023 budesonide hsa04020 Calcium signaling pathway 5533_1131_23236_1909 4 - 0.00203715829962369 0.0604356962221695 1024 budesonide hsa05210 Colorectal cancer 5594_596_5599_3480_6655_5295_1856_5291_4233_5881_3845_208_3725_8321 14 - 0.0210026732045999 0.174224468157257 1025 budesonide hsa05220 Chronic myeloid leukemia 5594_3551_613_6655_5295_6464_4193_5291_5925_3845_208_1869_598 13 - 0.0237734615509516 0.174224468157257 1026 mycophenolic acid hsa04740 Olfactory transduction 26212 1 + 0.000797092999981516 0.0178017436662539 1027 mycophenolic acid hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8370_83740_8368_8366_8360_8359_8362_8294_8367_554313_121504 17 + 7.09063295779481e-07 4.75072408172252e-05 1028 mycophenolic acid hsa04110 Cell cycle 995_1647_1026_5111_4193_472_651610 7 + 0.0424093719083953 0.528796916527569 1029 mycophenolic acid hsa04210 Apoptosis 331_472_355_651610_8794_8795 6 + 0.0344592318774405 0.528796916527569 1030 mycophenolic acid hsa04115 p53 signaling pathway 55367_1647_1026_5366_4193_5268_472_355_651610_8795_9540 11 + 5.36593841080896e-06 0.0001797589367621 1031 mycophenolic acid hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0473549477487375 0.528796916527569 1032 mycophenolic acid hsa04070 Phosphatidylinositol signaling system 5578_8394_5331_3708_3709_3707_23236 7 - 0.0442714749951332 0.6136648912269 1033 mycophenolic acid hsa04120 Ubiquitin mediated proteolysis 7329 1 - 0.0458818062700101 0.6136648912269 1034 mycophenolic acid hsa04080 Neuroactive ligand-receptor interaction 7067_3354_1131_56288 4 - 0.0497566128021811 0.6136648912269 1035 mycophenolic acid hsa04740 Olfactory transduction 157 1 - 5.77576347188257e-06 0.000213703248459655 1036 mycophenolic acid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8347_8346_8344_3021_3020_55766_8370_8359_554313_6738_121504_8339_727 24 - 3.72738706854097e-08 2.75826643072032e-06 1037 mycophenolic acid hsa04060 Cytokine-cytokine receptor interaction 5155_3566_7422 3 - 0.0147240731682602 0.363193804817085 1038 vancomycin hsa04080 Neuroactive ligand-receptor interaction 2902_2901_2925_2862_5724_134_1812_1813_799_2740_2688_2689_4986_1394_1442_147_2918_5027_6915_148_2550_4158_4829 23 + 0.0267786835270543 0.711567339894825 1039 vancomycin hsa04740 Olfactory transduction 81697 1 + 3.07149906318027e-08 2.58005921307143e-06 1040 vancomycin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_3014_8359_8294_720_721_121504_3119_3109_8367 19 + 0.000890864479017941 0.0374163081187535 1041 vancomycin hsa05012 Parkinson's disease 6571_5413 2 + 0.0495921992089202 0.711567339894825 1042 vancomycin hsa04940 Type I diabetes mellitus 3553_3109_3119_3107_3135_3382 6 + 0.0425617749684689 0.711567339894825 1043 vancomycin hsa05322 Systemic lupus erythematosus 85235_8969_8332_8330_8331_8329_8336 7 - 0.00127148763121284 0.0686603320854934 1044 tenoxicam hsa04120 Ubiquitin mediated proteolysis 8651_6502_7320_5371_4193 5 + 0.0439317544129077 0.666298275262433 1045 tenoxicam hsa05016 Huntington's disease 4899_4695_246721_7350_3708_10540 6 + 0.00737307238035317 0.167737396653035 1046 tenoxicam hsa04740 Olfactory transduction 23538_5616_26476_808_390892_801_805 7 + 5.26563128488448e-08 4.79172446924488e-06 1047 tenoxicam hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8342_3109_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119_2215_3113_3112_720_721_942_729 31 + 3.33905019858337e-05 0.00151926784035543 1048 tenoxicam hsa05012 Parkinson's disease 4695_6622 2 + 0.00139846282962215 0.0424200391652052 1049 tenoxicam hsa03010 Ribosome 6234_6181 2 + 0.0170911356140585 0.311058668175865 1050 piracetam hsa04740 Olfactory transduction 8390_442194 2 + 0.00922881517078771 0.627559431613564 1051 piracetam hsa04370 VEGF signaling pathway 5335_8398_10000_7422_5534 5 + 0.0412884542916034 1 1052 piracetam hsa04080 Neuroactive ligand-receptor interaction 4886 1 - 0.0001757571674212 0.0065030151945844 1053 piracetam hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8294_121504_8968_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_3012_3013 27 - 1.01353623923027e-08 7.500168170304e-07 1054 piracetam hsa04060 Cytokine-cytokine receptor interaction 7852_4233_8795_3572 4 - 0.0150988621822857 0.341197832598137 1055 piracetam hsa04020 Calcium signaling pathway 3708_5257 2 - 0.0184431260863858 0.341197832598137 1056 etamsylate hsa04740 Olfactory transduction 5137_5566 2 + 0.00954612436265917 0.34843353923706 1057 etamsylate hsa05322 Systemic lupus erythematosus 3013_8358_88_8968_8350_8351_8352_8353_8354_8355_8356_8357 12 + 0.000345048395331959 0.025188532859233 1058 etamsylate hsa05200 Pathways in cancer 3688_842_581_6655_6777_5371_998_4254_6932_405_2257_3725_5888 13 - 0.0252800411473471 0.395196105440753 1059 etamsylate hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_8336 7 - 0.0277390102233382 0.395196105440753 1060 etamsylate hsa04210 Apoptosis 8737_8837_5534_842_581 5 - 0.0359269186764321 0.395196105440753 1061 etamsylate hsa05221 Acute myeloid leukemia 6932_6655_6777_5371 4 - 0.0337685531898677 0.395196105440753 1062 etamsylate hsa04115 p53 signaling pathway 27113_10912_3732_842_581 5 - 0.0143310758423341 0.395196105440753 1063 etamsylate hsa05210 Colorectal cancer 6932_3725_6655_842_581 5 - 0.029324808633708 0.395196105440753 1064 beclometasone hsa03320 PPAR signaling pathway 2172_2710_5170_2170 4 + 0.0344938642201251 0.586395691742127 1065 beclometasone hsa04740 Olfactory transduction 2978 1 + 0.0228488206154537 0.582644925694069 1066 beclometasone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 3.44010701225683e-07 1.75445457625098e-05 1067 dobutamine hsa05016 Huntington's disease 5331_7802 2 + 0.0183501486356713 0.688130573837674 1068 dobutamine hsa04740 Olfactory transduction 818_26476_816 3 + 4.07532462991363e-05 0.00305649347243522 1069 dobutamine hsa05322 Systemic lupus erythematosus 85235_3013_8330_8332_8969_8331_8329_8351_8336 9 - 0.0212751605210759 1 1070 alcuronium chloride hsa04740 Olfactory transduction 23538 1 + 0.0230713779443961 1 1071 alcuronium chloride hsa04740 Olfactory transduction 818 1 - 0.00167914135823883 0.107465046927285 1072 alcuronium chloride hsa04710 Circadian rhythm - mammal 79365_9572 2 - 0.046653887934764 0.746462206956224 1073 alcuronium chloride hsa04912 GnRH signaling pathway 4214_1081_6655_818_8681_100137049_23236 7 - 0.0180080875193733 0.538890668948601 1074 alcuronium chloride hsa02010 ABC transporters 5826_1244_23457_9619 4 - 0.0252605001069657 0.538890668948601 1075 triflusal hsa04210 Apoptosis 824_10000_317_843 4 + 0.0179386842471671 0.713871745155337 1076 triflusal hsa05221 Acute myeloid leukemia 5371_10000_5914 3 + 0.0291319505264371 0.713871745155337 1077 triflusal hsa04920 Adipocytokine signaling pathway 8471_10000_1375 3 + 0.0396595413975187 0.713871745155337 1078 triflusal hsa04662 B cell receptor signaling pathway 10725_208_8519_7409_5534_3725_4793 7 - 0.0363628443231264 0.552715233711521 1079 triflusal hsa04080 Neuroactive ligand-receptor interaction 3354 1 - 0.000791935447598857 0.0300935470087566 1080 triflusal hsa04740 Olfactory transduction 818 1 - 8.27878022493393e-06 0.000629187297094979 1081 triflusal hsa04664 Fc epsilon RI signaling pathway 5578_208_8681_5335_9846_7409_81579_100137049 8 - 0.017548933448163 0.333429735515097 1082 triflusal hsa04370 VEGF signaling pathway 5578_10725_208_8681_5335_5534_81579_100137049 8 - 0.0154250744776034 0.333429735515097 1083 phenindione hsa05200 Pathways in cancer 5879_3910_3576_5371_4254_5156_5925_1956_1495_5337_91_2261_3082 13 + 0.00930001163771821 0.229518447911177 1084 phenindione hsa04740 Olfactory transduction 442194 1 + 0.0155732280236746 0.229518447911177 1085 phenindione hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_5879_1432_3576 4 + 0.0414216723977497 0.396464578664176 1086 phenindione hsa05219 Bladder cancer 5925_1956_3576_2261 4 + 0.00817241812118006 0.229518447911177 1087 phenindione hsa05218 Melanoma 5925_1956_3082_5156 4 + 0.0414216723977497 0.396464578664176 1088 phenindione hsa04010 MAPK signaling pathway 5879_1432_5156_1956_5871_91_8398_5971_2261_27330_3164 11 + 0.0171282423814311 0.229518447911177 1089 phenindione hsa04912 GnRH signaling pathway 8398_1081_1956_5337_1432_23236 6 + 0.014457765718517 0.229518447911177 1090 phenindione hsa05010 Alzheimer's disease 5534 1 - 0.0154721696558335 0.59567853174959 1091 phenindione hsa04660 T cell receptor signaling pathway 5163_1432_10725_6655_5600_5603_5534_9020_4793 9 - 0.0444209056893234 0.649405010329818 1092 phenindione hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294 21 - 8.28857992869301e-07 6.38220654509362e-05 1093 phenindione hsa04020 Calcium signaling pathway 5333_5534 2 - 0.0498996914454082 0.649405010329818 1094 phenindione hsa04940 Type I diabetes mellitus 3135_3106_3107_3552_2571 5 - 0.03517983682555 0.649405010329818 1095 CP-690334-01 hsa05332 Graft-versus-host disease 3812_57292_3811_3553_3804_3106_3803_3802_3135_356_3105_649853 12 + 0.0047636853911549 0.0819353887278643 1096 CP-690334-01 hsa04650 Natural killer cell mediated cytotoxicity 23533_57292_3809_3808_3805_3804_3806_5293_3803_3802_27040_5880_5336_3451_3105_3106_3812_3810_3811_4277_4276_3135_4772_5534_356_5879_2534 27 + 0.00729565896137785 0.104571111779749 1097 CP-690334-01 hsa04120 Ubiquitin mediated proteolysis 23327_7337_331_330_8916_9021_63893 7 + 0.0471944435585006 0.368974740548277 1098 CP-690334-01 hsa04612 Antigen processing and presentation 3812_57292_3811_3809_3808_3805_3804_3106_3806_3810_3803_3802_3135_3306_3451_3105_920_115653_649853 19 + 0.00865942644644191 0.106387239199143 1099 CP-690334-01 hsa05016 Huntington's disease 2902_4899_317_246721_3708_56901 6 + 0.000801598973507601 0.0172343779304134 1100 CP-690334-01 hsa04740 Olfactory transduction 26212_8388_8387_1179_2979_816_4995 7 + 2.91055923258025e-10 1.25154047000951e-08 1101 CP-690334-01 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_9103_8349_8348_8329_8294_121504_8343_8347_8346_8345_8344_8339_8969_8968_55766_8370_8358_8359_8330_8331_8336_8334_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_85236_3012_3013_3017_720_721_8970 50 + 5.92967717253926e-11 5.09952236838376e-09 1102 CP-690334-01 hsa04110 Cell cycle 995_1032_699_5925 4 + 0.0129686297196012 0.123922461765078 1103 CP-690334-01 hsa04350 TGF-beta signaling pathway 91_7044_5516 3 + 0.046137316976651 0.368974740548277 1104 CP-690334-01 hsa05012 Parkinson's disease 317_56901_6531 3 + 0.00077216594690703 0.0172343779304134 1105 CP-690334-01 hsa03010 Ribosome 6187_440589_6123 3 + 0.0121410491334413 0.123922461765078 1106 CP-690334-01 hsa05214 Glioma 51806_595_208_6655_5295_5154_4193_818_5335_3480_3845 11 - 0.0454901515286484 0.238823295525404 1107 CP-690334-01 hsa05211 Renal cell carcinoma 208_6655_5295_998_56924_405_5058_5781_1399_7042_3845_4233 12 - 0.0345974390561543 0.238823295525404 1108 CP-690334-01 hsa03320 PPAR signaling pathway 9415 1 - 0.0422060140052377 0.238823295525404 1109 CP-690334-01 hsa05010 Alzheimer's disease 51806_4695_348_489_23236 5 - 0.0102112339647833 0.142957275506966 1110 CP-690334-01 hsa04080 Neuroactive ligand-receptor interaction 5618_1813_64106_2901_5031_1241_7067_56288 8 - 0.00298626936445424 0.0836155422047187 1111 CP-690334-01 hsa05200 Pathways in cancer 595_596_598_7042_5154_9618_7175_5881_1487_3655_4254_3675_1050_6789_5914_1613_405_652_1399_208_2263_2260_5295_3480_998_4193_6934_4609_91_2956_3918_4233_4791_1436_2122_6655_3845_5335_7186 39 - 0.0360946014615872 0.238823295525404 1112 CP-690334-01 hsa04520 Adherens junction 3480_117178_998_5881_8826_5792_6934_91_56288_2260_4233_6714_8976 13 - 0.0286365464148434 0.238823295525404 1113 CP-690334-01 hsa05016 Huntington's disease 4899_4695_7052_3092_5978_9001_23236 7 - 0.0287439561745551 0.238823295525404 1114 CP-690334-01 hsa04740 Olfactory transduction 818_51806 2 - 3.02066406663007e-11 2.53735781596926e-09 1115 CP-690334-01 hsa05322 Systemic lupus erythematosus 8330 1 - 0.0002136706385537 0.0089741668192554 1116 CP-690334-01 hsa04360 Axon guidance 9353_5362_2043_2041_10725_998_1944_56924_7852_5881_3845_54910_10512_5058_4233_27289_7869_3983 18 - 0.0431215816984563 0.238823295525404 1117 CP-690334-01 hsa04370 VEGF signaling pathway 1432_5829_208_5295_998_10725_5881_3845_5603_5335_6714_8398 12 - 0.0436371717491851 0.238823295525404 1118 CP-690334-01 hsa05012 Parkinson's disease 7327_4695_7054 3 - 0.00934431499278721 0.142957275506966 1119 CP-690334-01 hsa03010 Ribosome 6168_6205 2 - 0.0238059197305522 0.238823295525404 1120 CP-690334-01 hsa05210 Colorectal cancer 595_596_3480_6655_5295_7042_5881_4609_3845_6934_208_91_2956_4233 14 - 0.0197017865192941 0.236421438231529 1121 CP-690334-01 hsa05220 Chronic myeloid leukemia 2122_595_208_6655_5295_4193_1487_5781_1399_4609_91_3845_7042_598 14 - 0.00784017854266065 0.142957275506966 1122 pancuronium bromide hsa05332 Graft-versus-host disease 3123_3126_3127_3119_3125 5 + 0.000381140608877311 0.00498617103530955 1123 pancuronium bromide hsa04640 Hematopoietic cell lineage 3123_3684_3126_3127_3125 5 + 0.00759127876518063 0.0466321409861096 1124 pancuronium bromide hsa05320 Autoimmune thyroid disease 3123_3126_3127_3119_3125 5 + 0.00101290620329867 0.00871099334836856 1125 pancuronium bromide hsa04612 Antigen processing and presentation 3119_3123_3126_3127_3125_3310 6 + 0.00164668781460035 0.0118012626713025 1126 pancuronium bromide hsa04514 Cell adhesion molecules (CAMs) 3119_3123_3126_3127_3684_3125 6 + 0.0109538009321869 0.0588766800105046 1127 pancuronium bromide hsa05322 Systemic lupus erythematosus 3123_3126_3127_3119_3125 5 + 0.0487682045689929 0.233003644051855 1128 pancuronium bromide hsa05310 Asthma 3123_3126_3127_3119_3125 5 + 9.16696073046177e-05 0.00394179311409856 1129 pancuronium bromide hsa05330 Allograft rejection 3123_3126_3127_3119_3125 5 + 0.000249587025968882 0.00498617103530955 1130 pancuronium bromide hsa04940 Type I diabetes mellitus 3123_3126_3127_3119_3125 5 + 0.000463829863749726 0.00498617103530955 1131 pancuronium bromide hsa04662 B cell receptor signaling pathway 4067_3551_8519_4775_5534_3725_27071_4793 8 - 0.00802611752741849 0.208679055712881 1132 pancuronium bromide hsa04080 Neuroactive ligand-receptor interaction 9568_64106_7433 3 - 0.0372764425420693 0.587310575484678 1133 pancuronium bromide hsa04740 Olfactory transduction 5566_393046_4991 3 - 0.000987209167996471 0.0385011575518624 1134 pancuronium bromide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_8359_8294_8367_121504_8368_8351_3108 17 - 4.30499780779332e-05 0.00335789829007879 1135 pancuronium bromide hsa04810 Regulation of actin cytoskeleton 7430_998 2 - 0.0376481138131204 0.587310575484678 1136 diperodon hsa04514 Cell adhesion molecules (CAMs) 3695_942_3109_1462 4 + 0.0289966654210745 0.396189540643174 1137 diperodon hsa04530 Tight junction 93408_79784_5588_208 4 + 0.031043152536804 0.396189540643174 1138 diperodon hsa04920 Adipocytokine signaling pathway 208_5588_2182 3 + 0.0210949713319225 0.396189540643174 1139 diperodon hsa05330 Allograft rejection 942_3109 2 + 0.044537468937765 0.396189540643174 1140 diperodon hsa05220 Chronic myeloid leukemia 861_5925_208 3 + 0.0279509654954838 0.396189540643174 1141 diperodon hsa03020 RNA polymerase 246721_5439_548644 3 - 0.00423032713108944 0.131140141063773 1142 PNU-0251126 hsa04115 p53 signaling pathway 55367_8795_4193_3486 4 - 0.0342640910639839 1 1143 PNU-0251126 hsa05220 Chronic myeloid leukemia 598_208_5781_4193 4 - 0.043825122349189 1 1144 folic acid hsa05014 Amyotrophic lateral sclerosis (ALS) 598_842_836_5600_581 5 + 0.0175441218668651 0.570183960673116 1145 folic acid hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344 12 + 0.000508720864977072 0.0330668562235097 1146 folic acid hsa05322 Systemic lupus erythematosus 85235_8969_8332_8330_8331_8329_8336 7 - 0.000772214248885672 0.0362940696976266 1147 folic acid hsa04210 Apoptosis 5533_472_7186_596 4 - 0.0139490244403679 0.327802074348646 1148 quipazine hsa05010 Alzheimer's disease 317 1 + 0.0051604529670075 0.1376120791202 1149 quipazine hsa04740 Olfactory transduction 818_81696_81797 3 + 2.83826832660142e-05 0.00113530733064057 1150 quipazine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8342_8341_8347_8346_8344_8969_8370_8332_8359_8330_8331_8336_8337_554313_121504_8339_85235_3119_729 31 + 3.78924479161861e-11 3.03139583329489e-09 1151 quipazine hsa05213 Endometrial cancer 23533_6655_5290_1956_1495_324 6 + 0.0447886908439988 0.650045343860815 1152 quipazine hsa05210 Colorectal cancer 23533_6655_5880_5290_1956_7040_324_3725_8326 9 + 0.0371495848920029 0.650045343860815 1153 quipazine hsa03010 Ribosome 439992_9349_6137_6181_6189_6171 6 - 0.00315084221961705 0.173296322078938 1154 PHA-00665752 hsa05214 Glioma 5728_5594_7157_6654_5155_5290_5605_808_805_801_816 11 - 0.00901067156871765 0.162192088236918 1155 PHA-00665752 hsa05211 Renal cell carcinoma 2271_5594_5062_6654_5155_5290_5605_2033_5781_1398_7423 11 - 0.0208556068174038 0.234625576695793 1156 PHA-00665752 hsa04080 Neuroactive ligand-receptor interaction 7068_5025_1081_9170 4 - 0.00027701194783481 0.0124655376525665 1157 PHA-00665752 hsa04740 Olfactory transduction 219464_808_109_816_801_805 6 - 4.58828787245588e-06 0.000412945908521029 1158 PHA-00665752 hsa05212 Pancreatic cancer 6934_5728_5970_5594_9134_7157_6654_5155_5290_5605_2033_3326_1385_1017 14 - 0.00712417258576978 0.16029388317982 1159 PHA-00665752 hsa04110 Cell cycle 5591_9134_4173_7157_983_699_4176_472_11200_7027_7534_1017_7531_2033_7465_4616 16 - 0.019394262479685 0.234625576695793 1160 PHA-00665752 hsa05215 Prostate cancer 6934_5728_5970_5594_9134_7157_6654_5155_5290_5605_2033_3326_1385_1017 14 - 0.00668626186458333 0.16029388317982 1161 PHA-00665752 hsa05219 Bladder cancer 4313_5594_7157_999_7057_5605_7423 7 - 0.0360906235184831 0.249858162820268 1162 PHA-00665752 hsa04115 p53 signaling pathway 472_5728_9134_7157_983_7057_64065_11200_1017_4616 10 - 0.0347023033219707 0.249858162820268 1163 PHA-00665752 hsa03450 Non-homologous end-joining 5591_7520_27343_7518 4 - 0.0252428265150195 0.249858162820268 1164 PHA-00665752 hsa03430 Mismatch repair 4436_5983_2956_6117_5985 5 - 0.0311462015749799 0.249858162820268 1165 PHA-00665752 hsa04060 Cytokine-cytokine receptor interaction 3597_2057_3459_5155_3572_4982_7423_655_51330 9 - 0.0323261413153783 0.249858162820268 1166 PHA-00665752 hsa04912 GnRH signaling pathway 4313_3710_1081_6654_5580_808_5605_109_5601_5600_805_801_6416_816_5594 15 - 0.0149283490640688 0.223925235961032 1167 AG-028671 hsa04080 Neuroactive ligand-receptor interaction 5618_7068_1909 3 + 0.0275146749906946 0.277575350351944 1168 AG-028671 hsa05200 Pathways in cancer 1026_4149_1613_4088_598_999_998_5899_1857_6772_4193_5900_3655_2271_331_1398_9618_10342_1017_355_7423 21 + 0.0292184579317836 0.277575350351944 1169 AG-028671 hsa05131 Shigellosis 7280_347733_999_998_60_7430_7534 7 + 0.00801137280539437 0.202954777736657 1170 AG-028671 hsa05130 Pathogenic Escherichia coli infection 7280_347733_999_998_60_7430_7534 7 + 0.00801137280539437 0.202954777736657 1171 AG-028671 hsa04110 Cell cycle 1026_4173_4088_699_4193_51433_10912_7534_1017_7531 10 + 0.0280084895143427 0.277575350351944 1172 AG-028671 hsa05219 Bladder cancer 7423_1026_999_1613_4193 5 + 0.0281358782532307 0.277575350351944 1173 AG-028671 hsa04115 p53 signaling pathway 1026_5366_6477_4193_355_10912_1017_8795 8 + 0.00706443640177231 0.202954777736657 1174 AG-028671 hsa03022 Basal transcription factors 10629_51616_2969_6872_728198 5 + 0.0180865086209032 0.277575350351944 1175 6-bromoindirubin-3'-oxime hsa05010 Alzheimer's disease 776_5534 2 + 0.0360850276806788 0.71432036218072 1176 6-bromoindirubin-3'-oxime hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 0.00768285325429644 0.553165434309344 1177 6-bromoindirubin-3'-oxime hsa04080 Neuroactive ligand-receptor interaction 4889_5618_64106_4158_5025_799_2150_2149 8 - 0.0361732547050368 0.621163917571648 1178 6-bromoindirubin-3'-oxime hsa04740 Olfactory transduction 5137 1 - 8.10544761235695e-10 6.97068494662698e-08 1179 6-bromoindirubin-3'-oxime hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_89_8329_8294_8343_8347_8346_8344_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235_3017_3014_727 30 - 2.1342843982251e-07 9.17742291236793e-06 1180 6-bromoindirubin-3'-oxime hsa03010 Ribosome 6233 1 - 0.0211991796780819 0.455782363078761 1181 6-bromoindirubin-3'-oxime hsa05220 Chronic myeloid leukemia 5970_2122_5594_4088_572_1398_5605_9846_6777_369_1488 11 - 0.0198174194310223 0.455782363078761 1182 16,16-dimethylprostaglandin E2 hsa05213 Endometrial cancer 2002_6934_324_842 4 - 0.0152194765967258 0.515560326035195 1183 16,16-dimethylprostaglandin E2 hsa05210 Colorectal cancer 3725_842_324_6934_581 5 - 0.0180898360012349 0.515560326035195 1184 aconitine hsa05322 Systemic lupus erythematosus 85235_3119_8969_8332_8330_8331_8329_8336 8 - 0.00124870442706325 0.084911901040301 1185 aconitine hsa04540 Gap junction 7278_6714_113457_6655_23236 5 - 0.0117048722686549 0.397965657134267 1186 epivincamine hsa04080 Neuroactive ligand-receptor interaction 64106 1 - 0.0156754121871989 0.215536917573985 1187 epivincamine hsa04740 Olfactory transduction 818 1 - 0.000824873011382486 0.0226840078130184 1188 epivincamine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 5.9751788456701e-05 0.00328634836511855 1189 epivincamine hsa04710 Circadian rhythm - mammal 1454_8553_1408 3 - 0.00750078650725706 0.137514419299713 1190 epivincamine hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0491083275387865 0.540191602926651 1191 racecadotril hsa05014 Amyotrophic lateral sclerosis (ALS) 4217_5534_581 3 + 0.0445656291556509 0.915328491401148 1192 racecadotril hsa05322 Systemic lupus erythematosus 85235_8969_9103_8332_8330_8331_8329_8336 8 + 0.000991611146598919 0.0466057238901492 1193 demecarium bromide hsa04740 Olfactory transduction 5566 1 + 0.00177904229185186 0.0587083956311114 1194 demecarium bromide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 2.58770100503729e-05 0.00170788266332461 1195 demecarium bromide hsa04340 Hedgehog signaling pathway 51384_1454_5566_652_7477 5 + 0.0163189105087803 0.359016031193167 1196 demecarium bromide hsa04012 ErbB signaling pathway 2002_3725_5335 3 - 0.0390284894864283 0.691129785178069 1197 vinburnine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_3014 32 - 1.75402136769688e-25 7.89309615463596e-24 1198 isocorydine hsa05131 Shigellosis 7278_5578_113457_2534_347733 5 + 0.014357525445389 0.125628347647154 1199 isocorydine hsa05130 Pathogenic Escherichia coli infection 7278_5578_113457_2534_347733 5 + 0.014357525445389 0.125628347647154 1200 isocorydine hsa05014 Amyotrophic lateral sclerosis (ALS) 2903_2902_596_581_5533_10452_5534 7 + 0.000675832226546402 0.012970589734107 1201 isocorydine hsa04740 Olfactory transduction 5593 1 + 0.0017046777088385 0.023865487923739 1202 isocorydine hsa05322 Systemic lupus erythematosus 2903_8361_8363_8362_8365_8364_8370_8360_8368_8366_3111_8359_8294_8367_554313_121504 16 + 1.12977348973019e-06 7.90841442811133e-05 1203 isocorydine hsa04370 VEGF signaling pathway 5578_56848_5533_7422_5534_6714 6 + 0.0135908501004096 0.125628347647154 1204 isocorydine hsa04720 Long-term potentiation 2903_2902_2911_5578_5533_6196_5534_27330 8 + 0.000741176556234686 0.012970589734107 1205 isocorydine hsa04150 mTOR signaling pathway 6196_27330_7422_7249 4 + 0.0429149834900709 0.273095349482269 1206 isocorydine hsa04010 MAPK signaling pathway 785_9344_5578_5598_27330_8817_6196_8911_5533_5534_2257_3164_5609 13 + 0.0261488260821028 0.18304178257472 1207 isocorydine hsa04540 Gap junction 2911_5593_347733_5598_7278_5578_113457_6714_1902 9 + 0.000670485677628635 0.012970589734107 1208 isocorydine hsa04020 Calcium signaling pathway 2903_2911_2902_56848_5578_3360_6261_5533_8911_5534 10 + 0.0260559789555028 0.18304178257472 1209 isocorydine hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_8336 7 - 0.0149520846291104 0.702747977568189 1210 isocorydine hsa04610 Complement and coagulation cascades 5627_5265_2149_5328 4 - 0.0361442183531338 0.849389131298644 1211 (+)-chelidonine hsa04740 Olfactory transduction 1179_816 2 + 0.00327440214364139 0.164491123308135 1212 (+)-chelidonine hsa04510 Focal adhesion 5170_22798_2316_7057_3685_5154_88_3696_7414_3725_6093_10627 12 + 0.0161992129528401 0.367182160264376 1213 (+)-chelidonine hsa04010 MAPK signaling pathway 3164_2316_1852_27092_8074_5154_1846_1843_4208_8911_10912_7042_3725_3304_3303_4763 16 + 0.00483797421494514 0.164491123308135 1214 (+)-chelidonine hsa04540 Gap junction 2911_7278_113457_5154_112_23236 6 + 0.0480804216349211 0.649565885358056 1215 (+)-chelidonine hsa04640 Hematopoietic cell lineage 3655_966_4254_7037 4 - 0.00269448258569801 0.0490395830597038 1216 (+)-chelidonine hsa04080 Neuroactive ligand-receptor interaction 7068_64106_1131_5025_4886_2149 6 - 7.63441375621469e-12 3.47365825907768e-10 1217 (+)-chelidonine hsa04742 Taste transduction 5613_5616_3710 3 - 0.0391769412886121 0.22566706734661 1218 (+)-chelidonine hsa04670 Leukocyte transendothelial migration 5295_5290_7410_7430_5781_5335_5747_1499_50848 9 - 0.00883092453192771 0.0886685939133696 1219 (+)-chelidonine hsa05016 Huntington's disease 5432_246721_5439_836_1327_4701_6392_642502_6391_317_4712_841_5978_2033_509_7419_6875_548644_23236 19 - 0.0178985333297934 0.116340466643657 1220 (+)-chelidonine hsa04740 Olfactory transduction 5613_5616_808_109_801_805 6 - 4.19695836277858e-20 3.81923211012851e-18 1221 (+)-chelidonine hsa04514 Cell adhesion molecules (CAMs) 965_4685_3105_3106_999_3135_3134_5792_3655_50848_9019 11 - 0.0129033421168631 0.106745830239504 1222 (+)-chelidonine hsa04510 Focal adhesion 2002_5728_5170_5594_5295_5062_4659_6655_5747_331_7057_5290_3915_7410_6654_1499_3655_4233_2335 19 - 0.00575447929102674 0.0748082307833476 1223 (+)-chelidonine hsa05322 Systemic lupus erythematosus 55506_8361_8363_8362_8365_8364_94239_8360_8368_8349_8329_8294_8343_8347_8346_8345_8344_6632_723790_8367_8366_8969_55766_8370_8332_8359_8330_8331_8336_8337_8334_554313_6738_121504_8339_8357_85235_85236_3014 39 - 0.0158562671291008 0.110993869903706 1224 (+)-chelidonine hsa04512 ECM-receptor interaction 3655_3915_7057_2335 4 - 0.00379097687137672 0.0574964825492136 1225 (+)-chelidonine hsa04630 Jak-STAT signaling pathway 5295_3597_8554_3454_6774_598_6655_6654_5290_6772_50616_2033_5781_9180_9655_10254 16 - 0.0396777261268765 0.22566706734661 1226 (+)-chelidonine hsa04062 Chemokine signaling pathway 2309_23236_5295_5594_5580_6774_5613_6655_6654_5616_6772_7410_109_5290_113_5747_10681_8976_408 19 - 0.0143816498826659 0.10906084494355 1227 (+)-chelidonine hsa04260 Cardiac muscle contraction 7168_1327 2 - 0.000305487490245938 0.00694984040309509 1228 (+)-chelidonine hsa04060 Cytokine-cytokine receptor interaction 27242_3597_9180_3454_4254_4982_355_50616_7043_7042_655_4233_90 13 - 1.08778213785811e-07 3.2996058181696e-06 1229 (+)-chelidonine hsa03010 Ribosome 6187_440589_6139_6137_6125_6168_6160 7 - 0.00974380152894171 0.0886685939133696 1230 (+)-chelidonine hsa03050 Proteasome 5683 1 - 0.00737957689289367 0.0839426871566655 1231 (+)-chelidonine hsa04610 Complement and coagulation cascades 966_2149_4179_2152_7035 5 - 0.0487585914694913 0.261001871983748 1232 alpha-yohimbine hsa05332 Graft-versus-host disease 3553_3126_3113_3127_3125_3123 6 + 0.00774272446651515 0.141307117030362 1233 alpha-yohimbine hsa05320 Autoimmune thyroid disease 1081_3123_3113_3127_3126_3125 6 + 0.0203572593079482 0.244287111695378 1234 alpha-yohimbine hsa05016 Huntington's disease 64446_5978 2 + 0.0499576944785816 0.419644633620085 1235 alpha-yohimbine hsa04740 Olfactory transduction 26476_5566 2 + 8.79207006818856e-05 0.0036926694286392 1236 alpha-yohimbine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2212_3013_3113_8970 32 + 3.32575212052621e-14 2.79363178124202e-12 1237 alpha-yohimbine hsa05310 Asthma 3123_3126_3127_3113_3125 5 + 0.00841113791847392 0.141307117030362 1238 alpha-yohimbine hsa04010 MAPK signaling pathway 3554_3553_3925_5599_5566_50487_5155_998_6196_23162_1950_7042_5494_2263_9344_9693_4763_5578 18 + 0.0260973576800029 0.27402225564003 1239 alpha-yohimbine hsa04540 Gap junction 2911_5578_5566_5155_113457_1950_6714_7278 8 + 0.0315827753039655 0.294772569503678 1240 alpha-yohimbine hsa05330 Allograft rejection 3126_3113_3127_3123_3125 5 + 0.0196754167997638 0.244287111695378 1241 alpha-yohimbine hsa04940 Type I diabetes mellitus 3553_3126_3113_3127_3125_1363_3123 7 + 0.00240387050891695 0.0673083742496746 1242 alpha-yohimbine hsa05332 Graft-versus-host disease 3135_3123_3126_3127_3125 5 - 0.00124585593264641 0.0237242743035916 1243 alpha-yohimbine hsa04640 Hematopoietic cell lineage 3655_3125_3126_3127_3123 5 - 0.0214888569876109 0.135379799021949 1244 alpha-yohimbine hsa05320 Autoimmune thyroid disease 3135_3123_3126_3127_3125 5 - 0.00319484292170798 0.0287535862953718 1245 alpha-yohimbine hsa04612 Antigen processing and presentation 3123_3126_3127_3125_3135_811 6 - 0.00600059062202408 0.0472546511484396 1246 alpha-yohimbine hsa04740 Olfactory transduction 219464 1 - 0.0154966916135747 0.108476841295023 1247 alpha-yohimbine hsa04514 Cell adhesion molecules (CAMs) 3123_3126_3127_3125_3135_3655 6 - 0.0345180646844054 0.196506157156227 1248 alpha-yohimbine hsa05322 Systemic lupus erythematosus 85235_3123_3126_3127_3125_8332_8969_8331_8336_8329_8330 11 - 7.59051732330278e-05 0.00478202591368075 1249 alpha-yohimbine hsa04115 p53 signaling pathway 472_581_7057_4616 4 - 0.0374297442202337 0.196506157156227 1250 alpha-yohimbine hsa05310 Asthma 3123_3126_3127_3125 4 - 0.00267456990071884 0.0280829839575478 1251 alpha-yohimbine hsa03020 RNA polymerase 246721_5439_548644_84172 4 - 0.00239178415036037 0.0280829839575478 1252 alpha-yohimbine hsa05330 Allograft rejection 3135_3123_3126_3127_3125 5 - 0.000826562949743296 0.0237242743035916 1253 alpha-yohimbine hsa04940 Type I diabetes mellitus 3135_3123_3126_3127_3125 5 - 0.00150630313038677 0.0237242743035916 1254 5279552 hsa04340 Hedgehog signaling pathway 656_353500 2 + 0.0412137851461406 0.224400589990146 1255 5279552 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_8517_1839_3725 4 + 0.000730272179334482 0.0211778932007 1256 5279552 hsa04012 ErbB signaling pathway 5599_3725_1839 3 + 0.0130106174194792 0.164393010375502 1257 5279552 hsa04620 Toll-like receptor signaling pathway 5599_8517_3725 3 + 0.019605771175515 0.164393010375502 1258 5279552 hsa04912 GnRH signaling pathway 5599_3725_1839 3 + 0.0226748979828279 0.164393010375502 1259 5279552 hsa05332 Graft-versus-host disease 3135_3105_3106_649853 4 - 0.000535489421863816 0.00606888011445658 1260 5279552 hsa05320 Autoimmune thyroid disease 3135_3105_3106_649853 4 - 0.00121031822804947 0.0102877049384205 1261 5279552 hsa04612 Antigen processing and presentation 3135_3105_3106_649853 4 - 0.00715582494472536 0.0486596096241324 1262 5279552 hsa04514 Cell adhesion molecules (CAMs) 3135_3105_3106_649853 4 - 0.0268829407475609 0.152336664236178 1263 5279552 hsa04540 Gap junction 7278_2767_113457 3 - 0.044500761082149 0.216146553827581 1264 5279552 hsa05330 Allograft rejection 3135_3105_3106_649853 4 - 0.000376584499305291 0.00606888011445658 1265 5279552 hsa04940 Type I diabetes mellitus 3135_3105_3106_1363_649853 5 - 4.80323693299374e-05 0.00163310055721787 1266 5253409 hsa04612 Antigen processing and presentation 3310_3304_3305_3303 4 + 0.0219529820629648 0.439059641259296 1267 5253409 hsa04310 Wnt signaling pathway 3725_5532_6477_27101_8061 5 + 0.0342875040036491 0.457166720048655 1268 5253409 hsa04010 MAPK signaling pathway 1843_1649_2353_5532_3725_7786_3310_3304_3305_3303 10 + 0.00149962031387139 0.0599848125548556 1269 dioxybenzone hsa04120 Ubiquitin mediated proteolysis 26232_5371_9820 3 + 0.0255928634159233 0.537450131734389 1270 dioxybenzone hsa04740 Olfactory transduction 8390_135948_26664_8392_81797_390892_3000 7 + 1.45246575235536e-05 0.000996888503796389 1271 dioxybenzone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8341_8340_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119_2215_2214_3111 27 + 2.37354405665807e-05 0.000996888503796389 1272 dioxybenzone hsa03010 Ribosome 9045 1 + 0.0144736095891313 0.405261068495676 1273 dioxybenzone hsa04670 Leukocyte transendothelial migration 7430_5600 2 - 0.0347680363578209 0.503427499068058 1274 dioxybenzone hsa04740 Olfactory transduction 810 1 - 1.26316290867729e-09 1.0736884723757e-07 1275 dioxybenzone hsa04514 Cell adhesion molecules (CAMs) 3119 1 - 0.00329933840406597 0.140221882172804 1276 dioxybenzone hsa05322 Systemic lupus erythematosus 6738_9555_3119 3 - 0.0355360587577453 0.503427499068058 1277 dioxybenzone hsa05012 Parkinson's disease 836_4694 2 - 0.0177257243835288 0.502228857533316 1278 dioxybenzone hsa04060 Cytokine-cytokine receptor interaction 5618_3554_3552_2057_3953_3624_1956_2690 8 - 0.0274526740500635 0.503427499068058 1279 5255229 hsa04662 B cell receptor signaling pathway 3725_4792_2353 3 + 0.0188514009661668 0.174375458937043 1280 5255229 hsa05200 Pathways in cancer 2308_3576_3725_2353_4791_4792 6 + 0.0354242004046467 0.256670196758042 1281 5255229 hsa04660 T cell receptor signaling pathway 3725_4792_2353 3 + 0.0485592264136836 0.256670196758042 1282 5255229 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_3576_4792 3 + 0.016395372390337 0.174375458937043 1283 5255229 hsa04010 MAPK signaling pathway 1647_1843_1649_2353_3725_3164_4791 7 + 0.00404895448504909 0.133784819345769 1284 5255229 hsa04620 Toll-like receptor signaling pathway 3725_3576_4792_2353 4 + 0.00723161185652804 0.133784819345769 1285 5255229 hsa04060 Cytokine-cytokine receptor interaction 23529_83729_3576_8743_3976 5 + 0.044018987339379 0.256670196758042 1286 5255229 hsa05332 Graft-versus-host disease 3135_3105_3106_649853 4 - 0.000280350535906333 0.00275675425113812 1287 5255229 hsa05320 Autoimmune thyroid disease 3135_3105_3106_649853 4 - 0.000640731687048658 0.00400457304405411 1288 5255229 hsa04612 Antigen processing and presentation 3135_3105_3106_649853 4 - 0.00392692076232262 0.0196346038116131 1289 5255229 hsa04514 Cell adhesion molecules (CAMs) 3135_3105_3106_649853 4 - 0.0154160600556352 0.0642335835651467 1290 5255229 hsa04330 Notch signaling pathway 8850_5664 2 - 0.0454241850019869 0.162229232149953 1291 5255229 hsa05330 Allograft rejection 3135_3105_3106_649853 4 - 0.00019635949432751 0.00275675425113812 1292 5255229 hsa04940 Type I diabetes mellitus 3135_3105_3106_649853 4 - 0.000330810510136574 0.00275675425113812 1293 5211181 hsa05131 Shigellosis 7278_113457 2 + 0.0254394944374782 0.13991721940613 1294 5211181 hsa05130 Pathogenic Escherichia coli infection 7278_113457 2 + 0.0254394944374782 0.13991721940613 1295 5211181 hsa05332 Graft-versus-host disease 3135_3105_3106_649853 4 - 0.00099600288425102 0.0167725089380379 1296 5211181 hsa04650 Natural killer cell mediated cytotoxicity 10725_3135_3106_3105 4 - 0.0491569748835859 0.301964274284885 1297 5211181 hsa05320 Autoimmune thyroid disease 3135_3105_3106_649853 4 - 0.00222268436361683 0.0238938569088809 1298 5211181 hsa04612 Antigen processing and presentation 3135_3105_3106_649853 4 - 0.0126122872698834 0.108465670520997 1299 5211181 hsa04514 Cell adhesion molecules (CAMs) 3135_3105_3106_649853 4 - 0.045072582620695 0.301964274284885 1300 5211181 hsa05330 Allograft rejection 3135_3105_3106_649853 4 - 0.000703707754775024 0.0167725089380379 1301 5211181 hsa04940 Type I diabetes mellitus 3135_3105_3106_649853 4 - 0.00117017504218869 0.0167725089380379 1302 5252917 hsa04350 TGF-beta signaling pathway 4088_1311_7042 3 + 0.0313684295786096 0.55413737444579 1303 5252917 hsa04120 Ubiquitin mediated proteolysis 51619_8453_8554_55294_57154 5 - 0.0420673116939888 0.311298106535517 1304 5252917 hsa05131 Shigellosis 7277_7280_203068_347733 4 - 0.00804684085464569 0.0883734217797743 1305 5252917 hsa05130 Pathogenic Escherichia coli infection 7277_7280_203068_347733 4 - 0.00804684085464569 0.0883734217797743 1306 5252917 hsa04350 TGF-beta signaling pathway 3398_655_652_4090_57154 5 - 0.00736477912617587 0.0883734217797743 1307 5252917 hsa04540 Gap junction 203068_5607_7280_7277_347733 5 - 0.00955388343565128 0.0883734217797743 1308 Y-27632 hsa04540 Gap junction 7278_2767_113457_2776 4 - 0.0218541735471449 0.808604421244361 1309 5248896 hsa05332 Graft-versus-host disease 3135_3105_3106_649853 4 + 9.53684682404243e-05 0.00086506084683883 1310 5248896 hsa04650 Natural killer cell mediated cytotoxicity 3135_3105_3106 3 + 0.0380259825737369 0.12494251417085 1311 5248896 hsa05320 Autoimmune thyroid disease 3135_3105_3106_649853 4 + 0.000221174649368319 0.00127175423386783 1312 5248896 hsa04612 Antigen processing and presentation 3135_3105_3106_649853 4 + 0.00142147600804209 0.00653878963699361 1313 5248896 hsa04514 Cell adhesion molecules (CAMs) 3135_3105_3106_649853 4 + 0.00591628367559919 0.0226790874231302 1314 5248896 hsa05330 Allograft rejection 3135_3105_3106_649853 4 + 6.64413223642681e-05 0.00086506084683883 1315 5248896 hsa04940 Type I diabetes mellitus 3135_3105_3106_649853 4 + 0.000112834023500717 0.00086506084683883 1316 5224221 hsa04080 Neuroactive ligand-receptor interaction 2908 1 + 0.0331976976654081 0.448168918483009 1317 5224221 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_8970 26 + 1.785084084208e-14 9.6394540547232e-13 1318 5224221 hsa04115 p53 signaling pathway 5366_1647_6477_8795_581 5 + 0.0295429138893837 0.448168918483009 1319 5224221 hsa04010 MAPK signaling pathway 1647_5534_5599_7042_1649_1845_1843_3725_3310_3304_3305_3303_11221 13 + 0.0254799508390233 0.448168918483009 1320 5224221 hsa04080 Neuroactive ligand-receptor interaction 4886 1 - 0.04883644616263 0.501486805969775 1321 5224221 hsa04740 Olfactory transduction 5613_5616 2 - 0.0130540623212433 0.291540725174434 1322 5224221 hsa04110 Cell cycle 5111_993_9134_898_6502_5933_1031 7 - 0.0225265104151498 0.377319049453759 1323 5224221 hsa04540 Gap junction 5613_7278_5616_113457_115_203068_107 7 - 0.00691170000343213 0.231541950114976 1324 5224221 hsa04912 GnRH signaling pathway 5608_5580_5613_5616_107_115_5606_6300 8 - 0.00434998967285318 0.231541950114976 1325 carbamazepine hsa05332 Graft-versus-host disease 3553_3123_3126_3127_3111_3125 6 + 0.0254652623222251 0.411374245469583 1326 carbamazepine hsa04080 Neuroactive ligand-receptor interaction 7434_3363_8484_7433 4 + 0.011034070697912 0.411374245469583 1327 carbamazepine hsa04740 Olfactory transduction 5613_5593_4991 3 + 1.43045393815656e-05 0.00115866768990681 1328 carbamazepine hsa05310 Asthma 3123_3126_3127_3111_3125 5 + 0.0239180297999799 0.411374245469583 1329 carbamazepine hsa04010 MAPK signaling pathway 9261_9344_22808_4763_10454_3305_3553_775_776_2258_5536_7786_3725_9175_785_1843_5613_1649_6196_23162_2005_2353_3310 23 + 0.0183058686723285 0.411374245469583 1330 carbamazepine hsa04940 Type I diabetes mellitus 3553_3123_3126_3127_3111_3125 6 + 0.0304721663310802 0.411374245469583 1331 carbamazepine hsa05010 Alzheimer's disease 11261_2776 2 - 0.0255826805175086 0.547832047389262 1332 carbamazepine hsa04080 Neuroactive ligand-receptor interaction 2561_4889_152_7067_4886 5 - 0.0458915276090948 0.547832047389262 1333 carbamazepine hsa04740 Olfactory transduction 157 1 - 7.658562861984e-07 6.35660717544672e-05 1334 carbamazepine hsa04510 Focal adhesion 8515_10298_1302_596_3911_2317_2909_3678_3914_3909_5881_1956_5747_7791_3655_3725 16 - 0.0462027027918655 0.547832047389262 1335 carbamazepine hsa05012 Parkinson's disease 291 1 - 0.0324288996984188 0.547832047389262 1336 carbamazepine hsa04060 Cytokine-cytokine receptor interaction 27242_1956_2057 3 - 0.00549595205295328 0.228082010197561 1337 carbamazepine hsa05222 Small cell lung cancer 3914_3911_9134_7157_596_3909_5747_3655_5970 9 - 0.0372764461319974 0.547832047389262 1338 blebbistatin hsa05332 Graft-versus-host disease 3135_3105_3106_649853 4 - 0.00196612264175145 0.0314723684976152 1339 blebbistatin hsa05320 Autoimmune thyroid disease 3135_3105_3106_649853 4 - 0.00431434697054704 0.0442220564481072 1340 blebbistatin hsa04612 Antigen processing and presentation 3135_3105_3106_649853 4 - 0.0231918290356787 0.190172998092565 1341 blebbistatin hsa05322 Systemic lupus erythematosus 8343_8339_8347_8346_8344 5 - 0.0300860821590016 0.205588228086511 1342 blebbistatin hsa05330 Allograft rejection 3135_3105_3106_649853 4 - 0.00139770712818843 0.0314723684976152 1343 blebbistatin hsa04940 Type I diabetes mellitus 3135_3105_3106_649853 4 - 0.00230285623153282 0.0314723684976152 1344 natamycin hsa04740 Olfactory transduction 1258 1 + 0.0224968487047365 0.551172793266044 1345 natamycin hsa04360 Axon guidance 57556_2041_1944_64221_27289_10507_80031 7 + 0.00763585694888391 0.374156990495312 1346 natamycin hsa04080 Neuroactive ligand-receptor interaction 5618_1081_1909 3 - 0.0102428486838247 0.218261575147664 1347 natamycin hsa05131 Shigellosis 7280_347733_7278_113457_7430_2017_2534 7 - 0.0133086326309551 0.218261575147664 1348 natamycin hsa05130 Pathogenic Escherichia coli infection 7280_347733_7278_113457_7430_2017_2534 7 - 0.0133086326309551 0.218261575147664 1349 natamycin hsa04740 Olfactory transduction 409 1 - 2.44566445481421e-06 0.000200544485294765 1350 natamycin hsa04060 Cytokine-cytokine receptor interaction 5618_3566_7042 3 - 0.0104386045897132 0.218261575147664 1351 natamycin hsa04020 Calcium signaling pathway 11261_1909 2 - 0.0362729673190216 0.495730553359962 1352 natamycin hsa04940 Type I diabetes mellitus 3135_3123_3106_3382_3119 5 - 0.0471205320998755 0.551983376027113 1353 saquinavir hsa04070 Phosphatidylinositol signaling system 3633_3631_5331_5330_3708_3709_3707_27124_9162 9 + 0.0207539917217915 0.348667060926097 1354 saquinavir hsa04910 Insulin signaling pathway 5256 1 + 0.0151734020647976 0.348667060926097 1355 saquinavir hsa04740 Olfactory transduction 26212_5593 2 + 1.40249863367009e-06 0.000117809885228288 1356 saquinavir hsa04514 Cell adhesion molecules (CAMs) 6402_3688_3119_3122_4099_3113_6383_6614_933_26285_25945_26047_5817 13 + 0.030700052203848 0.429800730853872 1357 saquinavir hsa04540 Gap junction 2911_5593_7278_5155_113457_3709_5331_5330_3708_1956_153 11 + 0.0170443396032299 0.348667060926097 1358 saquinavir hsa05012 Parkinson's disease 7416 1 + 0.0150806834482645 0.348667060926097 1359 saquinavir hsa04130 SNARE interactions in vesicular transport 6809_8773_662_9570_10228_6843_9554 7 - 0.0225154484218523 0.283051351589 1360 saquinavir hsa05010 Alzheimer's disease 4698_11261_5594_7385 4 - 0.0196480610346809 0.283051351589 1361 saquinavir hsa04080 Neuroactive ligand-receptor interaction 5618_7442_7068_7067_2908_5026 6 - 0.004338048463098 0.0763496529505248 1362 saquinavir hsa04740 Olfactory transduction 157 1 - 3.75766079805385e-10 3.30674150228739e-08 1363 saquinavir hsa05322 Systemic lupus erythematosus 55766 1 - 0.00159068032315949 0.0466599561460117 1364 saquinavir hsa04062 Chemokine signaling pathway 2309_6655_5594_157_9475 5 - 0.0258528621714856 0.284381483886342 1365 saquinavir hsa04060 Cytokine-cytokine receptor interaction 5618_2057_3455_4982_7422_8795 6 - 0.00318276514266995 0.0700208331387389 1366 saquinavir hsa04020 Calcium signaling pathway 11261_5026 2 - 0.000721660446963426 0.0317530596663907 1367 quercetin hsa05332 Graft-versus-host disease 3119_3126_942_3127_3125_3135_355_3123_941 9 + 0.0380121030920112 0.288258448447752 1368 quercetin hsa04120 Ubiquitin mediated proteolysis 26232_4214_4281_326_7337 5 + 0.0237944460728283 0.240588288069708 1369 quercetin hsa04080 Neuroactive ligand-receptor interaction 5618_11255_1081_7068_7067_2908_2925_3363_5733_2696_23566_5645 12 + 0.0144466260406447 0.219107161616445 1370 quercetin hsa05320 Autoimmune thyroid disease 3439_3449_1081_3119_942_3447_3126_3127_3125_3135_355_3123_941 13 + 0.00352997036993261 0.0642454607327735 1371 quercetin hsa05016 Huntington's disease 5439_246721_548644_6648_23236 5 + 0.0010554691436988 0.0320158973588636 1372 quercetin hsa04740 Olfactory transduction 4991_808_81797_390892_81696_801_393046_805 8 + 6.34568593612756e-08 5.77457420187608e-06 1373 quercetin hsa05322 Systemic lupus erythematosus 8348_8329_3123_3126_3127_3125_8969_8968_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013_942_941_727 27 + 0.00208771572572693 0.0474955327602877 1374 quercetin hsa05219 Bladder cancer 23604_4313_3576_1613_5925_7422_1869_2261_2064 9 + 0.0380121030920112 0.288258448447752 1375 quercetin hsa05012 Parkinson's disease 6622 1 + 0.000147995171978534 0.0067337803250233 1376 quercetin hsa04260 Cardiac muscle contraction 4635_6548 2 + 0.0322948469285634 0.288258448447752 1377 quercetin hsa05330 Allograft rejection 3119_3126_942_3127_3125_3135_355_3123_941 9 + 0.0168933927814731 0.21961410615915 1378 quercetin hsa04940 Type I diabetes mellitus 3382_3119_942_3126_3127_3125_3135_355_3123_941 10 + 0.0230368650364086 0.240588288069708 1379 quercetin hsa04080 Neuroactive ligand-receptor interaction 2859_1813_2561_7068_6754_3362_4887_7067_799_2692_2690 11 - 0.0203469823154401 0.382580008858813 1380 quercetin hsa04740 Olfactory transduction 818_5593_409 3 - 1.29115954696447e-10 1.12330880585909e-08 1381 quercetin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3017_940_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344 21 - 0.0263848281971595 0.382580008858813 1382 quercetin hsa04710 Circadian rhythm - mammal 406_8864_8863_9575 4 - 0.0383121291722489 0.476165033997951 1383 quercetin hsa05012 Parkinson's disease 4714_51465_836_6622 4 - 0.0250158509362229 0.382580008858813 1384 quercetin hsa04060 Cytokine-cytokine receptor interaction 3581_3553_1438_939_7422_7042_8795_2690 8 - 0.00119514545921394 0.0519888274758064 1385 quercetin hsa04020 Calcium signaling pathway 5331_5257_3362_818_3709_490 6 - 0.0131528983886056 0.381434053269562 1386 fludrocortisone hsa04916 Melanogenesis 7299_11211_8321_816 4 + 0.00212170373423183 0.0636511120269549 1387 fludrocortisone hsa05332 Graft-versus-host disease 3812_3824_3119_3105_3106_3126_3127_3125_3135_3811_5551_3123_649853 13 + 0.0245576251191993 0.26268141775496 1388 fludrocortisone hsa05010 Alzheimer's disease 2902_1339_3710_6392_317_6390_651820_3709_22926_4023_6622_517 12 + 0.00578260484521111 0.13010860901725 1389 fludrocortisone hsa04310 Wnt signaling pathway 56998_8945_324_5599_4775_8312_4776_11211_5467_5602_8321_816 12 + 0.0336061445372512 0.274959364395692 1390 fludrocortisone hsa05016 Huntington's disease 2902_6648_6392_317_6390_1339_651820_5468_517 9 + 0.000143963448025201 0.00647835516113404 1391 fludrocortisone hsa04740 Olfactory transduction 219464_26211_5593_8390_26664_9635_4991_393046_816 9 + 5.37535367252022e-14 4.8378183052682e-12 1392 fludrocortisone hsa05322 Systemic lupus erythematosus 3119_94239_3123_721_3126_3127_3125_727_720_8335_81 11 + 0.0291868241949955 0.26268141775496 1393 fludrocortisone hsa04530 Tight junction 9076_4301_10000_50848_5588_6709_51208_4626_3996_81_9223 11 + 0.0474980347727588 0.305344509253449 1394 fludrocortisone hsa04350 TGF-beta signaling pathway 91_7057_353500_4052 4 + 0.0112409388718425 0.184927503483006 1395 fludrocortisone hsa04062 Chemokine signaling pathway 1234_4283_3717_1230_1233_5829_6655_3576_7454_3718_7852_10000_5906_23533_2793_8503_6376 17 + 0.0370504726821603 0.277878545116202 1396 fludrocortisone hsa05012 Parkinson's disease 1339_7318_6392_651820_6390_317_7054_6622_517 9 + 0.0123285002322004 0.184927503483006 1397 fludrocortisone hsa03050 Proteasome 23198 1 + 0.0170805818047532 0.219607480346827 1398 fludrocortisone hsa05222 Small cell lung cancer 23533_8503_10000_598_3908_330_3673_3674_4149_3912_317_3918_1869_1284_1027_2335_3685_7189_5915_6257_7186_7187 22 + 0.0287071655569884 0.26268141775496 1399 fludrocortisone hsa04940 Type I diabetes mellitus 3382_3119_3105_3106_3126_3127_2571_3135_5551_1363_3123_3125_649853 13 + 0.0435154560500061 0.301260849576965 1400 fludrocortisone hsa04740 Olfactory transduction 1179 1 - 1.02509507430669e-07 8.81581763903753e-06 1401 fludrocortisone hsa05322 Systemic lupus erythematosus 8363_8362_3013_3017_940_8355_8358_8968_720_721_8350_8351_8352_8353_8354_87_8356_8357 18 - 0.00118569246206569 0.0509847758688247 1402 milrinone hsa05332 Graft-versus-host disease 3113_3126_3127_3123_3125 5 + 0.00350197591135074 0.039022542547861 1403 milrinone hsa04640 Hematopoietic cell lineage 1436_2812_3123_3126_3127_3125_931_925 8 + 0.00110842030957872 0.0360236600613084 1404 milrinone hsa05320 Autoimmune thyroid disease 3113_3126_3127_3123_3125 5 + 0.00861928840918619 0.0700317183246378 1405 milrinone hsa04612 Antigen processing and presentation 3123_3126_3127_3125_925_3113 6 + 0.0178586693508648 0.128979278645135 1406 milrinone hsa04740 Olfactory transduction 5137 1 + 0.00371544187378938 0.039022542547861 1407 milrinone hsa04514 Cell adhesion molecules (CAMs) 6403_3123_3126_3127_3125_57863_6614_925_3113 9 + 0.00417377796353587 0.039022542547861 1408 milrinone hsa05310 Asthma 3123_3126_3127_3113_3125 5 + 0.000916675680738481 0.0360236600613084 1409 milrinone hsa05330 Allograft rejection 3126_3113_3127_3123_3125 5 + 0.00235862041048418 0.039022542547861 1410 milrinone hsa04940 Type I diabetes mellitus 3113_3126_3127_3123_3125 5 + 0.00420242765900042 0.039022542547861 1411 milrinone hsa04080 Neuroactive ligand-receptor interaction 64106_1081_1909 3 - 0.0106068223309544 0.39775583741079 1412 milrinone hsa04740 Olfactory transduction 157_409 2 - 1.36308996451629e-05 0.00102231747338722 1413 milrinone hsa05322 Systemic lupus erythematosus 3013_8358_6738_8968_8350_8351_8352_8353_8354_8355_8356_8357 12 - 0.0399144160688463 0.748395301290868 1414 milrinone hsa04060 Cytokine-cytokine receptor interaction 3566_4233_9180_3572 4 - 0.0277378680555103 0.693446701387758 1415 dexpropranolol hsa04662 B cell receptor signaling pathway 933_23533_10000_11025 4 + 0.0230379468778312 0.67961943289602 1416 dexpropranolol hsa04350 TGF-beta signaling pathway 1875_653_4086_7042 4 + 0.0361931085644046 0.711797801766624 1417 dexpropranolol hsa04150 mTOR signaling pathway 23533_6794_10000_6196 4 + 0.00715977182507418 0.422426537679377 1418 dexpropranolol hsa04080 Neuroactive ligand-receptor interaction 64106 1 - 0.0228648010655793 1 1419 sertaconazole hsa04740 Olfactory transduction 56656 1 + 0.000793631690036713 0.0571414816826433 1420 sertaconazole hsa04130 SNARE interactions in vesicular transport 6804_9570_8417_2054_8675 5 - 0.0150564794204345 1 1421 sertaconazole hsa05200 Pathways in cancer 5154_6777_2737_7475_369 5 - 0.0462487685628102 1 1422 piperidolate hsa04740 Olfactory transduction 26211 1 + 0.00354340548427472 0.24803838389923 1423 piperidolate hsa04080 Neuroactive ligand-receptor interaction 64106_5618_7442_56288 4 - 0.0201158033596974 0.54312669071183 1424 piperidolate hsa04740 Olfactory transduction 157 1 - 7.658562861984e-07 6.20343591820704e-05 1425 piperidolate hsa05322 Systemic lupus erythematosus 85235_3123_3013_3126_3127_3125_8332_8969_8331_8336_8337_8351_8343_8329_8339_8347_8346_8330_8344 19 - 9.62245159898984e-05 0.00389709289759089 1426 clofibrate hsa05010 Alzheimer's disease 2903_2902_22926_489_6622_4842 6 + 0.0233123667834774 0.524528252628241 1427 clofibrate hsa05016 Huntington's disease 2902_246721_27113_5441_5439_548644 6 + 0.013141756899926 0.39425270699778 1428 clofibrate hsa04740 Olfactory transduction 5566_8390_26716_818_815_409_817 7 + 4.58023318048865e-07 4.12220986243979e-05 1429 clofibrate hsa04530 Tight junction 5010_93408_208_8573 4 + 0.0348382771291959 0.627088988325526 1430 clofibrate hsa05012 Parkinson's disease 6622 1 + 0.000468857790786056 0.0210986005853725 1431 clofibrate hsa05010 Alzheimer's disease 2902_1327_1329_351_8851_4843 6 - 0.031187204873256 0.918264108579534 1432 clofibrate hsa04080 Neuroactive ligand-receptor interaction 2911_7442_2902_3360_2568_4886_3062_3350_9568_4543_1901 11 - 0.042709958538583 0.918264108579534 1433 clofibrate hsa04740 Olfactory transduction 7932_157_8388_8387_5566_26476_815 7 - 9.57074734941692e-07 8.23084272049855e-05 1434 clofibrate hsa05012 Parkinson's disease 2861_1329_7416_1327 4 - 0.0340516685390701 0.918264108579534 1435 indometacin hsa04080 Neuroactive ligand-receptor interaction 2913_624_1133_4158_4829_4142_7434_3351_5644 9 + 0.0249694681343689 0.981516520645134 1436 indometacin hsa04740 Olfactory transduction 5566_26189_808_5137_801_393046_805 7 + 7.62146159541228e-06 0.000624959850823807 1437 indometacin hsa04740 Olfactory transduction 10798_815_8590 3 - 3.28327175220373e-12 2.95494457698336e-10 1438 indometacin hsa03010 Ribosome 6125_140801_9349 3 - 0.0343714070475982 1 1439 ciclosporin hsa04740 Olfactory transduction 26333_8390_5593_5568_157 5 + 1.52882571797727e-08 1.34536663182e-06 1440 ciclosporin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_2215_8370_8366_8348_8368_8367_554313_8359_89_8294_720_721_6738_121504_8364 20 + 0.0357238156067062 0.740994548661971 1441 ciclosporin hsa05212 Pancreatic cancer 64764_7184 2 + 0.0464021714605216 0.740994548661971 1442 ciclosporin hsa05012 Parkinson's disease 51465_6390_6622 3 + 0.00934262826227471 0.411075643540087 1443 ciclosporin hsa05010 Alzheimer's disease 4695_1327_5534_6263_1329_317_4137_487_3709_5664_810_4712_6622_517_842 15 - 0.0382224381270382 0.496891695651497 1444 ciclosporin hsa05016 Huntington's disease 5430_1211_4695_1327_4712_581_1329_317_246721_64446_23186_9001_5468_517_842 15 - 0.0149899238582277 0.311172551218172 1445 ciclosporin hsa04740 Olfactory transduction 26211_7932_8388_8387_5613_5566_5616_23538_81697_2978_26532_81797_810_815 14 - 8.77038273328274e-11 7.98104828728729e-09 1446 ciclosporin hsa05322 Systemic lupus erythematosus 2215_717_3013_942_720_721_8351_81 8 - 0.0031532019680718 0.143470689547267 1447 ciclosporin hsa04110 Cell cycle 995_9134_699_4193_5934_8556_8555_7042_8900 9 - 0.0461991741367595 0.525515605805639 1448 ciclosporin hsa05012 Parkinson's disease 4695_1327_4712_1329_317_6622_517_842 8 - 0.00560019793791726 0.16987267078349 1449 ciclosporin hsa04260 Cardiac muscle contraction 6546_1329_10369_1327_782 5 - 0.0381444387700191 0.496891695651497 1450 ciclosporin hsa03050 Proteasome 5717 1 - 0.0170973929240754 0.311172551218172 1451 LY-294002 hsa04916 Melanogenesis 4286_5579_5578_2775_1856_1857_5331_2535_6934_112_810_8324_23236_816_7306 15 + 0.0300754617527789 0.230578540104638 1452 LY-294002 hsa05010 Alzheimer's disease 2903_2902_1329_3553_842_841_54205_317_4137_5331_5532_3708_3709_6868_488_810_22926_7124_6622_517_23236 21 + 0.00025483090562507 0.00503698083226896 1453 LY-294002 hsa05016 Huntington's disease 2902_4899_1329_317_246721_5331_6875_1639_5439_7419_54205_7350_3708_9001_548644_23236_842_841_5441_5978_55567_517 22 + 0.000136209036481067 0.00417707711875272 1454 LY-294002 hsa04740 Olfactory transduction 26212_56656_23538_8390_1179_26539_5137_8392_810_393046_816 11 + 2.21961069342963e-26 2.04204183795526e-24 1455 LY-294002 hsa05322 Systemic lupus erythematosus 2903_8361_8363_8362_8365_8364_8367_8360_8368_8335_9103_6738_8349_8348_8329_8294_121504_8343_8341_8347_7124_8345_8344_959_8339_723790_3109_8366_87_8969_8968_8346_55766_8370_2212_92815_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_85236_3012_3013_3113_3017_940_8970 62 + 0.00123947942118167 0.0190053511247856 1456 LY-294002 hsa04110 Cell cycle 995_699_1021_4173_4088_51343_4193_1028_5925_1869_898_10393_10912_1870_8555_1032_5111_8556 18 + 0.0330097702454503 0.233607604813956 1457 LY-294002 hsa03410 Base excision repair 10039_27343_5111 3 + 0.0466882570041432 0.306808546027227 1458 LY-294002 hsa04340 Hedgehog signaling pathway 6608_2737_8945_5727_353500 5 + 0.0112876439435825 0.148351891829941 1459 LY-294002 hsa03030 DNA replication 5111_4173 2 + 0.0149936643368854 0.160787738202013 1460 LY-294002 hsa05110 Vibrio cholerae infection 3784_5579_5578_8992_535_4583 6 + 0.0205611764020709 0.189162822899052 1461 LY-294002 hsa04062 Chemokine signaling pathway 23533_10000_156_3718_5290_7852_56288_112_6359_2309_7454_3579_3551_3576_25759_4793_998_2931_2185_3702_6093_23236_5331_6352_5579_6655_6358_6773_6372_5879_8976_10803 32 + 0.0157292352588926 0.160787738202013 1462 LY-294002 hsa05012 Parkinson's disease 1329_842_5413_6622_54205_317_65018_7419_9627_517 10 + 6.95391325783647e-06 0.000319880009860478 1463 LY-294002 hsa04260 Cardiac muscle contraction 7168_7169_782_783_9254_1329_786_10368_4635_488_7170 11 + 0.0295979278315443 0.230578540104638 1464 LY-294002 hsa03050 Proteasome 5717 1 + 0.000273748958275487 0.00503698083226896 1465 LY-294002 hsa05010 Alzheimer's disease 55851_2597_1327_2905_2902_1329_317_5663_5330_51806_5664_489_6622_3553_4698_11261_4712_322_509_810_348_776_5534_5532_3708_3709_4035_56901_488_836_8851_5331_1020_841_840_642502_6391_4137_1537_355_808_805_351_824_801_517 46 - 0.00466166231817907 0.0486884731009814 1466 LY-294002 hsa04080 Neuroactive ligand-receptor interaction 2902_1269_1268_155_886_1081_64106_2908_2901_5030_5031_152_56288_136_135_134_887_6870_3354_2905_4161_1813_2561_5540_3362_4142_5029_57105_2742_2151_4987_7433_9568_4988_5646_7068_1909_2912_2917_5021_1132_5025_6915_146_10203_5724_6865_8001_9170_2550_5618_4157_2557_7067_4158_6751_2893_1241_2798_8484_2897_2690 62 - 0.000101531582237934 0.00238599218259145 1467 LY-294002 hsa04742 Taste transduction 2785_6340_5568_5613_5566_5616_5330_51764_346562 9 - 0.00799579987328252 0.0738966680871318 1468 LY-294002 hsa05131 Shigellosis 7280_7277_347733_7278_113457_9475_60_3688_7430_9181_6093_81873 12 - 0.043670875107931 0.255582663038722 1469 LY-294002 hsa05016 Huntington's disease 2902_4899_1327_8218_1329_317_246721_5331_5330_3064_10126_5432_6648_5434_7052_4698_2033_509_56901_7419_1213_1211_3708_9001_836_161_5481_163_27113_4712_841_642502_6391_1537_55567_1387_517 37 - 1.51213807414807e-05 0.000473803263233062 1470 LY-294002 hsa05130 Pathogenic Escherichia coli infection 7280_7277_347733_7278_113457_9475_60_3688_7430_9181_6093_81873 12 - 0.043670875107931 0.255582663038722 1471 LY-294002 hsa04740 Olfactory transduction 51806_7932_157_8388_8387_219464_26211_5568_26333_5566_818_810_409_8392_2978_109_5613_5616_808_4992_816_4991_801_393046_805 25 - 3.69020519820307e-32 3.46879288631089e-30 1472 LY-294002 hsa04710 Circadian rhythm - mammal 8864_5187_8553_1454_406_1408_9575_9572_4862_79365_1407_8863 12 - 0.0462223965070029 0.255582663038722 1473 LY-294002 hsa04530 Tight junction 5010_4619_50855_6709_5521_56288_81_9223_87_5584_6714_5583_5581_93408_2036_84612_51776_5865_50848_55844_8777_60_9080_5519_3265_4628_26285_4620_8189_5728_1364_1457_4624_27134_1365 35 - 0.0110787437671815 0.0801078395473124 1474 LY-294002 hsa04062 Chemokine signaling pathway 3717_3576_1147_157_156_5296_6464_5294_8503_113_9475_115_5330_6387_56288_6358_10235_6359_2785_3055_5568_6349_6348_5566_5196_728830_643_25759_7410_5906_1398_6362_6366_409_673_109_3265_6093_10681_107_4793_6356_5331_5613_6777_5616_6772_6773_51764_414062_5291_2793_5970 53 - 0.00864748243572819 0.0738966680871318 1475 LY-294002 hsa04810 Regulation of actin cytoskeleton 8503_10298_5296_2909_5155_5154_9475_5605_5881_23365_23396_3655_10458_4659_87_9459_81_3985_3690_1730_3693_1445_56924_93408_7410_50649_7430_324_1398_2245_2260_2261_28964_5294_2264_10152_2768_1793_1132_8396_673_1956_3265_2263_4628_6093_10788_10093_60_3688_2335_1729_8394_3678_54961_6548_5291_3984_10787_81873_2251_2250 62 - 0.00949555101702442 0.0743818163000246 1476 LY-294002 hsa05012 Parkinson's disease 2861_1327_1329_317_9246_7345_6531_6622_7327_836_4698_509_7419_51465_56901_5481_7332_4712_642502_6391_1537_517 22 - 8.79732024704943e-06 0.000413474051611323 1477 LY-294002 hsa04260 Cardiac muscle contraction 784_7168_776_1327_27092_1329_6548_1537_4624_488_482_781 12 - 0.000237008521542812 0.00360129627417837 1478 LY-294002 hsa04060 Cytokine-cytokine receptor interaction 944_3576_29949_3594_3441_55540_8744_5155_5154_8764_3439_6387_9180_1896_3572_3455_27242_3554_3553_3556_2057_2324_3575_6348_5196_3446_355_3558_657_939_655_8718_6362_6366_3581_3601_3606_3815_23529_3589_3624_1956_7040_7043_91_8792_4233_8995_3467_1437_5618_1435_3566_3460_3568_970_7292_6358_6359_6356_643_7424_7422_51330_3447_2690 66 - 0.000268181637438815 0.00360129627417837 1479 LY-294002 hsa03010 Ribosome 6187_440589_285053_6181_6168_140801_9349_6205_6125_6142_284393_439992_6203_6165_389342_6189_6139 17 - 0.000226587325748716 0.00360129627417837 1480 LY-294002 hsa03050 Proteasome 5717_10197_23198_5718 4 - 0.000314518728646556 0.00369559506159703 1481 LY-294002 hsa04730 Long-term depression 5519_2768_2781_2982_50487_2767_2775_673_5331_5330_3708_3709_8681_5320_3265_5605_100137049 17 - 0.0451959836879079 0.255582663038722 1482 genistein hsa04916 Melanogenesis 2778_7306_5578_51384_2775_1857_108_434_2535_7474_23236 11 + 0.0332738989580118 0.252181088604797 1483 genistein hsa05010 Alzheimer's disease 4714_836_1020_4701_5532_4698_4713_355_4137_51107_3708_3709_6868_351_5534_22926_4712_6622_23236 19 + 0.00516451595297152 0.0686142833751931 1484 genistein hsa04080 Neuroactive ligand-receptor interaction 623_151_886_624_5030_56288_135_1909_9038_2568_3360_799_2742_4987_9568_5023_4889_1132_1131_4886_4887_3355_6915_3351_10203_3269_4543_23566_8001_2550_7068_2570_2692 33 + 0.0108397258071379 0.112010500007092 1485 genistein hsa05016 Huntington's disease 4714_6648_4712_4701_581_7052_1639_4713_293_7350_3708_3066_4698_836_55567_163_10126_23236 18 + 0.000965989528138001 0.029945675372278 1486 genistein hsa04740 Olfactory transduction 7932_8390_26716_2978_26532_409_4991_5137_8590_1258 10 + 3.54274113367216e-20 3.29474925431511e-18 1487 genistein hsa04510 Focal adhesion 5170_22798_394_5154_9475_5058_5602_3673_87_3693_7057_93408_1399_5293_1293_55742_1291_5295_208_3909_3725_1284_2335_5578_5599_6655_7422_6696 28 + 0.0425435005626491 0.252181088604797 1488 genistein hsa04110 Cell cycle 995_5591_5001_5000_993_9134_699_4193_5934_10912_3066_1871_1869_4616 14 + 0.0479015029077483 0.252181088604797 1489 genistein hsa05216 Thyroid cancer 5979 1 + 0.0488143971830937 0.252181088604797 1490 genistein hsa04720 Long-term potentiation 5578_5532_3708_3709_5534_27330_23236 7 + 0.0388551639062543 0.252181088604797 1491 genistein hsa04062 Chemokine signaling pathway 3717_5295_3551_108_208_6655_3576_3718_6772_9475_51764_5293_56288_8976_1399_10663_6370_5058_6387_409_23236 21 + 0.00416931164987711 0.0646243305730952 1492 genistein hsa05012 Parkinson's disease 4714_836_4712_4701_5413_4698_4713_6622_293 9 + 0.000198466954120671 0.0092287133666112 1493 genistein hsa04260 Cardiac muscle contraction 9254_27092_482_4635_4634 5 + 0.00252034694014968 0.0468784530867841 1494 genistein hsa04060 Cytokine-cytokine receptor interaction 8744_5154_6387_3452_3556_53832_2057_3576_657_10663_8718_3587_658_3581_3601_3605_3604_3976_3624_8200_3626_8792_8794_4352_3566_3454_11009_355_7422_6370 30 + 0.00151864327238035 0.0353084560828431 1495 genistein hsa03010 Ribosome 440589_6205_6187_6168_284393_6181_6144_6160_389342 9 + 0.0105377817340376 0.112010500007092 1496 genistein hsa03020 RNA polymerase 661 1 + 0.0488143971830937 0.252181088604797 1497 genistein hsa03050 Proteasome 5717_5689 2 + 0.0123262480942031 0.114634107276089 1498 genistein hsa05010 Alzheimer's disease 2902_2905_317_5663_487_6622_3553_11261_779_3709_4035_489_102_7124_5595_5594_841_642502_6391_355_808_805_801_517 24 - 0.00846514265559277 0.123279205416217 1499 genistein hsa05016 Huntington's disease 2902_5430_5439_627_841_581_7157_1639_8218_6391_317_6667_1213_27113_642502_1385_548644_7419_161_517_246721 21 - 0.000493345665425987 0.0154581641833476 1500 genistein hsa04740 Olfactory transduction 808_26211_5593_4993_26333_5566_1179_393046_818_2979_10798_8590_23538_805_801_219464_815_816_817 19 - 8.36041335620929e-18 7.85878855483673e-16 1501 genistein hsa03410 Base excision repair 3980_27301 2 - 0.0356055199977968 0.371879875532544 1502 genistein hsa04062 Chemokine signaling pathway 8503_3576_10000_156_2771_9475_10235_7454_3055_4067_3551_5829_5566_5196_1398_408_1233_208_2931_6352_10681_4793_5595_5594_6772_673_8976 27 - 0.00918036636078209 0.123279205416217 1503 genistein hsa05012 Parkinson's disease 2861_6570_7327_642502_6391_317_6531_7419_6622_517 10 - 4.51817123429794e-05 0.00212354048012003 1504 genistein hsa04260 Cardiac muscle contraction 6546_782_779_6548_10369_7170_4635_27092_7171 9 - 0.0227648707288643 0.267487231064156 1505 genistein hsa03010 Ribosome 6204_440589_6181_6205_6187_6168_284393_439992_6144_389342_6189 11 - 0.00809237619278545 0.123279205416217 1506 genistein hsa03050 Proteasome 5690 1 - 0.000740982719436627 0.0174130939067607 1507 thalidomide hsa05010 Alzheimer's disease 1020_2905_642502_6391_317_4137_322_5534 8 + 0.00630457686836589 0.178204454616361 1508 thalidomide hsa05200 Pathways in cancer 8312_598_10297_7482_5155_3909_5605_5880_5747_26291_652671_2308_4286_3576_5371_1857_5925_5900_2249_675_2263_284217_3082_3910_3480_1612_998_5293_6932_1956_2322_5467_7042_1869_3918_1436_1284_3688_2271_5578_861_7184_4914_1282_867_8817_51588_5915_2254_6257_2250 51 + 0.0374607357721699 0.505404580531897 1509 thalidomide hsa05320 Autoimmune thyroid disease 3107 1 + 0.0397509220643065 0.505404580531897 1510 thalidomide hsa05016 Huntington's disease 5432_246721_1211_7052_642502_6391_317_55567_293 9 + 0.00800918897152186 0.178204454616361 1511 thalidomide hsa04740 Olfactory transduction 7932_3000_5566_26716_26532_4992_409_4991_5137_5568_26529_23538_2979_817 14 + 1.02353666497075e-06 9.10947631823967e-05 1512 thalidomide hsa04540 Gap junction 2911_7280_7082_5568_1813_347733_5598_5566_5578_5155_5605_5607_1956_2767_113_112_10746_1902 18 + 0.0380378649992668 0.505404580531897 1513 thalidomide hsa05012 Parkinson's disease 642502_6391_317_293 4 + 0.00255068133448419 0.113505319384546 1514 thalidomide hsa04120 Ubiquitin mediated proteolysis 7337_8945_23759_331_22888_8554_6921 7 - 0.00457177823575856 0.138677273151343 1515 thalidomide hsa05010 Alzheimer's disease 2902_842_351_317_5530_56901_5664_810_824_7124_6622_1020 12 - 0.0129135921300953 0.293784220959668 1516 thalidomide hsa05016 Huntington's disease 2902_246721_1211_6648_842_1639_5439_317_6667_1175_7350_10540_56901_548644 14 - 0.0218243732070668 0.397203592368616 1517 thalidomide hsa04740 Olfactory transduction 219464_26211_1179_393046_10798_4993_810_815_816 9 - 9.26759710094454e-13 8.43351336185953e-11 1518 thalidomide hsa05012 Parkinson's disease 6622_6570_317_842_56901 5 - 0.000626876669058752 0.0285228884421732 1519 prednisolone hsa04080 Neuroactive ligand-receptor interaction 5618_4158_6915_10203_4987_9568_9038 7 + 0.00740978601999336 0.301089641973364 1520 prednisolone hsa04740 Olfactory transduction 8387_815_8388 3 + 2.35731158277624e-08 1.95656861370428e-06 1521 prednisolone hsa04810 Regulation of actin cytoskeleton 8396_3696_8817_10787_2263_6093 6 + 0.0135154772032832 0.301089641973364 1522 prednisolone hsa03010 Ribosome 140801 1 + 0.0145103441914874 0.301089641973364 1523 prednisolone hsa05214 Glioma 1021_208_4193_673_5925_1956_5335_1869_7039_801_808_805 12 - 0.0113622195988725 0.329504368367303 1524 prednisolone hsa04070 Phosphatidylinositol signaling system 3710_3636_56623_8396_5305_3707_8394_808_5335_801_8526_805 12 - 0.0333937863311188 0.418007612198815 1525 prednisolone hsa04740 Olfactory transduction 26211_5593_5613_5566_808_4993_801_805 8 - 5.75849887297571e-06 0.000500989401948887 1526 prednisolone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8347_8346_8344_8370_8359_554313_6738_121504_8339_942_720_721 23 - 0.00214838917864267 0.0934549292709562 1527 prednisolone hsa05223 Non-small cell lung cancer 1021_842_208_5915_673_5925_1956_5335_1869_7039 10 - 0.0232938925087682 0.405313729652567 1528 prednisolone hsa05012 Parkinson's disease 6570_842_56901 3 - 0.0186783942956424 0.405313729652567 1529 prednisolone hsa03010 Ribosome 6204_6181 2 - 0.0336327963838127 0.418007612198815 1530 MK-886 hsa05332 Graft-versus-host disease 3811_3553_3122_3804_3126_3127_3125_3135_3123_942 10 + 0.000196081472070417 0.00843150329902793 1531 MK-886 hsa04640 Hematopoietic cell lineage 3553_3122_3123_3568_3126_3127_3125_3575_921_931 10 + 0.0285955075641561 0.351316235788204 1532 MK-886 hsa05010 Alzheimer's disease 3553_5594_4842 3 + 0.0363300517539503 0.390548056354966 1533 MK-886 hsa05320 Autoimmune thyroid disease 3122_3126_942_3127_3125_3135_3123 7 + 0.0279816600337329 0.351316235788204 1534 MK-886 hsa04740 Olfactory transduction 815 1 + 6.87015548837825e-08 5.90833372000529e-06 1535 MK-886 hsa05310 Asthma 3122_3123_3126_3127_3125 5 + 0.0277589522298356 0.351316235788204 1536 MK-886 hsa05330 Allograft rejection 3122_3126_942_3127_3125_3135_3123 7 + 0.00618952946528242 0.133074883503572 1537 MK-886 hsa05210 Colorectal cancer 1630_5594_581_5599_5900_1857_4437_91_5879 9 + 0.0490461872080459 0.468663566654661 1538 MK-886 hsa04940 Type I diabetes mellitus 3553_3122_942_3126_3127_3125_3135_1363_3123 9 + 0.00105291001351666 0.0301834203874776 1539 MK-886 hsa03320 PPAR signaling pathway 2710_51703_6257_1579_4023_1376_5468_284541 8 - 0.0250845816497114 1 1540 MK-886 hsa04740 Olfactory transduction 26211_8388_8387_810_815_409 6 - 0.00177978727694807 0.142382982155846 1541 SR-95531 hsa05332 Graft-versus-host disease 3804_3107_3126_3127_3111_3125_3123_942 8 + 0.00472235795547003 0.0640513462294758 1542 SR-95531 hsa04640 Hematopoietic cell lineage 2323_1435_2812_3123_2993_3126_3127_3125_3570_933_1378_931_926 13 + 0.00254070178320179 0.0470633945347187 1543 SR-95531 hsa05320 Autoimmune thyroid disease 3448_1081_942_3107_3126_3127_3111_3125_3123 9 + 0.00544468955020763 0.0640513462294758 1544 SR-95531 hsa04612 Antigen processing and presentation 3448_3123_3107_3126_3127_3111_3125_6891_3804_926 10 + 0.043077674519787 0.366160233418189 1545 SR-95531 hsa04740 Olfactory transduction 4992_26529_8383_816 4 + 9.0241707672673e-06 0.00076705451521772 1546 SR-95531 hsa05322 Systemic lupus erythematosus 942_3123_3013_3126_3127_3111_3125_8358_6738_8968_8341_8350_8351_8352_8353_8354_8355_8356_8357 19 + 0.00125163536899097 0.0417145074696403 1547 SR-95531 hsa05218 Melanoma 5159_8817_1021_2250_3479_5293_8822_4193_2246_2247_4233_3082 12 + 0.0014722767342226 0.0417145074696403 1548 SR-95531 hsa05310 Asthma 3123_3126_3127_3111_3125 5 + 0.0372130741247341 0.351456811178044 1549 SR-95531 hsa05330 Allograft rejection 3593_942_3107_3126_3127_3111_3125_3123 8 + 0.00276843497263051 0.0470633945347187 1550 SR-95531 hsa04940 Type I diabetes mellitus 3593_3126_3107_942_3127_3111_3125_3123 8 + 0.00602836199806831 0.0640513462294758 1551 SR-95531 hsa04080 Neuroactive ligand-receptor interaction 1131_7442_5025_136 4 - 7.36206020693446e-11 3.4601682972592e-09 1552 SR-95531 hsa04742 Taste transduction 5613_3710 2 - 0.0412518100717314 0.352515467885705 1553 SR-95531 hsa04740 Olfactory transduction 5613_818_808_409_801_805 6 - 6.80326215428348e-16 6.39506642502647e-14 1554 SR-95531 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8343_8347_8346_8344_8339_3123_3126_3127_3125_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_85236_3013_9555 44 - 3.08471562095641e-05 0.000724908170924756 1555 SR-95531 hsa04110 Cell cycle 699_4089_23595_651610_4616_51343_51433_7534_1017_7531_7533_9978_902_5001_996_4193_10393_7027_8555_5591_4176_4172_4173_6502_1022_472_8317_5933_8556 29 - 0.0122518295735627 0.164524568559271 1556 SR-95531 hsa04512 ECM-receptor interaction 3691_960_7057_3912 4 - 0.0220802725593394 0.259443202572238 1557 SR-95531 hsa04260 Cardiac muscle contraction 7168_7381_7385 3 - 0.00792157884238403 0.14892568223682 1558 SR-95531 hsa04060 Cytokine-cytokine receptor interaction 3597_2057_3588_3459_5154_8741_3572_1956_90_51330 10 - 6.10096974690914e-07 1.91163718736486e-05 1559 SR-95531 hsa04020 Calcium signaling pathway 115_3710_5613_1131_5025_3709_808_818_1956_7416_136_801_7419_805_5257 15 - 0.0303843268325538 0.317347413584451 1560 SR-95531 hsa02010 ABC transporters 20 1 - 0.0383999702033481 0.352515467885705 1561 SR-95531 hsa04610 Complement and coagulation cascades 966_5329 2 - 0.0102985163789599 0.161343423270372 1562 cyanocobalamin hsa04740 Olfactory transduction 816 1 + 0.0076376264228825 0.21385353984071 1563 cyanocobalamin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 2.68236688012278e-06 0.000150212545286876 1564 cyanocobalamin hsa04740 Olfactory transduction 818_157_816 3 - 0.00140018820391768 0.052507057646913 1565 cyanocobalamin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_6737_8359_8294_8367_554313_121504 15 - 0.000313208658448774 0.0234906493836581 1566 metrizamide hsa04740 Olfactory transduction 26664 1 + 8.07186853320966e-05 0.00613462008523934 1567 metrizamide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 0.000428688058629446 0.0162901462279189 1568 metrizamide hsa04070 Phosphatidylinositol signaling system 5331_5296_5333_8394_51763 5 - 0.0449966426598141 0.532899808525609 1569 metrizamide hsa04740 Olfactory transduction 157 1 - 0.00177904229185186 0.135207214180741 1570 metrizamide hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_6738_8336 8 - 0.0300684557528225 0.532899808525609 1571 metrizamide hsa04710 Circadian rhythm - mammal 79365_1408 2 - 0.0490828771010429 0.532899808525609 1572 metrizamide hsa04210 Apoptosis 3553_5296_472_51135_8837_651610 6 - 0.0265955714006995 0.532899808525609 1573 metrizamide hsa04150 mTOR signaling pathway 5296_6196_5170_7422 4 - 0.0450683359551042 0.532899808525609 1574 metrizamide hsa03020 RNA polymerase 5432_246721_5439_548644 4 - 0.00767867536494328 0.291789663867845 1575 lumicolchicine hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0363396115899527 1 1576 apigenin hsa05322 Systemic lupus erythematosus 3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 11 + 1.1659364407439e-06 5.01352669519877e-05 1577 apigenin hsa05219 Bladder cancer 1026_1612_4193 3 + 0.0137128735023958 0.196551186867673 1578 apigenin hsa04115 p53 signaling pathway 64393_55367_1026_4193_7249 5 + 0.00139063415704228 0.029898634376409 1579 apigenin hsa04640 Hematopoietic cell lineage 3554_3566_2057_4254_1604_3678 6 - 0.00246702633098743 0.020132603675824 1580 apigenin hsa05010 Alzheimer's disease 5533_776_836_842_840_2932_5530_5663_102_5532_3709_351_5534_5332_8851_7132_23236 17 - 0.00058350652396539 0.00649151007911496 1581 apigenin hsa04080 Neuroactive ligand-receptor interaction 5618_2561_2908_5025_4886_5031_3354_2150_136_7433_2690_2149_9170 13 - 2.50037277196114e-10 1.11266588352271e-08 1582 apigenin hsa04742 Taste transduction 2778_5567 2 - 0.00248829933071982 0.020132603675824 1583 apigenin hsa04612 Antigen processing and presentation 4801_2923_6891_3306_1385_3304_3305_3303 8 - 0.0109785762868044 0.0644454063227756 1584 apigenin hsa05016 Huntington's disease 23236_1387_836_842_581_5439_5430_246721_5978_2033_5332_1385_548644_5481_291 15 - 3.67381110532894e-05 0.000653938376748551 1585 apigenin hsa04740 Olfactory transduction 818_5567_157 3 - 5.83262506398221e-29 5.19103630694417e-27 1586 apigenin hsa04514 Cell adhesion molecules (CAMs) 9076_965_214_4685_9080_57863_6383_6693_26047_5817 10 - 0.000255556756671533 0.00324922162053806 1587 apigenin hsa04920 Adipocytokine signaling pathway 2181_7132_6257_1147 4 - 0.00460670523441338 0.0341663971552326 1588 apigenin hsa04512 ECM-receptor interaction 3912_961_7057_3678_6383_3339_3161 7 - 0.00864086096840896 0.0549311875848855 1589 apigenin hsa05012 Parkinson's disease 2861_7326_836_842_51465_5481_291 7 - 7.40177140848431e-06 0.000164689413838776 1590 apigenin hsa04260 Cardiac muscle contraction 784_776_7171_481_6548 5 - 0.00174741303440365 0.0172799733402139 1591 apigenin hsa04060 Cytokine-cytokine receptor interaction 5154_8741_6387_7132_3556_27242_3554_3454_3455_3572_657_4982_8718_3601_4254_8742_1956_7042_91_8792_92_4233_5618_3566_2057_7424_7422_51330_2690 29 - 0.000244045922287411 0.00324922162053806 1592 apigenin hsa03010 Ribosome 6125 1 - 7.15474709262777e-08 2.12257497081291e-06 1593 apigenin hsa03050 Proteasome 9491_23198 2 - 0.00808663623625701 0.0549311875848855 1594 apigenin hsa05210 Colorectal cancer 8503_8312_4087_4088_4089_5295_5290_4437_4436_8324_7976_8321_8322_836_1856_324_581_3480_2932_673_1956_6934_7042_91_3725_2956_4233_842_6655_3845_2535 31 - 0.0133955391456522 0.0701295872919439 1595 apigenin hsa04940 Type I diabetes mellitus 1363_2571 2 - 0.0115856910243192 0.0644454063227756 1596 dl-alpha tocopherol hsa04210 Apoptosis 5613_5575_5616 3 + 0.0353843286380251 0.219415218080338 1597 dl-alpha tocopherol hsa04340 Hedgehog signaling pathway 5613_5616_653 3 + 0.0115122906698037 0.157998911262238 1598 dl-alpha tocopherol hsa04010 MAPK signaling pathway 9064_5598_5616_8912_4763_5613 6 + 0.0219701304920012 0.171367017837609 1599 dl-alpha tocopherol hsa04540 Gap junction 5598_5616_5613 3 + 0.0393822186298043 0.219415218080338 1600 dl-alpha tocopherol hsa04020 Calcium signaling pathway 8912_5613_4638_5616_489 5 + 0.0162050165397167 0.157998911262238 1601 dl-alpha tocopherol hsa04912 GnRH signaling pathway 5598_5616_5613_5338 4 + 0.0114640438267695 0.157998911262238 1602 dl-alpha tocopherol hsa04270 Vascular smooth muscle contraction 5613_4638_5616_5581 4 + 0.0152921759457662 0.157998911262238 1603 dl-alpha tocopherol hsa04070 Phosphatidylinositol signaling system 8871_5728_5333_3709_3708_8821_4952_3707 8 - 0.0156292959704298 0.208390612939064 1604 dl-alpha tocopherol hsa04080 Neuroactive ligand-receptor interaction 5618_4886 2 - 0.00469421518058584 0.125179071482289 1605 dl-alpha tocopherol hsa05200 Pathways in cancer 5728_836_4149_841_581_898_5602_4193_6772_1613_355_1956_2271_8324_91_3655_4254_1017_4233_7475_7422 21 - 0.047767282823235 0.474486254462427 1606 dl-alpha tocopherol hsa04740 Olfactory transduction 5566 1 - 5.37516544324812e-06 0.00043001323545985 1607 dl-alpha tocopherol hsa04210 Apoptosis 836_3552_841_581_5566_472_355_651610_8795 9 - 0.0133353532053534 0.208390612939064 1608 dl-alpha tocopherol hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_28964_1956_5603_5602_102_1432_4233 8 - 0.0110369158881142 0.208390612939064 1609 dl-alpha tocopherol hsa04115 p53 signaling pathway 55367_5728_1017_836_841_581_898_4194_4193_472_355_651610_8795 13 - 1.39244079037515e-05 0.00055697631615006 1610 dl-alpha tocopherol hsa04912 GnRH signaling pathway 1432_5566_3709_2002_3708_1956_5603_5602_81579 9 - 0.0468660586451019 0.474486254462427 1611 convolamine hsa05211 Renal cell carcinoma 112399_6655_998_7422_1399_5781 6 + 0.0135592358162024 0.298303187956453 1612 convolamine hsa04740 Olfactory transduction 26212_9635 2 + 0.00461160868747326 0.152183086686618 1613 convolamine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3108_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013 27 + 1.40355634293858e-14 9.26347186339463e-13 1614 convolamine hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0456324494739526 0.752935416320218 1615 convolamine hsa05014 Amyotrophic lateral sclerosis (ALS) 5606_5600_5534 3 - 0.0268418898586403 0.881506226985325 1616 cinchonidine hsa05211 Renal cell carcinoma 405_7422_4233_5781_998 5 + 0.0385198480909035 0.953907779210348 1617 cinchonidine hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_998_5781_1432_4233_23545 6 + 0.0107096246069949 0.717544848668658 1618 cinchonidine hsa04662 B cell receptor signaling pathway 5296_933_27071_8519 4 - 0.0331195891243053 0.640312056403236 1619 cinchonidine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_8294_8367_554313_121504 15 - 1.92535735550526e-08 1.11670726619305e-06 1620 cinchonidine hsa05218 Melanoma 1869_5296_2260_4286 4 - 0.028067817486794 0.640312056403236 1621 cinchonidine hsa05222 Small cell lung cancer 1869_598_5296_2335 4 - 0.0495880093222256 0.719026135172271 1622 acepromazine hsa04640 Hematopoietic cell lineage 915_1378_3568_2993_3589 5 + 0.0125294880803543 0.226471139940915 1623 acepromazine hsa05014 Amyotrophic lateral sclerosis (ALS) 10452_5534_1432_581 4 + 0.0125817299967175 0.226471139940915 1624 acepromazine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_718_8368_8366_8359_8294_8367_554313_121504 15 + 1.48294095956821e-08 8.00788118166833e-07 1625 acepromazine hsa05332 Graft-versus-host disease 3135_3105_3106_3119_649853 5 - 0.0270797268022146 0.41285722560937 1626 acepromazine hsa04080 Neuroactive ligand-receptor interaction 64106 1 - 0.0011580126140762 0.0451624919489718 1627 acepromazine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8348_8294_8367_554313_121504_3119 16 - 0.000229269521454078 0.0178830226734181 1628 acepromazine hsa03020 RNA polymerase 246721_5439_548644_84172 4 - 0.030558707271677 0.41285722560937 1629 acepromazine hsa05330 Allograft rejection 3135_3105_3106_3119_649853 5 - 0.01910108263539 0.41285722560937 1630 acepromazine hsa04940 Type I diabetes mellitus 3135_3105_3106_3119_649853 5 - 0.0317582481237977 0.41285722560937 1631 berberine hsa04740 Olfactory transduction 2978 1 + 0.00517240453328015 0.170689349598245 1632 berberine hsa05322 Systemic lupus erythematosus 3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 11 + 0.000335008455707316 0.0221105580766829 1633 berberine hsa04916 Melanogenesis 5331_5578_2776_115_109_6934_7477 7 - 0.0484020940545352 0.552108717759592 1634 berberine hsa04080 Neuroactive ligand-receptor interaction 64106 1 - 0.00785381073135467 0.270956470231736 1635 berberine hsa04740 Olfactory transduction 109 1 - 0.000178996066782675 0.0123507286080046 1636 berberine hsa04540 Gap junction 5331_5578_7278_113457_2776_115_109 7 - 0.0299514285951862 0.552108717759592 1637 hydroquinine hsa05214 Glioma 5605_10000_4193_816 4 + 0.0209728852486814 0.250674271837379 1638 hydroquinine hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_842_836_5868_581 5 + 0.00232221331299478 0.0777941459853251 1639 hydroquinine hsa04210 Apoptosis 836_5566_10000_842_581 5 + 0.0143668257884237 0.250674271837379 1640 hydroquinine hsa04664 Fc epsilon RI signaling pathway 5605_1432_10000_2205 4 + 0.0379179655611649 0.250674271837379 1641 hydroquinine hsa04370 VEGF signaling pathway 5605_1432_10000_842 4 + 0.035130517085606 0.250674271837379 1642 hydroquinine hsa05219 Bladder cancer 5605_2261_4193 3 + 0.0310195261798149 0.250674271837379 1643 hydroquinine hsa05218 Melanoma 5605_2247_10000_4193 4 + 0.0275063546816006 0.250674271837379 1644 hydroquinine hsa04115 p53 signaling pathway 842_836_4193_581 4 + 0.0252087330056911 0.250674271837379 1645 hydroquinine hsa04010 MAPK signaling pathway 3305_1432_836_5566_5605_4763_51776_2261_10000_2247_23162_5536 12 + 0.00138179061294302 0.0777941459853251 1646 hydroquinine hsa04912 GnRH signaling pathway 5605_5566_1432_816_112 5 + 0.0292518349828937 0.250674271837379 1647 hydroquinine hsa05210 Colorectal cancer 836_10000_842_581 4 + 0.045427923983365 0.250674271837379 1648 hydroquinine hsa04740 Olfactory transduction 109 1 - 0.0221646098749858 0.354633757999773 1649 hydroquinine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294 21 - 1.47628370041054e-13 7.08616176197059e-12 1650 hydroquinine hsa04540 Gap junction 7278_112_113457_109_5154 5 - 0.020528015567313 0.354633757999773 1651 physostigmine hsa05322 Systemic lupus erythematosus 85235_8969_8332_8330_8331_8329_8336 7 + 0.00469434322987435 0.21593978857422 1652 physostigmine hsa04350 TGF-beta signaling pathway 3400_4090_83729_3624 4 + 0.0361931085644046 0.832441496981306 1653 physostigmine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_3020_8359_3021_8367_554313_121504_9555_8294 18 - 3.01533128150827e-08 1.92981202016529e-06 1654 hydrocotarnine hsa04640 Hematopoietic cell lineage 3690_3581_924 3 + 0.0488228911898949 0.866197651252266 1655 hydrocotarnine hsa04662 B cell receptor signaling pathway 8503_4067_6655_7409_5534_3725 6 - 0.0430515721877322 0.828742764613845 1656 hydrocotarnine hsa04740 Olfactory transduction 818 1 - 8.14787051303021e-05 0.00627386029503326 1657 hydrocotarnine hsa04060 Cytokine-cytokine receptor interaction 9180_3455 2 - 0.0187635844533333 0.502713967579963 1658 hydrocotarnine hsa03020 RNA polymerase 246721_5439_548644_10622 4 - 0.0195862584771414 0.502713967579963 1659 pseudopelletierine hsa05332 Graft-versus-host disease 3126_3108_3127_3123_3125 5 + 0.000435174684811538 0.00793872053694156 1660 pseudopelletierine hsa04640 Hematopoietic cell lineage 3123_3126_3127_3125 4 + 0.0361931085644046 0.241287390429364 1661 pseudopelletierine hsa05320 Autoimmune thyroid disease 3126_3108_3127_3123_3125 5 + 0.00115245538660453 0.0138294646392544 1662 pseudopelletierine hsa04612 Antigen processing and presentation 3123_3108_3126_3127_3125 5 + 0.00933430562124095 0.080008333896351 1663 pseudopelletierine hsa04514 Cell adhesion molecules (CAMs) 24146_965_3108_3123_3126_3127_3125 7 + 0.00321923647305307 0.0321923647305307 1664 pseudopelletierine hsa04115 p53 signaling pathway 8795_54205_27113_3486 4 + 0.0177631921026057 0.133223940769543 1665 pseudopelletierine hsa05310 Asthma 3123_3125_3108_3127_3126 5 + 0.000105069964695379 0.00630419788172274 1666 pseudopelletierine hsa05330 Allograft rejection 3126_3108_3127_3123_3125 5 + 0.000285336429790278 0.00793872053694156 1667 pseudopelletierine hsa04940 Type I diabetes mellitus 3126_3108_3127_3123_3125 5 + 0.000529248035796104 0.00793872053694156 1668 pseudopelletierine hsa04070 Phosphatidylinositol signaling system 64768_5578_8394_5295_3633_3709_51763_5336_23236 9 - 0.0386953804740182 0.336953265308008 1669 pseudopelletierine hsa04080 Neuroactive ligand-receptor interaction 64106_5618_2150_7068 4 - 0.00569246647978722 0.144209150821276 1670 pseudopelletierine hsa05131 Shigellosis 9076_5578_999_998_9475_60_2534 7 - 0.0378031671985338 0.336953265308008 1671 pseudopelletierine hsa05130 Pathogenic Escherichia coli infection 9076_5578_999_998_9475_60_2534 7 - 0.0378031671985338 0.336953265308008 1672 pseudopelletierine hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_842_596_598_11261_5606_5868 7 - 0.0378031671985338 0.336953265308008 1673 pseudopelletierine hsa04740 Olfactory transduction 219464 1 - 7.17201105417139e-08 5.45072840117026e-06 1674 pseudopelletierine hsa05322 Systemic lupus erythematosus 3014 1 - 0.0108925729633938 0.206958886304482 1675 pseudopelletierine hsa04210 Apoptosis 842_3551_596_598_11261_5295_331_8795_841_8717_8837_5576_5575 13 - 0.00172879829462365 0.0656943351956987 1676 pseudopelletierine hsa04370 VEGF signaling pathway 9261_1432_842_5578_11261_5295_998_7422_5336 9 - 0.039902360365422 0.336953265308008 1677 pseudopelletierine hsa05110 Vibrio cholerae infection 5578_375_5336_60_523_528_55176 7 - 0.0468787460830077 0.356278470230858 1678 lobeline hsa05332 Graft-versus-host disease 3812_3113_3119 3 + 0.0205997025835892 0.346917885610951 1679 lobeline hsa04612 Antigen processing and presentation 3812_3305_3113_3119 4 + 0.0330331947788169 0.346917885610951 1680 lobeline hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_842 3 + 0.0414230311177255 0.346917885610951 1681 lobeline hsa04360 Axon guidance 2047_57715_4233_10505_9475 5 + 0.0323530434071602 0.346917885610951 1682 lobeline hsa05218 Melanoma 5296_2247_4233_3479 4 + 0.0164179139287265 0.346917885610951 1683 lobeline hsa04350 TGF-beta signaling pathway 654_6667_10468_9475 4 + 0.0308371345107995 0.346917885610951 1684 lobeline hsa04540 Gap junction 2983_5607_1813_23236 4 + 0.0376938992552248 0.346917885610951 1685 lobeline hsa05210 Colorectal cancer 5296_11211_4233_842 4 + 0.0277098256900189 0.346917885610951 1686 lobeline hsa04080 Neuroactive ligand-receptor interaction 706_4886 2 - 1.48010593587561e-08 6.73448200823403e-07 1687 lobeline hsa04520 Adherens junction 7454_10458_5595_5594_4088_4233_2064_1457_8936_7082_5819_1500_1387_6934_7525_2260_81_3643_2534 19 - 0.00130683400034158 0.0396406313436946 1688 lobeline hsa04740 Olfactory transduction 818_5566_157 3 - 9.42854874400524e-13 8.57997935704477e-11 1689 lobeline hsa05012 Parkinson's disease 27429_7327_7332_4701_4713 5 - 0.0174188641748769 0.2641861066523 1690 lobeline hsa04260 Cardiac muscle contraction 481 1 - 0.00633532430024825 0.115302902264518 1691 lobeline hsa04060 Cytokine-cytokine receptor interaction 3556_3601_3554_3566_3588_3459_7852_50616_9180_7042_655_4233 12 - 0.00517681746540142 0.115302902264518 1692 lobeline hsa04020 Calcium signaling pathway 115_5578_5566_818_5532_3709_489_2064_56848 9 - 0.0306067640856479 0.397887933113423 1693 calycanthine hsa04330 Notch signaling pathway 2648_22938_1488 3 - 0.0138979945553778 0.542021787659734 1694 Prestwick-675 hsa04514 Cell adhesion molecules (CAMs) 8516_3119_5818_23308_920_26047_5817 7 + 0.0147172712732439 0.897753547667878 1695 Prestwick-675 hsa04740 Olfactory transduction 157 1 - 0.0233250572769127 0.322052892265194 1696 Prestwick-675 hsa05322 Systemic lupus erythematosus 85235_3113_8330_8332_8969_8331_8329_8336 8 - 0.00408881324140981 0.257595234208818 1697 Prestwick-675 hsa04360 Axon guidance 2050_10154_6405_7852_5881_6092_10505 7 - 0.00862894384811617 0.271811731215659 1698 Prestwick-675 hsa04710 Circadian rhythm - mammal 1408_8863 2 - 0.0255597533543805 0.322052892265194 1699 Prestwick-675 hsa04540 Gap junction 7278_1813_113457_113_23236 5 - 0.0245757921951691 0.322052892265194 1700 sulmazole hsa05322 Systemic lupus erythematosus 2903_8361_8363_8362_8365_8364_8370_8360_8368_8366_3014_8359_8294_8367_554313_121504 16 + 6.58111054916484e-09 3.81704411851561e-07 1701 sulmazole hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 - 0.000118293119960969 0.00106317190732927 1702 sulmazole hsa04640 Hematopoietic cell lineage 3123_3126_3127_3125 4 - 0.00160947502476726 0.008283338097648 1703 sulmazole hsa05320 Autoimmune thyroid disease 3123_3126_3127_3125 4 - 0.000273630670645293 0.00173299424742019 1704 sulmazole hsa04612 Antigen processing and presentation 3123_3126_3127_3125 4 - 0.00174386065213642 0.008283338097648 1705 sulmazole hsa04514 Cell adhesion molecules (CAMs) 3123_3126_3127_3125_6693_5817 6 - 0.00011983518988569 0.00106317190732927 1706 sulmazole hsa05322 Systemic lupus erythematosus 3123_3126_3127_3125 4 - 0.0091493353737821 0.0386305271337467 1707 sulmazole hsa05310 Asthma 3123_3126_3127_3125 4 - 3.53274892309583e-05 0.00106317190732927 1708 sulmazole hsa05330 Allograft rejection 3123_3126_3127_3125 4 - 8.24903222129372e-05 0.00106317190732927 1709 sulmazole hsa04940 Type I diabetes mellitus 3123_3126_3127_3125 4 - 0.000139891040438062 0.00106317190732927 1710 iproniazid hsa05332 Graft-versus-host disease 3119_3821_3123_3458_3126_3127_3111_3125_356_3558 10 + 0.000415964214934694 0.00873524851362857 1711 iproniazid hsa05211 Renal cell carcinoma 10000_5063_208_2889_5155_7042_1387_4233_3082 9 + 0.0418083461581409 0.234126738485589 1712 iproniazid hsa04640 Hematopoietic cell lineage 1436_3581_1435_960_948_2057_2812_3123_945_3126_3127_3125_3589_4254_3674 15 + 0.000383968964342867 0.00873524851362857 1713 iproniazid hsa05200 Pathways in cancer 10000_596_4089_5155_330_8321_3674_5371_5727_8822_324_208_3082_23604_10319_3910_331_54205_4193_4254_5467_7042_91_5468_4233_1436_3688_1021_861_862_356_1387 32 + 0.00656298765456734 0.0612545514426285 1714 iproniazid hsa05320 Autoimmune thyroid disease 3448_3119_3123_3126_3127_3111_3558_356_3125 9 + 0.00599441939971229 0.0612545514426285 1715 iproniazid hsa04740 Olfactory transduction 8388_8387_26333_2979_810_816 6 + 9.69595689928199e-05 0.00407230189769844 1716 iproniazid hsa04510 Focal adhesion 29780_3910_3688_10000_1280_5063_596_331_2889_5155_330_3696_1277_208_3691_10319_1281_55742_4233_3674_3082 21 + 0.0167119639013219 0.127618633428276 1717 iproniazid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8294_3123_3458_3126_3127_3125_8370_8359_6737_121504_3119_3014_3111 23 + 3.46860072096673e-05 0.00291362460561205 1718 iproniazid hsa04210 Apoptosis 10000_596_208_5575_54205_331_330_5532_356_8837_8794 11 + 0.02327102771194 0.150366640600228 1719 iproniazid hsa05310 Asthma 3119_3123_3126_3127_3111_3125 6 + 0.0121585718862806 0.102132003844757 1720 iproniazid hsa04512 ECM-receptor interaction 10319_3688_1281_1280_948_3910_3691_2812_3696_1277_960_51206_3674 13 + 0.00219915126957225 0.026389815234867 1721 iproniazid hsa05330 Allograft rejection 3119_3123_3458_3126_3127_3111_3558_356_3125 9 + 0.000829787108715314 0.0139404234264173 1722 iproniazid hsa05210 Colorectal cancer 10000_596_4089_54205_4233_324_208_91_7042_8321 10 + 0.0362841001088176 0.217704600652906 1723 iproniazid hsa05222 Small cell lung cancer 10319_3688_1021_3910_596_208_54205_331_330_10000_3674 11 + 0.0202468814313405 0.141728170019383 1724 iproniazid hsa04940 Type I diabetes mellitus 3119_3123_3458_3126_3127_3111_3558_356_3125 9 + 0.00201904272609053 0.026389815234867 1725 iproniazid hsa05211 Renal cell carcinoma 4233_3725_405_5155_6655 5 - 0.0454581576046267 1 1726 iproniazid hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0464898223041555 1 1727 mafenide hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8370_83740_3123_8366_8360_8359_8362_8294_8367_554313_8368_121504_8341_8340 20 + 0.000146799928779933 0.0117439943023946 1728 mafenide hsa04062 Chemokine signaling pathway 3576_10235 2 + 0.00648240458504209 0.259296183401684 1729 mafenide hsa04070 Phosphatidylinositol signaling system 8394_5290_3631_8821_51763_8526 6 - 0.0121606821496224 0.667277893346343 1730 mafenide hsa04650 Natural killer cell mediated cytotoxicity 4276_11261_5290_673_6452_5058_8795_3106 8 - 0.0210200505718104 0.667277893346343 1731 mafenide hsa04115 p53 signaling pathway 11200_8795_5366_3732_4616 5 - 0.0290972337207536 0.667277893346343 1732 mafenide hsa05220 Chronic myeloid leukemia 861_7040_867_5290_673 5 - 0.0388712448616835 0.667277893346343 1733 SC-560 hsa05010 Alzheimer's disease 5533 1 + 0.0160992362161158 0.301860679052171 1734 SC-560 hsa05016 Huntington's disease 246721 1 + 0.0112727844107636 0.28181961026909 1735 SC-560 hsa04740 Olfactory transduction 157 1 + 5.37516544324812e-06 0.000403137408243609 1736 SC-560 hsa05322 Systemic lupus erythematosus 55506_8361_8363_8362_8365_8364_8370_8360_8368_8366_8359_8294_8367_554313_121504_3108 16 + 0.000456635248357697 0.0171238218134136 1737 SC-560 hsa04710 Circadian rhythm - mammal 1408_5187_8863 3 + 0.0220544529534704 0.330816794302056 1738 SC-560 hsa04080 Neuroactive ligand-receptor interaction 6915_4157_9170 3 - 0.000231612710895687 0.0104225719903059 1739 SC-560 hsa05200 Pathways in cancer 23533_4088_598_331_9618_5605_3326_5747_10342_2308_613_4286_6789_1613_1857_405_369_2263_1017_7477_23604_208_1398_999_4193_673_1495_91_5599_6502_861_7422_5914_5970_7184 35 - 0.00419189591925739 0.0679024882559593 1740 SC-560 hsa04910 Insulin signaling pathway 2308_5170_2002_23533_5599_5576_9470_369_6464_7249_673_5605_5564_208_51806_51763_1398_6009 18 - 0.00502302356124942 0.0679024882559593 1741 SC-560 hsa04740 Olfactory transduction 51806_109 2 - 2.83629504684332e-08 2.55266554215899e-06 1742 SC-560 hsa05212 Pancreatic cancer 2308_5970_5170_23533_208_4193_673_5605_3326_369_2263_1017_7184 13 - 0.00823633494513361 0.0679024882559593 1743 SC-560 hsa05215 Prostate cancer 2308_5970_5170_23533_208_4193_673_5605_3326_369_2263_1017_7184 13 - 0.00788201205428176 0.0679024882559593 1744 SC-560 hsa05219 Bladder cancer 23604_999_4193_1613_5605_7422_369_673 8 - 0.00772024429599113 0.0679024882559593 1745 SC-560 hsa04150 mTOR signaling pathway 23533_5170_92335_208_9470_7249_673_7422_6009 9 - 0.00829919300906169 0.0679024882559593 1746 SC-560 hsa04060 Cytokine-cytokine receptor interaction 91_23765_7422_2057_51330 5 - 0.00316452483235134 0.0679024882559593 1747 SC-560 hsa05213 Endometrial cancer 23533_5170_2002_208_999_673_5605_1495_369 9 - 0.00829919300906169 0.0679024882559593 1748 SC-560 hsa05220 Chronic myeloid leukemia 23533_4088_613_1398_6464_4193_673_5605_861_208_369_91_5970_598 14 - 0.000583504931833173 0.0175051479549952 1749 mefexamide hsa05200 Pathways in cancer 861_2260_862 3 + 0.0370491851293972 0.900205736385582 1750 mefexamide hsa04740 Olfactory transduction 5566_56656_26212 3 + 0.0145136484917248 0.841791612520038 1751 mefexamide hsa04510 Focal adhesion 3381 1 + 0.0465623656751163 0.900205736385582 1752 mefexamide hsa04070 Phosphatidylinositol signaling system 8394_8871_5333_23236_3631 5 - 0.00127092047097068 0.0749843077872701 1753 hydrastinine hsa04740 Olfactory transduction 8392_56656_1179 3 + 0.000243287922205837 0.0187331700098494 1754 hydrastinine hsa04530 Tight junction 5865 1 + 0.0455903121898194 1 1755 hydrastinine hsa04740 Olfactory transduction 409 1 - 0.000791382117527979 0.0601450409321264 1756 hydrastinine hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_1956_50848_5781_5603 5 - 0.0422101434363093 0.867016540005099 1757 hydrastinine hsa04540 Gap junction 7280_347733_5154_5607_1956_23236 6 - 0.0384642181646017 0.867016540005099 1758 hydrastinine hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0456324494739526 0.867016540005099 1759 metampicillin hsa05010 Alzheimer's disease 4698_3553_842_517_5664 5 + 0.0334142017232678 0.590642747873403 1760 metampicillin hsa04660 T cell receptor signaling pathway 29851_10298 2 + 0.0339449855099657 0.590642747873403 1761 metampicillin hsa04740 Olfactory transduction 5566_26692_4991 3 + 1.50628597978312e-08 1.31046880241131e-06 1762 metampicillin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8341_3108_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119_3014_720_721 27 + 2.51199540147402e-05 0.0010927179996412 1763 metampicillin hsa04270 Vascular smooth muscle contraction 5566_5579 2 + 0.0243468244540521 0.590642747873403 1764 metampicillin hsa05322 Systemic lupus erythematosus 3113_8343_8339_8347_8346_8344 6 - 0.0251109267217339 0.891790152298642 1765 metampicillin hsa02010 ABC transporters 6891_23457_4363 3 - 0.0330292648999497 0.891790152298642 1766 nifenazone hsa05332 Graft-versus-host disease 3812_57292_3811_3109_3119_3117_3804_3107_3113_3111_3802_3803 12 + 8.51522532893094e-05 0.00241264717653043 1767 nifenazone hsa04612 Antigen processing and presentation 3812_57292_3811_3809_3808_3119_3117_3804_3806_3113_3810_3803_3802_115653_6892_3111_3109_3107_972 19 + 2.90270946587657e-05 0.00123365152299754 1768 nifenazone hsa04740 Olfactory transduction 219464_8392 2 + 8.7883417483218e-09 7.47009048607353e-07 1769 nifenazone hsa04210 Apoptosis 8837 1 + 0.044230026411576 0.564594893567383 1770 nifenazone hsa05310 Asthma 958_3109_3119_3117_3113_3111 6 + 0.0214351272567363 0.364397163364517 1771 nifenazone hsa05012 Parkinson's disease 4698_7419_4713 3 + 0.0487888985434819 0.564594893567383 1772 nifenazone hsa05330 Allograft rejection 958_3109_3119_3117_3107_3113_3111 7 + 0.0192122930926932 0.364397163364517 1773 nifenazone hsa04080 Neuroactive ligand-receptor interaction 56288_2555_1812 3 - 0.0274170195606435 0.507214861871905 1774 nifenazone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_8337_554313_121504_85235_3119 23 - 3.92609671412987e-08 2.9053115684561e-06 1775 nifenazone hsa04060 Cytokine-cytokine receptor interaction 5155_7040_3455 3 - 0.0196306499881991 0.484222699708911 1776 nifenazone hsa05220 Chronic myeloid leukemia 4088_208_6777_1029_867_5296_7040_598 8 - 0.0108069899200332 0.399858627041228 1777 ethosuximide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3111_9103_3014_8359_8294_8367_554313_121504_3119 18 + 2.66281935034209e-10 1.59769161020525e-08 1778 ethosuximide hsa04512 ECM-receptor interaction 2812_51206_1311_3674_7060 5 + 0.0180898360012349 0.361796720024698 1779 ethosuximide hsa04540 Gap junction 7082_7278_113457_5330_80310_57369_6714 7 + 0.00159711118981364 0.0479133356944092 1780 ethosuximide hsa04330 Notch signaling pathway 8650_6868_5664 3 - 0.0212713078239005 0.42542615647801 1781 ethosuximide hsa03020 RNA polymerase 246721_5439_548644 3 - 0.00627712214662827 0.251084885865131 1782 chlorphenesin hsa05320 Autoimmune thyroid disease 3439_3447_3565_3558 4 + 0.0464543224612795 0.715189661644771 1783 chlorphenesin hsa04740 Olfactory transduction 26212 1 + 0.0017359954844314 0.137143643270081 1784 chlorphenesin hsa05221 Acute myeloid leukemia 861_6777_5371_652671_5467 5 + 0.0179411019896219 0.708673528590065 1785 chlorphenesin hsa04610 Complement and coagulation cascades 2155_721_7035_720_1378 5 + 0.031368065969223 0.715189661644771 1786 chlorphenesin hsa04070 Phosphatidylinositol signaling system 5333_5578_8396_23236 4 - 0.0234537600020798 0.445621440039516 1787 chlorphenesin hsa04540 Gap junction 115_6714_23236_1813_5578 5 - 0.0107466446798519 0.445621440039516 1788 chlorphenesin hsa04912 GnRH signaling pathway 115_3725_6714_23236_5578 5 - 0.0189203303379765 0.445621440039516 1789 aztreonam hsa05010 Alzheimer's disease 348 1 + 0.015459886261876 0.587475677951288 1790 aztreonam hsa04740 Olfactory transduction 26659_7932_81797_5613 4 + 0.00156357994192492 0.118832075586294 1791 aztreonam hsa05322 Systemic lupus erythematosus 717 1 + 0.0457000031220386 1 1792 aztreonam hsa04070 Phosphatidylinositol signaling system 8394_3707_5333_51763_3708 5 - 0.0456355950734548 0.83284961009055 1793 aztreonam hsa04912 GnRH signaling pathway 776_8399_3708_8681_5606_3725_100137049 7 - 0.0210727666881657 0.769155984118048 1794 aztreonam hsa04730 Long-term depression 3708_8681_100137049_8399_673 5 - 0.036189707874405 0.83284961009055 1795 aztreonam hsa04270 Vascular smooth muscle contraction 776_8399_100137049_4882_673_3708_9826_8681_4659 9 - 0.00356172110700453 0.260005640811331 1796 aceclofenac hsa04540 Gap junction 7082_2983_7278_5155_113457_3708 6 + 0.00966566237012026 0.483283118506013 1797 aceclofenac hsa04730 Long-term depression 2983_3708_8681_100137049 4 + 0.0488322342968738 1 1798 aceclofenac hsa04070 Phosphatidylinositol signaling system 8394_56623_3633_23236 4 - 0.0463516218406881 0.785424307309382 1799 aceclofenac hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344 19 - 2.88887938348168e-11 1.70443883625419e-09 1800 telenzepine hsa05322 Systemic lupus erythematosus 3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 11 + 0.000177876566778717 0.0103168408731656 1801 telenzepine hsa05214 Glioma 5578_5154_5290_1956_808_5335_1869_801_805 9 - 0.000188617821484163 0.00688455048417195 1802 telenzepine hsa04070 Phosphatidylinositol signaling system 5578_5290_8526_808_5335_51763_801_3707_805 9 - 0.000539400578665701 0.0131254140808654 1803 telenzepine hsa04910 Insulin signaling pathway 5575_5290_808_23265_51763_9322_801_805_5792 9 - 0.020627072993189 0.210486484403397 1804 telenzepine hsa04740 Olfactory transduction 801_808_805 3 - 0.0104820571556017 0.153038034471785 1805 telenzepine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_727_8368_8366_6738_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344 21 - 4.70913793051365e-09 3.43767068927496e-07 1806 telenzepine hsa05212 Pancreatic cancer 5154_5290_1956_1869_2260_4790 6 - 0.0474767872053427 0.286833492825896 1807 telenzepine hsa05215 Prostate cancer 5154_5290_1956_1869_2260_4790 6 - 0.0454838606874425 0.286833492825896 1808 telenzepine hsa04664 Fc epsilon RI signaling pathway 5578_5290_8681_7409_5335_100137049 6 - 0.0298976489279751 0.242503152415798 1809 telenzepine hsa04370 VEGF signaling pathway 8877_5578_5290_8681_5335_7422_5534_100137049 8 - 0.00234123066475504 0.0427274596317795 1810 telenzepine hsa05218 Melanoma 4286_5154_5290_1956_1869_2260 6 - 0.0194137494573003 0.210486484403397 1811 telenzepine hsa05223 Non-small cell lung cancer 1869_1956_5335_5290_5578 5 - 0.0230670119894134 0.210486484403397 1812 telenzepine hsa04912 GnRH signaling pathway 5578_808_1956_8681_801_100137049_805 7 - 0.039904987716165 0.286833492825896 1813 lasalocid hsa04740 Olfactory transduction 26211_26212_5566_1179 4 + 2.58072485679973e-05 0.00113551893699188 1814 lasalocid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013 30 + 2.26839576069024e-09 1.99618826940741e-07 1815 lasalocid hsa05310 Asthma 3123_3126_3127_3119_3125 5 + 0.0291191989906682 0.854163170392934 1816 lasalocid hsa04010 MAPK signaling pathway 8912_5607_3554_4137_3925 5 - 0.0175815351992465 0.457119915180409 1817 cefotetan hsa04740 Olfactory transduction 23538_5568 2 + 6.41172981239079e-06 0.000525761844616045 1818 cefotetan hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_2215_8370_2214_3117_8368_8366_8359_88_8294_8367_554313_121504_8364 18 + 0.000248019344417785 0.0101687931211292 1819 cefotetan hsa05131 Shigellosis 7100_7278_6093_113457 4 - 0.0271111211223254 0.406666816834881 1820 cefotetan hsa05130 Pathogenic Escherichia coli infection 7100_7278_6093_113457 4 - 0.0271111211223254 0.406666816834881 1821 cefotetan hsa04740 Olfactory transduction 157 1 - 0.00740148004105896 0.222044401231769 1822 cefotetan hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_6738_121504 15 - 3.33138325703391e-07 1.99882995422035e-05 1823 iocetamic acid hsa04740 Olfactory transduction 26211_26212_5566_816 4 + 0.0363362451398112 1 1824 iocetamic acid hsa04020 Calcium signaling pathway 146_887_886_5330_5566_2925_6915_8911_2185_3269_816 11 + 0.0205305349720939 1 1825 iocetamic acid hsa04070 Phosphatidylinositol signaling system 1609_5333_51763_23236 4 - 0.0311521743989069 0.778804359972672 1826 iocetamic acid hsa05120 Epithelial cell signaling in Helicobacter pylori infection 10392_7082_5600_998 4 - 0.0253275523521581 0.778804359972672 1827 cefoxitin hsa05220 Chronic myeloid leukemia 7042_1488_6655_6777 4 + 0.0324664590984663 1 1828 cefoxitin hsa05131 Shigellosis 7278_7430_113457 3 - 0.00921493921890054 0.142831557892958 1829 cefoxitin hsa05130 Pathogenic Escherichia coli infection 7278_7430_113457 3 - 0.00921493921890054 0.142831557892958 1830 cefoxitin hsa04540 Gap junction 7278_2767_113457 3 - 0.033430288072879 0.345446310086416 1831 iopromide hsa05214 Glioma 5296_208_1956_1021 4 + 0.0318854344011399 0.157149640977047 1832 iopromide hsa05211 Renal cell carcinoma 5296_208_7428_1399_3725 5 + 0.0108417659090912 0.0831202053030325 1833 iopromide hsa05200 Pathways in cancer 11186_23604_1021_1282_861_208_5296_1956_1399_2258_91_3725_2247_7428 14 + 0.00284289639167702 0.0405463411812295 1834 iopromide hsa04510 Focal adhesion 8515_1282_5829_208_5296_1956_1399_3725_6714 9 + 0.0127715850686966 0.0881239369740066 1835 iopromide hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_6714_1956_1432 4 + 0.0414216723977497 0.185795741288512 1836 iopromide hsa04664 Fc epsilon RI signaling pathway 5296_208_5319_1432_5581 5 + 0.015381973132698 0.0964869223778329 1837 iopromide hsa04370 VEGF signaling pathway 5319_1432_5829_208_5296_6714 6 + 0.00317355237942815 0.0405463411812295 1838 iopromide hsa05219 Bladder cancer 23604_1956_11186 3 + 0.0430830704437129 0.185795741288512 1839 iopromide hsa05218 Melanoma 1021_5296_208_1956_2258_2247 6 + 0.00217128991066748 0.0405463411812295 1840 iopromide hsa04012 ErbB signaling pathway 5296_208_1956_1399_3725_6714 6 + 0.00556019866397136 0.0548076725448606 1841 iopromide hsa05223 Non-small cell lung cancer 5296_208_1956_11186_1021 5 + 0.00352576879836778 0.0405463411812295 1842 iopromide hsa04810 Regulation of actin cytoskeleton 10152_8515_5829_5296_1956_8394_1399_2258_2245_2247 10 + 0.00666832384286384 0.0575142931447006 1843 iopromide hsa04010 MAPK signaling pathway 5319_9479_1432_773_208_1956_27091_1399_2258_91_3725_2247_23162 13 + 0.0014497212693503 0.0405463411812295 1844 iopromide hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0177233074560524 0.101909017872301 1845 iopromide hsa04912 GnRH signaling pathway 3725_6714_1956_1432_5319 5 + 0.0470458374339006 0.190950751937597 1846 iopromide hsa05210 Colorectal cancer 5296_208_1956_91_3725 5 + 0.0193071442225378 0.10247638087347 1847 iopromide hsa05220 Chronic myeloid leukemia 1021_5296_208_861_1399_91 6 + 0.00280750086763194 0.0405463411812295 1848 iopromide hsa04710 Circadian rhythm - mammal 1454_1408 2 - 0.00640609671867943 0.204995094997742 1849 pyrithyldione hsa04070 Phosphatidylinositol signaling system 8394_5333_27124_5293_3631 5 + 0.0200771531629412 0.475159291522942 1850 pyrithyldione hsa04740 Olfactory transduction 390892 1 + 0.00743417234709774 0.26391311832197 1851 pyrithyldione hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_958_8359_8294_8367_554313_121504 15 + 4.04821076421931e-07 2.87422964259571e-05 1852 pyrithyldione hsa04360 Axon guidance 3688_2041_4772_23365_5534_4233 6 + 0.0495861360064879 0.704123131292128 1853 pyrithyldione hsa05330 Allograft rejection 958_3107_3133 3 + 0.0442670963237931 0.704123131292128 1854 pyrithyldione hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 - 0.000887536408065912 0.0106408842963508 1855 pyrithyldione hsa04640 Hematopoietic cell lineage 3123_960_3126_3127_3125 5 - 0.00171254232223561 0.0128821116147813 1856 pyrithyldione hsa05320 Autoimmune thyroid disease 3123_3126_3127_3125 4 - 0.00198566723813071 0.0128821116147813 1857 pyrithyldione hsa04612 Antigen processing and presentation 3123_3126_3127_3125 4 - 0.0113599459281832 0.0643730269263715 1858 pyrithyldione hsa05131 Shigellosis 7278_6093_113457 3 - 0.0179521670758961 0.0832327746246092 1859 pyrithyldione hsa05130 Pathogenic Escherichia coli infection 7278_6093_113457 3 - 0.0179521670758961 0.0832327746246092 1860 pyrithyldione hsa04514 Cell adhesion molecules (CAMs) 3123_3126_3127_3125_6383_6693 6 - 0.00202072339055393 0.0128821116147813 1861 pyrithyldione hsa04510 Focal adhesion 6093_3693_7422_1399_5602 5 - 0.0486387701971139 0.190813636927139 1862 pyrithyldione hsa05322 Systemic lupus erythematosus 85235_8969_3123_3126_3127_3125_8332_8330_8331_8336_8329 11 - 2.01905597411085e-07 1.02971854679653e-05 1863 pyrithyldione hsa05310 Asthma 3123_3126_3127_3125 4 - 0.000274930664913469 0.00701073195529346 1864 pyrithyldione hsa04512 ECM-receptor interaction 3693_960_6383 3 - 0.0485690761066715 0.190813636927139 1865 pyrithyldione hsa05330 Allograft rejection 3123_3126_3127_3125 4 - 0.000626491079127088 0.0106408842963508 1866 pyrithyldione hsa04940 Type I diabetes mellitus 3123_3126_3127_3125 4 - 0.00104322395062263 0.0106408842963508 1867 iopamidol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_8359_8294_8367_121504_8368_8351 16 + 1.90291324477177e-06 0.000127495187399709 1868 iopamidol hsa05212 Pancreatic cancer 6655_5155_6934_7039_2260_1017_7184 7 + 0.00929358036481263 0.170419432332434 1869 iopamidol hsa05215 Prostate cancer 6655_5155_6934_7039_2260_1017_7184 7 + 0.00879475906314941 0.170419432332434 1870 iopamidol hsa04115 p53 signaling pathway 1017_4194_6477_472_651610_8795 6 + 0.010174294467608 0.170419432332434 1871 iopamidol hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0431071596976787 0.577635939948895 1872 iopamidol hsa05332 Graft-versus-host disease 3135_3105_3106_649853 4 - 8.84995855588517e-05 0.0006981577898313 1873 iopamidol hsa04650 Natural killer cell mediated cytotoxicity 3135_3105_3106 3 - 0.0362437110478001 0.0906092776195003 1874 iopamidol hsa05320 Autoimmune thyroid disease 3135_3105_3106_649853 4 - 0.000205422120227089 0.00102711060113544 1875 iopamidol hsa04612 Antigen processing and presentation 3135_3105_3106_649853 4 - 0.00132395142857487 0.00529580571429948 1876 iopamidol hsa04514 Cell adhesion molecules (CAMs) 3135_3105_3106_649853 4 - 0.00552953919018456 0.0184317973006152 1877 iopamidol hsa04360 Axon guidance 3985_22885_9475 3 - 0.0318612882951281 0.0906092776195003 1878 iopamidol hsa05330 Allograft rejection 3135_3105_3106_649853 4 - 6.1636490476133e-05 0.0006981577898313 1879 iopamidol hsa04940 Type I diabetes mellitus 3135_3105_3106_649853 4 - 0.000104723668474695 0.0006981577898313 1880 methazolamide hsa04012 ErbB signaling pathway 5599_6714_1956_867 4 + 0.0234196739564208 0.786368330358592 1881 methazolamide hsa05220 Chronic myeloid leukemia 1869_4088_6777_3551 4 - 0.043058425978199 1 1882 cromoglicic acid hsa03440 Homologous recombination 7156_7516 2 + 0.0100285963238814 0.371058063983612 1883 cromoglicic acid hsa05221 Acute myeloid leukemia 3551_11040 2 + 0.0381953932793042 0.505172312613563 1884 cromoglicic acid hsa05131 Shigellosis 7278_113457 2 - 0.0105195160837215 0.0946756447534935 1885 cromoglicic acid hsa05130 Pathogenic Escherichia coli infection 7278_113457 2 - 0.0105195160837215 0.0946756447534935 1886 cromoglicic acid hsa04540 Gap junction 7278_113457 2 - 0.0267350719948195 0.142199358622267 1887 cromoglicic acid hsa04620 Toll-like receptor signaling pathway 3663_5602 2 - 0.0315998574716148 0.142199358622267 1888 levomepromazine hsa05332 Graft-versus-host disease 3553_3123_3126_3127_3125_3135_355_3108 8 + 6.45363686444832e-05 0.00219423653391243 1889 levomepromazine hsa04640 Hematopoietic cell lineage 1435_3553_2057_3123_3568_3126_3127_3125_3589 9 + 0.0014009542086136 0.019052977237145 1890 levomepromazine hsa05320 Autoimmune thyroid disease 3108_3123_3126_3127_3125_3135_355 7 + 0.00133197867890679 0.019052977237145 1891 levomepromazine hsa04612 Antigen processing and presentation 3108_3123_3126_3127_3125_3135_6892 7 + 0.0176527717785624 0.133376497882471 1892 levomepromazine hsa04740 Olfactory transduction 26212_157 2 + 0.00234802350074119 0.0226714938949405 1893 levomepromazine hsa04514 Cell adhesion molecules (CAMs) 8516_965_3108_3383_3683_3123_3680_3126_3127_3125_3135 11 + 0.00243012703549051 0.0226714938949405 1894 levomepromazine hsa05310 Asthma 3123_3125_3108_3127_3126 5 + 0.00266723457587535 0.0226714938949405 1895 levomepromazine hsa05330 Allograft rejection 3108_3123_3126_3127_3125_3135_355 7 + 0.000223467214248014 0.00506525685628832 1896 levomepromazine hsa04940 Type I diabetes mellitus 3108_2572_3126_3127_3125_3135_355_3123_3553 9 + 1.36239892386859e-05 0.000926431268230641 1897 sulfamonomethoxine hsa05330 Allograft rejection 3123_355_3126_3127_3125 5 + 0.037464071240783 0.744995631538791 1898 sulfamonomethoxine hsa05131 Shigellosis 7278_113457 2 - 0.043967757296479 0.373725937020071 1899 sulfamonomethoxine hsa05130 Pathogenic Escherichia coli infection 7278_113457 2 - 0.043967757296479 0.373725937020071 1900 ifosfamide hsa04080 Neuroactive ligand-receptor interaction 2561 1 + 0.0338230844910151 0.394602652395176 1901 ifosfamide hsa05200 Pathways in cancer 23604_4313_3551_3815_861_675_7186_7482_3914_652_3688_3845_3576_2263_10342_8324_7184_3725 18 + 0.00188426668500152 0.0439662226500355 1902 ifosfamide hsa04740 Olfactory transduction 219464 1 + 0.0017188876247026 0.0439662226500355 1903 ifosfamide hsa05322 Systemic lupus erythematosus 3013_3014_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 12 + 0.000332679148295651 0.0232875403806956 1904 ifosfamide hsa05219 Bladder cancer 23604_3576_3845_4313 4 + 0.0231445299149731 0.324023418809623 1905 ifosfamide hsa03010 Ribosome 6204_6205_6169_6168_6181_6157_9045 7 + 0.0149243083778805 0.261175396612909 1906 pralidoxime hsa04740 Olfactory transduction 818 1 + 2.53984994896457e-05 0.0017778949642752 1907 pralidoxime hsa04350 TGF-beta signaling pathway 9372_3624_91_1874_7046_653_10637 7 + 0.0433042222119241 0.690034398204924 1908 pralidoxime hsa04512 ECM-receptor interaction 2335_1302_22987_3690_3381_1290_961 7 + 0.0373167417400439 0.690034398204924 1909 pralidoxime hsa04912 GnRH signaling pathway 2778_5331_8398_4323_998_818_3708_5320_2796_23236 10 + 0.00750471012095506 0.262664854233427 1910 pralidoxime hsa04730 Long-term depression 2778_8398_5331_3708_5320_23236 6 + 0.0492881713003517 0.690034398204924 1911 pralidoxime hsa04070 Phosphatidylinositol signaling system 5298_8394_808_3709_8760_801_3631_805 8 - 0.00712666993375226 0.270813457482586 1912 pralidoxime hsa04740 Olfactory transduction 5613_801_808_157_805 5 - 0.0145204673208023 0.367851838793658 1913 pralidoxime hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_6738_121504 15 - 0.000295201632361917 0.0224353240595057 1914 pralidoxime hsa04360 Axon guidance 9353_3688_10298_1944_64218_6091_4233_5998_7869_57556 10 - 0.0282986263620654 0.506321023720584 1915 pralidoxime hsa04210 Apoptosis 3552_581_5613_23052_472_8837_651610 7 - 0.0426526805846747 0.54026728740588 1916 pralidoxime hsa04512 ECM-receptor interaction 7059_1289_3914_3918_3688_3655_3339 7 - 0.0333105936658279 0.506321023720584 1917 paracetamol hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 + 0.0371073952357455 0.338175660779744 1918 paracetamol hsa04640 Hematopoietic cell lineage 3123_3126_3127_3125_947_3674 6 + 0.0429429410513961 0.338175660779744 1919 paracetamol hsa05320 Autoimmune thyroid disease 3123_3126_3127_1081_3125 5 + 0.021300846625875 0.335488334357531 1920 paracetamol hsa04740 Olfactory transduction 818 1 + 0.000373324290726209 0.0117597151578756 1921 paracetamol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504_8341 19 + 1.03658536610841e-07 6.53048780648298e-06 1922 paracetamol hsa05310 Asthma 3123_3126_3127_3125 4 + 0.013604064056576 0.285685345188096 1923 paracetamol hsa05330 Allograft rejection 3123_3126_3127_3125 4 + 0.0276971024912213 0.338175660779744 1924 paracetamol hsa04940 Type I diabetes mellitus 3123_3126_3127_3125 4 + 0.0424214069398716 0.338175660779744 1925 paracetamol hsa05211 Renal cell carcinoma 405_2271_7422_5290_7042 5 - 0.0209841094520892 0.378083958346741 1926 paracetamol hsa05221 Acute myeloid leukemia 6932_5371_6934_5290 4 - 0.0404028066011905 0.457898474813492 1927 paracetamol hsa04330 Notch signaling pathway 182_1488_6868_5664 4 - 0.0204638982793302 0.378083958346741 1928 paracetamol hsa03020 RNA polymerase 246721_5439_548644 3 - 0.027454375328787 0.378083958346741 1929 paracetamol hsa05213 Endometrial cancer 6932_2002_6934_5290 4 - 0.0278002910549074 0.378083958346741 1930 paracetamol hsa05210 Colorectal cancer 581_596_5290_6932_6934_7042 6 - 0.0104837901053337 0.378083958346741 1931 alpha-estradiol hsa05322 Systemic lupus erythematosus 2215_2214_3013_8358_8968_8341_8350_8351_8352_8353_8354_8355_8356_8357 14 + 0.000921949936997463 0.075599894833792 1932 alpha-estradiol hsa04650 Natural killer cell mediated cytotoxicity 5881_6654_8795_5534_3455 5 - 0.0432645739444531 0.405592866600123 1933 alpha-estradiol hsa04640 Hematopoietic cell lineage 3554 1 - 0.0094869173452123 0.206340452258368 1934 alpha-estradiol hsa05010 Alzheimer's disease 842_4712_6868_351_5534_810_513 7 - 0.0284636615199899 0.405592866600123 1935 alpha-estradiol hsa04080 Neuroactive ligand-receptor interaction 9568_3354_2925_1241_64106 5 - 2.70654382563516e-05 0.00117734656415129 1936 alpha-estradiol hsa04612 Antigen processing and presentation 5641_6890 2 - 0.0327082528684854 0.405592866600123 1937 alpha-estradiol hsa04740 Olfactory transduction 818_810_2979_5616_5613 5 - 2.26040235853609e-09 1.9665500519264e-07 1938 alpha-estradiol hsa05012 Parkinson's disease 2861_513_293_4712_842 5 - 0.042943677245779 0.405592866600123 1939 alpha-estradiol hsa04620 Toll-like receptor signaling pathway 3725_5606_3455 3 - 0.0466198697241521 0.405592866600123 1940 alpha-estradiol hsa04260 Cardiac muscle contraction 27092 1 - 0.0139964147990271 0.243537617503072 1941 alpha-estradiol hsa04060 Cytokine-cytokine receptor interaction 3601_3554_3455_23529_7422_91_8795 7 - 0.000248538488752069 0.00720761617381 1942 gliquidone hsa05211 Renal cell carcinoma 2549_7428_8453_405_5781 5 + 0.0479235942612793 1 1943 gliquidone hsa04540 Gap junction 7278_5155_113457_5331_1956_3845_6714 7 - 0.0119591286317565 0.837139004222955 1944 Prestwick-1084 hsa04360 Axon guidance 9353_2047_57556_6585_56924_2048_5534 7 + 0.0206995932252714 0.455391050955971 1945 Prestwick-1084 hsa04512 ECM-receptor interaction 960_2335_3910_3690_3691_1277 6 + 0.00919074741312083 0.455391050955971 1946 Prestwick-1084 hsa04020 Calcium signaling pathway 5159_6261_5333_108_8911_7416_5534_1910_4638 9 + 0.0154201658461363 0.455391050955971 1947 Prestwick-1084 hsa04080 Neuroactive ligand-receptor interaction 4889_706_5026_2150_5031_1131 6 - 2.15262616757102e-05 0.000936392382893394 1948 Prestwick-1084 hsa04740 Olfactory transduction 5613_109 2 - 3.21204259985283e-13 2.79447706187196e-11 1949 Prestwick-1084 hsa04370 VEGF signaling pathway 1432_8399_5829_572_11261_5605_5296_5881_8681_3265_7422_5603_5534_6714_100137049_842 16 - 0.00851236336693538 0.185143903230845 1950 Prestwick-1084 hsa04630 Jak-STAT signaling pathway 3597_5296_1154_6655_6777_6772_3572 7 - 0.0484457423644207 0.591753725650513 1951 Prestwick-1084 hsa04260 Cardiac muscle contraction 6262_6548 2 - 0.0323428873361021 0.562766239648177 1952 Prestwick-1084 hsa04060 Cytokine-cytokine receptor interaction 27242_3597_2324_55540_3572_657_4982_7422_655_8792_51330_7040 12 - 0.0066301380494955 0.185143903230845 1953 15(S)-15-methylprostaglandin E2 hsa04080 Neuroactive ligand-receptor interaction 2911_2555_4829_2908_5030_3274_2150_2570_1909_886 10 + 0.0474727442492449 0.968407678496731 1954 15(S)-15-methylprostaglandin E2 hsa05016 Huntington's disease 4899_841_6667_10540_5468_161 6 + 0.0420037733869493 0.968407678496731 1955 15(S)-15-methylprostaglandin E2 hsa04740 Olfactory transduction 5568_816 2 + 8.0357848359679e-10 6.83041711057272e-08 1956 15(S)-15-methylprostaglandin E2 hsa04110 Cell cycle 4193 1 + 0.00501538066684252 0.213153678340807 1957 15(S)-15-methylprostaglandin E2 hsa04080 Neuroactive ligand-receptor interaction 5618_2740_4158_5732_2570_6915_56288_5030_135_134_2696 11 - 0.0161332191592912 0.228553938089959 1958 15(S)-15-methylprostaglandin E2 hsa05016 Huntington's disease 64446_246721_317_161_1213 5 - 0.00294216965506367 0.0833614735601373 1959 15(S)-15-methylprostaglandin E2 hsa04740 Olfactory transduction 810_4991_157_26716 4 - 4.96091455817957e-10 4.21677737445263e-08 1960 15(S)-15-methylprostaglandin E2 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8294_121504_3122_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_720_721_8970_729 31 - 2.98531447245616e-05 0.00126875865079387 1961 15(S)-15-methylprostaglandin E2 hsa05012 Parkinson's disease 7345_317_7054 3 - 0.00679884674025259 0.144475493230368 1962 15(S)-15-methylprostaglandin E2 hsa04260 Cardiac muscle contraction 488 1 - 0.0139460797660349 0.228553938089959 1963 15(S)-15-methylprostaglandin E2 hsa03010 Ribosome 140801_6234_6144 3 - 0.0465881289124342 0.565712993936701 1964 cefapirin hsa04630 Jak-STAT signaling pathway 3717_3448_3953_3589_5293_200734_5781 7 + 0.00521029632281888 0.291776594077857 1965 cefapirin hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0138316628568472 0.746909794269749 1966 prazosin hsa04740 Olfactory transduction 818 1 + 7.39179968537634e-08 6.13519373886236e-06 1967 prazosin hsa04510 Focal adhesion 2321_7059_7148_1302_1311_1729_5599_208_3910_7057_1277_25759_7410_1399_10000_55742_3918_29895 18 + 0.0444288303584191 0.564815058604352 1968 prazosin hsa05322 Systemic lupus erythematosus 3013_3113_8358_6738_8968_8341_8350_8351_8352_8353_8354_8355_8356_8357 14 + 0.0405393765318489 0.564815058604352 1969 prazosin hsa05221 Acute myeloid leukemia 10000_3815_861_208_862_5292_5371 7 + 0.0476350049425357 0.564815058604352 1970 prazosin hsa04920 Adipocytokine signaling pathway 51703_10000_3953_208_6513_5563_5599_1375_8471 9 + 0.0138453651615803 0.383055102803722 1971 prazosin hsa04512 ECM-receptor interaction 7059_7148_1302_1311_3910_2812_7057_1277_3918_51206_961 11 + 0.00811841599632862 0.336914263847638 1972 prazosin hsa04940 Type I diabetes mellitus 3382_3105_2572_3558_2571_3113 6 + 0.0387254850534462 0.564815058604352 1973 prazosin hsa04080 Neuroactive ligand-receptor interaction 1131 1 - 0.0051843013226196 0.165897642323827 1974 prazosin hsa05322 Systemic lupus erythematosus 85235_8330_3014_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344 13 - 0.0010000368195797 0.0640023564531008 1975 prazosin hsa04360 Axon guidance 10298_10505_11261_4775_5534_3985_4233_5998_64218 9 - 0.0399381766718031 0.71955520347752 1976 rottlerin hsa05010 Alzheimer's disease 348_23236 2 + 0.00149473822470562 0.0317631872749944 1977 rottlerin hsa05016 Huntington's disease 5978_23236 2 + 0.0011027165724047 0.0312436362181332 1978 rottlerin hsa04740 Olfactory transduction 219464_816 2 + 8.86643907618339e-09 3.76823660737794e-07 1979 rottlerin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8349_8348_8329_8294_121504_8343_8347_8346_8344_8339_723790_3126_8969_8968_8370_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_8970 44 + 6.15195036801452e-15 5.22915781281234e-13 1980 rottlerin hsa04710 Circadian rhythm - mammal 406_9572_5187_8553 4 + 0.0179698335427683 0.254572641855884 1981 rottlerin hsa04062 Chemokine signaling pathway 2309_7410_3576_4792_23236 5 + 0.0251859344953918 0.267600554013538 1982 rottlerin hsa04810 Regulation of actin cytoskeleton 3688_1729_7410_2263_2260_3675 6 + 0.0241320495252482 0.267600554013538 1983 rottlerin hsa05012 Parkinson's disease 7054 1 + 0.00342120684469676 0.0581605163598449 1984 rottlerin hsa04080 Neuroactive ligand-receptor interaction 4886_2690 2 - 0.0184191105813749 0.298389591418273 1985 rottlerin hsa05200 Pathways in cancer 1050_9134_112399_1147_26060_596_6789_6502_581_998_1856_1857_898_5979_5295_8453_3725_652_2956_2261_8321 21 - 0.00482124385651826 0.0976301880944948 1986 rottlerin hsa05014 Amyotrophic lateral sclerosis (ALS) 11261_581_4217_5534_596 5 - 0.0429334323935318 0.445880584444352 1987 rottlerin hsa04740 Olfactory transduction 5613_5616 2 - 0.000547079401824291 0.0221567157738838 1988 rottlerin hsa04360 Axon guidance 5361_11261_998_2049_7852_6387_5534_10512_3985 9 - 0.0440375885870965 0.445880584444352 1989 rottlerin hsa04210 Apoptosis 5295_1147_596_5613_11261_581_5616_23052_472_5534_651610 11 - 0.000302639839080058 0.0221567157738838 1990 rottlerin hsa04115 p53 signaling pathway 9134_64393_581_472_898_651610 6 - 0.030801123144775 0.415815162454462 1991 rottlerin hsa05210 Colorectal cancer 26060_581_5295_1856_1857_596_3725_2956_8321 9 - 0.00261281625691187 0.0705460389366205 1992 bergenin hsa03440 Homologous recombination 7156_8940_7516 3 + 0.0160267162628886 0.408681264703659 1993 bergenin hsa04740 Olfactory transduction 157 1 + 0.0154966916135747 0.408681264703659 1994 bergenin hsa03450 Non-homologous end-joining 27343_2547 2 + 0.0304459463276677 0.517581087570351 1995 bergenin hsa05213 Endometrial cancer 5170_8312_6934_842 4 - 0.0173099193238014 0.852571389572379 1996 vigabatrin hsa04070 Phosphatidylinositol signaling system 5331_5295_3707_3709 4 + 0.0488022775981728 0.781638164503108 1997 vigabatrin hsa05211 Renal cell carcinoma 405_5295_7042_10298_6513 5 + 0.0103639051594346 0.540487283724756 1998 vigabatrin hsa04740 Olfactory transduction 818 1 + 0.0154424938207073 0.540487283724756 1999 vigabatrin hsa05220 Chronic myeloid leukemia 7046_5295_4193_7042 4 + 0.0469673778283038 0.781638164503108 2000 vigabatrin hsa04070 Phosphatidylinositol signaling system 8394_3709_23236 3 - 0.0216554742863634 0.347029134873064 2001 vigabatrin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504 14 - 9.0409047220227e-12 2.98349855826749e-10 2002 vigabatrin hsa04540 Gap junction 6714_3709_23236 3 - 0.0357509587759586 0.347029134873064 2003 nocodazole hsa04510 Focal adhesion 5829_2317_80310_5155_998_859_2002_1292_3918_7409_7422_7414_3725_7791_3673_6093_1291_3675 18 + 0.0227158738267335 0.620900551264049 2004 nocodazole hsa04710 Circadian rhythm - mammal 1454_8553_9572_4862 4 + 0.00669836484004892 0.274632958442006 2005 nocodazole hsa04010 MAPK signaling pathway 5155_6722_4763_8681_5495_3164_1616_2260_100137049_57551_786_998_6885_5534_3725_1647_782_1843_2317_1649_1846_1845_2002_6196_23162_27092 26 + 0.00187684602862982 0.153901374347645 2006 nocodazole hsa04640 Hematopoietic cell lineage 1436_3655 2 - 0.0162472283076447 0.208892935384003 2007 nocodazole hsa04080 Neuroactive ligand-receptor interaction 3354_5618_56288_2149_4886 5 - 1.00890045064978e-06 4.54005202792401e-05 2008 nocodazole hsa04740 Olfactory transduction 157 1 - 6.31427634268426e-16 5.68284870841583e-14 2009 nocodazole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235_3017_727 28 - 0.0052905938245519 0.111186687663837 2010 nocodazole hsa05212 Pancreatic cancer 5728_1017_5594_9134_5296_6655_1871_5155_4193_5290_673_5605_6934_2263_1385_2260_1387_7184_842 19 - 0.00741244584425579 0.111186687663837 2011 nocodazole hsa04110 Cell cycle 995_472_9134_651610_990_993_4173_6502_699_4193_51433_1111_8317_7027_1017_1871_7534_1031_1387_7531_5933 21 - 0.0401242629049728 0.451397957680944 2012 nocodazole hsa05215 Prostate cancer 5728_1017_5594_9134_5296_6655_1871_5155_4193_5290_673_5605_6934_2263_1385_2260_1387_7184_842 19 - 0.00697351642177579 0.111186687663837 2013 nocodazole hsa04060 Cytokine-cytokine receptor interaction 1436_5618_3597_55540_5155_8742_8741_3572_355_4982_9180_91 12 - 0.002274189447849 0.06822568343547 2014 nocodazole hsa05213 Endometrial cancer 5728_6934_5296_6655_999_5290_673_5605_842_324_5594 11 - 0.0472970244047107 0.472970244047107 2015 5666823 hsa05212 Pancreatic cancer 1869_898_8503_1387 4 - 0.0449510333837329 0.601865992928071 2016 5666823 hsa05215 Prostate cancer 1869_898_8503_1387 4 - 0.0434854142787252 0.601865992928071 2017 5666823 hsa05223 Non-small cell lung cancer 1869_8503_6258 3 - 0.0486117226097312 0.601865992928071 2018 5666823 hsa04620 Toll-like receptor signaling pathway 3665_8737_8503_9641_7187 5 - 0.018984037755852 0.597997189309338 2019 5666823 hsa05222 Small cell lung cancer 8503_2335_898_6258_1869_7187 6 - 0.00206901116343769 0.130347703296574 2020 pentamidine hsa04740 Olfactory transduction 8390_26476_26532_10798_8590_810_2979 7 + 0.0398562762945638 1 2021 pentamidine hsa05219 Bladder cancer 23604_7422_1612_7057_4193 5 + 0.029217338099969 1 2022 pentamidine hsa04080 Neuroactive ligand-receptor interaction 7434_2908_1081_4886 4 - 0.0486693733828107 0.685356610650898 2023 pentamidine hsa04510 Focal adhesion 55742_998 2 - 0.0259943164413191 0.589204506003233 2024 pentamidine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_8970 22 - 3.10755769471548e-07 2.11313923240653e-05 2025 pentamidine hsa04062 Chemokine signaling pathway 998 1 - 0.00740860606552904 0.251892606227987 2026 4,5-dianilinophthalimide hsa04916 Melanogenesis 2771_1857 2 + 0.0168630929290407 0.252946393935611 2027 4,5-dianilinophthalimide hsa05214 Glioma 801_6654_805_808 4 - 0.0389926905949929 0.754306152450491 2028 4,5-dianilinophthalimide hsa04270 Vascular smooth muscle contraction 2778_808_6093_4659_801_805 6 - 0.0277680681708071 0.754306152450491 2029 benserazide hsa05010 Alzheimer's disease 4698_4842 2 + 0.0030978255341389 0.130108672433834 2030 benserazide hsa05016 Huntington's disease 3092_4698_90993 3 + 0.00711013803344682 0.149312898702383 2031 benserazide hsa04740 Olfactory transduction 219464_8390_26189_26707 4 + 2.06546068184649e-06 0.000173498697275105 2032 benserazide hsa05012 Parkinson's disease 4698 1 + 0.00485705607837149 0.135997570194402 2033 benserazide hsa04610 Complement and coagulation cascades 2161_5328_7035_2153_2244_5329_2266_5104_2243 9 + 0.043572513856936 0.732018232796525 2034 benserazide hsa04910 Insulin signaling pathway 8660_5565_2872_5613_5567_5616_5140_5605_23265_1398_8651 11 - 0.0310525204342281 0.694182276080371 2035 benserazide hsa04740 Olfactory transduction 5613_5567_5616 3 - 0.000363104499888687 0.0143426277456031 2036 benserazide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_727_8368_8366_3113_8359_8294_8367_554313_6738_121504 17 - 0.000145680990815295 0.0115087982744083 2037 benserazide hsa04720 Long-term potentiation 5613_5567_5616_5605_5534_4659_23236 7 - 0.0375932634998817 0.694182276080371 2038 paclitaxel hsa05010 Alzheimer's disease 836 1 + 0.0326237338205431 0.750345877872491 2039 paclitaxel hsa04740 Olfactory transduction 26532_816 2 + 0.000264383540719461 0.0182424643096428 2040 paclitaxel hsa04510 Focal adhesion 7408 1 + 0.0165663604976794 0.571539437169939 2041 paclitaxel hsa04740 Olfactory transduction 5567 1 - 8.08046843619865e-05 0.00606035132714899 2042 paclitaxel hsa05212 Pancreatic cancer 2308_898_5155_1956_2033_1869_2260 7 - 0.0315017774445311 0.787544436113278 2043 paclitaxel hsa05215 Prostate cancer 2308_898_5155_1956_2033_1869_2260 7 - 0.0299798799814195 0.787544436113278 2044 colchicine hsa05010 Alzheimer's disease 3708_5534 2 + 0.0182712809628199 0.473725060799487 2045 colchicine hsa05016 Huntington's disease 3708 1 + 0.00244841218241002 0.100384899478811 2046 colchicine hsa04740 Olfactory transduction 81696_26476_7932_26212_81797 5 + 0.000331474033045444 0.0271808707097264 2047 colchicine hsa04510 Focal adhesion 1284_7059_22798_1311_2316_2889_5880_998_330_93408_3918_1956_7414_7791_3725_3082_2534_3675 18 + 0.0231085395511945 0.473725060799487 2048 colchicine hsa04080 Neuroactive ligand-receptor interaction 9568_7434_2901 3 - 7.9625240637193e-05 0.00233567372535766 2049 colchicine hsa04740 Olfactory transduction 5566 1 - 3.6386650447569e-10 3.20202523938607e-08 2050 colchicine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8342_8347_8346_8344_8370_8359_8330_8336_8334_554313_6738_121504_8339_8357_3119_3017 27 - 9.48142715788378e-06 0.000417182794946886 2051 colchicine hsa05012 Parkinson's disease 842_7054 2 - 0.0124766617254363 0.219589246367679 2052 colchicine hsa04020 Calcium signaling pathway 5566_2776 2 - 0.000721848517634687 0.0158806673879631 2053 colchicine hsa05210 Colorectal cancer 5595_842_581_4088_6655_5290_5599_5881_5602_91_5879_8321 12 - 0.0198838172630469 0.291629319858021 2054 tioguanine hsa04670 Leukocyte transendothelial migration 2771_103910_7852_7408_399_5879 6 - 0.0458393941249869 0.806231723988553 2055 tioguanine hsa04360 Axon guidance 5595_5365_2771_7852_5879_10505_64218 7 - 0.022186133488115 0.806231723988553 2056 hexestrol hsa05010 Alzheimer's disease 3709 1 + 0.015463422538762 0.274475750063025 2057 hexestrol hsa04310 Wnt signaling pathway 3725 1 + 0.0470782642215276 0.668511351945692 2058 hexestrol hsa05016 Huntington's disease 64446 1 + 0.010728384072195 0.253905089708615 2059 hexestrol hsa04740 Olfactory transduction 8387_442194_8388 3 + 0.000492767491624049 0.0349864919053075 2060 hexestrol hsa05322 Systemic lupus erythematosus 3013_9103_8358_8968_8341_8350_8351_8352_8353_8354_8355_8356_8357 13 + 0.00787673151705127 0.253905089708615 2061 hexestrol hsa05332 Graft-versus-host disease 3552_3105_3106_3126_3127_3125_3123 7 - 0.0202501244210035 0.267928756014294 2062 hexestrol hsa05010 Alzheimer's disease 22926_6622 2 - 0.00309380538188461 0.0845640137715127 2063 hexestrol hsa04080 Neuroactive ligand-receptor interaction 9568_1131_2690 3 - 0.000334673491881409 0.0274432263342755 2064 hexestrol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3123_6737_3126_3127_3014_3125_8359_8294_8367_554313_8368_121504 20 - 0.00171533039286195 0.0703285461073399 2065 hexestrol hsa04062 Chemokine signaling pathway 5829_5290_4067_3551 4 - 0.0192961467247107 0.267928756014294 2066 hexestrol hsa04020 Calcium signaling pathway 7416_1131_490_5336 4 - 0.0261393908306628 0.267928756014294 2067 hexestrol hsa05330 Allograft rejection 3105_3106_3126_3127_3125_3123 6 - 0.0374859335882113 0.341538506025925 2068 hexestrol hsa04270 Vascular smooth muscle contraction 27094 1 - 0.0150436528121429 0.267928756014294 2069 hexestrol hsa04940 Type I diabetes mellitus 3552_3105_3106_3126_3127_3125_3123 7 - 0.0247646128934013 0.267928756014294 2070 halofantrine hsa04740 Olfactory transduction 818_1179 2 + 0.00242273596001322 0.169591517200925 2071 halofantrine hsa04340 Hedgehog signaling pathway 7479_3549_8643_5727_653 5 + 0.0301103274153708 1 2072 halofantrine hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_8336 7 - 0.00546393689848668 0.224021412837954 2073 alpha-ergocryptine hsa05016 Huntington's disease 64446_7802_627 3 + 0.0139962509497035 0.349906273742587 2074 alpha-ergocryptine hsa04740 Olfactory transduction 8392_7932_5568_442194_816 5 + 3.10028792733095e-05 0.00232521594549821 2075 alpha-ergocryptine hsa05012 Parkinson's disease 6531 1 + 0.00710813961017673 0.266555235381627 2076 alpha-ergocryptine hsa04912 GnRH signaling pathway 776_5568_3710_1081_5599_1839_998_3709_8681_2185_100137049_816 12 + 0.0378330720384464 0.70937010072087 2077 alpha-ergocryptine hsa05010 Alzheimer's disease 51806_841_4713_5331_351_348 6 - 0.0315725679440839 0.428469115561807 2078 alpha-ergocryptine hsa04080 Neuroactive ligand-receptor interaction 1241_3354_2901_56288_7433 5 - 0.000110049817507222 0.00484219197031777 2079 alpha-ergocryptine hsa04740 Olfactory transduction 219464_51806_5613 3 - 6.77621708516927e-10 5.96307103494896e-08 2080 alpha-ergocryptine hsa04514 Cell adhesion molecules (CAMs) 3135_23308_5792 3 - 0.0131043357565838 0.239181069132011 2081 alpha-ergocryptine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_6738_121504_85235_3014 23 - 0.00414902591309541 0.121704760117465 2082 alpha-ergocryptine hsa04530 Tight junction 208_56288_8777 3 - 0.0135898334734097 0.239181069132011 2083 alpha-ergocryptine hsa05012 Parkinson's disease 2861_4713_7419_65018 4 - 0.0340827705560528 0.428469115561807 2084 meptazinol hsa04740 Olfactory transduction 5613 1 - 0.0017359954844314 0.118047692941335 2085 meptazinol hsa04370 VEGF signaling pathway 3845_5881_5335_842_5603 5 - 0.0457088839642967 1 2086 meptazinol hsa05223 Non-small cell lung cancer 11186_3845_5335_842 4 - 0.0490000947447557 1 2087 CP-319743 hsa04612 Antigen processing and presentation 3444 1 + 0.0141845188012262 0.406622872301818 2088 CP-319743 hsa04660 T cell receptor signaling pathway 3725_940_208 3 + 0.0472186330843114 1 2089 CP-319743 hsa04740 Olfactory transduction 26692_26333_81285_1179_26539_816 6 + 1.34388997215777e-07 1.15574537605568e-05 2090 CP-319743 hsa05012 Parkinson's disease 6390_6622_4713 3 + 0.0136689624961811 0.406622872301818 2091 CP-319743 hsa05010 Alzheimer's disease 56901_317_2776_5332_3710_4695_810_348_776_779_5533_3708_3709_6868_489_23236_5594_4713_4137_355_351_22926 22 - 0.000390840183815854 0.00793930292577488 2092 CP-319743 hsa04080 Neuroactive ligand-receptor interaction 1269_155_147_2925_2901_5030_552_56288_5745_135_1909_5645_5644_5646_1812_5724_7434_2740_4988_5028_2642_2911_2916_3953_1131_4886_5026_3354_3350_5733_3269_1910_8001_2550_5618_5340_7068_7067_4159_2570_1241_8484_1511_2149 44 - 0.00758909881182527 0.0891719110389469 2093 CP-319743 hsa04742 Taste transduction 5613_5566_5616_3710_112 5 - 0.0156946590121089 0.147529794713824 2094 CP-319743 hsa05320 Autoimmune thyroid disease 3113_7038_3452_3439_3451_3122_3105_3106_3126_3127_3125_959_3135_3448_3119_3447_3446_3441_3111_356_355_3123_649853 23 - 0.046627024353637 0.313067163517277 2095 CP-319743 hsa05016 Huntington's disease 8218_4899_56901_317_246721_2776_5332_23186_7019_6874_5430_6648_7052_7419_1213_581_3708_9001_4695_548644_23236_27113_4713_1387 24 - 0.000422303347115685 0.00793930292577488 2096 CP-319743 hsa04740 Olfactory transduction 219464_5593_157_5137_5613_5566_8383_8392_818_5616_109_4992_390892_810_9635_816 16 - 1.45609307658508e-22 1.36872749198998e-20 2097 CP-319743 hsa04110 Cell cycle 995_472_1031_993_9134_4088_699_1029_8881_1111_10393_10912_1870_7042_1869_8556_1387_4616 18 - 0.0259259031697878 0.203086241496671 2098 CP-319743 hsa03410 Base excision repair 3980_4968 2 - 0.0149584625309807 0.147529794713824 2099 CP-319743 hsa04530 Tight junction 5584_7082_56288_5581_10207_5578_998_8777_6709_22800_79784_51776_3845_4636_8573_8531_6714_9223_55870 19 - 0.0070370621533072 0.0891719110389469 2100 CP-319743 hsa04062 Chemokine signaling pathway 3717_157_5296_3718_5290_7852_5332_56288_112_8503_7454_2786_5829_5566_3576_7410_998_109_729230_6093_3055_4790_23236_115_6355_5594_5613_6777_5616_6358_6359_7074_3845 33 - 0.0203566208747178 0.173956578383952 2101 CP-319743 hsa05012 Parkinson's disease 2861_6570_4695_4713_317_7345_51465_56901_7419 9 - 1.50484708532101e-06 7.07278130100875e-05 2102 CP-319743 hsa04260 Cardiac muscle contraction 786_776_782_9254_779_481_70_478_10479_7137_7170 11 - 0.0294896254485837 0.213232676320528 2103 CP-319743 hsa03010 Ribosome 6181_6141_284393_439992_6203_6160_389342_6189 8 - 0.000201895151531365 0.0063260480813161 2104 CP-319743 hsa03050 Proteasome 23198_5683 2 - 0.00138551902486598 0.0217064647229004 2105 atractyloside hsa05219 Bladder cancer 7422_1613_7057 3 + 0.0178812267415814 0.623441310129461 2106 atractyloside hsa04350 TGF-beta signaling pathway 91_3400_7057_7044 4 + 0.0259767212553942 0.623441310129461 2107 atractyloside hsa03020 RNA polymerase 246721_5439_548644 3 - 0.00423032713108944 0.190364720899025 2108 flurbiprofen hsa04740 Olfactory transduction 7932_815_9635 3 + 6.06620836591199e-05 0.00467098044175223 2109 flurbiprofen hsa04514 Cell adhesion molecules (CAMs) 6403_3384_3383_23308_947_29851_958_965_920_9672_933_4099_23562 13 + 0.0129435631956611 0.249163591516476 2110 flurbiprofen hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_958_9103_8359_8294_8367_554313_121504_8341 17 + 0.000617168123806171 0.0237609727665376 2111 flurbiprofen hsa04920 Adipocytokine signaling pathway 2475_51703_5599_208_57818_8660_5602_6257_4852_4793 10 + 0.00174191907721253 0.0447092563151216 2112 flurbiprofen hsa05010 Alzheimer's disease 3553 1 - 0.00735367773262529 0.551525829946897 2113 flurbiprofen hsa04350 TGF-beta signaling pathway 3399_4089_3624_7057_9475_656_353500_7042_6093 9 - 0.0179701535791451 0.673880759217941 2114 flurbiprofen hsa03020 RNA polymerase 5432_246721_5439_548644 4 - 0.0463078272464349 1 2115 paromomycin hsa05332 Graft-versus-host disease 3812_3811_3552_3119_3804_3113_3802_3002 8 + 0.000657819443776673 0.0519677360583572 2116 paromomycin hsa04910 Insulin signaling pathway 208 1 + 0.0456665842431597 0.601276692534936 2117 paromomycin hsa05016 Huntington's disease 1742_23236 2 + 0.0359643292743892 0.601276692534936 2118 paromomycin hsa04740 Olfactory transduction 5137_26476_26212_442194_3000 5 + 0.00317123676532053 0.125263852230161 2119 paromomycin hsa05218 Melanoma 208_1029_2250_2249_1870_2247_4233_3082 8 + 0.0119561108430819 0.314844252201157 2120 paromomycin hsa05012 Parkinson's disease 6622 1 + 0.0455433170812947 0.601276692534936 2121 paromomycin hsa04070 Phosphatidylinositol signaling system 1609_8503_8394_8396_3633_5333_23236 7 - 0.0163835934829738 0.430658501660583 2122 paromomycin hsa04662 B cell receptor signaling pathway 8503_6655_3845_5534_3725_4793 6 - 0.0440940191529154 0.77164533517602 2123 paromomycin hsa04080 Neuroactive ligand-receptor interaction 1131_2908 2 - 0.0184567929283107 0.430658501660583 2124 paromomycin hsa04060 Cytokine-cytokine receptor interaction 3454 1 - 0.00364972647981679 0.255480853587175 2125 scopolamine hsa04740 Olfactory transduction 9635 1 + 0.000791533991799135 0.0656973213193282 2126 scopolamine hsa04540 Gap junction 2911_5594_1813_7278_113457_5605_3710 7 + 0.0134229060544106 0.55705060125804 2127 scopolamine hsa04080 Neuroactive ligand-receptor interaction 3953_5618_2908 3 - 0.00273739115359918 0.110864341720767 2128 scopolamine hsa04740 Olfactory transduction 810_26211_5566 3 - 9.50033795222655e-06 0.000769527374130351 2129 furazolidone hsa05010 Alzheimer's disease 3553_3710 2 + 0.0183143334303477 0.421281700217377 2130 furazolidone hsa04740 Olfactory transduction 26211_8390_5566_8383_1179_9635 6 + 0.00130701501023582 0.109789260859809 2131 furazolidone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3112_8359_8294_8367_554313_121504_3119 16 + 0.00367470108777157 0.154337445686406 2132 furazolidone hsa04270 Vascular smooth muscle contraction 9138_3710_10266_4881_4882_3778_2977_108_8681_5322_100137049_5566 12 + 0.0200610333436846 0.421281700217377 2133 furazolidone hsa04650 Natural killer cell mediated cytotoxicity 6655_3107_5781_5534 4 - 0.023161739017216 0.637676553527139 2134 nadolol hsa04650 Natural killer cell mediated cytotoxicity 23533_8503_3107_6850_5293_3460_10451_6452_836_3455_4772_3106_3459_5781_4276_10725_3135_5532_4775_5894_3133_5534_5291_5777_5594_5578_6655_6654_6464_5881_355_3845_3265_2534 34 + 0.00669071835277573 0.0491211923659303 2135 nadolol hsa05010 Alzheimer's disease 55851_3710_51806_572_5534_317_9451_3416_5332_5664_7381_6622_1327_4705_836_3553_4702_4712_808_509_810_348_8772_5532_3709_374291_489_488_4695_801_23236_5594_841_4713_642502_6391_4137_4728_355_842_23385_351_513_8851_805 45 + 0.00285687779564735 0.0244133193446228 2136 nadolol hsa04080 Neuroactive ligand-receptor interaction 155_886_2908_2925_552_56288_5644_4161_799_8001_2688_2689_7433_1442_5029_4889_2914_2916_3953_5025_4886_3355_6915_3356_3352_3269_3358_9170_2550_5618_4157_7068_7067_2897_2570_1241_8484_1511_2357 39 + 8.64014963006774e-11 4.06087032613184e-09 2137 nadolol hsa04742 Taste transduction 2914_3710_5613_5566_5567_50834_112 7 + 0.00164284552440026 0.0171586088104027 2138 nadolol hsa05131 Shigellosis 4950_347733_5578_998_7099_7430_9181_8440_2017_9475_6093_2534 12 + 0.0437330357763693 0.183017071234722 2139 nadolol hsa04670 Leukocyte transendothelial migration 5010_23533_8503_2773_5293_9475_10451_4636_5603_5747_81_3676_5829_1500_7430_5781_50848_6300_4318_998_1495_6093_5291_1432_5578_27035_4689_1365_7408_4950 30 + 0.00920471383962397 0.0618030786374752 2140 nadolol hsa04614 Renin-angiotensin system 1511 1 + 0.0339577540609234 0.173991912544915 2141 nadolol hsa05016 Huntington's disease 4899_5440_1327_3064_317_55081_5332_23186_7019_6875_7381_5432_5433_4705_6874_6648_4702_5434_7157_6667_64446_836_2033_509_1212_5430_374291_10540_4712_4695_161_5481_23236_842_841_4713_642502_5441_6391_246721_3092_4728_9586_1385_513_1387_293_291 48 + 0.00235321885468479 0.022120257234037 2142 nadolol hsa05130 Pathogenic Escherichia coli infection 4950_347733_5578_998_7099_7430_9181_8440_2017_9475_6093_2534 12 + 0.0437330357763693 0.183017071234722 2143 nadolol hsa04740 Olfactory transduction 808_51806_157_26211_5613_5566_5567_442194_393046_818_109_805_390892_810_801_9635_816 17 + 1.49368377156923e-38 1.40406274527508e-36 2144 nadolol hsa04514 Cell adhesion molecules (CAMs) 5010_9672_3695_6385_23308_3111_6383_6382_3655_3676_9019_958_3123_3106_3107_3126_3127_3125_933_25945_29851_4099_3135_3133_23705_6402_965_4685_50848_3680_3685_1365_5792_4950_1002_926_5817 37 + 0.0338800452089114 0.173991912544915 2145 nadolol hsa04140 Regulation of autophagy 5289_115201_9474_9140_8678_23192 6 + 0.039571195729187 0.183017071234722 2146 nadolol hsa04530 Tight junction 5010_2773_4619_6709_64398_56288_4636_81_9223_5584_5581_84612_1365_5865_3996_2017_50848_79784_55844_207_208_998_8777_5519_22800_3265_1495_4628_5590_5520_7082_8189_5578_10207_5728_1457_3845_7525_4950 39 + 0.0447807727489214 0.183017071234722 2147 nadolol hsa04630 Jak-STAT signaling pathway 23533_3717_598_8503_5291_6772_9655_3558_30837_10254_1442_2057_3455_3459_3572_3588_2688_5781_3589_2033_81848_2689_10401_9063_207_3953_1271_3976_208_5293_5777_200734_8554_9021_8027_4352_5618_3460_6655_6654_867_51588_8835_1387 44 + 0.0277906259996709 0.163269927748067 2148 nadolol hsa04062 Chemokine signaling pathway 23533_3717_3576_1147_157_2773_8503_9475_10451_5332_56288_10235_112_2309_3551_5829_5566_5567_1399_6362_4793_408_1236_207_6357_5747_208_998_5293_109_3265_6093_5291_23236_5590_5594_5613_6655_6654_6464_6772_7074_3845_5894_5970 45 + 0.000310488288514256 0.00416941416004858 2149 nadolol hsa04810 Regulation of actin cytoskeleton 23533_8503_3680_10298_56034_10297_5154_9475_7074_5881_3679_10552_4636_23365_5747_3655_10458_3676_23396_81_5829_4638_3693_3695_1445_8826_7430_80310_1399_55740_2263_200576_2261_2264_79784_2768_324_5062_8394_2934_9138_998_2335_5293_22800_3265_3985_4628_6093_5291_23191_8874_10093_5594_1729_6655_6654_10451_3685_5894_3690_54961_3845_54434_2257_10787_6548 67 + 0.0351685780675892 0.173991912544915 2150 nadolol hsa05012 Parkinson's disease 2861_1327_7332_317_27429_7381_6622_4705_836_4702_5413_509_374291_4695_5481_4728_842_4712_4713_642502_6391_65018_51465_513_293_291 26 + 0.00012053450012741 0.00188837383532942 2151 nadolol hsa04260 Cardiac muscle contraction 784_7168_1327_9254_70_6548_4635_488_7381_10479_781 11 + 8.5649699415481e-05 0.00161021434901104 2152 nadolol hsa04060 Cytokine-cytokine receptor interaction 3459_56034_55540_5154_1896_3572_657_2322_27242_3554_3553_2057_2324_3455_3576_3953_958_3558_3588_4982_2688_2689_3976_8718_6362_3082_1236_3606_3556_23495_3589_23765_8771_3625_4055_4254_7042_91_90_8792_4233_7048_4352_1436_6357_5618_3460_970_7292_1271_8764_355_7422_83729_51330 55 + 1.27396565880672e-06 3.99175906426106e-05 2153 nadolol hsa03010 Ribosome 283412_284064_6137_6204_6125_6168_6192_6160_6158_6159_6129_9045_6171 13 + 6.82786826380686e-06 0.000160454904199461 2154 nadolol hsa04020 Calcium signaling pathway 51806_155_3710_5534_2925_3709_552_7220_5532_5332_4638_490_886_5256_5257_5566_5567_818_8911_810_816_5025_56848_2767_3356_6915_109_489_488_3269_3358_5481_23236_8877_5578_5613_8912_808_801_2064_293_805_291 43 + 0.000510063946130759 0.00599325136703642 2155 nadolol hsa03050 Proteasome 10197_5719_5717_5707_5689_9491_5683 7 + 0.00679335639103292 0.0491211923659303 2156 nadolol hsa04610 Complement and coagulation cascades 3827_966_5265_5327_5627_727_4179_1604_717_722_7035_2152_2153_1675_5329 15 + 0.0219003892658159 0.137242439399113 2157 harmol hsa04740 Olfactory transduction 51806_2979_4991 3 + 0.000171186927158491 0.00701866401349813 2158 harmol hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8360_8368_8348_8294_121504_3109_8366_8968_8370_8362_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2215_83740_3013_3111 32 + 3.50962072265735e-13 2.87788899257903e-11 2159 harmol hsa04115 p53 signaling pathway 55367_1647_1026_64393_7249_355_8795 7 + 0.0313264462554903 0.856256197650068 2160 harmol hsa04916 Melanogenesis 4157_5578_1855_3845_6934_107_2535 7 - 0.0138867575009082 0.168955549594383 2161 harmol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 1.56870994526924e-05 0.00114515826004655 2162 harmol hsa04530 Tight junction 8189_5578_8777_9080_3845_4636_27134 7 - 0.0480625034543895 0.350856275217043 2163 harmol hsa04664 Fc epsilon RI signaling pathway 5578_5336_7410_3845_5600_5602_2534 7 - 0.00354793286506912 0.118119629735008 2164 harmol hsa04370 VEGF signaling pathway 5578_842_3845_5600_5336 5 - 0.04007448389596 0.325048591600564 2165 harmol hsa05216 Thyroid cancer 3845_6934_673 3 - 0.0363396115899527 0.325048591600564 2166 harmol hsa05223 Non-small cell lung cancer 5578_673_3845_842_5336 5 - 0.0111858312249561 0.163313135884359 2167 harmol hsa04010 MAPK signaling pathway 4217_3554_4149_3925_5578_1649_673_7189_5607_3845_5600_5602_5495_3164 14 - 0.00758727789843505 0.13846782164644 2168 harmol hsa05213 Endometrial cancer 3845_842_6934_673 4 - 0.0392876154765905 0.325048591600564 2169 harmol hsa05210 Colorectal cancer 842_1855_673_3845_6934_5602_2535 7 - 0.00485423135897293 0.118119629735008 2170 ajmaline hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3109 15 + 1.68767076999665e-05 0.00119824624669762 2171 ajmaline hsa04115 p53 signaling pathway 472_4194_651610_7057_3486 5 + 0.0437669684546513 1 2172 ajmaline hsa03020 RNA polymerase 246721_5439_548644 3 + 0.049996516130574 1 2173 ajmaline hsa04916 Melanogenesis 801_808_805_7477 4 - 0.00542309243092516 0.111173394833966 2174 ajmaline hsa05214 Glioma 801_808_4193_805 4 - 0.00105842013860854 0.0433952256829501 2175 ajmaline hsa04070 Phosphatidylinositol signaling system 801_808_805 3 - 0.0149399938249783 0.153134936706028 2176 ajmaline hsa04720 Long-term potentiation 801_808_805 3 - 0.0144391705123542 0.153134936706028 2177 ajmaline hsa04912 GnRH signaling pathway 801_808_805 3 - 0.036174764620607 0.296633069888977 2178 ajmaline hsa04270 Vascular smooth muscle contraction 801_808_805 3 - 0.0448680221386449 0.30659815128074 2179 iodixanol hsa05332 Graft-versus-host disease 3553_3123_3126_3127_3125_355 6 + 0.00160213151100226 0.0357276304014228 2180 iodixanol hsa04640 Hematopoietic cell lineage 3553_3123_3126_3127_3125_947_915_914_3675 9 + 0.000996864799968949 0.0357276304014228 2181 iodixanol hsa05320 Autoimmune thyroid disease 1081_3123_3126_3127_3125_355 6 + 0.00461475942774704 0.064635884393764 2182 iodixanol hsa04612 Antigen processing and presentation 3123_3806_3126_3127_3125_6890 6 + 0.0406426660490277 0.325141328392222 2183 iodixanol hsa04740 Olfactory transduction 157 1 + 0.000547267868566916 0.0357276304014228 2184 iodixanol hsa05322 Systemic lupus erythematosus 474382_474381_83740_3123_3126_3127_3125_720_721 9 + 0.0208447193696945 0.18760247432725 2185 iodixanol hsa05310 Asthma 3123_3126_3127_3125 4 + 0.0120874509072427 0.124328066474496 2186 iodixanol hsa05330 Allograft rejection 3123_355_3126_3127_3125 5 + 0.00538632369948033 0.064635884393764 2187 iodixanol hsa04940 Type I diabetes mellitus 3553_3123_3126_3127_3125_355 6 + 0.0019848683556346 0.0357276304014228 2188 iodixanol hsa04070 Phosphatidylinositol signaling system 5333_51763_23236 3 - 0.0488703198646367 0.675895543838852 2189 iodixanol hsa05320 Autoimmune thyroid disease 355_3107_1081 3 - 0.0202977125809576 0.675895543838852 2190 doxazosin hsa05322 Systemic lupus erythematosus 3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 11 + 1.77596841612272e-05 0.00106558104967363 2191 doxazosin hsa04664 Fc epsilon RI signaling pathway 100137049_8681_10000_5320 4 + 0.0342855777198645 0.304618419683199 2192 doxazosin hsa04370 VEGF signaling pathway 100137049_8681_10000_5320 4 + 0.0317422989760171 0.304618419683199 2193 doxazosin hsa04350 TGF-beta signaling pathway 5519_4088_1634_3624_8200 5 + 0.0115877662036875 0.23175532407375 2194 doxazosin hsa04912 GnRH signaling pathway 5566_8681_5320_810_100137049_2797 6 + 0.00679672286452918 0.203901685935875 2195 doxazosin hsa04730 Long-term depression 5519_8681_100137049_5320 4 + 0.0247995566228356 0.304618419683199 2196 doxazosin hsa04270 Vascular smooth muscle contraction 810_5566_8681_100137049_5320 5 + 0.0355388156297066 0.304618419683199 2197 doxazosin hsa05332 Graft-versus-host disease 3552_3123_3106_3107_3126_3127_3125_3135 8 - 0.000969160527282951 0.0314696797253501 2198 doxazosin hsa05320 Autoimmune thyroid disease 3123_3106_3107_3126_3127_3125_3135 7 - 0.0118251592805122 0.155697930526744 2199 doxazosin hsa04740 Olfactory transduction 5566 1 - 1.65156179288403e-06 0.000130473381637838 2200 doxazosin hsa04060 Cytokine-cytokine receptor interaction 3552_7042 2 - 0.00159340150508102 0.0314696797253501 2201 doxazosin hsa05330 Allograft rejection 3123_3106_3107_3126_3127_3125_3135 7 - 0.00236586897603594 0.0373807298213679 2202 doxazosin hsa04940 Type I diabetes mellitus 3552_3123_3106_3107_3126_3127_3125_3135 8 - 0.00126341443125889 0.0314696797253501 2203 mometasone hsa05332 Graft-versus-host disease 3811_3553_941_3135_355_3133_3802 7 + 0.00773576733486777 0.197158642257167 2204 mometasone hsa04740 Olfactory transduction 56656_5132 2 + 2.07266346197528e-06 0.000169958403881973 2205 mometasone hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8370_83740_8368_8366_941_8360_8359_8362_8294_8367_554313_8970_121504 19 + 0.000244300247229892 0.0100163101364256 2206 mometasone hsa04710 Circadian rhythm - mammal 4862_8553_5187 3 + 0.0371132274123804 0.380410580976899 2207 mometasone hsa04115 p53 signaling pathway 1647_27113_5366_581_4193_355_1026_8795 8 + 0.0284348136313589 0.333093531110204 2208 mometasone hsa04010 MAPK signaling pathway 9479_9344_3925_22808_4763_5603_3310_3164_11221_5319_3553_27006_2260_4217_8398_23542_3727_1647_1843_1649_1846_355_8911 23 + 0.0174936920263942 0.286896549232865 2209 mometasone hsa05012 Parkinson's disease 6390 1 + 0.0227038266456732 0.3102856308242 2210 mometasone hsa04940 Type I diabetes mellitus 3382_2572_941_3135_355_3133_3553 7 + 0.00961749474425203 0.197158642257167 2211 mometasone hsa04115 p53 signaling pathway 27113_9134_4194_7057_1017_4616 6 - 0.00912256182505348 0.62945676592869 2212 mometasone hsa04060 Cytokine-cytokine receptor interaction 5155 1 - 0.0226824009229175 0.782542831840654 2213 dihydroergocristine hsa05214 Glioma 23533_5578_1029_51806_5335_816 6 + 0.0207454668511525 0.266233491256457 2214 dihydroergocristine hsa04070 Phosphatidylinositol signaling system 23533_5578_51806_3708_5335_3707 6 + 0.0385739542368635 0.371274309529811 2215 dihydroergocristine hsa04740 Olfactory transduction 51806_816 2 + 0.000783410305594005 0.0190079881686181 2216 dihydroergocristine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344 19 + 4.98337373255461e-07 3.83719777406705e-05 2217 dihydroergocristine hsa04664 Fc epsilon RI signaling pathway 23533_5578_50487_8681_5335_5603_100137049_6300 8 + 0.00489707009958715 0.0754148795336421 2218 dihydroergocristine hsa04370 VEGF signaling pathway 23533_5578_50487_8681_5335_7422_5603_5534_100137049_6300 10 + 0.000297095684673991 0.0114381838599487 2219 dihydroergocristine hsa04010 MAPK signaling pathway 9479_9344_5534_5578_50487_1846_5607_8681_5603_7042_7786_4149_100137049_6300_2264 15 + 0.0365450499312421 0.371274309529811 2220 dihydroergocristine hsa04912 GnRH signaling pathway 51806_1081_5578_50487_3708_8681_5603_5338_100137049_6300_816 11 + 0.000987427956811331 0.0190079881686181 2221 dihydroergocristine hsa05322 Systemic lupus erythematosus 85235_8969_8332_8330_8331_8329_8336 7 - 0.000314747229802896 0.00849817520467819 2222 raubasine hsa04740 Olfactory transduction 5137_26212 2 + 0.00653144968216864 0.215537839511565 2223 raubasine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 2.70412768791808e-05 0.00178472427402593 2224 raubasine hsa04070 Phosphatidylinositol signaling system 3628_3707_3708_3631_8526_23236 6 - 0.00499702576378896 0.146205389492922 2225 raubasine hsa04740 Olfactory transduction 157 1 - 0.00743417234709774 0.146205389492922 2226 raubasine hsa05322 Systemic lupus erythematosus 3013_8358_8968_8337_8350_8351_8352_8353_8354_8355_8356_8357 12 - 4.7796082021648e-05 0.00281996883927723 2227 raubasine hsa04360 Axon guidance 55558_57556_10725_2048_5998_7869_3983 7 - 0.017501600446111 0.258148606580137 2228 lobelanidine hsa04640 Hematopoietic cell lineage 1436_2812_3122_2209_2993_3690_915_931_3675 9 + 0.0498809666563509 1 2229 lobelanidine hsa04740 Olfactory transduction 8390_5568_442194_816 4 + 5.24956377447726e-05 0.00215232114753568 2230 lobelanidine hsa05322 Systemic lupus erythematosus 8329_8343_8347_8346_8344_8339_3122_2209_8969_8968_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3111 26 + 1.4680829580045e-07 1.20382802556369e-05 2231 lobelanidine hsa04120 Ubiquitin mediated proteolysis 11060_6477_4193_389898_22888_51619_6502 7 - 0.029702012223109 0.524105168806557 2232 lobelanidine hsa05014 Amyotrophic lateral sclerosis (ALS) 4217_5630_5608_834 4 - 0.0336610318143406 0.524105168806557 2233 lobelanidine hsa04740 Olfactory transduction 109_157 2 - 0.0259077107607063 0.524105168806557 2234 lobelanidine hsa04540 Gap junction 23236_7278_109_113457_5154 5 - 0.0496574494513312 0.524105168806557 2235 harmalol hsa04740 Olfactory transduction 26212_3000_816_5566 4 + 0.00220535824195511 0.172017942872499 2236 harmalol hsa04912 GnRH signaling pathway 775_8398_3710_5566_2776_5337_5603_6714_5609_816 10 + 0.0113839199224793 0.443972876976693 2237 harmalol hsa04916 Melanogenesis 7306_801_808_4286_805 5 - 0.0447270364629308 0.485201618930553 2238 harmalol hsa05131 Shigellosis 7278_7280_113457_347733 4 - 0.0217658585922602 0.326487878883903 2239 harmalol hsa05130 Pathogenic Escherichia coli infection 7278_7280_113457_347733 4 - 0.0217658585922602 0.326487878883903 2240 harmalol hsa05322 Systemic lupus erythematosus 718_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 12 - 2.10099626968242e-05 0.000945448321357089 2241 scoulerine hsa05332 Graft-versus-host disease 3553_3126_3127_3123_3125 5 + 0.0120441828477494 0.12445655609341 2242 scoulerine hsa04640 Hematopoietic cell lineage 3553_3690_3123_3126_3127_3125_931_3684 8 + 0.00689796273101951 0.10308271299276 2243 scoulerine hsa05320 Autoimmune thyroid disease 3439_3123_3447_3126_3127_3125 6 + 0.00761106928170358 0.10308271299276 2244 scoulerine hsa04612 Antigen processing and presentation 4800_3439_3123_3447_3126_3127_3125_6892 8 + 0.00779893860104637 0.10308271299276 2245 scoulerine hsa05016 Huntington's disease 161 1 + 0.0469760257858231 0.364064199840129 2246 scoulerine hsa05310 Asthma 3123_3126_3127_3125 4 + 0.0171627013954873 0.152012498074316 2247 scoulerine hsa05330 Allograft rejection 3592_3126_3127_3123_3125 5 + 0.00831312201554518 0.10308271299276 2248 scoulerine hsa04940 Type I diabetes mellitus 3592_3553_3123_3126_3127_3125 6 + 0.00334611638509011 0.10308271299276 2249 scoulerine hsa04080 Neuroactive ligand-receptor interaction 7067_4886_1909 3 - 0.0270776568069054 0.713044962581842 2250 scoulerine hsa05322 Systemic lupus erythematosus 85235_3113_8330_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344 13 - 0.0045025991217674 0.355705330619625 2251 scoulerine hsa04350 TGF-beta signaling pathway 5308_4088_3398_6667_7057_655_652_9475 8 - 0.0213943571771843 0.713044962581842 2252 scoulerine hsa05210 Colorectal cancer 4088_6655_5290_5599_1956_324_3725 7 - 0.0462347723326336 0.714574040518004 2253 thiamine hsa03440 Homologous recombination 7516_10111 2 - 0.0411910633528485 0.463399462719546 2254 thiamine hsa04662 B cell receptor signaling pathway 10725_3725_6654_4793 4 - 0.0103460419896608 0.463399462719546 2255 thiamine hsa04660 T cell receptor signaling pathway 10725_3725_6654_4793 4 - 0.0345896873886639 0.463399462719546 2256 thiamine hsa04912 GnRH signaling pathway 5338_6714_6654_3725 4 - 0.0327181107841322 0.463399462719546 2257 10-methoxyharmalan hsa04740 Olfactory transduction 810 1 + 0.000555425521773311 0.0194398932620659 2258 10-methoxyharmalan hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 8.47028425116568e-05 0.00592919897581598 2259 10-methoxyharmalan hsa04740 Olfactory transduction 157 1 - 0.00115197843420076 0.0783345335256517 2260 10-methoxyharmalan hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_8337_8336 8 - 0.0313058530244275 1 2261 metrifonate hsa04950 Maturity onset diabetes of the young 4760_3375_2494 3 + 0.00568353791008271 0.358062888335211 2262 metrifonate hsa04070 Phosphatidylinositol signaling system 8871_3631_808_51763_801_805 6 - 0.00704899032544712 0.422939419526827 2263 metrifonate hsa04210 Apoptosis 472_8837_651610_5534_8717 5 - 0.0457326426926645 0.72355515066693 2264 metrifonate hsa04060 Cytokine-cytokine receptor interaction 7042 1 - 0.0463884722135705 0.72355515066693 2265 morantel hsa04540 Gap junction 5598_7278_113457 3 + 0.023048389948331 0.524119915760964 2266 morantel hsa04740 Olfactory transduction 219464 1 - 0.000583676048585479 0.0420246754981545 2267 8-azaguanine hsa04070 Phosphatidylinositol signaling system 5728_1040_5578_1606_51763_5336_200576_8527_8760 9 - 0.0486680218219975 0.563158538225971 2268 8-azaguanine hsa04120 Ubiquitin mediated proteolysis 10277_868_51366_7322_4734_6502_7329_672_26091_51588_9820_8450_7320_11060 14 - 0.0471169221711689 0.563158538225971 2269 8-azaguanine hsa04080 Neuroactive ligand-receptor interaction 64106_7068 2 - 0.000123938684169286 0.0100390334177122 2270 8-azaguanine hsa04310 Wnt signaling pathway 5578_9475 2 - 0.0180039538942716 0.364580066359 2271 8-azaguanine hsa05012 Parkinson's disease 27429 1 - 0.00710405601876678 0.191809512506703 2272 8-azaguanine hsa04060 Cytokine-cytokine receptor interaction 91_5155_8795 3 - 0.000479138894038974 0.0194051252085784 2273 8-azaguanine hsa03010 Ribosome 6125 1 - 0.045197027462149 0.563158538225971 2274 meticrane hsa05322 Systemic lupus erythematosus 3013_3113_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 12 + 0.000166058866734449 0.0106277674710047 2275 meticrane hsa05010 Alzheimer's disease 11261_489 2 - 0.0499755701898441 0.427568767179777 2276 meticrane hsa04080 Neuroactive ligand-receptor interaction 7434_1131_4157 3 - 0.0142147657152755 0.279534814031895 2277 meticrane hsa04740 Olfactory transduction 5613_5616 2 - 4.30022173254872e-05 0.00165558536703126 2278 meticrane hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344 19 - 2.02091676957883e-05 0.0015561059125757 2279 meticrane hsa04210 Apoptosis 8503_5613_11261_5616_472_8737_8837_651610_8795 9 - 0.0145212890406179 0.279534814031895 2280 meticrane hsa05221 Acute myeloid leukemia 8503_6655_6777_673_6932_5914 6 - 0.0413736167364884 0.427568767179777 2281 meticrane hsa05110 Vibrio cholerae infection 30001_8992_5613_5616_523_528 6 - 0.0413736167364884 0.427568767179777 2282 meticrane hsa05012 Parkinson's disease 7419 1 - 0.0455433170812947 0.427568767179777 2283 meticrane hsa03020 RNA polymerase 246721_5439_548644_10622 4 - 0.0388238623856151 0.427568767179777 2284 sulfaphenazole hsa04130 SNARE interactions in vesicular transport 8773_9570_8417 3 + 0.0415790152418491 1 2285 sulfaphenazole hsa04740 Olfactory transduction 23538_816 2 + 0.0357622234054987 1 2286 sulfaphenazole hsa05211 Renal cell carcinoma 2271_5295_998_3845_5781_3725 6 - 0.0405302490056971 0.381093451090991 2287 sulfaphenazole hsa05010 Alzheimer's disease 4714 1 - 0.0321129216193618 0.381093451090991 2288 sulfaphenazole hsa04080 Neuroactive ligand-receptor interaction 64106_2561 2 - 0.0187658322903353 0.381093451090991 2289 sulfaphenazole hsa05131 Shigellosis 7278_2017_113457_8976_998 5 - 0.0471716382637231 0.381093451090991 2290 sulfaphenazole hsa05130 Pathogenic Escherichia coli infection 7278_2017_113457_8976_998 5 - 0.0471716382637231 0.381093451090991 2291 sulfaphenazole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8370_8332_8359_8330_8331_8336_554313_8351_85235_3013_3014 24 - 8.4209227795861e-10 6.14727362909785e-08 2292 sulfaphenazole hsa04060 Cytokine-cytokine receptor interaction 4982_8795 2 - 0.0130985700724591 0.381093451090991 2293 sulfaphenazole hsa04020 Calcium signaling pathway 3707 1 - 0.0328385267700159 0.381093451090991 2294 sulfaphenazole hsa05213 Endometrial cancer 2002_3845_5170_5295_324 5 - 0.0368051052897718 0.381093451090991 2295 procaine hsa04360 Axon guidance 2047_10154_2048_5058_4772_6093_10505 7 + 0.0197476887539301 0.795627016163491 2296 procaine hsa04740 Olfactory transduction 5566 1 - 0.000560974963402418 0.0179511988288774 2297 procaine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013 32 - 4.00596757640021e-18 2.56381924889613e-16 2298 chlortetracycline hsa04916 Melanogenesis 5331_801_808_805_23236 5 - 0.0389112936633165 0.278559729249942 2299 chlortetracycline hsa04070 Phosphatidylinositol signaling system 8871_56623_5331_808_51763_801_805_23236 8 - 8.9862902349252e-05 0.00395396770336709 2300 chlortetracycline hsa04910 Insulin signaling pathway 2308_2319_808_51763_801_805 6 - 0.0370352785966159 0.278559729249942 2301 chlortetracycline hsa05322 Systemic lupus erythematosus 81_92815_8343_8339_8347_8346_8344 7 - 0.0149520846291104 0.219297241226953 2302 chlortetracycline hsa04720 Long-term potentiation 5331_801_808_805_23236 5 - 0.011834317070567 0.219297241226953 2303 chlortetracycline hsa04062 Chemokine signaling pathway 157_156_6358_6359_5331_408_10681_23236 8 - 0.0220682380809696 0.242750618890666 2304 chlortetracycline hsa04912 GnRH signaling pathway 5331_801_808_805_23236 5 - 0.0443163205624908 0.278559729249942 2305 aciclovir hsa05332 Graft-versus-host disease 3105_3106_3126_3127_3125_3135_3123_649853 8 + 0.0057465335783056 0.07952872565974 2306 aciclovir hsa05010 Alzheimer's disease 6622_348 2 + 0.00445694916311101 0.0775509154381316 2307 aciclovir hsa05320 Autoimmune thyroid disease 3448_3105_3106_3126_3127_3125_3135_3123_649853 9 + 0.00672248916909407 0.07952872565974 2308 aciclovir hsa04612 Antigen processing and presentation 4261_3448_3123_3106_3126_3127_3125_3135_6892_3105_3305_925_649853 13 + 0.00401291159801296 0.0775509154381316 2309 aciclovir hsa05016 Huntington's disease 7416 1 + 0.000540178359499606 0.0234977586382329 2310 aciclovir hsa04740 Olfactory transduction 8387_26212_7932_1179_8388 5 + 2.23644211913969e-05 0.00194570464365153 2311 aciclovir hsa04514 Cell adhesion molecules (CAMs) 5010_6402_3688_965_3123_3106_3126_3127_3685_3125_3135_4359_9672_3105_925_649853 16 + 0.0106062259483432 0.102526850833984 2312 aciclovir hsa05310 Asthma 2207_3123_3126_3127_3125_8288 6 + 0.0132018703517719 0.114856272060416 2313 aciclovir hsa05012 Parkinson's disease 6622_7416 2 + 0.0360533357939741 0.285149110370522 2314 aciclovir hsa05330 Allograft rejection 3105_3106_3126_3127_3125_3135_3123_649853 8 + 0.00339002163424139 0.0775509154381316 2315 aciclovir hsa04940 Type I diabetes mellitus 3105_3106_3126_3127_3125_3135_3123_649853 8 + 0.0073129862675623 0.07952872565974 2316 aciclovir hsa05131 Shigellosis 7454_7846_7430_9181 4 - 0.0383105848570311 0.969749901033229 2317 aciclovir hsa05130 Pathogenic Escherichia coli infection 7454_7846_7430_9181 4 - 0.0383105848570311 0.969749901033229 2318 aciclovir hsa04710 Circadian rhythm - mammal 8553_79365 2 - 0.0393141851770228 0.969749901033229 2319 guanabenz hsa05332 Graft-versus-host disease 3811_3553_3109_3105_3106_3126_3127_3802_3135_3123_941_3125_649853 13 + 1.36927914676281e-05 0.00107568581148931 2320 guanabenz hsa04640 Hematopoietic cell lineage 1435_3553_2812_3690_3123_3568_952_3126_3127_3125_3589_1378_931 13 + 0.00803620885820599 0.112506924014884 2321 guanabenz hsa04080 Neuroactive ligand-receptor interaction 2904_2846_2570_1909_4142_1902_7433_1813_2561_5540_5724_2566_185_3953_4986_148_3356_3269_4544_2555_7253_8001_2893_8484_2357 25 + 0.0391658388973625 0.426864044993437 2322 guanabenz hsa05320 Autoimmune thyroid disease 3109_7253_3105_3106_3126_3127_3125_3135_3123_941_649853 11 + 0.00118622708468368 0.0199286150226858 2323 guanabenz hsa04612 Antigen processing and presentation 3811_3109_3123_3106_3126_3127_3125_3135_3105_3802_649853 11 + 0.0496793859090032 0.426864044993437 2324 guanabenz hsa04740 Olfactory transduction 26212_26664_818_390892_5137_816 6 + 2.56115669402216e-05 0.00107568581148931 2325 guanabenz hsa04920 Adipocytokine signaling pathway 3953_208_6513_8660_5599_1375_5781_5602_6257 9 + 0.0440670189639925 0.426864044993437 2326 guanabenz hsa05330 Allograft rejection 3109_3105_3106_3126_3127_3125_3135_3123_941_649853 10 + 0.000408716538330336 0.00858304730493705 2327 guanabenz hsa04940 Type I diabetes mellitus 3382_3109_3105_3106_3126_3127_3125_3135_3123_3553_941_649853 12 + 8.25178896941141e-05 0.00231050091143519 2328 guanabenz hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344 12 - 8.37590461228413e-05 0.00569561513635321 2329 guanabenz hsa04370 VEGF signaling pathway 8681_4775_100137049_842_7422 5 - 0.0262472142050331 0.892405282971125 2330 lisuride hsa04740 Olfactory transduction 26212 1 + 1.25721808933887e-05 0.000477742873948771 2331 lisuride hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013 33 + 1.00947382256744e-14 7.67200105151254e-13 2332 lisuride hsa04920 Adipocytokine signaling pathway 1375_4793 2 - 0.0239574459975162 0.431234027955292 2333 daunorubicin hsa04080 Neuroactive ligand-receptor interaction 2905_1813_9127_6754_1241_6915_8811_1909_1511_5644 10 + 0.00467586569537709 0.102869045298296 2334 daunorubicin hsa04670 Leukocyte transendothelial migration 5010_93408_8503_5335 4 + 0.0336163944073307 0.493040451307517 2335 daunorubicin hsa05016 Huntington's disease 5430_6648_642502_6391_317_9001_1339_6875 8 + 0.0261788976754271 0.460748599087517 2336 daunorubicin hsa04740 Olfactory transduction 818_5613_5616_816 4 + 1.46795890820131e-10 1.29180383921715e-08 2337 daunorubicin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_1511_9555 28 + 0.000677155422441182 0.0198632257249413 2338 daunorubicin hsa04115 p53 signaling pathway 55367_1647_1026_5366_55240_64393_317_4193_7249_3486_8493_898_355_10912_8795_5268_3732_9540_2810 19 + 9.53297553797211e-05 0.00419450923670773 2339 daunorubicin hsa04062 Chemokine signaling pathway 8503_156_5613_6655_6777_5616_7454_8976_4793 9 + 0.0399049699823133 0.501662479777653 2340 daunorubicin hsa04260 Cardiac muscle contraction 786_1339 2 + 0.0462747374004689 0.509022111405158 2341 daunorubicin hsa04916 Melanogenesis 23236_5567_6934_2535_5578_2773_2776_7475_7855_5332_2033_7477_113_8324_1385_1387_8321_107_8322 19 - 0.0154830794096102 0.0519789094465485 2342 daunorubicin hsa05332 Graft-versus-host disease 3123_355_3126_3127_3125 5 - 0.0263291118400188 0.0798366617084441 2343 daunorubicin hsa04650 Natural killer cell mediated cytotoxicity 8503_5295_5290_10451_3383_3455_3459_7410_5781_7535_10725_673_5533_5532_5530_5534_8795_5777_5578_6655_6654_6464_355_4775_7409 25 - 0.00447197609654688 0.0161679135798233 2344 daunorubicin hsa04640 Hematopoietic cell lineage 3581_3554_960_2057_3690_3123_3126_3127_3125_933_290 11 - 0.00134524228728326 0.00632263875023132 2345 daunorubicin hsa03320 PPAR signaling pathway 79966_5360_7316_6256_1375_9415_5467_6319_28965 9 - 0.00391552518047153 0.014722374678573 2346 daunorubicin hsa05010 Alzheimer's disease 2903_488_317_9451_2776_5332_7132_509_8772_5533_5532_3708_5530_5534_102_23236_842_841_4137_355_351_8851 22 - 1.81181834202029e-06 2.43301320214153e-05 2347 daunorubicin hsa04080 Neuroactive ligand-receptor interaction 2903_64106_2908_56288_136_134_1813_5540_3953_2150_5021_1131_4886_6915_5732_23566_9170_5618_7068_7067_4158_2740_2690 23 - 9.92247774807977e-13 4.66356454159749e-11 2348 daunorubicin hsa04742 Taste transduction 5567 1 - 5.05594319011958e-06 5.94073324839051e-05 2349 daunorubicin hsa05320 Autoimmune thyroid disease 3123_355_3126_3127_3125 5 - 0.00326890436288195 0.0133598700048219 2350 daunorubicin hsa04612 Antigen processing and presentation 4800_4801_4802_3123_3126_3127_3125_6890_1385_3304_3305_3303 12 - 0.0016759282099631 0.00750177389221578 2351 daunorubicin hsa05131 Shigellosis 4690_5578_7278_113457_9475_7430_25_9181_2017 9 - 0.0431588357080002 0.1014232639138 2352 daunorubicin hsa04670 Leukocyte transendothelial migration 8503_5295_1432_3383_5781_5578_5290_2773_6387_27035_9475_7852_10451_7430_4636_7410_5747_7409_23562 19 - 0.00115820533883937 0.00573006851846846 2353 daunorubicin hsa05016 Huntington's disease 4899_317_246721_2776_5332_23186_6874_5430_5439_2033_509_1213_3708_548644_23236_27113_842_841_5978_1385_1387_9519 22 - 2.68052481451156e-07 4.19948887606811e-06 2354 daunorubicin hsa05130 Pathogenic Escherichia coli infection 4690_5578_7278_113457_9475_7430_25_9181_2017 9 - 0.0431588357080002 0.1014232639138 2355 daunorubicin hsa04740 Olfactory transduction 4991_26529_5567_157_26716 5 - 4.24645400107485e-41 3.99166676101036e-39 2356 daunorubicin hsa04514 Cell adhesion molecules (CAMs) 965_214_4685_3383_5819_3123_4099_6693_3126_3127_3685_3125_23705_3897_6383_933_5792_9019_4897_23562 20 - 0.000459843058271953 0.00254266161632727 2357 daunorubicin hsa04510 Focal adhesion 8503_10298_596_6464_5295_331_5154_5290_9475_10451_4636_5747_4659_3690_3693_7057_7410_1399_1398_55742_329_3082_5062_1793_3480_673_1956_3725_6714_4233_5578_5228_3371_1729_2317_6655_6654_1289_3685_7409_7422_83660 42 - 0.00366499203746743 0.0143545521467474 2358 daunorubicin hsa05340 Primary immunodeficiency 7535_6890_64421 3 - 0.013443283034474 0.0468025409348354 2359 daunorubicin hsa04140 Regulation of autophagy 8408_5289_9474_5562 4 - 0.0393691327249643 0.1014232639138 2360 daunorubicin hsa04530 Tight junction 55844_10207_5578_2773_8777_50855_6709_51776_84612_1457_56288_4636_64398_7525_2017_2036_9223_6714_27134_23562 20 - 0.000256729710956941 0.00180780170139117 2361 daunorubicin hsa04664 Fc epsilon RI signaling pathway 8503_50487_1432_4067_5295_5578_6655_6416_10451_5290_7410_6654_7409_5609 14 - 0.0296327780735221 0.0819259158503258 2362 daunorubicin hsa05218 Melanoma 8503_3480_5295_5154_5290_4193_1956_1871_2260_673_4233_3082 12 - 0.0296065713463565 0.0819259158503258 2363 daunorubicin hsa05110 Vibrio cholerae infection 5567_3784_5578 3 - 4.87107730630679e-05 0.000416255697084398 2364 daunorubicin hsa04512 ECM-receptor interaction 960_3690_3693_1289_7057_3371_3685_6383_3161 9 - 0.00039293413637204 0.00246238725459812 2365 daunorubicin hsa04630 Jak-STAT signaling pathway 3717_6777_598_5295_5292_8503_5290_6772_9655_10253_10254_2057_3455_3459_3572_2033_5781_3581_3953_1154_200734_8554_4609_8027_5777_868_5618_6655_6654_867_51588_10379_8835_1387_2690 35 - 0.0421116654336978 0.1014232639138 2366 daunorubicin hsa04062 Chemokine signaling pathway 3717_6777_157_156_2773_8503_5290_9475_7852_6387_5332_56288_113_5747_2309_2786_4067_3551_5567_7410_1399_1398_6361_4793_5295_673_107_4792_23236_6655_6654_6464_10451_6772_7409_5970 36 - 0.00112287148226148 0.00573006851846846 2367 daunorubicin hsa04810 Regulation of actin cytoskeleton 8503_10298_10672_5295_5154_5290_9475_10451_4636_5747_10458_4659_3690_1730_3693_23191_8394_7410_50649_7430_1399_1398_2245_5962_8396_200576_324_5062_1793_1131_9138_673_1956_2260_8874_1729_6655_6654_5305_3685_8936_7409_54434_3985 44 - 0.00186776841352292 0.00798046503959793 2368 daunorubicin hsa05012 Parkinson's disease 2861_7326_842_7314_317_51465_509 7 - 2.85625119782829e-10 8.94958708652864e-09 2369 daunorubicin hsa04620 Toll-like receptor signaling pathway 8503_6416_1326_841_3551_3455_8772_5295_6772_148022_7189_1432_5290_3725_8737_29110_5970_5609_4792 19 - 0.0196612941234011 0.0616053882533234 2370 daunorubicin hsa04260 Cardiac muscle contraction 27092_481_488 3 - 2.04444207967944e-07 3.84355110979735e-06 2371 daunorubicin hsa04060 Cytokine-cytokine receptor interaction 8744_5154_8741_7852_6387_90_7132_27242_3554_2057_3455_3459_3572_657_4982_6361_3082_3581_3604_3953_23765_8742_1956_91_655_8792_92_4233_8795_5618_355_7422_2690 33 - 4.64024951761952e-09 1.09045863664059e-07 2372 daunorubicin hsa03010 Ribosome 6139_6181_9349_6137_6125_6168_6233_439992_6144_6234_6129_6189_6171 13 - 0.000453491681917588 0.00254266161632727 2373 daunorubicin hsa04020 Calcium signaling pathway 2903_5534_2776_7220_5333_5332_136_113_493_5532_5256_5567_3707_814_56848_5021_1131_5533_6915_3708_5530_488_107_23236_5578_1956_683 27 - 1.81764985784983e-05 0.000187847124931414 2374 daunorubicin hsa03050 Proteasome 23198 1 - 1.99837366948313e-05 0.000187847124931414 2375 daunorubicin hsa04912 GnRH signaling pathway 6416_113_50487_2776_5332_5337_5609_5567_4214_4216_468_3708_1956_3725_6714_107_23236_1432_5578_5598_6655_6654 22 - 0.0406311525620852 0.1014232639138 2376 daunorubicin hsa04730 Long-term depression 50487_2781_4067_5578_10672_2773_2776_673_3708_5332_3480_23236 12 - 0.0296065713463565 0.0819259158503258 2377 daunorubicin hsa04270 Vascular smooth muscle contraction 5567_5578_10672_50487_2776_673_27094_3708_5332_136_113_9138_9475_4659_107_23236 16 - 0.000269247061909323 0.00180780170139117 2378 daunorubicin hsa04940 Type I diabetes mellitus 3382_3123_3126_3127_3125_355 6 - 0.0333949406756477 0.0896892692431681 2379 daunorubicin hsa02010 ABC transporters 6890_215_8714_23457_22 5 - 0.0189110117976432 0.0612977623785676 2380 daunorubicin hsa04610 Complement and coagulation cascades 727_7056_7035_2152_5329 5 - 0.000111782091386297 0.000875626382525993 2381 methyldopate hsa04740 Olfactory transduction 393046 1 + 1.16979404802778e-05 0.000853949655060279 2382 methyldopate hsa05322 Systemic lupus erythematosus 3013_8358_8968_8341_8350_8351_8352_8353_8354_8355_8356_8357 12 + 0.0143464355809098 0.523644898703208 2383 methyldopate hsa05210 Colorectal cancer 11211_581_1856_7046_8312_5602_91 7 + 0.0473015402564626 0.921512001401661 2384 estrone hsa04740 Olfactory transduction 26212 1 + 0.010723060181307 0.64338361087842 2385 estrone hsa04730 Long-term depression 30814_3708_1394_23236 4 + 0.0480607763437941 1 2386 estrone hsa05332 Graft-versus-host disease 3105_3106_3126_3127_3125_3133_3123_3113 8 - 0.0112902324942281 0.119958720251174 2387 estrone hsa04080 Neuroactive ligand-receptor interaction 3953_1269_706_2692 4 - 0.000389027547495404 0.0165336707685547 2388 estrone hsa05016 Huntington's disease 4714_1350_4728 3 - 0.0036164373335614 0.102465724450906 2389 estrone hsa04740 Olfactory transduction 5566 1 - 5.2965888823509e-10 4.50210054999827e-08 2390 estrone hsa05221 Acute myeloid leukemia 1050_6932_6654_5295_5293_5605_3265_6934_6777_5914 10 - 0.00983450557083332 0.119958720251174 2391 estrone hsa05012 Parkinson's disease 4714_1350_4728 3 - 0.0491482511071127 0.379781940373144 2392 estrone hsa04060 Cytokine-cytokine receptor interaction 3454_23529_5155_8742_8741_3953_7042 7 - 0.00991605828810202 0.119958720251174 2393 estrone hsa04020 Calcium signaling pathway 5566_5335_489 3 - 0.00519828958771937 0.110463653739037 2394 estrone hsa05330 Allograft rejection 3105_3106_3126_3127_3125_3133_3123_3113 8 - 0.0068208750038613 0.115954875065642 2395 estrone hsa04940 Type I diabetes mellitus 3105_3106_3126_3127_3125_3133_3123_3113 8 - 0.0141990815697969 0.134102437048082 2396 estrone hsa05220 Chronic myeloid leukemia 1026_598_6654_5293_5605_2122_3265_6777_7042_5295 10 - 0.0416741240571288 0.354230054485595 2397 (-)-MK-801 hsa04740 Olfactory transduction 810_8390_1258 3 + 0.00765842933140497 0.275703455930579 2398 (-)-MK-801 hsa04630 Jak-STAT signaling pathway 3593_3451_10000_3454_23529_6654_200734_2688_2689_9180_10253_1442 12 + 0.00324730993904718 0.233806315611397 2399 (-)-MK-801 hsa04080 Neuroactive ligand-receptor interaction 3953_5028_5618_2925_1131 5 - 0.0260700042137355 0.52950670229379 2400 (-)-MK-801 hsa04910 Insulin signaling pathway 5584_5170_3551_5575_5293_7249_2002_6720_10211_51763_5602_8651_3845_5792 14 - 0.0186749627231066 0.52950670229379 2401 (-)-MK-801 hsa05322 Systemic lupus erythematosus 8330_3113 2 - 0.0491794487732384 0.629280197600058 2402 (-)-MK-801 hsa04210 Apoptosis 3552_3551_598_5575_5293_472_51135_651610_8795_7186 10 - 0.02715418986122 0.52950670229379 2403 (-)-MK-801 hsa04060 Cytokine-cytokine receptor interaction 3953_5618_3552_8795 4 - 0.00790361779685636 0.52950670229379 2404 (-)-MK-801 hsa04020 Calcium signaling pathway 1131_2925_5578 3 - 0.0364574685296592 0.568736509062683 2405 fluspirilene hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8360_8368_8349_8362_8294_121504_8366_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_83740_3013_3111_8970 31 + 2.0116997179259e-11 1.48865779126517e-09 2406 fluspirilene hsa05219 Bladder cancer 2277_1026_3576_1029_1613_7422 6 + 0.0176338129588275 0.469416304285415 2407 fluspirilene hsa04115 p53 signaling pathway 55367_1647_27113_5366_1029_1026_8795_4616 8 + 0.0190303907142736 0.469416304285415 2408 fluspirilene hsa05012 Parkinson's disease 7318 1 + 0.0322629605731282 0.596864770602872 2409 fluspirilene hsa04080 Neuroactive ligand-receptor interaction 3354_1269_4889 3 - 0.0375966244088989 1 2410 fluspirilene hsa04060 Cytokine-cytokine receptor interaction 91_4982_2324 3 - 0.0270071214859322 1 2411 megestrol hsa04740 Olfactory transduction 393046 1 + 0.000264270578457621 0.019556022805864 2412 megestrol hsa05219 Bladder cancer 5925_2277_1612_7057 4 + 0.0433364546473922 1 2413 megestrol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_3113_8359_8330_8294_8367_121504_8368_8351 18 - 1.44392234452774e-07 1.0251848646147e-05 2414 megestrol hsa04010 MAPK signaling pathway 3554_3925_6789_6655_1649_4137_4763_10912_5534_10746_2260_5971_3725 13 - 0.0359533499606474 0.987633594723948 2415 benzbromarone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_8294_8367_8342_121504_3119 16 + 4.10209864171793e-07 3.11759496770563e-05 2416 benzbromarone hsa04710 Circadian rhythm - mammal 8553_1408_5187 3 + 0.0047057761533757 0.178819493828277 2417 benzbromarone hsa04916 Melanogenesis 6934_1856 2 - 0.0498179773724322 0.236635392519053 2418 benzbromarone hsa05200 Pathways in cancer 405_3914_6934_1856 4 - 0.0259605035405503 0.216064570689521 2419 benzbromarone hsa05210 Colorectal cancer 6934_1856 2 - 0.0341154585299244 0.216064570689521 2420 benzbromarone hsa05217 Basal cell carcinoma 6934_1856 2 - 0.0158321651825013 0.216064570689521 2421 prasterone hsa04080 Neuroactive ligand-receptor interaction 2908_2359_728 3 + 0.0270396014602359 0.576491214956812 2422 prasterone hsa04310 Wnt signaling pathway 11261 1 + 0.0461897422766118 0.729797927970466 2423 prasterone hsa04740 Olfactory transduction 56656_4991 2 + 0.000129664304405291 0.010243480048018 2424 prasterone hsa05221 Acute myeloid leukemia 6654_862_5371_5605_3845_5914 6 + 0.0291894286054082 0.576491214956812 2425 prasterone hsa04620 Toll-like receptor signaling pathway 7097_3451_6352_7100_6772_5605_3627_3553_6373 9 + 0.0186784374552049 0.576491214956812 2426 prasterone hsa04740 Olfactory transduction 219464_26211 2 - 0.00461160868747326 0.285919738623342 2427 etynodiol hsa05131 Shigellosis 7278_113457_929_7430_6093_81027 6 + 0.0267790539097316 0.401685808645974 2428 etynodiol hsa05130 Pathogenic Escherichia coli infection 7278_113457_929_7430_6093_81027 6 + 0.0267790539097316 0.401685808645974 2429 etynodiol hsa04740 Olfactory transduction 51806_8390 2 + 8.96488152500427e-05 0.0067236611437532 2430 etynodiol hsa04710 Circadian rhythm - mammal 4862_8553_8863 3 + 0.0197643348366958 0.401685808645974 2431 etynodiol hsa04920 Adipocytokine signaling pathway 3717_3551_5602_2182_1375_5781_8717 7 + 0.019469832652075 0.401685808645974 2432 etynodiol hsa04070 Phosphatidylinositol signaling system 8394_8396_5578_3631 4 - 0.0262613664072924 0.748448942607833 2433 etynodiol hsa04310 Wnt signaling pathway 4040_5578_1855_9475_6934_5534 6 - 0.0242367077432905 0.748448942607833 2434 etynodiol hsa04210 Apoptosis 472_3554_651610_5534 4 - 0.042221706252878 0.802212418804682 2435 podophyllotoxin hsa05010 Alzheimer's disease 836_5663_3708_3709_6868_102_6622 7 + 0.0162352015805893 0.198708438533873 2436 podophyllotoxin hsa04080 Neuroactive ligand-receptor interaction 2917_64106_2893_6755_59340_56288_5733_5732_2150_5644 10 + 0.00260556939764433 0.0960877520901619 2437 podophyllotoxin hsa05016 Huntington's disease 246721_836_3708_2033_9001_3064_1385 7 + 0.0092783450378333 0.161443203658299 2438 podophyllotoxin hsa04740 Olfactory transduction 26212 1 + 3.26736221896154e-14 2.84260513049654e-12 2439 podophyllotoxin hsa04510 Focal adhesion 10000_1302_596_858_2909_5154_7057_4636_5602_7791_3655_81_3676_857_3381_3694_3695_7414_29780_1290_10627_1399_3918_3725_4233_1281_2335_5599_2317_1289_7422 31 + 0.0182720403249538 0.198708438533873 2440 podophyllotoxin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8341_81_8347_8346_8344_8370_718_8359_554313_121504_8339_3118_3117_3111 25 + 0.00773817652812672 0.161443203658299 2441 podophyllotoxin hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3579_836_5599_50848_3576_5602_6868_5600_5336_102_3725_4233_9020 13 + 0.0308204328754556 0.262979077538939 2442 podophyllotoxin hsa04512 ECM-receptor interaction 1289_2811_2335_1302_3381_960_3694_3695_7057_1281_3655_1290_3918_3676_3339 15 + 0.0284066369612204 0.262979077538939 2443 podophyllotoxin hsa05012 Parkinson's disease 6622_836_9627 3 + 0.00331337076172972 0.0960877520901619 2444 podophyllotoxin hsa03010 Ribosome 6181_6171 2 + 0.0120743282451723 0.175077759554998 2445 podophyllotoxin hsa04270 Vascular smooth muscle contraction 108_3709_3708_72 4 + 0.0332502281945785 0.262979077538939 2446 podophyllotoxin hsa05332 Graft-versus-host disease 3135_3105_3106_3111_649853 5 - 0.00077377510518561 0.0152457721040936 2447 podophyllotoxin hsa05320 Autoimmune thyroid disease 3135_3105_3106_3111_649853 5 - 0.002015446161421 0.0218340000820608 2448 podophyllotoxin hsa04612 Antigen processing and presentation 6891_3105_3106_3806_3111_3135_5994_649853 8 - 0.000128424702444046 0.00834760565886299 2449 podophyllotoxin hsa04514 Cell adhesion molecules (CAMs) 3688_3105_3106_3111_3135_57863_649853_5817 8 - 0.00165535131583628 0.0215195671058716 2450 podophyllotoxin hsa05322 Systemic lupus erythematosus 85235_8330_3111_8332_8969_8331_8329_8336 8 - 0.00253876320122376 0.0235742297256492 2451 podophyllotoxin hsa05330 Allograft rejection 3135_3105_3106_3111_649853 5 - 0.000510437857396215 0.0152457721040936 2452 podophyllotoxin hsa04940 Type I diabetes mellitus 3135_3105_3106_3111_649853 5 - 0.000938201360251912 0.0152457721040936 2453 paroxetine hsa04740 Olfactory transduction 26212_8388_8387_1179_2978_5137 6 + 0.00180439027317614 0.144351221854091 2454 paroxetine hsa04270 Vascular smooth muscle contraction 112 1 + 0.0451298228928404 1 2455 paroxetine hsa04912 GnRH signaling pathway 2778_1956_50487_1081_816 5 - 0.0168978368076828 0.861789677191823 2456 pheneticillin hsa05332 Graft-versus-host disease 3553_3123_3107_3126_3127_3125 6 + 0.0160438799399614 0.223812110037963 2457 pheneticillin hsa04640 Hematopoietic cell lineage 1437_960_3553_2814_3123_3126_3127_3125_1378_3684 10 + 0.00851505891435274 0.210038119887368 2458 pheneticillin hsa05016 Huntington's disease 7052_6648 2 + 0.0181469278409159 0.223812110037963 2459 pheneticillin hsa04740 Olfactory transduction 51806_5593_23538_26476_26532_1258 6 + 0.00321631449441225 0.210038119887368 2460 pheneticillin hsa05322 Systemic lupus erythematosus 85235_3123_3126_3127_3125_8332_8969_8331_8336_8342_8329_8330 12 + 0.0441477647131329 0.408366823596479 2461 pheneticillin hsa04512 ECM-receptor interaction 2814_7059_1281_22798_1311_7057_3371_960_1291 9 + 0.0180012479409633 0.223812110037963 2462 pheneticillin hsa05330 Allograft rejection 3123_3107_3126_3127_3125 5 + 0.0357547259438636 0.377978531406558 2463 pheneticillin hsa04940 Type I diabetes mellitus 3553_3123_3107_3126_3127_2571_3125 7 + 0.0057466947292528 0.210038119887368 2464 pheneticillin hsa05200 Pathways in cancer 5970_4149_581_572_998_5290_3918_7423_6934_5914_2247_3675 12 - 0.011324542149981 0.185791293034008 2465 pheneticillin hsa04210 Apoptosis 581_572_5290_472_8837_5970 6 - 0.00347587772387229 0.12165572033553 2466 pheneticillin hsa05221 Acute myeloid leukemia 572_5970_6934_5290_5914 5 - 0.00303011628039182 0.12165572033553 2467 pheneticillin hsa04370 VEGF signaling pathway 10725_572_998_5290 4 - 0.036541624905913 0.354913163199633 2468 pheneticillin hsa03020 RNA polymerase 246721_5439_548644 3 - 0.012942722770936 0.185791293034008 2469 pheneticillin hsa04912 GnRH signaling pathway 2778_5331_1839_998_23236 5 - 0.0306590743863604 0.354913163199633 2470 pheneticillin hsa05210 Colorectal cancer 572_5290_6934_581 4 - 0.0472053769081881 0.354913163199633 2471 pheneticillin hsa05222 Small cell lung cancer 3918_5970_4149_5290_3675 5 - 0.0132708066452863 0.185791293034008 2472 propidium iodide hsa05200 Pathways in cancer 91_861_1956_6257_3910 5 + 0.014520422880897 0.392051417784219 2473 propidium iodide hsa04910 Insulin signaling pathway 5770 1 + 0.0456116806113896 0.827768642268633 2474 propidium iodide hsa04740 Olfactory transduction 3000 1 + 5.53817030050105e-06 0.000448591794340585 2475 propidium iodide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_8294_720_721_121504_6737_8367 17 + 0.000177976160654142 0.00720803450649275 2476 propidium iodide hsa04080 Neuroactive ligand-receptor interaction 3953 1 - 0.00750306024646205 0.169610528650885 2477 propidium iodide hsa04350 TGF-beta signaling pathway 4090_4088_7057_5519_1874_5934_5933_57154 8 - 0.00581402813932293 0.169610528650885 2478 propidium iodide hsa04062 Chemokine signaling pathway 6655 1 - 0.0468723862078483 0.785112468981459 2479 propidium iodide hsa04060 Cytokine-cytokine receptor interaction 3953 1 - 0.00759450128287545 0.169610528650885 2480 PF-01378883-00 hsa04120 Ubiquitin mediated proteolysis 23327_23759_5371_867_8651_5071_9021 7 + 0.020524631718119 0.294186387959706 2481 PF-01378883-00 hsa05016 Huntington's disease 1213_4899_1339_7052_54205_651820_246721_6392_56901_55567 10 + 0.00722003049738694 0.155230655693819 2482 PF-01378883-00 hsa04740 Olfactory transduction 8388_8387_2978_1179_81697_26476_81797_810_81696_393046_816 11 + 3.6606569518813e-09 3.14816497861792e-07 2483 PF-01378883-00 hsa04514 Cell adhesion molecules (CAMs) 23308_22871_9672_5133_5797_3384_3383_3123_3126_3127_3125_7412_914_1272_3689_4684_3688_3119_947_3113_3685_3684_5818_6693_26047_1000 26 + 0.0272666843814946 0.334990693829791 2484 PF-01378883-00 hsa05322 Systemic lupus erythematosus 2903_474382_8363_474381_8365_8364_8367_8360_8368_88_8362_8294_121504_8341_3123_3458_8366_3126_3127_3125_8968_8370_717_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2213_3119_83740_3013_3113_8361 40 + 9.36018220475616e-06 0.000402487834804515 2485 PF-01378883-00 hsa04512 ECM-receptor interaction 1278_1291_375790_2811_1280_3910_3691_960_7057_3685_1277_5649_63923_3688_9672_1288_1281_51206_9899 19 + 0.0151498252926782 0.260576995034065 2486 PF-01378883-00 hsa03010 Ribosome 6141_6165_6171 3 + 0.00606938257775683 0.155230655693819 2487 PF-01378883-00 hsa04120 Ubiquitin mediated proteolysis 51343_7318_7189_331_23759_5371_4193_26232_26272_8916_8651_326_9021 13 - 0.0132412454526832 0.145812732488835 2488 PF-01378883-00 hsa05010 Alzheimer's disease 775_5331_4713_3553_3710_2904_2081_2776_4137_5533_5532_3708_3709_5534_810_801_6622_808_805_23236 20 - 0.0296938328692378 0.245648981009149 2489 PF-01378883-00 hsa05016 Huntington's disease 4899_1211_6648_2904_1639_4713_5430_2776_5331_64446_3708_7416_9001_9586_1742_23236 16 - 0.000933551866088106 0.0283177399380059 2490 PF-01378883-00 hsa03420 Nucleotide excision repair 2068 1 - 0.00686551122586931 0.104126920259018 2491 PF-01378883-00 hsa04740 Olfactory transduction 26211_26212_56656_8388_8387_23538_808_805_810_801_9635_816_81797 13 - 4.03203057419135e-16 3.66914782251413e-14 2492 PF-01378883-00 hsa04110 Cell cycle 5001_699_4088_51343_4193_1028_5000_8555_7042_8243 10 - 0.0102721292820967 0.133537680667257 2493 PF-01378883-00 hsa05340 Primary immunodeficiency 4261_3561_695_29851_925_6891_920_326_5897_915_5788_29760_926 13 - 0.0446494458294872 0.338591630873611 2494 PF-01378883-00 hsa04115 p53 signaling pathway 55367_3732_7249_4193 4 - 0.0144210394769177 0.145812732488835 2495 PF-01378883-00 hsa05110 Vibrio cholerae infection 525_5579 2 - 0.0041212796833776 0.0750072902374723 2496 PF-01378883-00 hsa03022 Basal transcription factors 6872 1 - 0.0232269552568319 0.21136529283717 2497 PF-01378883-00 hsa05012 Parkinson's disease 6622_4713_7416_7318_5413 5 - 6.63910016784746e-06 0.000302079057637059 2498 PF-01378883-00 hsa03010 Ribosome 284393_439992_6234_6165_389342_6189 6 - 0.00202129827415339 0.0459845357369896 2499 metoprolol hsa05332 Graft-versus-host disease 3553_3119_3123_3107_3126_3127_3111_3125_3135 9 + 0.00656066407972263 0.108907023723396 2500 metoprolol hsa04640 Hematopoietic cell lineage 2814_1435_3553_2812_3123_3568_960_3126_3127_3125_3674_1378_931_290 14 + 0.00862630490111463 0.114884901342716 2501 metoprolol hsa05010 Alzheimer's disease 348_3708_3709_3553_51806 5 + 0.0248684458023287 0.229342333510365 2502 metoprolol hsa05320 Autoimmune thyroid disease 3448_3119_3123_3107_3126_3127_3111_3125_3135 9 + 0.0355358002675075 0.268133765654829 2503 metoprolol hsa04612 Antigen processing and presentation 4800_6891_3448_3119_3123_3107_3126_3127_3111_3125_3135_6892 12 + 0.0462531333581556 0.319917505727243 2504 metoprolol hsa05016 Huntington's disease 5432_5468_3708_1211 4 + 0.00536745719371499 0.108907023723396 2505 metoprolol hsa04740 Olfactory transduction 51806_26212_5568_157_9635_3000_815 7 + 5.21150709944847e-06 0.000432555089254223 2506 metoprolol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8342_8341_8340_3123_3126_3127_3125_8370_8359_554313_121504_2213_3119_3111 24 + 0.000476887357750909 0.0197908253466627 2507 metoprolol hsa05310 Asthma 3119_3123_3126_3127_3111_3125 6 + 0.0319670281990092 0.265326334051776 2508 metoprolol hsa03010 Ribosome 9045 1 + 0.00985814137190907 0.114884901342716 2509 metoprolol hsa05330 Allograft rejection 3119_3123_3107_3126_3127_3111_3125_3135 8 + 0.0110732435029124 0.114884901342716 2510 metoprolol hsa04940 Type I diabetes mellitus 3553_3119_3123_3107_3126_3127_3111_2571_3135_3125 10 + 0.00296053573058521 0.0819081552128575 2511 metoprolol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3111_8359_8294_8367_554313_121504 15 - 7.30853890665181e-10 3.36192789705983e-08 2512 metformin hsa05332 Graft-versus-host disease 57292_3824_3553_3123_3107_3126_3127_3111_3125_3135_3133 11 + 0.0437604406035268 0.433545324694507 2513 metformin hsa04120 Ubiquitin mediated proteolysis 7337_23759_11060_51343_7329_22888_996_8651_6923 9 + 0.0481717027438341 0.433545324694507 2514 metformin hsa04612 Antigen processing and presentation 4800_4261_57292_3824_3448_5994_3123_3107_3126_3127_5641_3125_3135_6890_6891_3111_3133_4802_920_811 20 + 0.021147389900029 0.272275553231343 2515 metformin hsa05016 Huntington's disease 8218_7052_6390_1329_317_5331_7350_3708_5332_55567_23236 11 + 0.00859551882520892 0.154719338853761 2516 metformin hsa04740 Olfactory transduction 219464_5566_2979_8392_393046_5137_26476_26532_810_26529_815_816 12 + 2.81787987853335e-09 2.53609189068002e-07 2517 metformin hsa04110 Cell cycle 4174_996_993_51343_7042_8318 6 + 0.0211769874735489 0.272275553231343 2518 metformin hsa05012 Parkinson's disease 6390_1329_317 3 + 0.000116549526620441 0.00524472869791984 2519 metformin hsa04260 Cardiac muscle contraction 1329_779 2 + 0.00506056452932156 0.151816935879647 2520 metformin hsa04912 GnRH signaling pathway 112_5331_5332_5337_5602_5609_5566_810_100137049_6300_816_779_998_108_3725_23236_5605_100133953_6655_3708_815_2002_2798_8681_2797 25 + 0.00783326744943698 0.154719338853761 2521 metformin hsa04940 Type I diabetes mellitus 3382_3126_3107_2572_3127_3111_3125_3135_3133_3123_3553_5798 12 + 0.0290944732449275 0.327312824005434 2522 metformin hsa04080 Neuroactive ligand-receptor interaction 2902_7068_64106_5617_2893_4142_1241_2561_6752_56288_135_5645_5644_5646 14 - 0.000193085596613985 0.00585692976395755 2523 metformin hsa04742 Taste transduction 3710 1 - 0.0119189655057359 0.154946551574567 2524 metformin hsa04740 Olfactory transduction 26333_26476_5593_56656_817 5 - 6.39889467674063e-16 5.82299415583397e-14 2525 metformin hsa04514 Cell adhesion molecules (CAMs) 2734_1272_3685_3897_6383_6693_3655_925 8 - 0.0183560125833699 0.208799643135833 2526 metformin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_88_6741_8294_121504_8343_8347_87_8344_8339_8346_8968_8370_717_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_720_721 36 - 0.00170457729644091 0.0387791334940307 2527 metformin hsa04340 Hedgehog signaling pathway 7473_653 2 - 0.0421275324063615 0.27939339680942 2528 metformin hsa04062 Chemokine signaling pathway 2786_5595_56288_156_6774_208_2773_5290_6773_5332_5906_2793_6093_5291_2790 15 - 0.0308284027722918 0.27939339680942 2529 metformin hsa05012 Parkinson's disease 2861_4717_836_4701_4713_4698_7345_509_7385 9 - 0.0282892931581751 0.27939339680942 2530 metformin hsa04260 Cardiac muscle contraction 6548_4635_7385 3 - 0.0113250683006499 0.154946551574567 2531 metformin hsa04060 Cytokine-cytokine receptor interaction 27242_29949_3552_2057_3589_55540_5617_3572_3570_7422_8718_659 12 - 1.83890188424551e-05 0.000836700357331707 2532 metformin hsa03010 Ribosome 440589_51187_6187_284393_389342_9045 6 - 0.0365303022260517 0.27939339680942 2533 metformin hsa04020 Calcium signaling pathway 2902_3710_5578_11261_489_5530_5335_135_5336_5332_490_817 12 - 0.00765775392495784 0.139371121434233 2534 metformin hsa04940 Type I diabetes mellitus 3552 1 - 0.0376970227988163 0.27939339680942 2535 metformin hsa04610 Complement and coagulation cascades 717_720_721 3 - 0.0429835995091416 0.27939339680942 2536 kanamycin hsa05016 Huntington's disease 1213_317_9001 3 + 0.0100684049078542 0.417838803675949 2537 kanamycin hsa04740 Olfactory transduction 5592_135948_390892 3 + 4.79877482425156e-07 3.9829831041288e-05 2538 kanamycin hsa05012 Parkinson's disease 6622_317 2 + 0.0247541468218956 0.684864728739112 2539 kanamycin hsa04080 Neuroactive ligand-receptor interaction 9568_2918_5618_1081_3354 5 - 0.0261297925832536 0.597608252924213 2540 kanamycin hsa05016 Huntington's disease 3092_4698_836 3 - 0.0373505158077633 0.597608252924213 2541 kanamycin hsa04740 Olfactory transduction 157 1 - 1.53469045410092e-07 1.22775236328074e-05 2542 kanamycin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8330_8294_8367_554313_8970_121504 16 - 0.00448056168812053 0.179222467524821 2543 kanamycin hsa04020 Calcium signaling pathway 115_6262_3707 3 - 0.0364893051660468 0.597608252924213 2544 3-hydroxy-DL-kynurenine hsa05332 Graft-versus-host disease 3123_3113_3127_940_3126_3125 6 + 0.0325090450937999 0.325090450937999 2545 3-hydroxy-DL-kynurenine hsa04740 Olfactory transduction 51806_816_26211 3 + 4.60323510233393e-06 0.000368258808186714 2546 3-hydroxy-DL-kynurenine hsa04510 Focal adhesion 8516_4638_6696_2909_5295_7057_5154_5649_93408_3918_5880_7422_1277_3725_55742_1291_87_3675 18 + 0.0444288303584191 0.355430642867353 2547 3-hydroxy-DL-kynurenine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8294_87_3123_3126_3127_3125_8370_8359_8335_121504_3113_940 22 + 2.97493064003092e-05 0.00118997225601237 2548 3-hydroxy-DL-kynurenine hsa04370 VEGF signaling pathway 5319_56848_5295_5880_5533_8681_4772_7422_100137049 9 + 0.0402836974526889 0.355430642867353 2549 3-hydroxy-DL-kynurenine hsa05310 Asthma 3123_3126_3127_3113_3125 5 + 0.0297145115849815 0.325090450937999 2550 3-hydroxy-DL-kynurenine hsa04512 ECM-receptor interaction 8516_1291_961_7057_1277_5649_6383_9672_3918_6696_3675 11 + 0.00811841599632862 0.21649109323543 2551 3-hydroxy-DL-kynurenine hsa05012 Parkinson's disease 317 1 + 0.0158138942199357 0.253022307518971 2552 3-hydroxy-DL-kynurenine hsa05330 Allograft rejection 3123_3126_3127_940_3125_3113 6 + 0.0221126858030619 0.294835810707492 2553 3-hydroxy-DL-kynurenine hsa04940 Type I diabetes mellitus 3126_2572_3127_940_3125_3123_3113 7 + 0.0134293121814908 0.253022307518971 2554 3-hydroxy-DL-kynurenine hsa04080 Neuroactive ligand-receptor interaction 4889_1812 2 - 0.00231244660475544 0.0539570874442936 2555 3-hydroxy-DL-kynurenine hsa04740 Olfactory transduction 818_26212 2 - 1.36308996451629e-05 0.000954162975161403 2556 3-hydroxy-DL-kynurenine hsa05322 Systemic lupus erythematosus 8358_85235_8968_3013_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357 18 - 0.000142028046668385 0.00497098163339348 2557 3-hydroxy-DL-kynurenine hsa04530 Tight junction 24146 1 - 0.0316409456430316 0.553716548753053 2558 doxycycline hsa05332 Graft-versus-host disease 3123_3125_3126_3127_3558 5 + 0.00230943242778938 0.0648764331675178 2559 doxycycline hsa04640 Hematopoietic cell lineage 3123_960_3126_3127_3125 5 + 0.0362963210740992 0.317592809398368 2560 doxycycline hsa05320 Autoimmune thyroid disease 3123_3558_3126_3127_3125 5 + 0.00578651989210031 0.0810112784894043 2561 doxycycline hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6868_5336_1432_3579_5602 5 + 0.0175352608645901 0.204578043420218 2562 doxycycline hsa05310 Asthma 3123_3126_3127_3125 4 + 0.00442120789133818 0.0773711380984182 2563 doxycycline hsa04810 Regulation of actin cytoskeleton 7454_3694_8394_1730_5155_7430_1399_2263_2264 9 + 0.0482095575453031 0.374963225352357 2564 doxycycline hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0251987902392515 0.251987902392515 2565 doxycycline hsa05330 Allograft rejection 3123_3558_3126_3127_3125 5 + 0.00154526902120166 0.0648764331675178 2566 doxycycline hsa04940 Type I diabetes mellitus 3123_3558_3126_3127_3125 5 + 0.00278041856432219 0.0648764331675178 2567 doxycycline hsa05131 Shigellosis 7278_113457 2 - 0.0495375820369308 0.445838238332377 2568 doxycycline hsa05130 Pathogenic Escherichia coli infection 7278_113457 2 - 0.0495375820369308 0.445838238332377 2569 doxycycline hsa05322 Systemic lupus erythematosus 85235_8330_8332_727_8969_8331_8336_8329 8 - 3.82237493307575e-06 0.000172006871988409 2570 doxycycline hsa04540 Gap junction 2778_7278_113457 3 - 0.0212187241895041 0.445838238332377 2571 doxycycline hsa05217 Basal cell carcinoma 6932_2737 2 - 0.0480156907680054 0.445838238332377 2572 monensin hsa05332 Graft-versus-host disease 3126_3108_3127_3123_3125 5 + 0.0332034923250004 0.531255877200006 2573 monensin hsa04640 Hematopoietic cell lineage 2814_3123_3126_3127_3125_920_3655_4254 8 + 0.029231712979455 0.531255877200006 2574 monensin hsa05310 Asthma 3123_3125_3108_3127_3126 5 + 0.0101907182617144 0.468911411192428 2575 monensin hsa05330 Allograft rejection 3126_3108_3127_3123_3125 5 + 0.0235713251699894 0.531255877200006 2576 monensin hsa04940 Type I diabetes mellitus 3108_3123_3126_3127_3125_1363 6 + 0.0117227852798107 0.468911411192428 2577 12,13-EODE hsa05211 Renal cell carcinoma 2034 1 + 0.0288746740572694 0.0577493481145388 2578 12,13-EODE hsa04360 Axon guidance 10512 1 - 0.0131986801319868 0.0131986801319868 2579 (-)-catechin hsa03022 Basal transcription factors 27097 1 + 0.0037996200379962 0.0037996200379962 2580 demecolcine hsa05214 Glioma 5336 1 + 0.0452774847892847 0.0932929618042716 2581 demecolcine hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5336 1 + 0.0493050348981896 0.0932929618042716 2582 demecolcine hsa05110 Vibrio cholerae infection 5336 1 + 0.0412353185884104 0.0932929618042716 2583 demecolcine hsa05223 Non-small cell lung cancer 5336 1 + 0.0378556498171266 0.0932929618042716 2584 demecolcine hsa04540 Gap junction 2697_203068 2 - 0.040898875866603 0.42116704871409 2585 troglitazone hsa04660 T cell receptor signaling pathway 10298_6655_5290_4772_2353_920_3725_925_2534 9 + 0.0375498793821644 0.587141161939188 2586 troglitazone hsa04510 Focal adhesion 10627_3914_10298_3691_6655_5290_22798_1950_2335_3725_6093_1291_2534_1301 14 + 0.025606663359423 0.587141161939188 2587 troglitazone hsa05322 Systemic lupus erythematosus 3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 11 + 0.0238050188390939 0.587141161939188 2588 troglitazone hsa05223 Non-small cell lung cancer 842_6655_1029_5290_1950_6257 6 + 0.0178621791768703 0.587141161939188 2589 troglitazone hsa04512 ECM-receptor interaction 3914_2335_961_3691_1301_1291_22798 7 + 0.0396717001310262 0.587141161939188 2590 troglitazone hsa04080 Neuroactive ligand-receptor interaction 7067 1 - 0.0163205264530361 1 2591 rosiglitazone hsa04910 Insulin signaling pathway 6009 1 + 0.0223692761988106 0.353434563941207 2592 rosiglitazone hsa04740 Olfactory transduction 5137 1 + 3.4912265065923e-07 2.75806894020792e-05 2593 rosiglitazone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294 21 + 2.19854535442154e-05 0.000868425414996508 2594 rosiglitazone hsa04530 Tight junction 5578 1 + 0.0221676184414647 0.353434563941207 2595 rosiglitazone hsa05012 Parkinson's disease 317 1 + 0.0220127284880991 0.353434563941207 2596 rosiglitazone hsa04080 Neuroactive ligand-receptor interaction 64106_3354_5031 3 - 0.0274170195606435 0.324434731467615 2597 rosiglitazone hsa04740 Olfactory transduction 5613_5567_5616_157 4 - 0.00219405643475017 0.137470135129446 2598 rosiglitazone hsa05322 Systemic lupus erythematosus 8348_3013_8358_8968_8337_8350_8351_8352_8353_8354_8355_8356_8357 13 - 0.00774479634532092 0.137470135129446 2599 rosiglitazone hsa05120 Epithelial cell signaling in Helicobacter pylori infection 50848_5335_5600_3725_6714_4233_5781 7 - 0.0237587919133454 0.324434731467615 2600 rosiglitazone hsa04370 VEGF signaling pathway 9261_8398_5829_3845_5600_5335_6714 7 - 0.0338937415097862 0.343779378170689 2601 rosiglitazone hsa04010 MAPK signaling pathway 784_4908_9261_3554_8398_3925_5613_6655_5567_5616_91_8986_3845_5600_7042_7786_3725_2260_23162_3164 20 - 0.00669891163599396 0.137470135129446 2602 rosiglitazone hsa04912 GnRH signaling pathway 8398_5613_6655_5567_5616_3845_5600_3725_6714 9 - 0.040043053534032 0.355382100114534 2603 rosiglitazone hsa05210 Colorectal cancer 6655_1857_5900_3845_6934_7042_91_3725_4233 9 - 0.00686938147802149 0.137470135129446 2604 metergoline hsa04130 SNARE interactions in vesicular transport 8773_9527_8417_662_8675 5 - 0.0447843249258166 0.624014171416654 2605 metergoline hsa04080 Neuroactive ligand-receptor interaction 2918_4889_7442 3 - 0.00377445525211322 0.156639892962699 2606 metergoline hsa04350 TGF-beta signaling pathway 4090_5594_3397_3398_7057_5519_1874_7042_91 9 - 0.0418474278586037 0.624014171416654 2607 metergoline hsa04060 Cytokine-cytokine receptor interaction 91_3597_5155_7042 4 - 0.0106748966634868 0.295338807689801 2608 metergoline hsa04020 Calcium signaling pathway 11261 1 - 0.00360350710692177 0.156639892962699 2609 metergoline hsa04270 Vascular smooth muscle contraction 5594 1 - 0.0451094581746979 0.624014171416654 2610 methylergometrine hsa04060 Cytokine-cytokine receptor interaction 3593_3581_5155_8742_8741_355_10663_1896_8794 9 + 0.0102131859935683 0.510659299678415 2611 methylergometrine hsa03440 Homologous recombination 5425_7156_5893_8940 4 - 0.0111387880252624 0.205900083588672 2612 methylergometrine hsa04740 Olfactory transduction 5566 1 - 0.000375299642527819 0.0136984369522654 2613 methylergometrine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 0.000118222733183788 0.00863025952241652 2614 methylergometrine hsa04060 Cytokine-cytokine receptor interaction 4254 1 - 0.0112821963610231 0.205900083588672 2615 clorgiline hsa05010 Alzheimer's disease 1339 1 + 0.0461264446045339 0.807212780579343 2616 clorgiline hsa04740 Olfactory transduction 26212_7932_1179 3 + 0.00382384006747114 0.13383440236149 2617 clorgiline hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 0.000325082265498534 0.0227557585848974 2618 clorgiline hsa04350 TGF-beta signaling pathway 1634_6667_3624_5519_3400_652_7042_83729 8 + 0.0082726447664395 0.193028377883588 2619 clorgiline hsa04120 Ubiquitin mediated proteolysis 23759 1 - 0.0456130317587229 0.667179195857159 2620 clorgiline hsa04080 Neuroactive ligand-receptor interaction 64106_5618_2555_1909 4 - 0.0486856721120812 0.667179195857159 2621 clorgiline hsa04740 Olfactory transduction 219464_801_808_805_409 5 - 0.00435128771359997 0.22156663009907 2622 clorgiline hsa03020 RNA polymerase 5432_246721_5439_548644 4 - 0.0360346596979046 0.667179195857159 2623 clorgiline hsa04912 GnRH signaling pathway 776_5580_5599_6655_5331_808_3845_3725_801_805_23236 11 - 0.0058307007920808 0.22156663009907 2624 clopamide hsa04740 Olfactory transduction 818_5566 2 + 0.000546374896778923 0.0224013707679358 2625 clopamide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_718_8368_8366_3113_8359_8294_8367_554313_121504 16 + 4.28983095020991e-05 0.00351766137917213 2626 clopamide hsa04540 Gap junction 5566_7278_1813_113457_5331_5607_6655 7 + 0.0381050201929247 0.861502589086119 2627 clopamide hsa05220 Chronic myeloid leukemia 4088_4089_6655_861_7046_5781 6 + 0.0420245165407863 0.861502589086119 2628 clopamide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_8294_8367_554313_8343_121504_3119_8339_8347_8346_8344 21 - 1.98125472171988e-11 1.24819047468352e-09 2629 zaprinast hsa04740 Olfactory transduction 5137 1 + 0.00512843229948771 0.241036318075922 2630 zaprinast hsa05219 Bladder cancer 23604_1869_7423 3 - 0.0205997025835892 0.741589293009211 2631 clenbuterol hsa05332 Graft-versus-host disease 3804_355_3811_942_3802 5 + 0.0255426544464699 1 2632 clenbuterol hsa04630 Jak-STAT signaling pathway 23533 1 + 0.0466766731678079 1 2633 clenbuterol hsa04912 GnRH signaling pathway 776_8398_1839_5331_5606_5600_5603_23236 8 - 0.0263624758388903 0.906415040735192 2634 tyrphostin AG-825 hsa04115 p53 signaling pathway 1647_5366 2 + 0.00557558780037866 0.0223023512015146 2635 tyrphostin AG-825 hsa05010 Alzheimer's disease 5663_8772_7132_9451 4 - 0.00756557785781164 0.145637373762874 2636 tyrphostin AG-825 hsa04080 Neuroactive ligand-receptor interaction 4886 1 - 1.96142138054455e-07 1.5102944630193e-05 2637 tyrphostin AG-825 hsa04310 Wnt signaling pathway 23002_81839_57680_324_10725_5663_22943_6477_9475_5519_1457_1387_6934_4609_6885_7976_59343_4088_23291_7855 20 - 0.0240038145061402 0.231036714621599 2638 tyrphostin AG-825 hsa05016 Huntington's disease 246721_1387_3092_1385_6874_9519 6 - 0.0235725660844522 0.231036714621599 2639 tyrphostin AG-825 hsa04514 Cell adhesion molecules (CAMs) 965_1364_4897 3 - 0.018278703669731 0.231036714621599 2640 tyrphostin AG-825 hsa04350 TGF-beta signaling pathway 4092_57154_4086_9765_4088_64750_7057_9475_5519_657_655_4609_90_1387_659 15 - 0.00569208587966799 0.145637373762874 2641 tyrphostin AG-825 hsa04512 ECM-receptor interaction 7057 1 - 0.0303423939113077 0.234782575659682 2642 tyrphostin AG-825 hsa03022 Basal transcription factors 2967_2960_2959_6880_6877_6874_9519 7 - 0.0331201547997211 0.234782575659682 2643 tyrphostin AG-825 hsa05012 Parkinson's disease 7326 1 - 0.00106942361652475 0.0411728092362029 2644 tyrphostin AG-825 hsa04060 Cytokine-cytokine receptor interaction 5154_657_6387_4982_90_655_7132_8795_659 9 - 0.0113149890732151 0.174250831727513 2645 tyrphostin AG-825 hsa03010 Ribosome 6125_6168 2 - 0.0335403679513831 0.234782575659682 2646 tyrphostin AG-825 hsa04270 Vascular smooth muscle contraction 10672_4659_9475 3 - 0.047820944772852 0.306851062292467 2647 phenanthridinone hsa03440 Homologous recombination 4683 1 - 0.0144118453463398 0.0288236906926796 2648 metacycline hsa04670 Leukocyte transendothelial migration 9076_6494_4301_7294_93408_5880_7430_26285_5879 9 + 0.0465357994976641 0.985437469870031 2649 metacycline hsa04080 Neuroactive ligand-receptor interaction 146_5618_1081_3953_3354_56288 6 - 0.0425353314199935 0.414666550971553 2650 metacycline hsa04740 Olfactory transduction 51806_157 2 - 9.50494385515503e-07 7.31880676846937e-05 2651 metacycline hsa05322 Systemic lupus erythematosus 8353_8344_8347_8346_8358_8343_8968_3013_8350_8351_8352_8339_8354_8355_8356_8357 16 - 0.0080910469016988 0.149687124173296 2652 metacycline hsa04210 Apoptosis 3556_5534_581_5296_598_596_5290_5291_51135_208_7186 11 - 0.0097199431281361 0.149687124173296 2653 metacycline hsa04370 VEGF signaling pathway 9261_5829_208_50487_5290_5291_5296_5881_5335_5534_4772 11 - 0.00371434731526862 0.143002371637842 2654 metacycline hsa04060 Cytokine-cytokine receptor interaction 3556_5618_2057_3953_8771_7046 6 - 0.043133966975732 0.414666550971553 2655 metacycline hsa05210 Colorectal cancer 581_4088_208_596_5290_673_5296_5881_7046_5291 10 - 0.0252712313815682 0.324314136063459 2656 metacycline hsa05220 Chronic myeloid leukemia 2122_4088_208_5290_673_5296_7046_867_598_5291 10 - 0.00849413922033139 0.149687124173296 2657 repaglinide hsa05332 Graft-versus-host disease 3553_3126_3107_3113_3127_3125_3123 7 + 0.000116172914720499 0.00542131449272885 2658 repaglinide hsa04640 Hematopoietic cell lineage 3553_3123_3126_3127_3125_931 6 + 0.0199727153898521 0.15794858009018 2659 repaglinide hsa05320 Autoimmune thyroid disease 3126_3107_3113_3127_3125_3123 6 + 0.00224119540956852 0.0268943449148222 2660 repaglinide hsa04612 Antigen processing and presentation 3123_3107_3126_3127_3125_3305_3113 7 + 0.00649374146504705 0.0667927693547697 2661 repaglinide hsa04740 Olfactory transduction 810_1179 2 + 0.0137019527000038 0.123317574300034 2662 repaglinide hsa04514 Cell adhesion molecules (CAMs) 6403_965_3123_3107_3126_3127_3125_9672_3113_26047 10 + 0.0017580575668271 0.0253160289623102 2663 repaglinide hsa04360 Axon guidance 2044_57556_6405_2048_1944_5879_2534 7 + 0.0396887401840959 0.259780844841355 2664 repaglinide hsa04210 Apoptosis 3553_841_5575_472_9941_651610 6 + 0.0219373027903028 0.15794858009018 2665 repaglinide hsa05310 Asthma 3123_3126_3127_3113_3125 5 + 0.00113094447088521 0.0203570004759338 2666 repaglinide hsa05330 Allograft rejection 3113_3107_3126_3127_3125_3123 6 + 0.000467315815145111 0.0112155795634827 2667 repaglinide hsa04940 Type I diabetes mellitus 3553_3126_3107_3113_3127_3125_3123 7 + 0.000150592069242468 0.00542131449272885 2668 repaglinide hsa04080 Neuroactive ligand-receptor interaction 7442_1081 2 - 0.00655332628910822 0.138059293625054 2669 repaglinide hsa04740 Olfactory transduction 109 1 - 1.16979404802778e-05 0.000853949655060279 2670 repaglinide hsa05322 Systemic lupus erythematosus 8353_3123_8358_8968_3013_8350_8351_8352_81_8354_8355_8356_8357 13 - 0.00756489280137283 0.138059293625054 2671 repaglinide hsa04060 Cytokine-cytokine receptor interaction 7852 1 - 0.00118119303489489 0.0431135457736635 2672 PF-00562151-00 hsa04650 Natural killer cell mediated cytotoxicity 3107_6850_5578_3459_5293_5881_5880_8794_2534 9 + 0.00385164194091735 0.175249708311739 2673 PF-00562151-00 hsa05010 Alzheimer's disease 2902_2081_4694_4712_840_6392_4698_6390_6391_51806_5330_3708_3709_489_824_6622 16 + 0.0163645824462652 0.2198616750976 2674 PF-00562151-00 hsa04080 Neuroactive ligand-receptor interaction 2902_624_2908_5030_5724_134_9038_4161_799_2740_2150_2689_7433_2688_1442_2911_2913_2916_1131_4886_5732_7442_5340_1812_6755_1241_10800_728 28 + 0.0379985535207286 0.34578683703863 2675 PF-00562151-00 hsa04742 Taste transduction 5330_5567 2 + 0.019337297505388 0.219961759123788 2676 PF-00562151-00 hsa05016 Huntington's disease 2902_246721_6648_4694_4712_5330_7052_4698_6390_6391_6392_3708_5978_23186_1385_6874_161_291 18 + 0.0257333810894103 0.260193075459593 2677 PF-00562151-00 hsa04740 Olfactory transduction 51806_26529_7932_5567 4 + 8.02745739734722e-21 7.30498623158597e-19 2678 PF-00562151-00 hsa05012 Parkinson's disease 2861_4694_4712_6392_7314_6390_6391_51465_4698_6622_291 11 + 0.0169124365459692 0.2198616750976 2679 PF-00562151-00 hsa04260 Cardiac muscle contraction 782_9254_781_4635 4 + 0.00777564778004187 0.176895986995953 2680 PF-00562151-00 hsa04060 Cytokine-cytokine receptor interaction 55540_5155_7852_60401_1896_3556_27242_3579_3459_3570_655_2688_2689_3976_8718_3581_23529_1271_23765_1956_268_8794_7048_1436_3560_7423_7422 27 + 0.0164675661235413 0.2198616750976 2681 PF-00562151-00 hsa03010 Ribosome 285053_140801_6142_6181_6129_6233 6 + 0.00774204385574642 0.176895986995953 2682 PF-00562151-00 hsa04080 Neuroactive ligand-receptor interaction 151_2902_4159_154_64106_2908_1909_23566_4161_5724_2150_9568_1395_5028_2912_5025_3354_3352_2488_9170_5618_4157_6915_7067_7068_1241_728 27 - 0.0243869602133849 0.369868896569671 2683 PF-00562151-00 hsa05016 Huntington's disease 2902_1175_5439_51164_5434_7157_1639_6391_317_6667_161_1537_5978_642502_1385_7419_293_517_163 19 - 0.0431068047476657 0.415123836985568 2684 PF-00562151-00 hsa04740 Olfactory transduction 818_51806_5566_26529_4991 5 - 1.54313976179382e-19 1.40425718323238e-17 2685 PF-00562151-00 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8348_8329_8294_6628_121504_8343_8347_87_8344_723790_3123_3126_3127_3125_8969_8346_8370_8332_8359_8330_8331_8336_8337_554313_6738_8351_8339_85235_85236_3117_3013_942_3014_8970 44 - 0.000625986239606218 0.0284823739020829 2686 PF-00562151-00 hsa04512 ECM-receptor interaction 1284_960_7057_3912 4 - 0.0079527632030735 0.144740290295938 2687 PF-00562151-00 hsa04630 Jak-STAT signaling pathway 23533_3581_5618_2057_3594_598_3570_6772_3572_5781_208_8835_8503_10252_10254 15 - 0.0456180040643481 0.415123836985568 2688 PF-00562151-00 hsa05012 Parkinson's disease 2861_7318_642502_6391_317_7054_1537_7345_65018_7419_293_517 12 - 0.0323579171103138 0.415123836985568 2689 PF-00562151-00 hsa04260 Cardiac muscle contraction 1537_776_6262 3 - 0.00259853440349225 0.0788222102392649 2690 PF-00562151-00 hsa04060 Cytokine-cytokine receptor interaction 3594_5155_8742_8741_8995_3553_2057_3570_3572_4982_8718_6367_3581_7040_7042_93_268_8795_5618_1435_6358_6359_355_6372_51330 25 - 0.0074580104857792 0.144740290295938 2691 PF-00562151-00 hsa03010 Ribosome 440589_140801_6187_6142_439992_6159_6165_6189 8 - 0.0382377225652811 0.415123836985568 2692 benzathine benzylpenicillin hsa04080 Neuroactive ligand-receptor interaction 1241_3269_4158 3 + 0.000231907063218352 0.00664800247892609 2693 benzathine benzylpenicillin hsa04740 Olfactory transduction 818_5566_56656 3 + 2.23959301665213e-07 1.92604999432083e-05 2694 benzathine benzylpenicillin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8329_8294_87_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3014_720_721_3111 27 + 1.92014190593559e-06 8.25661019552304e-05 2695 benzathine benzylpenicillin hsa05220 Chronic myeloid leukemia 8517_861_208_6464_867_5605_91_7042_1869_7157 10 + 0.0315062482262643 0.677384336864682 2696 benzathine benzylpenicillin hsa04115 p53 signaling pathway 472_651610_3732 3 - 0.00456559318243911 0.114139829560978 2697 cefuroxime hsa04740 Olfactory transduction 5137_8392 2 + 0.000784445395025358 0.0572645138368511 2698 cefuroxime hsa04512 ECM-receptor interaction 7059_22798_3690_1289_3680_1605_1290 7 + 0.0210753368129616 0.769249793673098 2699 cefuroxime hsa05016 Huntington's disease 836_841 2 - 0.04992420570191 0.798237375347239 2700 cefuroxime hsa04740 Olfactory transduction 219464_5566_109_157_4991 5 - 0.00811096226780376 0.567767358746263 2701 cefuroxime hsa04510 Focal adhesion 83660_3918 2 - 0.0366226431267056 0.798237375347239 2702 cefuroxime hsa04920 Adipocytokine signaling pathway 3953_32_2182_1375_1374_7186 6 - 0.0489980116566018 0.798237375347239 2703 finasteride hsa04120 Ubiquitin mediated proteolysis 7320_5371_652671_55236_7329 5 + 0.0243060020647659 0.261289522196233 2704 finasteride hsa05010 Alzheimer's disease 775_3708_6622_517_2905 5 + 0.00204164022735999 0.0438952648882398 2705 finasteride hsa04910 Insulin signaling pathway 5599_8471_10211_5290_3991 5 + 0.0239970878608684 0.261289522196233 2706 finasteride hsa05016 Huntington's disease 1211_7052_64446_3708_1387_517 6 + 0.00286201616615258 0.0492266780578244 2707 finasteride hsa04740 Olfactory transduction 818_5593_9635_393046 4 + 2.90881952123998e-11 2.50158478826638e-09 2708 finasteride hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8360_8368_6738_8362_8294_121504_3586_8366_8968_8370_718_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_83740_3013_3113_3111_720_721_729 37 + 8.08367359203905e-07 3.47597964457679e-05 2709 finasteride hsa04110 Cell cycle 5925_1387_993 3 + 0.00904851552904813 0.12969538924969 2710 finasteride hsa04115 p53 signaling pathway 3732 1 + 0.0299286134157274 0.285984528194728 2711 finasteride hsa05012 Parkinson's disease 6622_517 2 + 0.000656629852550881 0.0188233891064586 2712 finasteride hsa03010 Ribosome 6125_6234_6181 3 + 0.0345892332220589 0.297467405709707 2713 finasteride hsa05320 Autoimmune thyroid disease 5551_3451_3113 3 - 0.0329821643556083 0.897863239353522 2714 memantine hsa04740 Olfactory transduction 26211_8390_2979_7932 4 + 0.0200417094282572 1 2715 memantine hsa04130 SNARE interactions in vesicular transport 8773_8417_6844 3 - 0.0194358206581049 0.583074619743147 2716 memantine hsa03020 RNA polymerase 246721_5439_548644 3 - 0.00990516326968448 0.583074619743147 2717 irinotecan hsa04916 Melanogenesis 112_1857_3265_7855_810_816 6 + 0.0273761240358027 0.180230295250012 2718 irinotecan hsa04120 Ubiquitin mediated proteolysis 23327_51343_7318_55294_22888_23759_4193_7329_26232_8651 10 + 0.0423924921469194 0.235808237567239 2719 irinotecan hsa05200 Pathways in cancer 572_10297_5154_9618_7855_10342_4149_4824_1857_5900_1017_1399_2261_3082_4313_998_4193_1026_3265_3725_3918_4791_4792_1436_5228_2335_8817_355_7422_2353 30 + 0.0264154840518333 0.180230295250012 2720 irinotecan hsa04742 Taste transduction 112 1 + 0.0118863769185171 0.151126792249717 2721 irinotecan hsa04310 Wnt signaling pathway 10297_8061_5519_5532_7855_5528_3725_64840_1857_816 10 + 0.0201426783236605 0.179269837080578 2722 irinotecan hsa05016 Huntington's disease 1213_5430_4712_642502_6391_246721_7416_9001_509_55567_7381 11 + 0.00282392739003876 0.0837765125711499 2723 irinotecan hsa04740 Olfactory transduction 393046_26539_2979_810_9635_816 6 + 3.67557335936689e-15 3.27126028983653e-13 2724 irinotecan hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_9103_8349_8329_8294_121504_8343_8347_8346_8344_8339_6737_3021_3020_8969_8968_55766_8370_718_8358_8359_8330_8331_8336_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3012_3013_3115_720_721 51 + 5.08966023492559e-08 2.26489880454189e-06 2725 irinotecan hsa04115 p53 signaling pathway 55367_1647_1026_5366_55240_64393_5268_4193_7249_3486_355_10912_2810_5054_1017_3732_9540_4616 18 + 0.0196015618482092 0.179269837080578 2726 irinotecan hsa05110 Vibrio cholerae infection 11015 1 + 0.0082900843730535 0.147563501840352 2727 irinotecan hsa04062 Chemokine signaling pathway 7454_2786_1399_156_5829_998_2788_7852_3265_10235_112_4792 12 + 0.00459382514643245 0.102212609508122 2728 irinotecan hsa05012 Parkinson's disease 7318_4712_642502_6391_7054_7345_7416_509_7381 9 + 0.0283508329606761 0.180230295250012 2729 irinotecan hsa04260 Cardiac muscle contraction 7139_7381_4635 3 + 0.0114202030806882 0.151126792249717 2730 irinotecan hsa04020 Calcium signaling pathway 2905_5532_487_3362_57105_5333_8911_7416_5724_489_1909_810_816 13 + 0.0148836805915456 0.165580946580945 2731 irinotecan hsa04930 Type II diabetes mellitus 8651 1 + 0.0381716561874646 0.226485160045623 2732 irinotecan hsa03050 Proteasome 5717 1 + 0.0258596653667492 0.180230295250012 2733 irinotecan hsa05332 Graft-versus-host disease 356_3107 2 - 0.00023920482586162 0.00187377113591602 2734 irinotecan hsa04640 Hematopoietic cell lineage 3554_3566_2057_4254_1604_3673_3655_3674_912 9 - 2.51176851474969e-05 0.00033729462912353 2735 irinotecan hsa03320 PPAR signaling pathway 11001_9370_7316_5360_10580_2181_2180_8310_1374_5467_6256 11 - 0.00541230077498117 0.0308525916143208 2736 irinotecan hsa05010 Alzheimer's disease 51806_3710_317_9451_2776_5663_5332_5664_7132_6622_4695_8883_808_776_2932_5530_5533_5532_3708_3709_6868_488_102_23236_3416_5594_841_840_4713_51107_842_22926_801_805 34 - 0.000169683413939961 0.00159502409103563 2737 irinotecan hsa04080 Neuroactive ligand-receptor interaction 155_4889_147_2908_2925_5030_5031_3062_56288_1909_5645_2488_1813_799_2740_4987_4988_5029_2911_2916_1131_4886_3354_3350_5733_3269_1910_8001_2550_5618_5340_1812_7068_7067_4159_2570_8484_1511_2690 39 - 8.80725842375761e-09 4.13941145916608e-07 2738 irinotecan hsa04742 Taste transduction 2785_3710_5613_5567_5616_6337 6 - 0.00193515094139387 0.0139926298839249 2739 irinotecan hsa05320 Autoimmune thyroid disease 3452_3439_3451_3447_3446_3441_3107_356_959_7038 10 - 0.0464566229303483 0.155436515256271 2740 irinotecan hsa04612 Antigen processing and presentation 4800_4801_4802_3312_3326_3439_3805_3441_3447_3446_5993_3107_3452_3451_3308_1385_3305_821 18 - 0.0159523178158698 0.06815990339508 2741 irinotecan hsa05016 Huntington's disease 8218_4899_64764_317_2776_5332_23186_3064_6875_6874_5431_4695_5434_7157_7416_2033_7419_1211_3708_5481_23236_842_841_4713_3092_55567_1385_1387 28 - 6.08702506201317e-07 1.14436071165848e-05 2742 irinotecan hsa04740 Olfactory transduction 51806_5593_157_5613_5567_8383_8392_808_5616_109_4992_801_9635_805 14 - 8.22169387096905e-37 7.72839223871091e-35 2743 irinotecan hsa04514 Cell adhesion molecules (CAMs) 2734_214_4897_3655_9019_959_3107_25945_1013_9378_999_3688_23705_23562_965_4685_3685_5819_1365_5792_4950_5817 22 - 0.00012659365251088 0.00148747541700284 2744 irinotecan hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_94239_8366_8368_6738_8294_121504_8343_8347_8346_8344_959_8339_8367_8968_8370_717_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_1511 35 - 0.0221203436083115 0.0904048825730992 2745 irinotecan hsa04110 Cell cycle 4089_9133_8243_4085_4087_4088_983_8555_701_51433_9184_996_23595_1871_651610_25_64682_7157_699_8881_8317_1111_5925_5934_2033_545_7534_1017_7531_995_902_5001_5000_991_990_993_9134_2932_8379_891_8454_7027_7042_9700_1031_8318_5591_1027_5347_4172_4173_890_6502_1022_1029_472_10393_5933_1387_7465_4999 61 - 0.0427811805144406 0.148941887716941 2746 irinotecan hsa05340 Primary immunodeficiency 959_23495_64421_3718_5993 5 - 0.0479538185365091 0.155436515256271 2747 irinotecan hsa05310 Asthma 959_3596 2 - 0.00485568816274572 0.0304289791532065 2748 irinotecan hsa04512 ECM-receptor interaction 3688_1281_22798_3910_3691_3693_1605_7057_3685_1277_961_1293_3673_3655_1290_1291_3674_3161 18 - 0.0331343577145408 0.129776234381951 2749 irinotecan hsa04630 Jak-STAT signaling pathway 3717_3446_3597_3596_3595_5295_3718_5290_5291_6772_3447_9655_8503_10254_3452_3439_3451_2057_2885_3572_2033_5781_3977_6777_9063_200734_8554_8027_868_5618_3566_3460_6774_6655_6654_3441_867_1387_11009_2690 40 - 0.0421218783621952 0.148941887716941 2750 irinotecan hsa05012 Parkinson's disease 6570_4695_842_4713_7314_317_7326_7416_51465_7419_6622_5481_7332 13 - 2.64118938304345e-08 8.27572673353614e-07 2751 irinotecan hsa04260 Cardiac muscle contraction 784_7168_776_27092_481_4635_488_10479_7137_7170 10 - 0.000153211961271785 0.00159502409103563 2752 irinotecan hsa04060 Cytokine-cytokine receptor interaction 3597_3596_3595_8742_8741_6387_1896_7132_3452_3439_2321_3554_2057_3451_4254_3572_657_4982_3977_6363_27242_659_959_7293_3604_23495_3624_608_1956_7042_90_4233_7048_5618_6355_3566_3460_11009_3446_3441_51330_356_3447_2690 44 - 1.07433711090018e-07 2.52469221061542e-06 2753 irinotecan hsa03010 Ribosome 6204_51187_6125_6168_284393_6123_389342_6233_6171 9 - 8.38684197647086e-07 1.31393857631377e-05 2754 irinotecan hsa04020 Calcium signaling pathway 51806_155_3710_147_5336_2925_2776_115_7220_1956_5332_5335_1909_490_493_1812_5567_3707_7416_7419_2911_776_1131_5530_5533_5532_3708_109_5733_488_3269_1910_107_5481_23236_5579_5578_5613_3709_5616_808_801_2065_805 44 - 0.00675850654018359 0.033436821830382 2755 irinotecan hsa03050 Proteasome 5718_5717_5706_5707_5690_23198_9491 7 - 0.0145536835206862 0.06815990339508 2756 irinotecan hsa05330 Allograft rejection 959_356_3107 3 - 0.00244333330891492 0.0164052379312859 2757 irinotecan hsa04950 Maturity onset diabetes of the young 3087 1 - 0.00590794307508271 0.0308525916143208 2758 irinotecan hsa04940 Type I diabetes mellitus 3329_3107_3382_5799_356 5 - 0.00575200847740741 0.0308525916143208 2759 irinotecan hsa05217 Basal cell carcinoma 6934_2737_324_7157_2932_1856_1857_8312_1499_7976 10 - 0.0352074485200484 0.132380006435382 2760 irinotecan hsa02010 ABC transporters 26154_5825_4363_19_9619_8714 6 - 0.0158541070704716 0.06815990339508 2761 irinotecan hsa04610 Complement and coagulation cascades 5340_717_629_4179_1604_7035_2152 7 - 0.000224588124325271 0.00187377113591602 2762 CP-944629 hsa04740 Olfactory transduction 157_1179_816 3 + 4.54084182664204e-06 0.000354185662478079 2763 CP-944629 hsa05322 Systemic lupus erythematosus 2903_8361_8363_8362_8365_8364_8367_8360_8368_8329_8294_8366_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235 22 + 2.52231811001113e-05 0.000983704062904341 2764 CP-944629 hsa04270 Vascular smooth muscle contraction 23236 1 + 0.0314987596378631 0.81896775058444 2765 CP-944629 hsa04740 Olfactory transduction 51806_157 2 - 2.10099101983866e-05 0.00174382254646609 2766 CP-944629 hsa04010 MAPK signaling pathway 57551_776_1432_2318_5578_100137049_6655_27092_5155_5154_355_4763_1956_5606_2005_8681_3725_5609_9693_11221 20 - 0.0254368277200018 0.703752233586716 2767 CP-944629 hsa04912 GnRH signaling pathway 51806_8681_776_1432_5578_100137049_6655_2776_1956_5606_3725_5609_23236 13 - 0.00150173639305846 0.0623220603119261 2768 CP-944629 hsa04270 Vascular smooth muscle contraction 51806_776_5578_3779_2776_9475_27094_8681_100137049_23236 10 - 0.0443386242664803 0.920026453529466 2769 16-phenyltetranorprostaglandin E2 hsa05332 Graft-versus-host disease 3119_3123_3126_3127_3125_3134 6 + 0.0421083403640012 0.447401116367513 2770 16-phenyltetranorprostaglandin E2 hsa04080 Neuroactive ligand-receptor interaction 7434_3269_4157 3 + 0.000674261267674012 0.0286561038761455 2771 16-phenyltetranorprostaglandin E2 hsa04740 Olfactory transduction 157_56656_816 3 + 1.52333189459986e-06 0.000129483211040988 2772 16-phenyltetranorprostaglandin E2 hsa05322 Systemic lupus erythematosus 6738_3119_718_3123_3126_3127_3125_8358_727_8968_3013_8350_8351_8352_8353_8354_8355_8356_8357 19 + 0.00127230202250106 0.0360485573041967 2773 16-phenyltetranorprostaglandin E2 hsa05310 Asthma 3123_3126_3127_3119_3125 5 + 0.0374424028625888 0.447401116367513 2774 16-phenyltetranorprostaglandin E2 hsa05330 Allograft rejection 3119_3123_3126_3127_3125_3134 6 + 0.0289435188639775 0.410033183906348 2775 16-phenyltetranorprostaglandin E2 hsa04270 Vascular smooth muscle contraction 27094 1 + 0.0218839080728113 0.372026437237792 2776 16-phenyltetranorprostaglandin E2 hsa04940 Type I diabetes mellitus 3119_3123_3126_3127_2571_3134_3125 7 + 0.0183510132883417 0.372026437237792 2777 16-phenyltetranorprostaglandin E2 hsa04070 Phosphatidylinositol signaling system 51806_5333_3631_3708_3709_3706_27124_23236 8 - 0.0333552975088288 0.439178083866246 2778 16-phenyltetranorprostaglandin E2 hsa04080 Neuroactive ligand-receptor interaction 3953_7067_1131_23566_3360 5 - 0.0464111186887846 0.523782625201998 2779 16-phenyltetranorprostaglandin E2 hsa04740 Olfactory transduction 51806_157 2 - 6.82853937847639e-06 0.000539454610899635 2780 16-phenyltetranorprostaglandin E2 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3113_8359_8294_8367_554313_8970_121504 16 - 0.00271512040960925 0.107247256179565 2781 16-phenyltetranorprostaglandin E2 hsa05221 Acute myeloid leukemia 861_572_6777_3845_6934_11040_5970 7 - 0.0270978288446313 0.428145695745175 2782 16-phenyltetranorprostaglandin E2 hsa05213 Endometrial cancer 6934_572_1956_3845_1495_8312_842 7 - 0.0154567653188896 0.407028153397426 2783 16-phenyltetranorprostaglandin E2 hsa04912 GnRH signaling pathway 51806_5598_8681_3709_3708_1956_3845_112_6714_100137049_23236 11 - 0.0213562273872372 0.421785490897935 2784 trihexyphenidyl hsa04662 B cell receptor signaling pathway 2353_5532_6655_5880_3725 5 + 0.0382983817972308 0.64679973748102 2785 trihexyphenidyl hsa04740 Olfactory transduction 26333_442194 2 + 0.009240709890108 0.34652662087905 2786 trihexyphenidyl hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_88_8294_8367_554313_121504_3119 17 + 1.87283814485197e-07 1.40462860863898e-05 2787 trihexyphenidyl hsa04350 TGF-beta signaling pathway 9372_5519_353500_7042_83729_10468 6 + 0.0210855961855305 0.527139904638262 2788 trihexyphenidyl hsa04010 MAPK signaling pathway 1848_782_6788_6655_7042_1649_1846_5532_4763_5880_2353_3725 12 + 0.0431199824987347 0.64679973748102 2789 trihexyphenidyl hsa05332 Graft-versus-host disease 3105_3111 2 - 0.0412958312524653 0.393898423524292 2790 trihexyphenidyl hsa04310 Wnt signaling pathway 5599_4088_64840_1856 4 - 0.0275833754292423 0.393898423524292 2791 trihexyphenidyl hsa05330 Allograft rejection 3105_3111 2 - 0.0346921513753222 0.393898423524292 2792 trihexyphenidyl hsa05210 Colorectal cancer 5599_4088_1856 3 - 0.0259793758759666 0.393898423524292 2793 trihexyphenidyl hsa04940 Type I diabetes mellitus 3105_3111 2 - 0.0447611844913968 0.393898423524292 2794 BCB000040 hsa04080 Neuroactive ligand-receptor interaction 4889_5618_2488_1813_2846_5025_2908_3360_1241_3953_2150_7067_1909_2740_4543_1394_7068_2690 18 + 6.60624932449225e-06 0.00030719059358889 2795 BCB000040 hsa04660 T cell receptor signaling pathway 1739_4690_1432_1147_5063_6655_6654_4776_3725_3551_5594 11 + 0.0443335186905362 0.458113026468874 2796 BCB000040 hsa04670 Leukocyte transendothelial migration 9076_24146_1432_5579_7070_9475_7430_4636_5747_5781 10 + 0.00777121942872637 0.120453901145259 2797 BCB000040 hsa05016 Huntington's disease 246721_1327_2776_9167_5436_7157_1639_10488_509_1175_9001_161_5481_23236_4714_4712_841_4713_642502_6390_6391_1385 22 + 0.0432484503673668 0.458113026468874 2798 BCB000040 hsa04740 Olfactory transduction 5613_5566_5567_5616_808_109_81797_81696_801_805 10 + 6.9241868239023e-18 6.43949374622914e-16 2799 BCB000040 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8329_8294_121504_6632_3021_3020_8969_8968_8370_8358_8359_8330_8331_8336_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3012_3013_942_3017_727_9555 41 + 0.0183111388925387 0.2432765595723 2800 BCB000040 hsa04260 Cardiac muscle contraction 27092_9167_1327_4635_488 5 + 0.00734377839387322 0.120453901145259 2801 BCB000040 hsa04060 Cytokine-cytokine receptor interaction 5154_7850_1489_3556_8794_3459_6354_3572_657_6363_3953_3589_4055_4254_8718_91_8792_4233_8795_5618_3449_3460_3568_355_7422_6370_11009_2690 28 + 0.00398950309172361 0.0927559468825739 2802 BCB000040 hsa03010 Ribosome 6125_9349_6192 3 + 3.75521411312812e-05 0.00116411637506972 2803 BCB000040 hsa05010 Alzheimer's disease 810_836_6622_2776_23236 5 - 0.0136941993032989 0.200848256448384 2804 BCB000040 hsa04080 Neuroactive ligand-receptor interaction 2901_7067_2925_4886_7434_6915_5732 7 - 0.00164815782120696 0.0725189441331062 2805 BCB000040 hsa05016 Huntington's disease 5978_836_2776_23236 4 - 0.0028503102699748 0.0824112713203289 2806 BCB000040 hsa04740 Olfactory transduction 219464_157_818_810_26529_816 6 - 2.73536393122254e-07 2.40712025947584e-05 2807 BCB000040 hsa05322 Systemic lupus erythematosus 8329_8343_8347_8346_8344_3123_3126_3127_3125_8969_8332_8330_8331_8336_8337_6737_8351_8339_85235_3013_720_721_8970 23 - 0.00374596687819677 0.0824112713203289 2808 BCB000040 hsa04010 MAPK signaling pathway 784_4217_9479_836_9064_5598_6655_23162_5603_5602_2257 11 - 0.0205525384224805 0.258374768739755 2809 BCB000040 hsa05012 Parkinson's disease 836_7345_6622_5413 4 - 0.0472102791398838 0.461611618256642 2810 BCB000040 hsa04260 Cardiac muscle contraction 784 1 - 0.0312727793988346 0.344000573387181 2811 BCB000040 hsa04060 Cytokine-cytokine receptor interaction 1435_3815_3624_6358_6359_7852_8718_1896_8794 9 - 0.0087322509360555 0.153687616474577 2812 semustine hsa05016 Huntington's disease 7052_2902_4899_1387_841 5 + 0.0101281683223515 0.258604440807829 2813 semustine hsa04740 Olfactory transduction 5593_8392_808_109_5137_801_805 7 + 2.6160964491308e-06 0.00022760039107438 2814 semustine hsa04530 Tight junction 7525_9223_5516 3 + 0.0184159682801101 0.258604440807829 2815 semustine hsa04920 Adipocytokine signaling pathway 5564_5106_57818_8660_3953_2180_32_5599_5105_9021_4793 11 + 0.0228218020200765 0.258604440807829 2816 semustine hsa05310 Asthma 3109_3119_3123_3126_3127_3125_5553 7 + 0.0130228527774113 0.258604440807829 2817 semustine hsa04062 Chemokine signaling pathway 2919_2788_6773_109_6376_4793 6 + 0.0237797186949728 0.258604440807829 2818 semustine hsa04810 Regulation of actin cytoskeleton 9087_3691_1131_8817_929_1956_3984 7 + 0.016965434679458 0.258604440807829 2819 semustine hsa05012 Parkinson's disease 7314 1 + 0.0010460176849155 0.0455017692938242 2820 semustine hsa03010 Ribosome 6233_6192 2 + 0.0335985482448837 0.324785966367209 2821 semustine hsa04662 B cell receptor signaling pathway 8503_6850_3551_10892_11261_8519_7410_3845_4794_4793_6655_4067 12 - 0.0433645161869122 0.433645161869122 2822 semustine hsa04080 Neuroactive ligand-receptor interaction 5028_3354_3953_5030_6915_3351_7067_5732 8 - 0.00222885352288075 0.0501492042648169 2823 semustine hsa05016 Huntington's disease 5432_7052_5441_5331_3708_55567_23236 7 - 0.0293680801976002 0.339394182213688 2824 semustine hsa04740 Olfactory transduction 810_51806_157_816 4 - 1.04747240716673e-09 4.71362583225029e-08 2825 semustine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8342_3122_3123_3126_3127_3125_8969_8968_55766_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3113_720_721_729 43 - 6.01423220562405e-11 5.41280898506164e-09 2826 semustine hsa04664 Fc epsilon RI signaling pathway 5320_8503_6850_5581_6655_6300_7410_3845_5600_5603_5602_5608_4067 13 - 0.0301683717523278 0.339394182213688 2827 semustine hsa05012 Parkinson's disease 27429_9246 2 - 0.00200730476300497 0.0501492042648169 2828 semustine hsa04260 Cardiac muscle contraction 9254 1 - 0.0212961324647614 0.339394182213688 2829 semustine hsa04912 GnRH signaling pathway 5608_51806_5603_6655_5602_107_5331_3708_3709_3845_5600_5320_112_810_6300_816_23236 17 - 0.0265601367443824 0.339394182213688 2830 karakoline hsa05016 Huntington's disease 64446_4899_6667_4713 4 + 0.00140317766612796 0.0603366396435023 2831 karakoline hsa04740 Olfactory transduction 26212_7932_26692_5566_1179_810_393046_816 8 + 1.48797972089867e-06 0.000127966255997286 2832 karakoline hsa04514 Cell adhesion molecules (CAMs) 23308_57863_22871_6383_3384_3383_3107_3126_933_8516_4099_6402_3688_3119_3113_3685_941_5797_1001_6693_3111_26047_5817 23 + 0.00212176357038948 0.0608238890178318 2833 karakoline hsa05322 Systemic lupus erythematosus 3018_3119_2215_3113_3013_3126_9103_3111_941_8358_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357 21 + 0.0174706906093514 0.300495878480844 2834 karakoline hsa04630 Jak-STAT signaling pathway 23529_6773_9021_3448_1439 5 + 0.0335548473993564 0.412245268049236 2835 karakoline hsa05012 Parkinson's disease 4713_6531 2 + 0.00300764072266891 0.0646642755373816 2836 karakoline hsa03010 Ribosome 140801_6181 2 + 0.0238302430283483 0.341566816739659 2837 karakoline hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_720_721_9555 24 - 1.04844801109227e-08 8.28273928762893e-07 2838 etiocholanolone hsa05332 Graft-versus-host disease 3812_3824_3119_3117_3804_3569_3126_3127_3125_356_3123_941_3558 13 + 0.000952377589969407 0.0202380237868499 2839 etiocholanolone hsa04640 Hematopoietic cell lineage 3581_3590_960_2057_3815_2208_3123_3569_3126_3127_3559_3125_920_933_3690_290 16 + 0.0351202622941971 0.298522229500675 2840 etiocholanolone hsa05010 Alzheimer's disease 810_3709 2 + 1.55140606099984e-05 0.000659347575924932 2841 etiocholanolone hsa04080 Neuroactive ligand-receptor interaction 2862_1268_886_134_2846_2908_59340_5745_1909_9038_1902_2488_1813_3360_3361_5724_2566_7434_2740_185_1395_719_2917_2918_6915_9002_5733_3352_3269_4161_9294_6752_2897_4829_6754_1241_2358_2359_10800 39 + 0.0131895418814729 0.194818726606368 2842 etiocholanolone hsa05016 Huntington's disease 7052_1213_1387 3 + 3.19375462135497e-05 0.000904897142717241 2843 etiocholanolone hsa04740 Olfactory transduction 26211_7932_5568_157_818_81697_3000_810_393046_816 10 + 2.28922625442235e-07 1.945842316259e-05 2844 etiocholanolone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8294_3123_3126_3127_3125_8370_717_8359_554313_6738_121504_8354_3119_3117_941 25 + 0.0137519101133907 0.194818726606368 2845 etiocholanolone hsa05310 Asthma 3119_3117_3123_3126_3127_3125_8288 7 + 0.0442586131163831 0.338781103338399 2846 etiocholanolone hsa03010 Ribosome 140801_284393_389342 3 + 0.0242446374723261 0.284831563522277 2847 etiocholanolone hsa05330 Allograft rejection 3119_3117_3123_3126_3127_3558_356_941_3125 9 + 0.0342455049905194 0.298522229500675 2848 etiocholanolone hsa04940 Type I diabetes mellitus 3119_3117_3126_2572_3127_3558_356_3123_941_3125 10 + 0.0268076765668025 0.284831563522277 2849 etiocholanolone hsa04070 Phosphatidylinositol signaling system 3708_8821_27124_3709_23236 5 - 0.038899154102893 1 2850 etiocholanolone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 1.64384544462594e-05 0.00106849953900686 2851 foliosidine hsa05016 Huntington's disease 1213_5330_3708_7416_55567_23236 6 + 0.0316874785275863 0.526012143557933 2852 foliosidine hsa04740 Olfactory transduction 5593_7932_26707_8392_4991_9635 6 + 8.157496776254e-07 6.77072232429082e-05 2853 foliosidine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_2215_8370_2214_3123_8366_3126_3127_3125_8359_8294_8367_554313_8368_121504_8341_8364 21 + 0.00793169171815395 0.208091720091903 2854 foliosidine hsa05012 Parkinson's disease 6622_7416 2 + 0.00620215097226254 0.208091720091903 2855 foliosidine hsa03010 Ribosome 6144 1 + 0.0100285166309351 0.208091720091903 2856 foliosidine hsa04730 Long-term depression 5593_5579_5519_5330_3708_8681_3845_5516_100137049_1392_23236 11 + 0.0455347562251668 0.629897461114807 2857 foliosidine hsa04740 Olfactory transduction 4991 1 - 0.000583676048585479 0.0227633658948337 2858 foliosidine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3113 23 - 1.20486704844586e-10 9.39796297787771e-09 2859 foliosidine hsa04920 Adipocytokine signaling pathway 6794_10000_5599_6513_5563_8660_4793 7 - 0.00383770454324603 0.0997803181243968 2860 gossypol hsa04120 Ubiquitin mediated proteolysis 23327_7337_4281_331_51343_6477_330_7329_25898_55236_9021 11 + 0.0291880457786246 0.265611216585484 2861 gossypol hsa05010 Alzheimer's disease 836_2904_4698_54205_779_4137_3708_824_6622 9 + 0.000192631464888852 0.00584315443496184 2862 gossypol hsa04742 Taste transduction 2914_5568 2 + 0.0285619002359873 0.265611216585484 2863 gossypol hsa05016 Huntington's disease 246721_54205_627_2904_7052_4698_5439_3708_1211_836_548644 11 + 0.000476684747583842 0.00867566240602592 2864 gossypol hsa04740 Olfactory transduction 7932_5568_26692_26333_2774_23538_135948_393046_818_5137_81797_26539_81696_9635 14 + 1.38868739164784e-11 1.26370552639953e-09 2865 gossypol hsa04514 Cell adhesion molecules (CAMs) 214_5175_9369_942_23308_57863_3111_941_3384_3383_3123_8506_3126_3127_3696_3125_1462_6693_4359_10686_6402_4684_3113_3685_925_5797_5792_920_923_1002_26047_1000 32 + 0.0381827914994205 0.289552835537272 2866 gossypol hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_2904_8368_554313_8360_8362_8294_121504_8343_8341_8347_8346_8344_8339_3123_8366_3126_3127_3125_8968_8370_8358_8359_8330_8335_8350_8351_8352_8353_8354_8355_8356_8357_83740_3013_3113_3111_941_720_721_8970_942 48 + 1.48916510675485e-05 0.000677570123573457 2867 gossypol hsa04110 Cell cycle 1647_1021_8243_51343_1028_8556_7042_894_4616 9 + 0.0359001328261242 0.289552835537272 2868 gossypol hsa04664 Fc epsilon RI signaling pathway 23533_10000_6850_50487_5293_5290_27040_8681_5600_5608_2206_2207_100137049_5163_8398_1432_5579_5578_5599_6655_5581_2534 22 + 0.0186940675291247 0.243022877878621 2869 gossypol hsa04810 Regulation of actin cytoskeleton 23533_29895_10095_5063_5290_6655_5155_998_3685_56924_3679_2248_3696_1399_5293_6093_2247_57144_26230_8976_3675 21 + 0.0279597158308017 0.265611216585484 2870 gossypol hsa05012 Parkinson's disease 2861_836_5413_4698_54205_6622 6 + 0.000446033727200842 0.00867566240602592 2871 gossypol hsa03010 Ribosome 6141_6139_6129_6224_6144 5 + 0.00420536868660043 0.0637814250801065 2872 gossypol hsa04080 Neuroactive ligand-receptor interaction 2901_1081_7068_4886_9568_2149 6 - 0.000172391501168735 0.00758522605142434 2873 gossypol hsa04740 Olfactory transduction 818_5613_219464_5616 4 - 7.12117897199071e-10 6.26663749535182e-08 2874 gossypol hsa04510 Focal adhesion 857_596_858_1289_998_1277_208_1398_9475 9 - 0.0404406934973916 0.777362325330835 2875 gossypol hsa05218 Melanoma 208 1 - 0.044168313939252 0.777362325330835 2876 gossypol hsa05012 Parkinson's disease 7419_7381_5413 3 - 0.00663690084115014 0.194682424673737 2877 myosmine hsa05016 Huntington's disease 7052_1212_6390_1387 4 + 0.00535451375420023 0.155280898871807 2878 myosmine hsa04740 Olfactory transduction 5568_26692_442194_818_810_9635 6 + 1.58185888473876e-06 0.000137621722972272 2879 myosmine hsa04514 Cell adhesion molecules (CAMs) 8516_965_3384_8174_3383_3119_3123_4099_3107_3126_3127_3125_3676_3695_923_25945_26047_5817 18 + 0.0201385959875761 0.309586070247002 2880 myosmine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_3123_3126_3127_3125_8370_8359_554313_6738_121504_8354_3119_729 22 + 0.00238755083529706 0.103858461335422 2881 myosmine hsa04512 ECM-receptor interaction 1278_8516_1291_7148_948_1289_3694_3695_7057_3679_3673_1277_3676 13 + 0.0135640568152167 0.295018235730963 2882 myosmine hsa03010 Ribosome 6192_6144 2 + 0.0473869271982337 0.531196332823086 2883 myosmine hsa04940 Type I diabetes mellitus 3382_3119_3126_3107_2572_3127_3125_3123 8 + 0.0213507634653105 0.309586070247002 2884 myosmine hsa04070 Phosphatidylinositol signaling system 8394_8396_5333_51763_27124_23236 6 - 0.0308105356018296 1 2885 myosmine hsa05200 Pathways in cancer 3551_3675 2 - 0.0067800547295784 0.440703557422596 2886 myosmine hsa05016 Huntington's disease 23236 1 - 0.0462786923541475 1 2887 benzamil hsa04120 Ubiquitin mediated proteolysis 8651_868_4281_330_26091 5 + 0.0431000795379022 0.421422999926155 2888 benzamil hsa05010 Alzheimer's disease 6622_836_3553 3 + 0.000421299308441025 0.0123581130476034 2889 benzamil hsa05016 Huntington's disease 836_64446_1387_7416 4 + 0.00102062518866232 0.022453754150571 2890 benzamil hsa04740 Olfactory transduction 81697_26333_23538_393046 4 + 7.12117897199071e-10 6.26663749535182e-08 2891 benzamil hsa04510 Focal adhesion 10000_10298_330_5290_3679_3673_6714_3675_3694_7057_22798_7414_29780_55742_1291_1399_5063_3910_3918_1281_6093_1284_3688_7148_5579_3685_7422 27 + 0.048538710571209 0.427140653026639 2892 benzamil hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8360_8368_6738_8362_8294_121504_8366_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2215_83740_3013_941 31 + 2.47126273666576e-05 0.00108735560413293 2893 benzamil hsa04512 ECM-receptor interaction 1284_3688_1281_22798_1291_3910_2812_3694_7057_3685_3918_3679_3673_7148_51206_3675 16 + 0.00760395068906817 0.111524610106333 2894 benzamil hsa05012 Parkinson's disease 6622_836_7416 3 + 0.00663690084115014 0.111524610106333 2895 benzamil hsa03010 Ribosome 6139_6171 2 + 0.016579058580917 0.208422450731528 2896 benzamil hsa05222 Small cell lung cancer 1284_3688_10000_22798_3551_3910_330_5290_3918_5925_3685_3673_6257_3675 14 + 0.0376362283619049 0.413998511980954 2897 benzamil hsa04120 Ubiquitin mediated proteolysis 57154_8945_6502_23759_5371_867_22888_8651_23221 9 - 0.0178961143139266 0.644260115301358 2898 benzamil hsa04740 Olfactory transduction 810 1 - 0.000555425521773311 0.0399906375676784 2899 PNU-0230031 hsa04120 Ubiquitin mediated proteolysis 6502_5371_7318 3 + 0.0189434011433876 0.329615179894944 2900 PNU-0230031 hsa04740 Olfactory transduction 5593_4992_56656_816 4 + 2.42912630645304e-08 2.11333988661414e-06 2901 PNU-0230031 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3018_3119_3013_3113_941 29 + 1.27719572118015e-05 0.000555580138713365 2902 PNU-0230031 hsa04110 Cell cycle 6502 1 + 0.00328651376640975 0.0953088992258827 2903 PNU-0230031 hsa04512 ECM-receptor interaction 1286_960_1301_948_2812_3694_3695_3685_1277_3679_1290_1291_3674_22798 14 + 0.0091891575390112 0.199864176473494 2904 PNU-0230031 hsa04670 Leukocyte transendothelial migration 7852 1 - 0.0451957452086435 1 2905 PNU-0230031 hsa04740 Olfactory transduction 51806 1 - 7.54805681527077e-07 2.9437421579556e-05 2906 PNU-0230031 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013 33 - 1.00600902295255e-12 7.84687037902989e-11 2907 0179445-0000 hsa05332 Graft-versus-host disease 3812_3824_3122_3113_3107_3126_3111_3558_356_355_941 11 + 0.00496374643994486 0.150566975344994 2908 0179445-0000 hsa05010 Alzheimer's disease 776_1339_6390_54205_779_355_509_810 8 + 0.0338714036501506 0.281713625168471 2909 0179445-0000 hsa05320 Autoimmune thyroid disease 3448_7253_3122_3126_3107_3113_3111_3558_356_355_941 11 + 0.0233362191996241 0.281713625168471 2910 0179445-0000 hsa05016 Huntington's disease 246721_1339_7052_6390_54205_509_1387 7 + 0.0094164840456742 0.214225012039088 2911 0179445-0000 hsa04740 Olfactory transduction 26212_5568_8388_8387_8390_442194_2979_810_816 9 + 2.11335583584085e-07 1.92315381061517e-05 2912 0179445-0000 hsa05322 Systemic lupus erythematosus 9103_8349_8348_8329_8341_3122_3126_8969_8968_8358_8330_8331_8336_8334_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3113_3111_941_720_721 30 + 0.000308560008045015 0.0140394803660482 2913 0179445-0000 hsa04115 p53 signaling pathway 5728_1026_894_64393_1647_54205_4193_7249_5268_355_575_5054_5366_8795 14 + 0.0160039080457206 0.26993466026096 2914 0179445-0000 hsa04512 ECM-receptor interaction 375790_960_22798_1311_3910_3688_3694_3695_7060_3679_961_7148_1277_3676_2335 15 + 0.0293742417674434 0.281713625168471 2915 0179445-0000 hsa05012 Parkinson's disease 6390_54205_1339_7054_509 5 + 0.0328320027200487 0.281713625168471 2916 0179445-0000 hsa03010 Ribosome 140801_6224_6144 3 + 0.034053295350035 0.281713625168471 2917 0179445-0000 hsa05330 Allograft rejection 3122_3113_3107_3126_3111_3558_356_355_941 9 + 0.0177978896875358 0.26993466026096 2918 0179445-0000 hsa04940 Type I diabetes mellitus 3122_3126_3107_3113_3111_3558_356_355_941 9 + 0.0446628917541949 0.338693595802645 2919 0179445-0000 hsa05332 Graft-versus-host disease 3135_3105_3106_3553_649853 5 - 0.0182725215230142 0.0636154453023457 2920 0179445-0000 hsa04650 Natural killer cell mediated cytotoxicity 8503_6850_5295_10451_6452_5335_5336_3451_836_3454_3455_3105_3106_7410_80328_4277_673_3135_5532_4775_4772_5534_5578_6655_6654_6464_7409_2534 28 - 0.0116634373595447 0.0456817963248834 2921 0179445-0000 hsa03440 Homologous recombination 5890_8940_5888_6118_675_7156_80198_641_5424_7517_7516_5892_5893_10714_8438_5889_25788_10111 18 - 0.0396412518605222 0.116446177340284 2922 0179445-0000 hsa04640 Hematopoietic cell lineage 3554_3553_2057_960_1604_3566_3655 7 - 1.30844315420948e-05 0.000153742070619614 2923 0179445-0000 hsa05010 Alzheimer's disease 51806_1327_5534_317_2776_5663_5332_5664_7132_3710_3553_23236_776_1339_8772_5532_3708_3709_488_102_836_8851_23621_4714_842_841_840_808_23385_801_805 31 - 0.000371952208849528 0.00291362563598797 2924 0179445-0000 hsa04080 Neuroactive ligand-receptor interaction 1081_64106_2908_5030_5031_56288_136_1909_1813_5021_7433_9568_5029_4889_3953_1131_4886_3354_9170_5618_7442_4157_7068_2740_2149_2690 26 - 8.46037155252409e-12 3.97637462968632e-10 2925 0179445-0000 hsa04742 Taste transduction 5613_5567_5616_3710_112 5 - 0.00224030401515347 0.0110836093381277 2926 0179445-0000 hsa05320 Autoimmune thyroid disease 958_3451_1081_3105_3106_3135_649853 7 - 0.0160887515388828 0.0581670247944224 2927 0179445-0000 hsa04612 Antigen processing and presentation 4801_3451_3105_3106_3135_5993_3306_1385_3304_3305_3303_649853 12 - 0.00119286837331412 0.00659586041714866 2928 0179445-0000 hsa05131 Shigellosis 25_5578_9475_7100_7430_9181_2017_2534 8 - 0.0199578435014803 0.0646909410047982 2929 0179445-0000 hsa04670 Leukocyte transendothelial migration 24146_1366_8503_5295_1432_5578_5336_7409_6387_7410_9475_7852_10451_7430_27035_5603_5747_5335_1500 19 - 0.000847758558967824 0.00531262030286503 2930 0179445-0000 hsa05016 Huntington's disease 246721_1327_64764_317_2776_5332_23186_3064_6874_10126_5430_836_7052_5439_2033_1339_581_3708_548644_161_23236_4714_842_841_3092_1385 26 - 3.29620488774928e-06 6.19686518896865e-05 2931 0179445-0000 hsa05130 Pathogenic Escherichia coli infection 25_5578_9475_7100_7430_9181_2017_2534 8 - 0.0199578435014803 0.0646909410047982 2932 0179445-0000 hsa04740 Olfactory transduction 51806_157_5613_5567_5616_808_801_393046_805 9 - 1.49518075664952e-37 1.40546991125055e-35 2933 0179445-0000 hsa04514 Cell adhesion molecules (CAMs) 24146_965_1366_958_3105_3106_4897_3135_23308_5792_9672_23705_3655_5817_25945_9019_649853 17 - 2.7466342501956e-05 0.000258183619518386 2934 0179445-0000 hsa04510 Focal adhesion 8503_5170_595_1302_596_5295_331_3909_9475_10451_5747_3655_5728_3911_2324_3693_7057_7410_23396_1398_1291_3912_896_1793_3480_1277_1956_3725_3918_4233_5578_2335_1729_2317_6655_6654_6464_7409_673_2534 40 - 0.000819696633000537 0.00531262030286503 2935 0179445-0000 hsa05340 Primary immunodeficiency 958_100_5993 3 - 0.0134697176625196 0.0506461384110737 2936 0179445-0000 hsa04530 Tight junction 50855_6709_56288_93643_24146_5584_5580_51776_2017_55844_10207_8777_5519_22800_4628_5590_5520_8189_5578_5728_1366_1457_1459_27134 24 - 0.00182939887324673 0.00955352744917737 2937 0179445-0000 hsa05218 Melanoma 8503_595_3480_5295_5728_673_5925_1956_2257_1869_2260_4233 12 - 0.0222550026302264 0.0697323415747094 2938 0179445-0000 hsa05310 Asthma 958 1 - 0.00280660691429399 0.0131910524971818 2939 0179445-0000 hsa04512 ECM-receptor interaction 1291_960_3912_1302_3911_9672_3693_1605_3909_2335_7057_3918_3655_3339_1277_3161 16 - 0.0367512603217344 0.111439305491711 2940 0179445-0000 hsa04630 Jak-STAT signaling pathway 3717_6777_595_5295_5292_8503_9180_10254_3451_2057_3455_3572_2033_8651_10401_896_3953_1271_8554_4609_868_5618_3566_3454_6655_6654_867_51588_50616_10379_2690 31 - 0.00633979796557398 0.0270882276710888 2941 0179445-0000 hsa04062 Chemokine signaling pathway 3717_6777_1147_157_6464_112_8503_9475_115_6387_5332_56288_5747_4067_3551_7074_5567_2788_7410_1398_4793_408_5295_673_10681_107_23236_5590_5580_5613_6655_6654_5616_10451_7409_5970_7852 37 - 0.000954829690457373 0.00560962443143707 2942 0179445-0000 hsa04810 Regulation of actin cytoskeleton 8503_5295_8826_9475_10451_23365_5747_3655_10458_23396_7074_3693_8394_7410_50649_7430_324_1398_2263_2260_2261_8396_2264_2768_1793_1131_673_22800_1956_10787_4628_23191_2335_1729_6655_6654_54961_8936_7409_54434_2257_26999_2149 43 - 0.000700644908864711 0.00506620164871406 2943 0179445-0000 hsa05012 Parkinson's disease 4714_836_1339_842_317_51465_65018_27429_1327 9 - 3.32625943833306e-09 7.81670968008269e-08 2944 0179445-0000 hsa04260 Cardiac muscle contraction 776_1339_1327_488_4635_27092 6 - 1.16761055505022e-05 0.000153742070619614 2945 0179445-0000 hsa04060 Cytokine-cytokine receptor interaction 8742_8741_7852_6387_9180_7132_3556_3554_3553_1956_2057_2324_3572_4982_8718_958_3953_1271_8771_4055_3451_7042_655_8792_4233_5618_3566_3454_3455_8764_50616_51330_2690 33 - 1.63449594474384e-09 5.12142062686403e-08 2946 0179445-0000 hsa03010 Ribosome 6168_6125_6205_6234_6181_6203_6158_6160_6129 9 - 7.61475855135939e-06 0.000119297883971297 2947 0179445-0000 hsa04020 Calcium signaling pathway 51806_3710_5336_2776_115_7220_5332_5335_136_1909_9630_493_5256_5567_3707_814_56848_776_5534_5021_1131_5532_3708_1956_488_107_23236_8877_5578_5613_3709_5616_8912_808_805_801_2065_2149 38 - 0.00487082195062438 0.0218027268266044 2948 0179445-0000 hsa03050 Proteasome 23198 1 - 1.87488407040578e-05 0.00019582122513127 2949 0179445-0000 hsa04950 Maturity onset diabetes of the young 3087 1 - 0.0102008111011608 0.0416902714569181 2950 0179445-0000 hsa04610 Complement and coagulation cascades 2157_7056_7035_2149_1604 5 - 7.05756130257116e-05 0.000603100693128808 2951 sulfamerazine hsa04650 Natural killer cell mediated cytotoxicity 3812_3824_3383_3805_3806_5880_5293_3802_4776_9436_7410_3811_5781_2185_3448_51744_259197 17 + 0.0079851588526989 0.331384092387004 2952 sulfamerazine hsa04080 Neuroactive ligand-receptor interaction 1268_9127_2846_3062_2568_1812_1813_3360_799_2918_2688_1442_4987_2914_2917_3953_5023_5733_3352_8001_5340_2892_2740_2696 24 + 0.0478496331904705 0.79430391096181 2953 sulfamerazine hsa04740 Olfactory transduction 26532_26664_26692 3 + 4.9355013254041e-07 4.0964661000854e-05 2954 sulfamerazine hsa04020 Calcium signaling pathway 2778_775_2769_51196_3710_1812_5260_5023_9127_3360_5156_5333_776_7416_2185_488_5733_8911_2065 19 + 0.0305251070977322 0.633395972277943 2955 sulfamerazine hsa04930 Type II diabetes mellitus 775_2475_776_5313_5293_3630_9021 7 + 0.0266573288334132 0.633395972277943 2956 sulfamerazine hsa05010 Alzheimer's disease 836_4712_841_572_3708_5534_823_23236 8 - 0.000727466355866777 0.0223089682465812 2957 sulfamerazine hsa04080 Neuroactive ligand-receptor interaction 1909_1269_1081_1813_3953_1131_2908_5618_4886_3354_56288_7067_134_9568_2690_7068_7433_2561 18 - 0.00723017872976587 0.110862740523077 2958 sulfamerazine hsa05016 Huntington's disease 246721_1387_836_4712_841_581_7052_6667_3708_5468_548644_161_23236 13 - 0.0192696580091114 0.221601067104781 2959 sulfamerazine hsa04740 Olfactory transduction 818_5613_5616_393046 4 - 3.76783041597252e-16 3.46640398269472e-14 2960 sulfamerazine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_94239_8366_8368_6737_8329_8294_8343_8347_8346_8344_8367_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235_3113_727_9555 35 - 0.0020036473362288 0.0368671109866099 2961 sulfamerazine hsa05012 Parkinson's disease 27429_836_7332_4712_5413 5 - 0.00128277929111537 0.0295039236956535 2962 sulfamerazine hsa04260 Cardiac muscle contraction 481_4635_27092 3 - 0.016389431316279 0.215403954442524 2963 sulfamerazine hsa04060 Cytokine-cytokine receptor interaction 1436_5618_8771_3594_3953_8744_4254_3572_3976_7422_7042_8718_2690 13 - 8.49200202986554e-05 0.00390632093373815 2964 sulfamerazine hsa03050 Proteasome 23198 1 - 0.0399862888524678 0.408748730491893 2965 bromopride hsa04070 Phosphatidylinositol signaling system 3633 1 + 0.0199130031704552 0.305332715280313 2966 bromopride hsa04120 Ubiquitin mediated proteolysis 7337_5371_330_55236 4 + 0.0186795320214144 0.305332715280313 2967 bromopride hsa05010 Alzheimer's disease 1339_2904_6392_651820_317_824 6 + 0.0129835604460179 0.298621890258412 2968 bromopride hsa04310 Wnt signaling pathway 5599_51384_894_7480_5516 5 + 0.0248944834637077 0.32718463980873 2969 bromopride hsa04660 T cell receptor signaling pathway 920_29851_10000 3 + 0.034575821568567 0.353441731589796 2970 bromopride hsa04910 Insulin signaling pathway 5599_8660_10000_10211_5105 5 + 0.0430877417308537 0.357087792287755 2971 bromopride hsa04740 Olfactory transduction 7932_8383_442194_5132_26539_393046 6 + 2.09460497276726e-08 1.92703657494588e-06 2972 bromopride hsa04514 Cell adhesion molecules (CAMs) 8516_8506_23308_3384_3383_3123_3126_3127_3125_51208_9379_29851_26285_965_3688_3683_3685_5797_3117_920_923_26047_1000 23 + 0.00447871161047819 0.137347156054665 2973 bromopride hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_2904_8368_8360_88_8362_8294_3123_8366_3126_3127_3125_8370_8359_554313_121504_83740_3117_720_721 26 + 0.00145692948602953 0.0670187563573584 2974 bromopride hsa04110 Cell cycle 5925_894_699_1029 4 + 0.0452905347887516 0.357087792287755 2975 bromopride hsa04720 Long-term potentiation 2904 1 + 0.0304030707283834 0.349635313376409 2976 bromopride hsa03010 Ribosome 6129_6192_6123 3 + 0.0465766685592724 0.357087792287755 2977 bromopride hsa05332 Graft-versus-host disease 3105_3106_3107_3113_3135_649853 6 - 0.0360579022973426 0.447083317900652 2978 bromopride hsa05211 Renal cell carcinoma 2271_2549_405_3845_7422_7042_10000_6655_7423 9 - 0.0368186261800537 0.447083317900652 2979 bromopride hsa05320 Autoimmune thyroid disease 1081_3105_3106_3107_3113_3135_649853 7 - 0.0342085742949445 0.447083317900652 2980 bromopride hsa04740 Olfactory transduction 810_51806_393046 3 - 3.24484532917465e-06 0.000227998436758947 2981 bromopride hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8347_8346_8344_8370_8359_8337_554313_121504_8339_3113_720_721_9555 24 - 5.36466910021051e-06 0.000227998436758947 2982 bromopride hsa05219 Bladder cancer 11186_4318_1613_1956_3845_7422_7423 7 - 0.0123312553596948 0.349385568524686 2983 bromopride hsa05330 Allograft rejection 3105_3106_3107_3113_3135_649853 6 - 0.0246270766146704 0.447083317900652 2984 bromopride hsa04940 Type I diabetes mellitus 3105_3106_3107_3113_3135_649853 6 - 0.04286617395233 0.455453098243506 2985 sulfapyridine hsa05332 Graft-versus-host disease 3553_3804_3126_3127_3125_3123_3113 7 + 0.0317145310909868 0.507432497455789 2986 sulfapyridine hsa05016 Huntington's disease 6392_3708_651820 3 + 0.00365412438623594 0.0974433169662917 2987 sulfapyridine hsa04740 Olfactory transduction 26212_5568_157_5566_8392_810_9635 7 + 2.81325323902185e-05 0.00112530129560874 2988 sulfapyridine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113_3014 31 + 1.14453341720212e-07 9.15626733761696e-06 2989 sulfapyridine hsa05012 Parkinson's disease 6392_651820 2 + 0.0123225247602426 0.246450495204852 2990 sulfapyridine hsa04070 Phosphatidylinositol signaling system 8394_3633_5291_5331_8821_23236_3705 7 - 0.0485960900722183 0.826133531227711 2991 sulfapyridine hsa04080 Neuroactive ligand-receptor interaction 9568 1 - 0.000547995010373429 0.0232897879408707 2992 sulfapyridine hsa05322 Systemic lupus erythematosus 8353_8344_8347_3013_8346_8358_8343_8968_720_721_8350_8351_8352_8339_8354_8355_8356_8357 18 - 8.51630073975869e-05 0.00723885562879489 2993 sulfapyridine hsa04530 Tight junction 84612 1 - 0.0460386141921171 0.826133531227711 2994 sulfapyridine hsa05213 Endometrial cancer 5170_6655_999_5291_6932_324 6 - 0.0280669015818164 0.795228878151465 2995 (+)-isoprenaline hsa05322 Systemic lupus erythematosus 85235_8969_8332_8330_8331_8329_8336 7 - 0.0011433199765097 0.0663125586375626 2996 amphotericin B hsa05332 Graft-versus-host disease 3123_3126_3127_3119_3125 5 + 0.0176765907633437 0.177271981179675 2997 amphotericin B hsa05320 Autoimmune thyroid disease 1081_3119_3123_3126_3127_3125 6 + 0.0119461813264957 0.177271981179675 2998 amphotericin B hsa04740 Olfactory transduction 8387_26211_5568_816_8388 5 + 0.0194894575002048 0.177271981179675 2999 amphotericin B hsa05310 Asthma 3123_3126_3127_3119_3125 5 + 0.00512899710399521 0.177271981179675 3000 amphotericin B hsa04912 GnRH signaling pathway 5568_1081_1839_5331_3708_8681_100137049_107_816 9 + 0.0138963065447919 0.177271981179675 3001 amphotericin B hsa05330 Allograft rejection 3123_3126_3127_3119_3125 5 + 0.0123183216201574 0.177271981179675 3002 amphotericin B hsa04730 Long-term depression 2781_6261_2892_5331_3708_8681_100137049 7 + 0.0132165148391284 0.177271981179675 3003 amphotericin B hsa04940 Type I diabetes mellitus 3123_3126_3127_3119_3125 5 + 0.0208555271976088 0.177271981179675 3004 amphotericin B hsa04740 Olfactory transduction 219464 1 - 0.0106899485444737 0.652086861212896 3005 methoxsalen hsa05222 Small cell lung cancer 6502_6257_1288_5925 4 + 0.0477186071565786 0.826570303053229 3006 methoxsalen hsa05219 Bladder cancer 1956_2261_1613 3 - 0.0492215265334523 1 3007 methoxsalen hsa04540 Gap junction 115_5331_5607_1956_5154 5 - 0.0341114664560538 1 3008 phenazopyridine hsa05332 Graft-versus-host disease 3553_3119_3105_3106_3107_3126_3135_649853 8 + 0.00619975009073197 0.106379578904936 3009 phenazopyridine hsa05016 Huntington's disease 7052_3708 2 + 0.00218228529104491 0.0589217028582126 3010 phenazopyridine hsa04740 Olfactory transduction 26212_8390_8590_816 4 + 2.97026891905134e-06 0.000240591782443159 3011 phenazopyridine hsa04514 Cell adhesion molecules (CAMs) 9378_3119_9071_3105_29851_3107_3126_3685_3135_6693_920_3106_26047_649853 14 + 0.0471323545772006 0.405473268371565 3012 phenazopyridine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3126_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119 23 + 5.5856719725883e-05 0.00226219714889826 3013 phenazopyridine hsa04630 Jak-STAT signaling pathway 1437_3560_3590_23533_3589_5618_5290_6773_50615_200734_51561_3952_81848_10252_9021_4352 16 + 0.042132506088818 0.405473268371565 3014 phenazopyridine hsa05012 Parkinson's disease 6622 1 + 0.0073968748351328 0.106379578904936 3015 phenazopyridine hsa05330 Allograft rejection 3119_3105_3106_3107_3126_3135_649853 7 + 0.0118977584603058 0.137674062183539 3016 phenazopyridine hsa04940 Type I diabetes mellitus 3553_3119_3105_3106_3107_3126_3135_649853 8 + 0.00787996880777304 0.106379578904936 3017 phenazopyridine hsa05200 Pathways in cancer 1436_2737_4286_581_6789_5154_867_3918_4088_7046_6934_7042_5914_2260_2261_3725_4149 17 - 0.00693020363140974 0.114348359918261 3018 phenazopyridine hsa04740 Olfactory transduction 157_4991 2 - 0.00658168907350965 0.114348359918261 3019 phenazopyridine hsa05322 Systemic lupus erythematosus 3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 11 - 0.00147658045113538 0.0885343917433556 3020 phenazopyridine hsa04010 MAPK signaling pathway 4217_9479_1432_4216_9448_6789_6416_5154_5607_7046_5606_7042_3725_2260_2261_4149 16 - 0.00268286035585926 0.0885343917433556 3021 phenazopyridine hsa05210 Colorectal cancer 581_4088_7046_6934_7042_3725 6 - 0.0228811460117648 0.302031127355295 3022 carbimazole hsa05214 Glioma 1021_6655_5155_4193_5578 5 + 0.0246567332966368 0.524577488744497 3023 carbimazole hsa04740 Olfactory transduction 4991 1 + 0.0017046777088385 0.0554020255372513 3024 carbimazole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_81 15 + 5.09677477804422e-06 0.000331290360572874 3025 carbimazole hsa04664 Fc epsilon RI signaling pathway 6655_81579_8398_6850_5578 5 + 0.048422537422569 0.524577488744497 3026 carbimazole hsa04730 Long-term depression 3708_81579_8398_4842_5578 5 + 0.0336369593013069 0.524577488744497 3027 carbimazole hsa05220 Chronic myeloid leukemia 861_6655_1021_4193_7042 5 + 0.0406207085080856 0.524577488744497 3028 carbimazole hsa04740 Olfactory transduction 109 1 - 0.0162930012040895 0.54292833244476 3029 carbimazole hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0190501169278863 0.54292833244476 3030 colecalciferol hsa05211 Renal cell carcinoma 4233_5781_1399 3 + 0.0292284170745252 0.676424328149331 3031 colecalciferol hsa04210 Apoptosis 472_8837_651610 3 + 0.0488465146610594 0.676424328149331 3032 colecalciferol hsa04115 p53 signaling pathway 472_651610_7249 3 + 0.026309141743502 0.676424328149331 3033 niridazole hsa05332 Graft-versus-host disease 3135_3105_3106_649853 4 + 0.0437709823557887 0.556353364270733 3034 niridazole hsa04062 Chemokine signaling pathway 4793 1 + 0.047527455646003 0.556353364270733 3035 niridazole hsa05330 Allograft rejection 3135_3105_3106_649853 4 + 0.032819019248853 0.556353364270733 3036 niridazole hsa04940 Type I diabetes mellitus 3105_3106_2572_2571_3135_649853 6 + 0.00309001532247077 0.173040858058363 3037 niridazole hsa04080 Neuroactive ligand-receptor interaction 3953_1812 2 - 0.001138472723761 0.048954327121723 3038 niridazole hsa04740 Olfactory transduction 219464_157 2 - 4.40769928341948e-06 0.000379062138374075 3039 niridazole hsa05322 Systemic lupus erythematosus 85235_3119_3013_8330_8332_8969_8331_8329_8351_8343_8336_8339_8347_8346_8344 15 - 0.00601030341131544 0.172295364457709 3040 niridazole hsa04062 Chemokine signaling pathway 23236_157_112 3 - 0.0365196996235061 0.785173541905381 3041 pilocarpine hsa04540 Gap junction 7278_113457_5154 3 - 0.0357509587759586 0.453137048119794 3042 pilocarpine hsa03020 RNA polymerase 246721_5439_548644 3 - 0.00174779567373024 0.0559294615593677 3043 neostigmine bromide hsa04662 B cell receptor signaling pathway 4776_5881_8519 3 + 0.0379824525031227 0.688037528979874 3044 neostigmine bromide hsa04370 VEGF signaling pathway 4776_5881_56848 3 + 0.0404727958223455 0.688037528979874 3045 neostigmine bromide hsa05016 Huntington's disease 5432_1213_246721_6648_5439_548644 6 - 0.0113711846818208 0.198660606016033 3046 neostigmine bromide hsa04540 Gap junction 7278_5607_5155_113457 4 - 0.0145361419036122 0.198660606016033 3047 neostigmine bromide hsa03020 RNA polymerase 5432_246721_5439_548644 4 - 0.000275028044252327 0.0112761498143454 3048 melatonin hsa05200 Pathways in cancer 5925 1 + 0.0107841588980198 0.612199263552571 3049 melatonin hsa04740 Olfactory transduction 5566_4991 2 + 0.0182746048821663 0.612199263552571 3050 melatonin hsa04710 Circadian rhythm - mammal 8553_9572 2 + 0.0383493942832031 0.856469805658203 3051 melatonin hsa03020 RNA polymerase 5432_246721_5439_548644 4 - 0.00177602362365207 0.106561417419124 3052 bisacodyl hsa04916 Melanogenesis 1906_1385 2 + 0.0481595202980174 0.376519885966318 3053 bisacodyl hsa05010 Alzheimer's disease 4311_6390_6622_4023 4 + 0.0101661672754142 0.174858077137124 3054 bisacodyl hsa04310 Wnt signaling pathway 10725_5599_324_3725 4 + 0.0347883924223354 0.332422416480094 3055 bisacodyl hsa05016 Huntington's disease 1385_6390_7802_161 4 + 0.0053537074813392 0.15347294779839 3056 bisacodyl hsa04740 Olfactory transduction 2774 1 + 6.67087334534737e-11 2.86847553849937e-09 3057 bisacodyl hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8360_8368_8335_9103_88_8362_8294_121504_8342_8341_723790_3123_8366_3126_3127_3125_8968_8370_8358_8359_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_83740_3012_3013_8349_941 42 + 1.72885235686949e-12 1.48681302690776e-10 3058 bisacodyl hsa05212 Pancreatic cancer 1385 1 + 0.030964878407629 0.332422416480094 3059 bisacodyl hsa05215 Prostate cancer 1385 1 + 0.0304902802604053 0.332422416480094 3060 bisacodyl hsa04062 Chemokine signaling pathway 5829_6464_998_7852_6368_56288 6 + 0.031409996790029 0.332422416480094 3061 bisacodyl hsa05012 Parkinson's disease 6390_6622 2 + 0.00893882088953797 0.174858077137124 3062 bisacodyl hsa03010 Ribosome 6139_6144 2 + 0.0474331394182444 0.376519885966318 3063 bisacodyl hsa05332 Graft-versus-host disease 355_3119 2 - 0.0258720761538244 0.0962441232922268 3064 bisacodyl hsa04650 Natural killer cell mediated cytotoxicity 8503_836_5296_4775_5295_355_673_10451_6452_5335_5058_2534 12 - 0.0015303354084977 0.00889507456189288 3065 bisacodyl hsa04640 Hematopoietic cell lineage 3554_4254_2057 3 - 6.8123639155427e-05 0.000703944271272746 3066 bisacodyl hsa05010 Alzheimer's disease 836_842_841_8772_4698_5664_317_8883_355_3709_23621_489_488_810_7132_23236 16 - 0.000365212658324492 0.0030877070203798 3067 bisacodyl hsa04080 Neuroactive ligand-receptor interaction 5618_7442_4157_3953_5031_7434_64106_2150_136_56288_2690_9170 12 - 1.6003097032894e-10 7.44144012029571e-09 3068 bisacodyl hsa04742 Taste transduction 5613_5616_112 3 - 0.012977175291832 0.0574703477209703 3069 bisacodyl hsa05320 Autoimmune thyroid disease 355_3119 2 - 0.00374304214856944 0.020476642342174 3070 bisacodyl hsa04612 Antigen processing and presentation 4801_5993_3119_1508_3308_811_3304_3305_3303 9 - 0.0315346541809378 0.110562181050407 3071 bisacodyl hsa04670 Leukocyte transendothelial migration 8503_5295_5296_2773_1500_9080_10451_4313_5335_5600_5603_9475_1365 13 - 0.0159979000455997 0.0676274865563987 3072 bisacodyl hsa05016 Huntington's disease 5432_3092_836_842_841_581_7157_1639_317_10488_4698_5481_23236 13 - 8.06485372126656e-06 0.000150006279215558 3073 bisacodyl hsa04740 Olfactory transduction 810_5613_5616_157 4 - 2.85143627179205e-27 2.65183573276661e-25 3074 bisacodyl hsa04514 Cell adhesion molecules (CAMs) 214_3385_3119_9080_1365_9672_9019 7 - 1.58663320645127e-05 0.000245928146999947 3075 bisacodyl hsa04510 Focal adhesion 8503_857_7094_5295_2324_5296_3691_596_5155_5154_9475_10451_1956_5058_207_6714_673_4233_2534_3912 20 - 0.00026910232431732 0.00250265161615108 3076 bisacodyl hsa05322 Systemic lupus erythematosus 55506_85235_3119_94239_8330_3021_3020_8332_8969_8331_8336_3014_8334_6738_8329_9555_55766 17 - 0.0208876446660077 0.0809396230807798 3077 bisacodyl hsa04530 Tight junction 5584_5583_5580_2773_9080_4619_1457_56288_207_6714_9223_1365 12 - 0.00149532093953015 0.00889507456189288 3078 bisacodyl hsa04720 Long-term potentiation 5613_5616_673_3709_810_23236 6 - 0.0175382081875412 0.0709153635409275 3079 bisacodyl hsa05110 Vibrio cholerae infection 11015_5335_5616_23545_5613 5 - 0.0458753308272921 0.147117440239247 3080 bisacodyl hsa05310 Asthma 3119 1 - 0.0320986977243116 0.110562181050407 3081 bisacodyl hsa04512 ECM-receptor interaction 3691_3912_9672_3161 4 - 0.000567310321684338 0.00439665499305362 3082 bisacodyl hsa04630 Jak-STAT signaling pathway 868_3717_6778_207_2057_3953_598_5295_5618_6772_5296_23529_9063_10379_8835_8503_2690 17 - 0.00814140203888283 0.042063910534228 3083 bisacodyl hsa04062 Chemokine signaling pathway 3717_157_5296_2773_8503_9475_10451_56288_113_112_7454_4067_5580_7074_408_5295_207_673_23236_5613_5616_6772_5058_5970 24 - 0.0112512567532149 0.0523183439024493 3084 bisacodyl hsa04810 Regulation of actin cytoskeleton 8503_5296_5295_5155_5154_9475_10451_5058_23365_7454_7074_3691_1445_2263_200576_2264_8394_8396_673_1956_6548_54434_3984_3985 24 - 0.00111482583503899 0.00797529251220201 3085 bisacodyl hsa05012 Parkinson's disease 836_842_7314_317_4698_5481 6 - 3.2363868113864e-06 7.52459933647338e-05 3086 bisacodyl hsa04260 Cardiac muscle contraction 6548_488 2 - 2.14523414676188e-05 0.000285009679498364 3087 bisacodyl hsa04060 Cytokine-cytokine receptor interaction 8792_3953_5618_3554_7132_2057_2324_23529_5155_5154_8741_8742_657_355_1956_90_4254_27242_4233_7048_2690 21 - 1.07632791253321e-06 3.33661652885295e-05 3088 bisacodyl hsa04020 Calcium signaling pathway 489_5613_5616_3709_7220_1956_5335_136_113_488_810_3707_5481_23236 14 - 2.75442380520602e-05 0.0003202017673552 3089 bisacodyl hsa05330 Allograft rejection 355_3119 2 - 0.0357195086584391 0.11863979661553 3090 bisacodyl hsa04730 Long-term depression 673_2773_4067_3709_23236 5 - 0.00934294963159699 0.0457312797757116 3091 bisacodyl hsa04610 Complement and coagulation cascades 7056_2152_5329 3 - 0.00148671078840099 0.00889507456189288 3092 amiodarone hsa03440 Homologous recombination 5890_8940_25788_5888 4 - 0.0389208648860616 1 3093 amiodarone hsa04740 Olfactory transduction 5566_26529_157 3 - 0.000180604205254886 0.0137259195993713 3094 amiodarone hsa04530 Tight junction 6714 1 - 0.0464091675189432 1 3095 methyldopa hsa05010 Alzheimer's disease 3709_4713 2 + 0.025423652078257 1 3096 methyldopa hsa04740 Olfactory transduction 816 1 + 1.16379246684923e-06 9.31033973479384e-05 3097 methyldopa hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_6738_121504 15 - 0.0150493682334963 1 3098 leflunomide hsa05010 Alzheimer's disease 5532_1339 2 + 0.00225804397296786 0.10048295679707 3099 leflunomide hsa05016 Huntington's disease 7052_7416_1339_7350 4 + 0.0140902124008252 0.418009634557814 3100 leflunomide hsa04740 Olfactory transduction 2978_5568_9635_8392 4 + 7.17449198704671e-07 6.38529786847157e-05 3101 leflunomide hsa04512 ECM-receptor interaction 2814_8515_960_1302_1311_3381_9900_3918_1284_7059_1291 11 + 0.0473338901559148 0.864380942185807 3102 leflunomide hsa05012 Parkinson's disease 7416_1339_7054 3 + 0.0485607270890903 0.864380942185807 3103 leflunomide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 1.19388696957879e-07 6.44698963572547e-06 3104 leflunomide hsa04370 VEGF signaling pathway 572_6714_50487_5603 4 - 0.035130517085606 0.859665731773711 3105 amikacin hsa04520 Adherens junction 4088_91_2260_1956_2241 5 + 0.0333049621967622 0.694214421826377 3106 amikacin hsa04740 Olfactory transduction 26212_1179 2 + 0.0182776174228042 0.618155294013757 3107 amikacin hsa04930 Type II diabetes mellitus 8651_775_776_773 4 + 0.0193173529379299 0.618155294013757 3108 carmustine hsa05010 Alzheimer's disease 355_22926 2 + 0.00149416932170313 0.0408406281265522 3109 carmustine hsa04080 Neuroactive ligand-receptor interaction 5618_7442_2150 3 + 0.000112977681860735 0.00926416991258027 3110 carmustine hsa05016 Huntington's disease 1385_7416_161_7019 4 + 0.0142177677025087 0.145732118950714 3111 carmustine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_720_721 23 + 0.000248623267268929 0.0101935539580261 3112 carmustine hsa04062 Chemokine signaling pathway 6093_6655_156 3 + 0.00375406413691183 0.057901634516544 3113 carmustine hsa04540 Gap junction 6655 1 + 0.0302988364802058 0.248450459137688 3114 carmustine hsa05012 Parkinson's disease 7416 1 + 0.00339914833744717 0.057901634516544 3115 carmustine hsa04060 Cytokine-cytokine receptor interaction 5618_2057_55540_657_355_8795 6 + 0.00423670496462517 0.057901634516544 3116 carmustine hsa03010 Ribosome 51187 1 + 0.0212673322343301 0.193769027023896 3117 carmustine hsa04020 Calcium signaling pathway 8912_7220_7416 3 + 0.00509716989379582 0.0597097044701796 3118 carmustine hsa04080 Neuroactive ligand-receptor interaction 5025_4157_4886_9170 4 - 0.00211099208445422 0.0886616675470772 3119 carmustine hsa04740 Olfactory transduction 818 1 - 1.42743508055367e-08 1.19904546766508e-06 3120 carmustine hsa05322 Systemic lupus erythematosus 8346_85235_3123_8330_3126_3127_3014_3125_8332_8969_8331_8336_8343_8329_8339_8347_87_8344 18 - 0.00413973590261896 0.115912605273331 3121 carmustine hsa04360 Axon guidance 1949 1 - 0.0104459253655587 0.219364432676733 3122 carmustine hsa05215 Prostate cancer 10488_5728_596_7157_572_5605_3326_367_2263_2260 10 - 0.0436653500562289 0.543233678405339 3123 carmustine hsa03010 Ribosome 9349 1 - 0.0452694732004449 0.543233678405339 3124 carmustine hsa05213 Endometrial cancer 5728_7157_572_999_5605_1495_324 7 - 0.0396285050489749 0.543233678405339 3125 dinoprostone hsa04740 Olfactory transduction 5137 1 + 5.0761942602293e-07 4.3655270637972e-05 3126 dinoprostone hsa04514 Cell adhesion molecules (CAMs) 3134 1 + 0.0325563462770413 0.478834313618663 3127 dinoprostone hsa05212 Pancreatic cancer 2308_842_6932_4193_5605_1956_2033_367_2263_2260 10 + 0.0130287644966834 0.280118436678693 3128 dinoprostone hsa05215 Prostate cancer 2308_842_6932_4193_5605_1956_2033_367_2263_2260 10 + 0.0121827648926792 0.280118436678693 3129 dinoprostone hsa05012 Parkinson's disease 842 1 + 0.0334070451361858 0.478834313618663 3130 dinoprostone hsa04270 Vascular smooth muscle contraction 8398_5583_10267_5581_9138_4660_2776_5605_108_3709_113_1909_81579 13 + 0.00818740912585714 0.280118436678693 3131 dinoprostone hsa05332 Graft-versus-host disease 3105_3106_3126_3127_3125_3135_3123_649853 8 - 0.000424912813308151 0.00892316907947117 3132 dinoprostone hsa05320 Autoimmune thyroid disease 3105_3106_3126_3127_3125_3135_3123_649853 8 - 0.00164116665137076 0.0229763331191906 3133 dinoprostone hsa04612 Antigen processing and presentation 4800_4801_3123_3106_3126_3127_3125_3135_3105_811_649853 11 - 0.00106428508337112 0.0178799894006348 3134 dinoprostone hsa04740 Olfactory transduction 5613_5616 2 - 8.79938194105053e-05 0.00488582554714233 3135 dinoprostone hsa05322 Systemic lupus erythematosus 3017_85235_3123_3126_3127_3125_8332_8969_8331_8336_8329_8330 12 - 0.0150520271862041 0.180624326234449 3136 dinoprostone hsa04210 Apoptosis 581_5613_5616_472_9941_51135_8837_651610 8 - 0.0259122929837366 0.272079076329234 3137 dinoprostone hsa05310 Asthma 3123_3126_3127_3125 4 - 0.0347694152830644 0.324514542641934 3138 dinoprostone hsa05330 Allograft rejection 3105_3106_3126_3127_3125_3135_3123_649853 8 - 0.00023471212244459 0.00657193942844852 3139 dinoprostone hsa05210 Colorectal cancer 581_1856_7040_6934_91_3725_2956 7 - 0.0494811327240081 0.415641514881668 3140 dinoprostone hsa04940 Type I diabetes mellitus 3382_3105_3106_3126_3127_3125_3135_3123_649853 9 - 0.000116329179693865 0.00488582554714233 3141 5140203 hsa04350 TGF-beta signaling pathway 91_7059 2 + 0.018952807917658 0.227433695011896 3142 clotrimazole hsa05332 Graft-versus-host disease 57292_3811_3119_3113_3111_3802_940 7 + 0.00520507853817141 0.0975952225907139 3143 clotrimazole hsa05320 Autoimmune thyroid disease 3439_1081_3119_3447_3113_3111_940 7 + 0.0155149663953492 0.232724495930238 3144 clotrimazole hsa04612 Antigen processing and presentation 4261_57292_3811_3119_3439_3447_3113_3111_3802_6890_925 11 + 0.00430793529126881 0.0975952225907139 3145 clotrimazole hsa05016 Huntington's disease 64446_3708_161 3 + 0.0499071007034309 0.623838758792886 3146 clotrimazole hsa04740 Olfactory transduction 26211_26212_135948_81797_81696 5 + 0.000907872991677754 0.0680904743758315 3147 clotrimazole hsa05322 Systemic lupus erythematosus 2212_3119_3013_3113_3111_8358_8968_940_8350_8351_8352_8353_8354_8355_8356_8357 16 + 0.00247737333231654 0.0929014999618702 3148 clotrimazole hsa04080 Neuroactive ligand-receptor interaction 2911_5618_4157_1131_7434_2149 6 - 0.00769478909613907 0.323181142037841 3149 clotrimazole hsa04740 Olfactory transduction 818_801_808_805 4 - 1.00103082609808e-06 8.40865893922387e-05 3150 clotrimazole hsa04010 MAPK signaling pathway 9479_5155_57551_5607_776_10454_3306_5608_3554_3552_6789_2249_2261_6300_4217_4216_8399_998_5534_3725_4791_5578_4763_4137_5606_9693 26 - 0.0473626863599345 0.74508702824461 3151 clotrimazole hsa05012 Parkinson's disease 7419_1327 2 - 0.0175139451020334 0.385491070565238 3152 clotrimazole hsa04912 GnRH signaling pathway 808_4216_8399_5578_998_2776_5608_818_5606_805_3725_801_6300_776 14 - 0.0183567176459637 0.385491070565238 3153 5109870 hsa05211 Renal cell carcinoma 3725_54583_6513_2034_7422 5 + 0.0155165283153216 0.173785117131602 3154 5109870 hsa04740 Olfactory transduction 157 1 + 0.00740148004105896 0.138160960766434 3155 5109870 hsa04710 Circadian rhythm - mammal 8553_5187_79365 3 + 0.00316552455143601 0.0886346874402083 3156 5109870 hsa05219 Bladder cancer 1956_1026_4193_7422 4 + 0.0111276831422784 0.155787563991898 3157 5109870 hsa04115 p53 signaling pathway 1647_1026_5366_1643_4193_3486_355_5054_5268_8795_9540 11 + 2.97879272112865e-07 1.66812392383204e-05 3158 5109870 hsa04740 Olfactory transduction 5567 1 - 0.00740105119142981 0.125817870254307 3159 5109870 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 30 - 1.23138191787011e-20 6.28004778113756e-19 3160 5109870 hsa04110 Cell cycle 995_890_5347_991_993_891_898_983_699_701_996_9700_1031 13 - 1.35023925099047e-06 3.4431100900257e-05 3161 5151277 hsa03450 Non-homologous end-joining 5591 1 + 0.0367857526230995 0.367857526230995 3162 decitabine hsa04740 Olfactory transduction 26211 1 + 0.0333351393004055 0.84267117337574 3163 decitabine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6738_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 26 + 8.19624014282895e-19 5.08166888855395e-17 3164 topiramate hsa05200 Pathways in cancer 355_8321_324 3 + 0.0241269078112142 0.176930657282237 3165 topiramate hsa04310 Wnt signaling pathway 8321_324 2 + 0.0338275161200467 0.186051338660257 3166 topiramate hsa05210 Colorectal cancer 8321_324 2 + 0.0113273378929259 0.124600716822185 3167 topiramate hsa05217 Basal cell carcinoma 8321_324 2 + 0.00511049406771198 0.112430869489664 3168 colforsin hsa05200 Pathways in cancer 2353_868_2271_842_596_898_3480_3576_3909_6772_4254_2034_2263_5914_2335_3725_3675 17 + 0.0318331705112837 0.512809440106611 3169 colforsin hsa04740 Olfactory transduction 818 1 + 0.000257068222455344 0.0195371849066061 3170 colforsin hsa04512 ECM-receptor interaction 2335_3693_3909_1277_3339_7057_3675 7 + 0.0154028353886968 0.512809440106611 3171 colforsin hsa05222 Small cell lung cancer 842_596_898_3909_2335_3675 6 + 0.0483497976878624 0.512809440106611 3172 colforsin hsa05014 Amyotrophic lateral sclerosis (ALS) 5606_836_5608_5603_5868 5 - 0.0258921469575653 0.578257948718958 3173 colforsin hsa04740 Olfactory transduction 109 1 - 0.000373324290726209 0.025012727478656 3174 colforsin hsa03020 RNA polymerase 5433_246721_5439_548644 4 - 0.0122628175809303 0.410804388961165 3175 HC toxin hsa04070 Phosphatidylinositol signaling system 8503_5578_8394_5293_5291_3708_23396 7 + 0.0335709017158505 0.579933877215852 3176 HC toxin hsa04080 Neuroactive ligand-receptor interaction 6915_2150_7433 3 + 0.0278671668967993 0.579933877215852 3177 HC toxin hsa04664 Fc epsilon RI signaling pathway 8503_8399_5578_5293_5291_5606_2534 7 + 0.0396050590997726 0.579933877215852 3178 HC toxin hsa04740 Olfactory transduction 5613 1 - 2.53984994896457e-05 0.00193028596121307 3179 HC toxin hsa05212 Pancreatic cancer 595_596_3480_5155_5154_2033_1871_1387 8 - 0.0185874281440306 0.353161134736581 3180 HC toxin hsa05215 Prostate cancer 595_596_3480_5155_5154_2033_1871_1387 8 - 0.0175620912660064 0.353161134736581 3181 HC toxin hsa05216 Thyroid cancer 6257_5979_595_6256_4609 5 - 0.00577955700507689 0.219623166192922 3182 cetirizine hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 + 0.00629570446095401 0.0730301717470665 3183 cetirizine hsa04640 Hematopoietic cell lineage 1436_2057_3123_3126_3127_3125 6 + 0.00386315936465716 0.0658083257824255 3184 cetirizine hsa05320 Autoimmune thyroid disease 3123_3126_3127_3125 4 + 0.013298598035491 0.120311434928514 3185 cetirizine hsa04612 Antigen processing and presentation 6891_3123_3126_3127_3125 5 + 0.0178664845997757 0.129532013348374 3186 cetirizine hsa05310 Asthma 3123_3126_3127_3125 4 + 0.00207778214889328 0.0602556823179051 3187 cetirizine hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0145203455948206 0.120311434928514 3188 cetirizine hsa05330 Allograft rejection 3123_3126_3127_3125 4 + 0.00453850522637417 0.0658083257824255 3189 cetirizine hsa04940 Type I diabetes mellitus 3382_3126_3127_3123_3125 5 + 0.00110594297968685 0.0602556823179051 3190 cetirizine hsa05332 Graft-versus-host disease 3552_3119_3123_3126_3127_3125_3135 7 - 0.0171662075324816 0.255935432410196 3191 cetirizine hsa04080 Neuroactive ligand-receptor interaction 5025_56288_4889 3 - 0.000473280746413829 0.019404510602967 3192 cetirizine hsa04612 Antigen processing and presentation 4800_4802_3308_3119_3123_3126_3127_3125_3135_3326_1385_567 12 - 0.0126403018905681 0.255935432410196 3193 cetirizine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_3123_3126_3127_3125_8370_8359_554313_8351_8339_3119_3013_3017 27 - 6.6371960778357e-07 5.44250078382527e-05 3194 cetirizine hsa05212 Pancreatic cancer 6934_5296_369_5155_5605_3326_367_1385_5970_7184_842 11 - 0.0249693104790435 0.255935432410196 3195 cetirizine hsa05215 Prostate cancer 6934_5296_369_5155_5605_3326_367_1385_5970_7184_842 11 - 0.023753030846168 0.255935432410196 3196 cetirizine hsa05310 Asthma 3123_3126_3127_3119_3125 5 - 0.041470105709058 0.291850725397631 3197 cetirizine hsa04060 Cytokine-cytokine receptor interaction 27242_3552_2324_5155_8742_8741_8795 7 - 0.0299377348554404 0.267257886363094 3198 cetirizine hsa05330 Allograft rejection 3119_3123_3126_3127_3125_3135 6 - 0.032592425166231 0.267257886363094 3199 cetirizine hsa04730 Long-term depression 5515_5605_3710_10672_2773_5331_8681_369_100137049_23236 10 - 0.0132877460528439 0.255935432410196 3200 cetirizine hsa05222 Small cell lung cancer 3914_4149_842_5296_598_9618_51588_3673_5970_7187 10 - 0.0427098622533119 0.291850725397631 3201 cetirizine hsa04940 Type I diabetes mellitus 3552_3119_3123_3126_3127_3125_3135 7 - 0.0210589388858193 0.255935432410196 3202 norcyclobenzaprine hsa04010 MAPK signaling pathway 8817_1326_50487_1846_8912_4763_2258_3310_5971_3164 10 + 0.0416629310905803 1 3203 norcyclobenzaprine hsa05332 Graft-versus-host disease 3119_3105_3126_3127_3125_3123 6 - 0.0202127463808413 0.289716031458725 3204 norcyclobenzaprine hsa04080 Neuroactive ligand-receptor interaction 146_3354_9170 3 - 0.00377247222188363 0.108144203693997 3205 norcyclobenzaprine hsa05320 Autoimmune thyroid disease 3119_3105_3126_3127_3125_3123 6 - 0.0492417222946572 0.41220672244267 3206 norcyclobenzaprine hsa04740 Olfactory transduction 219464_26211_5613 3 - 2.8643425781844e-05 0.00123166730861929 3207 norcyclobenzaprine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8347_8346_8344_3123_3126_3127_3125_8370_8359_554313_121504_8339_3119_9555 25 - 1.44851376677132e-07 1.24572183942334e-05 3208 norcyclobenzaprine hsa05310 Asthma 3123_3126_3127_3119_3125 5 - 0.0194978523009629 0.289716031458725 3209 norcyclobenzaprine hsa05213 Endometrial cancer 324_7157_5295_5605_5296_6934 6 - 0.0459048081683028 0.41220672244267 3210 norcyclobenzaprine hsa05330 Allograft rejection 3119_3105_3126_3127_3125_3123 6 - 0.0135148489121353 0.289716031458725 3211 norcyclobenzaprine hsa05222 Small cell lung cancer 9134_7157_5295_9618_5296_8554_3673_1017_6256 9 - 0.0395768420104277 0.41220672244267 3212 norcyclobenzaprine hsa04940 Type I diabetes mellitus 3119_3105_3126_3127_3125_3123 6 - 0.0242833872372692 0.29833875748645 3213 vorinostat hsa05010 Alzheimer's disease 842_4713_6392_651820_317_778_4137_5331_3708_3709_22926_5664_23621 13 + 0.00513280287898857 0.0827042738590205 3214 vorinostat hsa04080 Neuroactive ligand-receptor interaction 154_1081_1812_1132_2908_5724_4142_1241_6915_2358_2150_2689_7433_148_2688_728_1442 17 + 0.000149883743296128 0.00653923168652238 3215 vorinostat hsa04742 Taste transduction 5566_51764 2 + 0.0287039765764917 0.234850717444023 3216 vorinostat hsa04740 Olfactory transduction 26212_5566 2 + 3.64751995261694e-22 3.28276795735525e-20 3217 vorinostat hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_88_8329_8294_121504_8343_8341_8347_8346_8344_8339_3109_8969_8968_8370_92815_8358_8359_8330_8331_8336_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013 44 + 0.000217974389550746 0.00653923168652238 3218 vorinostat hsa04062 Chemokine signaling pathway 5331_2185_2770_2771_5566_2788_6773_7852_6774_51764_729230_10235_208_5293_4793 15 + 0.00551361825726803 0.0827042738590205 3219 vorinostat hsa05012 Parkinson's disease 842_5413_6392_7314_4713_317_9246_7345_7416_65018_651820 11 + 0.0286118161497251 0.234850717444023 3220 vorinostat hsa04260 Cardiac muscle contraction 10479_778_7137_6548 4 + 0.0110019128247323 0.126371172066153 3221 vorinostat hsa04060 Cytokine-cytokine receptor interaction 7852_3459_4804_3552_2057_3556_55540_8744_8743_8795_50615_1956_2688_2689_3977_7293_655_1896_8792_3587_729230 21 + 0.00147207054713383 0.0331215873105112 3222 vorinostat hsa03010 Ribosome 6123_6129_6125_6224_6181_6165_6233 7 + 0.0244491988057434 0.234850717444023 3223 vorinostat hsa03050 Proteasome 5698 1 + 0.0112329930725469 0.126371172066153 3224 vorinostat hsa05332 Graft-versus-host disease 355 1 - 0.0104262986176712 0.0619384952975195 3225 vorinostat hsa04650 Natural killer cell mediated cytotoxicity 6850_5534_3460_6464_5295_7409_355_5533_10451_5894_369_3845_8795 13 - 0.0170291379380636 0.0737929310649423 3226 vorinostat hsa04640 Hematopoietic cell lineage 3554_3566_960_4254_3673_3675 6 - 0.0135417009564623 0.0643995770944726 3227 vorinostat hsa05010 Alzheimer's disease 776_3710_4712_4700_8772_2776_5533_355_5332_23385_5534_4694_8851_7132_823_23236 16 - 0.00462777583748944 0.035309109510425 3228 vorinostat hsa04080 Neuroactive ligand-receptor interaction 5029_4889_5618_152_4157_64106_5025_4886_5031_3354_56288_136_5026_9170 14 - 2.09755401425508e-07 9.54387076486061e-06 3229 vorinostat hsa05320 Autoimmune thyroid disease 355 1 - 0.00208789357615023 0.0211109239366301 3230 vorinostat hsa04612 Antigen processing and presentation 1385_4802_4801 3 - 0.000380341160108163 0.00692220911396857 3231 vorinostat hsa05131 Shigellosis 25_2017_203068 3 - 0.0279876304889112 0.0979567067111892 3232 vorinostat hsa04670 Leukocyte transendothelial migration 2909_5295_6387_9080_10451_1365_7409_5600_6300 9 - 0.00476970827215536 0.035309109510425 3233 vorinostat hsa05016 Huntington's disease 4899_6874_51164_4694_4712_4700_7157_2776_5978_2033_5332_1385_1387_23236 14 - 0.000359561305189017 0.00692220911396857 3234 vorinostat hsa05130 Pathogenic Escherichia coli infection 25_2017_203068 3 - 0.0279876304889112 0.0979567067111892 3235 vorinostat hsa04740 Olfactory transduction 5613_109_5616_4991 4 - 2.92944150573694e-23 2.66579177022062e-21 3236 vorinostat hsa04514 Cell adhesion molecules (CAMs) 965_4685_4897_9080_1365_5792_6693_5817 8 - 0.000589848913522522 0.00894604185509158 3237 vorinostat hsa05340 Primary immunodeficiency 7374 1 - 0.0345947751355212 0.116597205086386 3238 vorinostat hsa04210 Apoptosis 596_598_5295_331_7132_4615_3554_3551_7157_839_51135_8717_8772_5533_5534_4790_8795_5613_5575_5616_355_9941_2021_8837_5970_823 26 - 0.0372193327392908 0.120962831402695 3239 vorinostat hsa04530 Tight junction 55844_8777_9080_4619_51776_1457_56288_3845_2017_6714_1365 11 - 0.0055706040049196 0.0362089260319774 3240 vorinostat hsa05110 Vibrio cholerae infection 5613_109_5616 3 - 0.0200091867545736 0.0791667823767912 3241 vorinostat hsa04810 Regulation of actin cytoskeleton 10298_2909_5295_5155_5154_10451_3673_3675_3691_3693_1445_1399_369_3845_5962_8396_8074_10787_10093_54961_7409_5894 22 - 0.00504415850148928 0.035309109510425 3242 vorinostat hsa05012 Parkinson's disease 7327_7332_4712_4700_51465_4694 6 - 3.4261423310686e-05 0.00103926317375748 3243 vorinostat hsa04260 Cardiac muscle contraction 784_776_27092 3 - 0.000784766100841157 0.010201959310935 3244 vorinostat hsa04060 Cytokine-cytokine receptor interaction 5155_5154_8741_6387_9180_4254_7132_3554_657_3601_23529_3625_4055_8742_7043_7042_91_93_4233_8795_5618_3566_3460_355_7424_51330 26 - 0.00162797198200451 0.0185181812953013 3245 vorinostat hsa03010 Ribosome 9349_6168_284393_6234_6129_389342 6 - 0.00285268489727878 0.0259594325652369 3246 vorinostat hsa04020 Calcium signaling pathway 776_3710_8877_5025_5613_5616_2776_5026_5533_9630_109_136_113_5534_5332_3707_2064_107_23236 19 - 0.014026321510714 0.0643995770944726 3247 vorinostat hsa03050 Proteasome 5717_5713 2 - 0.0183867258918128 0.0760541843706802 3248 vorinostat hsa05330 Allograft rejection 355 1 - 0.0235370970230062 0.0892448262122318 3249 vorinostat hsa04940 Type I diabetes mellitus 355 1 - 0.0109469577733591 0.0619384952975195 3250 vorinostat hsa05220 Chronic myeloid leukemia 595_4088_4089_5295_1487_1871_1488_25_3551_7157_1399_369_598_5894_7043_4609_91_4790_1027_861_6777_6464_3845_7042_5970 25 - 0.0115709276929432 0.0619384952975195 3251 vorinostat hsa04610 Complement and coagulation cascades 2161_7056_7035_5329 4 - 0.0141537532075764 0.0643995770944726 3252 alvespimycin hsa05214 Glioma 208_6464_4193_5293_818_5925_1950_3480_810_7039 10 + 0.0255792820796346 0.373746412218047 3253 alvespimycin hsa04612 Antigen processing and presentation 4800_3805_3105_3106_3107_3135_3308_3309_920_3310_3304_3305_3303_649853 14 + 0.00599012421474601 0.130285201670726 3254 alvespimycin hsa04740 Olfactory transduction 818_810_5566_7932 4 + 3.25941110898852e-07 2.83568766482001e-05 3255 alvespimycin hsa04510 Focal adhesion 5170_2909_5293_394_4638_3675_2321_5829_3693_3791_7057_7410_208_55742_10627_8516_3480_1277_1950_5228_5599_6464_83660 23 + 0.0257756146357274 0.373746412218047 3256 alvespimycin hsa05212 Pancreatic cancer 367_5170_842_3551_3480_64764_4193_5293_5925_208_1950_7039_2263_7184 14 + 0.00599012421474601 0.130285201670726 3257 alvespimycin hsa05215 Prostate cancer 367_5170_842_3551_3480_64764_4193_5293_5925_208_1950_7039_2263_7184 14 + 0.00567200493480483 0.130285201670726 3258 alvespimycin hsa04270 Vascular smooth muscle contraction 146_5319_3778_3710_5581_5566_50487_553_72_113_1909_810_4638_800 14 + 0.0454851523540813 0.565315464972153 3259 alvespimycin hsa04650 Natural killer cell mediated cytotoxicity 5295_5594_3460_6654_673_6850_5530_5335_5781_5291_8795_5578 12 - 0.0325094262414245 0.219235563414281 3260 alvespimycin hsa04640 Hematopoietic cell lineage 3123_3126_3127_3125_7037_933 6 - 0.0346442477396408 0.219235563414281 3261 alvespimycin hsa03320 PPAR signaling pathway 11001_1375_1374_28965 4 - 0.0405843071638493 0.235896285389874 3262 alvespimycin hsa05010 Alzheimer's disease 5594_1327_23621_572_842_5530_4137_3709_22926_5664_7381_3710 12 - 0.00137481037645936 0.0255714730021441 3263 alvespimycin hsa04080 Neuroactive ligand-receptor interaction 5029_4889_7442_1081_5025_4886_5026_152_2690 9 - 1.36147634313183e-08 6.33086499556301e-07 3264 alvespimycin hsa04612 Antigen processing and presentation 3123_5721_3126_3127_3125_6890 6 - 0.0353605747442389 0.219235563414281 3265 alvespimycin hsa05016 Huntington's disease 5433_5430_548644_6648_1327_7157_5439_246721_1175_842_3064_7419_55567_7381_10126_6908 16 - 0.0103083862281503 0.116511567848609 3266 alvespimycin hsa04740 Olfactory transduction 5613_5566_5616_109_4991_409 6 - 2.35995277644309e-18 2.19475608209207e-16 3267 alvespimycin hsa04630 Jak-STAT signaling pathway 6777_3460_1154_6654_6772_5291_200734_5781_4609_5295_2690 11 - 0.00448207762716543 0.0595476027609121 3268 alvespimycin hsa05012 Parkinson's disease 7419_1327_7327_65018_27429_7381_842 7 - 0.000877691124174684 0.0204063186370614 3269 alvespimycin hsa04260 Cardiac muscle contraction 784_7381_1327 3 - 0.00254816731669531 0.0394965934087773 3270 alvespimycin hsa04060 Cytokine-cytokine receptor interaction 3460_5155_5154_8795_6387_655_7422_7042_93_51330_7040_2690 12 - 3.16279121597282e-07 9.80465276951574e-06 3271 alvespimycin hsa03010 Ribosome 285053_9349_6142_6227_439992_6234_6189 7 - 0.0246981037868074 0.191410304347757 3272 alvespimycin hsa04020 Calcium signaling pathway 3710_5261_5578_5613_5566_3709_5616_8877_5530_5026_115_109_5335_5025_7419_2064_3707 17 - 0.0232489308817801 0.191410304347757 3273 alvespimycin hsa03050 Proteasome 5721 1 - 0.0112753130176073 0.116511567848609 3274 alvespimycin hsa05210 Colorectal cancer 4088_572_5295_5291_4436_7855_8321_8322_7157_1855_5900_673_7040_8312_4609_3725_2956_842_5594_6654_7042_2535 22 - 0.0474710351767128 0.257538177678697 3275 alvespimycin hsa04610 Complement and coagulation cascades 1675_2161_727 3 - 0.0151132380312389 0.140553113690522 3276 probenecid hsa04740 Olfactory transduction 26539 1 + 0.0106850639503664 0.25109900283361 3277 probenecid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_88_8294_8367_554313_121504 15 + 1.69090966235892e-07 7.94727541308692e-06 3278 probenecid hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0195956239110533 0.306998107939835 3279 probenecid hsa03320 PPAR signaling pathway 1962 1 - 0.0287679164680007 0.369873211731438 3280 probenecid hsa04080 Neuroactive ligand-receptor interaction 5618_2908_2150 3 - 8.43395264297423e-07 3.33930496691508e-05 3281 probenecid hsa04740 Olfactory transduction 5613_5616_157 3 - 3.9808813625665e-11 3.58279322630985e-09 3282 probenecid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6738_8294_121504_8343_8347_8346_8344_8339_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 35 - 1.11310165563836e-06 3.33930496691508e-05 3283 probenecid hsa04060 Cytokine-cytokine receptor interaction 5618_3552_2057_3459_5154_3572_657_6387_4982_355_659 11 - 0.00954953406691186 0.143243011003678 3284 probenecid hsa03010 Ribosome 51187 1 - 0.00309437100308944 0.0556986780556099 3285 probenecid hsa04020 Calcium signaling pathway 5613_11261_3709_490_5616 5 - 0.0028519279888858 0.0556986780556099 3286 probenecid hsa04940 Type I diabetes mellitus 3552_3123_3107_3126_3127_3125_355_1363_3133 9 - 0.0372046397644924 0.41855219735054 3287 probenecid hsa04610 Complement and coagulation cascades 1675 1 - 0.043944444523063 0.43944444523063 3288 selegiline hsa04330 Notch signaling pathway 113878_9612_1856 3 + 0.0465593705261004 1 3289 selegiline hsa05016 Huntington's disease 6390 1 - 0.0164561612350442 0.457107022553511 3290 selegiline hsa04740 Olfactory transduction 26212 1 - 1.1773820096551e-05 0.000871262687144774 3291 selegiline hsa04920 Adipocytokine signaling pathway 3717_948_3953_5565_1374_5602_5781 7 - 0.0185313657791964 0.457107022553511 3292 selegiline hsa04010 MAPK signaling pathway 4217_1432_5534_5578_4149_6788_7042_5155_5154_1846_2002_7189_6196_5602_91_3725_4763_408 18 - 0.0264626382861109 0.489558808293052 3293 6-azathymine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 2.95455540403034e-09 1.30000437777335e-07 3294 6-azathymine hsa03020 RNA polymerase 246721_5439_548644 3 + 0.00571995866419287 0.125839090612243 3295 6-azathymine hsa05010 Alzheimer's disease 4713_6622_5664 3 - 0.0365233553726998 0.670400582366825 3296 6-azathymine hsa04080 Neuroactive ligand-receptor interaction 3953_3354_5618_4886_1813 5 - 0.0198915364549626 0.670400582366825 3297 6-azathymine hsa04740 Olfactory transduction 818_219464_157_409 4 - 2.56651750173347e-05 0.00218153987647345 3298 6-azathymine hsa05322 Systemic lupus erythematosus 3119_3013_8358_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357 14 - 0.0394353283745191 0.670400582366825 3299 6-azathymine hsa04060 Cytokine-cytokine receptor interaction 5618_3953_5155_27242_3572_7042 6 - 0.0323821720870219 0.670400582366825 3300 omeprazole hsa05211 Renal cell carcinoma 6654_2271_5295_8453_5605_7424_3265_5781_1398_3725_7042_4233_7422 13 - 0.0110055231056263 0.19820662433457 3301 omeprazole hsa03440 Homologous recombination 8940_6118_7156_5890_5892_8438 6 - 0.0371473520408784 0.338040903571993 3302 omeprazole hsa04080 Neuroactive ligand-receptor interaction 3354_5618_1081_4886 4 - 3.37053305245551e-05 0.0010223950259115 3303 omeprazole hsa04740 Olfactory transduction 5566_157 2 - 7.21411846987531e-11 6.56484780758653e-09 3304 omeprazole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_81_8347_8346_8344_3123_3126_3127_3125_87_8370_8359_554313_8351_8339_85236_3013_3017 29 - 2.8921044328365e-05 0.0010223950259115 3305 omeprazole hsa05216 Thyroid cancer 6932_7157_999_5605_5979_3265_6934 7 - 0.0152466634103515 0.19820662433457 3306 omeprazole hsa04060 Cytokine-cytokine receptor interaction 7424_5618_3552_4254_8795_655_7422_7042_4233_51330 10 - 0.0135326617093735 0.19820662433457 3307 omeprazole hsa04020 Calcium signaling pathway 5566_488_5333_3709_5534_107 6 - 0.0241078388059229 0.274226666417373 3308 omeprazole hsa05213 Endometrial cancer 2309_3611_5728_6654_842_7157_999_5295_6932_5605_3265_6934 12 - 0.0023591330160677 0.0536702761155402 3309 omeprazole hsa05220 Chronic myeloid leukemia 613_5295_7157_4089_6654_4193_5605_3265_5781_1398_7042_9846 12 - 0.0362663738280552 0.338040903571993 3310 LM-1685 hsa05332 Graft-versus-host disease 3123_3126_3127_3111_3125_3134_355 7 + 0.0218437583497713 0.313093869680055 3311 LM-1685 hsa05320 Autoimmune thyroid disease 3439_3123_3447_3126_3127_3111_3125_3134_355 9 + 0.00896263092185254 0.256928753093106 3312 LM-1685 hsa04740 Olfactory transduction 219464_157_8388_8387_26333_10798_26539_26529_815 9 + 0.00129885348181119 0.0558506997178812 3313 LM-1685 hsa05322 Systemic lupus erythematosus 55506_8360_8363_8362_8365_8364_8367_8366_8368_8335_88_8294_3123_3126_3127_3125_8370_8359_554313_121504_8354_2213_3017_3111_8361 25 + 1.34010215986122e-05 0.00115248785748065 3314 LM-1685 hsa04110 Cell cycle 5934_7465 2 + 0.0483993861615545 0.520293401236711 3315 LM-1685 hsa05310 Asthma 3123_3126_3127_3111_3125_6037 6 + 0.0162428348670097 0.279376759712567 3316 LM-1685 hsa05330 Allograft rejection 3123_3126_3127_3111_3125_3134_355 7 + 0.0140676462076647 0.279376759712567 3317 LM-1685 hsa04940 Type I diabetes mellitus 3123_3126_3127_3111_3125_3134_355 7 + 0.0266739814638243 0.327708915126984 3318 LM-1685 hsa05010 Alzheimer's disease 3553_3710_317_5532_3709_22926_351_102_513_517 10 - 0.0160465258665891 0.162248205984401 3319 LM-1685 hsa04670 Leukocyte transendothelial migration 93408_5578_23562_7070_9475 5 - 0.0124806357855632 0.162248205984401 3320 LM-1685 hsa05016 Huntington's disease 246721_548644_27019_1211_5439_317_5978_513_1387_517 10 - 0.00963079668417773 0.146067083043362 3321 LM-1685 hsa04740 Olfactory transduction 5592_5567 2 - 2.07270771728515e-16 1.88616402272949e-14 3322 LM-1685 hsa04062 Chemokine signaling pathway 7454_5580_3551_6655_5567_9475_56288_10235_6360_107_8976 11 - 0.0149561738599329 0.162248205984401 3323 LM-1685 hsa05012 Parkinson's disease 2861_513_317_517 4 - 0.0012270365651424 0.0558301637139792 3324 LM-1685 hsa04260 Cardiac muscle contraction 6546_4635 2 - 0.00744100393027162 0.135426271530943 3325 LM-1685 hsa04060 Cytokine-cytokine receptor interaction 3581_3601_3561_3553_3552_3587_3589_3459_939_7424_8718_58985_6360_94 14 - 0.00192799672270376 0.0584825672553474 3326 LM-1685 hsa03010 Ribosome 6142_285053_6165 3 - 0.00600190744942394 0.135426271530943 3327 SC-58125 hsa04740 Olfactory transduction 26539_26212_2979_5592 4 + 0.00597419745216453 0.221045305730088 3328 SC-58125 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8335_554313_8359_8294_720_721_121504_8354_8367 18 + 9.14846851286092e-06 0.000676986669951708 3329 SC-58125 hsa05010 Alzheimer's disease 4714_3553_841_8883_22926_517_6622_4842 8 - 0.000272565855068679 0.00844954150712905 3330 SC-58125 hsa04742 Taste transduction 2784_6337 2 - 0.0412332896777199 0.348608721820723 3331 SC-58125 hsa05016 Huntington's disease 1212_4714_246721_1211_51164_841_5978_2033_55567_6648_161_517 12 - 0.0045557423832135 0.0847368083277711 3332 SC-58125 hsa04740 Olfactory transduction 5592_81697_2979_8390_815 5 - 1.13696917301755e-16 1.05738133090632e-14 3333 SC-58125 hsa05322 Systemic lupus erythematosus 2209_940_3020_55766_3021_729 6 - 0.000658316599577814 0.0153058609401842 3334 SC-58125 hsa04062 Chemokine signaling pathway 2784_6360_10000_1147_3551_6655_2773_673_5880_3845_10235_56288_6773_6375_6376 15 - 0.0192714272608111 0.224030341906929 3335 SC-58125 hsa05012 Parkinson's disease 4714_51465_6622_517 4 - 0.000137002220784541 0.00637060326648116 3336 SC-58125 hsa04260 Cardiac muscle contraction 6546_782_70 3 - 0.00783042664593063 0.105756500404627 3337 SC-58125 hsa04060 Cytokine-cytokine receptor interaction 2690_3439_1435_3553_3552_3575_3447_8771_8742_8741_94_939_7424_7422_650_3597_1896_6360_6375_6376_3596 21 - 0.00796016669712249 0.105756500404627 3338 SC-58125 hsa03010 Ribosome 440589_9349_6187_6168_6160_6165 6 - 0.027120194098628 0.280242005685823 3339 SC-58125 hsa04020 Calcium signaling pathway 623_6546_5578_5724_7220_8911_4842_5733_1909_3269_6865_490_815_57105_6870 15 - 0.0383925950681303 0.348608721820723 3340 tanespimycin hsa05332 Graft-versus-host disease 3812_57292_3811_3553_3109_3119_3105_3106_3107_3126_3127_3125_3135_356_355_3133_3123_649853 18 + 0.0468478520765845 0.396077294829305 3341 tanespimycin hsa04742 Taste transduction 2778_51764_50832_50834 4 + 0.0121654381554237 0.276334369553243 3342 tanespimycin hsa04740 Olfactory transduction 26211_1179_818_2979_81797_4991_81697_409 8 + 1.87124863891982e-26 1.74026123419543e-24 3343 tanespimycin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_9103_88_8329_8294_121504_2212_958_3109_3123_3126_3127_3125_8969_8968_8370_718_8358_8359_8330_8331_8336_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_3018_85235_3119_3013_720_721_8970_729 50 + 0.0270435394755034 0.314381146402727 3344 tanespimycin hsa03410 Base excision repair 27343 1 + 0.0058185754121693 0.180375837777248 3345 tanespimycin hsa04340 Hedgehog signaling pathway 51384_8945_655_652_53944 5 + 0.0229910951676734 0.308366155998308 3346 tanespimycin hsa03030 DNA replication 5983_6742 2 + 0.0232103558278296 0.308366155998308 3347 tanespimycin hsa05012 Parkinson's disease 4714_2861_836_1339_1327_4712_4713_4698_6390_7345_51465_5481_509_4695_6622_517 16 + 0.00494790263382786 0.180375837777248 3348 tanespimycin hsa04260 Cardiac muscle contraction 785_786_1339_1327_782_27092_4635_488_482_781 10 + 0.0347268393680194 0.32295960612258 3349 tanespimycin hsa04060 Cytokine-cytokine receptor interaction 8744_608_7852_9180_2323_3556_3553_2057_3576_3570_3572_3953_655_2688_2689_6363_6362_3601_3606_958_23495_3589_3624_3627_4254_1435_1950_91_3626_4233_8795_1436_5618_3561_3448_50615_356_355_50616_3560_83729_10803 42 + 0.0148566865351206 0.276334369553243 3350 tanespimycin hsa03050 Proteasome 5698_5689_5701_5719 4 + 0.0334131122453099 0.32295960612258 3351 tanespimycin hsa05010 Alzheimer's disease 2903_2902_3710_2905_51806_1329_317_2776_5663_4023_5664_6622_3553_11261_8851_810_23621_348_22926_776_1339_5534_5533_3709_4712_489_1020_102_836_513_23236_5331_5595_5594_841_4713_642502_6391_4137_355_808_351_824_801_805 45 - 0.00286341279109692 0.0332871736965017 3352 tanespimycin hsa04080 Neuroactive ligand-receptor interaction 151_2902_1269_4159_135_2905_4889_2846_2847_5031_59340_5724_5746_134_154_2488_1813_2561_3360_799_5029_64106_2150_7433_9568_186_1395_4161_2859_5028_1132_185_4886_5026_7067_5733_3352_3269_2903_23566_9170_5618_7442_4157_7068_6752_4160_5617_6754_1241_2740_2357_728_2690 54 - 1.87594590426205e-06 4.36157422740927e-05 3353 tanespimycin hsa04612 Antigen processing and presentation 4800_3452_4802_3449_3133_3119_3117_3123_3446_3126_3127_3125_6891_6890_5993_1385_811_1508_3804_925_3113 21 - 0.02016306797387 0.156263776797492 3354 tanespimycin hsa05016 Huntington's disease 2902_4899_627_1329_317_246721_2776_5331_3064_6875_5432_5433_5430_836_6648_1639_5439_6667_7419_1213_1339_581_163_9001_5468_548644_161_23236_4712_841_4713_642502_5441_6391_3092_1385_513_291 38 - 2.26627843138998e-05 0.000351273156865447 3355 tanespimycin hsa04740 Olfactory transduction 51806_157_23538_26532_5137_219464_26333_5566_442194_818_810_815_409_1179_109_81797_5593_5613_5616_808_4992_816_801_393046_805 25 - 2.17930948387091e-32 2.02675781999995e-30 3356 tanespimycin hsa04530 Tight junction 10000_50855_4619_5521_88_4636_81_9223_5584_5583_5580_5581_93408_5588_2037_2036_84612_51776_3996_207_998_9080_5519_22800_3265_8573_4628_6714_7082_8189_5578_10207_5728_1366_1364_1365_7525_4950_27134 39 - 0.0447733098398111 0.320301370392495 3357 tanespimycin hsa04062 Chemokine signaling pathway 6777_10000_157_156_5296_112_5290_115_6387_6358_5747_6359_2309_2786_4067_3551_5829_5566_3576_7410_1399_6367_409_408_8517_5295_207_1233_5580_998_673_108_109_3265_2185_10681_107_4792_23236_7852_5595_5594_5331_5613_6655_6654_5616_6772_2783_51764_2793_2790_5970_8976_10803 55 - 0.0162968427605373 0.137782397884543 3358 tanespimycin hsa05012 Parkinson's disease 2861_4713_1329_1339_4712_5413_836_642502_6391_317_7054_9246_7327_65018_27429_513_7419_6622_291 19 - 7.29562976512889e-07 3.39246784078493e-05 3359 tanespimycin hsa04260 Cardiac muscle contraction 784_7169_1339_782_1329_6548_776_7170_4635 9 - 1.38684188075239e-05 0.000257952589819945 3360 tanespimycin hsa04060 Cytokine-cytokine receptor interaction 3446_3594_8794_55540_5155_5154_8741_7852_6387_6358_4254_8995_3452_3455_27242_3554_3553_3586_3454_2324_4055_3576_3570_3559_3572_657_939_4982_7424_8718_6367_3604_3581_3605_1233_3588_3589_23765_3625_3624_958_1956_7040_7042_3449_93_268_4233_8795_3587_1436_5618_3566_2057_3460_3568_970_5617_1438_6359_50615_356_355_50616_7422_2690_51330_10803 68 - 0.000458245384187976 0.00608811724706882 3361 tanespimycin hsa03010 Ribosome 285053_140801_9349_6125_6142_284393_6160_6165_6204_6129_6187_6205_6181_389342_440589_6157_6158_9045_6171_6169_6192_6234 22 - 0.00517417823058532 0.053466508382715 3362 tanespimycin hsa03050 Proteasome 5690 1 - 1.68471705129449e-06 4.36157422740927e-05 3363 tanespimycin hsa04610 Complement and coagulation cascades 5345_966_728_727_2158_7056_5648_2157_7035_1675_5329_2161_5328_2243 14 - 0.0147517573261074 0.137191343132799 3364 tomelukast hsa04740 Olfactory transduction 135948_442194 2 - 4.38310999883985e-06 0.000359415019904868 3365 tomelukast hsa05322 Systemic lupus erythematosus 727 1 - 0.0229720175397565 0.941852719130017 3366 raloxifene hsa04070 Phosphatidylinositol signaling system 8871_8503_5578_8394_3707_23236 6 + 0.0295548070204522 0.688466403437988 3367 raloxifene hsa04740 Olfactory transduction 26476_26212 2 + 0.00160817160968228 0.128653728774582 3368 raloxifene hsa05322 Systemic lupus erythematosus 474382_474381_83740_3017_8343_8339_8347_8346_8344 9 + 0.0427466613391946 0.688466403437988 3369 raloxifene hsa04740 Olfactory transduction 4992_56656 2 - 4.1993039965491e-05 0.00319147103737732 3370 raloxifene hsa05322 Systemic lupus erythematosus 8369 1 - 0.0469471405818105 0.891995671054399 3371 raloxifene hsa05216 Thyroid cancer 7849_10342_5979_595 4 - 0.0376941292863171 0.891995671054399 3372 raloxifene hsa03020 RNA polymerase 246721_5439_548644_84172 4 - 0.0376941292863171 0.891995671054399 3373 nordihydroguaiaretic acid hsa04740 Olfactory transduction 816 1 + 2.3190493105776e-07 1.94800142088518e-05 3374 nordihydroguaiaretic acid hsa05322 Systemic lupus erythematosus 55506_8361_8363_8362_8365_8364_8370_8360_8368_8366_8359_8294_8367_554313_121504_3119_8354_6737 18 + 0.000590914324020092 0.0248184016088439 3375 nordihydroguaiaretic acid hsa04080 Neuroactive ligand-receptor interaction 1081_7067_2908_6754_1241_3354_56288_23566 8 - 0.0160330234216669 0.344710003565838 3376 nordihydroguaiaretic acid hsa04740 Olfactory transduction 818_5613_109_816 4 - 1.62907653093753e-07 1.40100581660628e-05 3377 nordihydroguaiaretic acid hsa04010 MAPK signaling pathway 4915_5155_8074_776_3725_5495_3164_836_6789_51347_51776_2872_57551_4216_208_5154_5533_1956_5320_3310_4791_51701_782_5613_6654_1649_2002_6196_23162_2005_9693 31 - 0.0127908106114016 0.344710003565838 3378 nordihydroguaiaretic acid hsa05012 Parkinson's disease 836_6622 2 - 0.00862136399240038 0.344710003565838 3379 sulfasalazine hsa04740 Olfactory transduction 135948_9635_816 3 + 0.00143253742124115 0.0558689594284048 3380 sulfasalazine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_8294_720_721_121504_8367 16 + 0.000110610688502099 0.00862763370316372 3381 sulfasalazine hsa04650 Natural killer cell mediated cytotoxicity 5296_6655 2 - 0.0349308025184347 0.672417948479868 3382 sulfasalazine hsa04740 Olfactory transduction 157 1 - 3.22953545733533e-08 2.4867423021482e-06 3383 sulfasalazine hsa05322 Systemic lupus erythematosus 8369 1 - 0.00729517483644315 0.280864231203061 3384 sulfasalazine hsa04020 Calcium signaling pathway 6915_5332_776 3 - 0.0192105922533342 0.493071867835578 3385 celecoxib hsa04120 Ubiquitin mediated proteolysis 25898_23759_10075_7329_8916 5 + 0.0176048872267307 0.226348550057966 3386 celecoxib hsa05010 Alzheimer's disease 2902_5595_1329_317_3708_3709_489_348 8 + 0.0260433748942138 0.260433748942138 3387 celecoxib hsa04910 Insulin signaling pathway 5595_5599_5562_23265_10211_5568 6 + 0.0394068747058096 0.354661872352286 3388 celecoxib hsa05016 Huntington's disease 2902_3708_1329_317_5978 5 + 0.000777753647382052 0.0174994570660962 3389 celecoxib hsa04740 Olfactory transduction 219464_5568_157_26333_1179_26539_26529_815 8 + 1.4764310845825e-08 1.32878797612425e-06 3390 celecoxib hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8294_121504_3108_8968_8370_8358_8359_8330_8335_8350_8351_8352_8353_8354_8355_8356_8357_3012_3013_3113_3017_720_721 33 + 4.49114176741511e-05 0.0020210137953368 3391 celecoxib hsa04530 Tight junction 5519_3996_55844_4633_93408 5 + 0.0174617556974026 0.226348550057966 3392 celecoxib hsa04630 Jak-STAT signaling pathway 3581_5618_2057_6774_3568_3446 6 + 0.0170199383234632 0.226348550057966 3393 celecoxib hsa04062 Chemokine signaling pathway 5595_6347_157_2921_9475_6774_5880_5568_8976 9 + 0.024017457492416 0.260433748942138 3394 celecoxib hsa05012 Parkinson's disease 1329_317 2 + 0.000438468932684945 0.0131540679805483 3395 celecoxib hsa04740 Olfactory transduction 26211_5592_157_8390_2979_10798_409_4991_8590 9 - 5.20746117583891e-08 4.84293889353019e-06 3396 celecoxib hsa05322 Systemic lupus erythematosus 717_7124_942_3111_2215 5 - 0.00947353795041469 0.293679676462855 3397 celecoxib hsa03010 Ribosome 9349 1 - 0.00144517676963416 0.0672007197879884 3398 NS-398 hsa04080 Neuroactive ligand-receptor interaction 1813 1 + 0.00116823258598373 0.0946268394646821 3399 NS-398 hsa03022 Basal transcription factors 51616_6884_2957_2969_728198 5 + 0.0186268079054103 0.754385720169117 3400 NS-398 hsa04650 Natural killer cell mediated cytotoxicity 5605_3106_369 3 - 0.0487096593419894 0.698171783901848 3401 NS-398 hsa04080 Neuroactive ligand-receptor interaction 1241_1269_5025_5724_7068 5 - 0.00223120900466313 0.0479709936002573 3402 NS-398 hsa04740 Olfactory transduction 157_816 2 - 1.28981626303095e-08 1.10924198620662e-06 3403 NS-398 hsa04630 Jak-STAT signaling pathway 3588 1 - 0.00106804924384046 0.0306174116567599 3404 NS-398 hsa05012 Parkinson's disease 7314_65018 2 - 0.0176948885315838 0.304352082743241 3405 NS-398 hsa04060 Cytokine-cytokine receptor interaction 3588_51330_7043_7040 4 - 0.000571325969815403 0.0245670167020623 3406 piperacetazine hsa04740 Olfactory transduction 810 1 + 0.000375299642527819 0.0144495300529571 3407 piperacetazine hsa05322 Systemic lupus erythematosus 85235_3119_8330_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344 13 + 0.000401375834804363 0.0144495300529571 3408 piperacetazine hsa05322 Systemic lupus erythematosus 3119_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 12 - 9.5730178948197e-05 0.00459504858951346 3409 TTNPB hsa04740 Olfactory transduction 26539_2979_815_4991 4 + 0.0109398209038626 0.787667105078107 3410 TTNPB hsa04740 Olfactory transduction 5593 1 - 0.000547267868566916 0.038856018668251 3411 tretinoin hsa04742 Taste transduction 6337 1 + 0.0180163623883073 0.276250889954045 3412 tretinoin hsa04740 Olfactory transduction 8387_3000_409_816_8388 5 + 2.02694753904494e-14 1.86479173592134e-12 3413 tretinoin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3586_2209_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2213_3119_3013_3113_3111_942 32 + 0.00531765581104022 0.163074778205233 3414 tretinoin hsa04710 Circadian rhythm - mammal 4862_406_1408_5187_8553 5 + 0.0433953756256356 0.465027494725571 3415 tretinoin hsa04110 Cell cycle 5000_5111_993_4088_4193_10912_8243 7 + 0.0454918201361972 0.465027494725571 3416 tretinoin hsa04810 Regulation of actin cytoskeleton 623_10093_79784_3688_9459_624_9087_998_93408_8394_324_2258_4342_2335 14 + 0.0084883352899892 0.195231711669752 3417 tretinoin hsa05012 Parkinson's disease 7318_4712_4698_6390_317_7416_842 7 + 0.0153486829516853 0.276250889954045 3418 tretinoin hsa03010 Ribosome 6181 1 + 0.000113008294932057 0.00519838156687462 3419 tretinoin hsa03050 Proteasome 23198 1 + 0.0387523623532283 0.465027494725571 3420 tretinoin hsa03320 PPAR signaling pathway 10062_2710_51703_1375_5467_1376_28965 7 - 0.00740706190293151 0.0870329773594452 3421 tretinoin hsa05010 Alzheimer's disease 2903_3710_2905_2776_5663_487_5332_5664_6622_1327_836_3553_509_810_4842_4843_5533_5534_102_4695_5331_5594_4712_642502_6391_4137_51107_351 28 - 0.00921381101559813 0.0962331372740249 3422 tretinoin hsa04080 Neuroactive ligand-receptor interaction 151_2903_135_2905_64106_2908_2925_56288_5746_1909_1813_2561_799_7434_5021_2150_7433_2859_4889_2913_3953_185_5025_4886_3354_148_5733_3269_9170_2550_5618_4157_7068_6752_4160_5617_7067_8484_2692_2690 40 - 0.00110321735086227 0.0207404861962107 3423 tretinoin hsa04742 Taste transduction 2778_3710_773_5567_50834_112 6 - 0.0377891381098207 0.296014915193595 3424 tretinoin hsa05016 Huntington's disease 4899_627_1327_246721_2776_5331_5332_3064_10126_5432_4695_7052_1639_5439_6667_509_7419_2876_581_9001_836_548644_161_4712_642502_6391_5978_1385_1387_291 30 - 0.00713408995715438 0.0870329773594452 3425 tretinoin hsa04740 Olfactory transduction 157_26333_23538_5567_393046_3000_810_815_409_81797 10 - 7.96185944933645e-28 7.48414788237626e-26 3426 tretinoin hsa05322 Systemic lupus erythematosus 55506_2903_8363_474381_8365_8364_8367_8360_8368_8335_474382_6738_88_8362_8329_8294_8351_8343_8347_8346_8344_8353_3122_3123_8366_3126_3127_3125_8969_8968_55766_8370_8332_8359_8330_8331_8336_8334_554313_8350_121504_8352_8339_8354_8355_8356_8357_8358_85235_83740_3013_942_3014_727_8361 55 - 0.0225212481529085 0.206380391290264 3427 tretinoin hsa04530 Tight junction 50855_6709_5521_88_56288_22800_24146_5728_5581_2037_4619_10627_8777_998_5519_10207_9080_60_7082_5578_1365_6237 22 - 0.024150896853116 0.206380391290264 3428 tretinoin hsa04062 Chemokine signaling pathway 3717_3576_157_5747_9475_115_6387_5332_56288_112_7454_3579_4067_5567_2931_7410_1398_6366_409_8517_5295_1233_998_673_3702_10681_107_5331_4793_6356_7852_5594_6655_6777_10451_6772 36 - 0.049293284642924 0.356428365879604 3429 tretinoin hsa05012 Parkinson's disease 2861_836_4695_1327_4712_642502_6391_51465_509_27429_7419_6622_291 13 - 9.91072316884108e-05 0.00465803988935531 3430 tretinoin hsa04260 Cardiac muscle contraction 784_7168_1327_6548_27092_478 6 - 0.000353100247269054 0.00892614761989352 3431 tretinoin hsa03010 Ribosome 6234_285053_6142_6141_284393_6144_6160_389342_6139 9 - 0.000379836068931639 0.00892614761989352 3432 tretinoin hsa03050 Proteasome 5690_23198 2 - 0.00137629028015231 0.0215618810557195 3433 coralyne hsa04740 Olfactory transduction 4991 1 + 1.11326742453151e-06 9.01746613870523e-05 3434 coralyne hsa04060 Cytokine-cytokine receptor interaction 3581_5618_3446_3448_2057_1233_3953_970_5154_3624_91_1956_2688_1950_7042_6363_1896_6374_6366 19 + 0.0491903608018535 0.680413506039326 3435 coralyne hsa04730 Long-term depression 50487_5331_3708_3709_5320_4842_23236 7 + 0.0479462111713006 0.680413506039326 3436 coralyne hsa04080 Neuroactive ligand-receptor interaction 64106 1 - 0.0112185142222026 0.437522054665901 3437 coralyne hsa04060 Cytokine-cytokine receptor interaction 7852 1 - 0.00750524147694089 0.437522054665901 3438 suloctidil hsa05010 Alzheimer's disease 487_2081_842_9451 4 + 0.0353098574129801 0.403541227576915 3439 suloctidil hsa04740 Olfactory transduction 56656 1 + 4.05539865619215e-09 1.62215946247686e-07 3440 suloctidil hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8360_8368_554313_8349_8362_8294_121504_8343_8341_8347_8346_8344_8339_723790_3109_8366_8968_8370_8358_8359_8337_8334_8335_8350_8351_8352_8353_8354_8355_8356_8357_83740_3012_3013_941_8970 43 + 1.31587191378351e-15 1.05269753102681e-13 3441 suloctidil hsa04530 Tight junction 6709_8189 2 + 0.024999479671795 0.39999167474872 3442 suloctidil hsa04010 MAPK signaling pathway 1326_1649_50487_5606_3310_3164_11221_4616_8823_2260_2247_4214_468_1950_4609_3725_3727_4791_1647_1848_782_5599_1847_1846_8817_1843_2353_5971 28 + 0.0107731924370303 0.287285131654141 3443 suloctidil hsa05012 Parkinson's disease 7416_842 2 + 0.0248391105463483 0.39999167474872 3444 suloctidil hsa03010 Ribosome 6192 1 + 0.0307305996642044 0.403541227576915 3445 suloctidil hsa04740 Olfactory transduction 109 1 - 0.00121196596094889 0.0702940257350356 3446 suloctidil hsa04060 Cytokine-cytokine receptor interaction 3455 1 - 0.0156349486123104 0.453413509757002 3447 androsterone hsa05332 Graft-versus-host disease 3119_3123_3107_3126_3127_3125 6 + 0.0342544307823136 0.382716499916253 3448 androsterone hsa04640 Hematopoietic cell lineage 2811_948_3690_3123_3126_3127_3559_3125_929_1378_931 11 + 0.0168511901765593 0.382716499916253 3449 androsterone hsa05320 Autoimmune thyroid disease 3119_3123_3107_3126_3127_3125_3442 7 + 0.0323070733389873 0.382716499916253 3450 androsterone hsa04660 T cell receptor signaling pathway 4793 1 + 0.0463567233255046 0.40330349293189 3451 androsterone hsa04740 Olfactory transduction 26211_135948_4992_816 4 + 1.80063409040719e-05 0.00156655165865426 3452 androsterone hsa05310 Asthma 3123_3126_3127_3119_3125 5 + 0.0311325179115522 0.382716499916253 3453 androsterone hsa04540 Gap junction 7082_1813_5598_7278_113457_5331_108_1956_2982_81027 10 + 0.0415859775643342 0.401997783121897 3454 androsterone hsa04020 Calcium signaling pathway 2769_886_1131_2925_5724_5331_9630_108_1956_816_5733_4842_3269_1910_10800_2066_493 17 + 0.0351923218313796 0.382716499916253 3455 androsterone hsa05330 Allograft rejection 3119_3123_3107_3126_3127_3125 6 + 0.0233476271617157 0.382716499916253 3456 androsterone hsa04940 Type I diabetes mellitus 3119_3123_3107_3126_3127_3630_3125 7 + 0.0143033523871876 0.382716499916253 3457 androsterone hsa04080 Neuroactive ligand-receptor interaction 7434_2150_1081 3 - 2.68279989522472e-05 0.00118043195389888 3458 androsterone hsa04670 Leukocyte transendothelial migration 24146_5600_9475 3 - 0.0480843123133599 0.470157720397297 3459 androsterone hsa04740 Olfactory transduction 219464 1 - 4.4881089717018e-11 3.94953589509758e-09 3460 androsterone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8348_8294_8343_8347_8346_8344_3123_8370_8359_8330_554313_121504_8339 22 - 0.00273738430737198 0.0802966063495781 3461 androsterone hsa05012 Parkinson's disease 836_1339_517 3 - 0.0259529533981329 0.437011651487287 3462 androsterone hsa04260 Cardiac muscle contraction 1339 1 - 0.0297962489650423 0.437011651487287 3463 androsterone hsa04060 Cytokine-cytokine receptor interaction 2057_3624_4254_355_7422_9180_7042_4233_7040 9 - 0.0196501375860841 0.43230302689385 3464 androsterone hsa03010 Ribosome 284393_389342 2 - 0.0479757682758115 0.470157720397297 3465 androsterone hsa04020 Calcium signaling pathway 5256_3710_11261_2776_5534_5257 6 - 0.0413406214691224 0.470157720397297 3466 testosterone hsa04640 Hematopoietic cell lineage 2811_3565_2812_915_933_921_910_3675 8 + 0.0299621810592695 0.389508353770504 3467 testosterone hsa04662 B cell receptor signaling pathway 974_973_3551_5293_2353_4772_5534_933_3845 9 + 0.00491497803111355 0.191684143213428 3468 testosterone hsa04660 T cell receptor signaling pathway 2353_3551_3565_4772_5293_3558_5335_5534_915_3845 10 + 0.0260932778093627 0.389508353770504 3469 testosterone hsa04740 Olfactory transduction 26212_23538_816 3 + 0.000242850164036666 0.0189423127948599 3470 testosterone hsa05322 Systemic lupus erythematosus 3108_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 12 + 0.0195222056859972 0.389508353770504 3471 testosterone hsa05221 Acute myeloid leukemia 3551_5371_5293_3845_5914_652671 6 + 0.0386442366065029 0.430607207901032 3472 testosterone hsa04512 ECM-receptor interaction 2811_22798_2812_7057_3918_9672_3339_3675 8 + 0.0253150695947602 0.389508353770504 3473 testosterone hsa04740 Olfactory transduction 26212_5566_157 3 - 2.92692911013108e-05 0.00240008187030749 3474 testosterone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_6738_121504 15 - 0.00638113202727184 0.261626413118145 3475 testosterone hsa04210 Apoptosis 8503_3554_3553_842_5296_5566_472_8837_651610_8795 10 - 0.0142709819592414 0.390073506885932 3476 hesperidin hsa04740 Olfactory transduction 1179_816 2 + 0.000814310419506536 0.0627019023020033 3477 hesperidin hsa04630 Jak-STAT signaling pathway 3581_3560_3953_598_5293_867_3572_2033_3558_9021_4352 11 + 0.01959622824668 0.75445478749718 3478 hesperidin hsa04520 Adherens junction 5881_4233_117178_998 4 - 0.0417159347834235 0.501563128468101 3479 hesperidin hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5335_4233_9020_998 4 - 0.0292109289033992 0.501563128468101 3480 hesperidin hsa04370 VEGF signaling pathway 5829_5881_5335_998_5534 5 - 0.00891681789113834 0.490424984012609 3481 fusidic acid hsa04070 Phosphatidylinositol signaling system 8394_5298_5336 3 - 0.0231646405918976 0.641076864167068 3482 clebopride hsa04660 T cell receptor signaling pathway 10000_6655_998_5588_5533_5600_5290_3725_5609 9 + 0.0413255370257008 0.47840674289843 3483 clebopride hsa04740 Olfactory transduction 5593 1 + 1.16842750029456e-05 0.000817899250206192 3484 clebopride hsa04510 Focal adhesion 1278_8515_10000_1302_3910_3690_6655_998_5290_5154_93408_29780_3725_55742 14 + 0.0421790360056681 0.47840674289843 3485 clebopride hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 0.00186551643950446 0.0652930753826561 3486 clebopride hsa04512 ECM-receptor interaction 1278_8515_9672_1302_3910_3690_6383 7 + 0.047840674289843 0.47840674289843 3487 clebopride hsa04540 Gap junction 5593_2982_6655_5154_3708_5331_5607_113 8 + 0.0307742089429726 0.47840674289843 3488 clebopride hsa04730 Long-term depression 5519_5593_6261_2982_5331_3708_4842 7 + 0.0231844412760623 0.47840674289843 3489 droperidol hsa04910 Insulin signaling pathway 3630 1 + 0.00731872962511326 0.3037272794422 3490 droperidol hsa04740 Olfactory transduction 5137_135948_390892 3 + 1.07485658254293e-06 8.92130963510632e-05 3491 droperidol hsa04514 Cell adhesion molecules (CAMs) 9076_24146_3383_5175_9369_3117_941_23308_51208_6383_6693_1000_25945_1462 14 + 0.0432312171550478 0.761470969037132 3492 droperidol hsa04512 ECM-receptor interaction 1278_3690_3691_1277_3679_6383_1101_1292_1290_1291 10 + 0.0378771755767269 0.761470969037132 3493 droperidol hsa03010 Ribosome 6165 1 + 0.0458717451227188 0.761470969037132 3494 droperidol hsa04640 Hematopoietic cell lineage 2057 1 - 0.0303630665156237 0.455341877997836 3495 droperidol hsa04080 Neuroactive ligand-receptor interaction 7434_64106_7067_4157_1812 5 - 0.000430427801820053 0.0187236093791723 3496 droperidol hsa04612 Antigen processing and presentation 3119 1 - 0.0314028881377818 0.455341877997836 3497 droperidol hsa04740 Olfactory transduction 810_5566_157 3 - 6.9432796822845e-09 6.04065332358751e-07 3498 droperidol hsa04514 Cell adhesion molecules (CAMs) 9076_23705_3119 3 - 0.0254237116567693 0.455341877997836 3499 droperidol hsa04350 TGF-beta signaling pathway 5308_4092_4091_4089_3624_656_652_653_353500_7042_91_5933 12 - 0.0429500972590377 0.53380835164804 3500 droperidol hsa05210 Colorectal cancer 8503_836_324_5599_4089_6655_5900_6934_7042_91_8324_4233_2535 13 - 0.0223287874335507 0.455341877997836 3501 mephenytoin hsa05332 Graft-versus-host disease 3126_3107_3113_3127_3125_3123 6 + 0.00151655576264493 0.0344867855732262 3502 mephenytoin hsa04640 Hematopoietic cell lineage 2812_3123_3126_3127_3125_925 6 + 0.035596669442669 0.264997428073203 3503 mephenytoin hsa05320 Autoimmune thyroid disease 3126_3107_3113_3127_3125_3123 6 + 0.00437968548227676 0.0446092702544428 3504 mephenytoin hsa04612 Antigen processing and presentation 3123_3107_3126_3127_3125_925_3113 7 + 0.0131185636362545 0.109867970453631 3505 mephenytoin hsa04514 Cell adhesion molecules (CAMs) 3113_3123_3107_3126_3127_3696_3125_6383_925_26047 10 + 0.00466067002658358 0.0446092702544428 3506 mephenytoin hsa05310 Asthma 3123_3126_3127_3113_3125 5 + 0.00205891257153589 0.0344867855732262 3507 mephenytoin hsa04512 ECM-receptor interaction 8515_2812_3381_3696_3918_1282_6383_1292 8 + 0.00284363551846434 0.0381047159474222 3508 mephenytoin hsa05330 Allograft rejection 3113_3107_3126_3127_3125_3123 6 + 0.000952294303969139 0.0344867855732262 3509 mephenytoin hsa04940 Type I diabetes mellitus 3126_3107_3113_3127_3125_3123 6 + 0.00187974625228664 0.0344867855732262 3510 mephenytoin hsa05332 Graft-versus-host disease 3123_3126_3127_3119_3125 5 - 0.00127712493221666 0.0189123527154106 3511 mephenytoin hsa04640 Hematopoietic cell lineage 3123_3126_3127_2057_3125 5 - 0.0219518993807399 0.129794745599467 3512 mephenytoin hsa05320 Autoimmune thyroid disease 3123_3126_3127_3119_3125 5 - 0.00327220221755053 0.0271076968111329 3513 mephenytoin hsa04612 Antigen processing and presentation 3123_3126_3127_3119_3125 5 - 0.0238398512325551 0.129794745599467 3514 mephenytoin hsa04514 Cell adhesion molecules (CAMs) 24146_214_3119_3123_3126_3127_3125_6693 8 - 0.00331930981360811 0.0271076968111329 3515 mephenytoin hsa05322 Systemic lupus erythematosus 3119_3123_3126_3127_3125_3013_8351 7 - 0.0162609059772748 0.113826341840924 3516 mephenytoin hsa05310 Asthma 3123_3126_3127_3119_3125 5 - 0.000319781808537569 0.0156693086183409 3517 mephenytoin hsa05330 Allograft rejection 3123_3126_3127_3119_3125 5 - 0.000847576319559014 0.0189123527154106 3518 mephenytoin hsa04940 Type I diabetes mellitus 3123_3126_3127_3119_3125 5 - 0.00154386552778862 0.0189123527154106 3519 kaempferol hsa04740 Olfactory transduction 81697_26211_393046_816 4 + 5.18989795784544e-05 0.00404812040711944 3520 kaempferol hsa05322 Systemic lupus erythematosus 85235_3119_717_8330_8969_8332_88_8331_8336_6737_8343_8329_8339_8347_8346_8344 16 + 0.00448056168812053 0.174741905836701 3521 kaempferol hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 - 0.0307038730807558 0.320729972620829 3522 kaempferol hsa05322 Systemic lupus erythematosus 85235_3123_8330_3126_3127_3125_8332_8969_8331_8336_8343_8329_8339_8347_8346_8344 16 - 3.77776649712096e-06 0.000253110355307104 3523 kaempferol hsa05310 Asthma 3123_3126_3127_3125 4 - 0.011092332285671 0.185796565784989 3524 kaempferol hsa04350 TGF-beta signaling pathway 4090_4088_3398_9475_7042_93 6 - 0.0335091016171015 0.320729972620829 3525 kaempferol hsa05330 Allograft rejection 3123_3126_3127_3125 4 - 0.0228066485725353 0.305609090871973 3526 kaempferol hsa05210 Colorectal cancer 8503_581_4088_596_6934_7042_2535 7 - 0.00922184111081994 0.185796565784989 3527 kaempferol hsa04940 Type I diabetes mellitus 3382_3126_3127_3123_3125 5 - 0.0084619404305288 0.185796565784989 3528 oxedrine hsa04740 Olfactory transduction 26539_26211_5593 3 + 0.027541973097492 0.801725749420098 3529 oxedrine hsa04510 Focal adhesion 3688_10000_1301_1302_5578_3691_3908_3696_858_3725 10 + 0.0442272477750386 0.801725749420098 3530 oxedrine hsa04512 ECM-receptor interaction 3688_1301_1302_2812_3691_3908_3696 7 + 0.00685205016240932 0.513903762180699 3531 oxedrine hsa04070 Phosphatidylinositol signaling system 8871_8394_3631_5331_5335_8760_23236 7 - 0.00355996118810826 0.242077360791362 3532 oxedrine hsa05211 Renal cell carcinoma 201163_5155_998_1399_673 5 - 0.036359050272449 0.541966734104616 3533 oxedrine hsa04080 Neuroactive ligand-receptor interaction 64106 1 - 0.0340677484309554 0.541966734104616 3534 oxedrine hsa04540 Gap junction 7278_5155_113457_5331_5607_23236 6 - 0.0306729157336743 0.541966734104616 3535 oxedrine hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0398504951547512 0.541966734104616 3536 benzylpenicillin hsa05320 Autoimmune thyroid disease 3108_3119_7253_3107_3111_356 6 + 0.0484485330698142 0.436036797628328 3537 benzylpenicillin hsa04910 Insulin signaling pathway 5105 1 + 0.0219338909365014 0.296107527642769 3538 benzylpenicillin hsa05016 Huntington's disease 2902_1387 2 + 0.0128544561389607 0.296107527642769 3539 benzylpenicillin hsa04740 Olfactory transduction 26333_9635_8392 3 + 2.84297921723074e-05 0.0023028131659569 3540 benzylpenicillin hsa05310 Asthma 3119_3111_3108_2205_8288 5 + 0.019193129187389 0.296107527642769 3541 benzylpenicillin hsa04062 Chemokine signaling pathway 6375 1 + 0.00242515656619709 0.0982188409309821 3542 benzylpenicillin hsa05012 Parkinson's disease 6622 1 + 0.0218837606255094 0.296107527642769 3543 benzylpenicillin hsa05330 Allograft rejection 356_3107_3108_3119_3111 5 + 0.0425692339205554 0.436036797628328 3544 benzylpenicillin hsa04270 Vascular smooth muscle contraction 776 1 + 0.0451021047493209 0.436036797628328 3545 benzylpenicillin hsa05332 Graft-versus-host disease 3123_3126_3127_3125_3135_3134 6 - 0.00660341943662932 0.101692659324092 3546 benzylpenicillin hsa04080 Neuroactive ligand-receptor interaction 1131_1909 2 - 0.00938898100382993 0.120491922882484 3547 benzylpenicillin hsa05320 Autoimmune thyroid disease 3123_3126_3127_3125_3135_3134 6 - 0.0175518692400845 0.193070561640929 3548 benzylpenicillin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8347_8346_8344_3123_3126_3127_3125_8370_8359_554313_121504_8339 23 - 2.10366149111533e-08 1.6198193481588e-06 3549 benzylpenicillin hsa05310 Asthma 3123_3126_3127_3125 4 - 0.0310220331377667 0.298587068951004 3550 benzylpenicillin hsa04060 Cytokine-cytokine receptor interaction 23765 1 - 0.00180281540847558 0.051025640911158 3551 benzylpenicillin hsa05330 Allograft rejection 3123_3126_3127_3125_3135_3134 6 - 0.0042750417592729 0.0822945538660033 3552 benzylpenicillin hsa04940 Type I diabetes mellitus 3382_3123_3126_3127_3125_3135_3134 7 - 0.00198801198355161 0.051025640911158 3553 Prestwick-664 hsa05016 Huntington's disease 1211 1 + 0.033774091187147 1 3554 Prestwick-664 hsa04740 Olfactory transduction 3000 1 + 5.49505155592137e-05 0.00395643712026339 3555 Prestwick-664 hsa04080 Neuroactive ligand-receptor interaction 146_2911_7067_1909 4 - 0.00412389806883351 0.112719880548116 3556 Prestwick-664 hsa04740 Olfactory transduction 810_26212_4991 3 - 3.3219266353207e-06 0.00023338875874469 3557 Prestwick-664 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3113_720_721 24 - 5.69240874987048e-06 0.00023338875874469 3558 Prestwick-664 hsa04710 Circadian rhythm - mammal 8553_8863_9572 3 - 0.046921780613705 0.769517202064762 3559 Prestwick-664 hsa05210 Colorectal cancer 581_4088_208_6655_7042_5599_324_3725_8324_8321 10 - 0.0300141495776227 0.615290066341265 3560 vanoxerine hsa05010 Alzheimer's disease 1339_841_2081_5331_3708_4023_517 7 + 0.000196496919845383 0.00447030492648246 3561 vanoxerine hsa05016 Huntington's disease 1212_4899_1339_841_7052_1639_246721_5331_7350_3708_9001_55567_517 13 + 0.0150232264345828 0.205585302610741 3562 vanoxerine hsa03420 Nucleotide excision repair 5111 1 + 0.0378674513132597 0.265072159192818 3563 vanoxerine hsa04740 Olfactory transduction 5593_56656 2 + 5.9653124071998e-19 5.42843429055182e-17 3564 vanoxerine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8349_89_8294_121504_8343_8342_8347_8346_8344_8339_723790_3123_3126_3127_3125_8968_3108_8370_8358_8359_8337_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113_941_8348_8970_942 46 + 2.06658258632575e-06 9.40295076778216e-05 3565 vanoxerine hsa05212 Pancreatic cancer 51176_2260_5155_1950 4 + 0.0225917914956858 0.205585302610741 3566 vanoxerine hsa05215 Prostate cancer 51176_2260_5155_1950 4 + 0.0222536840788475 0.205585302610741 3567 vanoxerine hsa04210 Apoptosis 843_8743_331_841 4 + 0.0225917914956858 0.205585302610741 3568 vanoxerine hsa04530 Tight junction 5010_9074_10207_5581_23136_93408_89_6714_26285 9 + 0.0283751581833867 0.234739944971654 3569 vanoxerine hsa05110 Vibrio cholerae infection 115 1 + 0.00817513283274065 0.14878741755588 3570 vanoxerine hsa05012 Parkinson's disease 1339_517 2 + 7.80934842648112e-06 0.000236883568936594 3571 vanoxerine hsa03010 Ribosome 140801_6234_6129_6181_6171 5 + 0.0158920878818658 0.205585302610741 3572 vanoxerine hsa04940 Type I diabetes mellitus 3593_4049_3108_3126_3107_942_3127_3125_3123_3382_941_3113 12 + 0.0362494329938447 0.265072159192818 3573 vanoxerine hsa04080 Neuroactive ligand-receptor interaction 3953_1812 2 - 0.0130941969929277 0.865092431282356 3574 vanoxerine hsa05016 Huntington's disease 842 1 - 0.0224699332800612 0.865092431282356 3575 ouabain hsa04080 Neuroactive ligand-receptor interaction 2859_1081_2925_5030_1241_2740_186_9568 8 + 0.027383375637793 0.429151403854118 3576 ouabain hsa04740 Olfactory transduction 26212_4991 2 + 8.86643907618339e-09 3.76823660737794e-07 3577 ouabain hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8349_8329_8294_121504_8343_8342_8347_8346_8344_8339_723790_92815_8969_8968_8370_717_8358_8359_8330_8331_8336_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3012_3013_3017_3014_941 48 + 1.99048452327492e-17 1.69191184478368e-15 3578 ouabain hsa04350 TGF-beta signaling pathway 4088_4090_1634_3397_3399_7057_6667_3400_7042_6093_92_57154 12 + 0.0203081128493232 0.429151403854118 3579 ouabain hsa04810 Regulation of actin cytoskeleton 6093_7430_2909_7414_1398 5 + 0.0106206001701078 0.300917004819721 3580 ouabain hsa04540 Gap junction 108 1 + 0.0302930402720554 0.429151403854118 3581 ouabain hsa05012 Parkinson's disease 1339_7318_509 3 + 0.0488383278240244 0.593036837863153 3582 ouabain hsa04650 Natural killer cell mediated cytotoxicity 6850_6655_5295_5881_3135_5532_10451_5335_3845_355 10 - 0.0110707448789919 0.0612797671257586 3583 ouabain hsa03440 Homologous recombination 10714_5888_4683_5425_675_641_5892_5889_25788_10111 10 - 0.0314872638845677 0.1220131475527 3584 ouabain hsa04640 Hematopoietic cell lineage 960_3554_3566_2057 4 - 0.00817371614810519 0.0542968286981273 3585 ouabain hsa05010 Alzheimer's disease 3710_841_8772_317_5532_355_3709_351_488_7132_23236 11 - 0.000824367128778212 0.00766661429763737 3586 ouabain hsa04080 Neuroactive ligand-receptor interaction 4157_5021_1131_7067_2150_136_2690 7 - 9.4956134124662e-10 4.41546023679678e-08 3587 ouabain hsa05200 Pathways in cancer 5467_5295_5155_5154_5881_5335_5888_8321_8322_1050_4149_3551_5727_8772_5900_652_1019_613_367_9134_898_675_7043_4609_2956_4233_841_26060_6502_6655_6772_7188_355_3845_7187_2535 36 - 0.0303092651714099 0.1220131475527 3588 ouabain hsa05320 Autoimmune thyroid disease 3135_355 2 - 0.0282431424878921 0.119391465971544 3589 ouabain hsa04670 Leukocyte transendothelial migration 1432_5829_5295_1500_9080_7852_10451_5335_9475 9 - 0.0206750328570012 0.0961389027850556 3590 ouabain hsa05016 Huntington's disease 5433_841_5438_317_7419_5481_23236 7 - 4.13886435061958e-06 0.000107890628391801 3591 ouabain hsa04740 Olfactory transduction 5613_5616_409 3 - 3.7835379483583e-21 3.51869029197322e-19 3592 ouabain hsa04514 Cell adhesion molecules (CAMs) 965_214_3385_4897_9080_3135_5792_9019 8 - 0.00298635474476546 0.0213639224048606 3593 ouabain hsa04510 Focal adhesion 5154_5062_5829_6655_5295_5155_10451_9475_5881_6714_4233 11 - 5.42998727322141e-05 0.000721412594870845 3594 ouabain hsa05322 Systemic lupus erythematosus 55506_55766_3021_3020 4 - 9.41119071633988e-06 0.000175048147323922 3595 ouabain hsa04512 ECM-receptor interaction 960 1 - 9.28531348700365e-05 0.00107941769286417 3596 ouabain hsa04630 Jak-STAT signaling pathway 3717_3566_2057_6655_5295_6772_10379_4609_8835_2690 10 - 0.00276100909052701 0.0213639224048606 3597 ouabain hsa04150 mTOR signaling pathway 9470_5295 2 - 0.0279263922583517 0.119391465971544 3598 ouabain hsa04062 Chemokine signaling pathway 3717_5580_3551_5829_5613_6655_5295_5616_6772_9475_7852_7074_10451_3845_23236_409_408 17 - 0.0190175923516154 0.0930861099315912 3599 ouabain hsa04810 Regulation of actin cytoskeleton 5154_8394_5295_5062_5829_26999_6655_1131_5155_5881_54961_9475_8396_7074_10451_3845_3985_2934_1445 19 - 0.00961689010146467 0.059624718629081 3600 ouabain hsa05012 Parkinson's disease 7419_317_5481 3 - 4.64045713513121e-06 0.000107890628391801 3601 ouabain hsa04260 Cardiac muscle contraction 784_488 2 - 0.000689192092593755 0.0071216516234688 3602 ouabain hsa04060 Cytokine-cytokine receptor interaction 27242_3554_3566_2057_23765_5155_5154_8741_8742_7852_657_355_7043_7132_4233_2690 16 - 2.7680741542045e-05 0.000429051493901697 3603 ouabain hsa03010 Ribosome 6125_6168_3921_9349 4 - 0.00147745329166853 0.0124911960113794 3604 ouabain hsa04020 Calcium signaling pathway 23236_5256_3710_5532_5021_5613_1131_5616_5257_3709_5335_136_488_7419_5481_493 16 - 0.0166070417759157 0.0858030491755644 3605 ouabain hsa03050 Proteasome 23198 1 - 0.0112016778616978 0.0612797671257586 3606 ouabain hsa04730 Long-term depression 3709_3845_3710_23236 4 - 0.0405095531049697 0.144899555337007 3607 ouabain hsa04610 Complement and coagulation cascades 2161_7056_7035_5329 4 - 0.0394000038695739 0.144899555337007 3608 domperidone hsa05332 Graft-versus-host disease 3811_3553_3552_3821_3804_3107_3126_3127_3802_3123_3125 11 + 0.021966301916431 0.279285838651766 3609 domperidone hsa05211 Renal cell carcinoma 3725_5781 2 + 0.0216550725536305 0.279285838651766 3610 domperidone hsa05016 Huntington's disease 4714_2902_246721_1213_317_1346_3708_9377_146754 9 + 0.00446765353284508 0.132540388141071 3611 domperidone hsa04740 Olfactory transduction 5593_8390_135948_808_390892_801_805 7 + 1.93782862975167e-11 1.72466748047899e-09 3612 domperidone hsa05322 Systemic lupus erythematosus 958_3123_3126_3127_3014_3125_8290_88 8 + 0.0322905488059783 0.319317649303563 3613 domperidone hsa04110 Cell cycle 995_4088_10744_5111_4193 5 + 0.0169413061904335 0.279285838651766 3614 domperidone hsa04530 Tight junction 6709_5865_88_56288_4626 5 + 0.00350729963648685 0.132540388141071 3615 domperidone hsa04115 p53 signaling pathway 317_4193 2 + 0.0307706452859919 0.319317649303563 3616 domperidone hsa04630 Jak-STAT signaling pathway 3467_3600_3596_64109_3589_3718_3443_5781_8651 9 + 0.0383771198298299 0.341556366485486 3617 domperidone hsa05012 Parkinson's disease 4714_5413_317_1346_9377_6622 6 + 0.0121108922412098 0.269467352366918 3618 domperidone hsa04640 Hematopoietic cell lineage 3655_966_960_3675 4 - 0.0307917767431479 0.367370955769804 3619 domperidone hsa04080 Neuroactive ligand-receptor interaction 5025_5618_7068_2150_5031 5 - 1.45235972068198e-08 6.53561874306891e-07 3620 domperidone hsa04740 Olfactory transduction 219464 1 - 3.24359967390181e-19 2.91923970651163e-17 3621 domperidone hsa05322 Systemic lupus erythematosus 6632_85236_3113_6628_8343_8339_8347_8346_8344 9 - 0.0288275818153474 0.367370955769804 3622 domperidone hsa04110 Cell cycle 4087_4088_983_651610_4616_699_51433_4089_7534_1017_7531_995_5001_996_9134_4193_7027_5591_1647_1031_4173_1022_472_5934_7529 25 - 0.032655196068427 0.367370955769804 3623 domperidone hsa04720 Long-term potentiation 5605_5594_2776 3 - 0.0310903647062909 0.367370955769804 3624 domperidone hsa04060 Cytokine-cytokine receptor interaction 5618_3597_3459_5154_3572_4982_268_4233_51330 9 - 2.36791675199769e-06 7.10375025599307e-05 3625 domperidone hsa04020 Calcium signaling pathway 5256_5025_2776_115_7416_113_7419_293 8 - 0.00075141956494671 0.016906940211301 3626 domperidone hsa03050 Proteasome 5702 1 - 0.0388994824037773 0.388994824037773 3627 flucytosine hsa05214 Glioma 5605_818_1956_1029 4 + 0.0377511003917877 0.475663864936525 3628 flucytosine hsa04740 Olfactory transduction 818 1 + 0.0107660088990159 0.402147112197559 3629 flucytosine hsa05219 Bladder cancer 5605_1956_1029 3 + 0.0492215265334523 0.516826028601249 3630 flucytosine hsa05218 Melanoma 5605_1956_1029_26281_2258 5 + 0.0127665749903987 0.402147112197559 3631 flucytosine hsa05216 Thyroid cancer 5605_51176_7849 3 + 0.0204297237745126 0.429024199264765 3632 flucytosine hsa04540 Gap junction 5605_7278_1956_113457_2977 5 + 0.0341114664560538 0.475663864936525 3633 flucytosine hsa04740 Olfactory transduction 219464_5567_816 3 - 0.0269672830823965 1 3634 flucytosine hsa04010 MAPK signaling pathway 4217_5534_3925_5567_4137_10912_27092_91_5971_3727_3164_2264 12 - 0.0494545215958468 1 3635 clofazimine hsa05016 Huntington's disease 4899_6392_317_651820_64446_3708_90993_5468 8 + 0.0443755229824974 0.749948867800296 3636 clofazimine hsa04740 Olfactory transduction 8392_4991_9635_26692_56656 5 + 4.8748216973004e-09 4.19234665967834e-07 3637 clofazimine hsa03010 Ribosome 6165_6129 2 + 0.0165548324582652 0.711857795705404 3638 clofazimine hsa04912 GnRH signaling pathway 6655_3708_1956_8681_3725_100137049 6 - 0.0496886160907359 0.859032728608926 3639 alexidine hsa04740 Olfactory transduction 816 1 + 1.72827151558826e-05 0.00126163820637943 3640 alexidine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8330_8294_8367_554313_121504 15 + 0.000536608822928617 0.0195862220368945 3641 alexidine hsa04640 Hematopoietic cell lineage 3675 1 - 0.0302615572409898 0.292528386662901 3642 alexidine hsa04080 Neuroactive ligand-receptor interaction 5031_7442_2690_7433 4 - 0.000137808977952259 0.00599469054092327 3643 alexidine hsa05016 Huntington's disease 5331_3064_161_539_581 5 - 0.0191864169728482 0.27649908886113 3644 alexidine hsa04740 Olfactory transduction 5613_5566_109_5616_157 5 - 3.01558759253055e-07 2.62356120550158e-05 3645 alexidine hsa04514 Cell adhesion molecules (CAMs) 23705_9672_6382 3 - 0.0254252035734372 0.27649908886113 3646 alexidine hsa05322 Systemic lupus erythematosus 3014_94239 2 - 0.00425168197895157 0.0739792664337573 3647 alexidine hsa04210 Apoptosis 207_581_5613_11261_5616_355_5291_208_8717_5575_5576_5566 12 - 0.0462531333581556 0.344617001633825 3648 alexidine hsa05012 Parkinson's disease 539 1 - 0.00157575836284432 0.034272744391864 3649 alexidine hsa04260 Cardiac muscle contraction 6262 1 - 0.0449110285279731 0.344617001633825 3650 alexidine hsa04060 Cytokine-cytokine receptor interaction 355_23765_7423_6387_2690 5 - 0.000448775225130474 0.0130144815287837 3651 alexidine hsa03010 Ribosome 6125_9045 2 - 0.0475333795357 0.344617001633825 3652 alexidine hsa05222 Small cell lung cancer 4149_3912_207_9134_898_6502_208_5291_7188_51588_1871_1869_3675 13 - 0.0234208622709767 0.27649908886113 3653 aminophylline hsa04740 Olfactory transduction 818_51806 2 + 0.009240709890108 0.16009942258431 3654 aminophylline hsa04510 Focal adhesion 8515_3690_83660_998_3371_5156_93408_4636_5602_824_55742_1277_3676 13 + 0.00180146230929621 0.042634607986677 3655 aminophylline hsa05322 Systemic lupus erythematosus 3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 11 + 0.000970631410380718 0.042634607986677 3656 aminophylline hsa04720 Long-term potentiation 775_5533_51806_818_3708_3709 6 + 0.0112746072242472 0.16009942258431 3657 aminophylline hsa04020 Calcium signaling pathway 146_51806_775_3360_3274_5156_818_3708_3709_5533 10 + 0.0151647862520512 0.179449970649273 3658 aminophylline hsa04912 GnRH signaling pathway 775_51806_8398_1081_998_818_3708_3709_5602 9 + 0.00159264384636309 0.042634607986677 3659 aminophylline hsa04270 Vascular smooth muscle contraction 146_51806_775_3779_3708_3709_8398 7 + 0.0264969083790568 0.268754356416148 3660 aminophylline hsa04740 Olfactory transduction 157 1 - 0.00520657650434988 0.291568284243593 3661 esculetin hsa04070 Phosphatidylinositol signaling system 5289_5333_3705_3708_3631 5 + 0.0241711680836563 1 3662 esculetin hsa04670 Leukocyte transendothelial migration 3383_27035_7852_5781_6093_4636 6 + 0.0458393941249869 1 3663 esculetin hsa04740 Olfactory transduction 109 1 - 0.0110987502387991 0.710320015283142 3664 esculetin hsa04512 ECM-receptor interaction 3655_7059_960_3693_3675 5 - 0.0256881952074261 0.822022246637635 3665 STOCK1N-35696 hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_5534_836_5868_581 5 + 0.0121864423983014 0.25997743783043 3666 STOCK1N-35696 hsa05219 Bladder cancer 1026_11186_4193_7422 4 + 0.0199718220547343 0.319549152875749 3667 STOCK1N-35696 hsa04115 p53 signaling pathway 55367_1647_1026_836_581_4193_355_5366_8795 9 + 6.3456947404484e-05 0.00406124463388698 3668 STOCK1N-35696 hsa04010 MAPK signaling pathway 1647_836_22800_5534_1649_1846_4791_91_355_1432_3310_7786_3725_3304_3303 15 + 0.00356637691778082 0.114124061368986 3669 STOCK1N-35696 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_3017_3014_8359_8330_8336_8294_8367_8351_8368_121504_8357 21 - 2.79358835286972e-15 9.21884156447008e-14 3670 Gly-His-Lys hsa04080 Neuroactive ligand-receptor interaction 3953_4157_4886 3 + 0.0269852090540785 0.971467525946826 3671 Gly-His-Lys hsa04740 Olfactory transduction 818_109 2 + 0.00012753831781683 0.00918275888281176 3672 Gly-His-Lys hsa05322 Systemic lupus erythematosus 3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 11 - 2.22977721887052e-08 5.79742076906335e-07 3673 etilefrine hsa03320 PPAR signaling pathway 2710_1579_1375_284541_8309_5105 6 + 0.00835449978014248 0.186583828423182 3674 etilefrine hsa04740 Olfactory transduction 5568 1 + 0.00167624308094183 0.0561541432115513 3675 etilefrine hsa05322 Systemic lupus erythematosus 8361_8360_3018_8362_8365_8364_8370_8366_8368_8363_8359_8294_8367_554313_6738_121504 16 + 9.09841432531214e-07 6.09593759795913e-05 3676 etilefrine hsa04540 Gap junction 5568_7278_113457_5330_5607_112 6 + 0.0276740203886831 0.370831873208354 3677 etilefrine hsa04270 Vascular smooth muscle contraction 5568_4881_3778_5330_1579_112_284541 7 + 0.0264969083790568 0.370831873208354 3678 benfluorex hsa05010 Alzheimer's disease 810_3708 2 + 0.0363506779247356 0.654312202645241 3679 benfluorex hsa04740 Olfactory transduction 810 1 + 1.7519988391434e-06 6.30719582091624e-05 3680 benfluorex hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8294_121504_8968_55766_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_8970 28 + 6.41362943820397e-10 4.61781319550686e-08 3681 benfluorex hsa05012 Parkinson's disease 5413 1 + 0.0316128154762042 0.654312202645241 3682 benfluorex hsa04080 Neuroactive ligand-receptor interaction 706_9170 2 - 0.00946354225123319 0.302670355493329 3683 benfluorex hsa04740 Olfactory transduction 109 1 - 1.72827151558826e-05 0.00139989992762649 3684 benfluorex hsa04514 Cell adhesion molecules (CAMs) 2734_24146_1366_4267_999_9080_3135_1364_1365_5792_3655 11 - 0.0194044212829003 0.392939530978731 3685 benfluorex hsa04530 Tight junction 24146_2037_1366_1364_9080_60_5518_84612_1365_3265_4627_1460 12 - 0.0112100131664196 0.302670355493329 3686 benfluorex hsa04630 Jak-STAT signaling pathway 10379 1 - 0.0464571082736837 0.606824006234043 3687 benfluorex hsa04060 Cytokine-cytokine receptor interaction 355_655_4233 3 - 0.0272605224235788 0.441620463261977 3688 amoxicillin hsa05332 Graft-versus-host disease 3105_3106_3126_3127_3125_3135_3123_3113_649853 9 + 8.68753030808742e-05 0.0023421051838188 3689 amoxicillin hsa04640 Hematopoietic cell lineage 1435_947_3123_3126_3127_3125_924_7850_3589_3676 10 + 0.00293951925991538 0.0293763845338135 3690 amoxicillin hsa05320 Autoimmune thyroid disease 958_3105_3106_3126_3127_3125_3135_3123_3113_649853 10 + 9.03816535015953e-05 0.0023421051838188 3691 amoxicillin hsa04612 Antigen processing and presentation 3123_3106_3126_3127_3125_3135_3105_3113_649853 9 + 0.00989260559871746 0.0868350935887422 3692 amoxicillin hsa04740 Olfactory transduction 5566_8392_1179 3 + 0.000492767491624049 0.00778572636765998 3693 amoxicillin hsa04514 Cell adhesion molecules (CAMs) 958_947_3683_3123_3106_3126_3127_3125_3135_3105_3676_3113_649853 13 + 0.0029748237502596 0.0293763845338135 3694 amoxicillin hsa05310 Asthma 958_3113_3126_3127_3125_3123 6 + 0.00182142008720132 0.0239820311481507 3695 amoxicillin hsa05330 Allograft rejection 958_3113_3106_3126_3127_3125_3135_3123_3105_649853 10 + 7.56576628949064e-06 0.000597695536869761 3696 amoxicillin hsa04940 Type I diabetes mellitus 3105_3106_3126_3127_3125_3135_3123_3113_649853 9 + 0.00011858760424399 0.0023421051838188 3697 amoxicillin hsa05214 Glioma 595_5578_3480_5295_5155_808_5336_801_805 9 - 0.0214146277515631 0.340025044438751 3698 amoxicillin hsa04070 Phosphatidylinositol signaling system 5578_8394_8396_5295_808_5336_801_3705_805_23236 10 - 0.0280756364457068 0.340025044438751 3699 amoxicillin hsa04080 Neuroactive ligand-receptor interaction 5618_2908_4886 3 - 0.000485037673578109 0.0191589881063353 3700 amoxicillin hsa04740 Olfactory transduction 5613_5616_808_109_801_805 6 - 6.98925541104549e-05 0.00552151177472594 3701 amoxicillin hsa04514 Cell adhesion molecules (CAMs) 3655_5792 2 - 0.0356356848274939 0.340025044438751 3702 amoxicillin hsa05322 Systemic lupus erythematosus 55506_8358_85235_8968_3013_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357 19 - 0.00268406515759486 0.0706803824833313 3703 amoxicillin hsa05110 Vibrio cholerae infection 5578_11015_5336_5616_115_109_5613_523 8 - 0.0321791084667405 0.340025044438751 3704 amoxicillin hsa04540 Gap junction 5578_5613_7278_5155_113457_2776_115_5616_109_2697_23236 11 - 0.0479319078601194 0.340972197536508 3705 amoxicillin hsa05012 Parkinson's disease 7332_4713 2 - 0.0247787113254396 0.340025044438751 3706 amoxicillin hsa03020 RNA polymerase 246721_5439_9533_10622_548644 5 - 0.0387370303790982 0.340025044438751 3707 amoxicillin hsa04912 GnRH signaling pathway 5578_5613_5616_2776_808_115_109_3725_801_81579_805_23236 12 - 0.0433745540984529 0.340972197536508 3708 isoetarine hsa05016 Huntington's disease 1639_246721_548644_836_5439 5 + 0.0313755313965567 0.486320736646629 3709 isoetarine hsa03020 RNA polymerase 246721_5439_548644 3 + 0.00300319928097167 0.0930991777101218 3710 isoetarine hsa05322 Systemic lupus erythematosus 3013_8358_727_8968_8350_8351_8352_8353_8354_8355_8356_8357 12 - 3.92453855307116e-05 0.00231547774631198 3711 corbadrine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 1.30883300987175e-10 6.15151514639723e-09 3712 corbadrine hsa05332 Graft-versus-host disease 3105_3106_3135_3134_355_649853 6 - 0.00456541486888761 0.0839645941989705 3713 corbadrine hsa05320 Autoimmune thyroid disease 3105_3106_3135_3134_355_649853 6 - 0.012425141335532 0.15531426669415 3714 corbadrine hsa04612 Antigen processing and presentation 3134_3105_3106_3135_6890_811_649853 7 - 0.0380274556049007 0.347193472807144 3715 corbadrine hsa04310 Wnt signaling pathway 8312_5613_6477_1856_5881_4775_79718_6934_5534_8321 10 - 0.0448375884446203 0.347193472807144 3716 corbadrine hsa04740 Olfactory transduction 5613 1 - 5.59348872511932e-05 0.00419511654383949 3717 corbadrine hsa05322 Systemic lupus erythematosus 8353_3013_3014_8358_8968_8350_8351_8352_81_8354_8355_8356_8357 13 - 0.00194869075781682 0.0730759034181307 3718 corbadrine hsa05330 Allograft rejection 3105_3106_3135_3134_355_649853 6 - 0.00292999141042652 0.073249785260663 3719 corbadrine hsa05210 Colorectal cancer 836_6934_1856_5881_8312_7042_8321 7 - 0.029598197153705 0.317123540932554 3720 corbadrine hsa04940 Type I diabetes mellitus 3105_3106_3135_3134_355_649853 6 - 0.0055976396132647 0.0839645941989705 3721 corbadrine hsa05217 Basal cell carcinoma 6934_2737_8321_1856_8312 5 - 0.0462924630409525 0.347193472807144 3722 butyl hydroxybenzoate hsa05332 Graft-versus-host disease 3123_3126_3127_3119_3125 5 + 0.0100139429599229 0.150209144398844 3723 butyl hydroxybenzoate hsa04640 Hematopoietic cell lineage 960_3690_3123_2993_3126_3127_3125_3589_920 9 + 0.00150256630770224 0.0696654916438667 3724 butyl hydroxybenzoate hsa05320 Autoimmune thyroid disease 3123_3126_3127_3119_3125 5 + 0.0233264059235366 0.26540985904895 3725 butyl hydroxybenzoate hsa05131 Shigellosis 9076_7278_7454_7430_113457 5 + 0.0283103849652213 0.26540985904895 3726 butyl hydroxybenzoate hsa05130 Pathogenic Escherichia coli infection 9076_7278_7454_7430_113457 5 + 0.0283103849652213 0.26540985904895 3727 butyl hydroxybenzoate hsa05310 Asthma 3123_3126_3127_3119_3125 5 + 0.00278661966575467 0.0696654916438667 3728 butyl hydroxybenzoate hsa05330 Allograft rejection 3123_3126_3127_3119_3125 5 + 0.00688260399368625 0.129048824881617 3729 butyl hydroxybenzoate hsa04940 Type I diabetes mellitus 3382_3119_3123_3126_3127_3125 6 + 0.00266595622290431 0.0696654916438667 3730 butyl hydroxybenzoate hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8294_8343_8347_8346_8344_8370_8359_8337_6737_121504_8339_9555 22 - 7.29108740458899e-06 0.00057599590496253 3731 butyl hydroxybenzoate hsa04060 Cytokine-cytokine receptor interaction 3554_7040_7042 3 - 0.00269256258029824 0.10635622192178 3732 indapamide hsa04080 Neuroactive ligand-receptor interaction 1269_886_64106_2908_3274_5724_134_2488_2740_3362_57105_2688_2689_1442_146_2914_2918_6915_9002_23566_2550_5618_4158_6755_1241_2696 26 + 0.00163404639285315 0.0452086168689372 3733 indapamide hsa05200 Pathways in cancer 2475_22798_596_331_330_9618_3479_5881_7039_26291_652671_51176_3910_5371_1613_7471_2260_7475_3815_51384_208_4193_4254_1496_91_1284_2335_5599_1288_8817_861_6257 32 + 0.00105117340214435 0.0436236961889905 3734 indapamide hsa05016 Huntington's disease 317_6667 2 + 0.00924541329301081 0.153473860663979 3735 indapamide hsa04740 Olfactory transduction 7932_816 2 + 1.42030783582891e-06 0.0001178855503738 3736 indapamide hsa04514 Cell adhesion molecules (CAMs) 9076_3117_947_1272_3107_3111_3684_23308_57863_6693_26285_925_5817 13 + 0.0312391109023673 0.351309237273261 3737 indapamide hsa04510 Focal adhesion 1284_22798_3910_596_5599_858_2909_3693_331_7057_330_3479_5881_208_824_6093_1288_6696_2335 19 + 0.017143252855607 0.23714833116923 3738 indapamide hsa05322 Systemic lupus erythematosus 3117_3111 2 + 0.0494774689690275 0.351309237273261 3739 indapamide hsa05221 Acute myeloid leukemia 51176_2475_3815_861_208_5371_652671 7 + 0.0393917796494806 0.351309237273261 3740 indapamide hsa04512 ECM-receptor interaction 1284_2335_9900_3910_3693_7057_1288_6696_22798 9 + 0.0452044902570014 0.351309237273261 3741 indapamide hsa05222 Small cell lung cancer 1284_22798_596_331_3910_317_330_9618_1288_208_6257_2335 12 + 0.00262452991829641 0.0544589958046505 3742 indapamide hsa05010 Alzheimer's disease 5534 1 - 0.0336308147028267 0.653749738351472 3743 indapamide hsa04740 Olfactory transduction 5566_816 2 - 0.000278064652115934 0.00987129515011566 3744 indapamide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_6737_8359_8330_8294_8367_554313_121504 16 - 0.00011786151393602 0.00836816748945742 3745 indapamide hsa04810 Regulation of actin cytoskeleton 8394_6655 2 - 0.0368309711747308 0.653749738351472 3746 camptothecin hsa05010 Alzheimer's disease 779_348 2 + 0.0498757341385087 0.527257760892806 3747 camptothecin hsa04740 Olfactory transduction 26476_2978_816 3 + 0.00024631082830821 0.00911350064740377 3748 camptothecin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_9103_8294_121504_8341_3021_3020_8968_55766_8370_8358_8359_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_1511 33 + 3.82637768790043e-14 2.83151948904632e-12 3749 camptothecin hsa04110 Cell cycle 995_1647_1026_2810_4088_4193_1028_10912_8900_4616 10 + 0.0349856921320743 0.5177882435547 3750 camptothecin hsa04530 Tight junction 5010 1 + 0.045559938950939 0.527257760892806 3751 camptothecin hsa05219 Bladder cancer 1026_5228_1612_4193_1956_2261_1890 7 + 0.00272138112444121 0.0596777323519666 3752 camptothecin hsa04115 p53 signaling pathway 1647_1026_5366_2810_4193_5268_10912_5054_4616 9 + 0.00322582337037657 0.0596777323519666 3753 camptothecin hsa05332 Graft-versus-host disease 5551_355_3108 3 - 0.000679321594063684 0.0035098282359957 3754 camptothecin hsa04650 Natural killer cell mediated cytotoxicity 8503_6850_5058_5295_5290_5291_10451_6452_5335_5336_836_3455_4772_3459_7410_3845_4277_10725_673_5533_5532_4775_5894_5534_8795_5777_5578_6655_6654_355_5530_7409_5551_2534 34 - 0.0203164743736369 0.0609494231209107 3755 camptothecin hsa04640 Hematopoietic cell lineage 3554_3566_2057_960_4254_1604_3678_3673 8 - 4.77666638127169e-06 4.44229973458267e-05 3756 camptothecin hsa03320 PPAR signaling pathway 11001_5170_1962_2182_2181_1375_1374_5467_5468_6257_6256 11 - 0.00384415805091869 0.0143002679494175 3757 camptothecin hsa05010 Alzheimer's disease 51806_3710_5534_317_9451_2776_5663_5332_7132_836_509_776_8772_2932_5533_5532_3708_5530_6868_488_23236_4714_842_841_840_355_3709_351_22926 29 - 4.34342448534819e-06 4.44229973458267e-05 3758 camptothecin hsa04080 Neuroactive ligand-receptor interaction 5029_4889_5618_7442_4157_7068_3953_1131_2908_2901_4886_5031_3354_2150_136_7433_56288_2690_2149_9170 20 - 9.68408612068614e-18 4.50310004611905e-16 3759 camptothecin hsa04742 Taste transduction 3710_5613_5567_5616_6337_112 6 - 0.00127442118117412 0.00592605849245966 3760 camptothecin hsa05320 Autoimmune thyroid disease 5551_355_3108 3 - 3.45829721096608e-05 0.000214414427079897 3761 camptothecin hsa04612 Antigen processing and presentation 4800_4801_4802_3312_3108_5993_5994_3308_1385_3304_3305_3303 12 - 0.000192238821168221 0.00111738814804028 3762 camptothecin hsa04670 Leukocyte transendothelial migration 9076_8503_2909_5295_5290_9475_6387_5335_394_5829_1500_5336_7410_7430_2773_5747_6093_5291_1432_5578_10451_27035_1366_1364_7409_4950 26 - 0.00538558855678707 0.0192638359915845 3763 camptothecin hsa05016 Huntington's disease 4899_64764_317_246721_2776_5332_23186_3064_6875_6874_6908_5433_5430_5431_836_7052_5439_6667_2033_509_3708_5468_548644_23236_4714_51164_842_841_3092_5978_1385_1387_9519 33 - 9.31608178707701e-06 7.21996338498468e-05 3764 camptothecin hsa04740 Olfactory transduction 51806_157_5613_5567_5616_818_109 7 - 4.92804754112711e-45 4.58308421324821e-43 3765 camptothecin hsa04514 Cell adhesion molecules (CAMs) 9076_965_214_4685_3108_6383_5819_4897_1366_23308_1364_5792_9672_4950_25945_9019_5817 17 - 1.39616337510827e-06 1.8549027697867e-05 3766 camptothecin hsa04510 Focal adhesion 8503_5170_595_10298_596_2909_5747_5155_5154_5290_9475_3678_5058_394_3673_4659_6093_5501_5728_5829_7057_7410_23396_331_1399_1398_329_5295_3911_1793_3480_2932_3909_5894_3725_6714_5291_4233_5578_1729_2317_6655_6654_10451_2002_7424_7409_673_2534 49 - 0.0018466696493733 0.00780637624507804 3767 camptothecin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_718_3108_8368_8366_6738_8359_8294_8367_554313_8970_121504_6632_6737 20 - 2.44184002223397e-06 2.83863902584699e-05 3768 camptothecin hsa05340 Primary immunodeficiency 8517_64421_5993_5994 4 - 0.0118458144191656 0.0381085116310176 3769 camptothecin hsa04530 Tight junction 9076_2773_50855_6709_64398_56288_55870_9223_5728_5583_5580_5581_51776_2017_55844_10207_8777_5519_22800_9218_8573_6714_5515_5590_5520_7082_5578_1366_1364_1457_3845_4950_1459_27134 34 - 0.0202946145191121 0.0609494231209107 3770 camptothecin hsa05310 Asthma 3108 1 - 0.000917331946161061 0.00449009847331467 3771 camptothecin hsa04512 ECM-receptor interaction 960_9672_3911_7057_3909_3678_6383_3673_3161 9 - 3.44221161836631e-05 0.000214414427079897 3772 camptothecin hsa04630 Jak-STAT signaling pathway 3717_6777_595_598_5295_8503_5290_5291_9180_9655_10254_2057_3455_3459_3572_3588_2033_10401_9063_3953_1154_200734_8554_10379_6778_8027_5777_23529_868_5618_3566_6655_6654_51588_8835_1387_3601_2690 38 - 0.0118832993258012 0.0381085116310176 3773 camptothecin hsa04062 Chemokine signaling pathway 3717_6777_1147_157_156_2773_8503_5290_9475_115_6387_5332_56288_5747_2309_4067_3551_5829_5567_112_7410_1399_1398_7409_4793_408_8517_5295_2932_673_109_5894_6093_5291_107_23236_5590_5580_5613_6655_6654_5616_10451_7074_3845_5058_5970_8976 48 - 0.00574017873149413 0.0197717267418131 3774 camptothecin hsa04810 Regulation of actin cytoskeleton 8503_10298_10672_2909_5295_5155_5154_5290_9475_3678_5058_23396_5747_3673_10458_4659_5501_5829_1730_23191_8394_7410_50649_7430_1399_1398_2263_5962_8396_54434_324_1793_1131_673_22800_5894_3985_6093_5291_200576_10451_8874_1729_6655_6654_5305_6548_7074_8936_3845_8976_7409_26999_2149 54 - 0.00262280637947524 0.0101633747204666 3775 camptothecin hsa05012 Parkinson's disease 4714_2861_7326_836_842_317_51465_509_27429 9 - 6.72362935215511e-11 1.8472876025277e-09 3776 camptothecin hsa04260 Cardiac muscle contraction 776_6262_6548_488_10479_481 6 - 1.08104348202925e-06 1.67561739714534e-05 3777 camptothecin hsa04060 Cytokine-cytokine receptor interaction 5155_5154_6387_9180_90_7132_657_27242_3554_2057_3455_3459_3953_3572_3588_4982_10913_659_3601_23529_3625_4254_7042_91_655_93_92_4233_7048_5618_3566_355_7424_8795_51330_2690 36 - 7.94532302162451e-11 1.8472876025277e-09 3778 camptothecin hsa03010 Ribosome 6139_6205_51187_6137_6125_6168_6171 7 - 3.29232036523052e-08 6.12371587932877e-07 3779 camptothecin hsa04020 Calcium signaling pathway 51806_3710_5534_2776_115_7220_5332_5335_136_5336_490_6262_5567_3707_818_56848_776_1131_5533_5532_3708_5530_488_107_23236_8877_5578_5613_3709_5616_109_2149 32 - 7.6637509001528e-06 6.47935303376555e-05 3780 camptothecin hsa03050 Proteasome 5717_5706_23198_5718 4 - 0.000523600114629487 0.00286440062709072 3781 camptothecin hsa05330 Allograft rejection 5551_355_3108 3 - 0.00240565032156279 0.00972719477849302 3782 camptothecin hsa04940 Type I diabetes mellitus 5551_355_3382_3108 4 - 0.00175915126024504 0.00779052700965661 3783 camptothecin hsa02010 ABC transporters 23461_4363_5826_10057_9619_8714_23457 7 - 0.0271632487530281 0.0789431916884879 3784 camptothecin hsa04610 Complement and coagulation cascades 1604_5329_7035_2149_718 5 - 1.04955924439357e-05 7.50838536373862e-05 3785 ethisterone hsa05010 Alzheimer's disease 776_4695_841 3 + 9.51198283056801e-06 0.000423283235960276 3786 ethisterone hsa05016 Huntington's disease 8218_4899_1387_4695_841_7052_5439_246721_1211_5468_548644_10126 12 + 0.0450656741112452 0.60311926591995 3787 ethisterone hsa04740 Olfactory transduction 157_8388_8387_23538_8383_1179_818_5137_816 9 + 9.38869403884232e-10 8.35593769456966e-08 3788 ethisterone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8294_8341_8340_3123_3126_3127_3125_8370_8359_554313_121504_3119_2215_3113_941_720_721 27 + 0.0213714088086308 0.475513845992035 3789 ethisterone hsa05110 Vibrio cholerae infection 11015 1 + 0.0288776504875716 0.514022178678775 3790 ethisterone hsa05012 Parkinson's disease 27429_4695_9627_7054 4 + 0.0017458385419235 0.0517932100770638 3791 ethisterone hsa04080 Neuroactive ligand-receptor interaction 2901_1812_3953_1131_3355_3354 6 - 3.08501352278327e-05 0.00140368115286639 3792 ethisterone hsa04740 Olfactory transduction 4991 1 - 2.18734789182875e-14 1.99048658156416e-12 3793 ethisterone hsa04514 Cell adhesion molecules (CAMs) 999_3655_25945_3135 4 - 0.00947405882928943 0.287379784488446 3794 ethisterone hsa05012 Parkinson's disease 642502_6391_842_4712_2861 5 - 0.0236636685353515 0.538348459179247 3795 ethisterone hsa04260 Cardiac muscle contraction 784_776 2 - 0.0322457669116335 0.58687295779173 3796 mexiletine hsa05320 Autoimmune thyroid disease 1081_3586_3444_3107_3126_3127_3125_5551_3123_3448 10 + 0.0100540765263036 0.427298252367903 3797 mexiletine hsa05016 Huntington's disease 2902_246721_841_7052_6390_6667 6 + 0.0312978895166823 0.545827020457169 3798 mexiletine hsa04740 Olfactory transduction 810_8392_9635_816 4 + 3.387035586426e-08 2.8789802484621e-06 3799 mexiletine hsa05012 Parkinson's disease 6390_9627_5413 3 + 0.0260021540329818 0.545827020457169 3800 mexiletine hsa05330 Allograft rejection 3586_3123_3107_3126_3127_3125_5551 7 + 0.0321074717915982 0.545827020457169 3801 mexiletine hsa05016 Huntington's disease 1213 1 - 0.032509155562764 0.715201422380808 3802 mexiletine hsa04740 Olfactory transduction 157 1 - 8.06890403763305e-05 0.00266273833241891 3803 mexiletine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_720_721 28 - 5.43184089426118e-13 3.58501499021238e-11 3804 dantrolene hsa05332 Graft-versus-host disease 3811_3119_3113_3107_3126_3127_3125_3123_3802 9 + 0.000993008909336295 0.0284321800767445 3805 dantrolene hsa05320 Autoimmune thyroid disease 3119_3126_3107_3113_3127_3125_3123 7 + 0.0325743710807838 0.325743710807838 3806 dantrolene hsa04612 Antigen processing and presentation 3811_3809_972_3119_3123_3107_3126_3127_3125_3802_925_3113 12 + 0.00529558625366047 0.0847293800585675 3807 dantrolene hsa04910 Insulin signaling pathway 5584_5105 2 + 0.0499583761953745 0.444074455069996 3808 dantrolene hsa04514 Cell adhesion molecules (CAMs) 8174_3383_3119_3123_1272_3107_3126_3127_3125_23308_57863_51208_1000_26285_923_925_3113_4359 18 + 0.00106620675287792 0.0284321800767445 3809 dantrolene hsa05322 Systemic lupus erythematosus 474382_474381_3123_3126_3127_3125_8968_8358_8330_8350_8351_8352_8353_8354_8355_8356_8357_2215_3119_2214_3013_83740_3113 23 + 1.30988079410359e-05 0.00104790463528287 3810 dantrolene hsa05310 Asthma 3119_3123_3113_3127_3126_3125 6 + 0.00914357563062265 0.104498007207116 3811 dantrolene hsa05330 Allograft rejection 3119_3113_3107_3126_3127_3125_3123 7 + 0.00735396364773898 0.0980528486365197 3812 dantrolene hsa04940 Type I diabetes mellitus 3119_3126_3107_2572_3127_3125_3123_3113 8 + 0.00457198777943113 0.0847293800585675 3813 dantrolene hsa05211 Renal cell carcinoma 2271_5291_405_5058_7422_1399_7042_3725_4233 9 - 0.00297166953726288 0.0594333907452576 3814 dantrolene hsa04662 B cell receptor signaling pathway 5291_5533_4775_933_3725_29760_4793 7 - 0.0320766008764636 0.410524604064822 3815 dantrolene hsa04080 Neuroactive ligand-receptor interaction 7434_7442_1909 3 - 0.0280045071021875 0.410524604064822 3816 dantrolene hsa05200 Pathways in cancer 8312_4088_5291_8324_652671_4149_5371_1613_405_1399_2263_2260_2261_7477_324_3480_7046_6934_7042_91_3725_4233_1436_2271_2335_6502_7422_5914_10928_6256 30 - 4.43894524569651e-05 0.0017755780982786 3817 dantrolene hsa04520 Adherens junction 4088_3480_7046_6934_91_2260_4233 7 - 0.0422386603879876 0.422386603879876 3818 dantrolene hsa04740 Olfactory transduction 109 1 - 1.22103417781159e-05 0.000976827342249272 3819 dantrolene hsa04370 VEGF signaling pathway 1432_5829_56848_5291_5533_4775_7422 7 - 0.0359209028556719 0.410524604064822 3820 dantrolene hsa05210 Colorectal cancer 6934_4088_3480_7042_8312_5291_7046_324_3725_91_8324_4233 12 - 0.000212766097015791 0.00567376258708776 3821 vincamine hsa05332 Graft-versus-host disease 57292_3824_3109_3113_3107_3126_3127_3111_3125_355_3123_941 12 + 0.0143702317755846 0.183782424100194 3822 vincamine hsa05010 Alzheimer's disease 2904_6392_651820_4713_317_355_489_6622_23236 9 + 0.00434596743099819 0.15197631537854 3823 vincamine hsa04080 Neuroactive ligand-receptor interaction 1269_886_2904_5732_5032_153_5030_59340_56288_2893_135_1909_2569_2488_1813_2561_5540_799_2741_57105_2688_2151_4987_7433_9568_680_1442_2692_2918_185_148_6869_3352_3269_23566_4161_7253_11255_2570_2892_2696_2563_728_5745 44 + 0.0484516578549364 0.392017959008122 3824 vincamine hsa05320 Autoimmune thyroid disease 3446_3109_7253_3441_3107_3126_3127_3111_3125_355_3123_941_3113_3448 14 + 0.0164323360226249 0.183782424100194 3825 vincamine hsa04740 Olfactory transduction 26211_7932_26333_5616_1179_26476_816_5137_8590_3000 10 + 2.43266916480272e-10 2.16507555667442e-08 3826 vincamine hsa04514 Cell adhesion molecules (CAMs) 5010_8506_3695_23308_57863_6383_3384_3383_3123_3107_3126_3127_3125_10666_914_1272_1462_965_4099_4359_3109_6403_6404_3113_3111_941_5797_6693_923_5817 30 + 0.00512279714759123 0.15197631537854 3827 vincamine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_2904_8368_9103_8294_81_3109_3123_8366_3126_3127_3125_8370_717_8359_554313_121504_8354_2215_3113_3111_941 28 + 0.0353282607835159 0.314421520973292 3828 vincamine hsa04110 Cell cycle 1029_5001_1387_1021_993 5 + 0.00884809154594558 0.183782424100194 3829 vincamine hsa05012 Parkinson's disease 7318_4713_6392_651820_317_6622_291 7 + 0.0150355008092584 0.183782424100194 3830 vincamine hsa05330 Allograft rejection 3592_3109_3126_3107_3113_3127_3111_3125_355_3123_941 11 + 0.01858473951575 0.183782424100194 3831 vincamine hsa04940 Type I diabetes mellitus 3592_3382_3109_3113_3107_3126_3127_3111_3125_355_3123_941 12 + 0.0180868945619152 0.183782424100194 3832 vincamine hsa05131 Shigellosis 7100_7278_7430_113457_998 5 - 0.0308651532974298 0.532423894380664 3833 vincamine hsa05130 Pathogenic Escherichia coli infection 7100_7278_7430_113457_998 5 - 0.0308651532974298 0.532423894380664 3834 vincamine hsa04010 MAPK signaling pathway 1326_3551_9344_998_5881_5154_2002_5607_23162_5536_10454_3553_2260_9693_4149 15 - 0.0291060045582524 0.532423894380664 3835 vincamine hsa04540 Gap junction 7278_113457_5154_5331_5607_6714_23236 7 - 0.0253484117461748 0.532423894380664 3836 thioguanosine hsa04740 Olfactory transduction 26211 1 + 0.000560974963402418 0.0171097363837737 3837 thioguanosine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8349_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 26 + 4.57381129713023e-13 2.79002489124944e-11 3838 thioguanosine hsa04115 p53 signaling pathway 1647_1026_5366_4193_8795 5 + 0.0484586849974959 0.985326594949083 3839 thioguanosine hsa04640 Hematopoietic cell lineage 3655_3554 2 - 0.000489360522763937 0.00550530588109429 3840 thioguanosine hsa05010 Alzheimer's disease 841_840_5664_317_2776_4137_808_22926_489_488_102_801_805_23621 14 - 0.00773345331570176 0.0696010798413158 3841 thioguanosine hsa04080 Neuroactive ligand-receptor interaction 5029_152_7068_5025_4886_5031_56288_136 8 - 5.69184980741641e-09 2.56133241333738e-07 3842 thioguanosine hsa05320 Autoimmune thyroid disease 3135_3107 2 - 0.0283342922322976 0.196160484685137 3843 thioguanosine hsa05016 Huntington's disease 1213_246721_841_317_2776_23186_3064_6874_161_6908 10 - 9.94730792186571e-05 0.00127893958995416 3844 thioguanosine hsa04740 Olfactory transduction 157_5613_5616_818_808_805_801_409 8 - 2.69021148647826e-16 2.42119033783043e-14 3845 thioguanosine hsa04514 Cell adhesion molecules (CAMs) 2734_965_4685_3107_9080_3135_1364_23705_3655_50848 10 - 0.0144475520202704 0.108356640152028 3846 thioguanosine hsa04110 Cell cycle 51343_595_891_983_701_51433_23595_651610_4616_699_8881_5934_1031_890_994_5001_996_2810_9134_898_8454_7040_8555_9700_8697_5591_5347_4173_6502_472_8317_5933 32 - 0.011698880788246 0.0957181155401945 3847 thioguanosine hsa04630 Jak-STAT signaling pathway 10401_3717_6777_595_3588_6655_6654_9063_867_5291_5290_8554_10379_10254 14 - 0.041700929735821 0.234567729763993 3848 thioguanosine hsa05012 Parkinson's disease 7327_317 2 - 5.96691923295031e-07 1.34255682741382e-05 3849 thioguanosine hsa04260 Cardiac muscle contraction 488 1 - 9.1900452341398e-05 0.00127893958995416 3850 thioguanosine hsa04060 Cytokine-cytokine receptor interaction 3554_3588_23765_3625_5154_6358_6359_7852_6387_655_7040_4233 12 - 4.46633025877419e-07 1.33989907763226e-05 3851 thioguanosine hsa03010 Ribosome 6125_6171 2 - 7.16165358979583e-05 0.00127893958995416 3852 thioguanosine hsa04020 Calcium signaling pathway 115_5256_8877_5578_5613_5616_2776_818_808_5335_136_489_488_5025_801_107_805_493 18 - 0.0491770544183572 0.260349111626597 3853 thioguanosine hsa03050 Proteasome 23198_5709 2 - 0.0398514856558441 0.234567729763993 3854 thioguanosine hsa04730 Long-term depression 5519_5605_2776_5578 4 - 0.0407872961102172 0.234567729763993 3855 thioguanosine hsa04610 Complement and coagulation cascades 5104 1 - 0.000695914638362391 0.00695914638362391 3856 procainamide hsa05332 Graft-versus-host disease 3553_3126_3113_3127_3125_3123 6 + 0.0310588949787608 0.146159505782404 3857 procainamide hsa04640 Hematopoietic cell lineage 2323_3553_948_3575_3123_2993_3126_3127_3125_933 10 + 0.0293210451186829 0.146159505782404 3858 procainamide hsa05131 Shigellosis 347688_7454_7278_113457_7099_56604_3059_6093 8 + 0.0137502530524588 0.127654519582156 3859 procainamide hsa04670 Leukocyte transendothelial migration 23533_4301_3689_3383_5829_7410_4688_5293_7852_93408_88_27035_5603_6093 14 + 0.00875716387460685 0.127654519582156 3860 procainamide hsa05016 Huntington's disease 3708_10540_9001 3 + 0.0270925251999095 0.144493467732851 3861 procainamide hsa05130 Pathogenic Escherichia coli infection 347688_7454_7278_113457_7099_56604_3059_6093 8 + 0.0137502530524588 0.127654519582156 3862 procainamide hsa04740 Olfactory transduction 5592_5616_8392_4991_5137_816 6 + 0.000509573873324765 0.0203829549329906 3863 procainamide hsa04510 Focal adhesion 23533_88_2318_2324_5829_6655_596_331_7057_3371_56924_93408_7410_1956_1950_1277_5293_3725_6093_1291 20 + 0.0123384138284133 0.127654519582156 3864 procainamide hsa05322 Systemic lupus erythematosus 2212_958_9103_3123_3126_3127_3113_3125_8358_88_8968_3013_8350_8351_8352_8353_8354_8355_8356_8357 20 + 0.000187482875121027 0.0149986300096822 3865 procainamide hsa05212 Pancreatic cancer 23533_596_83439_6655_4193_3630_5293_1956_1950_367_2260 11 + 0.0167590472311926 0.127654519582156 3866 procainamide hsa05215 Prostate cancer 23533_596_83439_6655_4193_3630_5293_1956_1950_367_2260 11 + 0.0163094839477211 0.127654519582156 3867 procainamide hsa05218 Melanoma 23533_4193_5293_8822_8823_1956_2249_2260_1950 9 + 0.0177434129160491 0.127654519582156 3868 procainamide hsa05310 Asthma 958_3578_3123_3126_3127_3125_3113 7 + 0.00205861918649225 0.041172383729845 3869 procainamide hsa04810 Regulation of actin cytoskeleton 23533_7454_8823_5829_6655_9138_93408_3689_3630_56924_8822_1133_7410_1956_1950_88_5293_6093_2260_2249 20 + 0.0227468977982347 0.12998227313277 3870 procainamide hsa04540 Gap junction 347688_5592_3710_6655_5616_113457_3708_1956_56604_1950_7278 11 + 0.0191481779373234 0.127654519582156 3871 procainamide hsa05330 Allograft rejection 958_3113_3126_3127_3125_3123 6 + 0.021089180355771 0.129779571420129 3872 procainamide hsa04940 Type I diabetes mellitus 3382_3126_2572_3127_3630_3125_3123_3553_3113 9 + 0.00110832614645279 0.0295553639054077 3873 procainamide hsa04080 Neuroactive ligand-receptor interaction 146_3354_4157 3 - 5.9162844284513e-06 0.000254400230423406 3874 procainamide hsa04740 Olfactory transduction 810_5613_109_157 4 - 5.26136269283312e-09 4.52477191583648e-07 3875 procainamide hsa04210 Apoptosis 472_8503_3554_842_596_5296_5613_5575_331_5290_23052_5533_355_5576_8837_651610 16 - 0.00734163880023056 0.210460312273276 3876 procainamide hsa04010 MAPK signaling pathway 9261_9344_5154_5607_5603_5494_8399_1844_4616_3554_4149_6789_9448_51347_8491_2264_408_4214_57551_9064_5062_2005_5533_3727_5613_6655_1846_4137_355_23162_27092_1386_4763 33 - 0.0349166304040562 0.500471702458139 3877 procainamide hsa05012 Parkinson's disease 51465_1339_842_7054 4 - 0.0340986791536527 0.500471702458139 3878 procainamide hsa03010 Ribosome 6234_6141 2 - 0.0236224082921838 0.500471702458139 3879 procainamide hsa04020 Calcium signaling pathway 146_5533_5613_115_109_810_490 7 - 0.0498921445904023 0.556208096268107 3880 ethionamide hsa04740 Olfactory transduction 5566_1179 2 + 0.00973812372536636 0.592163994106454 3881 ethionamide hsa05221 Acute myeloid leukemia 861_5914_862_5371_5467 5 + 0.0185051248158267 0.592163994106454 3882 ethionamide hsa04010 MAPK signaling pathway 3164_5534_998_4763_5536 5 - 0.021646912699916 0.619577442679178 3883 nafcillin hsa04070 Phosphatidylinositol signaling system 8394_3633_5333_8821_4952_27124_3705 7 - 0.0186409356117104 0.340197074913715 3884 nafcillin hsa04740 Olfactory transduction 219464_157 2 - 0.000381890712786446 0.0139390110167053 3885 nafcillin hsa05322 Systemic lupus erythematosus 8358_85235_8968_3119_3013_8351_8330_8332_8969_8331_8329_720_721_8350_8336_8352_8353_8354_8355_8356_8357 21 - 9.00822287219392e-08 6.57600269670156e-06 3886 nafcillin hsa04210 Apoptosis 651610_581_598_5575_472_8837_1677_7186 8 - 0.0139343822897638 0.339069969050919 3887 liothyronine hsa04540 Gap junction 347688_5598_56604_23236 4 + 0.0188210863342491 0.502566216037111 3888 liothyronine hsa04080 Neuroactive ligand-receptor interaction 1131 1 - 0.00261134975992408 0.0900915667173808 3889 liothyronine hsa04740 Olfactory transduction 818_157 2 - 0.00018365400327406 0.0126721262259101 3890 liothyronine hsa04060 Cytokine-cytokine receptor interaction 1435_5155_9180 3 - 0.038337077919225 0.881752792142175 3891 napelline hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 + 0.0317832766173061 0.387755974731134 3892 napelline hsa04640 Hematopoietic cell lineage 1435_3815_3575_3123_3126_3127_3125_3690_2209 9 + 0.000900615634658503 0.0549375537141687 3893 napelline hsa05310 Asthma 3123_3126_3127_3125 4 + 0.0115121783786528 0.23408096036594 3894 napelline hsa05330 Allograft rejection 3123_3126_3127_3125 4 + 0.0236287002903575 0.360337679427952 3895 napelline hsa04940 Type I diabetes mellitus 3123_2571_3126_3127_3125 5 + 0.00884849337964686 0.23408096036594 3896 napelline hsa05010 Alzheimer's disease 6868 1 - 0.0106717328857972 0.421533448988989 3897 napelline hsa04080 Neuroactive ligand-receptor interaction 2692_2149 2 - 0.0048930280774295 0.38654921811693 3898 napelline hsa05310 Asthma 3123_3126_3127_3125 4 - 0.0429996127231619 0.679393881025958 3899 napelline hsa04062 Chemokine signaling pathway 2786_1399 2 - 0.0372882559803965 0.679393881025958 3900 napelline hsa04020 Calcium signaling pathway 2778_2149 2 - 0.0357361635094348 0.679393881025958 3901 cefotiam hsa05200 Pathways in cancer 23533_405_7849_330_324 5 + 0.0472689519401 0.719555034909214 3902 cefotiam hsa04740 Olfactory transduction 9635 1 + 2.59097952592214e-05 0.00106230160562808 3903 cefotiam hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3109_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2212_3013_3113 28 + 6.99467795024053e-12 5.73563591919723e-10 3904 cefotiam hsa04610 Complement and coagulation cascades 623_5265_624_5327_2161_5328 6 + 0.0462423514144286 0.719555034909214 3905 cefotiam hsa05219 Bladder cancer 4318_1869_1613 3 - 0.0121582562751758 0.285719022466631 3906 cefotiam hsa03020 RNA polymerase 246721_5439_548644 3 - 0.00469701594463385 0.220759749397791 3907 nitrofural hsa05010 Alzheimer's disease 517_4713 2 + 0.0131983061617145 0.990030596160587 3908 nitrofural hsa05016 Huntington's disease 7416_517_4713 3 + 0.0267714137010555 0.990030596160587 3909 nitrofural hsa05212 Pancreatic cancer 8503_5154_6934_596 4 - 0.014413654637358 0.208140605912926 3910 nitrofural hsa05215 Prostate cancer 8503_5154_6934_596 4 - 0.0138990213565885 0.208140605912926 3911 nitrofural hsa04010 MAPK signaling pathway 784_9261_2768_5154_2002_355_5606_91_408 9 - 0.00214677842851631 0.124513148853946 3912 nitrofural hsa05213 Endometrial cancer 2002_8503_6934 3 - 0.0179431556821488 0.208140605912926 3913 nitrofural hsa05210 Colorectal cancer 91_8503_6934_596 4 - 0.011958159748395 0.208140605912926 3914 biperiden hsa05010 Alzheimer's disease 4695_3710_2904_6392_651820_4137_5532_3709_489 9 + 0.0136561720858039 0.251273566378792 3915 biperiden hsa05016 Huntington's disease 5430_4695_2904_7052_5439_651820_246721_6392_7416_55567_548644 11 + 0.0319248062746114 0.419583168180607 3916 biperiden hsa04740 Olfactory transduction 7932_56656_26333_5566_1179_81797_9635 7 + 4.03436953266876e-11 3.71161997005526e-09 3917 biperiden hsa04062 Chemokine signaling pathway 5579_5829_5566_3576_7852_7074_5880_112_6363 9 + 0.00450608896040348 0.13818672811904 3918 biperiden hsa05012 Parkinson's disease 6392_7416_4695_651820_51465 5 + 0.00692368970891621 0.159244863305073 3919 biperiden hsa04620 Toll-like receptor signaling pathway 7097_3576_1326_2353 4 + 0.0232979170778222 0.357234728526607 3920 biperiden hsa03010 Ribosome 6129_9045 2 + 0.00270858150248774 0.124594749114436 3921 biperiden hsa04070 Phosphatidylinositol signaling system 8394_3628_3633_23236 4 - 0.0251154674033064 0.571064499245981 3922 biperiden hsa05131 Shigellosis 7278_7430_113457 3 - 0.0486534736239775 0.571064499245981 3923 biperiden hsa05130 Pathogenic Escherichia coli infection 7278_7430_113457 3 - 0.0486534736239775 0.571064499245981 3924 iohexol hsa05010 Alzheimer's disease 810_775_489 3 + 0.00251870269622765 0.0713632430597834 3925 iohexol hsa05016 Huntington's disease 7802_9001 2 + 0.000363910113584696 0.0154661798273496 3926 iohexol hsa04740 Olfactory transduction 8388_8387_5566_8390_26539_816_810_5137 8 + 1.56798779322207e-05 0.00133278962423876 3927 iohexol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3111_8359_88_8294_8367_554313_6738_121504_3108 18 + 0.0392761604059692 0.667694726901476 3928 iohexol hsa05012 Parkinson's disease 2861_9627 2 + 0.00601672337194239 0.127855371653776 3929 iohexol hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_8336 7 - 0.0145328924954532 0.732507302334983 3930 iohexol hsa04370 VEGF signaling pathway 8503_4775_5600_6300 4 - 0.0489787802383406 0.732507302334983 3931 glycocholic acid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_6737_8359_8294_8367_554313_121504 15 + 5.7279877479735e-11 2.06207558927046e-09 3932 glycocholic acid hsa04370 VEGF signaling pathway 6714_8681_100137049 3 + 0.0481040298570947 0.577248358285136 3933 glycocholic acid hsa03020 RNA polymerase 246721_5439_548644 3 + 0.00411823661471148 0.0741282590648066 3934 glycocholic acid hsa05016 Huntington's disease 246721_5439_548644_23236_581 5 - 0.0233189474775376 0.559654739460902 3935 glycocholic acid hsa03022 Basal transcription factors 51616_728198 2 - 0.0425385693516587 0.566123349784133 3936 glycocholic acid hsa04540 Gap junction 10746_5155_23236 3 - 0.0471769458153444 0.566123349784133 3937 glycocholic acid hsa03020 RNA polymerase 246721_5439_548644 3 - 0.00240249077732702 0.115319557311697 3938 hycanthone hsa05016 Huntington's disease 5430_7802_581_6390_64446_27113 6 + 0.0100001486462789 0.293337693624181 3939 hycanthone hsa04740 Olfactory transduction 26212_7932_5613_5616_390892_9635_8590 7 + 1.08689785506344e-07 9.56470112455827e-06 3940 hycanthone hsa04210 Apoptosis 8503_4803_843_581_5613_5616_11213_355_9941_8743_5534_8837_8794_8795 14 + 0.0419359491237895 0.527194788984782 3941 hycanthone hsa04340 Hedgehog signaling pathway 8945_5613_5616_5727_3549_656_7479_655_353500_7471_7475 11 + 0.0208177926640852 0.3663931508879 3942 hycanthone hsa04115 p53 signaling pathway 55367_1647_27113_5366_581_64393_4193_3486_8493_898_355_1026_10912_8795_5268_3732_9540_4616 18 + 0.000131450372765801 0.00578381640169524 3943 hycanthone hsa05012 Parkinson's disease 6390_6571_6622_7318 4 + 0.0256105032126112 0.375620713784964 3944 hycanthone hsa04020 Calcium signaling pathway 154_624_5333_135_51196_3360_3363_814_2911_776_773_2767_148_6915_108_3709_5733_5534_3358_8877_5578_5613_5616_8913_107_8911 26 + 0.0200963769029547 0.3663931508879 3945 hycanthone hsa04080 Neuroactive ligand-receptor interaction 3354_5618 2 - 5.79524753729768e-06 0.000463619802983814 3946 hycanthone hsa04350 TGF-beta signaling pathway 4088_4089_3624_4609_6667_7057_1874_1875_652_653_7043_7042 12 - 0.0388799788097411 0.622079660955858 3947 hycanthone hsa04062 Chemokine signaling pathway 10451_6777_5295_7410_5291 5 - 0.0138228670765069 0.552914683060276 3948 hycanthone hsa05012 Parkinson's disease 836_842_517 3 - 0.0365636867310889 0.622079660955858 3949 hycanthone hsa05210 Colorectal cancer 836_7043_4088_4089_5295_5291_1956_6934_4609_7042_4233_842 12 - 0.034869256217985 0.622079660955858 3950 ciclopirox hsa05332 Graft-versus-host disease 3553_3119_3105_3107_3126_3127_3125_355_3123 9 + 0.0026739630138082 0.0727770495964093 3951 ciclopirox hsa05211 Renal cell carcinoma 23533_112399_6513_5155_405_5228_7422_1399_7042_3725_54583 11 + 0.00925827702053173 0.128072832117356 3952 ciclopirox hsa05200 Pathways in cancer 23533_9134_4088_5155_330_1488_5888_3551_27006_6513_405_8823_5900_1399_4842_23604_9063_112399_581_4193_4254_1956_7042_3725_54583_1026_861_6502_355_7422_2353_5228_6256 33 + 0.0127445835886142 0.151114348264997 3953 ciclopirox hsa05320 Autoimmune thyroid disease 3119_3105_3107_3126_3127_3125_355_3123 8 + 0.0260852149368679 0.240563648862226 3954 ciclopirox hsa04740 Olfactory transduction 810_23538_157 3 + 2.35324309289451e-07 1.95319176710244e-05 3955 ciclopirox hsa04210 Apoptosis 23533_3553_3551_581_5575_317_330_355_8717_8837_8794_8795 12 + 0.0176167027314862 0.182773290839169 3956 ciclopirox hsa04115 p53 signaling pathway 55367_1647_27113_5366_9134_581_317_4193_3486_355_1026_5054_8795_9540_4616 15 + 0.000102059805170717 0.00423548191458476 3957 ciclopirox hsa05330 Allograft rejection 3119_3105_3107_3126_3127_3125_355_3123 8 + 0.00499270270647776 0.0828788649275308 3958 ciclopirox hsa04940 Type I diabetes mellitus 3553_3119_3105_3107_3126_3127_3125_355_3123 9 + 0.00350732769139322 0.0727770495964093 3959 ciclopirox hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3014 31 - 2.39746871709944e-23 1.17475967137873e-21 3960 ciclopirox hsa04110 Cell cycle 995_891_5347_991_699_701_996_9700_51343 9 - 0.000312094267778001 0.00764630956056103 3961 hexetidine hsa05332 Graft-versus-host disease 3553_3105_3106_3113_3135_356_649853 7 + 0.0105615709593913 0.208591026447978 3962 hexetidine hsa05320 Autoimmune thyroid disease 1081_3105_3106_3113_3135_356_649853 7 + 0.0297130189158643 0.335332642050469 3963 hexetidine hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8360_8368_8348_8294_121504_87_8366_8968_8370_8362_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_83740_3013_3113_8970 32 + 1.59579229991702e-10 1.26067591693445e-08 3964 hexetidine hsa04062 Chemokine signaling pathway 5331_208_10803 3 + 0.019382078676028 0.284359408883255 3965 hexetidine hsa04010 MAPK signaling pathway 8074_4763_3310_3164_5609_11221_3553_775_8398_208_1956_7042_3725_3727_785_1647_1848_1843_1649_1846_356_23162_2353_5971_9693 25 + 0.0102455520612486 0.208591026447978 3966 hexetidine hsa05012 Parkinson's disease 6392_651820 2 + 0.0489081747141402 0.482968225302134 3967 hexetidine hsa05330 Allograft rejection 3105_3106_3113_3135_356_649853 6 + 0.0215969171303738 0.284359408883255 3968 hexetidine hsa04940 Type I diabetes mellitus 3382_3105_3106_3113_3135_356_3553_649853 8 + 0.00406217091463316 0.16045575112801 3969 hexetidine hsa04740 Olfactory transduction 5566 1 - 0.00740148004105896 0.362672522011889 3970 hexetidine hsa04270 Vascular smooth muscle contraction 5581_4882_3709_4637_5566_23236 6 - 0.0309471186581671 0.758204407125094 3971 ritodrine hsa05332 Graft-versus-host disease 3553_3123_3126_3127_3125_3558 6 + 0.0157380286687947 0.369554044686624 3972 ritodrine hsa05200 Pathways in cancer 2735_652346_5880_7855_1630_4149_5371_8822_51384_7471_4842_4318_3918_1956_5467_7042_2950_3688_5579_5578_5599_4914_862_5915 24 + 0.0312641314917209 0.369554044686624 3973 ritodrine hsa04514 Cell adhesion molecules (CAMs) 9378_3689_3688_965_3123_3126_3127_3125_5797_23308_923_1002 12 + 0.0347232300330472 0.369554044686624 3974 ritodrine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_718_3123_8366_3126_3127_3125_8359_89_8294_8367_554313_8368_121504 20 + 2.16595828320453e-05 0.00181940495789181 3975 ritodrine hsa05310 Asthma 3123_3125_3126_3127_2207 5 + 0.0156409612150278 0.369554044686624 3976 ritodrine hsa05012 Parkinson's disease 4698 1 + 0.0316621542107996 0.369554044686624 3977 ritodrine hsa05330 Allograft rejection 3123_3558_3126_3127_3125 5 + 0.035195623303488 0.369554044686624 3978 ritodrine hsa04940 Type I diabetes mellitus 3553_3123_3126_3127_3558_3125 6 + 0.0189837035139892 0.369554044686624 3979 ritodrine hsa05010 Alzheimer's disease 6622_4137 2 - 0.00154839352682569 0.0321291656816331 3980 ritodrine hsa04080 Neuroactive ligand-receptor interaction 2908_1081 2 - 1.25475175740538e-05 0.00104144395864647 3981 ritodrine hsa04612 Antigen processing and presentation 3119 1 - 0.045321872081162 0.417968375859605 3982 ritodrine hsa05016 Huntington's disease 7419_5978_3064_6667_10126 5 - 0.034448561689115 0.417968375859605 3983 ritodrine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8347_8346_8344_55766_8370_8359_554313_121504_8339_3119_8970 22 - 0.000957405430985653 0.0303102794487631 3984 ritodrine hsa05221 Acute myeloid leukemia 1050_8503_861_6655_6777_5292_5291_6932_5914 9 - 0.037979992116548 0.417968375859605 3985 ritodrine hsa05012 Parkinson's disease 7419_6622 2 - 0.0123800414503969 0.205508688076589 3986 ritodrine hsa04060 Cytokine-cytokine receptor interaction 9180_2057_3455_5155_5154_3572_7043_91_8792 9 - 0.0416999589180895 0.417968375859605 3987 ritodrine hsa04020 Calcium signaling pathway 7419_5257 2 - 0.0010955522692324 0.0303102794487631 3988 guanfacine hsa05322 Systemic lupus erythematosus 85235_3113_8330_8332_8969_8331_8329_8336 8 + 0.031937316019146 1 3989 guanfacine hsa05221 Acute myeloid leukemia 5914_5371_652671_5467_11040 5 + 0.0193726121294375 1 3990 guanfacine hsa04650 Natural killer cell mediated cytotoxicity 10725_6655_5781 3 - 0.0486375449254527 0.459354590962609 3991 guanfacine hsa05010 Alzheimer's disease 4698_3709_517_23236 4 - 0.0260831586373033 0.369511414028463 3992 guanfacine hsa04080 Neuroactive ligand-receptor interaction 9568_2908_7433 3 - 0.000163091902269265 0.00462093723096251 3993 guanfacine hsa04612 Antigen processing and presentation 6891 1 - 0.0437774088596001 0.459354590962609 3994 guanfacine hsa04740 Olfactory transduction 818_5566_4991 3 - 1.63528636980909e-07 6.94996707168863e-06 3995 guanfacine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 30 - 1.41457633677996e-07 6.94996707168863e-06 3996 guanfacine hsa04530 Tight junction 6714_5583_5581 3 - 0.0485650639084856 0.459354590962609 3997 guanfacine hsa05012 Parkinson's disease 4698_517 2 - 0.0176152560086299 0.299459352146708 3998 guanfacine hsa04060 Cytokine-cytokine receptor interaction 23529_7422_4233_3570_3572 5 - 0.00161695026512593 0.034360193133926 3999 resveratrol hsa04740 Olfactory transduction 219464 1 + 1.00380201344982e-10 8.43193691297849e-09 4000 resveratrol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8349_8294_121504_8341_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 27 + 2.72294905139077e-05 0.00114363860158412 4001 resveratrol hsa04115 p53 signaling pathway 55367_1647_27113_5366_842_1643_4193_355_1026_8795_9540_4616 12 + 0.0105031056954017 0.290378916698613 4002 resveratrol hsa04512 ECM-receptor interaction 960 1 + 0.0444080915295653 0.532897098354784 4003 resveratrol hsa04062 Chemokine signaling pathway 2309_6774_7410_3576_10000 5 + 0.0138275674618387 0.290378916698613 4004 resveratrol hsa05012 Parkinson's disease 6622_842_4712 3 + 0.0364737354209542 0.532897098354784 4005 resveratrol hsa04260 Cardiac muscle contraction 4635 1 + 0.0438347373224112 0.532897098354784 4006 resveratrol hsa05332 Graft-versus-host disease 3135 1 - 0.0370778052097614 0.22741053861987 4007 resveratrol hsa04640 Hematopoietic cell lineage 960_4254 2 - 0.00109521662427089 0.0201519858865844 4008 resveratrol hsa05010 Alzheimer's disease 1327_5534_5664_317_2776_808_3708_5530_489_488_102_801_805 13 - 0.0113532775222296 0.0919478720226383 4009 resveratrol hsa04080 Neuroactive ligand-receptor interaction 5029_5618_7068_7067_2908_5026_5031 7 - 1.02145074102384e-08 4.69867340870966e-07 4010 resveratrol hsa04742 Taste transduction 5613_5616 2 - 0.0415567696248354 0.238951425342804 4011 resveratrol hsa05320 Autoimmune thyroid disease 3135 1 - 0.011993200698605 0.0919478720226383 4012 resveratrol hsa04740 Olfactory transduction 5613_5616_808_109_801_805 6 - 2.85713543518152e-16 2.628564600367e-14 4013 resveratrol hsa04514 Cell adhesion molecules (CAMs) 965_3688_9019_3135_6693_9080_25945_3897 8 - 0.00753216861140241 0.0692959512249022 4014 resveratrol hsa05322 Systemic lupus erythematosus 55506_8361_8363_8362_8365_8364_8367_8360_8368_8294_121504_8343_8347_87_6632_8344_8339_8366_3021_3020_8968_8346_55766_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3014 37 - 0.00318740867473572 0.0418916568679552 4015 resveratrol hsa04110 Cell cycle 9133_983_8555_701_9184_4616_699_8881_1111_5925_890_545_1031_995_891_996_991_993_4193_8317_8556_7042_9700_8697_5347_4173_472_5934_10926_1387_7465 31 - 0.00612364714667597 0.0681100804935335 4016 resveratrol hsa04330 Notch signaling pathway 2648_3714_3280_1387_8850_1855_1856_3516_8650_5664_22938_1488_4853_9541 14 - 0.030856204381374 0.202769343077601 4017 resveratrol hsa04630 Jak-STAT signaling pathway 5618_6655_5295_3572_5291_5781_8554_9655_8835_1387 10 - 0.0066629426569761 0.0681100804935335 4018 resveratrol hsa05012 Parkinson's disease 2861_7326_317_1327_5481 5 - 0.000304185142488443 0.00699625827723419 4019 resveratrol hsa04060 Cytokine-cytokine receptor interaction 5618_2324_55540_3576_5154_3572_1956_7042_655_4254_27242_8795_659 13 - 1.30629251662291e-05 0.000400596371764359 4020 resveratrol hsa03010 Ribosome 6125_6160_6129_6234 4 - 0.0030068545948766 0.0418916568679552 4021 resveratrol hsa04610 Complement and coagulation cascades 5627_2161_7035 3 - 0.0308083714071066 0.202769343077601 4022 butein hsa04740 Olfactory transduction 7932_26664_26532_4992_5137_409 6 + 0.00585708937628562 0.340353502422655 4023 butein hsa04810 Regulation of actin cytoskeleton 93408_5155 2 + 0.00919874330872042 0.340353502422655 4024 butein hsa05012 Parkinson's disease 4695 1 + 0.0461709073268393 1 4025 butein hsa04080 Neuroactive ligand-receptor interaction 7067_10203 2 - 0.00931242552036944 0.605314825627153 4026 butein hsa05016 Huntington's disease 90993 1 - 0.0155208929647988 0.605314825627153 4027 butein hsa04020 Calcium signaling pathway 107 1 - 0.0233963143648621 0.608304173486415 4028 ketoconazole hsa05332 Graft-versus-host disease 3824_3553_3105_3106_3126_3127_940_3125_3135_3123_3113_649853 12 + 7.41260991391157e-05 0.00326154836212109 4029 ketoconazole hsa04120 Ubiquitin mediated proteolysis 11060_9820_4193 3 + 0.0491932946206311 0.360750827217961 4030 ketoconazole hsa04640 Hematopoietic cell lineage 3581_1435_3553_2057_3123_2993_3126_3127_3125_3570_3673_921_931_917 14 + 0.00478944837382946 0.0702452428161654 4031 ketoconazole hsa05320 Autoimmune thyroid disease 3448_3105_3106_3126_3127_940_3125_3135_3123_3113_649853 11 + 0.0014878227356844 0.0261856801480454 4032 ketoconazole hsa04612 Antigen processing and presentation 4261_3824_3448_3123_3106_3126_3127_3125_3135_3105_3113_649853 12 + 0.0208822769638353 0.20418226364639 4033 ketoconazole hsa05016 Huntington's disease 64446_6390_90993_3708_4698 5 + 0.0458199470712217 0.360750827217961 4034 ketoconazole hsa04740 Olfactory transduction 8392_135948_9635_442194 4 + 6.97503174144954e-07 6.1380279324756e-05 4035 ketoconazole hsa04514 Cell adhesion molecules (CAMs) 9076_24146_3688_3106_3123_29851_3126_3127_3696_3125_3135_4359_3105_940_3113_649853 16 + 0.0244016845776372 0.214734824283207 4036 ketoconazole hsa05310 Asthma 6356_3123_3126_3127_3125_3113 6 + 0.0201112224951047 0.20418226364639 4037 ketoconazole hsa05012 Parkinson's disease 4698_6390 2 + 0.017831108811382 0.20418226364639 4038 ketoconazole hsa05330 Allograft rejection 3105_3106_3126_3127_940_3125_3135_3123_3113_649853 10 + 0.000510378343434986 0.0112283235555697 4039 ketoconazole hsa04940 Type I diabetes mellitus 3553_3105_3106_3126_3127_940_3125_3135_3123_3113_649853 11 + 0.000393596942506251 0.0112283235555697 4040 ketoconazole hsa04080 Neuroactive ligand-receptor interaction 3354_2908_136_1081_1812 5 - 0.00060089513022755 0.017826555530084 4041 ketoconazole hsa04740 Olfactory transduction 810_157 2 - 1.16479485480459e-09 1.03666742077609e-07 4042 ketoconazole hsa04210 Apoptosis 8503_3552_581_5296_5295_23052_472_5534_8737_8837_651610_842 12 - 0.0429359349053793 0.437466297515854 4043 ketoconazole hsa05221 Acute myeloid leukemia 1050_8503_5296_6655_5295_5371_6932_6934_652671 9 - 0.0443455517573456 0.437466297515854 4044 ketoconazole hsa04330 Notch signaling pathway 2648_3714_4854_1856_182_6868_22938_1488 8 - 0.0278512329398701 0.413126621941406 4045 ketoconazole hsa05012 Parkinson's disease 2861_1339_842 3 - 0.0254973261147637 0.413126621941406 4046 ketoconazole hsa04060 Cytokine-cytokine receptor interaction 4254_3455_4233_3552_3572 5 - 0.000433018421238777 0.017826555530084 4047 ketoconazole hsa03010 Ribosome 6125_6234 2 - 0.0473694092357845 0.437466297515854 4048 ketoconazole hsa05210 Colorectal cancer 8503_842_581_5296_3480_6655_5295_5602_1856_6932_6934_3725_8324_4233 14 - 0.00630785230330391 0.140349713748512 4049 mimosine hsa04740 Olfactory transduction 5566 1 + 0.00115957261243775 0.0452233318850723 4050 mimosine hsa05322 Systemic lupus erythematosus 8361_2212_8363_8362_8365_8364_8370_8360_8368_8366_8359_8294_8367_554313_121504_3108_9555 17 + 3.932078269003e-07 3.06702104982234e-05 4051 mimosine hsa05332 Graft-versus-host disease 3135_3105_3106_649853 4 - 0.00318624100038684 0.078168131041107 4052 mimosine hsa04650 Natural killer cell mediated cytotoxicity 8503_3105_3106_3135_5881_7409 6 - 0.0124655872539925 0.130888666166921 4053 mimosine hsa05320 Autoimmune thyroid disease 3135_3105_3106_649853 4 - 0.00689325190586788 0.104543927669549 4054 mimosine hsa04612 Antigen processing and presentation 3135_4800_3106_3105_649853 5 - 0.00829713711663085 0.104543927669549 4055 mimosine hsa04514 Cell adhesion molecules (CAMs) 3135_3105_3106_4756_649853 5 - 0.0380176472999414 0.299388972487038 4056 mimosine hsa04664 Fc epsilon RI signaling pathway 8503_7409_5600_5881 4 - 0.0246427333937663 0.221784600543897 4057 mimosine hsa05330 Allograft rejection 3135_3105_3106_649853 4 - 0.00227687423481183 0.078168131041107 4058 mimosine hsa04940 Type I diabetes mellitus 3135_3105_3106_649853 4 - 0.00372229195433843 0.078168131041107 4059 buspirone hsa04662 B cell receptor signaling pathway 10725_7409_27071_3551_5336 5 - 0.0191282714845942 0.264660221107648 4060 buspirone hsa04660 T cell receptor signaling pathway 5163_3551_10725_7409_5600_6300 6 - 0.024811895728842 0.264660221107648 4061 buspirone hsa04670 Leukocyte transendothelial migration 5829_9475_7409_5600_5336_6300 6 - 0.0376220844289014 0.343973343349956 4062 buspirone hsa05120 Epithelial cell signaling in Helicobacter pylori infection 102_6300_5600_3551_5336 5 - 0.0156291963603083 0.264660221107648 4063 buspirone hsa04664 Fc epsilon RI signaling pathway 6300_5163_7409_5600_5336 5 - 0.0231071848833635 0.264660221107648 4064 buspirone hsa04370 VEGF signaling pathway 5829_6300_10725_5600_5336 5 - 0.0210563822148342 0.264660221107648 4065 buspirone hsa03020 RNA polymerase 5432_246721_5439_548644 4 - 0.00356613842832798 0.228232859412991 4066 dextromethorphan hsa04120 Ubiquitin mediated proteolysis 23759_5371 2 + 0.0357935785513216 0.587014688241674 4067 dextromethorphan hsa05016 Huntington's disease 5331_1213_54205_7416 4 + 0.0354922634210706 0.587014688241674 4068 dextromethorphan hsa04740 Olfactory transduction 8388_8387_1179_818_8392_4991_810_9635 8 + 0.00129907046017507 0.106523777734356 4069 dextromethorphan hsa05322 Systemic lupus erythematosus 8330_3108 2 + 0.0250414913338113 0.587014688241674 4070 dextromethorphan hsa05012 Parkinson's disease 54205_7416 2 + 0.0349855469064194 0.587014688241674 4071 dextromethorphan hsa05214 Glioma 8503_5155_6655_6464_5290_808_1869_801_805 9 - 0.0451816835520126 1 4072 dextromethorphan hsa04080 Neuroactive ligand-receptor interaction 5029_7442_7068 3 - 0.000112419533252506 0.00472162039660525 4073 dextromethorphan hsa04740 Olfactory transduction 219464_801_808_5566_805 5 - 2.6456048456082e-06 0.000222230807031089 4074 fluphenazine hsa04916 Melanogenesis 5579_2775_6932_7482_1906_434_23236 7 + 0.0245419559268497 0.181740111110121 4075 fluphenazine hsa05214 Glioma 8503_1956_5579 3 + 0.0298819379532273 0.181740111110121 4076 fluphenazine hsa05332 Graft-versus-host disease 3119_3804_3458_3126_3127_940_3125_3135_355_3133_3123_941_942 13 + 0.0433256026752838 0.20300219964993 4077 fluphenazine hsa05010 Alzheimer's disease 2902_1339_4713_6622_6390_355_4137_3708_3709_6868_4023_348_23236 13 + 0.00680904652487309 0.102135697873096 4078 fluphenazine hsa05200 Pathways in cancer 8503_2737_22798_596_4088_598_330_867_5602_3673_4149_5371_5900_405_2263_2260_4312_998_6932_1956_7849_1496_7482_91_3725_1436_1284_2271_5579_5599_862_3685_861_355_7422_6257 36 + 0.042593280752478 0.20300219964993 4079 fluphenazine hsa04742 Taste transduction 50835_50834 2 + 0.02842551218698 0.181740111110121 4080 fluphenazine hsa05320 Autoimmune thyroid disease 3439_3449_1081_3119_942_3447_3126_3127_940_3125_3135_355_3133_3123_941 15 + 0.0469743594003611 0.20300219964993 4081 fluphenazine hsa04310 Wnt signaling pathway 8945_5579_5599_7482_6932_4088_5602_3725_6093_23236 10 + 0.00494019852186316 0.0889235733935369 4082 fluphenazine hsa04910 Insulin signaling pathway 8660_8503_5599_5575_3635_867_23433_5602_8651_5105 10 + 0.0146322349040576 0.145794883815297 4083 fluphenazine hsa05016 Huntington's disease 2902_246721_27113_6648_4713_1639_6390_5439_64446_3708_9001_1339_548644_23236 14 + 0.00470044743002981 0.0889235733935369 4084 fluphenazine hsa04740 Olfactory transduction 26212_81285_4991_8390_442194_3000_390892_393046 8 + 9.62918796529653e-16 8.66626916876688e-14 4085 fluphenazine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_6738_8294_121504_3123_3458_3126_3127_3125_8968_8370_718_8358_8359_8330_554313_8350_8351_8352_8353_8354_8355_8356_8357_2213_3119_3013_942_940_941_720_721_8970 42 + 0.000473678087449603 0.0213155139352321 4086 fluphenazine hsa05212 Pancreatic cancer 8503_596_6932_1956_2263_2260 6 + 0.0473671799183171 0.20300219964993 4087 fluphenazine hsa04110 Cell cycle 995_1647_4088_51343_5934_8556_8243_4616 8 + 0.017415445561138 0.145794883815297 4088 fluphenazine hsa05215 Prostate cancer 8503_596_6932_1956_2263_2260 6 + 0.0468669917055992 0.20300219964993 4089 fluphenazine hsa05218 Melanoma 8503_1956_2260 3 + 0.0151073169693196 0.145794883815297 4090 fluphenazine hsa05110 Vibrio cholerae infection 8992_5579 2 + 0.013708165039528 0.145794883815297 4091 fluphenazine hsa05012 Parkinson's disease 6570_1339_4713_6622_6390_6531_9627 7 + 0.00121530588949614 0.0364591766848842 4092 fluphenazine hsa03050 Proteasome 3458 1 + 0.0178193746885363 0.145794883815297 4093 fluphenazine hsa05330 Allograft rejection 3119_942_3458_3126_3127_940_3125_3135_355_3133_3123_941 12 + 0.035777937857464 0.201250900448235 4094 fluphenazine hsa04940 Type I diabetes mellitus 3382_2572_3119_942_3458_3126_3127_940_3125_3135_355_3133_3123_941 14 + 0.0302900185183535 0.181740111110121 4095 fluphenazine hsa04640 Hematopoietic cell lineage 921_3589_3675 3 - 0.045205301442739 0.45205301442739 4096 fluphenazine hsa05010 Alzheimer's disease 488_5331_22926_489_5534_810_7381 7 - 0.00677277527328443 0.101591629099266 4097 fluphenazine hsa04080 Neuroactive ligand-receptor interaction 4889_5618_2846_4158_2908_5031_7434_64106_8484_1909_9568_9170 12 - 0.00387427158899603 0.0697368886019285 4098 fluphenazine hsa05016 Huntington's disease 5331_7381_2876_55567 4 - 8.21440924536894e-05 0.00246432277361068 4099 fluphenazine hsa04740 Olfactory transduction 5613_5616_818_109_810_409 6 - 1.42068021470662e-10 1.27861219323596e-08 4100 fluphenazine hsa05221 Acute myeloid leukemia 1050_8503_6934_3551_2885_5296_6777_5371_5605_861_5467_5914 12 - 0.0381037872654808 0.428667606736659 4101 fluphenazine hsa05012 Parkinson's disease 7345_7381_7332 3 - 0.00111956052510256 0.0251901118148076 4102 fluphenazine hsa04060 Cytokine-cytokine receptor interaction 3601_3579_3589_23765_5618_7043_7042_8718 8 - 7.06498656361596e-05 0.00246432277361068 4103 fluphenazine hsa04610 Complement and coagulation cascades 5104 1 - 0.0202986880535607 0.260983132117209 4104 dopamine hsa05322 Systemic lupus erythematosus 8353_3013_8358_8968_8350_8351_8352_81_8354_8355_8356_8357 12 - 0.000219500174824699 0.0120725096153584 4105 deferoxamine hsa05332 Graft-versus-host disease 3553_3119_3123_3107_3126_3127_3125_3135_356_355 10 + 0.00350751676261309 0.0435934226210484 4106 deferoxamine hsa04070 Phosphatidylinositol signaling system 5578 1 + 0.0431844582224559 0.336875320284395 4107 deferoxamine hsa05320 Autoimmune thyroid disease 3439_3107_3119_3123_3447_3446_3126_3127_3125_3135_356_355 12 + 0.00207354626669385 0.0390604552341117 4108 deferoxamine hsa05016 Huntington's disease 1212_4713_317_291 4 + 0.00276852627288502 0.0401436309568328 4109 deferoxamine hsa04740 Olfactory transduction 219464_26211_157_135948_8392_26532_5137_26529 8 + 5.83245120319644e-06 0.00050742325467809 4110 deferoxamine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8294_3123_3126_3127_3125_8370_717_8359_554313_121504_3119_720_721_729 24 + 0.00126280769293789 0.0390604552341117 4111 deferoxamine hsa05219 Bladder cancer 1026_5595_3576_1029_1613_4193_1956_7422 8 + 0.0252757271941666 0.24433202954361 4112 deferoxamine hsa04115 p53 signaling pathway 1647_1026_894_9134_1029_317_4193_7249_3486_355_5366_8795_9540_4616 14 + 0.00224485374908688 0.0390604552341117 4113 deferoxamine hsa05012 Parkinson's disease 4713_317_7054_291 4 + 0.0464655614185373 0.336875320284395 4114 deferoxamine hsa03010 Ribosome 6187_440589 2 + 0.0337866363076536 0.293943735876586 4115 deferoxamine hsa05330 Allograft rejection 3119_3123_3107_3126_3127_3125_3135_356_355 9 + 0.00566877240668849 0.0616478999227373 4116 deferoxamine hsa04940 Type I diabetes mellitus 3553_3119_3123_3107_3126_3127_3125_3135_356_355_5798 11 + 0.00161088898331493 0.0390604552341117 4117 deferoxamine hsa05010 Alzheimer's disease 3553_351_841_5664_355_489_488_6622_517_23236 10 - 0.012416729309938 0.161417481029194 4118 deferoxamine hsa04080 Neuroactive ligand-receptor interaction 152_1813_64106_1132_2908_3360_4886_2566_7434_3354_5026_2742_2150_4160_7433_3351_4142_5646 18 - 0.0182020008047843 0.184042452581708 4119 deferoxamine hsa04910 Insulin signaling pathway 3667_5256_1977_6655_7249_23265_867_5602 8 - 0.0319443352394194 0.220653627568207 4120 deferoxamine hsa05016 Huntington's disease 4899_1211_6648_841_581_5441_6667_163_161_517_23236 11 - 0.0112613287224897 0.161417481029194 4121 deferoxamine hsa04740 Olfactory transduction 26333_10798_409 3 - 4.43010431157606e-16 4.03139492353421e-14 4122 deferoxamine hsa04510 Focal adhesion 5063_1302_5578_6655_88_3918_5881_5602_7791_3655_55742_1291_4233 13 - 0.0155614281255085 0.177011244927659 4123 deferoxamine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_94239_8366_8368_88_8329_8294_8343_8347_8346_8345_8344_8367_8969_8370_717_8332_8359_8330_8331_8336_8334_554313_6738_121504_8339_8357_85235_3119_85236_720_721 37 - 0.000157988479896367 0.00518607392592632 4124 deferoxamine hsa04710 Circadian rhythm - mammal 1454_406_1407_8863_8553 5 - 0.0395211272849949 0.220653627568207 4125 deferoxamine hsa05212 Pancreatic cancer 1869_7039_6655_6934 4 - 0.0430653314231194 0.220653627568207 4126 deferoxamine hsa05215 Prostate cancer 1869_7039_6655_6934 4 - 0.0425458837791378 0.220653627568207 4127 deferoxamine hsa04530 Tight junction 55844_5580_5578_2771_5581_88 6 - 0.0065004849470024 0.147886032544305 4128 deferoxamine hsa04720 Long-term potentiation 6196_5578_23236 3 - 0.0436457724860189 0.220653627568207 4129 deferoxamine hsa04810 Regulation of actin cytoskeleton 10152_10093_7454_5063_8394_1132_6655_88_54961_5881_7430_2249_23365_3655_26999 15 - 0.0255120242167784 0.211054018520621 4130 deferoxamine hsa05012 Parkinson's disease 2861_6622_517 3 - 0.000170969470085483 0.00518607392592632 4131 deferoxamine hsa04260 Cardiac muscle contraction 27092_4635_488 3 - 0.0227646502475915 0.207158317253083 4132 deferoxamine hsa03010 Ribosome 6168_6234_6181_9349 4 - 0.012060576764999 0.161417481029194 4133 deferoxamine hsa04020 Calcium signaling pathway 5256_5578_56848_3360_5026_8912_7220_5333_489_488_9630_23236_493 13 - 0.0497507597039028 0.228210666855106 4134 deferoxamine hsa03050 Proteasome 23198 1 - 0.0388057255486692 0.220653627568207 4135 deferoxamine hsa04270 Vascular smooth muscle contraction 5580_5578_5581_27094_23365_23236 6 - 0.0286291314737333 0.217104247009144 4136 calmidazolium hsa05010 Alzheimer's disease 6868_317_9451 3 + 9.56076168780071e-05 0.0027407516838362 4137 calmidazolium hsa05016 Huntington's disease 8218_317_2033_55567_10126_291 6 + 0.00206670067688451 0.033045380074624 4138 calmidazolium hsa04740 Olfactory transduction 26212_5593_818_26532_4991_816 6 + 9.83637871063502e-10 4.22964284557306e-08 4139 calmidazolium hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8349_8348_8329_8294_121504_8343_8347_8346_8345_8344_8339_723790_8969_8968_8370_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_85236_3012_3013_3017_3111_8970 49 + 5.71371105114786e-12 4.91379150398716e-10 4140 calmidazolium hsa04530 Tight junction 9223_998 2 + 0.000439756884630052 0.00945477301954612 4141 calmidazolium hsa05012 Parkinson's disease 6531_317_291 3 + 0.0023054916331133 0.033045380074624 4142 calmidazolium hsa04730 Long-term depression 5593 1 + 0.0197041601080309 0.242079681327237 4143 calmidazolium hsa04270 Vascular smooth muscle contraction 27094_800_59_553 4 + 0.0241989532837374 0.260138747800177 4144 calmidazolium hsa04080 Neuroactive ligand-receptor interaction 5029_2847_3360_5021 4 - 0.0490649428798482 1 4145 calmidazolium hsa05322 Systemic lupus erythematosus 3014 1 - 0.0469471405818105 1 4146 probucol hsa04740 Olfactory transduction 816 1 + 1.72322686492842e-05 0.00136134922329345 4147 probucol hsa04940 Type I diabetes mellitus 3135_3106_3107_3382_3119 5 + 0.028832433408699 1 4148 probucol hsa04610 Complement and coagulation cascades 624_2_720_721_5328_729 6 + 0.049288236034181 1 4149 probucol hsa04080 Neuroactive ligand-receptor interaction 3354_7442_2925_3360_7433 5 - 0.00222205628072922 0.0599955195796889 4150 probucol hsa04670 Leukocyte transendothelial migration 5829 1 - 0.00696611276686716 0.14106378352906 4151 probucol hsa04740 Olfactory transduction 26476 1 - 1.19771570802309e-09 9.70149723498703e-08 4152 probucol hsa05322 Systemic lupus erythematosus 55506_8361_8363_8362_8365_8364_8367_8360_8368_8294_8343_8347_8346_8344_8366_8370_8359_8337_554313_121504_8339_3017_3014 23 - 0.000187096776517707 0.00757741944896713 4153 probucol hsa04062 Chemokine signaling pathway 5829_6655_23236_1230_408 5 - 0.0337394226680405 0.491312409682308 4154 probucol hsa04060 Cytokine-cytokine receptor interaction 1230_2057_2324_3624_8995_7424_3553_8795 8 - 0.0363935118283191 0.491312409682308 4155 geldanamycin hsa05010 Alzheimer's disease 842_841_840_9451_5332_23236 6 + 0.00380709647167059 0.110405797678447 4156 geldanamycin hsa04080 Neuroactive ligand-receptor interaction 2859_5618_1133_1131_2908_3362_2692_6915_2743_8484_5733_1902_4158 13 + 0.0165911990205753 0.206204902112864 4157 geldanamycin hsa04612 Antigen processing and presentation 4800_3135_3308_3119_3805_3105_3106_3107_3303_3320_3326_3309_811_3304_3305_925_3310_649853 18 + 0.00918861607633184 0.133234933106812 4158 geldanamycin hsa05016 Huntington's disease 842_841_64764_5332_90993_5481_23236 7 + 0.00508149029484721 0.110522413912927 4159 geldanamycin hsa04740 Olfactory transduction 157 1 + 5.68229888108641e-15 4.94360002654518e-13 4160 geldanamycin hsa05322 Systemic lupus erythematosus 55506_3119 2 + 0.000208354365979375 0.00906341492010281 4161 geldanamycin hsa04720 Long-term potentiation 5332_23236 2 + 0.0450012166921703 0.392103508107911 4162 geldanamycin hsa05012 Parkinson's disease 51465_7054_5481_842 4 + 0.00682429466515402 0.11874272717368 4163 geldanamycin hsa04260 Cardiac muscle contraction 782_4635 2 + 0.0328949061572424 0.357732104460011 4164 geldanamycin hsa03320 PPAR signaling pathway 3611_11001_2171_8310 4 - 0.0395940887490792 0.26301787526174 4165 geldanamycin hsa05010 Alzheimer's disease 1327_4712_351_8883_355_489_810_513_7381_8851_23621 11 - 0.00112403573145713 0.0261338307563783 4166 geldanamycin hsa04080 Neuroactive ligand-receptor interaction 5029_4889_7442_7067_706_2925_4886_5026_1241_55879_4988_5646_9170 13 - 3.3519319050474e-06 0.000155864833584704 4167 geldanamycin hsa05016 Huntington's disease 5432_548644_1387_55567_1327_4712_1639_5439_5430_246721_27113_7019_6875_7381_513 15 - 0.00916210210978907 0.104648259295755 4168 geldanamycin hsa04740 Olfactory transduction 5613_5566_5616_109_4991_810 6 - 1.3926398383945e-17 1.29515504970689e-15 4169 geldanamycin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_6738_8294_121504_8343_8347_8346_8344_8339_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3014_727_9555 39 - 0.00307986481168513 0.0409182039266739 4170 geldanamycin hsa04062 Chemokine signaling pathway 5295_5580_3551_156_5829_5613_5566_3576_5616_9475_5296_6387_109_1399_112_5970_4792 17 - 0.0187791890068136 0.134343429048743 4171 geldanamycin hsa05012 Parkinson's disease 7327_1327_4712_7054_65018_27429_513_7381 8 - 0.00301172315603399 0.0409182039266739 4172 geldanamycin hsa04260 Cardiac muscle contraction 784_7381_1327_6548 4 - 0.0109891899670721 0.104648259295755 4173 geldanamycin hsa04060 Cytokine-cytokine receptor interaction 55540_5154_8741_6387_27242_3554_2057_3455_3576_3572_4982_659_3588_3589_3625_8742_7040_7042_655_8795_4055_3460_355_7422_51330 25 - 0.0141818795553026 0.114887407342966 4174 geldanamycin hsa03010 Ribosome 6234_6189_439992 3 - 0.000440362392882142 0.0136512341793464 4175 geldanamycin hsa04020 Calcium signaling pathway 2925_5578_5613_5566_5616_5026_109_5335_489_5336_810_3707_493 13 - 0.00302247205855531 0.0409182039266739 4176 geldanamycin hsa03050 Proteasome 10197 1 - 0.0112525009995435 0.104648259295755 4177 geldanamycin hsa04610 Complement and coagulation cascades 1675_2161_727 3 - 0.0148241815926408 0.114887407342966 4178 3-aminobenzamide hsa04620 Toll-like receptor signaling pathway 3665_5595_9641 3 + 0.032645594830153 0.513184021690425 4179 3-aminobenzamide hsa05220 Chronic myeloid leukemia 861_613_5595 3 + 0.0150292311168249 0.513184021690425 4180 3-aminobenzamide hsa04310 Wnt signaling pathway 2535 1 - 0.045868874376683 0.996670932290273 4181 3-aminobenzamide hsa04740 Olfactory transduction 4991 1 - 1.72414848472591e-05 0.00132759433323895 4182 3-aminobenzamide hsa04115 p53 signaling pathway 581_317_3479_472_3732_9540 6 - 0.0498073921676779 0.996670932290273 4183 bucladesine hsa04520 Adherens junction 4088_91_2260_5881_8976 5 + 0.0125591802964668 0.316945628816937 4184 bucladesine hsa04010 MAPK signaling pathway 8398_9064_27006_208_4137_5881_5922_91_3725_3164_2260 11 + 0.00683701346401784 0.316945628816937 4185 bucladesine hsa05210 Colorectal cancer 4088_208_5881_91_3725 5 + 0.0150926489912827 0.316945628816937 4186 bucladesine hsa05220 Chronic myeloid leukemia 4088_613_91_208 4 + 0.0400672743400602 0.631059570855948 4187 bucladesine hsa05214 Glioma 6655_3479_4193_808_801_805 6 - 0.0242943847111911 0.299742248206897 4188 bucladesine hsa05332 Graft-versus-host disease 3553_3105_3106_3107_3111_3135_355_649853 8 - 0.000152798407967205 0.00719760230457058 4189 bucladesine hsa05211 Renal cell carcinoma 5063_6655_998_3725_6923_3082 6 - 0.0363650653954758 0.322739955384848 4190 bucladesine hsa05320 Autoimmune thyroid disease 3105_3106_3107_3111_3135_355_649853 7 - 0.00269122328939016 0.0477692133866753 4191 bucladesine hsa05016 Huntington's disease 10126 1 - 0.0326865552328388 0.322739955384848 4192 bucladesine hsa04514 Cell adhesion molecules (CAMs) 6402_3105_3106_3107_3111_3135_57863_5792_6693_649853 10 - 0.0253303308343857 0.299742248206897 4193 bucladesine hsa05330 Allograft rejection 3105_3106_3107_3111_3135_355_649853 7 - 0.000473463201563967 0.0112052957703472 4194 bucladesine hsa04940 Type I diabetes mellitus 3553_3105_3106_3107_3111_3135_355_649853 8 - 0.000202749360692129 0.00719760230457058 4195 bendroflumethiazide hsa05332 Graft-versus-host disease 3123_3824_3126_3127_3125 5 + 0.00245849676326974 0.0719901236313455 4196 bendroflumethiazide hsa05320 Autoimmune thyroid disease 3123_3126_3127_3125 4 + 0.0277190432989178 0.252936270102625 4197 bendroflumethiazide hsa04612 Antigen processing and presentation 3824_3123_3806_3126_3127_3125 6 + 0.0123525094115223 0.180346637408226 4198 bendroflumethiazide hsa05322 Systemic lupus erythematosus 718_3123_3126_3127_3125_720_721 7 + 0.0332643368894535 0.26981073254779 4199 bendroflumethiazide hsa04360 Axon guidance 57556_5365_1947_5534_3984_8829_57144 7 + 0.0216827232514991 0.226119828194205 4200 bendroflumethiazide hsa05310 Asthma 3123_3125_3126_3127_2207 5 + 0.00063273616188057 0.0461897398172816 4201 bendroflumethiazide hsa05330 Allograft rejection 3123_3126_3127_3125 4 + 0.00990999058489191 0.180346637408226 4202 bendroflumethiazide hsa04940 Type I diabetes mellitus 3382_3126_3127_3123_3125 5 + 0.00295849823142516 0.0719901236313455 4203 bendroflumethiazide hsa04610 Complement and coagulation cascades 721_2_728_720_718 5 + 0.016694684460332 0.203118660934039 4204 bendroflumethiazide hsa04740 Olfactory transduction 51806_5566 2 - 4.39230065256548e-06 0.000175692026102619 4205 bendroflumethiazide hsa05322 Systemic lupus erythematosus 8329_8343_8347_8346_8344_8339_8969_8968_8358_8330_8331_8336_6737_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_720_721 26 - 3.74711708347916e-08 2.99769366678333e-06 4206 fluocinonide hsa04640 Hematopoietic cell lineage 3123_3126_3127_1438_3125_1378_3673 7 + 0.0314034075517237 0.412496027157858 4207 fluocinonide hsa05010 Alzheimer's disease 5330 1 + 0.0484738904585509 0.448383486741596 4208 fluocinonide hsa04080 Neuroactive ligand-receptor interaction 2741_1813 2 + 0.0185723587631897 0.412496027157858 4209 fluocinonide hsa05016 Huntington's disease 5330 1 + 0.0334456238236101 0.412496027157858 4210 fluocinonide hsa05322 Systemic lupus erythematosus 729_3123_3126_3127_3125_8358_8968_3013_8350_8351_8352_8353_8354_8355_8356_8357 16 + 5.49439500023222e-05 0.00406585230017184 4211 fluocinonide hsa05310 Asthma 3123_3126_3127_8288_3125 5 + 0.00488417924096964 0.180714631915877 4212 fluocinonide hsa05330 Allograft rejection 3123_3126_3127_3125 4 + 0.0449848356281538 0.448383486741596 4213 fluocinonide hsa04610 Complement and coagulation cascades 5327_2_2153_1378_729_2243 6 + 0.0331705690996771 0.412496027157858 4214 fluocinonide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_3108_8969_8370_8332_8359_8330_8331_8336_554313_8351_85235_3119_3013_720_721 27 - 4.3645574701426e-07 3.75351942432264e-05 4215 fluocinonide hsa04012 ErbB signaling pathway 6777_5599_1839_867_2002_1956_1399_3725_6714_2064 10 - 0.0406596477677605 0.874182427006851 4216 fluocinonide hsa04010 MAPK signaling pathway 9479_50487_5154_5881_3725_3164_3554_4149_1852_836_1399_408_2768_1956_5536_7042_7786_23542_1432_5599_5607_2002_23162_2005_9693 25 - 0.0264740265199892 0.758922093573024 4217 fluocinonide hsa05210 Colorectal cancer 836_6934_5599_1855_1857_5881_1956_324_7042_3725_4233 11 - 0.0181702240632858 0.758922093573024 4218 furaltadone hsa02010 ABC transporters 19_64137_10347_1244 4 + 0.0309103031883806 1 4219 furaltadone hsa05016 Huntington's disease 7052_6390_27113_23236 4 - 0.0356349339664411 0.9301997799163 4220 furaltadone hsa04740 Olfactory transduction 810_26529 2 - 1.39984595272578e-07 1.20386751934417e-05 4221 furaltadone hsa05322 Systemic lupus erythematosus 8358_85235_8968_3013_6737_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357 19 - 0.00150201823052572 0.064586783912606 4222 fenoprofen hsa05010 Alzheimer's disease 3708_54205 2 + 0.0363506779247356 1 4223 fenoprofen hsa04740 Olfactory transduction 5593 1 + 1.7519988391434e-06 0.000141911905970615 4224 fenoprofen hsa04070 Phosphatidylinositol signaling system 8871_5728_8394_3631_808_5335_51763_801_5291_805 10 - 0.0388523425391673 0.812960155832828 4225 fenoprofen hsa04080 Neuroactive ligand-receptor interaction 3953_7067 2 - 2.75126627670736e-05 0.00115553183621709 4226 fenoprofen hsa04740 Olfactory transduction 219464_801_808_805 4 - 6.86439339134637e-07 5.76609044873095e-05 4227 flunixin hsa05212 Pancreatic cancer 5925_2260_3845 3 + 0.0424579227294816 0.414142056183184 4228 flunixin hsa05215 Prostate cancer 5925_2260_3845 3 + 0.0413174507847608 0.414142056183184 4229 flunixin hsa05218 Melanoma 5925_2260_3845_2258 4 + 0.00362594398551882 0.170419367319385 4230 flunixin hsa04810 Regulation of actin cytoskeleton 2245_2934_3845_2260_2258 5 + 0.0405098019973177 0.414142056183184 4231 flunixin hsa04540 Gap junction 5598_3709_3845 3 + 0.0471769458153444 0.414142056183184 4232 flunixin hsa05210 Colorectal cancer 6934_5295_8312_3725_8324_8321 6 - 0.0154155600418533 1 4233 flunixin hsa05217 Basal cell carcinoma 8324_8321_6934_8312 4 - 0.042763754558798 1 4234 flumetasone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_8359_8294_8367_121504_8368_8351_6738 17 - 7.73180614686699e-05 0.00579885461015024 4235 flumetasone hsa04360 Axon guidance 9353_57556_5364_998_1944_2049_64221_3985_6092_10505_7869 11 - 0.019541462665895 0.732804849971063 4236 sulfamethoxypyridazine hsa04120 Ubiquitin mediated proteolysis 7320_4281_5371 3 + 0.0486426240309054 0.474265584301328 4237 sulfamethoxypyridazine hsa05010 Alzheimer's disease 3553_3710 2 + 0.00215386210842862 0.0560004148191441 4238 sulfamethoxypyridazine hsa05200 Pathways in cancer 1284_596_208_5578_5371_4254_2034_652_2249_2247_2253_3674 12 + 0.0485520913863006 0.474265584301328 4239 sulfamethoxypyridazine hsa05016 Huntington's disease 4899_1211_90993 3 + 0.00506767153278376 0.0805213291380911 4240 sulfamethoxypyridazine hsa04740 Olfactory transduction 2979_5568_816 3 + 1.53089286430737e-07 5.97048217079874e-06 4241 sulfamethoxypyridazine hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8360_8368_9103_8362_8294_121504_8366_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_2215_83740_3117_3013_940 33 + 3.33361136015003e-09 2.60021686091702e-07 4242 sulfamethoxypyridazine hsa04512 ECM-receptor interaction 2814_1281_1301_1311_3381_2812_1277_1284_7148_960_3674 11 + 0.0278661592142213 0.362260069784877 4243 sulfamethoxypyridazine hsa05012 Parkinson's disease 5413 1 + 0.00516162366269815 0.0805213291380911 4244 sulfamethoxypyridazine hsa04080 Neuroactive ligand-receptor interaction 64106_2908_1081_2149_1909 5 - 0.00226123038092342 0.141713148762321 4245 sulfamethoxypyridazine hsa04210 Apoptosis 841_581_598_5534_331_355_5291_208_5576_8837_23052_8795 12 - 0.0210623782208542 0.596767382924202 4246 sulfamethoxypyridazine hsa05012 Parkinson's disease 7419 1 - 0.00333442702970168 0.141713148762321 4247 cloperastine hsa04662 B cell receptor signaling pathway 973_6655_5533_2353_933_3725_4792 7 + 0.0410049963436798 0.474486386262581 4248 cloperastine hsa05016 Huntington's disease 1211 1 + 0.00739318421873896 0.155948889378097 4249 cloperastine hsa04740 Olfactory transduction 5566 1 + 5.60600127383518e-06 0.000227043051590325 4250 cloperastine hsa04514 Cell adhesion molecules (CAMs) 9076_965_959_3383_3119_29851_3107_23308_933_923_25945_4099_26047 13 + 0.00770117972237514 0.155948889378097 4251 cloperastine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8294_121504_959_8968_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_729 29 + 2.37791076248414e-11 1.92610771761215e-09 4252 cloperastine hsa05219 Bladder cancer 23604_2277_3576_1612_2261 5 + 0.0356229428104666 0.474486386262581 4253 cloperastine hsa04010 MAPK signaling pathway 775_4214_3164_1848_783_1843_1647_6655_1649_1846_5533_776_5598_2353_3725_5971_2261_5566_11221 19 + 0.0301316978531953 0.474486386262581 4254 cloperastine hsa04912 GnRH signaling pathway 775_4214_776_3710_5598_6655_1839_3725_5566 9 + 0.0487830298299236 0.493928177027976 4255 cloperastine hsa04740 Olfactory transduction 51806_393046_816 3 - 0.000170762609413611 0.0136610087530889 4256 cloperastine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 0.0056923538908616 0.227694155634464 4257 trioxysalen hsa04510 Focal adhesion 29895_91807_2335_5599_3480_6655_3371_824_6093 9 + 0.0160389617891934 1 4258 trioxysalen hsa04662 B cell receptor signaling pathway 3551_10725_6655_5290_8519_5534_4794 7 - 0.0423337753578843 0.51397302588126 4259 trioxysalen hsa04080 Neuroactive ligand-receptor interaction 146_4889_2692 3 - 0.0142545937656616 0.375370969162422 4260 trioxysalen hsa04740 Olfactory transduction 157 1 - 3.6246258347933e-06 0.000286345440948671 4261 trioxysalen hsa05322 Systemic lupus erythematosus 3123_8358_8350_8968_3013_8970_8351_8352_8353_8354_8355_8356_8357 13 - 0.0107892182965035 0.375370969162422 4262 trioxysalen hsa04010 MAPK signaling pathway 9479_3551_5534_1850_5598_6655_6789_5155_1846_2002_6722_4763_8911_7040_27092_2263_3164_1852_4616 19 - 0.0309750069900018 0.51397302588126 4263 trioxysalen hsa05012 Parkinson's disease 5413 1 - 0.0455419136856813 0.51397302588126 4264 trioxysalen hsa04060 Cytokine-cytokine receptor interaction 5155_3566_8795_7040 4 - 0.0364124657962445 0.51397302588126 4265 flecainide hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_1432_834_596_598_6506_5533 7 + 0.0378031671985338 0.936736208321016 4266 flecainide hsa04740 Olfactory transduction 219464_5568_26692_816_81797 5 + 0.00012521945645134 0.0103932148854612 4267 flecainide hsa04920 Adipocytokine signaling pathway 10000_3953_10645_2182_1375_5781_8717_8471_4793 9 + 0.0135501907462872 0.562332915970919 4268 flecainide hsa04080 Neuroactive ligand-receptor interaction 7434_56288_2925_6754 4 - 0.0488836650289631 0.562162147833076 4269 flecainide hsa04740 Olfactory transduction 5137_51806 2 - 4.18881819303832e-05 0.00289028455319644 4270 flecainide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_8294_8367_554313_121504 15 - 0.00124476381648196 0.0429443516686276 4271 flecainide hsa04062 Chemokine signaling pathway 6777_56288 2 - 0.036393492941567 0.549869954600787 4272 flecainide hsa04010 MAPK signaling pathway 1326_3925_5155_4763_9344_4137_3553_1852_2260_2261_57551_776_5536_5534_3725_3727_784_2122_5598_1844_7189_27092 22 - 0.00308031478317911 0.0708472400131195 4273 flecainide hsa02010 ABC transporters 19_8714_10347_5243_5244 5 - 0.039845648884115 0.549869954600787 4274 eucatropine hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 + 0.0266023951081043 0.309577849094829 4275 eucatropine hsa04640 Hematopoietic cell lineage 3123_2993_3126_3127_3125_924 6 + 0.0277233894711787 0.309577849094829 4276 eucatropine hsa05322 Systemic lupus erythematosus 8361_2212_8363_8362_8365_8364_8370_8360_3123_8366_3126_3127_3125_8359_8294_8367_554313_8368_121504 19 + 1.91723196993574e-08 1.28454541985695e-06 4277 eucatropine hsa05310 Asthma 3123_3125_3126_3127_2207 5 + 0.0015845620920559 0.0530828300838727 4278 eucatropine hsa05330 Allograft rejection 3123_3126_3127_3125 4 + 0.0196921039716548 0.309577849094829 4279 eucatropine hsa04940 Type I diabetes mellitus 3123_2571_3126_3127_3125 5 + 0.00703132074955166 0.15703283007332 4280 eucatropine hsa04740 Olfactory transduction 801_808_805 3 - 1.10448251557087e-07 9.05675662768113e-06 4281 eucatropine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8329_8294_121504_8969_8370_8332_8359_8330_8331_8336_554313_6738_8351_85235_3013 25 - 5.45512454734861e-05 0.00223660106441293 4282 eucatropine hsa05012 Parkinson's disease 513_517 2 - 0.0180016818891018 0.492045971635449 4283 difenidol hsa05200 Pathways in cancer 6789_5371_4791_861_652671_4842 6 + 0.0334306904070756 0.451124390500625 4284 difenidol hsa05221 Acute myeloid leukemia 861_5371_652671 3 + 0.00979978299938338 0.323392838979652 4285 difenidol hsa04662 B cell receptor signaling pathway 10892_11261_5291_5881_3725_27071 6 - 0.0313052818385064 0.298233663751962 4286 difenidol hsa04080 Neuroactive ligand-receptor interaction 2908_5031 2 - 0.0368649281035182 0.298233663751962 4287 difenidol hsa05014 Amyotrophic lateral sclerosis (ALS) 4217_598_11261_5608_581 5 - 0.0327744560709963 0.298233663751962 4288 difenidol hsa04740 Olfactory transduction 5613 1 - 0.000173466585528261 0.0121426609869783 4289 difenidol hsa04210 Apoptosis 581_5613_11261_5291_598_8837_5575 7 - 0.0224751229959667 0.298233663751962 4290 difenidol hsa04664 Fc epsilon RI signaling pathway 5291_5881_8681_5335_100137049_5608 6 - 0.0383443281966808 0.298233663751962 4291 difenidol hsa04370 VEGF signaling pathway 5829_11261_5291_5881_8681_5335_100137049 7 - 0.0114617313422141 0.267440397984996 4292 difenidol hsa04060 Cytokine-cytokine receptor interaction 91_4055 2 - 0.0258369400560081 0.298233663751962 4293 difenidol hsa05210 Colorectal cancer 581_5881_5291_5900_6934_3725_91_8324 8 - 0.0054853385390329 0.191986848866151 4294 0198306-0000 hsa05010 Alzheimer's disease 776_22926_842 3 + 0.0497552506323472 0.547307756955819 4295 0198306-0000 hsa05131 Shigellosis 9076_7277_5578_7278_113457_7100_7430_2534 8 + 0.0100354246261005 0.25757589873658 4296 0198306-0000 hsa05016 Huntington's disease 1387_6648_842 3 + 0.0367485118681179 0.471605902307513 4297 0198306-0000 hsa05130 Pathogenic Escherichia coli infection 9076_7277_5578_7278_113457_7100_7430_2534 8 + 0.0100354246261005 0.25757589873658 4298 0198306-0000 hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8370_83740_8368_8366_8360_8359_8362_8294_8367_554313_121504_3119_3108 19 + 0.000238400879718131 0.0183568677382961 4299 0198306-0000 hsa04062 Chemokine signaling pathway 6357_6655_4793 3 + 0.0265728262546214 0.471605902307513 4300 0198306-0000 hsa04020 Calcium signaling pathway 5333_776_5578 3 + 0.0364002380814932 0.471605902307513 4301 0198306-0000 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_8359_8294_8367_121504_8368_8351 16 - 1.63209804833607e-06 0.000104454275093508 4302 dexamethasone hsa04120 Ubiquitin mediated proteolysis 8651_867_55236 3 + 0.0185553291766875 0.525734326672813 4303 dexamethasone hsa04740 Olfactory transduction 810_26476_7932_26664_393046 5 + 1.43944656494173e-07 1.22352958020047e-05 4304 dexamethasone hsa05012 Parkinson's disease 6392_651820_842 3 + 0.0183433074846159 0.525734326672813 4305 dexamethasone hsa04070 Phosphatidylinositol signaling system 8871_5293_3631_808_5336_801_1606_3707_805_23236 10 - 0.0396304645498831 0.918546391884827 4306 dexamethasone hsa04740 Olfactory transduction 801_2978_808_393046_805 5 - 3.91949415284836e-06 0.000344915485450656 4307 dexamethasone hsa04060 Cytokine-cytokine receptor interaction 3601_3594_23765_3559_657_643_6362 7 - 0.013236420695427 0.582402510598788 4308 betaxolol hsa05016 Huntington's disease 1213_4695_317 3 + 0.0193435879468211 0.483589698670527 4309 betaxolol hsa04740 Olfactory transduction 26212_26476_2979_81797_81696_815 6 + 0.000260180533625848 0.0195135400219386 4310 betaxolol hsa05322 Systemic lupus erythematosus 8361_2212_8363_8362_8365_8364_8370_8360_8368_8366_8359_8294_8367_554313_121504_8341_6737 17 + 0.00568417353499154 0.213156507562183 4311 betaxolol hsa05010 Alzheimer's disease 4698_11261_355_5664 4 - 0.0102712836095801 0.210561313996392 4312 betaxolol hsa04080 Neuroactive ligand-receptor interaction 5618_3953_2908_7434_64106_9170 6 - 0.00166166681726004 0.0454188930051078 4313 betaxolol hsa05012 Parkinson's disease 4698 1 - 0.00158738791176149 0.0454188930051078 4314 betaxolol hsa04020 Calcium signaling pathway 11261_2767 2 - 0.00034193783326899 0.0280389023280572 4315 doxepin hsa05322 Systemic lupus erythematosus 8343_8339_8347_8346_8344 5 + 0.00306908839470495 0.0767272098676237 4316 doxepin hsa05131 Shigellosis 7278_113457 2 - 0.00977821566755428 0.0440019705039943 4317 doxepin hsa05130 Pathogenic Escherichia coli infection 7278_113457 2 - 0.00977821566755428 0.0440019705039943 4318 doxepin hsa04540 Gap junction 7278_113457 2 - 0.0249106811237921 0.0747320433713763 4319 hemicholinium hsa04740 Olfactory transduction 818 1 + 0.00780899247073287 0.367022646124445 4320 hemicholinium hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344 12 - 4.72916650857004e-06 0.000264833324479922 4321 scriptaid hsa04070 Phosphatidylinositol signaling system 8867_3612_5578_3632_5293_3631_3708_5333_808_23396_5336_4952_200576_5286_801_805 16 + 0.0175092406672949 0.152689572602116 4322 scriptaid hsa04640 Hematopoietic cell lineage 3655_2057 2 + 0.01608127483119 0.152689572602116 4323 scriptaid hsa05010 Alzheimer's disease 842_317_3708_808_351_801_805_23621 8 + 0.0150329004952554 0.152689572602116 4324 scriptaid hsa04080 Neuroactive ligand-receptor interaction 2550_2908_1241_6915_2150_5732_7433_728 8 + 6.75431908512707e-05 0.00186869494688516 4325 scriptaid hsa05016 Huntington's disease 55081_842_64764_5440_317_246721_3708_90993_9519 9 + 0.0183963340484477 0.152689572602116 4326 scriptaid hsa04740 Olfactory transduction 818_801_808_5566_805 5 + 2.10451630162652e-11 1.74674853035001e-09 4327 scriptaid hsa04530 Tight junction 6709_5865_5578_10627_5581 5 + 0.0129375297166465 0.152689572602116 4328 scriptaid hsa04630 Jak-STAT signaling pathway 868_2057_3455_3587_5293_8554_10379 7 + 0.0208811047383074 0.157557426661774 4329 scriptaid hsa04062 Chemokine signaling pathway 4067_5566_5293_7852_5604_5880_10235_4793 8 + 0.00483484959958406 0.0828836872450896 4330 scriptaid hsa05012 Parkinson's disease 2861_317_842_65018 4 + 0.00499299320753552 0.0828836872450896 4331 scriptaid hsa04260 Cardiac muscle contraction 10479_6548 2 + 0.0229553844215249 0.158774742248881 4332 scriptaid hsa04060 Cytokine-cytokine receptor interaction 2057_3455_55540_8744_7852_655_8718_3587 8 + 4.92715964615922e-05 0.00186869494688516 4333 scriptaid hsa03010 Ribosome 6189_439992_6123_6203 4 + 0.0439405998130941 0.280543829575909 4334 scriptaid hsa04640 Hematopoietic cell lineage 3673_3566 2 - 0.046507548142608 0.244164627748692 4335 scriptaid hsa05010 Alzheimer's disease 637_8772_4700_51107_355_489_7132 7 - 0.0377366868824893 0.21132544654194 4336 scriptaid hsa04080 Neuroactive ligand-receptor interaction 5029_4889_1269_152_5025_5618_4886_5031_56288_5724_9170 11 - 0.0158094577161783 0.120726768014452 4337 scriptaid hsa05016 Huntington's disease 4899_581_4700_2033_1387_163 6 - 0.0100564833971501 0.105916462035897 4338 scriptaid hsa04740 Olfactory transduction 5613_5616_816 3 - 8.82347605676173e-11 7.41171988767985e-09 4339 scriptaid hsa04514 Cell adhesion molecules (CAMs) 965_1365_5792 3 - 0.00661423808115756 0.105916462035897 4340 scriptaid hsa05322 Systemic lupus erythematosus 55506 1 - 0.000143573885381776 0.00603010318603459 4341 scriptaid hsa05212 Pancreatic cancer 1027_5295_595_596_3480_1871_5155_5154_5894_6934_369_2033_1387_4790_4792 15 - 0.0259437954962354 0.155662772977412 4342 scriptaid hsa05215 Prostate cancer 1027_5295_595_596_3480_1871_5155_5154_5894_6934_369_2033_1387_4790_4792 15 - 0.0252009857979242 0.155662772977412 4343 scriptaid hsa04210 Apoptosis 637_5295_596_8772_598_581_331_5616_355_9941_4615_5613_8837_7132_4790_4792 16 - 0.0100872820986569 0.105916462035897 4344 scriptaid hsa04512 ECM-receptor interaction 3673 1 - 0.0139356813313039 0.117059723182953 4345 scriptaid hsa05012 Parkinson's disease 51465_7332_7054_4700 4 - 0.0257191323503661 0.155662772977412 4346 scriptaid hsa04260 Cardiac muscle contraction 27092 1 - 0.0137969488579486 0.117059723182953 4347 scriptaid hsa03010 Ribosome 6234 1 - 0.00305142027632793 0.0640798258028865 4348 scriptaid hsa05222 Small cell lung cancer 10401_9063_5295_595_596_598_4609_331_1027_7188_1871_3673_4790_6256_4792_7187 16 - 0.00844063131366868 0.105916462035897 4349 scriptaid hsa05220 Chronic myeloid leukemia 1027_595_4088_598_5295_861_4609_1487_9846_7043_1871_5894_1488_4790_369_4792 16 - 0.00250845575198746 0.0640798258028865 4350 sulfinpyrazone hsa05332 Graft-versus-host disease 57292_3811_3553_942_3112_3802_5551 7 + 0.0162150433763094 0.356730954278807 4351 sulfinpyrazone hsa04080 Neuroactive ligand-receptor interaction 887_1081_2908_2925_59340_5644_5729_4160_2740_2688_1442_1394_2914_2917_3953_148_6915_5737_5027_57105_5618_2554_7067_3357_680 25 + 0.0156420724706723 0.356730954278807 4352 sulfinpyrazone hsa04740 Olfactory transduction 9635 1 + 9.15639960365419e-09 8.05763165121569e-07 4353 sulfinpyrazone hsa05221 Acute myeloid leukemia 23533_10000_83439_208_862_5371_861_652346_3845 9 + 0.0111498792415109 0.356730954278807 4354 sulfinpyrazone hsa05012 Parkinson's disease 1339_56901 2 + 0.0353474313572283 0.622114791887218 4355 sulfinpyrazone hsa04740 Olfactory transduction 818 1 - 3.74513311188125e-06 0.000295865515838619 4356 sulfinpyrazone hsa04514 Cell adhesion molecules (CAMs) 3135 1 - 0.0455042240198137 0.868071506855025 4357 sulfinpyrazone hsa05322 Systemic lupus erythematosus 55506_474382_474381_83740_3013_8343_8970_8351_8339_8347_8346_8344 12 - 0.0350399817584352 0.868071506855025 4358 sulfinpyrazone hsa05012 Parkinson's disease 842 1 - 0.0457439033213505 0.868071506855025 4359 mebeverine hsa05332 Graft-versus-host disease 3811_3108_3119_3821_3113_3126_3127_3111_3802_356_3123_941_3125 13 + 3.25282907893279e-05 0.000539969627102843 4360 mebeverine hsa05320 Autoimmune thyroid disease 959_958_3108_1081_3119_3113_3126_3127_3111_3125_356_3123_941 13 + 0.00023851104967144 0.00282805958896136 4361 mebeverine hsa04612 Antigen processing and presentation 3811_3108_3822_3821_3123_3126_3127_3111_3125_6892_3119_3802_3113 13 + 0.0142783077237487 0.118509954107114 4362 mebeverine hsa05016 Huntington's disease 7350_2904_1339_23236 4 + 0.0104549570688934 0.096417937413128 4363 mebeverine hsa04740 Olfactory transduction 26211_5593_4991_442194_81285 5 + 8.99658975361956e-07 3.73358474775212e-05 4364 mebeverine hsa04514 Cell adhesion molecules (CAMs) 9073_5175_3111_6383_3676_959_958_3108_3383_3123_3126_3127_3125_10666_51208_1462_6403_923_3119_3113_3685_941_6693_5817_1000 25 + 2.55135543499907e-05 0.000529406252762307 4365 mebeverine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_2904_8368_554313_8348_8294_121504_8341_959_958_3108_3123_8366_3126_3127_3125_8968_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_3113_3111_941 40 + 4.69879746486273e-12 3.90000189583607e-10 4366 mebeverine hsa05212 Pancreatic cancer 51176 1 + 0.0301115376749196 0.205511016173079 4367 mebeverine hsa05215 Prostate cancer 51176 1 + 0.0456115893750773 0.252384127875428 4368 mebeverine hsa05310 Asthma 959_958_3108_2205_3119_3123_3126_3127_3111_3125_3113_8288 12 + 8.12049073135749e-06 0.000224666910234224 4369 mebeverine hsa04512 ECM-receptor interaction 10319_3910_3690_2812_3694_7057_3685_3918_1282_6383_1290_3676 12 + 0.0321884724126509 0.205511016173079 4370 mebeverine hsa04062 Chemokine signaling pathway 6093_23236_6846_6375_6773 5 + 0.0186935452684117 0.141051296116197 4371 mebeverine hsa05012 Parkinson's disease 1339_7318_5413 3 + 0.0352892859700431 0.209215052536684 4372 mebeverine hsa05330 Allograft rejection 959_958_3108_3119_3126_3113_3127_3111_3125_356_3123_941 12 + 5.54845667550293e-05 0.000767536506777905 4373 mebeverine hsa04940 Type I diabetes mellitus 3108_3119_3113_3126_3127_3111_3125_356_3123_941 10 + 0.00200606728104264 0.0208129480408174 4374 mebeverine hsa04080 Neuroactive ligand-receptor interaction 7067_4157 2 - 0.00655973296462713 0.491979972347035 4375 mebeverine hsa04630 Jak-STAT signaling pathway 5781 1 - 0.0478947097491633 1 4376 fendiline hsa05010 Alzheimer's disease 2902_836_841_9451_355_6868_4035_23236 8 + 0.043939275316653 0.397634607340784 4377 fendiline hsa05320 Autoimmune thyroid disease 1081_3119_3113_3126_3127_3125_355_3123_7038_3448 10 + 0.0388797235571777 0.397634607340784 4378 fendiline hsa05016 Huntington's disease 2902_27113_836_841_1639_7802_23236 7 + 0.012390632502033 0.213118879034968 4379 fendiline hsa04740 Olfactory transduction 26211_4995_4991 3 + 1.71882700820561e-11 7.39095613528412e-10 4380 fendiline hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_88_8348_8329_8294_121504_8343_8347_8346_8345_8344_8353_723790_6737_3123_3126_3127_3125_8969_8968_55766_8370_92815_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_8352_8339_8354_8355_8356_8357_8332_85235_3119_3012_3013_3113_8349_8970_729 57 + 4.10009682848383e-17 3.52608327249609e-15 4381 fendiline hsa05310 Asthma 2205_3119_3123_3126_3127_3125_3113 7 + 0.0311565229500819 0.382780139101006 4382 fendiline hsa05012 Parkinson's disease 836_7318_7054 3 + 0.00477515790129401 0.136887859837095 4383 fendiline hsa04260 Cardiac muscle contraction 782_783 2 + 0.0462365822489284 0.397634607340784 4384 fendiline hsa03010 Ribosome 6165_6171 2 + 0.0115663618679391 0.213118879034968 4385 fendiline hsa04020 Calcium signaling pathway 2902_155_5578_2925_5335_1910_23236 7 + 0.0165659936608281 0.237445909138536 4386 fendiline hsa04080 Neuroactive ligand-receptor interaction 7434_5618 2 - 0.00942390272259794 0.381668060265217 4387 fendiline hsa04740 Olfactory transduction 810_219464_157_409 4 - 0.00302943888392157 0.245384549597647 4388 fendiline hsa04060 Cytokine-cytokine receptor interaction 3566_5618_3553 3 - 0.027192164952712 0.734188453723224 4389 quinidine hsa04740 Olfactory transduction 5593_4991 2 + 6.41172981239079e-06 0.000519350114803654 4390 quinidine hsa05322 Systemic lupus erythematosus 958_717_3013_942_3014_8358_3117_88_8968_8350_8351_8352_8353_8354_8355_8356_8357 17 + 0.000662508266513299 0.0268315847937886 4391 quinidine hsa04080 Neuroactive ligand-receptor interaction 2911_5618_4157_1131_1909 5 - 0.0260173858318738 0.580474652410529 4392 quinidine hsa04740 Olfactory transduction 5567_157 2 - 2.15792720635243e-06 0.000185581739746309 4393 quinidine hsa05322 Systemic lupus erythematosus 9555 1 - 0.0159100978790098 0.580474652410529 4394 quinidine hsa04210 Apoptosis 8503_3553_5575_5567_5290_472_836_8837_651610_8795 10 - 0.0269988210423502 0.580474652410529 4395 quinidine hsa04330 Notch signaling pathway 2648_1856_1857_5664_22938_9541 6 - 0.0391207826202533 0.672877461068357 4396 alprenolol hsa04740 Olfactory transduction 26211_5566_5616_816_5613 5 + 0.00168248123821402 0.132916017818908 4397 alprenolol hsa04060 Cytokine-cytokine receptor interaction 958_8771_6367_8794 4 + 0.0271405801525545 1 4398 alprenolol hsa04080 Neuroactive ligand-receptor interaction 5025 1 - 1.11669804890252e-05 0.000474596670783571 4399 alprenolol hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8360_8368_8362_8329_8294_8366_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119_83740 25 - 6.26163104858496e-06 0.000474596670783571 4400 alprenolol hsa04530 Tight junction 55870_50848 2 - 0.0247955448656462 0.351270218929988 4401 alprenolol hsa04062 Chemokine signaling pathway 6093_5594_6655 3 - 0.0104217998835088 0.17717059801965 4402 alprenolol hsa05012 Parkinson's disease 842 1 - 0.00724025126466816 0.153855339374198 4403 alprenolol hsa04060 Cytokine-cytokine receptor interaction 2324_8742_8741_3572_7423_10913_4254 7 - 0.02998944421317 0.364157536874207 4404 alprenolol hsa04020 Calcium signaling pathway 5025_2776 2 - 0.00313400828996996 0.0887969015491489 4405 praziquantel hsa05332 Graft-versus-host disease 57292_3811_3553_3109_3123_3126_3127_3111_3802_3125 10 + 0.00178579781485308 0.0517881366307393 4406 praziquantel hsa04640 Hematopoietic cell lineage 3553_3690_3123_3126_3127_1438_3125_915_3674_933_931_925_290 13 + 0.0223445243291791 0.277710516662655 4407 praziquantel hsa04310 Wnt signaling pathway 23236_11211_5526_9475 4 + 0.0480653237508967 0.460279750854906 4408 praziquantel hsa04740 Olfactory transduction 26476_9635 2 + 1.76251980616697e-09 7.66696115682632e-08 4409 praziquantel hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_2904_8369_8368_8290_88_8294_121504_3109_3123_8366_3126_3127_3125_8968_8370_8358_8359_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3111 36 + 1.28999490157424e-09 7.66696115682632e-08 4410 praziquantel hsa05310 Asthma 3109_3123_3126_3127_3111_3125_8288 7 + 0.00933275673945626 0.202987459083174 4411 praziquantel hsa04062 Chemokine signaling pathway 115_23533_23236_2785_9475 5 + 0.0191343885739413 0.277710516662655 4412 praziquantel hsa05012 Parkinson's disease 6390_54205_6531 3 + 0.0360718507240769 0.392281376624336 4413 praziquantel hsa04940 Type I diabetes mellitus 3382_3109_3123_3126_3127_3111_3125_3553 8 + 0.0191950443449569 0.277710516662655 4414 praziquantel hsa04080 Neuroactive ligand-receptor interaction 2911 1 - 0.00256848440579345 0.0988866496230478 4415 praziquantel hsa04740 Olfactory transduction 810 1 - 2.53984994896457e-05 0.00195568446070272 4416 praziquantel hsa05213 Endometrial cancer 8503_2064_8312_324_842 5 - 0.0459482992819594 1 4417 amodiaquine hsa05332 Graft-versus-host disease 3119_3105_3106_3107_3126_3127_3125_3135_3123_3113_649853 11 + 0.000202880379146704 0.00348954252132331 4418 amodiaquine hsa05320 Autoimmune thyroid disease 3119_3105_3106_3107_3126_3127_3125_3135_3123_3113_649853 11 + 0.00110208402946602 0.0157965377556796 4419 amodiaquine hsa04612 Antigen processing and presentation 3119_3123_3106_3107_3126_3127_3125_3135_3105_3113_926_649853 12 + 0.0168980365906383 0.181653893349362 4420 amodiaquine hsa04740 Olfactory transduction 5137 1 + 2.91033491953625e-09 2.50288803080118e-07 4421 amodiaquine hsa04514 Cell adhesion molecules (CAMs) 3119_3123_3106_3107_3126_3127_3125_3135_26047_6383_3105_3684_3676_3113_926_649853 16 + 0.0205107262597745 0.195991384260067 4422 amodiaquine hsa05322 Systemic lupus erythematosus 6737_9103_8348_8329_3123_3126_3127_3125_8969_8968_8358_8330_8331_8336_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013_3113 28 + 7.21403097575626e-07 3.10203331957519e-05 4423 amodiaquine hsa05310 Asthma 6356_3119_3123_3126_3127_3125_3113 7 + 0.00504169040067654 0.0619407677797404 4424 amodiaquine hsa03010 Ribosome 140801 1 + 0.0314651000226775 0.270599860195027 4425 amodiaquine hsa05330 Allograft rejection 3119_3105_3106_3107_3126_3127_3125_3135_3123_3113_649853 11 + 9.60230040276305e-05 0.00206449458659406 4426 amodiaquine hsa04270 Vascular smooth muscle contraction 23236_5578 2 + 0.0484067352988905 0.378452657791326 4427 amodiaquine hsa04940 Type I diabetes mellitus 3119_3105_3106_3107_3126_3127_3630_2571_3135_3123_3125_3113_649853 13 + 1.88124777143318e-05 0.000539291027810845 4428 amodiaquine hsa04740 Olfactory transduction 818_810_157 3 - 1.97612269567446e-05 0.000839852145661645 4429 amodiaquine hsa04510 Focal adhesion 6654_7409_2324 3 - 0.0274218575540288 0.582714473023112 4430 amodiaquine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235 25 - 1.82333414452726e-07 1.54983402284817e-05 4431 amodiaquine hsa04060 Cytokine-cytokine receptor interaction 5618_3601_2324 3 - 0.00269266046792551 0.0762920465912228 4432 clofilium tosylate hsa04740 Olfactory transduction 26211_7932_9635_393046 4 + 1.00103082609808e-06 4.15427792830703e-05 4433 clofilium tosylate hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8294_121504_8968_8370_716_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2215_2214_3013_3113_3111 31 + 3.75108936955929e-08 3.11340417673421e-06 4434 clofilium tosylate hsa04630 Jak-STAT signaling pathway 3581_59067_3561_6778_2057_3953_11009_5293_6773_50615_3600_2688_2689_9180_3449_81848_1442 17 + 0.0345385405611304 0.716674716643456 4435 clofilium tosylate hsa04060 Cytokine-cytokine receptor interaction 5156_9180_2322_59067_3553_2057_8794_3576_939_2688_2689_650_10663_3581_3600_1233_3953_7042_268_6846_8795_3561_3449_11009_8995_50615_7423_7422_83729_6375 30 + 0.0035622685119195 0.0985560954964395 4436 clofilium tosylate hsa04080 Neuroactive ligand-receptor interaction 7434_2911_5618_7442_3354 5 - 0.0258671394311278 0.452613516258542 4437 clofilium tosylate hsa05016 Huntington's disease 246721_5978_5441 3 - 0.0365501306883046 0.452613516258542 4438 clofilium tosylate hsa04740 Olfactory transduction 818_810 2 - 2.04550179247412e-06 0.000147276129058137 4439 clofilium tosylate hsa04514 Cell adhesion molecules (CAMs) 214 1 - 0.021994583692132 0.452613516258542 4440 clofilium tosylate hsa04062 Chemokine signaling pathway 115_7852_8976 3 - 0.0377177930215452 0.452613516258542 4441 clofilium tosylate hsa05012 Parkinson's disease 7054 1 - 0.0223702836765635 0.452613516258542 4442 N-acetyl-L-leucine hsa04740 Olfactory transduction 56656_2774_26664_442194_818_390892_9635 7 + 0.000375650357240148 0.0155894898254661 4443 N-acetyl-L-leucine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_9103_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_942_729 29 + 4.41294244607382e-08 3.66274223024127e-06 4444 N-acetyl-L-leucine hsa03010 Ribosome 6192 1 + 0.0451279921208915 0.693006536671903 4445 N-acetyl-L-leucine hsa04730 Long-term depression 2911_8398_5579_5578_2890_2892_5331_3708_5519 9 + 0.0397638721266451 0.693006536671903 4446 N-acetyl-L-leucine hsa04080 Neuroactive ligand-receptor interaction 5618_56288_1131_1081 4 - 1.58576034139888e-05 0.000673948145094524 4447 N-acetyl-L-leucine hsa04740 Olfactory transduction 810_5613_5616_816 4 - 1.54207579255638e-09 1.31076442367292e-07 4448 N-acetyl-L-leucine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294 21 - 0.0254578980536339 0.309131619222697 4449 N-acetyl-L-leucine hsa04062 Chemokine signaling pathway 7454_5613_6777_5616_9475_56288_5291 7 - 0.0219455765860301 0.309131619222697 4450 N-acetyl-L-leucine hsa05012 Parkinson's disease 4698_836_517 3 - 0.0094166228871445 0.266804315135761 4451 N-acetyl-L-leucine hsa04260 Cardiac muscle contraction 7168 1 - 0.0208845281154313 0.309131619222697 4452 N-acetyl-L-leucine hsa04060 Cytokine-cytokine receptor interaction 5618_3554_2057_5155_3601_5154_7042_4254_268_4233_8792 11 - 0.0206008982253686 0.309131619222697 4453 tonzonium bromide hsa04640 Hematopoietic cell lineage 1435_3123_3568_3126_3127_3125_947_1604_3676_3674 10 + 0.0302858919204704 0.605717838409408 4454 tonzonium bromide hsa04740 Olfactory transduction 442194_2979_815_26692_1258 5 + 0.000126290891302217 0.00505163565208868 4455 tonzonium bromide hsa04514 Cell adhesion molecules (CAMs) 24146_3676_3383_5175_3123_4099_3107_3126_3127_3125_10666_947_25945_26047 14 + 0.0210483254667401 0.561288679113069 4456 tonzonium bromide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 29 + 8.8914552641836e-09 7.11316421134688e-07 4457 tonzonium bromide hsa04940 Type I diabetes mellitus 3382_3123_3107_3126_3127_3125 6 + 0.0384396525916161 0.615034441465858 4458 tonzonium bromide hsa04080 Neuroactive ligand-receptor interaction 64106_2925_4157_1081 4 - 0.00413808404409266 0.167592403785753 4459 tonzonium bromide hsa05016 Huntington's disease 7419_161_581 3 - 0.0195610257885037 0.249144879432665 4460 tonzonium bromide hsa04740 Olfactory transduction 219464_26211 2 - 2.97548090156828e-07 2.41013953027031e-05 4461 tonzonium bromide hsa04062 Chemokine signaling pathway 3717_6655_2931 3 - 0.0139133868761791 0.249144879432665 4462 tonzonium bromide hsa05012 Parkinson's disease 7419 1 - 0.0104343053717622 0.249144879432665 4463 tonzonium bromide hsa04020 Calcium signaling pathway 7419_2925_489 3 - 0.0191564894404037 0.249144879432665 4464 tonzonium bromide hsa04270 Vascular smooth muscle contraction 5583 1 - 0.0215310389633167 0.249144879432665 4465 tyloxapol hsa04310 Wnt signaling pathway 4088_51176 2 + 0.0352613803616647 0.402861377877713 4466 tyloxapol hsa04740 Olfactory transduction 81697_81797_442194_390892 4 + 7.64261630611819e-05 0.00611409304489455 4467 tyloxapol hsa04510 Focal adhesion 3082_3679_22798_1302_3381_3690_208_3908_5156_93408_1956_1950_29780_7148_55742_1277_4233_1301 18 + 0.0254163920327074 0.402861377877713 4468 tyloxapol hsa04512 ECM-receptor interaction 7148_22798_1302_3381_3690_3908_1277_3679_1301 9 + 0.0426249465063344 0.402861377877713 4469 tyloxapol hsa04010 MAPK signaling pathway 9479_3925_5156_4763_30814_4908_3553_2260_208_779_8550_1956_1950_91_4791_1432_782_5598_4208_4137_355_8911 22 + 0.0356136417030351 0.402861377877713 4470 tyloxapol hsa04060 Cytokine-cytokine receptor interaction 64109_8743_5156_9180_3553_10850_3576_6368_2688_3082_7292_3953_2919_1956_1950_91_4233_3565_5617_8995_355_6374 22 + 0.0224898502842774 0.402861377877713 4471 tyloxapol hsa04940 Type I diabetes mellitus 3382_942_2572_3111_355_3002_3553 7 + 0.00981136625246247 0.392454650098499 4472 tyloxapol hsa04080 Neuroactive ligand-receptor interaction 5029_146_5618_4157_1081_3953_64106_7067_56288_136 10 - 0.00794971698375115 0.238491509512535 4473 tyloxapol hsa04740 Olfactory transduction 157 1 - 4.31300182927649e-13 3.88170164634884e-11 4474 tyloxapol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_6738_121504_8357_85235_3119_9555 29 - 0.000105377851022244 0.00474200329600098 4475 tyloxapol hsa04060 Cytokine-cytokine receptor interaction 5618_3460_3953_3459_8742_8741_5154_7852_355_10913_91_4254_268 13 - 0.0421717471364133 0.759091448455439 4476 tyloxapol hsa04020 Calcium signaling pathway 146_5257_490_136_489_7419_2064 7 - 0.0217055730890721 0.488375394504122 4477 metyrapone hsa05332 Graft-versus-host disease 3553_3123_3126_3127_941_355_3125 7 + 0.00254534115973224 0.0670273172062823 4478 metyrapone hsa04640 Hematopoietic cell lineage 2323_1435_3553_3690_3123_3126_3127_3125_915_2811 10 + 0.00409958411334349 0.0809667862385339 4479 metyrapone hsa05320 Autoimmune thyroid disease 3123_3126_3127_941_355_3125 6 + 0.0254958297104945 0.251771318391133 4480 metyrapone hsa04740 Olfactory transduction 8390_9635 2 + 4.19331777148339e-05 0.00331272103947188 4481 metyrapone hsa04360 Axon guidance 5362_57715_10298_5365_7852_219699_4772_2534_3985_57144_7869 11 + 0.0249151136180536 0.251771318391133 4482 metyrapone hsa04115 p53 signaling pathway 1647_1026_5366_581_4193_3479_355_3732 8 + 0.00938358404509309 0.123550523260392 4483 metyrapone hsa05310 Asthma 3123_3126_3127_3125 4 + 0.0405482261223165 0.3203309863663 4484 metyrapone hsa04062 Chemokine signaling pathway 7852_156 2 + 0.0362992542157734 0.318626787005122 4485 metyrapone hsa05330 Allograft rejection 3123_3126_3127_941_355_3125 6 + 0.00645584869570818 0.102002409392189 4486 metyrapone hsa04940 Type I diabetes mellitus 3553_3126_2572_3127_941_355_3123_3125 8 + 0.000772555187357999 0.030515929900641 4487 metyrapone hsa04080 Neuroactive ligand-receptor interaction 5618_1081_7067_2150_9568_2149 6 - 0.0325476082632542 0.983101298451377 4488 metyrapone hsa04740 Olfactory transduction 810_26211_109 3 - 3.2138242071424e-06 0.000273175057607104 4489 valinomycin hsa05332 Graft-versus-host disease 3824_3109_3821_3113_3107_3126_3127_3125_355_3123_3119 11 + 0.00831016208758673 0.109418228550644 4490 valinomycin hsa05010 Alzheimer's disease 1339_3710_317_355_2776_5532_3708_6622_4842 9 + 0.0399271039388322 0.32304656823237 4491 valinomycin hsa05320 Autoimmune thyroid disease 3586_958_3109_3119_3113_3107_3126_3127_3125_355_3123 11 + 0.0466849472552093 0.335299290641216 4492 valinomycin hsa05016 Huntington's disease 1339_7052_1639_317_2776_3092_3708_5468 8 + 0.00860592808825287 0.109418228550644 4493 valinomycin hsa04740 Olfactory transduction 5566_4995_393046_816 4 + 3.83145778212412e-12 1.79665661031803e-10 4494 valinomycin hsa04514 Cell adhesion molecules (CAMs) 9076_8506_23308_57863_3655_3676_958_3383_3123_3107_3126_3127_3125_933_5788_1462_4099_3109_3119_3113_6693_923_925_1000 24 + 0.0175936951040278 0.173982096028719 4495 valinomycin hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8360_8368_8335_8348_8329_8294_3109_121504_8341_958_8370_3123_8366_3126_3127_3125_8969_8968_3586_717_8362_8358_8359_8330_8331_8336_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_83740_3013_3113_720_721 51 + 4.03743058498433e-12 1.79665661031803e-10 4496 valinomycin hsa05219 Bladder cancer 1026_1029_7057_4193_5925_1956_7422_4609_2261 9 + 0.049795797975284 0.335299290641216 4497 valinomycin hsa05310 Asthma 958_3109_3586_2207_3123_3126_3127_3125_3119_3113 10 + 0.00288042759117221 0.0854526852047756 4498 valinomycin hsa04062 Chemokine signaling pathway 3717_5566_2773_7454_5290_7410_2829_10663_4793 9 + 0.013902383580441 0.154664017332406 4499 valinomycin hsa05012 Parkinson's disease 1339_6622_317_7318 4 + 0.00488285414235126 0.0869148037338524 4500 valinomycin hsa05330 Allograft rejection 958_3109_3586_3113_3107_3126_3127_3125_355_3123_3119 11 + 0.00446682132242353 0.0869148037338524 4501 valinomycin hsa04940 Type I diabetes mellitus 3109_3119_3113_3107_3126_3127_2571_355_3123_3125 10 + 0.0301408950554447 0.268253965993458 4502 valinomycin hsa05332 Graft-versus-host disease 3812_57292_3811_3804_3569_3126_3127_3803_3802_3123_3125_942 12 - 0.0149758221217602 0.188267478102128 4503 valinomycin hsa04120 Ubiquitin mediated proteolysis 4214_996_7322_6502_5371_4281_9021 7 - 0.0112594823084325 0.16513907385701 4504 valinomycin hsa05010 Alzheimer's disease 775_776_348_5533_3708_3709_488_6622_517_23236 10 - 0.00931729396163535 0.163984373724782 4505 valinomycin hsa04612 Antigen processing and presentation 57292_3809_3808_3804_3806_3803_3802_6892_3306_3304_3305_3303_3123_3126_3127_3125_3812_3810_3811_3310_3449_3448_920_115653 24 - 0.00136216291810084 0.059935168396437 4506 valinomycin hsa05016 Huntington's disease 8218_4899_7802_64446_3708_7416_9001_161_517_23236 10 - 0.00410562878606019 0.0903238332933242 4507 valinomycin hsa04740 Olfactory transduction 8388_8387_1179_26531_26476_4991_26529_9635 8 - 7.4912288827906e-12 6.59228141685573e-10 4508 valinomycin hsa05012 Parkinson's disease 7314_6622_7416_517_5413 5 - 0.00256143332628865 0.0751353775711337 4509 AG-013608 hsa05332 Graft-versus-host disease 57292_3824_3119_3821_3123_3122_3125_3107_3126_3127_3111_3558_3135_355_3811_5551_940_3133_941_3802_3113 21 + 0.0171953844928767 0.115454724452172 4510 AG-013608 hsa04120 Ubiquitin mediated proteolysis 23327_4214_51343_8945_5371_23759_6477_330_867_4193_7337_7329_996_8916_331_55236_10075_9246_9021_7428 20 + 0.012966650597336 0.101789327396635 4511 AG-013608 hsa05010 Alzheimer's disease 836_3710_2904_6392_642502_6622_6391_651820_3708_4137_5330_5532_4035_351_5534_810_824_102_355_6263 20 + 0.000161709591612894 0.00380017540290301 4512 AG-013608 hsa04910 Insulin signaling pathway 8660_2475_10000_867_5599_32_5140_6009_6194_25759_10211_51763_2002_810_5568_7249_5563_9021_5577_51422 20 + 0.0164805403455776 0.115454724452172 4513 AG-013608 hsa05016 Huntington's disease 4899_83447_6648_2904_7052_642502_6391_651820_246721_6392_3708_1211_90993_9001_55567_836_5330_161 18 + 7.11879093499307e-06 0.000334583173944674 4514 AG-013608 hsa03420 Nucleotide excision repair 5425_5111 2 + 0.00489990407196026 0.0575738728455331 4515 AG-013608 hsa05014 Amyotrophic lateral sclerosis (ALS) 836_834_5532_2904_10452_5534 6 + 0.0386009014175008 0.182502993285037 4516 AG-013608 hsa04740 Olfactory transduction 26211_26212_5568_4991_135948_26664_8392_81697_390892_810_816 11 + 9.52636033130137e-26 8.95477871142329e-24 4517 AG-013608 hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_2904_8368_8360_8362_8329_8294_8351_8342_8341_958_3122_3123_8366_3126_3127_3125_8969_8968_940_8370_718_717_8358_8359_8330_8331_8336_554313_8350_121504_8352_8353_8354_8355_8356_8357_8332_85235_3119_83740_3013_3113_3014_941_720_721_8970_3111_729 56 + 0.00989855970226284 0.0930464612012707 4518 AG-013608 hsa04110 Cell cycle 5591_51343_1021_9134_699_1029_4193_1028_996_8556_7040_8555_7042_5111_894_1017 16 + 0.012994382220847 0.101789327396635 4519 AG-013608 hsa04530 Tight junction 5521_6709_10000_9073_5581_7122_5578_998_5519_2036_84612_4625_1496_22808_5865_8531_26285_9223_5583 19 + 0.00911257169133148 0.0930464612012707 4520 AG-013608 hsa05110 Vibrio cholerae infection 5568_3784_5578_525_535_4583 6 + 0.0289796808471148 0.151338333312711 4521 AG-013608 hsa03022 Basal transcription factors 54457_2957_51616 3 + 0.047337954455875 0.202262169038739 4522 AG-013608 hsa04062 Chemokine signaling pathway 10000_7852_5330_5058_10235_112_7454_5568_3576_25759_6369_6367_6366_1237_1230_2919_998_2185_9844_10681_4793_6355_6358_6359_643_2792_6373_10803 28 + 0.00397292252500146 0.0533506739071625 4523 AG-013608 hsa05012 Parkinson's disease 83447_836_6392_642502_6622_6391_651820_7054_9246_7345_6531_9627 12 + 7.72272182915049e-05 0.00241978617313382 4524 AG-013608 hsa04620 Toll-like receptor signaling pathway 3593_3439_3451_10000_958_5599_3447_3576_3446_941_2353_3725_6373_5609 14 + 0.0270257490370056 0.149436494675207 4525 AG-013608 hsa04260 Cardiac muscle contraction 7169_6262_782_783_7170_9254_477_4635_23439_478_4625 11 + 0.0388304241031994 0.182502993285037 4526 AG-013608 hsa03010 Ribosome 6123_6192_6194_6205_6141_284393_439992_6234_6165_389342_6189 11 + 0.00322173933256368 0.0504739162101643 4527 AG-013608 hsa03020 RNA polymerase 246721 1 + 0.0201397670600941 0.119294231059028 4528 AG-013608 hsa03050 Proteasome 5689 1 + 0.000281140946721173 0.00528544979835805 4529 AG-013608 hsa05330 Allograft rejection 3593_958_3119_3123_3122_3126_3107_3113_3127_3111_3125_3135_355_5551_940_3133_941_3558 18 + 0.0436354879121562 0.195320755416318 4530 AG-013608 hsa04940 Type I diabetes mellitus 3593_3382_2572_3119_3123_3122_3558_3107_3126_3127_3111_2571_3135_355_5551_940_3133_941_3125_3113_5799 21 + 0.0203054010313239 0.119294231059028 4531 AG-013608 hsa05332 Graft-versus-host disease 3812_57292_3824_3119_3804_3107_3126_3127_3111_3802_3135_356_355_3811_5551_3803_3123_3125_3112_3569 20 - 0.014638299071644 0.224453919098541 4532 AG-013608 hsa04120 Ubiquitin mediated proteolysis 7337_4214_4281_652671_7332_6502_23759_5371_4193_330_22888_996_51465_8452_331_89910_51343_8065_26091_9021_55958 21 - 0.044078740381341 0.36865855591667 4533 AG-013608 hsa03320 PPAR signaling pathway 2710_33_9370_5360_5465_9415_5467_6257 8 - 0.0433047645079649 0.36865855591667 4534 AG-013608 hsa05010 Alzheimer's disease 2902_51806_317_5331_6622_4842_775_776_1339_5532_3708_3709_6868_488_801_23236_841_2081_4137_355_808_8851_805 23 - 0.00373073812292202 0.0686455814617652 4535 AG-013608 hsa05016 Huntington's disease 2902_4899_27113_1339_841_581_8218_317_3708_1213_5331_163_55567_1387_161_23236 16 - 6.21112241465003e-06 0.000190474420715934 4536 AG-013608 hsa03420 Nucleotide excision repair 5887_5111_2072 3 - 0.0244885827434367 0.279908700622498 4537 AG-013608 hsa04740 Olfactory transduction 51806_7932_26211_5613_23538_5616_1179_5132_26531_808_805_4991_801_9635_816 15 - 1.1961074270855e-20 1.10041883291866e-18 4538 AG-013608 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_6738_88_89_8329_8294_121504_81_958_3123_3126_3127_3125_8969_8968_55766_8370_717_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_2215_2214_3013_3112_3111_729 50 - 0.0273823728869835 0.279908700622498 4539 AG-013608 hsa03030 DNA replication 5111_4173 2 - 0.0231095679790742 0.279908700622498 4540 AG-013608 hsa05012 Parkinson's disease 2861_1339_7332_5413_317_51465_6622 7 - 9.8853815544762e-07 4.54727551505905e-05 4541 AG-013608 hsa03010 Ribosome 6187_440589_6224_6125_6192_6144_6234_6129 8 - 0.000599656831756579 0.0137921071304013 4542 streptomycin hsa04910 Insulin signaling pathway 23433_9021_5602 3 + 0.0259304287382987 0.544539003504273 4543 streptomycin hsa04740 Olfactory transduction 26539_7932_8390_9635_1179 5 + 3.00737150314173e-07 2.52619206263905e-05 4544 streptomycin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8347_8346_8344_8370_716_8359_8330_554313_6738_121504_8339_2215_3113_3111 25 + 0.00025050377458102 0.0105211585324028 4545 streptomycin hsa04530 Tight junction 6709_84612_27134 3 + 0.0256947207788007 0.544539003504273 4546 streptomycin hsa04260 Cardiac muscle contraction 6262 1 + 0.0446764681692909 0.750564665244087 4547 streptomycin hsa04512 ECM-receptor interaction 3914_3691_1277_3678_9672_3675 6 - 0.0380401636605284 1 4548 tremorine hsa05332 Graft-versus-host disease 3812_3824_3558_356_355_3811_3802 7 + 0.0204057969239467 0.723289774040129 4549 tremorine hsa04740 Olfactory transduction 26211_26212_26707_5593 4 + 2.06180265195029e-06 0.000177315028067725 4550 tremorine hsa04510 Focal adhesion 5599_858_1292_5058_1950 5 + 0.0343097048870476 0.723289774040129 4551 tremorine hsa04810 Regulation of actin cytoskeleton 10095_2934_5058_1950_10552_2247 6 + 0.0420517310488447 0.723289774040129 4552 tremorine hsa03010 Ribosome 6165 1 + 0.0307870357467574 0.723289774040129 4553 tremorine hsa03440 Homologous recombination 5890_7156_25788_10111 4 - 0.049552034873741 0.51675693511187 4554 tremorine hsa05010 Alzheimer's disease 5534_488 2 - 0.0255105297942681 0.442821382249741 4555 tremorine hsa04080 Neuroactive ligand-receptor interaction 2846_146_2908 3 - 0.00527516188996067 0.192543408983564 4556 tremorine hsa05200 Pathways in cancer 4149_4088_6502_51588_7423_8321_4791 7 - 0.0303302316609412 0.442821382249741 4557 tremorine hsa04740 Olfactory transduction 818 1 - 7.54805681527077e-07 5.51008147514766e-05 4558 tremorine hsa04630 Jak-STAT signaling pathway 8651_51588 2 - 0.0494315132939392 0.51675693511187 4559 tremorine hsa04060 Cytokine-cytokine receptor interaction 8718_7423_3579_8741 4 - 0.0145470989196285 0.353979407044293 4560 moxisylyte hsa04130 SNARE interactions in vesicular transport 8417_6844 2 + 0.0281430708517663 0.675433700442391 4561 moxisylyte hsa04070 Phosphatidylinositol signaling system 8394_8396_23396_64768_5336 5 - 0.0400762617033482 0.512976149802857 4562 moxisylyte hsa04080 Neuroactive ligand-receptor interaction 64106 1 - 0.0328713783888333 0.512976149802857 4563 moxisylyte hsa04740 Olfactory transduction 5567 1 - 0.00167624308094183 0.0536397785901386 4564 moxisylyte hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344 12 - 0.000276293531118023 0.0176827859915535 4565 moxisylyte hsa04060 Cytokine-cytokine receptor interaction 355 1 - 0.0339851411534415 0.512976149802857 4566 epirizole hsa05332 Graft-versus-host disease 3135_3105_3106_649853 4 + 0.00472771581811366 0.110195271730947 4567 epirizole hsa05320 Autoimmune thyroid disease 3135_3105_3106_649853 4 + 0.0100936574255413 0.15140486138312 4568 epirizole hsa04612 Antigen processing and presentation 3135_3105_3106_649853 4 + 0.0497118044851575 0.497118044851575 4569 epirizole hsa04740 Olfactory transduction 81797 1 + 0.0318206650307395 0.381847980368874 4570 epirizole hsa05330 Allograft rejection 3135_3105_3106_649853 4 + 0.00339483616283194 0.110195271730947 4571 epirizole hsa04940 Type I diabetes mellitus 3135_3105_3106_649853 4 + 0.00550976358654737 0.110195271730947 4572 epirizole hsa05332 Graft-versus-host disease 3108_3105_3126_3127_3125_3123 6 - 0.00523144663604968 0.0728027747227827 4573 epirizole hsa05320 Autoimmune thyroid disease 3108_3105_3126_3127_3125_3123 6 - 0.0141176887158016 0.147227325179074 4574 epirizole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3014_3125_8359_8294_8367_554313_8368_121504_3108 20 - 6.08231574783046e-07 4.44009049591624e-05 4575 epirizole hsa05310 Asthma 3123_3125_3108_3127_3126 5 - 0.00598378970324241 0.0728027747227827 4576 epirizole hsa04060 Cytokine-cytokine receptor interaction 1436 1 - 0.00257989451190809 0.0614648220320135 4577 epirizole hsa05330 Allograft rejection 3108_3105_3126_3127_3125_3123 6 - 0.00336793545380896 0.0614648220320135 4578 epirizole hsa04940 Type I diabetes mellitus 3108_3105_3126_3127_2571_3123_3125 7 - 0.00150599351821017 0.0549687634146712 4579 imipramine hsa04740 Olfactory transduction 26211 1 + 0.00353478575855988 0.0989740012396766 4580 imipramine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_942 26 + 1.29134936247008e-15 7.23155642983245e-14 4581 imipramine hsa05222 Small cell lung cancer 3688_3910_317_331_330_3685 6 + 0.0128975695984851 0.240754632505055 4582 imipramine hsa04070 Phosphatidylinositol signaling system 8394_3633_808_801_805_23236 6 - 0.0148383807944823 0.361756071937309 4583 imipramine hsa05200 Pathways in cancer 1869_5888 2 - 0.0183943765391852 0.361756071937309 4584 imipramine hsa04740 Olfactory transduction 801_808_805 3 - 0.0273798740959356 0.391598407714103 4585 imipramine hsa04720 Long-term potentiation 801_808_107_805_23236 5 - 0.0455131237678675 0.447545717050697 4586 imipramine hsa03020 RNA polymerase 5432_246721_5439_548644 4 - 0.00810914792024726 0.361756071937309 4587 imipramine hsa04270 Vascular smooth muscle contraction 5581_808_23365_801_107_805_23236 7 - 0.0331863057384833 0.391598407714103 4588 homatropine hsa05332 Graft-versus-host disease 3812_57292_3811_3804_3803_3802_3135 7 + 0.000384602414933173 0.00910225715341843 4589 homatropine hsa04650 Natural killer cell mediated cytotoxicity 3812_57292_3811_3809_3808_3440_3804_6655_3806_3810_3803_3802_3135_5532_3845_8794 16 + 5.92752091243061e-06 0.000210426992391287 4590 homatropine hsa04612 Antigen processing and presentation 3812_57292_3811_3809_3808_3440_3804_3806_3810_3803_3802_3135_811_115653 14 + 9.34502203439851e-07 6.63496564442294e-05 4591 homatropine hsa04912 GnRH signaling pathway 6655_2776_3708_3845_5603_5338_5609 7 + 0.0417904817188738 0.74178105051001 4592 homatropine hsa05221 Acute myeloid leukemia 861_5914_11040_673 4 - 0.0205184094798966 1 4593 allantoin hsa05131 Shigellosis 7278_7280_113457_347733 4 - 0.0221521422634581 0.556576796509571 4594 allantoin hsa05130 Pathogenic Escherichia coli infection 7278_7280_113457_347733 4 - 0.0221521422634581 0.556576796509571 4595 allantoin hsa04540 Gap junction 7278_5607_7280_113457_347733 5 - 0.0309209331394206 0.556576796509571 4596 todralazine hsa04670 Leukocyte transendothelial migration 5579_88_26285_5603_5175 5 + 0.0380636540946127 1 4597 todralazine hsa04740 Olfactory transduction 26333 1 + 0.0471055774427457 1 4598 todralazine hsa04080 Neuroactive ligand-receptor interaction 2149 1 - 0.00750091973044751 0.182522380107556 4599 todralazine hsa04740 Olfactory transduction 5613_5616 2 - 0.0016234761991335 0.0592568812683728 4600 todralazine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3113_8359_8294_8367_554313_121504 15 - 5.19696067186177e-05 0.00379378129045909 4601 todralazine hsa04370 VEGF signaling pathway 5595_5829_5881_5335_7422_5534 6 - 0.0319972623350774 0.46716003009213 4602 todralazine hsa05219 Bladder cancer 1869_7422_5595_7057_369 5 - 0.0108531636446472 0.198070236514811 4603 todralazine hsa04810 Regulation of actin cytoskeleton 5595_5829_2909_3678_54961_5154_8394_5881_7430_324_369_2149 12 - 0.0435232835610174 0.508129171281816 4604 dexpanthenol hsa04916 Melanogenesis 107_816_1857 3 + 0.0317161251102666 0.61761440168519 4605 dexpanthenol hsa04930 Type II diabetes mellitus 8660_5581 2 + 0.0368486730590384 0.61761440168519 4606 dexpanthenol hsa05332 Graft-versus-host disease 3135_3123_3126_3127_3125 5 - 0.00151237887920548 0.0371335708881467 4607 dexpanthenol hsa04640 Hematopoietic cell lineage 3123_3126_3127_2057_3125 5 - 0.0253732025355783 0.186568792673853 4608 dexpanthenol hsa05320 Autoimmune thyroid disease 3135_3123_3126_3127_3125 5 - 0.00385165237434462 0.0425257217099336 4609 dexpanthenol hsa04612 Antigen processing and presentation 3135_3123_3126_3127_3125 5 - 0.0275265431813881 0.186568792673853 4610 dexpanthenol hsa04514 Cell adhesion molecules (CAMs) 2734_3123_3126_3127_3125_3135_5792_6693 8 - 0.00418285787310822 0.0425257217099336 4611 dexpanthenol hsa05310 Asthma 3123_3126_3127_3125 4 - 0.00313136133770117 0.0425257217099336 4612 dexpanthenol hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0195956239110533 0.170761865510607 4613 dexpanthenol hsa05330 Allograft rejection 3135_3123_3126_3127_3125 5 - 0.00100592577482153 0.0371335708881467 4614 dexpanthenol hsa04940 Type I diabetes mellitus 3135_3123_3126_3127_3125 5 - 0.00182624119122033 0.0371335708881467 4615 benzonatate hsa05322 Systemic lupus erythematosus 474382_959_474381_83740_3111_88 6 + 0.0427770035406753 1 4616 benzonatate hsa04080 Neuroactive ligand-receptor interaction 64106 1 - 0.0328713783888333 0.547856306480555 4617 benzonatate hsa04740 Olfactory transduction 157 1 - 0.00167624308094183 0.0838121540470915 4618 benzonatate hsa05322 Systemic lupus erythematosus 85235_8330_3014_8332_8969_8331_8329_8336 8 - 0.0254525875733712 0.547856306480555 4619 thapsigargin hsa04916 Melanogenesis 64764_5578_4286_1857 4 + 0.0121205774647769 0.0868641384975678 4620 thapsigargin hsa04130 SNARE interactions in vesicular transport 55850_6811_9527_10282_662_53407_9570_8675_9554_6844_6845 11 + 0.0173526937259693 0.099488777362224 4621 thapsigargin hsa05010 Alzheimer's disease 22926_55851_836_11261_9451_5533_5663_3709_23385_5534_6868_6390 12 + 0.0444991524336152 0.201417216278469 4622 thapsigargin hsa04080 Neuroactive ligand-receptor interaction 5618_7068_3953_2908_5025_64106_7067 7 + 9.57023579051699e-07 8.23040277984461e-05 4623 thapsigargin hsa05320 Autoimmune thyroid disease 3135 1 + 0.0267014168234982 0.131910236997442 4624 thapsigargin hsa04670 Leukocyte transendothelial migration 10451_7409_5600_5603_5578 5 + 0.00897121671714638 0.0754863366761926 4625 thapsigargin hsa05016 Huntington's disease 246721_51164_5434_7052_1639_6390_6667_10126_836_64764_5481 11 + 0.0148284555625356 0.0910890841698616 4626 thapsigargin hsa04514 Cell adhesion molecules (CAMs) 3135_3655_5817_999_23308 5 + 0.00348804710835167 0.0395354365114486 4627 thapsigargin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8349_8348_8329_8294_121504_723790_8969_8968_8370_92815_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_8970 39 + 3.11743168121875e-05 0.00134049562292406 4628 thapsigargin hsa04710 Circadian rhythm - mammal 8864_5187_8553_406_9572_79365_1407 7 + 0.0036777150243208 0.0395354365114486 4629 thapsigargin hsa04530 Tight junction 4619_5590_55870_5583_5578 5 + 0.00250564814735648 0.0359142901121095 4630 thapsigargin hsa04062 Chemokine signaling pathway 2309_5590_7454_3551_6774_6464_10451_7409_1398_5058_4790_4793 12 + 0.0222729281563577 0.119716988840423 4631 thapsigargin hsa04810 Regulation of actin cytoskeleton 7454_9138_2335_3985_8394_10672_5058_1398_6548_10451_7409_2263_3655_3675 14 + 0.0140048007414763 0.0910890841698616 4632 thapsigargin hsa05012 Parkinson's disease 7327_836_6390_51465_27429_5481 6 + 0.00897926271854564 0.0754863366761926 4633 thapsigargin hsa04260 Cardiac muscle contraction 6548 1 + 0.00122521768150875 0.0210737441219505 4634 thapsigargin hsa04060 Cytokine-cytokine receptor interaction 5618_2057_3953_3459_3572_50615_7422_90_8795_83729_51330 11 + 6.7514717487622e-05 0.00193542190131183 4635 thapsigargin hsa03010 Ribosome 6234_6137 2 + 0.00120797827574491 0.0210737441219505 4636 thapsigargin hsa04020 Calcium signaling pathway 5578_11261_5025_5533_7220_5333_3709_5534_490_5481 10 + 0.00965522910974557 0.0754863366761926 4637 thapsigargin hsa05217 Basal cell carcinoma 1857 1 + 0.0276091193715576 0.131910236997442 4638 thapsigargin hsa05010 Alzheimer's disease 1340_5331_317 3 - 0.0498818765920741 0.428047029835232 4639 thapsigargin hsa04080 Neuroactive ligand-receptor interaction 9568_7434_2908_1081_4886 5 - 0.0259336707201681 0.428047029835232 4640 thapsigargin hsa05016 Huntington's disease 1340_5331_317 3 - 0.0369668878069196 0.428047029835232 4641 thapsigargin hsa04740 Olfactory transduction 5613_5616 2 - 2.10795854420246e-06 0.000177068517713007 4642 thapsigargin hsa05215 Prostate cancer 5295_9134_5296_6655_596_5155_898_367_1017 9 - 0.0490783624479566 0.428047029835232 4643 thapsigargin hsa03030 DNA replication 10714_5427_5111_5558_4173 5 - 0.0432444512268716 0.428047029835232 4644 thapsigargin hsa03022 Basal transcription factors 11037_6884_51616_2969_728198 5 - 0.0472541448001823 0.428047029835232 4645 thapsigargin hsa05222 Small cell lung cancer 5295_3912_9134_5296_598_596_317_7188_898_6502_1017 11 - 0.00608817397232652 0.255703306837714 4646 ascorbic acid hsa05016 Huntington's disease 5331_3708 2 + 0.0181520351867528 0.662549284316477 4647 ascorbic acid hsa04740 Olfactory transduction 810_26211 2 + 9.42272387105964e-06 0.000687858842587354 4648 ascorbic acid hsa05012 Parkinson's disease 6622 1 + 0.0317869971452826 0.773483597201877 4649 ascorbic acid hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_8336 7 - 0.0252236104123388 1 4650 hydroflumethiazide hsa05332 Graft-versus-host disease 3135_3105_3106_649853 4 + 0.00107326168563954 0.022689996258202 4651 hydroflumethiazide hsa05320 Autoimmune thyroid disease 3135_3105_3106_649853 4 + 0.0023910481410965 0.0322791499048028 4652 hydroflumethiazide hsa04612 Antigen processing and presentation 3135_3105_3106_649853 4 + 0.013493960732424 0.121445646591816 4653 hydroflumethiazide hsa04514 Cell adhesion molecules (CAMs) 3135_3105_3106_5817_649853 5 + 0.0121843158968029 0.121445646591816 4654 hydroflumethiazide hsa05330 Allograft rejection 3135_3105_3106_649853 4 + 0.000758762343697103 0.022689996258202 4655 hydroflumethiazide hsa04940 Type I diabetes mellitus 3135_3105_3106_649853 4 + 0.00126055534767789 0.022689996258202 4656 hydroflumethiazide hsa04210 Apoptosis 5533_598_5566_5567_8837 5 - 0.020485113435409 0.782418110448804 4657 acetazolamide hsa04640 Hematopoietic cell lineage 3690_3581_925 3 + 0.0334688327153247 0.630356832370786 4658 acetazolamide hsa05014 Amyotrophic lateral sclerosis (ALS) 598_4217_5606_834 4 - 0.0298167696480739 0.678192586246771 4659 acetazolamide hsa04710 Circadian rhythm - mammal 406_8863 2 - 0.0339674474721561 0.678192586246771 4660 acetazolamide hsa04540 Gap junction 7278_6714_5155_113457_5607 5 - 0.0433231492780001 0.678192586246771 4661 aminocaproic acid hsa04510 Focal adhesion 4638_3910_3695_6714_1291_55742 6 + 0.0259229367531145 0.380203072379013 4662 aminocaproic acid hsa05120 Epithelial cell signaling in Helicobacter pylori infection 10392_6714_5781 3 + 0.0445374961712682 0.48991245788395 4663 aminocaproic acid hsa03450 Non-homologous end-joining 27343_7518 2 + 0.0123101252866745 0.270822756306839 4664 aminocaproic acid hsa04540 Gap junction 5598_6714_113457_7278_2977 5 + 0.00392264596287144 0.172596422366343 4665 aminocaproic acid hsa05332 Graft-versus-host disease 3135_3123_3126_3127_3125 5 - 0.00412729836921924 0.0817529559399273 4666 aminocaproic acid hsa05200 Pathways in cancer 3688_4149_861_675_5155_1613_1856_4088_405_3845_6934_6502_91_2271 14 - 0.0400428655845 0.390417939448875 4667 aminocaproic acid hsa05320 Autoimmune thyroid disease 3135_3123_3126_3127_3125 5 - 0.0100814294582427 0.11233592824899 4668 aminocaproic acid hsa05322 Systemic lupus erythematosus 85235_3123_3126_3127_3125_8332_8969_8331_8336_8329_8330 11 - 0.000818776735024822 0.0638645853319361 4669 aminocaproic acid hsa04710 Circadian rhythm - mammal 1454_9572_8863 3 - 0.00524057409871329 0.0817529559399273 4670 aminocaproic acid hsa05310 Asthma 3123_3126_3127_3125 4 - 0.00710730540460966 0.0923949702599256 4671 aminocaproic acid hsa05330 Allograft rejection 3135_3123_3126_3127_3125 5 - 0.0027875578129311 0.0817529559399273 4672 aminocaproic acid hsa04940 Type I diabetes mellitus 3135_3123_3126_3127_3125 5 - 0.0049459398732897 0.0817529559399273 4673 (-)-isoprenaline hsa04670 Leukocyte transendothelial migration 9076_29895_1432_5829_7852_88_5600 7 + 0.0268143892645187 0.483518541304042 4674 (-)-isoprenaline hsa04740 Olfactory transduction 810 1 + 0.00247112864017181 0.091431759686357 4675 (-)-isoprenaline hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_88_8294_8367_554313_121504_3109 16 + 6.15707379785781e-07 4.55623461041478e-05 4676 (-)-isoprenaline hsa04710 Circadian rhythm - mammal 8864_5187 2 + 0.0439322194821785 0.541830706946868 4677 (-)-isoprenaline hsa05218 Melanoma 8817_208_2247_4193_2258 5 + 0.0284201059263572 0.483518541304042 4678 (-)-isoprenaline hsa04060 Cytokine-cytokine receptor interaction 7852 1 + 0.0326701717097326 0.483518541304042 4679 (-)-isoprenaline hsa04080 Neuroactive ligand-receptor interaction 2908_4157 2 - 0.0361057824251333 0.7512639737077 4680 (-)-isoprenaline hsa04740 Olfactory transduction 818 1 - 0.000253935638586774 0.0177754947010742 4681 (-)-isoprenaline hsa05210 Colorectal cancer 6934_1956_324_5602_3725_4233 6 - 0.0419078758472061 0.7512639737077 4682 chlorambucil hsa05332 Graft-versus-host disease 3812_3119_3123_3107_3126_3127_3125 7 + 0.00206886920759591 0.0382740803405243 4683 chlorambucil hsa05010 Alzheimer's disease 348 1 + 0.015451931306315 0.16334898809533 4684 chlorambucil hsa05320 Autoimmune thyroid disease 3119_3123_3107_3126_3127_3125 6 + 0.021747623099015 0.190674994558562 4685 chlorambucil hsa04612 Antigen processing and presentation 3812_3119_3805_3123_3107_3126_3127_3125 8 + 0.0276567600834386 0.204660024617446 4686 chlorambucil hsa04740 Olfactory transduction 7932 1 + 1.23788797164225e-05 0.000458018549507633 4687 chlorambucil hsa04514 Cell adhesion molecules (CAMs) 3119_3123_1272_3107_3126_3127_3125_23308_6693_3684_1462 11 + 0.0231902020409062 0.190674994558562 4688 chlorambucil hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8341_8340_3123_3126_3127_3125_8370_8359_554313_121504_3119_720_721 23 + 5.18610804797918e-08 3.83771995550459e-06 4689 chlorambucil hsa05310 Asthma 3119_2207_3123_3126_3127_3125 6 + 0.00191661871965266 0.0382740803405243 4690 chlorambucil hsa05330 Allograft rejection 3119_3123_3107_3126_3127_3125 6 + 0.00541353898418081 0.080120376965876 4691 chlorambucil hsa04940 Type I diabetes mellitus 3119_3123_3107_3126_3127_3125 6 + 0.010118961968049 0.124800530939271 4692 chlorambucil hsa05214 Glioma 1021_208_6655_5335_816 5 - 0.0487911956674146 0.534036375871946 4693 chlorambucil hsa04640 Hematopoietic cell lineage 960_3552_2057_3589_933_3675 6 - 0.049187560935574 0.534036375871946 4694 chlorambucil hsa04740 Olfactory transduction 816 1 - 0.000254596725577247 0.00967467557193539 4695 chlorambucil hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_88_8294_8367_554313_121504 15 - 4.64007568002974e-05 0.0035264575168226 4696 chlorambucil hsa05221 Acute myeloid leukemia 208_6655_5371_652671_11040 5 - 0.0351910250529954 0.534036375871946 4697 chlorambucil hsa05223 Non-small cell lung cancer 6789_208_6655_5335_1021 5 - 0.0258795788712189 0.534036375871946 4698 chlorambucil hsa02010 ABC transporters 6891_19_20_11194 4 - 0.0470338313643512 0.534036375871946 4699 ramipril hsa04070 Phosphatidylinositol signaling system 8394_23533_5333_3709 4 + 0.0324521192217598 1 4700 ramipril hsa04080 Neuroactive ligand-receptor interaction 1081_2149_1909 3 - 3.86214626655342e-05 0.0031669599385738 4701 ramipril hsa04514 Cell adhesion molecules (CAMs) 24146_5792 2 - 0.00862614661736168 0.176836005655914 4702 ramipril hsa04062 Chemokine signaling pathway 2309_6655_5290_115_5332_4793 6 - 0.0314119147286759 0.515155401550285 4703 ramipril hsa05012 Parkinson's disease 4714 1 - 0.0015373327207857 0.0420204277014758 4704 ramipril hsa04260 Cardiac muscle contraction 783 1 - 0.0442645730376372 0.604949164847708 4705 ramipril hsa04060 Cytokine-cytokine receptor interaction 27242_8744_355_9180_3572 5 - 0.000434452124893446 0.0178125371206313 4706 pregnenolone hsa05131 Shigellosis 7278_9181_113457_8976_10382 5 + 0.0429334323935318 1 4707 pregnenolone hsa05130 Pathogenic Escherichia coli infection 7278_9181_113457_8976_10382 5 + 0.0429334323935318 1 4708 pregnenolone hsa04740 Olfactory transduction 810 1 - 0.0457283284698548 0.983159062101878 4709 pregnenolone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504 14 - 4.36818634118614e-08 1.87832012671004e-06 4710 R-atenolol hsa04910 Insulin signaling pathway 8660 1 + 0.0470697077702323 0.759014107814753 4711 R-atenolol hsa05016 Huntington's disease 6667 1 + 0.0077438567313224 0.302010412521574 4712 R-atenolol hsa04740 Olfactory transduction 5137_26211 2 + 1.9847155207215e-05 0.00154807810616277 4713 R-atenolol hsa05012 Parkinson's disease 6531 1 + 0.0462646797697766 0.759014107814753 4714 R-atenolol hsa05010 Alzheimer's disease 7381 1 - 0.0154887810395437 0.254016009048517 4715 R-atenolol hsa04080 Neuroactive ligand-receptor interaction 7442_7068 2 - 0.00679687887925378 0.185781356032937 4716 R-atenolol hsa05016 Huntington's disease 7381 1 - 0.0107586433088101 0.220552187830607 4717 R-atenolol hsa04740 Olfactory transduction 5566 1 - 7.91468369705668e-06 0.000649004063158648 4718 R-atenolol hsa05322 Systemic lupus erythematosus 727 1 - 0.0457363354263737 0.584848186883167 4719 R-atenolol hsa04060 Cytokine-cytokine receptor interaction 3455 1 - 0.000795867731949319 0.0326305770099221 4720 R-atenolol hsa04020 Calcium signaling pathway 115_5566 2 - 0.0499260647339289 0.584848186883167 4721 azaperone hsa04740 Olfactory transduction 157 1 + 8.02953981878795e-06 0.000698569964234552 4722 azaperone hsa04740 Olfactory transduction 5613_157 2 - 0.00160167797179698 0.118524169912977 4723 azaperone hsa05120 Epithelial cell signaling in Helicobacter pylori infection 50617_6868_5603_3725_6714_5335 6 - 0.0218490753319069 0.808415787280555 4724 sotalol hsa04070 Phosphatidylinositol signaling system 8394_3708_3633_5333_5335_23236 6 - 0.0151003232692566 0.327173670833893 4725 sotalol hsa05322 Systemic lupus erythematosus 8358_85235_8968_3013_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357 18 - 8.10382501569756e-08 5.26748626020341e-06 4726 sotalol hsa04540 Gap junction 1813_7278_113457_2776_115_3708_23236 7 - 0.0112718072307257 0.327173670833893 4727 sitosterol hsa05332 Graft-versus-host disease 3113_3126_3127_3123_3125 5 + 0.00115541904000397 0.0234101631126769 4728 sitosterol hsa04640 Hematopoietic cell lineage 3123_3126_3127_3125_7850_1378 6 + 0.00498951886008809 0.0529632037410561 4729 sitosterol hsa05320 Autoimmune thyroid disease 3113_3126_3127_3123_3125 5 + 0.00297061878003074 0.0398062916524119 4730 sitosterol hsa04612 Antigen processing and presentation 3123_3126_3127_3125_3310_3113 6 + 0.00553346904757303 0.0529632037410561 4731 sitosterol hsa05322 Systemic lupus erythematosus 3123_3126_3127_3125_8341_3113 6 + 0.0427770035406753 0.318451026358361 4732 sitosterol hsa05310 Asthma 3123_3126_3127_3113_3125 5 + 0.000288207436471272 0.0193098982435752 4733 sitosterol hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0166998559191926 0.139861293323238 4734 sitosterol hsa05330 Allograft rejection 3126_3113_3127_3123_3125 5 + 0.000765835293985578 0.0234101631126769 4735 sitosterol hsa04940 Type I diabetes mellitus 3113_3126_3127_3123_3125 5 + 0.00139762167836877 0.0234101631126769 4736 sitosterol hsa04080 Neuroactive ligand-receptor interaction 3953_3354_4158_2925_56288 5 - 0.0463028217558367 0.359252366355953 4737 sitosterol hsa04740 Olfactory transduction 26212_157_4991 3 - 4.26109001977813e-05 0.00332365021542694 4738 sitosterol hsa04110 Cell cycle 1028 1 - 0.0451489085492641 0.359252366355953 4739 sitosterol hsa05012 Parkinson's disease 6622 1 - 0.0330389792827607 0.359252366355953 4740 sitosterol hsa04620 Toll-like receptor signaling pathway 7097_1326_51135_3455_5296_208_6772_5603_10454_7187 10 - 0.0333338839229477 0.359252366355953 4741 sitosterol hsa05330 Allograft rejection 3123_3126_3127_3133_3125 5 - 0.0410274133713901 0.359252366355953 4742 methoxamine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_717_8368_8359_8294_8367_554313_121504 15 + 0.000143852355740275 0.00992581254607897 4743 methoxamine hsa05131 Shigellosis 7278_7454_113457 3 - 0.00120054039443906 0.0114051337471711 4744 methoxamine hsa05130 Pathogenic Escherichia coli infection 7278_7454_113457 3 - 0.00120054039443906 0.0114051337471711 4745 methoxamine hsa04540 Gap junction 7278_113457 2 - 0.0453602851325868 0.287281805839716 4746 rifampicin hsa04070 Phosphatidylinositol signaling system 8394_5333_3709_8526 4 + 0.0488022775981728 1 4747 rifampicin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_2215_8370_2214_3122_8368_8366_8359_8294_8367_554313_121504_8364 17 + 2.07599016436673e-09 1.47395301670038e-07 4748 rifampicin hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0172073619700195 0.610861349935692 4749 rifampicin hsa04740 Olfactory transduction 818 1 - 0.0113627622120339 0.369289771891102 4750 rifampicin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119_3113 23 - 6.3175321566227e-14 4.10639590180476e-12 4751 nifuroxazide hsa05211 Renal cell carcinoma 5293_201163_405_3845_7422_3725 6 + 0.0173564239153649 0.316754736455409 4752 nifuroxazide hsa04740 Olfactory transduction 26212 1 + 0.000547267868566916 0.0399505544053849 4753 nifuroxazide hsa05219 Bladder cancer 3576_3845_4193_7422 4 + 0.0332562067373262 0.485540618364962 4754 nifuroxazide hsa04115 p53 signaling pathway 1647_5366_4193_472_5054_651610 6 + 0.0145256651409798 0.316754736455409 4755 nifuroxazide hsa03450 Non-homologous end-joining 5591_7518_10111 3 + 0.00957604737408777 0.316754736455409 4756 nifuroxazide hsa05322 Systemic lupus erythematosus 3013_720_721_8343_8351_8339_8347_8346_8344 9 - 0.00335172447273208 0.187696570472996 4757 nifuroxazide hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0248849431528665 0.696778408280262 4758 tetramisole hsa04740 Olfactory transduction 26476 1 + 0.00517240453328015 0.168103147331605 4759 tetramisole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_8294_8367_554313_121504 15 + 8.51407771861203e-07 5.53415051709782e-05 4760 tetramisole hsa05211 Renal cell carcinoma 3725_405_2271_6655_201163 5 - 0.0181156487225315 0.615932056566071 4761 tetramisole hsa05322 Systemic lupus erythematosus 85235_3119_8330_8332_8969_8331_8329_8336 8 - 0.0106422130337086 0.615932056566071 4762 tiaprofenic acid hsa05010 Alzheimer's disease 6263 1 + 0.00522165187769987 0.216698552924545 4763 tiaprofenic acid hsa04740 Olfactory transduction 5568_5566_4992_26692_816 5 + 0.000669479909633289 0.055566832499563 4764 tiaprofenic acid hsa05310 Asthma 3123_3126_3127_3113_3125 5 + 0.0194978523009629 0.403104228138669 4765 tiaprofenic acid hsa05012 Parkinson's disease 7318 1 + 0.0218711894234331 0.403104228138669 4766 tiaprofenic acid hsa05330 Allograft rejection 3126_3113_3127_3123_3125 5 + 0.0431953829613096 0.597536130964783 4767 tiaprofenic acid hsa04940 Type I diabetes mellitus 3382_3123_3126_3127_3125_3113 6 + 0.0242833872372692 0.403104228138669 4768 tiaprofenic acid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8367_8370_8366_8368_8359_8294_554313_121504_8364 14 - 3.10261712352789e-10 1.67541324670506e-08 4769 tiaprofenic acid hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_5781_51382_5602 4 - 0.00599033999586549 0.161739179888368 4770 colistin hsa04740 Olfactory transduction 26211_7932_816 3 + 0.00759862840334894 0.202630090755972 4771 colistin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3109_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 26 + 2.226477695284e-12 1.7811821562272e-10 4772 colistin hsa04210 Apoptosis 3553_5575_317_5290_472_355_8837_651610 8 + 0.00671048260390647 0.202630090755972 4773 lovastatin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_8970 33 + 1.66513018816113e-14 1.26549894300246e-12 4774 lovastatin hsa04210 Apoptosis 843_581_5575_5290_472_5534_8837_651610_8794 9 + 0.0118666986819552 0.450934549914298 4775 lovastatin hsa03020 RNA polymerase 5432_246721_5439_548644 4 + 0.0349517806731214 0.885445110385742 4776 lovastatin hsa04540 Gap junction 7278_3708_113457 3 - 0.0345805547517935 0.622801113969115 4777 sisomicin hsa04740 Olfactory transduction 5137_5593_26532 3 + 0.0147268604099909 0.4859863935297 4778 sisomicin hsa05322 Systemic lupus erythematosus 958_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 12 + 0.000972831774062073 0.0642068970880968 4779 conessine hsa04740 Olfactory transduction 5132 1 + 0.0161038528923037 0.934023467753615 4780 conessine hsa04080 Neuroactive ligand-receptor interaction 7067_5031_9170 3 - 0.00381955379991998 0.101854767997866 4781 conessine hsa04910 Insulin signaling pathway 10000_2319_5613_9470_5616_6464_5562_8835_23265_5792_5290_5565_810 13 - 0.0285031316759293 0.380041755679057 4782 conessine hsa04740 Olfactory transduction 810_5613_5616 3 - 1.97959226772412e-05 0.000791836907089648 4783 conessine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235_3014_9555 32 - 1.75715474555533e-11 1.40572379644426e-09 4784 conessine hsa04210 Apoptosis 10000_842_581_5613_11261_839_5616_5290_596 9 - 0.0460535899867562 0.460535899867562 4785 conessine hsa05210 Colorectal cancer 10000_842_581_4089_596_5881_5290_4437_91_3725 10 - 0.0110839952002154 0.221679904004308 4786 conessine hsa05222 Small cell lung cancer 4149_842_596_10000_5290_51588_9618_3673_1017 9 - 0.0417437303030478 0.460535899867562 4787 conessine hsa04940 Type I diabetes mellitus 3123_3126_3127_2571_1363_3125 6 - 0.0264694891251076 0.380041755679057 4788 co-dergocrine mesilate hsa05131 Shigellosis 7454_5578_7278_113457_7430_6093_8976 7 + 0.0289240745735362 0.819515446250192 4789 co-dergocrine mesilate hsa05130 Pathogenic Escherichia coli infection 7454_5578_7278_113457_7430_6093_8976 7 + 0.0289240745735362 0.819515446250192 4790 co-dergocrine mesilate hsa04740 Olfactory transduction 26211_5593_8390_5132_816 5 + 0.000237526985276061 0.0201897937484652 4791 co-dergocrine mesilate hsa04512 ECM-receptor interaction 960_3693_1288_3685_3918_3679_1293_1290_6696 9 + 0.0426249465063344 0.83958705649711 4792 co-dergocrine mesilate hsa04910 Insulin signaling pathway 51806_5575_10211_6655_5140 5 - 0.0478781715921736 0.883418660332225 4793 co-dergocrine mesilate hsa05322 Systemic lupus erythematosus 85235_8969_8332_8330_8331_8329_8336 7 - 0.00487859975463617 0.278080186014262 4794 co-dergocrine mesilate hsa04210 Apoptosis 3556_5575_3553_5534 4 - 0.0395880394946956 0.883418660332225 4795 mitoxantrone hsa05332 Graft-versus-host disease 355_3107_3119_3133 4 + 0.0208090736186946 0.305482909563666 4796 mitoxantrone hsa05320 Autoimmune thyroid disease 355_3107_3133_3119 4 + 0.0415202091031253 0.366373215094115 4797 mitoxantrone hsa04740 Olfactory transduction 23538 1 + 0.00257268872524751 0.162616750525593 4798 mitoxantrone hsa04514 Cell adhesion molecules (CAMs) 3119_3107_3696_5797_3133_3676_925 7 + 0.0437460555336257 0.366373215094115 4799 mitoxantrone hsa04115 p53 signaling pathway 355_1647_1026_5366_8795 5 + 0.027356678468388 0.305482909563666 4800 mitoxantrone hsa04512 ECM-receptor interaction 2335_3381_3693_1289_3696_1291_3676 7 + 0.00485423135897293 0.162616750525593 4801 mitoxantrone hsa05330 Allograft rejection 355_3107_3119_3133 4 + 0.0153192003034885 0.305482909563666 4802 mitoxantrone hsa04940 Type I diabetes mellitus 355_3107_3119_3133 4 + 0.0239525478020956 0.305482909563666 4803 mitoxantrone hsa04650 Natural killer cell mediated cytotoxicity 3459_3460_10725_3105_11261_6654_355_5291_10451_4775_7409_4772_8795_5295_6655 15 - 0.0440597902016293 0.143602279175681 4804 mitoxantrone hsa04640 Hematopoietic cell lineage 3566_3552_2057_4254_3673_3655 6 - 0.00976355567867418 0.0409139476058728 4805 mitoxantrone hsa03320 PPAR signaling pathway 7316_2180_6256 3 - 0.00330293225806 0.0223515928310105 4806 mitoxantrone hsa05010 Alzheimer's disease 1327_841_8772_642502_11261_6391_9451_355_351_509_7132_23236 12 - 0.000115245233633289 0.00229615482560059 4807 mitoxantrone hsa04080 Neuroactive ligand-receptor interaction 5029_4889_5618_7068_4886_5031_3354_2150_9170 9 - 1.21024248383615e-10 1.06501338577581e-08 4808 mitoxantrone hsa04742 Taste transduction 112 1 - 0.00135227793042947 0.0119000457877793 4809 mitoxantrone hsa05320 Autoimmune thyroid disease 3105_355 2 - 0.00862028652622791 0.0379292607154028 4810 mitoxantrone hsa04670 Leukocyte transendothelial migration 5295_1432_2773_1364_5291_10451_7409_394_7430 9 - 0.0035559352231153 0.0223515928310105 4811 mitoxantrone hsa05016 Huntington's disease 1213_4899_6874_1327_841_642502_6391_246721_9519_23186_509_1385_548644_5439_23236 15 - 0.000438158210674792 0.00428421361548686 4812 mitoxantrone hsa04514 Cell adhesion molecules (CAMs) 965_4685_3105_1364_5792_3655 6 - 3.37478956698213e-05 0.000989938272981425 4813 mitoxantrone hsa04510 Focal adhesion 5295_1398_596_3480_6655_6654_7057_5154_2002_10451_5228_7409_7422_1399_394_3673_3655_1291_4659_3725_5291 21 - 0.00436246670568802 0.0239935668812841 4814 mitoxantrone hsa04530 Tight junction 6709_5584_64398_8189_5581_2773_1364_5519_84612_7525_2017_9223_27134 13 - 0.0130173453509994 0.0520693814039976 4815 mitoxantrone hsa04720 Long-term potentiation 11261_4659_468_23236 4 - 0.00504454374639254 0.0261129323342673 4816 mitoxantrone hsa05110 Vibrio cholerae infection 526_23545 2 - 0.00414107178253155 0.0239935668812841 4817 mitoxantrone hsa04512 ECM-receptor interaction 3655_1291_7057_3673 4 - 0.00180172623174843 0.0144138098539874 4818 mitoxantrone hsa03022 Basal transcription factors 2967_2966_2960_9519_2969_27097_10629_6884_6879_6877_9569_6874_51616_728198 14 - 0.0326691780908656 0.110572602769084 4819 mitoxantrone hsa04062 Chemokine signaling pathway 2309_3717_2773_4067_3551_6655_6654_1398_113_5291_10451_7409_4792_1399_112_5295_5970_6777_8976_23236 20 - 0.00780313137357274 0.0361408189933895 4820 mitoxantrone hsa04810 Regulation of actin cytoskeleton 5295_5154_5291_10451_3655_3673_4659_7430_324_1398_2263_200576_1399_8396_10787_2260_8874_5962_6655_6654_7409_54434_3985_8976 24 - 0.00773986404551083 0.0361408189933895 4821 mitoxantrone hsa05012 Parkinson's disease 2861_7326_1327_7314_6391_642502_509_7332 8 - 0.000209718352054983 0.00307586916347308 4822 mitoxantrone hsa04260 Cardiac muscle contraction 1327_4635 2 - 0.00013046334236367 0.00229615482560059 4823 mitoxantrone hsa04060 Cytokine-cytokine receptor interaction 55540_5154_7132_27242_3552_2057_3459_3572_657_4982_23529_3625_4254_7042_91_655_93_7048_5618_3566_3460_355_7422_8795_51330 25 - 0.000414915259529517 0.00428421361548686 4824 mitoxantrone hsa03010 Ribosome 6139_9349_6137_6125_6168_6234_6160_6233_6171 9 - 0.0254772820509223 0.0956005533968382 4825 mitoxantrone hsa04020 Calcium signaling pathway 3707_11261_56848_113_23236 5 - 4.66393979697042e-09 2.05213351066698e-07 4826 mitoxantrone hsa04912 GnRH signaling pathway 4216_1432_468_6655_6654_2002_113_112_3725_23236 10 - 0.0302233726085912 0.106386271582241 4827 mitoxantrone hsa04730 Long-term depression 5519_3480_2773_4067_23236 5 - 0.0260728781991377 0.0956005533968382 4828 mitoxantrone hsa04270 Vascular smooth muscle contraction 5581_4660_113_112_4659_23236 6 - 0.000272402138131838 0.00342448402222882 4829 mitoxantrone hsa04610 Complement and coagulation cascades 7056_7035_5329 3 - 0.00326181293624625 0.0223515928310105 4830 metitepine hsa04740 Olfactory transduction 818_26476 2 + 8.7981177064175e-05 0.003519247082567 4831 metitepine hsa04514 Cell adhesion molecules (CAMs) 6402_942_29851_3107_3113_925_3134_933_4099_1462 10 + 0.0425919864139347 0.586590031768083 4832 metitepine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3113_8359_8294_8367_554313_8970_121504_942 17 + 7.97793270053258e-05 0.003519247082567 4833 metitepine hsa04710 Circadian rhythm - mammal 8553_5187_9572 3 + 0.0189882407850018 0.434087499203818 4834 metitepine hsa05223 Non-small cell lung cancer 842_2272_5925_5335_5915_6257 6 + 0.0217043749601909 0.434087499203818 4835 metitepine hsa05131 Shigellosis 7278_6093_7430_113457 4 - 0.0161381666116209 0.435730498513764 4836 metitepine hsa05130 Pathogenic Escherichia coli infection 7278_6093_7430_113457 4 - 0.0161381666116209 0.435730498513764 4837 ambroxol hsa04740 Olfactory transduction 8392 1 + 1.72546782310925e-05 0.00134586490202522 4838 ambroxol hsa04512 ECM-receptor interaction 8516_1284_948_2812_3690_3691_3679_6383 8 + 0.0158214846957276 0.617037903133376 4839 ambroxol hsa04810 Regulation of actin cytoskeleton 8516_79784_10787_3679_324_3690_3691_1131_1956_7430_1399_3985_2263_2260 14 + 0.0466942617205191 1 4840 ambroxol hsa04662 B cell receptor signaling pathway 5533_27071_5534 3 - 0.0296556290092785 0.479298492545343 4841 ambroxol hsa04910 Insulin signaling pathway 5599_5576_2002_8835 4 - 0.0341421949321313 0.479298492545343 4842 ambroxol hsa04210 Apoptosis 5533_5576_5534 3 - 0.0449601810682269 0.479298492545343 4843 adenosine phosphate hsa04740 Olfactory transduction 818_51806_109 3 + 5.92203562969166e-05 0.00491528957264408 4844 adenosine phosphate hsa05012 Parkinson's disease 6390 1 + 0.0318300197901184 1 4845 adenosine phosphate hsa04060 Cytokine-cytokine receptor interaction 3082_23765_3976_8794_3815 5 + 0.0460200439743997 1 4846 adenosine phosphate hsa04120 Ubiquitin mediated proteolysis 331_51343_6477_4193_26091_83737_51619_51433_55958_23291 10 - 0.0284584962337992 1 4847 maprotiline hsa04612 Antigen processing and presentation 926 1 + 0.0437923546213035 0.700677673940856 4848 maprotiline hsa05016 Huntington's disease 7052_163_27113_581 4 + 0.014060995785719 0.35700190190532 4849 maprotiline hsa04740 Olfactory transduction 8390 1 + 1.2292623616916e-09 9.8340988935328e-08 4850 maprotiline hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_720_721_8970 24 + 9.4451930235596e-05 0.00377807720942384 4851 maprotiline hsa04530 Tight junction 4619_50848 2 + 0.017850095095266 0.35700190190532 4852 maprotiline hsa05322 Systemic lupus erythematosus 3014_6738_8343_8339_8347_8346_8344 7 - 0.000645792583261657 0.0238943255806813 4853 maprotiline hsa05219 Bladder cancer 1869_2261_1613 3 - 0.00936613620110265 0.173273519720399 4854 chlormezanone hsa05332 Graft-versus-host disease 3553_3126_3107_942_3127_3125_3123_941 8 + 0.0228036175166741 0.456072350333482 4855 chlormezanone hsa04640 Hematopoietic cell lineage 3581_3553_948_3815_3690_3123_2993_3126_3127_3125_915_2812_7066_921_933_3566_2814 17 + 0.00139872492719066 0.0559489970876264 4856 chlormezanone hsa04740 Olfactory transduction 51806_26212_26692_135948_5593_5137_9635 7 + 2.71288161586335e-06 0.000217030529269068 4857 chlormezanone hsa04512 ECM-receptor interaction 2814_7059_2335_948_2812_3690_1277_1284_3679_6383_1101_3918 12 + 0.0445263528525757 0.593684704701009 4858 chlormezanone hsa05330 Allograft rejection 3126_3107_942_3127_941_3123_3125 7 + 0.0369246680470195 0.590794688752312 4859 chlormezanone hsa04940 Type I diabetes mellitus 3382_942_3107_3126_3127_3125_3123_3553_941 9 + 0.0111428026478663 0.297141403943101 4860 chlormezanone hsa05010 Alzheimer's disease 5534 1 - 0.0223183649333304 0.362673430166619 4861 chlormezanone hsa04080 Neuroactive ligand-receptor interaction 7067_5618 2 - 0.0138072116841897 0.362673430166619 4862 chlormezanone hsa03450 Non-homologous end-joining 27343_3981_7518 3 - 0.0194191337186275 0.362673430166619 4863 chlormezanone hsa04062 Chemokine signaling pathway 408 1 - 0.0156288283789566 0.362673430166619 4864 retrorsine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 2.53999337365774e-08 1.39699635551176e-06 4865 retrorsine hsa04070 Phosphatidylinositol signaling system 8394_3633_3631_5333_808_801_27124_805 8 - 0.00425389618939566 0.103511473941961 4866 retrorsine hsa04740 Olfactory transduction 801_808_805 3 - 0.00390401890718805 0.103511473941961 4867 retrorsine hsa05322 Systemic lupus erythematosus 85235_3013_8330_8332_8969_8331_8329_8351_8343_8336_8339_8347_8346_8344 14 - 0.000368134018848984 0.0268737833759758 4868 retrorsine hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_3551_535_10392_5781_6714_528 7 - 0.0100623948265914 0.146910964468234 4869 retrorsine hsa04912 GnRH signaling pathway 4214_1432_6655_50487_808_113_6714_801_805 9 - 0.0100595653556249 0.146910964468234 4870 rescinnamine hsa04940 Type I diabetes mellitus 3382_3109_3119 3 + 0.0447994549245091 0.761758569717304 4871 rescinnamine hsa04120 Ubiquitin mediated proteolysis 5371 1 - 0.0316814956581608 0.905825797461685 4872 rescinnamine hsa04740 Olfactory transduction 818_5566_157 3 - 0.000121619987259411 0.00936473901897465 4873 rescinnamine hsa05012 Parkinson's disease 2861 1 - 0.0468298222690974 0.905825797461685 4874 corynanthine hsa05010 Alzheimer's disease 5331 1 - 0.000518265267972556 0.0145114275032316 4875 corynanthine hsa04080 Neuroactive ligand-receptor interaction 146_5025_4157_7068 4 - 0.00109996442699656 0.0230992529669278 4876 corynanthine hsa04740 Olfactory transduction 5613_5566_5616 3 - 2.23959301665213e-07 1.88125813398779e-05 4877 corynanthine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3108_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3014_720_721 25 - 1.48743338027696e-05 0.000624722019716323 4878 corynanthine hsa04060 Cytokine-cytokine receptor interaction 7852_7424_659_7422_3572 5 - 0.00318015736869026 0.0534266437939964 4879 corynanthine hsa03020 RNA polymerase 246721_5435_5439_661_548644_84172 6 - 0.014612564330565 0.20457590062791 4880 galantamine hsa05131 Shigellosis 7278_113457_2534 3 + 0.0300166843560646 0.570317002765227 4881 galantamine hsa05130 Pathogenic Escherichia coli infection 7278_113457_2534 3 + 0.0300166843560646 0.570317002765227 4882 galantamine hsa04540 Gap junction 7278_1813_113457_23236 4 + 0.0251672722027301 0.570317002765227 4883 galantamine hsa05010 Alzheimer's disease 5331_4700_6392_4698_11261_840_2776_8883_5663_5532_351_513_7381_7385 14 - 0.00594447909991382 0.0921394260486642 4884 galantamine hsa04080 Neuroactive ligand-receptor interaction 5618_4157_3953_2908_4886_64106_2150_5030 8 - 2.51358694692851e-09 1.16881793032176e-07 4885 galantamine hsa04742 Taste transduction 5613_5567 2 - 0.0193299136783218 0.187969551814917 4886 galantamine hsa04740 Olfactory transduction 26211_109_5567_409_5613 5 - 2.32563764898521e-19 2.16284301355625e-17 4887 galantamine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_94239_8366_8368_6738_8329_8294_121504_8343_8347_8346_8344_8339_8367_3123_3126_3127_3125_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3017_3014_8970_9555 47 - 7.56429476710721e-05 0.00175869853335243 4888 galantamine hsa05012 Parkinson's disease 2861_7327_4700_6392_4698_51465_27429_513_7381_7385 10 - 0.0109960381455099 0.131075513829685 4889 galantamine hsa04260 Cardiac muscle contraction 7168_7381_7171_481_7385 5 - 0.0202117797650448 0.187969551814917 4890 galantamine hsa04060 Cytokine-cytokine receptor interaction 5618_3554_3953_4055_55540_3459_5154_3572_657_1956_91_90_4233_8795_659 15 - 6.13857739967934e-06 0.00019029589939006 4891 galantamine hsa04020 Calcium signaling pathway 5256_109_5613_11261_5567_2776_3707_5331_5532_1956_5335_490_107 13 - 0.001708992754268 0.0317872652293848 4892 galantamine hsa03050 Proteasome 5718 1 - 0.0112753130176073 0.131075513829685 4893 galantamine hsa04270 Vascular smooth muscle contraction 5567_5613_50487_2776_5331_109_23365_4659_107 9 - 0.0271850766474848 0.229837466201462 4894 xylazine hsa05332 Graft-versus-host disease 3117_3804_3126_3127_3125_3123 6 + 0.0265268093033219 0.348736540406711 4895 xylazine hsa05320 Autoimmune thyroid disease 3117_3441_3446_3126_3127_3125_3123_7038 8 + 0.00842723001248594 0.332875585493195 4896 xylazine hsa04612 Antigen processing and presentation 4261_3441_3117_3123_3446_3126_3127_3125_6891_3804 10 + 0.0278023663623649 0.348736540406711 4897 xylazine hsa04310 Wnt signaling pathway 5532_23500 2 + 0.0353150926994138 0.348736540406711 4898 xylazine hsa04740 Olfactory transduction 26212_2774_442194_26716_26532_4992_4993_5132 8 + 0.00549412895065593 0.332875585493195 4899 xylazine hsa04530 Tight junction 10000_9073_5581_93643_9071_998_4620_93408_88_51208_3059_7525_4629_9223 14 + 0.0187366216134315 0.348736540406711 4900 xylazine hsa05310 Asthma 3117_3123_3126_3127_3125 5 + 0.0248001520444242 0.348736540406711 4901 xylazine hsa04940 Type I diabetes mellitus 3117_3126_2572_3127_3125_3123 6 + 0.0317191858746506 0.348736540406711 4902 xylazine hsa04080 Neuroactive ligand-receptor interaction 7068_3953_2908_7067_56288_134 6 - 0.00765809505467692 0.214426661530954 4903 xylazine hsa05016 Huntington's disease 5331_7157_4714_6667_10126 5 - 0.0448522203579755 0.538226644295706 4904 xylazine hsa04740 Olfactory transduction 51806 1 - 1.84142474854577e-09 1.54679678877845e-07 4905 xylazine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8370_94239_727_8368_8366_3014_8359_8294_8367_554313_121504_8364 17 - 0.0178179532748221 0.249451345847509 4906 xylazine hsa05012 Parkinson's disease 4714_7345 2 - 0.0174893798324476 0.249451345847509 4907 xylazine hsa04020 Calcium signaling pathway 5331_51806_776 3 - 0.00714108781491408 0.214426661530954 4908 xylazine hsa05210 Colorectal cancer 5595_7043_4088_208_8312_1857_7157_5881_7046_3845_324_4233 12 - 0.0137332240242405 0.249451345847509 4909 cinchonine hsa04650 Natural killer cell mediated cytotoxicity 836_3383_5579_2214_7410_27040_6452_5551_2215_2185_5336_9436 12 + 0.00363618242255335 0.150901570535964 4910 cinchonine hsa04740 Olfactory transduction 5593_9635 2 + 0.000380862575276841 0.0316115937479778 4911 cinchonine hsa05223 Non-small cell lung cancer 5925_5170_1021_5579_5336 5 + 0.0426687298782336 0.791492259072354 4912 cinchonine hsa04740 Olfactory transduction 157 1 - 0.00520657650434988 0.179626889400071 4913 cinchonine hsa05322 Systemic lupus erythematosus 3119_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 12 - 8.75979205494013e-05 0.00604425651790869 4914 cinchonine hsa03020 RNA polymerase 246721_5439_548644 3 - 0.027454375328787 0.631450632562101 4915 sparteine hsa04080 Neuroactive ligand-receptor interaction 2912_3953_2563_2901_799_6755_2741_2688_1442_4987_5732_5644 12 + 0.0373563761629302 0.50710065176281 4916 sparteine hsa04740 Olfactory transduction 8390 1 + 0.0017188876247026 0.0567232916151858 4917 sparteine hsa04510 Focal adhesion 8516_10298_5599_998_3679_2335_1290_1291_2534_3675 10 + 0.0384167160426371 0.50710065176281 4918 sparteine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_717_8368_8359_8294_8367_554313_121504_8341 16 + 1.19173973068795e-06 7.86548222254047e-05 4919 sparteine hsa04512 ECM-receptor interaction 8516_2335_3679_1290_1291_3675 6 + 0.0199352042939815 0.438574494467593 4920 sparteine hsa05211 Renal cell carcinoma 2271_208_2549_5155_5291_1399_7042_3725_6655 9 - 0.00514885345358795 0.176348775326125 4921 sparteine hsa04662 B cell receptor signaling pathway 10725_208_6655_8519_3725_5291_4793 7 - 0.0469596353512887 0.427854455422853 4922 sparteine hsa03420 Nucleotide excision repair 2967_5425_2068_5887_8450_2072 6 - 0.0146733181736828 0.300803022560497 4923 sparteine hsa04514 Cell adhesion molecules (CAMs) 3119 1 - 0.0455625490193181 0.427854455422853 4924 sparteine hsa05322 Systemic lupus erythematosus 3119_3013_3017_8358_8968_8337_8342_8350_8351_8352_8353_8354_8355_8356_8357 15 - 0.00188473514450552 0.154548281849453 4925 sparteine hsa04210 Apoptosis 841_581_7157_208_5291_472_9941_8837_651610_8795 10 - 0.00645178446315091 0.176348775326125 4926 sparteine hsa05012 Parkinson's disease 509 1 - 0.0459282792363712 0.427854455422853 4927 sparteine hsa04020 Calcium signaling pathway 2778_2149 2 - 0.0361064305028764 0.427854455422853 4928 sparteine hsa05220 Chronic myeloid leukemia 7157_208_6655_867_5291_1399_7042 7 - 0.0469596353512887 0.427854455422853 4929 salsolinol hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 + 0.0175847908161456 0.180872134108926 4930 salsolinol hsa04640 Hematopoietic cell lineage 3690_3123_2993_3126_3127_3125_947_925 8 + 0.00107761318997032 0.077588149677863 4931 salsolinol hsa04080 Neuroactive ligand-receptor interaction 2918 1 + 0.0473588855919152 0.284153313551491 4932 salsolinol hsa05320 Autoimmune thyroid disease 3123_3126_3127_3125 4 + 0.035420935828681 0.248436303514449 4933 salsolinol hsa04612 Antigen processing and presentation 3805_3123_3126_3127_3125_6892_925 7 + 0.00493234879252745 0.110126223269159 4934 salsolinol hsa04520 Adherens junction 51176_3480_5879_1496_10580 5 + 0.0379555463702631 0.248436303514449 4935 salsolinol hsa04740 Olfactory transduction 4991 1 + 0.0036721383782321 0.110126223269159 4936 salsolinol hsa04514 Cell adhesion molecules (CAMs) 965_5175_3123_3126_3127_3125_947_925 8 + 0.0124878279187571 0.154804057554061 4937 salsolinol hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_5879_3576_23545_525 5 + 0.0249653587438241 0.199722869950593 4938 salsolinol hsa05310 Asthma 3123_3126_3127_3125 4 + 0.00611812351495329 0.110126223269159 4939 salsolinol hsa05330 Allograft rejection 3123_3126_3127_3125 4 + 0.0129003381295051 0.154804057554061 4940 salsolinol hsa04940 Type I diabetes mellitus 3123_3126_3127_3125 4 + 0.0202764273902911 0.18248784651262 4941 salsolinol hsa04080 Neuroactive ligand-receptor interaction 2908_5025_1909 3 - 3.94794202977699e-06 0.000173709449310188 4942 salsolinol hsa04740 Olfactory transduction 818_801_808_805 4 - 3.56346590682381e-09 3.13584999800495e-07 4943 salsolinol hsa04510 Focal adhesion 3912_6654_858_60_5601_1398_6714 7 - 0.0125860933815907 0.158225173939997 4944 salsolinol hsa04110 Cell cycle 5591_902_5001_5000_993_4173_7157_6502_996_51343_4193_51433_1022_7027_4089_7534_1031_1017_7531_7533_4616 21 - 0.00309783765796975 0.0908699046337793 4945 salsolinol hsa04062 Chemokine signaling pathway 3717_6654_2773_7852_1398_10681 6 - 0.0098108697368367 0.143892756140272 4946 salsolinol hsa04810 Regulation of actin cytoskeleton 60_8394_6654_5605_22800_10787_1398 7 - 0.00715005318598598 0.125840936073353 4947 salsolinol hsa04060 Cytokine-cytokine receptor interaction 3556_27242_3597_2057_3459_7852_9180_90_8795 9 - 0.00494531782663859 0.108796992186049 4948 oxybenzone hsa04662 B cell receptor signaling pathway 11025_23533_974_5579_8519_4772_4793 7 + 0.0418878402047447 0.4053193522628 4949 oxybenzone hsa05016 Huntington's disease 1213_7416 2 + 0.0360237377689641 0.4053193522628 4950 oxybenzone hsa04740 Olfactory transduction 1258_816 2 + 4.34262179630241e-05 0.00351752365500495 4951 oxybenzone hsa04710 Circadian rhythm - mammal 8553_5187_79365 3 + 0.023036523938346 0.4053193522628 4952 oxybenzone hsa04664 Fc epsilon RI signaling pathway 23533_8398_3596_5579_2207_5599_27040_5320_5609_2205 10 + 0.00249837516843532 0.10118419432163 4953 oxybenzone hsa03450 Non-homologous end-joining 2547_3981_10111 3 + 0.0271758481859034 0.4053193522628 4954 oxybenzone hsa05310 Asthma 2205_3596_3119_2207 4 + 0.0429996127231619 0.4053193522628 4955 oxybenzone hsa05012 Parkinson's disease 7416 1 + 0.0455393144787829 0.4053193522628 4956 oxybenzone hsa04912 GnRH signaling pathway 4313_8398_5579_5599_5598_4323_776_5320_5609_816 10 + 0.0262060428245463 0.4053193522628 4957 oxybenzone hsa03440 Homologous recombination 5890_25788_5888 3 - 0.0341945217295925 1 4958 parbendazole hsa04640 Hematopoietic cell lineage 3690_7066_960_3674_2812 5 + 0.0395790283253699 0.857545613716348 4959 parbendazole hsa04740 Olfactory transduction 5568 1 + 0.00514637275561102 0.334514229114716 4960 parbendazole hsa04512 ECM-receptor interaction 3690_1293_960_3674_2812 5 + 0.035052211170729 0.857545613716348 4961 parbendazole hsa04080 Neuroactive ligand-receptor interaction 1241_2561_2908_2149 4 - 0.00027975565880761 0.0123092489875348 4962 parbendazole hsa04740 Olfactory transduction 219464_157_5613_5616_818_109_393046_409 8 - 5.86531236725665e-05 0.00516147488318585 4963 parbendazole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8348_8294_8343_8347_8346_8344_8370_718_8359_8336_554313_121504_8339_3119 23 - 0.000619077700953465 0.0136197094209762 4964 parbendazole hsa04210 Apoptosis 472_8503_836_5296_5613_5534_331_5290_5533_5616_5576_8737 12 - 0.0384114566210274 0.636229844937796 4965 parbendazole hsa04260 Cardiac muscle contraction 4635 1 - 0.0433793076093952 0.636229844937796 4966 parbendazole hsa04060 Cytokine-cytokine receptor interaction 8718_50616_23765_1435_3594 5 - 0.000605782776045234 0.0136197094209762 4967 isoxsuprine hsa02010 ABC transporters 6891_5244_5243 3 + 0.0454350492513249 1 4968 isoxsuprine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344 19 - 3.8041917468376e-13 1.40755094632991e-11 4969 oxetacaine hsa04540 Gap junction 5159_3708_7082_5568 4 + 0.036824172503419 1 4970 oxetacaine hsa04910 Insulin signaling pathway 5256_5257_3551_5613_6654_5616_7249_2997_2002_23265_10211_51763_369_5507 14 - 0.00839715295260321 0.23512028267289 4971 oxetacaine hsa05016 Huntington's disease 246721_10126_5435 3 - 0.049897974756834 0.551933110452068 4972 oxetacaine hsa04740 Olfactory transduction 5613_5616_409 3 - 4.14783465464367e-05 0.00348418110990068 4973 oxetacaine hsa05012 Parkinson's disease 2861 1 - 0.0327129104651748 0.551933110452068 4974 oxetacaine hsa04060 Cytokine-cytokine receptor interaction 5155_5154_8795 3 - 0.00377670868959973 0.158621764963189 4975 dicycloverine hsa04740 Olfactory transduction 26333_8390 2 + 0.000405137868222432 0.0295750643802375 4976 dicycloverine hsa05322 Systemic lupus erythematosus 3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 11 + 0.0196129019643251 0.477247281131911 4977 dicycloverine hsa04010 MAPK signaling pathway 1647_1848_9344_1843_4791_9254_2005_1649_2353_8817_6196_1399_7042_3725_5971_2247_3164_11221 18 + 0.011583499642368 0.422797736946432 4978 dicycloverine hsa04510 Focal adhesion 5296_5829_6464_5154_1793_6093_55742 7 - 0.035198300085149 0.847171266943613 4979 hexamethonium bromide hsa05131 Shigellosis 7100_6093_7430_10382 4 + 0.00230922229316842 0.0577305573292105 4980 hexamethonium bromide hsa05130 Pathogenic Escherichia coli infection 7100_6093_7430_10382 4 + 0.00230922229316842 0.0577305573292105 4981 hexamethonium bromide hsa04350 TGF-beta signaling pathway 6093_7046_652_653 4 + 0.0101750699988169 0.169584499980282 4982 ethambutol hsa04662 B cell receptor signaling pathway 11025_5532_6655_2353 4 + 0.049403103974803 1 4983 ethambutol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 6.42262348212653e-07 3.59666914999086e-05 4984 ethambutol hsa04080 Neuroactive ligand-receptor interaction 7434_3354 2 - 0.0261980179881082 1 4985 ethambutol hsa03022 Basal transcription factors 51616_6875_2969_728198 4 - 0.0363019436287728 1 4986 idoxuridine hsa04740 Olfactory transduction 393046 1 + 0.000835389899918386 0.0593126828942054 4987 idoxuridine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235 26 - 1.73407261207524e-16 1.07512501948665e-14 4988 amprolium hsa05131 Shigellosis 7278_9181_113457_8976_9475 5 + 0.00500762205346713 0.0984832337181869 4989 amprolium hsa05130 Pathogenic Escherichia coli infection 7278_9181_113457_8976_9475 5 + 0.00500762205346713 0.0984832337181869 4990 amprolium hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_9103_8359_8294_8367_554313_121504_3109 16 + 3.27697424574409e-08 1.93341480498901e-06 4991 amprolium hsa04070 Phosphatidylinositol signaling system 8871_5298_8394_8396_5290_3631_5335_5291_3707 9 - 0.0367445343722891 0.395003744502108 4992 amprolium hsa05010 Alzheimer's disease 841_4137 2 - 0.0130241755353557 0.217759811753684 4993 amprolium hsa04080 Neuroactive ligand-receptor interaction 146_706_5025 3 - 0.0019206823924426 0.0825893428750318 4994 amprolium hsa05016 Huntington's disease 6667_841_161 3 - 0.0266058779163456 0.326872214400817 4995 amprolium hsa04740 Olfactory transduction 157 1 - 1.04920644954525e-07 9.02317546608915e-06 4996 amprolium hsa05322 Systemic lupus erythematosus 3108_3123_3013_8358_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357 15 - 0.0143220155808813 0.217759811753684 4997 amprolium hsa05012 Parkinson's disease 51465 1 - 0.015192545006071 0.217759811753684 4998 amprolium hsa04060 Cytokine-cytokine receptor interaction 9180_3601_7422_2057_8795 5 - 0.0143497273697583 0.217759811753684 4999 prednisone hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 + 0.0340071390869801 0.339340405625345 5000 prednisone hsa05212 Pancreatic cancer 5170_6655_5293_2263_1387_7184 6 + 0.0418364883647686 0.339340405625345 5001 prednisone hsa05215 Prostate cancer 5170_6655_5293_2263_1387_7184 6 + 0.0400536767922787 0.339340405625345 5002 prednisone hsa05310 Asthma 3123_3126_3127_3125 4 + 0.0123817687678885 0.339340405625345 5003 prednisone hsa05223 Non-small cell lung cancer 2309_6655_5170_1029_5293 5 + 0.0204576735988595 0.339340405625345 5004 prednisone hsa04060 Cytokine-cytokine receptor interaction 6367 1 + 0.0108563414149734 0.339340405625345 5005 prednisone hsa05213 Endometrial cancer 2309_6655_5170_5293_1495 5 + 0.0178579135163694 0.339340405625345 5006 prednisone hsa05330 Allograft rejection 3123_3126_3127_3125 4 + 0.0253253423262972 0.339340405625345 5007 prednisone hsa04940 Type I diabetes mellitus 3123_3126_3127_3125 4 + 0.0389211077816334 0.339340405625345 5008 prednisone hsa04910 Insulin signaling pathway 5584_5576_5575_8660_23265_208 6 - 0.0453299893597705 0.936819780101924 5009 prednisone hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0193218143937172 0.678864258349532 5010 prednisone hsa05210 Colorectal cancer 4088_208_4233_6934_7042 5 - 0.0218988470435333 0.678864258349532 5011 miconazole hsa05332 Graft-versus-host disease 3108_3123_3126_3127_3125_3113 6 + 0.00327042812582992 0.0451319081364529 5012 miconazole hsa04640 Hematopoietic cell lineage 1435_2057_3123_3126_3570_3127_1378_3125 8 + 0.0085703604920507 0.0739193592439373 5013 miconazole hsa05320 Autoimmune thyroid disease 3108_1081_3113_3126_3127_3125_3123 7 + 0.00227125291652047 0.0391791128099781 5014 miconazole hsa04612 Antigen processing and presentation 3108_3123_3126_3127_3125_5994_3310_3113 8 + 0.00967127302110405 0.074146426495131 5015 miconazole hsa04514 Cell adhesion molecules (CAMs) 3108_3383_8506_3123_3126_3127_3125_9672_923_3113 10 + 0.0130204769222437 0.0898412907634815 5016 miconazole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_3108_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113_8970 37 + 1.14103894463732e-20 7.87316871799751e-19 5017 miconazole hsa05310 Asthma 3126_3108_3123_3113_3127_3125 6 + 0.000705955579083137 0.0243554674783682 5018 miconazole hsa04010 MAPK signaling pathway 4908_1647_8398_4214_5599_6655_1649_1846_2353_1843_5607_4791_3725_3310_5971_3164_11221_4616 18 + 0.00474117942891569 0.0467344829421689 5019 miconazole hsa04020 Calcium signaling pathway 2149 1 + 0.0478542511732697 0.30017666645051 5020 miconazole hsa05330 Allograft rejection 3108_3113_3126_3127_3125_3123 6 + 0.00208379848559925 0.0391791128099781 5021 miconazole hsa04940 Type I diabetes mellitus 3108_3123_3126_3127_3125_3113 6 + 0.00402428989555311 0.0462793337988608 5022 miconazole hsa05332 Graft-versus-host disease 3123_3126_3127_3125_3135_355 6 - 0.0209407047137389 0.209142343745949 5023 miconazole hsa04080 Neuroactive ligand-receptor interaction 3953 1 - 0.000116369985205178 0.00500390936382265 5024 miconazole hsa05016 Huntington's disease 5331_6648 2 - 0.0128909302661379 0.17759415177805 5025 miconazole hsa04740 Olfactory transduction 5613_5566_157 3 - 2.95615086680781e-05 0.00254228974545472 5026 miconazole hsa05322 Systemic lupus erythematosus 85235_3123_8330_3126_3127_3125_8332_8969_8331_8336_8343_8329_8339_8347_8346_8344 16 - 0.00309283876913936 0.0886613780486617 5027 miconazole hsa04210 Apoptosis 3554_5296_5613_5566_5291_472_355_598_8837_7186 10 - 0.0144553379354227 0.17759415177805 5028 miconazole hsa05012 Parkinson's disease 7327 1 - 0.0218869894617854 0.209142343745949 5029 miconazole hsa04060 Cytokine-cytokine receptor interaction 3953_355_3554_5154 4 - 0.010660051973716 0.17759415177805 5030 miconazole hsa05330 Allograft rejection 3123_3126_3127_3125_3135_355 6 - 0.0140183224050417 0.17759415177805 5031 miconazole hsa04940 Type I diabetes mellitus 3123_3126_3127_3125_3135_355 6 - 0.0251430514152364 0.216230242171033 5032 oxybuprocaine hsa04662 B cell receptor signaling pathway 10725_933_5579_4793 4 + 0.00825242721913699 0.111407767458349 5033 oxybuprocaine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 5.33085045919504e-10 2.87865924796532e-08 5034 oxybuprocaine hsa04664 Fc epsilon RI signaling pathway 8398_5608_5579 3 + 0.0499172200521906 0.373808175680877 5035 oxybuprocaine hsa04370 VEGF signaling pathway 10725_8398_5579 3 + 0.0469739320381311 0.373808175680877 5036 oxybuprocaine hsa04010 MAPK signaling pathway 8912_8398_5579_6789_8817_4763_3164_5608 8 + 0.00744595778738966 0.111407767458349 5037 oxybuprocaine hsa04540 Gap junction 7278_5593_113457_5579 4 + 0.0165925097079472 0.17919910484583 5038 oxybuprocaine hsa04730 Long-term depression 5593_8398_5579_6261 4 + 0.00688302657647992 0.111407767458349 5039 oxybuprocaine hsa05211 Renal cell carcinoma 2271_5296_6655_405_8453_1399_3725_4233 8 - 0.0204714514501731 0.334190136541288 5040 oxybuprocaine hsa04080 Neuroactive ligand-receptor interaction 146_3354_7067_4886 4 - 0.0276458544725297 0.35018082331871 5041 oxybuprocaine hsa04740 Olfactory transduction 5613_5616_409_4991 4 - 0.000293163316972195 0.0222804120898868 5042 oxybuprocaine hsa05322 Systemic lupus erythematosus 8336 1 - 0.0219861931935058 0.334190136541288 5043 oxybuprocaine hsa04210 Apoptosis 581_5296_5613_11261_5616_472_355_5576_8837_651610 10 - 0.00950840782701803 0.334190136541288 5044 oxybuprocaine hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_4233_535_5600_523_3725_528 7 - 0.0484060094872951 0.459857090129303 5045 oxybuprocaine hsa04010 MAPK signaling pathway 4214_4149_3925_5599_5613_11261_5616_5154_51347_2002_6789_355_6885_3725_5600_1399_2005_2263_6655_409 20 - 0.0383533724392711 0.416408043626372 5046 oxybuprocaine hsa04912 GnRH signaling pathway 4214_5599_5613_6655_5616_2776_2002_5600_3725_4323_23236 11 - 0.0180842005481891 0.334190136541288 5047 homosalate hsa04740 Olfactory transduction 26211_7932 2 + 0.00117767718657919 0.0895034661800184 5048 homosalate hsa05200 Pathways in cancer 6655 1 - 0.00790661389478138 0.217431882106488 5049 homosalate hsa05131 Shigellosis 7278_6093_7430_113457 4 - 0.0498733051130063 0.685757945303837 5050 homosalate hsa05130 Pathogenic Escherichia coli infection 7278_6093_7430_113457 4 - 0.0498733051130063 0.685757945303837 5051 homosalate hsa05322 Systemic lupus erythematosus 8358_85235_8968_3013_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357 18 - 3.42783346367185e-08 1.88530840501952e-06 5052 mebhydrolin hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 + 0.01658331664773 0.202316463102306 5053 mebhydrolin hsa04640 Hematopoietic cell lineage 3123_947_3126_3127_3125 5 + 0.0474107779404671 0.346819797900513 5054 mebhydrolin hsa05320 Autoimmune thyroid disease 3123_3126_3127_3125 4 + 0.0335098461951773 0.292014373986545 5055 mebhydrolin hsa04740 Olfactory transduction 8392 1 + 0.00355761273421362 0.116676690626228 5056 mebhydrolin hsa04514 Cell adhesion molecules (CAMs) 3383_3123_3126_3127_3125_23308_947 7 + 0.0319303196085425 0.292014373986545 5057 mebhydrolin hsa05310 Asthma 3123_3126_3127_3125 4 + 0.00574931485827325 0.116902735451556 5058 mebhydrolin hsa05330 Allograft rejection 3123_3126_3127_3125 4 + 0.0121514155252609 0.185309086760229 5059 mebhydrolin hsa04940 Type I diabetes mellitus 3382_3126_3127_3123_3125 5 + 0.00382546526643372 0.116676690626228 5060 mebhydrolin hsa05016 Huntington's disease 246721_1639_5439_10126_5978_548644_161 7 - 0.0325354921720786 0.397430958515651 5061 mebhydrolin hsa04740 Olfactory transduction 5613 1 - 0.0327012806720513 0.397430958515651 5062 mebhydrolin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344 19 - 6.4888921485525e-12 4.1528909750736e-10 5063 mebhydrolin hsa04370 VEGF signaling pathway 5605_5747_5335_5578 4 - 0.0372591523608423 0.397430958515651 5064 mebhydrolin hsa05110 Vibrio cholerae infection 5613_5578_5335_523 4 - 0.0164984685856936 0.35196732982813 5065 mebhydrolin hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0131618236293192 0.35196732982813 5066 santonin hsa05211 Renal cell carcinoma 2271_5155_998_5290_405_5781_3725 7 - 0.028802138465907 0.57604276931814 5067 santonin hsa04080 Neuroactive ligand-receptor interaction 1131_4157_1081 3 - 0.0196424203801176 0.523797876803136 5068 santonin hsa04740 Olfactory transduction 4991 1 - 7.94191065063184e-06 0.000317676426025274 5069 santonin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8342_8968_8370_718_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_720_721 30 - 1.88194042026234e-12 1.50555233620987e-10 5070 santonin hsa04010 MAPK signaling pathway 4214_57551_6789_6788_5155_998_8074_8912_6722_4763_5871_10912_5600_2258_91_3725_9693_5536 18 - 0.0398536051696814 0.637657682714902 5071 quinethazone hsa04740 Olfactory transduction 26476 1 + 0.00542586424405386 0.261329915965432 5072 quinethazone hsa04664 Fc epsilon RI signaling pathway 5581_8681_100137049_5293_5600 5 + 0.0313370074142915 0.544390287077264 5073 quinethazone hsa04370 VEGF signaling pathway 5293_4776_8681_4772_5600_100137049 6 + 0.00780089301389348 0.261329915965432 5074 quinethazone hsa04912 GnRH signaling pathway 776_8681_5600_5337_5338_100137049 6 + 0.0325009126613292 0.544390287077264 5075 quinethazone hsa04270 Vascular smooth muscle contraction 776_5581_553_8681_6093_100137049 6 + 0.0459682714274368 0.582891350964783 5076 quinethazone hsa04662 B cell receptor signaling pathway 208_6655_4772_5534_27071_4793 6 - 0.034808002596871 0.661352049340549 5077 quinethazone hsa04660 T cell receptor signaling pathway 1432_208_6655_56924_867_4772_5534_4793 8 - 0.0257678432674675 0.652785362775843 5078 quinethazone hsa04740 Olfactory transduction 157 1 - 0.000183438351176054 0.0139413146893801 5079 quinethazone hsa05221 Acute myeloid leukemia 5292_6655_5371_208_5914_652671 6 - 0.0131422479943432 0.499405423785042 5080 rifabutin hsa05332 Graft-versus-host disease 3811_3119_3821_3804_3126_3127_3125_3134_3123_3802 10 + 0.0334791189629222 0.293920578470657 5081 rifabutin hsa05010 Alzheimer's disease 6392_651820_317_4137_3708_6868_824_348_4842_23621 10 + 0.0349905450560306 0.293920578470657 5082 rifabutin hsa04080 Neuroactive ligand-receptor interaction 2550_2898_140_624_6752_5540_2908_552_1241_6915_2150_2689_3269_2688_3358_2149_1442 17 + 0.0396602349851303 0.302859976250086 5083 rifabutin hsa05016 Huntington's disease 8218_246721_6392_651820_64764_317_3708_1387 8 + 0.00355445470464148 0.126157695683747 5084 rifabutin hsa04740 Olfactory transduction 26211_26333_1179_816_5137_409 6 + 1.99966634704824e-11 1.67971973152052e-09 5085 rifabutin hsa05322 Systemic lupus erythematosus 3123_3126_3127_3119_3125 5 + 0.00510872993624749 0.126157695683747 5086 rifabutin hsa04530 Tight junction 4301_10000_29895_998_5865_9863 6 + 0.0163902405441536 0.22946336761815 5087 rifabutin hsa04062 Chemokine signaling pathway 10000_998_5293_7852_51764_10235_112_6367_409 9 + 0.00600750931827368 0.126157695683747 5088 rifabutin hsa04620 Toll-like receptor signaling pathway 7100_10000_1326_5293 4 + 0.0321627543383219 0.293920578470657 5089 rifabutin hsa04260 Cardiac muscle contraction 785_478 2 + 0.0159094626292853 0.22946336761815 5090 rifabutin hsa04060 Cytokine-cytokine receptor interaction 2323_50615_4804_3606_2057_56034_64806_8200_7852_655_2688_2689_3556_1896_6367_8792_51561 17 + 0.0322477885479667 0.293920578470657 5091 rifabutin hsa05210 Colorectal cancer 4088_10000_5293 3 + 0.0450913715198661 0.315639600639063 5092 rifabutin hsa04640 Hematopoietic cell lineage 3589_960_4254 3 - 0.0230405252192084 0.166277808690835 5093 rifabutin hsa05010 Alzheimer's disease 355_5534_489_488 4 - 3.74604033353257e-05 0.00114878570228332 5094 rifabutin hsa04080 Neuroactive ligand-receptor interaction 5029_146_5618_152_4157_1813_3953_706_5025_3354_56288_1909_1131_9170 14 - 0.00319242065837031 0.0489504500950114 5095 rifabutin hsa04742 Taste transduction 112 1 - 0.0412168559102651 0.223055926102611 5096 rifabutin hsa05320 Autoimmune thyroid disease 355 1 - 0.0401931263650536 0.223055926102611 5097 rifabutin hsa04612 Antigen processing and presentation 4800_4802_3308 3 - 0.0234957773150093 0.166277808690835 5098 rifabutin hsa05016 Huntington's disease 246721_548644_581_7052_5439_7157_2033_9001_1387_161 10 - 0.0126707325571783 0.11657073952604 5099 rifabutin hsa04740 Olfactory transduction 818_219464 2 - 4.99077327092132e-16 4.59151140924761e-14 5100 rifabutin hsa04514 Cell adhesion molecules (CAMs) 9076_23308_1365_5792_5817 5 - 0.00484535467268465 0.056214878094536 5101 rifabutin hsa03410 Base excision repair 5424_5426_7374_7515_10039_10038_27343_4350_3980 9 - 0.0453286261710399 0.231679644874204 5102 rifabutin hsa04530 Tight junction 9076_207_2036_1365_56288_3265_55870 7 - 0.0268518059944311 0.176454725106262 5103 rifabutin hsa05110 Vibrio cholerae infection 10312 1 - 0.0185336051870162 0.155008334291408 5104 rifabutin hsa05012 Parkinson's disease 7332 1 - 1.21291409011854e-05 0.000557940481454528 5105 rifabutin hsa04260 Cardiac muscle contraction 488 1 - 0.00185541940631431 0.0341397170761833 5106 rifabutin hsa04060 Cytokine-cytokine receptor interaction 5618_4055_3594_3953_3589_5155_5154_8741_8742_355_6387_4982_8718_4254_51330 15 - 0.00488825026909009 0.056214878094536 5107 rifabutin hsa03010 Ribosome 140801_6129 2 - 0.00176860158260358 0.0341397170761833 5108 rifabutin hsa05220 Chronic myeloid leukemia 595_207_3551_4088_613_4609_6464_5605_7157_1487_369_1869_3265_5970_4790_598 16 - 0.0353013865394314 0.216515170775179 5109 rifabutin hsa04610 Complement and coagulation cascades 2161 1 - 0.00888530834913704 0.0908275964578453 5110 nialamide hsa04740 Olfactory transduction 26539_8392 2 + 0.0137019527000038 0.493270297200137 5111 nialamide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3119_8354 16 + 7.71056870767938e-07 5.55160946952915e-05 5112 nialamide hsa04360 Axon guidance 2044_64221_4772_10501_6093_8829_2242 7 + 0.0396887401840959 0.952529764418302 5113 nialamide hsa04740 Olfactory transduction 157 1 - 8.46575634697791e-05 0.00258205568582826 5114 nialamide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8329_8294_121504_8969_8370_718_8332_8359_8330_8331_8336_554313_8351_85235_3013 25 - 1.3462679119122e-10 8.21223426266442e-09 5115 levcycloserine hsa04740 Olfactory transduction 7932 1 + 0.000808163090172309 0.054955090131717 5116 levcycloserine hsa04512 ECM-receptor interaction 961_3381_1288_7057_5649_63923 6 + 0.0282612916284905 0.960883915368677 5117 levcycloserine hsa05332 Graft-versus-host disease 3135_3105_3106_649853 4 - 0.035926696819254 0.438282671421907 5118 levcycloserine hsa04650 Natural killer cell mediated cytotoxicity 3383_3454_4772_3105_3106_3135_5881_4775_6452_5335 10 - 0.00719012486851364 0.230083995792436 5119 levcycloserine hsa05320 Autoimmune thyroid disease 3135_3105_3106_1081_649853 5 - 0.0204686151292847 0.428687540035632 5120 levcycloserine hsa05322 Systemic lupus erythematosus 3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 11 - 0.00339121308305717 0.217037637315659 5121 levcycloserine hsa05330 Allograft rejection 3135_3105_3106_649853 4 - 0.026792971252227 0.428687540035632 5122 levcycloserine hsa04940 Type I diabetes mellitus 3135_3105_3106_649853 4 - 0.0410890004458038 0.438282671421907 5123 myricetin hsa04740 Olfactory transduction 26476 1 + 2.68134386809313e-05 0.00225232884919823 5124 myricetin hsa04660 T cell receptor signaling pathway 4793_4772_925_5600 4 - 0.0181027956622834 0.427703530609021 5125 myricetin hsa04920 Adipocytokine signaling pathway 3717_5781_4793 3 - 0.0237613072560567 0.427703530609021 5126 nilutamide hsa05332 Graft-versus-host disease 5551_3126_3127_3123_3125 5 + 0.0317437958481046 0.514249492739294 5127 nilutamide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8329_8294_121504_3123_3126_3127_3125_8969_8968_8370_2212_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013 38 + 2.73101205292635e-18 2.21211976287034e-16 5128 nilutamide hsa05310 Asthma 3123_3126_3127_3125 4 + 0.0384687526893953 0.519328161306837 5129 nilutamide hsa05330 Allograft rejection 3593_3123_3126_3127_3125_5551 6 + 0.00595299195718749 0.160730782844062 5130 nilutamide hsa05210 Colorectal cancer 10000_4088_6654_1857_83439_5880_5602_91 8 + 0.023162738187171 0.469045448290213 5131 nilutamide hsa04940 Type I diabetes mellitus 3593_3382_3123_3126_3127_3125_5551 7 + 0.00292261784857387 0.118366022867242 5132 nilutamide hsa04120 Ubiquitin mediated proteolysis 7326_7334_51366_1161_7322_7328_8065_6477_4193_26091_3093_51588_10393_51465_51433_55236_8450_7320_9039 19 - 0.0170691571981729 0.209706788434696 5133 nilutamide hsa04080 Neuroactive ligand-receptor interaction 7068_4886_2150_136_2692_2690 6 - 0.00121175754644808 0.0521055744972674 5134 nilutamide hsa04110 Cell cycle 5591_472_5001_1017_7027_4085_4173_7157_983_9134_4193_51433_1111_10393_23594_4089_7534_1387_7531_7465 20 - 0.0019247163710737 0.0551752026374461 5135 nilutamide hsa04115 p53 signaling pathway 1111_472_841_9134_7157_983_6477_4193_64065_355_8493_1017 12 - 0.0125541466264606 0.179942768312602 5136 nilutamide hsa03430 Mismatch repair 5982_5983_5985_5425_4436_2956_4292 7 - 0.00375512855974366 0.0807352640344887 5137 nilutamide hsa04060 Cytokine-cytokine receptor interaction 3556_3597_7852_355_4982_2690 6 - 0.000885353424517742 0.0521055744972674 5138 nilutamide hsa03010 Ribosome 51187 1 - 0.00992190871879748 0.170656829963317 5139 ticarcillin hsa05322 Systemic lupus erythematosus 9103_8343_8339_8347_8346_8344 6 + 0.000306897070731441 0.00920691212194323 5140 ticarcillin hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 - 0.00137661941454725 0.0110365907208365 5141 ticarcillin hsa04640 Hematopoietic cell lineage 960_3123_3126_3127_3125_933 6 - 0.000442175504890779 0.00604306523350731 5142 ticarcillin hsa05320 Autoimmune thyroid disease 3123_3126_3127_3125 4 - 0.00304881772539611 0.0178573609630344 5143 ticarcillin hsa04612 Antigen processing and presentation 3123_3126_3127_3125 4 - 0.0168823150612669 0.0769083241679936 5144 ticarcillin hsa04514 Cell adhesion molecules (CAMs) 3123_4099_3126_3127_3125_933 6 - 0.0036501924381076 0.0187072362453015 5145 ticarcillin hsa05322 Systemic lupus erythematosus 8329_3123_3126_3127_3125_8969_8968_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013 22 - 1.57521092428246e-18 6.45836478955809e-17 5146 ticarcillin hsa05310 Asthma 3123_3126_3127_3125 4 - 0.000431211841636473 0.00604306523350731 5147 ticarcillin hsa05330 Allograft rejection 3123_3126_3127_3125 4 - 0.000975330179740702 0.0099971343423422 5148 ticarcillin hsa04940 Type I diabetes mellitus 3123_3126_3127_3125 4 - 0.00161511083719558 0.0110365907208365 5149 Chicago Sky Blue 6B hsa04340 Hedgehog signaling pathway 652_653_4036 3 + 0.014442581214635 0.707686479517115 5150 Chicago Sky Blue 6B hsa04130 SNARE interactions in vesicular transport 6804_6844 2 - 0.036412217298797 0.600655072824528 5151 Chicago Sky Blue 6B hsa04630 Jak-STAT signaling pathway 3566_5292_6778_2057 4 - 0.0318875613043585 0.600655072824528 5152 triflupromazine hsa05322 Systemic lupus erythematosus 3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 11 + 1.38729761896932e-06 8.04632619002206e-05 5153 triflupromazine hsa04920 Adipocytokine signaling pathway 8660_208_2182 3 + 0.0452448500643457 0.847742129115768 5154 triflupromazine hsa04010 MAPK signaling pathway 208_50487_1846_91_355_2257_3164_11221 8 + 0.0146732648620007 0.42552468099802 5155 triflupromazine hsa04662 B cell receptor signaling pathway 10892_11261_6850_5534 4 - 0.00217323325954588 0.0318740878066729 5156 triflupromazine hsa04310 Wnt signaling pathway 5613_11261_5616_5534 4 - 0.0230677532685166 0.169163523969122 5157 triflupromazine hsa04660 T cell receptor signaling pathway 10892_11261_5534 3 - 0.0438001925116376 0.196699369571722 5158 triflupromazine hsa04210 Apoptosis 5613_11261_5616_7186_5534 5 - 0.000477512669176227 0.021010557443754 5159 triflupromazine hsa04340 Hedgehog signaling pathway 5613_655_5616 3 - 0.00829509395695988 0.0729968268212469 5160 triflupromazine hsa04720 Long-term potentiation 5613_11261_5616_5534 4 - 0.00217323325954588 0.0318740878066729 5161 triflupromazine hsa04062 Chemokine signaling pathway 5613_3717_6777_5616 4 - 0.0479674283449789 0.196699369571722 5162 triflupromazine hsa04010 MAPK signaling pathway 5155_11261_5534_5616_4137_5613_7186 7 - 0.00320141192295935 0.0352155311525528 5163 triflupromazine hsa04540 Gap junction 5616_5155_5613 3 - 0.0290319441743307 0.18248650623865 5164 triflupromazine hsa04020 Calcium signaling pathway 5613_11261_5616_5534 4 - 0.0415882277269646 0.196699369571722 5165 Prestwick-1100 hsa05014 Amyotrophic lateral sclerosis (ALS) 5533_5534_317_5879_581 5 + 0.0447880857323696 0.79498852174956 5166 Prestwick-1100 hsa04740 Olfactory transduction 816 1 + 8.36278484608592e-05 0.005937577240721 5167 Prestwick-1100 hsa04514 Cell adhesion molecules (CAMs) 5010_214_29851_3107_3113_3695_3685_5797_23308_1272 10 + 0.026030988703533 0.79498852174956 5168 Prestwick-1100 hsa04020 Calcium signaling pathway 623_5534_5333_5724_5533_108_3709_135_1909_4638_3706_816 12 + 0.0356719309023123 0.79498852174956 5169 phenazone hsa04512 ECM-receptor interaction 3690_1289_7148 3 + 0.039116987897416 0.772741595128502 5170 diflunisal hsa05214 Glioma 23533_5594_6655_4193_1956_3845 6 + 0.0185832734315519 0.198161501896307 5171 diflunisal hsa04662 B cell receptor signaling pathway 23533_5594_6655_7409_3845_4793 6 + 0.0330269169827178 0.198161501896307 5172 diflunisal hsa04660 T cell receptor signaling pathway 23533_1326_5594_6655_867_7409_3845_4793 8 + 0.0241272894850073 0.198161501896307 5173 diflunisal hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8370_94239_8366_8364_8368_8359_55766_8294_8367_554313_121504_3119_8337 18 + 1.41249465257991e-06 0.000110174582901233 5174 diflunisal hsa05212 Pancreatic cancer 23533_5594_6655_4193_1956_3845_80310 7 + 0.0238992669051341 0.198161501896307 5175 diflunisal hsa05215 Prostate cancer 23533_5594_6655_4193_1956_3845_80310 7 + 0.0227117673845967 0.198161501896307 5176 diflunisal hsa05221 Acute myeloid leukemia 23533_6655_3845_5594_5914 5 + 0.0410190659644138 0.228534796087448 5177 diflunisal hsa05219 Bladder cancer 1956_3845_4193_5594 4 + 0.0468798252766041 0.243775091438341 5178 diflunisal hsa05218 Melanoma 23533_5594_4193_1956_3845_80310_2258_2246 8 + 0.00230727953998841 0.0599892680396987 5179 diflunisal hsa05223 Non-small cell lung cancer 23533_5594_6789_6655_1956_3845 6 + 0.00850268173703074 0.165802293872099 5180 diflunisal hsa04010 MAPK signaling pathway 4214_9479_1326_5594_6789_6655_1846_8912_355_4763_1956_3845_2258_10746_2246 15 + 0.0325009035347101 0.198161501896307 5181 diflunisal hsa04540 Gap junction 7082_5594_6655_113457_3708_1956_3845_80310_112_10746_7278 11 + 0.000252248366196934 0.00983768628168043 5182 diflunisal hsa05213 Endometrial cancer 23533_6655_1956_3845_5594 5 + 0.0265788088220521 0.198161501896307 5183 diflunisal hsa04912 GnRH signaling pathway 4214_5594_6655_3708_1956_3845_112_10746 8 + 0.0220316037592724 0.198161501896307 5184 diflunisal hsa05220 Chronic myeloid leukemia 23533_5594_6655_4193_867_3845 6 + 0.0330269169827178 0.198161501896307 5185 diflunisal hsa05214 Glioma 5578_673_5155_5154_4193 5 - 0.00993307029745197 0.163895659907958 5186 diflunisal hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 1.48015288795689e-06 9.76900906051547e-05 5187 diflunisal hsa04710 Circadian rhythm - mammal 1408_8863 2 - 0.0312587547138942 0.257884726389627 5188 diflunisal hsa05212 Pancreatic cancer 2308_5155_4193_5154_2260_673 6 - 0.00877271150792296 0.163895659907958 5189 diflunisal hsa05215 Prostate cancer 2308_5155_4193_5154_2260_673 6 - 0.00834518631875071 0.163895659907958 5190 diflunisal hsa05218 Melanoma 2260_673_5155_5154_4193 5 - 0.01386545191711 0.183023965305852 5191 diflunisal hsa04810 Regulation of actin cytoskeleton 3691_5155_5154_673_3678_3985_2245_2260_3675 9 - 0.0404875147941476 0.296908441823749 5192 diflunisal hsa04010 MAPK signaling pathway 5578_11261_5155_5154_673_6722_6196_3725_2260_3727_11221 11 - 0.0222382627450653 0.209675048739187 5193 diflunisal hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0215714135987266 0.209675048739187 5194 hydrochlorothiazide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 4.20232581421347e-06 0.0002185209423391 5195 hydrochlorothiazide hsa04020 Calcium signaling pathway 56848_5724_5331_3708_5335_1909_3269_1910_814 9 + 0.0177330731099683 0.461059900859176 5196 hydrochlorothiazide hsa05211 Renal cell carcinoma 3725_405_2271_5290 4 - 0.0128750153739696 0.59910962425344 5197 hydrochlorothiazide hsa04010 MAPK signaling pathway 4217_9252_355_4763_23162_2005_5494_3725 8 - 0.0193261169114013 0.59910962425344 5198 captopril hsa04740 Olfactory transduction 26211_26212 2 + 0.000557837173830556 0.0209188940186458 5199 captopril hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_88_8294_720_721_121504_3119_8367 18 + 3.99668642127223e-06 0.000299751481595417 5200 captopril hsa04060 Cytokine-cytokine receptor interaction 6367_4233 2 + 0.0190396233230149 0.475990583075373 5201 captopril hsa04210 Apoptosis 472_8503_5534_841_581 5 - 0.0129703129484267 0.415050014349654 5202 captopril hsa04010 MAPK signaling pathway 4149_9344_9252_5607_5534_7786_3725_2260_408 9 - 0.0386320420529095 0.824150230462069 5203 captopril hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0116718468232832 0.415050014349654 5204 acebutolol hsa04520 Adherens junction 4088_2260_3643_998 4 + 0.0385893242140818 0.888356083871494 5205 acebutolol hsa04350 TGF-beta signaling pathway 656_4088_268_652_353500 5 + 0.0128544834647941 0.78412349135244 5206 acebutolol hsa05210 Colorectal cancer 4088_23533_324_581 4 + 0.0445533610938917 0.888356083871494 5207 acebutolol hsa04664 Fc epsilon RI signaling pathway 5606_3845_5581 3 - 0.0263690020337931 0.665649436969556 5208 diphemanil metilsulfate hsa04740 Olfactory transduction 5566_157 2 + 0.00461160868747326 0.163712108405301 5209 diphemanil metilsulfate hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_717_8368_8359_8294_8367_554313_121504 15 + 1.08549277824982e-05 0.000770699872557372 5210 diphemanil metilsulfate hsa04210 Apoptosis 5575_8837_841_5534 4 - 0.0458820294467293 0.321174206127105 5211 diphemanil metilsulfate hsa04664 Fc epsilon RI signaling pathway 100137049_8681_5606_8399 4 - 0.0322068488344349 0.269765046850816 5212 diphemanil metilsulfate hsa04370 VEGF signaling pathway 8681_100137049_8399_5534 4 - 0.0298048484504091 0.269765046850816 5213 diphemanil metilsulfate hsa04010 MAPK signaling pathway 8399_5534_1846_5154_5606_8681_2258_5494_100137049 9 - 0.0213808331291266 0.269765046850816 5214 diphemanil metilsulfate hsa04912 GnRH signaling pathway 2778_8681_5606_100137049_8399 5 - 0.0240318158869602 0.269765046850816 5215 diphemanil metilsulfate hsa04730 Long-term depression 2778_8681_100137049_8399 4 - 0.0232554536228689 0.269765046850816 5216 diphemanil metilsulfate hsa04270 Vascular smooth muscle contraction 2778_27094_8681_100137049_8399 5 - 0.0330324547164265 0.269765046850816 5217 amylocaine hsa05332 Graft-versus-host disease 3824_3119_3117_3126_3113_3127_3125_3123 8 + 0.0251160902672448 0.268246086940379 5218 amylocaine hsa04070 Phosphatidylinositol signaling system 3710 1 + 0.0431481395609272 0.268246086940379 5219 amylocaine hsa04120 Ubiquitin mediated proteolysis 4281_23759_5371_330 4 + 0.0478059761554476 0.268246086940379 5220 amylocaine hsa05010 Alzheimer's disease 6390_4695_3710_841_4842 5 + 0.0136139216191346 0.268246086940379 5221 amylocaine hsa04910 Insulin signaling pathway 10580_208_23265_25759 4 + 0.0472244807297245 0.268246086940379 5222 amylocaine hsa05016 Huntington's disease 4695_841_6390_64446_7416_9586_6648 7 + 0.0493326136901847 0.268246086940379 5223 amylocaine hsa04740 Olfactory transduction 5137_26476_8390_26692_816 5 + 6.91441679967904e-08 6.01554261572076e-06 5224 amylocaine hsa05322 Systemic lupus erythematosus 8329_3123_3126_3127_3125_8969_8968_717_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_2215_3117_3013_3113 27 + 0.000122223053746257 0.00531670283796218 5225 amylocaine hsa04530 Tight junction 4619_208_29895_3059 4 + 0.0467642487208966 0.268246086940379 5226 amylocaine hsa05219 Bladder cancer 11186_1029_3576_1612_7057_5925_1950_7422 8 + 0.0251160902672448 0.268246086940379 5227 amylocaine hsa05310 Asthma 3119_3117_3123_3126_3127_3125_3113 7 + 0.0149325278508403 0.268246086940379 5228 amylocaine hsa05012 Parkinson's disease 2861_6390_4695_7416 4 + 0.0464255209784611 0.268246086940379 5229 amylocaine hsa04912 GnRH signaling pathway 3710_816 2 + 0.0240867678206172 0.268246086940379 5230 amylocaine hsa05330 Allograft rejection 3119_3117_3113_3126_3127_3125_3123 7 + 0.0401582800989625 0.268246086940379 5231 amylocaine hsa04270 Vascular smooth muscle contraction 4881_3710_2977 3 + 0.0486394828746825 0.268246086940379 5232 amylocaine hsa04940 Type I diabetes mellitus 3119_3117_3126_3113_3127_3125_1363_3123 8 + 0.0310638529158163 0.268246086940379 5233 pheniramine hsa04650 Natural killer cell mediated cytotoxicity 23533_3448_3106_3107_27040_6452_80328_9436_259197_6850 10 + 0.0286340989538913 0.406921756520589 5234 pheniramine hsa05320 Autoimmune thyroid disease 958_3448_3106_3107_3113_3134 6 + 0.0113277586164542 0.214596727583778 5235 pheniramine hsa05016 Huntington's disease 4713 1 + 0.0334456238236101 0.406921756520589 5236 pheniramine hsa04740 Olfactory transduction 56656 1 + 8.58486772527606e-05 0.00313347671972576 5237 pheniramine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8342_958_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3113_3014 36 + 4.22918568029719e-19 3.08730554661695e-17 5238 pheniramine hsa05330 Allograft rejection 958_3106_3107_3113_3134 5 + 0.0117587247991111 0.214596727583778 5239 pheniramine hsa04070 Phosphatidylinositol signaling system 8394_8871_23236 3 - 0.0231646405918976 0.386098187392693 5240 pheniramine hsa05322 Systemic lupus erythematosus 6738_3113_720_721 4 - 0.0275784419566209 0.386098187392693 5241 pheniramine hsa04115 p53 signaling pathway 472_651610_10912 3 - 0.0181523756695633 0.386098187392693 5242 cyclic adenosine monophosphate hsa05332 Graft-versus-host disease 3553_3119_3123_3126_3127_3111_3125_3803 8 + 0.000305023138292865 0.010192461793775 5243 cyclic adenosine monophosphate hsa04640 Hematopoietic cell lineage 1435_3553_2812_3690_3123_3126_3127_3125_7066_1378 10 + 0.00201635819959263 0.030648644633808 5244 cyclic adenosine monophosphate hsa05320 Autoimmune thyroid disease 3119_3123_3126_3127_3111_3125 6 + 0.0165465260798046 0.157191997758144 5245 cyclic adenosine monophosphate hsa04612 Antigen processing and presentation 4800_3119_3123_3126_3127_3803_3125_3111_3310 9 + 0.00716121093430761 0.0777502901439112 5246 cyclic adenosine monophosphate hsa04740 Olfactory transduction 5613 1 + 2.61600081345331e-05 0.00198816061822452 5247 cyclic adenosine monophosphate hsa05310 Asthma 3119_3123_3126_3127_3111_3125 6 + 0.00139753381666203 0.0265531425165786 5248 cyclic adenosine monophosphate hsa04512 ECM-receptor interaction 961_2812_3690_3693_1277_63923_1290 7 + 0.0396717001310262 0.33500546777311 5249 cyclic adenosine monophosphate hsa04630 Jak-STAT signaling pathway 6775 1 + 0.0459587951931624 0.349286843468034 5250 cyclic adenosine monophosphate hsa05330 Allograft rejection 3119_3123_3126_3127_3111_3125 6 + 0.00400705360180902 0.0507560122895809 5251 cyclic adenosine monophosphate hsa04940 Type I diabetes mellitus 3382_3119_3123_3126_3127_3111_3125_3553 8 + 0.000402334018175328 0.010192461793775 5252 cyclic adenosine monophosphate hsa04740 Olfactory transduction 5566 1 - 0.000575084618898805 0.0316296540394343 5253 pepstatin hsa04520 Adherens junction 51176_7082_8936_5797_5795_91_5770_6714_25945 9 + 0.00137704455602728 0.0271966299815388 5254 pepstatin hsa04740 Olfactory transduction 5566 1 + 0.000183438351176054 0.00724581487145413 5255 pepstatin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_2215_8370_2214_8368_8366_8359_8294_8367_554313_121504_3119_8364 17 + 6.62165655473359e-06 0.000523110867823954 5256 pepstatin hsa04540 Gap junction 153_7082_5598_5566_6654_113457_3708_5607_57369_6714_7278 11 + 0.000281158328590728 0.0074038359862225 5257 pepstatin hsa05016 Huntington's disease 246721_7381_842_5439_161_27113_548644_10126 8 - 0.0243943548624139 0.292732258348967 5258 pepstatin hsa04740 Olfactory transduction 810 1 - 0.0162930012040895 0.285751753918295 5259 pepstatin hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_8336 7 - 0.0186179972499394 0.285751753918295 5260 pepstatin hsa04115 p53 signaling pathway 472_651610_6477_842_27113 5 - 0.010295652017677 0.285751753918295 5261 pepstatin hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0190501169278863 0.285751753918295 5262 sulfaguanidine hsa05211 Renal cell carcinoma 3725_201163_112399_5155_7042 5 - 0.024130557017842 0.512674840079675 5263 sulfaguanidine hsa04740 Olfactory transduction 5566 1 - 0.00354340548427472 0.240951572930681 5264 sulfaguanidine hsa04010 MAPK signaling pathway 4149_8399_2005_5566_7042_5155_7189_4763_5600_3725_2263_2264_408 13 - 0.0102251720044263 0.347655848150494 5265 sulfaguanidine hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0301573435340985 0.512674840079675 5266 minoxidil hsa05332 Graft-versus-host disease 3123_3107_3126_3127_3125_355 6 + 0.00128044150249544 0.0354958222875813 5267 minoxidil hsa05320 Autoimmune thyroid disease 3123_3107_3126_3127_3125_355 6 + 0.00372694038514689 0.0624262514512104 5268 minoxidil hsa04340 Hedgehog signaling pathway 53944_8945_8643_1452_7480 5 + 0.0204207442483245 0.22803164410629 5269 minoxidil hsa05310 Asthma 3123_3126_3127_3125 4 + 0.010414477929686 0.139554004257792 5270 minoxidil hsa05330 Allograft rejection 3123_3107_3126_3127_3125_355 6 + 0.000801718478058394 0.0354958222875813 5271 minoxidil hsa04940 Type I diabetes mellitus 3123_3107_3126_3127_3125_355 6 + 0.00158936517705588 0.0354958222875813 5272 minoxidil hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 - 0.00712216334574369 0.115873650147503 5273 minoxidil hsa05320 Autoimmune thyroid disease 3123_3126_3127_3125 4 - 0.0149707836137009 0.159544089408897 5274 minoxidil hsa04612 Antigen processing and presentation 6890_3123_3126_3127_3125 5 - 0.020485113435409 0.179244742559829 5275 minoxidil hsa05016 Huntington's disease 246721_842_841_5439_1175_548644_161 7 - 0.0451914743040692 0.316340320128484 5276 minoxidil hsa05322 Systemic lupus erythematosus 3123_3126_3127_3125_8358_6738_8968_3013_8350_8351_8352_8353_8354_8355_8356_8357 16 - 9.24180050838477e-09 6.46926035586934e-07 5277 minoxidil hsa05310 Asthma 3123_3126_3127_3125 4 - 0.00236333203995391 0.0827166213983869 5278 minoxidil hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0159544089408897 0.159544089408897 5279 minoxidil hsa05330 Allograft rejection 3123_3126_3127_3125 4 - 0.00514354113705703 0.115873650147503 5280 minoxidil hsa04940 Type I diabetes mellitus 3123_3126_3127_3125 4 - 0.00827668929625024 0.115873650147503 5281 minoxidil hsa02010 ABC transporters 6890_215_23457 3 - 0.0435415159121094 0.316340320128484 5282 dropropizine hsa04010 MAPK signaling pathway 776_4149_9064_782_1649_998_1399_6196_5322_5536_5603_5534_7786_8398_3164_5609 16 + 0.00309329065381804 0.1886907298829 5283 dropropizine hsa04912 GnRH signaling pathway 776_8398_998_108_5322_5603_5609 7 + 0.0253855710457802 0.542535458973139 5284 dropropizine hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_1956_28964_5781 4 - 0.0353321347005482 0.972894648606165 5285 dropropizine hsa04940 Type I diabetes mellitus 3134_1363_2571 3 - 0.0423013235022654 0.972894648606165 5286 brompheniramine hsa05332 Graft-versus-host disease 3107_3553_3119 3 + 0.022671183690745 0.27205420428894 5287 brompheniramine hsa04514 Cell adhesion molecules (CAMs) 214_3119_3107_57863_1002_5817 6 + 0.0117102906138672 0.187364649821875 5288 brompheniramine hsa04210 Apoptosis 8794_5566_3553_330 4 + 0.0370501584378202 0.355681521003074 5289 brompheniramine hsa04270 Vascular smooth muscle contraction 5566_4881_4882_148_9826_3779 6 + 0.00663392561652256 0.159214214796541 5290 brompheniramine hsa04940 Type I diabetes mellitus 3553_3107_3382_3119_2571 5 + 0.000495731620726132 0.0237951177948543 5291 brompheniramine hsa04080 Neuroactive ligand-receptor interaction 3354 1 - 0.023221541309235 0.434333334264448 5292 brompheniramine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3111_8359_8294_8367_554313_6738_121504_81 17 - 5.4459170189337e-07 4.08443776420027e-05 5293 brompheniramine hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_3725_1956_3551_523 5 - 0.0416397341365514 0.434333334264448 5294 N-acetyl-L-aspartic acid hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 + 0.00152316435345407 0.0163740167996313 5295 N-acetyl-L-aspartic acid hsa04640 Hematopoietic cell lineage 3123_3126_3127_3125 4 + 0.0171976785909439 0.11353126059679 5296 N-acetyl-L-aspartic acid hsa05320 Autoimmune thyroid disease 3123_3126_3127_3125 4 + 0.00336486536345938 0.0289378421257507 5297 N-acetyl-L-aspartic acid hsa04612 Antigen processing and presentation 3123_3126_3127_3125 4 + 0.0184818331204077 0.11353126059679 5298 N-acetyl-L-aspartic acid hsa05310 Asthma 3123_3126_3127_3125 4 + 0.00047844275329595 0.0102865191958629 5299 N-acetyl-L-aspartic acid hsa05330 Allograft rejection 3123_3126_3127_3125 4 + 0.00108015363533252 0.0154822021064328 5300 N-acetyl-L-aspartic acid hsa04940 Type I diabetes mellitus 3382_3126_3127_3123_3125 5 + 0.000181285513235626 0.00779527706913192 5301 N-acetyl-L-aspartic acid hsa04080 Neuroactive ligand-receptor interaction 2908_5030_1081_1813 4 - 0.0373935807034095 1 5302 N-acetyl-L-aspartic acid hsa04740 Olfactory transduction 409_816 2 - 2.01637930877376e-05 0.00083679741314111 5303 N-acetyl-L-aspartic acid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 25 - 2.34092897351276e-08 1.94297104801559e-06 5304 niflumic acid hsa04740 Olfactory transduction 393046 1 + 0.00180505677094514 0.12274386042427 5305 niflumic acid hsa05322 Systemic lupus erythematosus 85235_8330_3111_8332_8969_8331_8329_6737_8336 9 + 0.011711510454876 0.398191355465784 5306 rilmenidine hsa04520 Adherens junction 4088_4089_3480_5770_2260_25945_6714 7 + 0.0446634592641868 1 5307 rilmenidine hsa04740 Olfactory transduction 818_23538_1258 3 + 0.000345116116340051 0.0279544054235441 5308 rilmenidine hsa05322 Systemic lupus erythematosus 85235_3119_8330_3111_8332_8969_8331_8329_8343_8336_8339_8347_8346_8344 14 + 0.00246250976286012 0.0997316453958349 5309 rilmenidine hsa05322 Systemic lupus erythematosus 3123_3013_8343_8351_8339_8347_8346_8344 8 - 0.0249123614581388 1 5310 N-acetylmuramic acid hsa05332 Graft-versus-host disease 3804_3811_3552_3119_3802 5 + 0.0365569836712732 0.681467905783428 5311 N-acetylmuramic acid hsa04080 Neuroactive ligand-receptor interaction 6915_8001_5724_7433 4 + 0.0499356564900858 0.681467905783428 5312 N-acetylmuramic acid hsa05016 Huntington's disease 5331_3708 2 + 0.0360911283330569 0.681467905783428 5313 N-acetylmuramic acid hsa04740 Olfactory transduction 5566 1 + 3.6246258347933e-06 0.000143172720474335 5314 N-acetylmuramic acid hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8360_8368_8362_8329_8294_8366_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3119_83740_720_721 27 + 5.61811181741582e-10 4.4383083357585e-08 5315 N-acetylmuramic acid hsa05211 Renal cell carcinoma 6655_5295_8453_3845_7422_7042_3725 7 - 0.0215088384892117 0.446308398651143 5316 N-acetylmuramic acid hsa04080 Neuroactive ligand-receptor interaction 2561_135 2 - 0.00938898100382993 0.389642711658942 5317 N-acetylmuramic acid hsa05200 Pathways in cancer 5295_581_6502_6655_2258_5371_4254_8453_4437_1956_3845_7422_7184_7042_10342_1488_4313_6256_3725_3675 20 - 0.037966232484036 0.450171042310713 5318 N-acetylmuramic acid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_3123_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235 27 - 5.04614036026745e-11 4.18829649902198e-09 5319 N-acetylmuramic acid hsa04012 ErbB signaling pathway 27_6655_5295_2002_1956_3845_3725 7 - 0.0487695083086434 0.465763173735358 5320 N-acetylmuramic acid hsa03020 RNA polymerase 246721_5439_548644_10622 4 - 0.0281325060612184 0.450171042310713 5321 N-acetylmuramic acid hsa04912 GnRH signaling pathway 4214_4313_6655_2002_1956_3845_113_3725_23236 9 - 0.0372519214107314 0.450171042310713 5322 N-acetylmuramic acid hsa05210 Colorectal cancer 581_6655_5295_4437_1956_3845_7042_3725 8 - 0.0160504556056122 0.444062605088604 5323 bupivacaine hsa05332 Graft-versus-host disease 942_3126_3127_3123_3125 5 + 0.0153968066172923 0.28389042721904 5324 bupivacaine hsa05320 Autoimmune thyroid disease 942_3126_3127_3123_3125 5 + 0.0348841776113888 0.453494308948054 5325 bupivacaine hsa04514 Cell adhesion molecules (CAMs) 6404_5175_3123_3126_3127_3125_57863_4359_942 9 + 0.0462003785471777 0.514804218097123 5326 bupivacaine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504_8354_942 20 + 1.92209570504199e-07 1.49923464993275e-05 5327 bupivacaine hsa05310 Asthma 3123_2205_3126_3127_3125 5 + 0.00441932030517448 0.172353491901805 5328 bupivacaine hsa05330 Allograft rejection 942_3126_3127_3123_3125 5 + 0.0106912259147959 0.277971873784693 5329 bupivacaine hsa04940 Type I diabetes mellitus 3126_942_3127_3123_3125 5 + 0.0181981043089128 0.28389042721904 5330 bupivacaine hsa04080 Neuroactive ligand-receptor interaction 5026 1 - 0.00245861845319168 0.0885102643149005 5331 bupivacaine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 30 - 7.42146450804742e-14 5.34345444579414e-12 5332 bupivacaine hsa05223 Non-small cell lung cancer 2064_6257_1956_5335_6654 5 - 0.0458160055250065 0.71403127158548 5333 bupivacaine hsa05210 Colorectal cancer 581_6654_5881_1956_324_91_8321 7 - 0.031624790428609 0.71403127158548 5334 piperine hsa04740 Olfactory transduction 5137_9635 2 + 0.00326156705840893 0.24461752938067 5335 piperine hsa04510 Focal adhesion 3695_2324_6655_3908_56924_3685_1277_1292_88_5293_55742_3082 12 + 0.0159097782511441 0.397744456278603 5336 piperine hsa04012 ErbB signaling pathway 6655_5293_867_56924_3084_7039 6 + 0.0366707220878275 0.52630419418576 5337 piperine hsa04512 ECM-receptor interaction 2812_3908_3695_3685_1277_1292 6 + 0.0319499632373126 0.52630419418576 5338 piperine hsa04630 Jak-STAT signaling pathway 3581_3589_6655_3446_5293_867_50616_3976_9021 9 + 0.0421043355348608 0.52630419418576 5339 piperine hsa04810 Regulation of actin cytoskeleton 9459_6655_9138_3695_3685_56924_88_7430_8976_324_5293_26281_2250 13 + 0.0106232161758326 0.397744456278603 5340 piperine hsa05214 Glioma 7157_5155_5290_5291_5605_5296_808_801_673_805 10 - 0.00973438471316213 0.128311217445731 5341 piperine hsa04070 Phosphatidylinositol signaling system 3636_5290_5291_5331_5296_808_4952_200576_801_805 10 - 0.0302039525876869 0.19981076327239 5342 piperine hsa05211 Renal cell carcinoma 5296_5155_5290_5291_5605_405_8453_7042_673 9 - 0.0486887055830183 0.254026523530042 5343 piperine hsa04080 Neuroactive ligand-receptor interaction 4889 1 - 7.49911324532445e-06 0.000644923739097903 5344 piperine hsa05131 Shigellosis 3688_347733_7278_999_113457_7280_7430_7534 8 - 0.0280792635797552 0.19981076327239 5345 piperine hsa05130 Pathogenic Escherichia coli infection 3688_347733_7278_999_113457_7280_7430_7534 8 - 0.0280792635797552 0.19981076327239 5346 piperine hsa04740 Olfactory transduction 219464_5613_5616_808_801_805 6 - 5.02456690035753e-05 0.00216056376715374 5347 piperine hsa04514 Cell adhesion molecules (CAMs) 3688_999 2 - 0.0247047041286468 0.19981076327239 5348 piperine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344 19 - 0.00301836249205877 0.0865263914390181 5349 piperine hsa05212 Pancreatic cancer 5170_6934_9134_7157_5155_5290_673_5605_5296_3326_1385_5291 12 - 0.0146216063977395 0.139717572245066 5350 piperine hsa05215 Prostate cancer 5170_6934_9134_7157_5155_5290_673_5605_5296_3326_1385_5291 12 - 0.0139086602169409 0.139717572245066 5351 piperine hsa04210 Apoptosis 5296_836_7157_5613_5575_331_5290_5291_472_5616_8737_8837_651610 13 - 0.00754979501503082 0.128311217445731 5352 piperine hsa05216 Thyroid cancer 5605_7157_999_6934_673 5 - 0.0417538225776831 0.239388582778716 5353 piperine hsa04060 Cytokine-cytokine receptor interaction 27242_3459_5155_8742_8741_7042 6 - 0.0104439363037223 0.128311217445731 5354 piperine hsa03020 RNA polymerase 5432_246721_5439_548644_5440 5 - 0.0417538225776831 0.239388582778716 5355 piperine hsa05213 Endometrial cancer 5170_7157_999_5290_5291_5605_5296_6934_673 9 - 0.00724117171598011 0.128311217445731 5356 enilconazole hsa04740 Olfactory transduction 4991_2979_135948_9635_81797 5 + 0.00017017978485692 0.0132740232188398 5357 enilconazole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_88_8294_8367_554313_121504_3119 16 + 0.00784407580322803 0.305918956325893 5358 enilconazole hsa04110 Cell cycle 4088 1 + 0.0312562382363703 0.741919367572533 5359 enilconazole hsa04062 Chemokine signaling pathway 7409 1 - 0.0322052370198929 1 5360 nipecotic acid hsa05016 Huntington's disease 4899 1 + 0.0461965873576664 1 5361 nipecotic acid hsa04510 Focal adhesion 1278_5170_10298_8515_596_3690_5880_1277_1956_5923_55742_2335 12 + 0.0355602413354333 1 5362 nipecotic acid hsa04360 Axon guidance 2047_1949_57715_10298_57556_2048_8482_5880_6092_80031 10 + 0.0072802734080674 0.495058591748583 5363 nipecotic acid hsa04740 Olfactory transduction 157 1 - 8.20410400770718e-05 0.0063992011260116 5364 nipecotic acid hsa04370 VEGF signaling pathway 5829_5296_3845_5600_5534_6714 6 - 0.0481237499279745 0.956368418434057 5365 nipecotic acid hsa04540 Gap junction 2911_7278_6654_5155_113457_5607_3845_6714_23236 9 - 0.00505308041184886 0.197070136062106 5366 meteneprost hsa04640 Hematopoietic cell lineage 3655_1604_3673 3 + 0.0324026434855582 0.469838330540594 5367 meteneprost hsa04080 Neuroactive ligand-receptor interaction 4889_5618_64106_4158_2908_2688_1442_2150_728 9 + 9.45856614905446e-05 0.00411447627483869 5368 meteneprost hsa04670 Leukocyte transendothelial migration 2909_5747_7409_5175_9475 5 + 0.0231585970217581 0.402959588178591 5369 meteneprost hsa04740 Olfactory transduction 818_5613_5567_5616_816 5 + 4.10646561699688e-12 3.57262508678729e-10 5370 meteneprost hsa04260 Cardiac muscle contraction 9167_1327_4635 3 + 0.0446968764247962 0.554708833515973 5371 meteneprost hsa04060 Cytokine-cytokine receptor interaction 91_3556_5618_8771_3449_3588_3459_5154_3572_23529_355_7424_2688_7422_8718_8795 16 + 0.018603541234541 0.402959588178591 5372 meteneprost hsa03010 Ribosome 9349 1 + 0.000625118601885761 0.0181284394546871 5373 meteneprost hsa04740 Olfactory transduction 219464 1 - 1.79862086217508e-05 0.00136695185525306 5374 meteneprost hsa05219 Bladder cancer 7157_999_7057_1613_1871_1890 6 - 0.00720079328638052 0.251008260850346 5375 meteneprost hsa05223 Non-small cell lung cancer 5170_5578_7157_6655_1871_5336 6 - 0.0205220310989245 0.389918590879565 5376 meteneprost hsa05220 Chronic myeloid leukemia 3551_7157_6655_1871_867_861_1398_91 8 - 0.00990822082303998 0.251008260850346 5377 nabumetone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_717_8368_3126_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344 21 + 4.4285623971438e-09 3.27713617388641e-07 5378 nabumetone hsa04920 Adipocytokine signaling pathway 208_32_5781_5588_3952 5 + 0.0478911497182891 0.71159869356353 5379 nabumetone hsa04020 Calcium signaling pathway 146_5533_1812_818_9630_7416_8912_5733_810_816 10 + 0.0461389898792003 0.71159869356353 5380 nabumetone hsa04080 Neuroactive ligand-receptor interaction 5618 1 - 0.0160192294729924 0.608730719973711 5381 nabumetone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3123_3113_8359_8294_8367_554313_8368_121504_9555 17 - 1.17897671592696e-06 8.9602230410449e-05 5382 PHA-00846566E hsa03440 Homologous recombination 5890_7156_10111 3 + 0.00355952018356934 0.16373792844419 5383 PHA-00846566E hsa05221 Acute myeloid leukemia 5970_5292_3551 3 - 0.0402162510893904 0.482595013072685 5384 PHA-00846566E hsa05120 Epithelial cell signaling in Helicobacter pylori infection 6714_5970_50848_3551 4 - 0.0133557786069969 0.439812979765137 5385 PHA-00846566E hsa05222 Small cell lung cancer 51588_5970_331_3551 4 - 0.0244340544313965 0.439812979765137 5386 carbachol hsa04640 Hematopoietic cell lineage 920_1378_2812_3690 4 + 0.0253225240557822 0.325301009408079 5387 carbachol hsa05322 Systemic lupus erythematosus 3013_9103_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 12 + 4.22555359085047e-07 1.60571036452318e-05 5388 carbachol hsa04360 Axon guidance 2047_6093_57144_80031_2534 5 + 0.0256816586374799 0.325301009408079 5389 carbachol hsa05222 Small cell lung cancer 2335_598_3918_5747_1869_3675 6 - 0.0186904336541929 1 5390 flavoxate hsa04740 Olfactory transduction 1179 1 + 0.0110987502387991 0.721418765521942 5391 flavoxate hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344 19 - 0.000119497395984913 0.0092012994908383 5392 flavoxate hsa05012 Parkinson's disease 4712 1 - 0.0332796934550896 0.733761899870331 5393 flavoxate hsa05210 Colorectal cancer 595_581_3480_5295_5881_5900_324_4609_8324_8322 10 - 0.00908274535022182 0.34968569598354 5394 PNU-0293363 hsa05214 Glioma 5594_5578_7157_6654_6464_5154_5290_5605_5296_808_5335_801_805 13 + 0.0107108697602622 0.206136556928093 5395 PNU-0293363 hsa04070 Phosphatidylinositol signaling system 8867_3710_5298_5578_5296_5290_5333_808_5335_4952_801_3707_805 13 + 0.0311013179812248 0.270548771469781 5396 PNU-0293363 hsa04640 Hematopoietic cell lineage 3655_966 2 + 0.0474153867411097 0.328260369746144 5397 PNU-0293363 hsa04080 Neuroactive ligand-receptor interaction 4157_7068_5025_56288_2150_9170 6 + 0.000123171962509143 0.00554273831291143 5398 PNU-0293363 hsa05200 Pathways in cancer 6777_8554_5296_331_5154_5290_5605_4436_5335_3326_5747_3655_7976_25_4149_7157_1857_5900_2034_324_1398_367_1017_9134_613_999_1495_6934_2263_5899_2956_4791_2335_2271_5594_5578_6774_6654_6772_355_5970_7184 42 + 0.0330670720685288 0.270548771469781 5399 PNU-0293363 hsa04740 Olfactory transduction 801_808_805 3 + 3.82833852896898e-11 3.44550467607208e-09 5400 PNU-0293363 hsa05212 Pancreatic cancer 6934_367_5970_5594_9134_7157_6654_5154_5290_5605_5296_3326_1385_2263_1017_7184 16 + 0.0114520309404496 0.206136556928093 5401 PNU-0293363 hsa05215 Prostate cancer 6934_367_5970_5594_9134_7157_6654_5154_5290_5605_5296_3326_1385_2263_1017_7184 16 + 0.0106991445280812 0.206136556928093 5402 PNU-0293363 hsa03430 Mismatch repair 9156_5983_6117_5985_4436_2956 6 + 0.0262519482778256 0.270548771469781 5403 PNU-0293363 hsa04060 Cytokine-cytokine receptor interaction 3597_3460_3588_23765_3459_5154_8741_8742_355_4982_655_51330 12 + 0.0183642172163826 0.236111364210633 5404 PNU-0293363 hsa05213 Endometrial cancer 2309_6934_5296_6654_999_5290_5605_7157_1495_324_5594 11 + 0.0163441806023136 0.236111364210633 5405 PNU-0293363 hsa05220 Chronic myeloid leukemia 25_6777_5594_5296_613_6654_6464_5290_5605_7157_5781_1398_5970 13 + 0.0293412149732509 0.270548771469781 5406 PNU-0293363 hsa04610 Complement and coagulation cascades 966 1 + 0.0434153516858221 0.325615137643666 5407 PNU-0293363 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 1.43383891915227e-08 6.30889124426999e-07 5408 tamoxifen hsa04640 Hematopoietic cell lineage 2815_3581_966_3554_2057_1437_3123_2812_3126_3127_3125_947_933 13 + 0.02248169721205 0.659463118220133 5409 tamoxifen hsa04740 Olfactory transduction 8390_7932_10798 3 + 1.52370935931768e-08 6.70432118099779e-07 5410 tamoxifen hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8349_8348_8294_121504_8343_8347_8346_8344_8339_3123_3126_3127_3125_8968_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_3012_3013_3017_8970 40 + 1.0957888041329e-11 9.64294147636952e-10 5411 tamoxifen hsa05010 Alzheimer's disease 5595_22926_351_102_4842_23236 6 - 0.0233054398630736 0.32627615808303 5412 tamoxifen hsa04080 Neuroactive ligand-receptor interaction 2859_4889_2914_7068_4886_5027_135_7433_3269_5646 10 - 0.0177176178015766 0.32627615808303 5413 tamoxifen hsa05016 Huntington's disease 581_23236 2 - 7.50674566518868e-05 0.00315283317937925 5414 tamoxifen hsa04740 Olfactory transduction 219464_5566_157_409 4 - 3.4005859955384e-09 2.85649223625226e-07 5415 tamoxifen hsa05322 Systemic lupus erythematosus 717_3111 2 - 0.00140793462169595 0.0394221694074866 5416 tamoxifen hsa04260 Cardiac muscle contraction 782 1 - 0.0203867507549758 0.32627615808303 5417 tolbutamide hsa04740 Olfactory transduction 8387_8392_1179_8388 4 + 4.50645747150294e-06 0.000187017985067372 5418 tolbutamide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_3017 27 + 8.53184720314838e-07 7.08143317861316e-05 5419 tolbutamide hsa04530 Tight junction 26285_5584 2 + 0.0247773038631141 0.514129055159618 5420 tolbutamide hsa04630 Jak-STAT signaling pathway 3560_2057 2 + 0.0127795022796688 0.353566229737504 5421 tolbutamide hsa05010 Alzheimer's disease 3553_1329_3708_351_4695_6622 6 - 0.0410450593658884 0.435952429609474 5422 tolbutamide hsa04080 Neuroactive ligand-receptor interaction 1269_2917_64106_2908_2901_5030_3354_3351 8 - 0.00698808960061512 0.197995872017428 5423 tolbutamide hsa04660 T cell receptor signaling pathway 5163_1432_3551_208_5058_5295_56924_5588_998_4776_4775_5335_3725_1326_4793 15 - 0.0499147691875745 0.435952429609474 5424 tolbutamide hsa04740 Olfactory transduction 219464 1 - 1.95471138953607e-11 1.66150468110566e-09 5425 tolbutamide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8294_121504_8968_8370_8358_8359_8330_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3014 29 - 1.31492686566397e-05 0.000558843917907187 5426 tolbutamide hsa05120 Epithelial cell signaling in Helicobacter pylori infection 7082_1432_3551_8992_5058_998_10392_1956_5335_3725_50848 11 - 0.0461502029834893 0.435952429609474 5427 tolbutamide hsa04720 Long-term potentiation 3708 1 - 0.042743077696034 0.435952429609474 5428 tolbutamide hsa04260 Cardiac muscle contraction 1329 1 - 0.0299281296276071 0.435952429609474 5429 dexverapamil hsa03010 Ribosome 6204_6169_6205_284393_6181_6157_389342_9045 8 + 3.41487075288974e-05 0.00184403020656046 5430 dexverapamil hsa04110 Cell cycle 4174_25_890_5111_990_10971_4088_983_9184_7027_10926_8243_8697_4999 14 - 0.038540491337109 0.761174703907903 5431 dexverapamil hsa05216 Thyroid cancer 5595_8030_999_5979_3845_6256 6 - 0.0157551760730481 0.414886303256933 5432 dexverapamil hsa04060 Cytokine-cytokine receptor interaction 657_27242_3597_3572 4 - 0.000551369490037194 0.0435581897129383 5433 dexverapamil hsa04270 Vascular smooth muscle contraction 5595 1 - 0.0101394111122438 0.40050673893363 5434 verapamil hsa04916 Melanogenesis 51176_7306_51384_2771_5566_2775_5331_2033_90993_113_112_1906_7475_816_23236 15 + 0.0271546353971208 0.258262139121874 5435 verapamil hsa05332 Graft-versus-host disease 3804_3107_3113_941_3135_356_5551_942 8 + 0.0214888954151342 0.258262139121874 5436 verapamil hsa04120 Ubiquitin mediated proteolysis 22888_5371_4193 3 + 0.0187026952583117 0.258262139121874 5437 verapamil hsa04740 Olfactory transduction 26212_157_5566_5593_8392_4991_816 7 + 2.61349224888959e-06 0.000114993658951142 5438 verapamil hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3113_941_942 35 + 2.005500432823e-08 1.76484038088424e-06 5439 verapamil hsa04540 Gap junction 2911_5593_2771_5598_5566_113457_3709_5331_5607_80310_10382_113_112_2982_7278_23236 16 + 0.00394842778637002 0.115820548400187 5440 verapamil hsa05012 Parkinson's disease 1329_5413_65018 3 + 0.0183255119463029 0.258262139121874 5441 verapamil hsa05330 Allograft rejection 942_3107_3113_941_3135_356_5551 7 + 0.0350671684086227 0.280537347268982 5442 verapamil hsa04730 Long-term depression 2911_5593_3480_2771_2775_5331_3709_2982_30814_4842_23236 11 + 0.0293479703547584 0.258262139121874 5443 verapamil hsa04270 Vascular smooth muscle contraction 147_135_2982_3779_1909_552_5331_185_3709_10203_113_112_4629_6093_30814_5566_23236 17 + 0.0161563241387462 0.258262139121874 5444 verapamil hsa04940 Type I diabetes mellitus 942_3107_2572_941_3135_356_5551_3113 8 + 0.0266716870346853 0.258262139121874 5445 verapamil hsa05010 Alzheimer's disease 572_5595_23236 3 - 0.0263835860212645 0.534267616930606 5446 verapamil hsa05016 Huntington's disease 23236 1 - 0.000758614864678671 0.0307239020194862 5447 verapamil hsa05322 Systemic lupus erythematosus 8363_8362_94239_8329_87_3123_3126_3127_3125_8969_8968_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3014 27 - 1.87107934983652e-07 1.51557427336758e-05 5448 verapamil hsa05012 Parkinson's disease 51465_7332 2 - 0.0497714492355486 0.669476613795662 5449 verapamil hsa04060 Cytokine-cytokine receptor interaction 8792_657_23765_4254_9180 5 - 0.0108533685187642 0.293040950006633 5450 rofecoxib hsa04120 Ubiquitin mediated proteolysis 23759_51366_55284_8065_55236_8450_7320_9021_63893 9 + 0.0287637933103217 0.489010833863483 5451 rofecoxib hsa05016 Huntington's disease 2902_1211_6648_1327_7052_1639_1329_27113_29796_4698_1385_55567_517_842 14 + 0.027671795675663 0.489010833863483 5452 rofecoxib hsa04740 Olfactory transduction 219464_51806_5568_157_26333_8390_2978_26476_4995_10798_81797 11 + 4.33076205790049e-11 3.94099347268945e-09 5453 rofecoxib hsa05322 Systemic lupus erythematosus 3126_3017_720_721_8341_8340 6 + 0.00131465064801093 0.0598166044844973 5454 rofecoxib hsa04630 Jak-STAT signaling pathway 3581_3566_2057_3594_3589_64109_3441_1438_1439_9021_3592 11 + 0.0389460422424111 0.489010833863483 5455 rofecoxib hsa04810 Regulation of actin cytoskeleton 5595_1133_26999_2909_3693_5155_998_3696_673_27006_4659_3690_6237_2260_28964_6093 16 + 0.0140815528607565 0.42714043677628 5456 rofecoxib hsa05012 Parkinson's disease 2861_842_4698_1329_29796_65018_6622_517_1327 9 + 0.0375691753629587 0.489010833863483 5457 rofecoxib hsa04740 Olfactory transduction 393046_5592_815_9635 4 - 2.54373268866698e-12 2.34023407357362e-10 5458 rofecoxib hsa05322 Systemic lupus erythematosus 3122_2209 2 - 0.000142348531853141 0.00654803246524449 5459 rofecoxib hsa05110 Vibrio cholerae infection 11015 1 - 0.041481675658419 0.683419464841416 5460 rofecoxib hsa04260 Cardiac muscle contraction 6546_782 2 - 0.0227590565791817 0.523458301321179 5461 rofecoxib hsa03010 Ribosome 6165 1 - 0.000926043905733005 0.0283986797758122 5462 exemestane hsa04520 Adherens junction 4088_5595_56288 3 - 0.0478270596159521 0.954245032728618 5463 sulindac hsa05010 Alzheimer's disease 6390_4713 2 + 0.00310433786077157 0.0690715174021674 5464 sulindac hsa05320 Autoimmune thyroid disease 3439_3107_7252_3123_3447_3446_3126_3127_3111_3125 10 + 0.00295416205751804 0.0690715174021674 5465 sulindac hsa04612 Antigen processing and presentation 4261_3107_3439_3123_3447_3446_3126_3127_3111_3125_6891_6890 12 + 0.0153272343068124 0.232701453451601 5466 sulindac hsa04740 Olfactory transduction 26333 1 + 4.33547459965979e-09 3.85857239369721e-07 5467 sulindac hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_9103_8294_87_3123_3126_3127_3125_8370_8359_554313_121504_3017_3111 22 + 0.000254798533212157 0.011338534727941 5468 sulindac hsa05310 Asthma 3123_3126_3127_3111_3125_8288 6 + 0.0156877384349394 0.232701453451601 5469 sulindac hsa05012 Parkinson's disease 6390_4713 2 + 0.0250689219322907 0.285995168278667 5470 sulindac hsa05330 Allograft rejection 3123_3107_3126_3127_3111_3125 6 + 0.0387147779666205 0.382846137669914 5471 sulindac hsa04940 Type I diabetes mellitus 3382_3123_3107_3126_3127_3111_3125 7 + 0.0257074308565094 0.285995168278667 5472 sulindac hsa05010 Alzheimer's disease 355_5534_5664 3 - 0.0100590168065878 0.175026892434628 5473 sulindac hsa04080 Neuroactive ligand-receptor interaction 2859_2901_2908_3360_5733_1902 6 - 0.00772671417356551 0.16805603327505 5474 sulindac hsa04612 Antigen processing and presentation 3306 1 - 0.0437784437316627 0.380872460465465 5475 sulindac hsa05016 Huntington's disease 6648 1 - 0.000252107476160217 0.0109666752129694 5476 sulindac hsa04740 Olfactory transduction 5566 1 - 1.18797793078161e-09 1.03354079978e-07 5477 sulindac hsa04514 Cell adhesion molecules (CAMs) 6693_57863 2 - 0.0174584601863631 0.190737995738739 5478 sulindac hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3013_554313_721_3014_8359_8294_720_121504_8368_8351_8367 19 - 0.0065895300399518 0.16805603327505 5479 sulindac hsa05012 Parkinson's disease 7345_9246 2 - 0.0175391260449415 0.190737995738739 5480 sulindac hsa04060 Cytokine-cytokine receptor interaction 3561_3597_2057_3572_7852_355_7042 7 - 0.0130840292805042 0.189718424567311 5481 sulindac hsa04270 Vascular smooth muscle contraction 5566_5581 2 - 0.049297281904896 0.389896684156905 5482 sulindac hsa05220 Chronic myeloid leukemia 1027_2122_6776_1029_5290_5291_25759_9846_7042_1869 10 - 0.0349863071119416 0.338200968748769 5483 amitriptyline hsa04120 Ubiquitin mediated proteolysis 6921_51343_331_4193_868 5 + 0.043139880814698 0.776517854664564 5484 amitriptyline hsa04910 Insulin signaling pathway 8835_868_10000_5139 4 + 0.0182331544623851 0.410245975403665 5485 amitriptyline hsa04740 Olfactory transduction 26212_7932_56656_157_26333_5593_3000_4991_26529_815_816 11 + 2.42988067013692e-05 0.00109344630156161 5486 amitriptyline hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_2209_8969_8968_8370_718_717_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_942_3017_1511 38 + 2.09001595835887e-08 1.88101436252298e-06 5487 amitriptyline hsa03010 Ribosome 6187_440589 2 + 0.0165515115132361 0.410245975403665 5488 amitriptyline hsa04080 Neuroactive ligand-receptor interaction 2902_56288_2740 3 - 0.01974246077047 0.49356151926175 5489 amitriptyline hsa04740 Olfactory transduction 5137_409 2 - 6.11338939106797e-05 0.00458504204330098 5490 amitriptyline hsa04060 Cytokine-cytokine receptor interaction 8718_1271_2057 3 - 0.0142228227732093 0.49356151926175 5491 15-delta prostaglandin J2 hsa04080 Neuroactive ligand-receptor interaction 7068_2908_3362_5031_186_7433_8484 7 + 6.50544211085864e-05 0.00299250337099497 5492 15-delta prostaglandin J2 hsa05016 Huntington's disease 246721_51164_841_581_7052_7416_9001_161_23236 9 + 0.0308352662677911 0.567368899327356 5493 15-delta prostaglandin J2 hsa04740 Olfactory transduction 818_8390 2 + 1.28755723172303e-13 1.18455265318519e-11 5494 15-delta prostaglandin J2 hsa05322 Systemic lupus erythematosus 2213_8970_8348 3 + 0.00114667212812283 0.0351646119291001 5495 15-delta prostaglandin J2 hsa04810 Regulation of actin cytoskeleton 23533_26230_5063_8394_2909_5293_3678_10109_3984_6093_10458_2260 12 + 0.0463964828354503 0.665167850350028 5496 15-delta prostaglandin J2 hsa05012 Parkinson's disease 7314_7345_7416 3 + 0.00232367459940534 0.0534445157863228 5497 15-delta prostaglandin J2 hsa04650 Natural killer cell mediated cytotoxicity 10451_3460_5295_5578 4 - 0.00963162000734975 0.144474300110246 5498 15-delta prostaglandin J2 hsa04120 Ubiquitin mediated proteolysis 6502_867_23759_9820_672 5 - 0.0238552272475138 0.26837130653453 5499 15-delta prostaglandin J2 hsa05010 Alzheimer's disease 351_3709_489_5664_102_6622_823 7 - 0.0162872529396688 0.209407537795742 5500 15-delta prostaglandin J2 hsa04080 Neuroactive ligand-receptor interaction 5029_5618_7442_4886_1241_3354_6754_2690 8 - 0.000341505905955671 0.0153677657680052 5501 15-delta prostaglandin J2 hsa05016 Huntington's disease 5430_6648_7157_5439_246721_3064_1385_55567_548644 9 - 0.0397321654598719 0.325081353762588 5502 15-delta prostaglandin J2 hsa04740 Olfactory transduction 818_5613_5566_109_409 5 - 3.24576208349125e-10 2.92118587514212e-08 5503 15-delta prostaglandin J2 hsa05012 Parkinson's disease 2861_6622_7054 3 - 0.00333382737481461 0.100014821244438 5504 15-delta prostaglandin J2 hsa04620 Toll-like receptor signaling pathway 208_5295_5608 3 - 0.0339076706229827 0.305169035606844 5505 15-delta prostaglandin J2 hsa04260 Cardiac muscle contraction 27092 1 - 0.0095198231512492 0.144474300110246 5506 15-delta prostaglandin J2 hsa04060 Cytokine-cytokine receptor interaction 7424_5618_3597_3460_3575_5155_4254_6387_4982_7046_7042_2690 12 - 0.00860324695836732 0.144474300110246 5507 15-delta prostaglandin J2 hsa03010 Ribosome 9349_6189_439992 3 - 0.0339076706229827 0.305169035606844 5508 tacrolimus hsa05010 Alzheimer's disease 5595_3710_808_489_102_801_805_23621 8 + 0.0439661110920196 0.660212635569548 5509 tacrolimus hsa04080 Neuroactive ligand-receptor interaction 7068_1132_4158_6754_8484_4986_2692 7 + 0.000248551899802069 0.00729085572752736 5510 tacrolimus hsa05016 Huntington's disease 7052_5441_27113_55567 4 + 0.000499827670561101 0.0109962087523442 5511 tacrolimus hsa04740 Olfactory transduction 801_808_805 3 + 1.69253370382534e-11 1.4894296593663e-09 5512 tacrolimus hsa05012 Parkinson's disease 7318 1 + 0.000138579654343025 0.0060975047910931 5513 tacrolimus hsa04260 Cardiac muscle contraction 481_6548 2 + 0.0461008759193632 0.660212635569548 5514 tacrolimus hsa04740 Olfactory transduction 5593_56656_8388_8387_5566_8590 6 - 7.0903604203133e-05 0.00588499914886004 5515 tacrolimus hsa04514 Cell adhesion molecules (CAMs) 5010_3383_3111_3897_3134_5817_57863_940_3133_6614_23705_1013_925_1462 14 - 0.0471323545772006 0.900606203592502 5516 tacrolimus hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3111_8359_940_8294_8367_554313_8343_121504_8339_8347_8346_8344 21 - 0.000422473826291573 0.0175326637911003 5517 pivampicillin hsa04740 Olfactory transduction 5137_26212_8390 3 + 0.0368312587018577 1 5518 pivampicillin hsa04080 Neuroactive ligand-receptor interaction 64106_7067_9170 3 - 0.0200606868987033 0.367506229803516 5519 pivampicillin hsa05131 Shigellosis 7280_347733_7278_113457_9475_7430 6 - 0.0309913252753445 0.367506229803516 5520 pivampicillin hsa05130 Pathogenic Escherichia coli infection 7280_347733_7278_113457_9475_7430 6 - 0.0309913252753445 0.367506229803516 5521 pivampicillin hsa04740 Olfactory transduction 818_219464_109 3 - 0.000363104499888687 0.0286852554912063 5522 pivampicillin hsa05322 Systemic lupus erythematosus 3119 1 - 0.0463608405436187 0.444646171303597 5523 pivampicillin hsa04210 Apoptosis 842_3551_5575_472_8837_651610_8795_7186 8 - 0.032563843147147 0.367506229803516 5524 pivampicillin hsa03022 Basal transcription factors 11037_2967_2969_10629_6884_6872 6 - 0.00562645703547517 0.222245052901269 5525 pivampicillin hsa03020 RNA polymerase 5432_246721_5439_548644_10622 5 - 0.00901177484336183 0.237310070875195 5526 proguanil hsa05332 Graft-versus-host disease 3135_3105_3106_649853 4 + 0.0213788851378137 0.235469878052175 5527 proguanil hsa04650 Natural killer cell mediated cytotoxicity 3451_3105_6655_3135_27040_80328_80329_3106 8 + 0.0201211181872895 0.235469878052175 5528 proguanil hsa05320 Autoimmune thyroid disease 3135_3105_3106_3451_649853 5 + 0.0107821721099832 0.235469878052175 5529 proguanil hsa04514 Cell adhesion molecules (CAMs) 965_214_3105_3106_3135_6383_649853 7 + 0.0453949499380206 0.337940182871931 5530 proguanil hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 1.72212601254469e-05 0.00115382442840494 5531 proguanil hsa04664 Fc epsilon RI signaling pathway 10000_5603_5581_6655_27040_5320 6 + 0.0138213005063993 0.235469878052175 5532 proguanil hsa05330 Allograft rejection 3135_3105_3106_649853 4 + 0.015747833067242 0.235469878052175 5533 proguanil hsa04940 Type I diabetes mellitus 3135_3105_3106_649853 4 + 0.0246013305427646 0.235469878052175 5534 proguanil hsa05220 Chronic myeloid leukemia 5925_6655_7046_10000_1399 5 + 0.0377306554406555 0.31599423931549 5535 proguanil hsa05214 Glioma 5578_808_5605_1956_5335_1869_801_673_805 9 - 0.00104401479883599 0.0319191562499208 5536 proguanil hsa04070 Phosphatidylinositol signaling system 5578_8396_808_5335_51763_801_805_3705 8 - 0.00887875934108212 0.0784051287189541 5537 proguanil hsa04080 Neuroactive ligand-receptor interaction 2561_2149 2 - 0.00928481787461298 0.0784051287189541 5538 proguanil hsa05200 Pathways in cancer 2308_2271_8312_5578_7042_3913_8074_5881_673_5605_405_1956_5335_6934_5747_1869_3725_5888_7186_3675 20 - 0.0365147720016338 0.163242510124951 5539 proguanil hsa04910 Insulin signaling pathway 2308_5256_2002_5575_673_5605_808_51763_5509_801_5566_805 12 - 0.00627280791481664 0.0784051287189541 5540 proguanil hsa04740 Olfactory transduction 801_808_5566_805 4 - 0.00432887062154051 0.0784051287189541 5541 proguanil hsa04510 Focal adhesion 5578_3913_1302_1729_394_3678_7057_2002_93408_5881_1956_5747_3725_673_83660_3675 16 - 0.00802262971923534 0.0784051287189541 5542 proguanil hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 0.00125996669407582 0.0319191562499208 5543 proguanil hsa04370 VEGF signaling pathway 8398_5578_5605_5881_5335_5600_5747 7 - 0.0272225962481114 0.129307332178529 5544 proguanil hsa05219 Bladder cancer 5605_1869_1956_7057_673 5 - 0.0233421460887232 0.122740331040037 5545 proguanil hsa04720 Long-term potentiation 5578_5566_673_5605_808_801_805 7 - 0.0242250653368494 0.122740331040037 5546 proguanil hsa04012 ErbB signaling pathway 2002_5578_673_5605_1956_5335_5747_3725 8 - 0.0178295134844818 0.104425047495549 5547 proguanil hsa05223 Non-small cell lung cancer 5578_673_5605_1956_5335_1869 6 - 0.0178621791768703 0.104425047495549 5548 proguanil hsa04512 ECM-receptor interaction 960_961_1302_7057_3678_6383_3913_3675 8 - 0.0149289405140688 0.104425047495549 5549 proguanil hsa05213 Endometrial cancer 2002_6934_673_5605_1956_8312 6 - 0.0152992726052204 0.104425047495549 5550 proguanil hsa04912 GnRH signaling pathway 2002_8398_5578_5566_2767_808_5605_1956_5600_3725_801_805 12 - 0.000973770857094756 0.0319191562499208 5551 proguanil hsa05210 Colorectal cancer 6934_673_5881_1956_8312_7042_3725 7 - 0.0396717001310262 0.167502733886555 5552 proguanil hsa04270 Vascular smooth muscle contraction 8398_5578_4882_2767_673_5605_9826_805_801_5566_808 11 - 0.00544275936927545 0.0784051287189541 5553 risperidone hsa04660 T cell receptor signaling pathway 10892_867_4772_5534_920_6300 6 + 0.0164303870563514 0.366945310925181 5554 risperidone hsa04740 Olfactory transduction 26529 1 + 0.0157935121512961 0.366945310925181 5555 risperidone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 6.86713964860064e-07 4.60098356456243e-05 5556 risperidone hsa04080 Neuroactive ligand-receptor interaction 2908 1 - 0.0325181116063122 0.693719714267994 5557 risperidone hsa04740 Olfactory transduction 409 1 - 0.00257268872524751 0.0823260392079203 5558 risperidone hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_8337_8343_8336_8339_8347_8346_8344 13 - 6.43634900485786e-05 0.00411926336310903 5559 tribenoside hsa04650 Natural killer cell mediated cytotoxicity 3451_4775_3107_5880_356_27040_6452_3845_5781_5534_2534 11 + 0.021406483290175 0.661205451950336 5560 tribenoside hsa04740 Olfactory transduction 4992 1 + 1.72414848472591e-05 0.00137931878778073 5561 tribenoside hsa04360 Axon guidance 5362_57715_6585_2041_4775_5880_3845_5534_27289_2534 10 + 0.0343750905373956 0.687501810747912 5562 tribenoside hsa05219 Bladder cancer 1029_9252_3845_4193_7422 5 + 0.0247952044481376 0.661205451950336 5563 tribenoside hsa04080 Neuroactive ligand-receptor interaction 2901 1 - 0.0024569286691251 0.191640436191758 5564 tribenoside hsa05200 Pathways in cancer 4088_4286_4149_5578_6789_6655_6777_8074_1856_2122_4318_51588_1956_5335_112399_652_3655_4254_5888_8321_3675 21 - 0.00955958923852102 0.37282398030232 5565 tribenoside hsa04670 Leukocyte transendothelial migration 5578_4318_2909_1364_9475_1535_5335_5600_7430 9 - 0.0424526499707412 0.555470210318831 5566 tribenoside hsa05223 Non-small cell lung cancer 6789_6655_1956_5335_5578 5 - 0.0462764071935147 0.555470210318831 5567 roxarsone hsa05332 Graft-versus-host disease 3824_3108_3804_3107_3126_3127_3125_3135_3123 9 + 2.76072701959941e-05 0.000993861727055787 5568 roxarsone hsa04640 Hematopoietic cell lineage 1436_960_948_3123_3126_3127_3125_3684 8 + 0.010526200881755 0.08420960705404 5569 roxarsone hsa05320 Autoimmune thyroid disease 3108_3123_3107_3126_3127_3125_3135 7 + 0.00278186491928626 0.0333823790314351 5570 roxarsone hsa04612 Antigen processing and presentation 3824_3108_3123_3107_3126_3127_3125_3135_3804 9 + 0.00387568371771405 0.0398641753822017 5571 roxarsone hsa04740 Olfactory transduction 26212_816 2 + 0.000550856349552911 0.0099154142919524 5572 roxarsone hsa04514 Cell adhesion molecules (CAMs) 3108_3123_3107_3126_3127_3125_3135_23308_4359_3684 10 + 0.0256686190187567 0.184814056935048 5573 roxarsone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504_3108_9555 20 + 2.3294855765518e-07 1.6772296151173e-05 5574 roxarsone hsa05310 Asthma 3123_3125_3108_3127_3126 5 + 0.00464766940428165 0.0418290246385348 5575 roxarsone hsa05330 Allograft rejection 3108_3123_3107_3126_3127_3125_3135 7 + 0.000490595536382789 0.0099154142919524 5576 roxarsone hsa04940 Type I diabetes mellitus 3108_3123_3107_3126_3127_3125_3135 7 + 0.00106361456593691 0.0153160497494915 5577 levocabastine hsa05322 Systemic lupus erythematosus 2904_3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 12 + 9.5730178948197e-05 0.00536089002109903 5578 levocabastine hsa04512 ECM-receptor interaction 7148_6383_2812_3690_3685_9672 6 + 0.0109418622616449 0.306372143326057 5579 levocabastine hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0281176343032377 0.52486250699377 5580 levocabastine hsa04080 Neuroactive ligand-receptor interaction 9568 1 - 0.00258902635180791 0.100972027720508 5581 levocabastine hsa04740 Olfactory transduction 818 1 - 2.54544194284767e-05 0.00198544471542118 5582 lansoprazole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_2904_8368_8366_9103_8359_8294_8367_554313_6738_121504 17 + 0.000163445057197367 0.0135659397473815 5583 lansoprazole hsa04930 Type II diabetes mellitus 5313_5599_776_3551_5581 5 + 0.0432970507402539 1 5584 lansoprazole hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_8336 7 - 0.0107888075475664 0.377608264164824 5585 triprolidine hsa04540 Gap junction 6714_5154_23236 3 + 0.0147254395287222 0.201247673559203 5586 triprolidine hsa04060 Cytokine-cytokine receptor interaction 3566_8742_5154_8741_3570 5 + 0.0139417953349538 0.201247673559203 5587 triprolidine hsa04912 GnRH signaling pathway 5599_4214_6714_23236 4 + 0.00300713450751266 0.123292514808019 5588 triprolidine hsa04662 B cell receptor signaling pathway 10725_10892_11261_5336_5534_27071 6 - 0.0183823850629042 0.275735775943563 5589 triprolidine hsa05014 Amyotrophic lateral sclerosis (ALS) 836_581_11261_5606_5534_5608 6 - 0.00521990724151232 0.130497681037808 5590 triprolidine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294 21 - 1.49054788274845e-09 1.11791091206134e-07 5591 triprolidine hsa04060 Cytokine-cytokine receptor interaction 3460 1 - 0.0160528412440084 0.275735775943563 5592 triprolidine hsa03020 RNA polymerase 5432_246721_5439_10622_548644_84172 6 - 0.000246712377633696 0.0092517141612636 5593 Prestwick-674 hsa05332 Graft-versus-host disease 3824_942_3126_3127_3111_3125_356_3123_7124 9 + 0.000267472178286134 0.00939233807350236 5594 Prestwick-674 hsa05320 Autoimmune thyroid disease 3126_942_3127_3111_3125_356_3123 7 + 0.0135080690110678 0.131703672857911 5595 Prestwick-674 hsa04740 Olfactory transduction 26212_26692_8388_8387_26476_5137_816 7 + 0.0102683783600602 0.130118848151769 5596 Prestwick-674 hsa04514 Cell adhesion molecules (CAMs) 965_4684_5175_3123_3126_3127_3111_3125_5818_6614_942_26047_5817 13 + 0.0116773325264408 0.130118848151769 5597 Prestwick-674 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8294_3123_3126_3127_3125_8370_8359_554313_121504_7124_942_3111 22 + 2.1230241402264e-06 0.000165595882937659 5598 Prestwick-674 hsa05310 Asthma 3123_3126_3127_3111_3125_7124 6 + 0.00383500340953482 0.0598260531887432 5599 Prestwick-674 hsa04010 MAPK signaling pathway 2353_776_627_782_8823_5599_1852_4915_8913_4137_1850_4208_356_5600_4791_2260_10000_2246_8398_7124 20 + 0.0383533724392711 0.332395894473683 5600 Prestwick-674 hsa05330 Allograft rejection 3126_942_3127_3111_3125_356_3123_7124 8 + 0.000647456476028801 0.0126254012825616 5601 Prestwick-674 hsa04940 Type I diabetes mellitus 942_3126_3127_3111_2571_356_3123_7124_3125 9 + 0.000361243772057783 0.00939233807350236 5602 Prestwick-674 hsa04070 Phosphatidylinositol signaling system 8394_3633_3631_5331_3709_23396_805_801_8526_808_23236 11 - 0.0162509154906073 0.427940774585992 5603 Prestwick-674 hsa04080 Neuroactive ligand-receptor interaction 7442_1081_1813_7067_1131_2908_1909 7 - 0.030132543763059 0.476094191456332 5604 Prestwick-674 hsa04740 Olfactory transduction 801_808_805 3 - 3.28111836907644e-07 2.59208351157039e-05 5605 Prestwick-674 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294 21 - 0.000511894291581981 0.0202198245174883 5606 Prestwick-674 hsa05012 Parkinson's disease 1339_517 2 - 0.0249201025451067 0.476094191456332 5607 SR-95639A hsa04740 Olfactory transduction 26211_26664 2 + 0.0264175891289086 0.766110084738349 5608 SR-95639A hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 4.68521123511845e-06 0.00027174225163687 5609 SR-95639A hsa04662 B cell receptor signaling pathway 3725_7410_8519 3 - 0.0441198653293717 0.782405300460519 5610 5194442 hsa05332 Graft-versus-host disease 3135_3134_355_3107_3108 5 + 0.0286734365250726 0.315407801775799 5611 5194442 hsa04080 Neuroactive ligand-receptor interaction 2550_5031 2 + 0.00661338472597906 0.206402234975138 5612 5194442 hsa04612 Antigen processing and presentation 4800_3108_3107_3135_3134_3310_3304_3305_3303 9 + 0.0100470417675026 0.206402234975138 5613 5194442 hsa05016 Huntington's disease 836 1 + 0.0107221940246825 0.206402234975138 5614 5194442 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3108 15 + 0.000777344118684371 0.0598554971386966 5615 5194442 hsa04010 MAPK signaling pathway 1647_3554_1326_836_9252_6655_5155_355_9693_7189_4763_1848_1649_3725_3310_3304_3305_5609_3303 19 + 0.0166020831453031 0.255672080437668 5616 5194442 hsa05330 Allograft rejection 3135_3134_355_3107_3108 5 + 0.0202607698135175 0.260013212606808 5617 5194442 hsa04940 Type I diabetes mellitus 3135_3134_355_3107_3108 5 + 0.0335980395300168 0.323381130476412 5618 5194442 hsa04080 Neuroactive ligand-receptor interaction 1813_7068_7433 3 - 0.0199818827857794 0.388848740372132 5619 5194442 hsa05131 Shigellosis 7278_999_113457_60_7534_6093 6 - 0.0306771861955479 0.388848740372132 5620 5194442 hsa05130 Pathogenic Escherichia coli infection 7278_999_113457_60_7534_6093 6 - 0.0306771861955479 0.388848740372132 5621 5194442 hsa04740 Olfactory transduction 801_808_805 3 - 0.000359279589642466 0.0301794855299671 5622 5194442 hsa05322 Systemic lupus erythematosus 85235_8330_3014_8332_8969_8331_8329_8337_8343_8336_8339_8347_8346_8344 14 - 0.00294125554206251 0.123532732766625 5623 5194442 hsa04630 Jak-STAT signaling pathway 3572 1 - 0.0324040616976777 0.388848740372132 5624 5194442 hsa04060 Cytokine-cytokine receptor interaction 655_5155_51330_3572 4 - 0.0495566943965294 0.520345291163559 5625 5194442 hsa05213 Endometrial cancer 2309_842_999_2002_6934_369 6 - 0.0229135416210191 0.388848740372132 5626 ioxaglic acid hsa04740 Olfactory transduction 26529_9635_81797 3 + 0.000242850164036666 0.00886403098733831 5627 ioxaglic acid hsa04514 Cell adhesion molecules (CAMs) 965_3689_3122_29851_3107_3113_3135_5792_6693_923_5817 11 + 0.0276381461382543 0.672528222697521 5628 ioxaglic acid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_3122_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3113 34 + 5.08858668839459e-15 3.71466828252805e-13 5629 ioxaglic acid hsa05332 Graft-versus-host disease 3123_3126_3127_3133_3125 5 - 0.000613463423455204 0.0104267824050892 5630 ioxaglic acid hsa04640 Hematopoietic cell lineage 1435_3123_3126_3127_3125_3678_3675 7 - 0.000468008336258701 0.0104267824050892 5631 ioxaglic acid hsa05320 Autoimmune thyroid disease 3123_3126_3127_3133_3125 5 - 0.00160905844253304 0.015017878796975 5632 ioxaglic acid hsa04612 Antigen processing and presentation 3123_3126_3127_3133_3125 5 - 0.0126359974013138 0.10108797921051 5633 ioxaglic acid hsa05310 Asthma 3123_3126_3127_3125 4 - 0.00150522676071001 0.015017878796975 5634 ioxaglic acid hsa05330 Allograft rejection 3123_3126_3127_3133_3125 5 - 0.000403654328986396 0.0104267824050892 5635 ioxaglic acid hsa04940 Type I diabetes mellitus 3123_3126_3127_3133_3125 5 - 0.000744770171792084 0.0104267824050892 5636 ioxaglic acid hsa02010 ABC transporters 5244_215_5243 3 - 0.0319526304154972 0.22366841290848 5637 rolitetracycline hsa04080 Neuroactive ligand-receptor interaction 9170 1 - 0.00170772074701942 0.0623318072662088 5638 rolitetracycline hsa05131 Shigellosis 7280_347733_999_7430_2017_8976 6 - 0.0221906375412961 0.323983308102923 5639 rolitetracycline hsa05130 Pathogenic Escherichia coli infection 7280_347733_999_7430_2017_8976 6 - 0.0221906375412961 0.323983308102923 5640 rolitetracycline hsa04740 Olfactory transduction 157_409 2 - 0.000127166757348859 0.00928317328646671 5641 rolitetracycline hsa04115 p53 signaling pathway 25898_841_581_4193_472_51512_651610 7 - 0.0179658159798706 0.323983308102923 5642 rolitetracycline hsa03020 RNA polymerase 246721_5439_548644_661 4 - 0.028369872934001 0.345166787363679 5643 tridihexethyl hsa04740 Olfactory transduction 26333 1 + 0.00542586424405386 0.096309090331956 5644 tridihexethyl hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3108_9555 16 + 2.23046028621081e-07 1.58362680320968e-05 5645 tridihexethyl hsa04664 Fc epsilon RI signaling pathway 8503_8398_695_5881_5335_5603_1432_2534 8 + 0.000460139134839792 0.0163349392868126 5646 tridihexethyl hsa04370 VEGF signaling pathway 8503_1432_5829_5881_5335_5603_8398 7 + 0.0018572390220602 0.0439546568554247 5647 tridihexethyl hsa05211 Renal cell carcinoma 8503_5295_998_5291_405_3845_7422_1398_4233 9 - 0.0155503086870796 0.16582863811041 5648 tridihexethyl hsa04080 Neuroactive ligand-receptor interaction 2561_4889_7442 3 - 0.00279456264904341 0.0776543231773072 5649 tridihexethyl hsa05200 Pathways in cancer 8503_5295_1613_5899_4254_3675_4149_6789_5900_1856_405_1398_2263_1017_7475_581_999_998_4193_4286_5291_4233_4791_3688_842_5602_6772_7157_3845_7422_7184 31 - 0.00169683838733918 0.0776543231773072 5650 tridihexethyl hsa05131 Shigellosis 7280_347733_7278_999_113457_998_3688_7430_8976 9 - 0.00374237702059312 0.0776543231773072 5651 tridihexethyl hsa05130 Pathogenic Escherichia coli infection 7280_347733_7278_999_113457_998_3688_7430_8976 9 - 0.00374237702059312 0.0776543231773072 5652 tridihexethyl hsa05212 Pancreatic cancer 8503_842_7157_5295_4193_5291_3845_2263_1017_7184 10 - 0.0279710955848884 0.16582863811041 5653 tridihexethyl hsa05215 Prostate cancer 8503_842_7157_5295_4193_5291_3845_2263_1017_7184 10 - 0.0270658849439038 0.16582863811041 5654 tridihexethyl hsa04210 Apoptosis 8503_842_581_7157_5576_5295_5291_472_8837_8795 10 - 0.0279710955848884 0.16582863811041 5655 tridihexethyl hsa04370 VEGF signaling pathway 8503_5295_842_10725_50487_998_5291_3845_7422 9 - 0.0363131768129238 0.188374604717042 5656 tridihexethyl hsa05219 Bladder cancer 7157_999_1613_4193_3845_7422 6 - 0.026742516163667 0.16582863811041 5657 tridihexethyl hsa05218 Melanoma 8503_4286_7157_5295_999_4193_5291_3845_4233 9 - 0.014415113591443 0.16582863811041 5658 tridihexethyl hsa05223 Non-small cell lung cancer 8503_842_6789_5295_5291_7157_3845 7 - 0.026572793218406 0.16582863811041 5659 tridihexethyl hsa03022 Basal transcription factors 2967_2969_10629_6884_51616_728198 6 - 0.0162341151486592 0.16582863811041 5660 tridihexethyl hsa04930 Type II diabetes mellitus 8503_5581_5295_5291_5602_8651 6 - 0.0348200926324001 0.188374604717042 5661 tridihexethyl hsa05213 Endometrial cancer 8503_842_7157_5295_999_5291_3845 7 - 0.0225429977161168 0.16582863811041 5662 tridihexethyl hsa05210 Colorectal cancer 8503_842_581_7157_5295_1856_5291_5900_3845_5602_4233 11 - 0.00581793127128607 0.0965776591033488 5663 tridihexethyl hsa05222 Small cell lung cancer 8503_3688_4149_842_7157_5295_5291_1017_3675 9 - 0.0480316281991665 0.234507361207695 5664 mecamylamine hsa04740 Olfactory transduction 5593 1 + 0.00512843229948771 0.369247125563115 5665 mecamylamine hsa05214 Glioma 1869_801_1956_805_808 5 - 0.0194105375962432 0.379076933457682 5666 mecamylamine hsa03440 Homologous recombination 7517_7516_5890 3 - 0.0307186083664589 0.379076933457682 5667 mecamylamine hsa04080 Neuroactive ligand-receptor interaction 2908 1 - 0.0484921760566231 0.379076933457682 5668 mecamylamine hsa05014 Amyotrophic lateral sclerosis (ALS) 5533_4217_5600_6300 4 - 0.0438803586412794 0.379076933457682 5669 mecamylamine hsa05120 Epithelial cell signaling in Helicobacter pylori infection 50617_1956_5600_3725_28964_6300 6 - 0.007153210572944 0.379076933457682 5670 mecamylamine hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0333565244986777 0.379076933457682 5671 mecamylamine hsa04912 GnRH signaling pathway 808_1956_5600_3725_801_6300_805 7 - 0.0140157539243805 0.379076933457682 5672 mecamylamine hsa05210 Colorectal cancer 4088_6932_1956_1855_3725 5 - 0.0476992124943657 0.379076933457682 5673 loracarbef hsa04740 Olfactory transduction 26211_390892 2 + 0.000385635411266152 0.0138828748055815 5674 loracarbef hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_959_8359_8294_8367_554313_6738_121504 16 + 7.22544780353125e-05 0.0052023224185425 5675 loracarbef hsa04740 Olfactory transduction 157 1 - 0.000793631690036713 0.0595223767527535 5676 loracarbef hsa04210 Apoptosis 8503_11261_5533_5575_8837_8795 6 - 0.0339289024056962 1 5677 sulfametoxydiazine hsa04720 Long-term potentiation 5331_2911_3709 3 + 0.0409933631272488 0.509480867781907 5678 sulfametoxydiazine hsa04020 Calcium signaling pathway 5331_2911_4638_3709_2149 5 + 0.0379869857270452 0.509480867781907 5679 sulfametoxydiazine hsa04730 Long-term depression 5331_2911_3709 3 + 0.0359122374786516 0.509480867781907 5680 sulfametoxydiazine hsa04662 B cell receptor signaling pathway 6654_5336_7409_8915_3725_5970 6 - 0.0435708695519306 0.580498611469617 5681 sulfametoxydiazine hsa04080 Neuroactive ligand-receptor interaction 5021_56288 2 - 0.0184355760808882 0.424018249860429 5682 sulfametoxydiazine hsa04740 Olfactory transduction 409 1 - 8.20410400770718e-05 0.00566083176531795 5683 sulfametoxydiazine hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_8992_5781_5336_3725_5970_50848 7 - 0.0117386305401834 0.404982753636327 5684 sulfametoxydiazine hsa05210 Colorectal cancer 836_581_6654_6932_6934_3725_8322 7 - 0.025448886071419 0.438993284731978 5685 Prestwick-1082 hsa04740 Olfactory transduction 7932 1 + 0.0161038528923037 0.56363485123063 5686 Prestwick-1082 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_718_8368_8366_3111_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344 21 + 1.15572341497433e-12 8.09006390482031e-11 5687 Prestwick-1082 hsa05014 Amyotrophic lateral sclerosis (ALS) 5534_842_581 3 - 0.0369254038661997 0.290128173234426 5688 Prestwick-1082 hsa05322 Systemic lupus erythematosus 85235_8969_8332_8330_8331_8329_8336 7 - 0.00274462709793502 0.150954490386426 5689 Prestwick-1082 hsa05212 Pancreatic cancer 2308_6655_842_1871 4 - 0.0285630295141301 0.290128173234426 5690 Prestwick-1082 hsa05215 Prostate cancer 2308_6655_842_1871 4 - 0.0275919206304634 0.290128173234426 5691 Prestwick-1082 hsa04210 Apoptosis 472_651610_842_5534_581 5 - 0.00625929699195455 0.17213066727875 5692 Prestwick-1082 hsa04115 p53 signaling pathway 472_651610_842_581 4 - 0.0128529444315414 0.235637314578259 5693 Prestwick-1082 hsa05223 Non-small cell lung cancer 6655_842_1871 3 - 0.0338296634596582 0.290128173234426 5694 ganciclovir hsa04740 Olfactory transduction 26539 1 + 0.00175603490987794 0.0553150996611551 5695 ganciclovir hsa05322 Systemic lupus erythematosus 3013_941_8358_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357 14 + 2.47568888924219e-05 0.00155968400022258 5696 ganciclovir hsa03440 Homologous recombination 7156_5893_5888_7516 4 - 0.0201663090888024 0.194100724979723 5697 ganciclovir hsa04662 B cell receptor signaling pathway 3551_10725_8519_7410_4775_3725_27071_4793 8 - 0.00591411006413046 0.151795491646015 5698 ganciclovir hsa04080 Neuroactive ligand-receptor interaction 7067_5618 2 - 0.0193871813282217 0.194100724979723 5699 ganciclovir hsa05131 Shigellosis 9076_7278_999_113457_9475_8976 6 - 0.0160329014656343 0.194100724979723 5700 ganciclovir hsa05130 Pathogenic Escherichia coli infection 9076_7278_999_113457_9475_8976 6 - 0.0160329014656343 0.194100724979723 5701 ganciclovir hsa04740 Olfactory transduction 219464 1 - 5.70566879535971e-05 0.00439336497242698 5702 ganciclovir hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 0.000721506058259534 0.0277779832429921 5703 ganciclovir hsa04210 Apoptosis 3552_3551_581_5575_596_472_8837_651610 8 - 0.0146062205169713 0.194100724979723 5704 ondansetron hsa04740 Olfactory transduction 815_409 2 + 0.00477873709700603 0.32495412259641 5705 ondansetron hsa04940 Type I diabetes mellitus 3107_3553_3111_2571 4 + 0.0351854071227421 1 5706 ondansetron hsa04740 Olfactory transduction 818 1 - 0.00780899247073287 0.413876600948842 5707 2-deoxy-D-glucose hsa04130 SNARE interactions in vesicular transport 23673_10282_662_10228_9554_6844 6 + 0.0214267813093456 0.557096314042986 5708 2-deoxy-D-glucose hsa05016 Huntington's disease 6648 1 + 0.00111793449379094 0.0435994452578467 5709 2-deoxy-D-glucose hsa04740 Olfactory transduction 26532_109 2 + 6.45943425733958e-07 5.03835872072487e-05 5710 2-deoxy-D-glucose hsa05322 Systemic lupus erythematosus 2903_3017 2 + 0.0350864084329086 0.684184964441718 5711 2-deoxy-D-glucose hsa05332 Graft-versus-host disease 3123_57292_3126_3127_3125 5 - 0.00181834320054086 0.0459940418589765 5712 2-deoxy-D-glucose hsa04640 Hematopoietic cell lineage 3123_3126_3127_3125_3678_3589 6 - 0.00812613292515402 0.0853243957141172 5713 2-deoxy-D-glucose hsa05320 Autoimmune thyroid disease 3123_3126_3127_3125 4 - 0.0221954969189903 0.174789538237049 5714 2-deoxy-D-glucose hsa04612 Antigen processing and presentation 57292_3123_3126_3127_3125_3304_3303 7 - 0.00219019246947507 0.0459940418589765 5715 2-deoxy-D-glucose hsa04740 Olfactory transduction 1179_816 2 - 0.0357622234054987 0.250335563838491 5716 2-deoxy-D-glucose hsa05322 Systemic lupus erythematosus 85235_94239_3123_8330_3126_3127_3125_8332_8969_8331_8336_8343_8329_8339_8347_8346_8344 17 - 8.36832003010467e-09 5.27204161896594e-07 5717 2-deoxy-D-glucose hsa05310 Asthma 3123_3126_3127_3125 4 - 0.00363819883090631 0.0573016315867744 5718 2-deoxy-D-glucose hsa05330 Allograft rejection 3123_3126_3127_3125 4 - 0.00781410430781572 0.0853243957141172 5719 2-deoxy-D-glucose hsa04940 Type I diabetes mellitus 3123_3126_3127_3125 4 - 0.0124510803976396 0.112059723578756 5720 procarbazine hsa05332 Graft-versus-host disease 3812_3119_3122_3804_3106_3126_3127_3125_3135_5551_3123_3105_3113_649853 14 + 2.82368779322898e-05 0.000847106337968694 5721 procarbazine hsa05010 Alzheimer's disease 5331_5330_3710_9377 4 + 0.00528635060124138 0.0528635060124138 5722 procarbazine hsa05320 Autoimmune thyroid disease 3119_3440_3122_3105_3106_3126_3127_3125_3135_5551_3123_3113_649853 13 + 0.000689359073235017 0.0103403860985253 5723 procarbazine hsa04612 Antigen processing and presentation 3812_3119_3440_3122_3123_3106_3126_3127_3125_3135_3105_3804_3113_649853 14 + 0.0189023545397897 0.141767659048423 5724 procarbazine hsa05016 Huntington's disease 9377_5331_5330_7416_6875_1387 6 + 0.0236084322359617 0.163442992402812 5725 procarbazine hsa04740 Olfactory transduction 26212_26529_8390 3 + 1.42552219134962e-09 1.28296997221466e-07 5726 procarbazine hsa04514 Cell adhesion molecules (CAMs) 5797_3383_9073_3119_965_3122_3123_3106_3126_3127_3105_3125_3135_23308_57863_4359_6383_5818_3676_3113_649853 21 + 0.00420021132318711 0.0528635060124138 5727 procarbazine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8329_8294_8342_3122_3123_3126_3127_3125_8969_8370_718_8332_8359_8330_8331_8336_554313_121504_85235_3119_3113 31 + 2.10372013655418e-06 9.46674061449381e-05 5728 procarbazine hsa05310 Asthma 3119_2207_3122_3123_3126_3127_3125_3113 8 + 0.00474064297295496 0.0528635060124138 5729 procarbazine hsa04350 TGF-beta signaling pathway 4091_7059_1634_7044_3624_7060_5519_91_654_1875_10637_1387_83729_10468 14 + 0.0172732399308464 0.141767659048423 5730 procarbazine hsa05012 Parkinson's disease 7416_7318_9377 3 + 0.0187153658440734 0.141767659048423 5731 procarbazine hsa04620 Toll-like receptor signaling pathway 3576_3440 2 + 0.0336533292953544 0.201919975772126 5732 procarbazine hsa03010 Ribosome 6165_6202 2 + 0.0336533292953544 0.201919975772126 5733 procarbazine hsa05330 Allograft rejection 3119_3122_3105_3106_3126_3127_3125_3135_5551_3123_3113_649853 12 + 0.000159907195404782 0.00287832951728608 5734 procarbazine hsa04940 Type I diabetes mellitus 3382_3119_3122_3105_3106_3126_3127_3125_3135_5551_3123_3113_649853 13 + 0.00015011390995832 0.00287832951728608 5735 procarbazine hsa04080 Neuroactive ligand-receptor interaction 1131_2908_4157 3 - 0.0274170195606435 0.495996673014509 5736 procarbazine hsa04740 Olfactory transduction 818_109 2 - 8.79207006818856e-05 0.00720949745591462 5737 procarbazine hsa05322 Systemic lupus erythematosus 55506_85235_3119_8348_8330_8332_8969_8331_8336_8337_8970_8329 12 - 0.0148699290370446 0.495996673014509 5738 procarbazine hsa05210 Colorectal cancer 4088_6655_7042_5296_5900_6934_3725_5599 8 - 0.0192460593934298 0.495996673014509 5739 procarbazine hsa05220 Chronic myeloid leukemia 613_4088_598_6655_5296_5781_7042 7 - 0.0302436995740554 0.495996673014509 5740 alprostadil hsa05010 Alzheimer's disease 2903_2597_4695_3710_642502_6391_4137_5533_488_810_348_517 12 + 0.0166035152093222 0.340199945222488 5741 alprostadil hsa05320 Autoimmune thyroid disease 1081_3119_3117_3113_3106_3107_3126_3127_3125_3135_3123_941_7038_3442_3448 15 + 0.0138821103967785 0.340199945222488 5742 alprostadil hsa05016 Huntington's disease 1211_6648_5434_642502_6391_27113_64446_5978_10540_55567_4695_7419_161_517 14 + 0.0275763022420253 0.36243140089519 5743 alprostadil hsa03420 Nucleotide excision repair 5983 1 + 0.0379119800203857 0.379783925345676 5744 alprostadil hsa04740 Olfactory transduction 26211_7932_157_26692_5566_442194_26189_818_26532_23538_810_9635_816 13 + 7.21877334127145e-10 6.64127147396973e-08 5745 alprostadil hsa05322 Systemic lupus erythematosus 2903_474382_8363_474381_8365_8364_8367_8360_8368_554313_6738_8362_8294_121504_8341_6632_3123_8366_3126_3127_3125_8968_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_2212_3119_2215_2214_3117_3013_83740_3113_3014_941_8361 45 + 3.57501816311291e-06 0.000164450835503194 5746 alprostadil hsa04110 Cell cycle 5591_990_51343_1029_8555_7042_1031 7 + 0.0257665854413551 0.36243140089519 5747 alprostadil hsa05012 Parkinson's disease 2861_4695_7318_5413_642502_6391_7419_517 8 + 0.0184891274577439 0.340199945222488 5748 alprostadil hsa05330 Allograft rejection 3119_3117_3113_3106_3107_3126_3127_3125_3135_3123_941 11 + 0.0413376034386278 0.379783925345676 5749 alprostadil hsa04940 Type I diabetes mellitus 3119_3117_3126_3106_3107_2572_3127_3125_3135_3123_941_3113 12 + 0.0359495116175733 0.379783925345676 5750 alprostadil hsa04514 Cell adhesion molecules (CAMs) 9076_24146_947_3685_23308_6693 6 - 0.0431386891239559 1 5751 alprostadil hsa05322 Systemic lupus erythematosus 3013_8358_6738_8968_8350_8351_8352_8353_8354_8355_8356_8357 12 - 2.74318005364866e-05 0.00170077163326217 5752 molindone hsa04740 Olfactory transduction 5568_442194_390892 3 + 0.00286175825793737 0.237525935408802 5753 molindone hsa04540 Gap junction 5568_5594_6655_6654_3708_10746_23236 7 + 0.0418420086333608 0.91804373523762 5754 molindone hsa04210 Apoptosis 10000_3551_5575_7186_8737_8837_823 7 - 0.0110878356801005 0.734266475273464 5755 molindone hsa04540 Gap junction 2771_7278_2767_113457_5605_112 6 - 0.0402813196791601 0.734266475273464 5756 BCB000038 hsa04120 Ubiquitin mediated proteolysis 26232_51343_9820 3 + 0.00479888049104238 0.0835005205441374 5757 BCB000038 hsa05010 Alzheimer's disease 51806_11261_1339_842 4 + 0.00139562104102993 0.030354757642401 5758 BCB000038 hsa04080 Neuroactive ligand-receptor interaction 1816_1812_1813_7068_6755_7434_2150_4987 8 + 0.000873523706617755 0.0253321874919149 5759 BCB000038 hsa05200 Pathways in cancer 7471_4313_1021_842_3551_51176_2950_862_9618_5881_5467_2263_3655_5888_4233 15 + 0.00678708029760538 0.0924163933062975 5760 BCB000038 hsa05016 Huntington's disease 246721_1339_842_7052_55567_6648 6 + 0.00743580176027681 0.0924163933062975 5761 BCB000038 hsa04740 Olfactory transduction 5137_51806_2979_816 4 + 3.29506957928669e-10 2.86671053397942e-08 5762 BCB000038 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8290_8348_8329_8294_8969_8370_8332_8359_8330_8331_8336_8337_554313_6738_121504_85235_3113_720_721 28 + 0.000368679261351463 0.0160375478687886 5763 BCB000038 hsa04810 Regulation of actin cytoskeleton 5063_3691_8396_9138_3684_5881_10787_2263_3655_8976 10 + 0.0368802427858884 0.320858112237229 5764 BCB000038 hsa05012 Parkinson's disease 7314_1339_842_5413 4 + 0.0184156479177209 0.200270171105215 5765 BCB000038 hsa04730 Long-term depression 8398 1 + 0.0288916171463763 0.279285632414971 5766 BCB000038 hsa04270 Vascular smooth muscle contraction 115_51806_9138_8398 4 + 0.0451924824963024 0.357431452470755 5767 BCB000038 hsa04080 Neuroactive ligand-receptor interaction 5618_624_3953_2908_5025_4886_6915_56288_7067_7068 10 - 0.00195634762113563 0.0851011215193999 5768 BCB000038 hsa05016 Huntington's disease 4899_836_4712_7052_1175_3708_2033_23236 8 - 0.0203240175608383 0.442047381948233 5769 BCB000038 hsa04740 Olfactory transduction 219464_51806 2 - 2.99774418634234e-13 2.60803744211784e-11 5770 BCB000038 hsa04370 VEGF signaling pathway 8503_4775_5578_5296_11261_9261_5605_10725_5530_4772_5600_6714_56848_5594 14 - 0.0367696922115953 0.458884836519502 5771 BCB000038 hsa05012 Parkinson's disease 7314_836_6622_4712 4 - 0.00955032242628506 0.276959350362267 5772 BCB000038 hsa04060 Cytokine-cytokine receptor interaction 5618_3597_2057_3953_83729_8742_8741_3572_7852_1956_91_27242_3601_8795 14 - 0.0298852487401816 0.458884836519502 5773 diphenylpyraline hsa04120 Ubiquitin mediated proteolysis 7337_7318_6502_5371_7329_8651_5071_9021 8 + 0.0419670315608338 0.466883226114276 5774 diphenylpyraline hsa03320 PPAR signaling pathway 2173_5465 2 + 0.0316702277096249 0.402664323736659 5775 diphenylpyraline hsa05010 Alzheimer's disease 776_4695_3710_11261_779_3709_6868_56901_6622 9 + 0.00777081990723928 0.138320594348859 5776 diphenylpyraline hsa05016 Huntington's disease 1639_4899_4695_56901_1213 5 + 4.53839490373807e-05 0.00201958573216344 5777 diphenylpyraline hsa04740 Olfactory transduction 26211_56656_26692_8388_8387_23538_8390_1179_393046_4991_9635_816 12 + 1.66509179676494e-08 1.4819316991208e-06 5778 diphenylpyraline hsa04110 Cell cycle 6502_8556_8555 3 + 0.00155529755970437 0.0461404942712296 5779 diphenylpyraline hsa05110 Vibrio cholerae infection 525 1 + 0.0186115167104127 0.276070831204455 5780 diphenylpyraline hsa03010 Ribosome 9045_6181_6123 3 + 0.00603080295840828 0.134185365824584 5781 diphenylpyraline hsa04740 Olfactory transduction 816 1 - 0.0024378876118808 0.185279458502941 5782 diphenylpyraline hsa04710 Circadian rhythm - mammal 9572_1408 2 - 0.0429268924297477 0.882125296966429 5783 diphenylpyraline hsa05210 Colorectal cancer 4088_208_5602_91_3725_4233 6 - 0.0151225068346758 0.57465525971768 5784 capsaicin hsa05332 Graft-versus-host disease 3811_3553_3109_3119_3123_3126_3127_3125_3112_941_3802 11 + 0.000165780953268484 0.00593603670926836 5785 capsaicin hsa05320 Autoimmune thyroid disease 3109_3119_7253_3123_3126_3127_3112_941_3125 9 + 0.00829589565505113 0.117525188446558 5786 capsaicin hsa04612 Antigen processing and presentation 3811_3109_3119_3123_3806_3126_3127_3125_3112_3310_3802 11 + 0.0300771581710203 0.365222634933818 5787 capsaicin hsa04740 Olfactory transduction 26212_9635_815_442194_390892 5 + 1.0978429594428e-05 0.00093316651552638 5788 capsaicin hsa05310 Asthma 3596_3119_3123_3126_3127_3125_3109_3112_2205 9 + 0.00027934290396557 0.00593603670926836 5789 capsaicin hsa05330 Allograft rejection 3109_3119_3123_3126_3127_3112_941_3125 8 + 0.00415214687807792 0.0705864969273246 5790 capsaicin hsa04940 Type I diabetes mellitus 3553_3109_3119_3126_2572_3127_3630_3125_3123_941_3112 11 + 0.00023448338762573 0.00593603670926836 5791 capsaicin hsa04080 Neuroactive ligand-receptor interaction 7434_64106_2908_146 4 - 0.0486693733828107 0.455761599461812 5792 capsaicin hsa05016 Huntington's disease 7419 1 - 0.0109610700914488 0.405559593383606 5793 capsaicin hsa05322 Systemic lupus erythematosus 3013_8358_8350_8968_8970_8351_8352_8353_8354_8355_8356_8357 12 - 0.0182530657037292 0.450242287358654 5794 capsaicin hsa05221 Acute myeloid leukemia 3551_5371_5290_6934_5914_652671 6 - 0.0367655070820237 0.453441254011626 5795 capsaicin hsa04340 Hedgehog signaling pathway 1454_656_654_652_653_353500 6 - 0.0321947422144149 0.453441254011626 5796 capsaicin hsa03450 Non-homologous end-joining 5591_3981_10111 3 - 0.0250676441018443 0.453441254011626 5797 capsaicin hsa04350 TGF-beta signaling pathway 4089_654_656_1874_652_653_353500_7042_57154 9 - 0.010756834886247 0.405559593383606 5798 capsaicin hsa04060 Cytokine-cytokine receptor interaction 10913_8794_7422_7042 4 - 0.0492715242661418 0.455761599461812 5799 thiethylperazine hsa05332 Graft-versus-host disease 3123_3126_3127_3125_3135_356 6 + 0.000601949010271426 0.012239629875519 5800 thiethylperazine hsa04080 Neuroactive ligand-receptor interaction 1910 1 + 0.0478766684936508 0.365059597264087 5801 thiethylperazine hsa05320 Autoimmune thyroid disease 3123_3126_3127_3125_3135_356 6 + 0.00180839347961988 0.0275780005642032 5802 thiethylperazine hsa04612 Antigen processing and presentation 3123_3126_3127_3125_3135_3310 6 + 0.0182062834686705 0.158654755941271 5803 thiethylperazine hsa04740 Olfactory transduction 810 1 + 0.00376473012532381 0.0459297075289505 5804 thiethylperazine hsa05310 Asthma 3123_3126_3127_3125 4 + 0.0063082227404273 0.0641335978610109 5805 thiethylperazine hsa05330 Allograft rejection 3123_3126_3127_3125_3135_356 6 + 0.000372550482472251 0.0113627897154037 5806 thiethylperazine hsa04940 Type I diabetes mellitus 3123_3126_3127_2571_3135_356_3125 7 + 0.000115590221423929 0.00705100350685967 5807 thiethylperazine hsa04916 Melanogenesis 805_5566_808_801_6934 5 - 0.0168995236208734 0.358293277619997 5808 thiethylperazine hsa04340 Hedgehog signaling pathway 1455_5566_4036 3 - 0.0489910117743183 0.449084274597918 5809 thiethylperazine hsa04720 Long-term potentiation 801_808_5566_805 4 - 0.0230379468778312 0.358293277619997 5810 thiethylperazine hsa04912 GnRH signaling pathway 3725_5566_808_801_805 5 - 0.0194495425203855 0.358293277619997 5811 thiethylperazine hsa05210 Colorectal cancer 8312_3725_7040_6934 4 - 0.0325721161472725 0.358293277619997 5812 thiethylperazine hsa04270 Vascular smooth muscle contraction 5566_9826_801_805_808 5 - 0.0268953261857075 0.358293277619997 5813 diethylstilbestrol hsa04740 Olfactory transduction 7932_1179_2979_26529_9635_816 6 + 0.000699309291681939 0.0594412897929648 5814 diethylstilbestrol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_716_3113_3111_8359_8294_8367_554313_8368_121504 17 + 0.00249383895917311 0.105988155764857 5815 diethylstilbestrol hsa04010 MAPK signaling pathway 627_7850_3725_3164_3305_5609_3304_4616_3554_355_3303_8823_5607_5534_91_3310_4791_26281_1848_1843_1649_1846_6196_2353_5971 25 + 0.00869830817139263 0.246452064856124 5816 diethylstilbestrol hsa05012 Parkinson's disease 1339 1 + 0.0151336174133733 0.321589370034183 5817 diethylstilbestrol hsa04060 Cytokine-cytokine receptor interaction 56034_7852_7850_3554_3576_3572_6368_10913_8718_6362_6366_1236_3606_1233_3953_51561_91_8794_3441_355_7422_83729 22 + 0.0344154875881934 0.585063288999288 5818 diethylstilbestrol hsa04130 SNARE interactions in vesicular transport 8417_2054_6844_662 4 - 0.0130920057243964 0.283660124028589 5819 diethylstilbestrol hsa04080 Neuroactive ligand-receptor interaction 7433 1 - 0.0476055344379078 0.442051391209144 5820 diethylstilbestrol hsa05131 Shigellosis 7278_7430_113457_998 4 - 0.0421648747330504 0.442051391209144 5821 diethylstilbestrol hsa05130 Pathogenic Escherichia coli infection 7278_7430_113457_998 4 - 0.0421648747330504 0.442051391209144 5822 diethylstilbestrol hsa04740 Olfactory transduction 818 1 - 0.00371544187378938 0.120751860898155 5823 diethylstilbestrol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 9.20854725744041e-06 0.000598555571733627 5824 diethylstilbestrol hsa04330 Notch signaling pathway 113878_22938_6868_5664 4 - 0.0251176559635493 0.408161909407676 5825 hyoscyamine hsa04740 Olfactory transduction 8390 1 + 0.00122861187930656 0.0847742196721526 5826 hyoscyamine hsa04510 Focal adhesion 2335_5599_6464_3479_3690_63923_5880_88_7791_55742_2534 11 + 0.0245359020102019 0.777931506090562 5827 hyoscyamine hsa04930 Type II diabetes mellitus 5599_8660_5315_5581 4 + 0.0338231089604592 0.777931506090562 5828 hyoscyamine hsa05214 Glioma 6655_5155_5154_5290_5335_3845 6 - 0.0183241832780245 0.271197912514763 5829 hyoscyamine hsa04070 Phosphatidylinositol signaling system 8871_8394_5290_5333_5335_4952_3707 7 - 0.0113114280696261 0.271197912514763 5830 hyoscyamine hsa05221 Acute myeloid leukemia 6655_6777_5371_5290_6932_3845 6 - 0.0122310306134333 0.271197912514763 5831 hyoscyamine hsa04540 Gap junction 6655_5155_113457_5154_3845_10746_7278 7 - 0.0286447851703559 0.344532953914529 5832 hyoscyamine hsa05213 Endometrial cancer 2002_6655_5290_6932_3845_8312 6 - 0.00711275437947541 0.271197912514763 5833 hyoscyamine hsa05210 Colorectal cancer 4088_6655_1856_6932_3845_5290_8312 7 - 0.0180846769451188 0.271197912514763 5834 hyoscyamine hsa05220 Chronic myeloid leukemia 4088_6655_6777_5290_3845_5781 6 - 0.032590955100023 0.344532953914529 5835 ornidazole hsa05016 Huntington's disease 246721 1 + 0.0329018073829691 0.789643377191258 5836 ornidazole hsa04740 Olfactory transduction 135948_10798 2 + 0.000550856349552911 0.0396616571678096 5837 ornidazole hsa04012 ErbB signaling pathway 6654_5579_5599_208_2549_1839_3084 7 + 0.0297262939063489 0.789643377191258 5838 ornidazole hsa04080 Neuroactive ligand-receptor interaction 2149_9170 2 - 0.0134748328536113 0.485093982730007 5839 ornidazole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 30 - 1.54531126477782e-13 1.11262411064003e-11 5840 fenspiride hsa04120 Ubiquitin mediated proteolysis 5371 1 + 0.0458231044149514 0.425500255281692 5841 fenspiride hsa05010 Alzheimer's disease 1339 1 + 0.0106735886422891 0.138756652349758 5842 fenspiride hsa04740 Olfactory transduction 26539_81797_409_4991 4 + 0.00118063170230003 0.025580353549834 5843 fenspiride hsa04514 Cell adhesion molecules (CAMs) 8516_965_4684_3383_1272_942_3696_57863_26047_9672_3109_3676_926_1462 14 + 0.00199248168771049 0.0323778274252955 5844 fenspiride hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_6737_942_8359_88_89_8294_8367_554313_121504_3109 19 + 2.02091676957883e-05 0.00131359590022624 5845 fenspiride hsa04512 ECM-receptor interaction 8516_2814_1281_2335_3910_3381_3696_2812_1282_9672_1291_3676 12 + 0.000354852576752974 0.0115327087444717 5846 fenspiride hsa05012 Parkinson's disease 1339 1 + 0.0455433170812947 0.425500255281692 5847 fenspiride hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 0.000146456077471123 0.010691293655392 5848 fenspiride hsa04920 Adipocytokine signaling pathway 3717_5599_1375_5781_8717_4793 6 - 0.0167125082281534 0.3050032751638 5849 fenspiride hsa04010 MAPK signaling pathway 9261_3725_10912_5599_27092_57551_4763_5607_3845_5600_5534_7042_2263_2260_3164_2264 16 - 0.00996576599458173 0.3050032751638 5850 fenspiride hsa03020 RNA polymerase 5432_246721_5439_548644 4 - 0.0132875693626117 0.3050032751638 5851 xylometazoline hsa04740 Olfactory transduction 5568_1179 2 + 0.0363716250021558 0.503606023156227 5852 xylometazoline hsa05340 Primary immunodeficiency 23495_958_915 3 + 0.0369806621002928 0.503606023156227 5853 xylometazoline hsa05218 Melanoma 23533_5155_2249_2251_80310 5 + 0.0159368787584597 0.503606023156227 5854 xylometazoline hsa04920 Adipocytokine signaling pathway 32_5105_5588_4793 4 + 0.0489616966957443 0.503606023156227 5855 xylometazoline hsa04810 Regulation of actin cytoskeleton 23533_3690_5155_5829_2249_3984_4342_2251_80310 9 + 0.0445984732531473 0.503606023156227 5856 xylometazoline hsa04010 MAPK signaling pathway 5568_5578_5155_8913_4763_23162_2249_9344_3164_4342_2251 11 + 0.0261782373200097 0.503606023156227 5857 xylometazoline hsa04540 Gap junction 5568_5155_80310_1812_5578 5 + 0.0418190848974923 0.503606023156227 5858 xylometazoline hsa05211 Renal cell carcinoma 5296_5155_405_3845_7040_7039 6 - 0.0208710311144972 0.292194435602961 5859 xylometazoline hsa04080 Neuroactive ligand-receptor interaction 2901 1 - 0.0109440795954649 0.191521392920636 5860 xylometazoline hsa05200 Pathways in cancer 367_4149_4318_841_5599_5155_5296_405_3845_7040_2263_7039_91_5914_2260_7184 16 - 0.0442544026419859 0.442544026419859 5861 xylometazoline hsa04740 Olfactory transduction 219464 1 - 0.000377942953289968 0.0264560067302978 5862 xylometazoline hsa05212 Pancreatic cancer 7039_5155_5296_3845_367_2263_2260_7184 8 - 0.00540513550496691 0.126119828449228 5863 xylometazoline hsa05215 Prostate cancer 7039_5155_5296_3845_367_2263_2260_7184 8 - 0.00507795257932506 0.126119828449228 5864 xylometazoline hsa04664 Fc epsilon RI signaling pathway 5163_5581_5296_5599_3845_5603 6 - 0.0303319551158294 0.353872809684676 5865 nimesulide hsa05010 Alzheimer's disease 3708_6622 2 + 0.0180578599715242 0.365671664423365 5866 nimesulide hsa04740 Olfactory transduction 26212_5593 2 + 4.54372625797698e-06 0.000368041826896135 5867 nimesulide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_2215_8370_8366_8368_8367_554313_9103_8359_8330_8294_720_721_121504_8354_8364 20 + 5.24247160555671e-05 0.00212320100025047 5868 nimesulide hsa04062 Chemokine signaling pathway 3579_2931 2 + 0.013358809056018 0.360687844512486 5869 nimesulide hsa05214 Glioma 6655_5155_5154_816_4193 5 - 0.0160648728522906 0.433124885196986 5870 nimesulide hsa04080 Neuroactive ligand-receptor interaction 2570 1 - 0.0463229704115086 0.494930879004887 5871 nimesulide hsa04740 Olfactory transduction 5613_816 2 - 0.0183010514871966 0.433124885196986 5872 nimesulide hsa05322 Systemic lupus erythematosus 55506_8361_8363_8362_8365_8364_8370_8360_8368_8366_8359_8294_8367_554313_121504 15 - 1.28153756932843e-06 9.09891674223185e-05 5873 nimesulide hsa05212 Pancreatic cancer 367_6655_5155_5154_4193 5 - 0.0487960021554114 0.494930879004887 5874 nimesulide hsa05215 Prostate cancer 367_6655_5155_5154_4193 5 - 0.0469730549889842 0.494930879004887 5875 nimesulide hsa03450 Non-homologous end-joining 27343_79840 2 - 0.0439533986311432 0.494930879004887 5876 flumequine hsa05332 Graft-versus-host disease 3811_3126_3113_3127_3125_3123_3802 7 + 0.00594614180962966 0.145530260605269 5877 flumequine hsa04640 Hematopoietic cell lineage 3581_3690_3123_3126_3127_3125_915_1378_4254_290 10 + 0.0116850954980626 0.193972585267839 5878 flumequine hsa05320 Autoimmune thyroid disease 3448_3126_3113_3127_3125_3123 6 + 0.0484485330698142 0.368892415681871 5879 flumequine hsa04612 Antigen processing and presentation 3811_3448_3805_3123_3126_3127_3125_3802_3113 9 + 0.0427241579693594 0.368892415681871 5880 flumequine hsa04520 Adherens junction 4301_4089_5880_5797_88_5787_91_25945_2241_2534 10 + 0.00701350653519367 0.145530260605269 5881 flumequine hsa04740 Olfactory transduction 4991 1 + 5.14858282954276e-07 4.27332374852049e-05 5882 flumequine hsa04514 Cell adhesion molecules (CAMs) 7412_3695_965_3123_3126_3127_3125_5797_22871_9672_25945_3113_26047 13 + 0.0239199294777263 0.283622020950183 5883 flumequine hsa05322 Systemic lupus erythematosus 3123_3126_3127_3113_3125_8358_88_8968_3013_8350_8351_8352_8353_8354_8355_8356_8357 17 + 0.00148429459285522 0.0615982256034916 5884 flumequine hsa05310 Asthma 3123_3126_3127_3113_3125 5 + 0.019193129187389 0.265504953758881 5885 flumequine hsa05330 Allograft rejection 3126_3113_3127_3123_3125 5 + 0.0425692339205554 0.368892415681871 5886 flumequine hsa04270 Vascular smooth muscle contraction 5319_5583_3779_2776_5330_553_112_148_6093_800_2977 11 + 0.0488893562951877 0.368892415681871 5887 flumequine hsa04740 Olfactory transduction 816 1 - 0.000793631690036713 0.0265866616162299 5888 flumequine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_727_3013_554313_8366_3014_8359_8294_8367_121504_8368_8351 18 - 1.44392234452774e-07 9.67427970833586e-06 5889 alverine hsa04920 Adipocytokine signaling pathway 5599_208_32 3 + 0.0370057766884508 0.875192047747896 5890 alverine hsa04662 B cell receptor signaling pathway 3725_27071_5534 3 - 0.0495836077113667 0.607399194464242 5891 alverine hsa05016 Huntington's disease 1213_246721_6648_5439_5331_548644 6 - 0.0168978166373607 0.413996507615337 5892 alverine hsa04720 Long-term potentiation 5331_814_5534 3 - 0.0495836077113667 0.607399194464242 5893 alverine hsa03020 RNA polymerase 246721_5439_548644 3 - 0.00457757875989916 0.224301359235059 5894 methocarbamol hsa04740 Olfactory transduction 810_5593 2 + 0.00114446908852178 0.0869796507276553 5895 methocarbamol hsa05340 Primary immunodeficiency 920_4261_29760_5897 4 + 0.0282827051696428 0.716495197630951 5896 methocarbamol hsa04115 p53 signaling pathway 55367_25898_4194_3479_3486_4616 6 + 0.0243582244894227 0.716495197630951 5897 methocarbamol hsa04070 Phosphatidylinositol signaling system 8394_51806_5333_3707_3631 5 - 0.0127259124348639 0.254235568470876 5898 methocarbamol hsa04740 Olfactory transduction 51806 1 - 0.0154424938207073 0.254235568470876 5899 methocarbamol hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_8337_8336 8 - 0.00468782461531664 0.254235568470876 5900 methocarbamol hsa05210 Colorectal cancer 3725_5900_6655_1856_581 5 - 0.0184898595251546 0.254235568470876 5901 methocarbamol hsa02010 ABC transporters 6890_23457_4363 3 - 0.0467194256635237 0.513913682298761 5902 PHA-00767505E hsa04662 B cell receptor signaling pathway 4067_3551_8519_3845_5534_3725_4793 7 + 0.019075914657386 0.364012919136991 5903 PHA-00767505E hsa05320 Autoimmune thyroid disease 958_3106_3119_1081_3134 5 + 0.0430564074434268 0.577898302015703 5904 PHA-00767505E hsa05016 Huntington's disease 581 1 + 0.0224699332800612 0.364012919136991 5905 PHA-00767505E hsa04740 Olfactory transduction 816 1 + 5.95646130584261e-05 0.00334423507731987 5906 PHA-00767505E hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_958_8359_8294_8367_554313_121504_3119 16 + 8.25737056128362e-05 0.00334423507731987 5907 PHA-00767505E hsa05120 Epithelial cell signaling in Helicobacter pylori infection 7082_1432_4067_3551_998_10392_6868_3725 8 + 0.0046086162021713 0.124432637458625 5908 PHA-00767505E hsa05330 Allograft rejection 958_3106_3119_3134 4 + 0.0499418285692583 0.577898302015703 5909 PHA-00767505E hsa04662 B cell receptor signaling pathway 5295_10892_6654_5605_5881_3725_5970_27071_4793 9 - 0.0499839373638842 0.286574574219603 5910 PHA-00767505E hsa04080 Neuroactive ligand-receptor interaction 5029_4889_1813_7068_9568_2149_9170 7 - 0.0392009830299794 0.259329580044479 5911 PHA-00767505E hsa05200 Pathways in cancer 2475_5295_5605_5881_5335_3326_5747_3655_3725_3675_7157_1857_324_1398_367_1017_9134_613_999_6932_6934_5899_2956_4791_2271_842_6654_6772_7189_5970 30 - 0.0254361016303109 0.218750474020674 5912 PHA-00767505E hsa04740 Olfactory transduction 219464_5613_5616 3 - 6.99326133085389e-07 6.01420474453435e-05 5913 PHA-00767505E hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8367_554313_8359_8337_720_721_121504_9555_8294 18 - 0.00460293570064749 0.0659754117092807 5914 PHA-00767505E hsa05212 Pancreatic cancer 6932_2475_5970_6934_9134_7157_6654_5605_3326_367_1385_1017_5295_842 14 - 0.00153597473163477 0.026418765384118 5915 PHA-00767505E hsa05215 Prostate cancer 6932_2475_5970_6934_9134_7157_6654_5605_3326_367_1385_1017_5295_842 14 - 0.00139616279607092 0.026418765384118 5916 PHA-00767505E hsa05216 Thyroid cancer 5605_7157_6932_999_6934 5 - 0.037389716544412 0.259329580044479 5917 PHA-00767505E hsa04115 p53 signaling pathway 1017_842_9134_7157_6477_7249_472_51512_651610_4616 10 - 0.0113575232910238 0.129781810749549 5918 PHA-00767505E hsa05110 Vibrio cholerae infection 8992_11015_5616_10945_60_5335_5613_523_375 9 - 0.0120727265813534 0.129781810749549 5919 PHA-00767505E hsa04010 MAPK signaling pathway 9261_3925_5605_4763_3164_4616_7157_51776_5922_1398_2264_776_5536_5607_3725_4791_5613_6654_5616_5881_2002_7189_8911_1386_5970 25 - 0.0382052339009974 0.259329580044479 5920 PHA-00767505E hsa04060 Cytokine-cytokine receptor interaction 3597_51330_659 3 - 0.000332576653894951 0.0143007961174829 5921 PHA-00767505E hsa05213 Endometrial cancer 2309_6932_6654_6934_7157_5295_999_2002_5605_324_842 11 - 0.000595596124762384 0.0170737555765217 5922 PHA-00767505E hsa05210 Colorectal cancer 6654_6934_7157_5295_1857_6932_5881_324_3725_2956_842 11 - 0.0198128091564443 0.189322398606023 5923 PHA-00767505E hsa05222 Small cell lung cancer 1017_842_9134_7157_5295_7189_5747_3655_5970_3675 10 - 0.0430322226368485 0.264340796197784 5924 gemfibrozil hsa04660 T cell receptor signaling pathway 1437_3551_208_998_5533_915_27040_5600_920 9 + 0.011807541181327 0.436879023709099 5925 gemfibrozil hsa04740 Olfactory transduction 5132_8392 2 + 0.000814310419506536 0.0602589710434837 5926 gemfibrozil hsa04210 Apoptosis 4803_3553_3551_208_331_5533_5576 7 + 0.0297835199415654 0.734660158558613 5927 gemfibrozil hsa04664 Fc epsilon RI signaling pathway 8398_7410_5335_5290_5602 5 - 0.0470534307384299 0.975836944032109 5928 gemfibrozil hsa04010 MAPK signaling pathway 4217_8398_9064_3925_9254_27092_1844_23162_5602_3725_2260_5971 12 - 0.0445668217925434 0.975836944032109 5929 oxymetazoline hsa03420 Nucleotide excision repair 2072_2967_2074 3 - 0.0240112469591337 0.424198696278029 5930 oxymetazoline hsa05322 Systemic lupus erythematosus 85235_8969_8332_8330_8331_8329_8336 7 - 0.00385023797741216 0.204062612802844 5931 oxymetazoline hsa04540 Gap junction 7278_1813_113457_23236 4 - 0.0394682101212528 0.5229537841066 5932 oxymetazoline hsa03020 RNA polymerase 246721_5439_548644 3 - 0.00847379057363697 0.22455545020138 5933 ethaverine hsa04540 Gap junction 5566_6714_3708 3 + 0.033430288072879 0.445737174305053 5934 ethaverine hsa04912 GnRH signaling pathway 1432_5566_6714_3708_2185 5 + 0.00141441181743605 0.056576472697442 5935 ethaverine hsa04270 Vascular smooth muscle contraction 3708_4882_3778_5566 4 + 0.0122812062462891 0.245624124925782 5936 ethaverine hsa04080 Neuroactive ligand-receptor interaction 4157 1 - 0.0224963290339683 0.487420462402647 5937 ethaverine hsa04740 Olfactory transduction 157 1 - 0.00177904229185186 0.115637748970371 5938 ethaverine hsa03020 RNA polymerase 5432_246721_5439_548644 4 - 0.00767867536494328 0.249556949360657 5939 glipizide hsa04740 Olfactory transduction 5566 1 + 0.0337156197226511 1 5940 glipizide hsa04080 Neuroactive ligand-receptor interaction 2908 1 - 0.0108470440379936 0.639975598241622 5941 glipizide hsa04115 p53 signaling pathway 472_651610_836_841_27113 5 - 0.0496755386085276 1 5942 bromocriptine hsa05010 Alzheimer's disease 779 1 + 0.0107675004338887 0.279955011281106 5943 bromocriptine hsa05016 Huntington's disease 10126_161 2 + 0.0367856403366142 0.542434498951155 5944 bromocriptine hsa04740 Olfactory transduction 8387_26212_8388_390892 4 + 0.000828711084976945 0.0646394646282017 5945 bromocriptine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3119 15 + 0.00176232390923428 0.0687306324601369 5946 bromocriptine hsa04010 MAPK signaling pathway 10369_782_3725_5578_1649_9254_779_5607_5156_8912_356_4208_8911_27091_5602_23542_2260_27330_5971_11221 20 + 0.0215815149113951 0.420839540772204 5947 bromocriptine hsa05012 Parkinson's disease 2861 1 + 0.0457439033213505 0.542434498951155 5948 bromocriptine hsa04930 Type II diabetes mellitus 8660_5294_5581_8471_5602 5 + 0.0486800191366421 0.542434498951155 5949 bromocriptine hsa05211 Renal cell carcinoma 6655_5290_405_5781_7042_3725_4233 7 - 0.0281388945474457 0.231364244056776 5950 bromocriptine hsa04650 Natural killer cell mediated cytotoxicity 10725_6655_3107_5290_3135_6452_5781_3133_5534_8794_8795 11 - 0.0274095385733751 0.231364244056776 5951 bromocriptine hsa04662 B cell receptor signaling pathway 10725_10892_6655_5290_5534_3725_27071 7 - 0.0335945648937371 0.248599780213655 5952 bromocriptine hsa04080 Neuroactive ligand-receptor interaction 7434_4889 2 - 0.00679687887925378 0.146461617198649 5953 bromocriptine hsa04910 Insulin signaling pathway 5599_5576_5575_5140_8660_5562_5290_5602_8835_5507_6655 11 - 0.0274095385733751 0.231364244056776 5954 bromocriptine hsa04740 Olfactory transduction 818 1 - 7.91468369705668e-06 0.000292843296791097 5955 bromocriptine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_6738_8359_8294_8367_554313_8343_121504_8339_8347_8346_8344 20 - 3.09118420195148e-06 0.00022874763094441 5956 bromocriptine hsa04210 Apoptosis 3554_581_5576_5575_5290_5534_8837_8794_8795 9 - 0.0110116908669164 0.162973024830363 5957 bromocriptine hsa04350 TGF-beta signaling pathway 4090_4088_656_654_653_353500_7042_57154 8 - 0.0257608579545053 0.231364244056776 5958 bromocriptine hsa04930 Type II diabetes mellitus 5599_8660_8835_5290_5602 5 - 0.0382822983322369 0.257535461507776 5959 bromocriptine hsa05210 Colorectal cancer 581_4088_6655_7042_5290_5599_5602_3725_4233 9 - 0.00791684417289994 0.146461617198649 5960 cotinine hsa05211 Renal cell carcinoma 5879_10298_7428_6655_998_56924_7042_7039_1387_3082 10 + 0.00148842227676484 0.0595368910705936 5961 cotinine hsa04650 Natural killer cell mediated cytotoxicity 3824_3449_3804_6655_3107_5880_3440_3451_6452_7535_5879_8794_2534 13 + 0.00930968241181119 0.248258197648298 5962 cotinine hsa04520 Adherens junction 4301_5879_998_5797_5880_91_1387_2534 8 + 0.0237470142255201 0.379952227608322 5963 cotinine hsa04740 Olfactory transduction 5137_8383_390892 3 + 0.000171186927158491 0.0136949541726793 5964 cotinine hsa04360 Axon guidance 2051_2047_10298_6585_56924_2048_998_5880_10154_2534_5879_7869 12 + 0.0146037398536839 0.292074797073678 5965 cotinine hsa05012 Parkinson's disease 6622 1 + 0.045653492931148 0.608713239081973 5966 cotinine hsa05332 Graft-versus-host disease 3108_3105_3106_3135_355_649853 6 - 0.032264420521798 0.49040645756563 5967 cotinine hsa04080 Neuroactive ligand-receptor interaction 146_2555_64106_1131_2925_1909 6 - 0.0432465057697327 0.49040645756563 5968 cotinine hsa04740 Olfactory transduction 818_393046 2 - 6.54470721019383e-07 5.23576576815506e-05 5969 cotinine hsa05322 Systemic lupus erythematosus 3108_8336 2 - 0.0350800204085935 0.49040645756563 5970 cotinine hsa04530 Tight junction 4619_84612 2 - 0.049040645756563 0.49040645756563 5971 cotinine hsa05012 Parkinson's disease 4698_65018 2 - 0.0489201727035693 0.49040645756563 5972 cotinine hsa05330 Allograft rejection 3108_3105_3106_3135_355_649853 6 - 0.0219398677385395 0.49040645756563 5973 cotinine hsa04940 Type I diabetes mellitus 3108_3105_3106_3135_355_649853 6 - 0.0384396525916161 0.49040645756563 5974 erythromycin hsa05131 Shigellosis 7278_113457_2534 3 - 0.0469972292193889 0.815891086749208 5975 erythromycin hsa05130 Pathogenic Escherichia coli infection 7278_113457_2534 3 - 0.0469972292193889 0.815891086749208 5976 amoxapine hsa05214 Glioma 23533_6655_5293_5290_4193 5 + 0.0107839193158983 0.0613853868751134 5977 amoxapine hsa04070 Phosphatidylinositol signaling system 23533_8394_8396_5293_5290_23236 6 + 0.00476081575088212 0.0391444850628085 5978 amoxapine hsa05211 Renal cell carcinoma 23533_6655_5293_5290_3725 5 + 0.0158270119333927 0.0836570630765043 5979 amoxapine hsa04662 B cell receptor signaling pathway 23533_3551_6655_5293_5290_5534_3725 7 + 0.000952261326866715 0.0199454175053129 5980 amoxapine hsa04660 T cell receptor signaling pathway 23533_1432_3551_6655_5293_5290_5534_3725 8 + 0.001886728682935 0.0199454175053129 5981 amoxapine hsa04670 Leukocyte transendothelial migration 5010_23533_1432_5293_5290_27035 6 + 0.0360995601857365 0.121425793352023 5982 amoxapine hsa04910 Insulin signaling pathway 23533_3551_6655_5293_5290_8660_10211 7 + 0.021250778809706 0.0914379743889125 5983 amoxapine hsa05014 Amyotrophic lateral sclerosis (ALS) 2902_5534_1432_5630_581 5 + 0.00608139707618852 0.045002338363795 5984 amoxapine hsa05212 Pancreatic cancer 23533_3551_6655_4193_5290_5293 6 + 0.00964394033086622 0.059470965373675 5985 amoxapine hsa05215 Prostate cancer 23533_3551_6655_4193_5290_5293 6 + 0.00917683314042961 0.059470965373675 5986 amoxapine hsa04210 Apoptosis 23533_3553_3551_581_5293_5290_355_5534 8 + 0.000523779818922925 0.0199454175053129 5987 amoxapine hsa05221 Acute myeloid leukemia 23533_3551_6655_5371_5293_5290 6 + 0.00146684779838444 0.0199454175053129 5988 amoxapine hsa04664 Fc epsilon RI signaling pathway 23533_6655_1432_5293_5290 5 + 0.0222416694459517 0.0914379743889125 5989 amoxapine hsa04370 VEGF signaling pathway 23533_1432_5293_5290_5534 5 + 0.020261606224127 0.0914379743889125 5990 amoxapine hsa04012 ErbB signaling pathway 3725_6655_5293_5290_23533 5 + 0.0314005112793662 0.110649420698719 5991 amoxapine hsa05223 Non-small cell lung cancer 23533_6655_5293_5290 4 + 0.0246814488859084 0.0961277482924854 5992 amoxapine hsa04620 Toll-like receptor signaling pathway 23533_1432_3551_5293_5290_7100_3725_3553 8 + 0.00120271505319107 0.0199454175053129 5993 amoxapine hsa04020 Calcium signaling pathway 146_2902_135_8911_113_5534_493_23236 8 + 0.0311263006823815 0.110649420698719 5994 amoxapine hsa04930 Type II diabetes mellitus 5290_23533_8660_5293_3551 5 + 0.00256390947020155 0.0237161625993643 5995 amoxapine hsa05213 Endometrial cancer 23533_6655_5293_5290 4 + 0.0220005161094239 0.0914379743889125 5996 amoxapine hsa05210 Colorectal cancer 23533_581_4088_6655_5293_5290_3725 7 + 0.00175536972403237 0.0199454175053129 5997 amoxapine hsa05220 Chronic myeloid leukemia 23533_3551_4088_6655_5293_5290_4193 7 + 0.000952261326866715 0.0199454175053129 5998 amoxapine hsa04740 Olfactory transduction 818 1 - 0.000542209766835862 0.0401235227458538 5999 zimeldine hsa05214 Glioma 5159_3480_4193_818_1956_816 6 + 0.0246070609920452 0.147642365952271 6000 zimeldine hsa05332 Graft-versus-host disease 3804_3126_3127_3111_3125_5551_3123_941 8 + 0.000155953970678472 0.00935186333549162 6001 zimeldine hsa04640 Hematopoietic cell lineage 1436_960_3123_3126_3127_3125_3589_933_1378_3684_925 11 + 0.000259773981541434 0.00935186333549162 6002 zimeldine hsa05320 Autoimmune thyroid disease 3449_3123_3126_3127_3111_941_5551_3125 8 + 0.000632461920714502 0.011384314572861 6003 zimeldine hsa04612 Antigen processing and presentation 4261_3449_3123_3126_3127_3111_3125_6891_3804_925 10 + 0.00113198658141298 0.0135838389769558 6004 zimeldine hsa05131 Shigellosis 7278_347733_7430_113457_9181 5 + 0.0433927497741373 0.208285198915859 6005 zimeldine hsa05130 Pathogenic Escherichia coli infection 7278_347733_7430_113457_9181 5 + 0.0433927497741373 0.208285198915859 6006 zimeldine hsa04740 Olfactory transduction 818_1258_816 3 + 0.00275268233646811 0.0283133040322434 6007 zimeldine hsa04514 Cell adhesion molecules (CAMs) 3123_4099_3126_3127_3111_3125_23308_941_933_3684_925 11 + 0.00630767084937712 0.050461366795017 6008 zimeldine hsa05218 Melanoma 5159_3480_4193_8817_1956_3082 6 + 0.0348714737445518 0.193134316123672 6009 zimeldine hsa05310 Asthma 3123_3126_3127_3111_3125 5 + 0.00458982283884464 0.0413084055496018 6010 zimeldine hsa04540 Gap junction 5159_347733_7278_1813_113457_1956_3358_23236 8 + 0.0146404045020379 0.0958281021951572 6011 zimeldine hsa04020 Calcium signaling pathway 5159_8912_56848_818_9630_3274_1956_5733_3269_10800_3358_816_23236 13 + 0.0115212785412246 0.0829532054968171 6012 zimeldine hsa05330 Allograft rejection 3123_3126_3127_3111_941_5551_3125 7 + 0.000481969170418311 0.011384314572861 6013 zimeldine hsa04940 Type I diabetes mellitus 3123_3126_3127_3111_941_5551_3125 7 + 0.00104542116848358 0.0135838389769558 6014 zimeldine hsa04080 Neuroactive ligand-receptor interaction 9568_3953_146_1081 4 - 0.0199440417968554 0.339048710546542 6015 zimeldine hsa04740 Olfactory transduction 810_5613_5616 3 - 4.07769897027873e-05 0.00346604412473692 6016 zimeldine hsa04514 Cell adhesion molecules (CAMs) 3113 1 - 0.0317490503010113 0.390842392790249 6017 zimeldine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3113_8359_8348_8294_8367_554313_121504 16 - 0.00242641480640106 0.103122629272045 6018 zimeldine hsa05012 Parkinson's disease 4714 1 - 0.0321870205827264 0.390842392790249 6019 zimeldine hsa04060 Cytokine-cytokine receptor interaction 3953_4233_2057_3455 4 - 0.014541627531815 0.309009585051069 6020 zimeldine hsa04270 Vascular smooth muscle contraction 146_776_5581_5613_5616_673_8681_112_810_6093_9475_100137049 12 - 0.0142648712379222 0.309009585051069 6021 metanephrine hsa04920 Adipocytokine signaling pathway 9021_181_5465 3 + 0.0462113018103781 0.865839906647906 6022 metanephrine hsa04664 Fc epsilon RI signaling pathway 50487_8681_100137049_5581 4 - 0.034995261451836 0.361617701668972 6023 metanephrine hsa04370 VEGF signaling pathway 5829_572_50487_4775_8681_100137049 6 - 0.00144352954391763 0.0894988317228931 6024 metanephrine hsa04912 GnRH signaling pathway 5331_8681_50487_100137049_2776 5 - 0.0265606596888303 0.361617701668972 6025 metanephrine hsa04730 Long-term depression 5331_8681_50487_100137049_2776 5 - 0.00539571357023182 0.167267120677186 6026 metanephrine hsa04270 Vascular smooth muscle contraction 5581_50487_2776_5331_8681_100137049 6 - 0.0104095439495169 0.215130574956683 6027 metanephrine hsa02010 ABC transporters 215_8714_23457 3 - 0.0324886344728408 0.361617701668972 6028 metolazone hsa04740 Olfactory transduction 818_26211 2 + 0.0368647341977576 0.911828188609026 6029 metolazone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3113_8359_8294_8367_554313_121504 15 + 4.90099808601492e-07 3.33267869849015e-05 6030 metolazone hsa04630 Jak-STAT signaling pathway 3454_5290_3572_50616_2688_1442_10252 7 + 0.0402277142033394 0.911828188609026 6031 metolazone hsa04070 Phosphatidylinositol signaling system 5296_1606_5290_3631 4 - 0.0188752668423732 0.440948857826451 6032 metolazone hsa04662 B cell receptor signaling pathway 5296_4793_5290_8519 4 - 0.0181053072493353 0.440948857826451 6033 metolazone hsa04330 Notch signaling pathway 182_1856_5664 3 - 0.025611456878796 0.440948857826451 6034 metolazone hsa04150 mTOR signaling pathway 5296_7422_5290 3 - 0.0327557100126648 0.440948857826451 6035 dipyridamole hsa04740 Olfactory transduction 810_816 2 + 0.000187229404022681 0.012918828877565 6036 dipyridamole hsa04270 Vascular smooth muscle contraction 113_4660_10242_3709_5320_185_810_6093_800 9 + 0.0447034574182091 1 6037 dipyridamole hsa04070 Phosphatidylinositol signaling system 8867_8503_5578_3628_5295_3633_3631_8821_5335_8526_23236 11 - 0.00820212309783216 0.136155243424014 6038 dipyridamole hsa05010 Alzheimer's disease 572_776_489_23236 4 - 0.047702193929529 0.51031945858739 6039 dipyridamole hsa04080 Neuroactive ligand-receptor interaction 64106_56288_2925_2555 4 - 0.00216008776367245 0.0597624281282711 6040 dipyridamole hsa04740 Olfactory transduction 818_26212 2 - 9.26024896494002e-08 7.68600664090022e-06 6041 dipyridamole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6738_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 26 - 2.04616923130675e-06 8.49160230992301e-05 6042 dipyridamole hsa05012 Parkinson's disease 27429_2861 2 - 0.0359593441209476 0.497437593673109 6043 dipyridamole hsa04060 Cytokine-cytokine receptor interaction 7852_7423_5155_3552_4254 5 - 0.00421162987861167 0.0873913199811922 6044 loxapine hsa02010 ABC transporters 6890_23457 2 + 0.0458483483889308 0.73876754222843 6045 loxapine hsa04330 Notch signaling pathway 2648_5986_1856 3 - 0.0368017695007498 0.985152031721386 6046 propranolol hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 + 0.0307038730807558 0.262291216733168 6047 propranolol hsa04640 Hematopoietic cell lineage 3123_3126_3127_3125_933_925 6 + 0.0335091016171015 0.262291216733168 6048 propranolol hsa05200 Pathways in cancer 3688_51384_841_83439_2950_3576_5371_1613_861_2122_7849_1950_324_3082_4233_7048_7422 17 + 0.0144017697371329 0.23618902368898 6049 propranolol hsa04740 Olfactory transduction 810_5568 2 + 0.00477873709700603 0.0979641104886236 6050 propranolol hsa04514 Cell adhesion molecules (CAMs) 8516_3688_8174_3123_3126_3127_3125_5797_933_925 10 + 0.00420927752803839 0.0979641104886236 6051 propranolol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504 18 + 1.90695425717573e-07 1.5637024908841e-05 6052 propranolol hsa05219 Bladder cancer 3576_7422_1613_1950 4 + 0.0307038730807558 0.262291216733168 6053 propranolol hsa05310 Asthma 6356_3123_3126_3127_3125 5 + 0.00193180784623251 0.0792041216955329 6054 propranolol hsa05330 Allograft rejection 3123_3126_3127_3125 4 + 0.0228066485725353 0.262291216733168 6055 propranolol hsa04940 Type I diabetes mellitus 3123_3126_3127_3125 4 + 0.0351854071227421 0.262291216733168 6056 propranolol hsa02010 ABC transporters 5244_64137_5243_89845 4 + 0.0351854071227421 0.262291216733168 6057 bretylium tosilate hsa05332 Graft-versus-host disease 3123_3126_3127_3119_3125 5 + 0.00300554529844356 0.047667576874964 6058 bretylium tosilate hsa04640 Hematopoietic cell lineage 3123_3126_4254_3127_3125_3674 6 + 0.0138338544088556 0.101448265664941 6059 bretylium tosilate hsa05320 Autoimmune thyroid disease 3123_3126_3127_3119_3125 5 + 0.0074477881278281 0.0819256694061091 6060 bretylium tosilate hsa04612 Antigen processing and presentation 3123_3126_3127_3119_3125 5 + 0.0487960021554114 0.292776012932468 6061 bretylium tosilate hsa04514 Cell adhesion molecules (CAMs) 9076_3119_3123_1272_3126_3127_3125_26285 8 + 0.0104815340724208 0.0981735607121734 6062 bretylium tosilate hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504_3119 19 + 1.3870195927391e-09 9.15432931207806e-08 6063 bretylium tosilate hsa04664 Fc epsilon RI signaling pathway 5599_208_5881_10000_6850 5 + 0.0324099653585933 0.213905771366716 6064 bretylium tosilate hsa05310 Asthma 3123_3126_3127_3119_3125 5 + 0.000780844903483688 0.0257678818149617 6065 bretylium tosilate hsa05330 Allograft rejection 3123_3126_3127_3119_3125 5 + 0.00201923333080066 0.0444231332776145 6066 bretylium tosilate hsa05210 Colorectal cancer 10000_581_5599_208_5881_324 6 + 0.0118998255408695 0.0981735607121734 6067 bretylium tosilate hsa04940 Type I diabetes mellitus 3123_3126_3127_3119_3125 5 + 0.00361118006628515 0.047667576874964 6068 bretylium tosilate hsa03020 RNA polymerase 246721_5439_548644 3 - 0.00358485908465126 0.136224645216748 6069 penbutolol hsa05010 Alzheimer's disease 489 1 + 0.0324550053483119 0.60041759894377 6070 penbutolol hsa05016 Huntington's disease 163 1 + 0.0225111777028222 0.555275716669614 6071 penbutolol hsa04740 Olfactory transduction 818_26529 2 + 0.000405137868222432 0.01499010112423 6072 penbutolol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_8341 15 + 0.00026985703855734 0.01499010112423 6073 penbutolol hsa05131 Shigellosis 7278_7430_113457_8976_9475 5 - 0.0031107523095433 0.0855456885124408 6074 penbutolol hsa05130 Pathogenic Escherichia coli infection 7278_7430_113457_8976_9475 5 - 0.0031107523095433 0.0855456885124408 6075 penbutolol hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_8336 7 - 0.011828979498774 0.162648468108142 6076 penbutolol hsa04360 Axon guidance 2050_1949_6405_2048_9475_5361_6092 7 - 0.00740130048222042 0.135690508840708 6077 oligomycin hsa05010 Alzheimer's disease 22926_6622 2 + 0.00150048230859712 0.0420135046407194 6078 oligomycin hsa04310 Wnt signaling pathway 818_23002_5467 3 + 0.0269314898025878 0.377040857236229 6079 oligomycin hsa05016 Huntington's disease 246721_5441 2 + 0.00072648506342367 0.0305123726637941 6080 oligomycin hsa04740 Olfactory transduction 8388_8387_442194_818_409_8590_3000 7 + 4.02240536665133e-05 0.00337882050798712 6081 oligomycin hsa04062 Chemokine signaling pathway 2309_2771_3576_409_2931 5 + 0.0251689779157158 0.377040857236229 6082 oligomycin hsa04810 Regulation of actin cytoskeleton 5605_3693_4659_2249_80310 5 + 0.0107711466840143 0.2261940803643 6083 oligomycin hsa05012 Parkinson's disease 7345_6622_6531 3 + 0.0490779133225238 0.588934959870286 6084 oligomycin hsa05322 Systemic lupus erythematosus 85235_8969_8332_8330_8331_8329_8336 7 - 0.00108314636560306 0.035743830064901 6085 arachidonic acid hsa05332 Graft-versus-host disease 57292_3553_3552_3105_3106_941_3135_649853 8 + 0.00435391229099638 0.111299413736305 6086 arachidonic acid hsa04130 SNARE interactions in vesicular transport 23673_2054_6809_10652_9570_10228_6616 7 + 0.00874826091328107 0.116643478843748 6087 arachidonic acid hsa04910 Insulin signaling pathway 23265_5256 2 + 0.0349794531259059 0.310928472230275 6088 arachidonic acid hsa05016 Huntington's disease 5441 1 + 0.000777383379494913 0.0310953351797965 6089 arachidonic acid hsa04740 Olfactory transduction 157_442194_818_409_5137_8590 6 + 0.000190291363193725 0.015223309055498 6090 arachidonic acid hsa04514 Cell adhesion molecules (CAMs) 9076_5010_3383_5818_3105_3106_1013_941_3135_5797_5817_923_5133_1272_926_649853 16 + 0.00832037138685099 0.116643478843748 6091 arachidonic acid hsa04510 Focal adhesion 93408_55742_10298_859 4 + 0.0272060938149429 0.31092678645649 6092 arachidonic acid hsa05322 Systemic lupus erythematosus 3013_941_8358_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357 14 + 0.0487567320863701 0.390053856690961 6093 arachidonic acid hsa04810 Regulation of actin cytoskeleton 10093_93408_10298_8976_2249 5 + 0.0341394219540957 0.310928472230275 6094 arachidonic acid hsa04940 Type I diabetes mellitus 3382_3552_3105_3106_941_3135_3553_649853 8 + 0.00556497068681525 0.111299413736305 6095 arachidonic acid hsa05010 Alzheimer's disease 5530_351_4712 3 - 0.0366413862698618 0.575453098627929 6096 arachidonic acid hsa04080 Neuroactive ligand-receptor interaction 2911_2901_7252_5031_1902_5646 6 - 0.0430307494992151 0.575453098627929 6097 arachidonic acid hsa04670 Leukocyte transendothelial migration 5747 1 - 0.0216264559702292 0.555079036569216 6098 arachidonic acid hsa04740 Olfactory transduction 26476 1 - 7.08490444881201e-08 5.45537642558525e-06 6099 arachidonic acid hsa05322 Systemic lupus erythematosus 3017 1 - 0.0108517629378092 0.417792873105654 6100 arachidonic acid hsa04912 GnRH signaling pathway 8398 1 - 0.0448405011917867 0.575453098627929 6101 W-13 hsa05016 Huntington's disease 2902_513_10126_4712_509 5 + 0.00294216965506367 0.0872843664335556 6102 W-13 hsa04740 Olfactory transduction 8387_26476_23538_8392_8388 5 + 3.50827377757318e-09 3.12236366204013e-07 6103 W-13 hsa04510 Focal adhesion 596_5296_2909_3678_5880_5602_87_7058_3911_5829_3691_93408_1398_55742_1291_1278_207_1956_5595_2318_5579_5578_2316_6655_1289_2002_5599_7423 28 + 0.0378497911570546 0.259125493305989 6104 W-13 hsa04664 Fc epsilon RI signaling pathway 5579_5595_3596_207_5578_5296_6655_5605_5599_5880_5335_9846_5602_5322_8399 15 + 0.0113046087977736 0.167685030500308 6105 W-13 hsa05219 Bladder cancer 23604_11186_1029_9252_1613_5605_1956_7423_369_5595 10 + 0.00781788557547052 0.167685030500308 6106 W-13 hsa04012 ErbB signaling pathway 2002_5595_207_5579_5578_5599_6655_5602_3084_5605_5296_1956_5335_1398_6776_369 16 + 0.00981795693421826 0.167685030500308 6107 W-13 hsa05223 Non-small cell lung cancer 2309_11186_5579_207_5578_5296_6655_1029_5605_1956_5335_369_5595_6256 14 + 0.000900462220817545 0.0400705688263807 6108 W-13 hsa04010 MAPK signaling pathway 9261_9344_5605_6722_5607_5880_5602_3553_773_7189_1850_8823_1398_2246_408_8399_207_27092_9252_1956_5322_1616_3727_1647_5595_2318_5579_5578_5599_6655_4915_4763_2002_2316_8911_2005_7186 37 + 0.014735094321433 0.187346199229648 6109 W-13 hsa04540 Gap junction 2911_7280_5595_3710_5579_347733_2771_6655_5578_3709_115_5607_1956_5605_1902_1813 16 + 0.0194261338951394 0.216115739583426 6110 W-13 hsa03010 Ribosome 6204_6139_6181 3 + 0.0465881289124342 0.276422898213776 6111 W-13 hsa05213 Endometrial cancer 2309_2002_5595_207_5296_6655_5605_1956_8312_369 10 + 0.0310532450830617 0.251248982944772 6112 W-13 hsa04912 GnRH signaling pathway 2185_5605_5595_3710_5579_5578_5599_6655_3709_2002_115_1956_5322_5337_5602_2797_8399 17 + 0.0304095634451811 0.251248982944772 6113 W-13 hsa04730 Long-term depression 2911_5595_8399_773_5578_2771_5579_5605_3709_5322_369_3710 12 + 0.041244873435534 0.262199552554466 6114 W-13 hsa05210 Colorectal cancer 5595_207_596_4088_6655_5602_5880_1857_5296_1956_8312_369_5599_7976 14 + 0.037114307858392 0.259125493305989 6115 W-13 hsa05220 Chronic myeloid leukemia 5595_207_4088_6776_369_1029_5605_5296_9846_861_1398_1488_6655 13 + 0.0289032365385975 0.251248982944772 6116 oxamic acid hsa04650 Natural killer cell mediated cytotoxicity 4776_3451_5595_5578_5293_3135_5879 7 + 0.0187644708000249 0.223743591008811 6117 oxamic acid hsa04662 B cell receptor signaling pathway 4776_5879_5595_5293_8519 5 + 0.0166616881583249 0.223743591008811 6118 oxamic acid hsa04740 Olfactory transduction 26476 1 + 0.0109912837241042 0.223743591008811 6119 oxamic acid hsa04664 Fc epsilon RI signaling pathway 5879_5578_5595_5293_9846 5 + 0.0201699450201208 0.223743591008811 6120 oxamic acid hsa04370 VEGF signaling pathway 4776_5879_5595_5293_5578 5 + 0.0183605141140869 0.223743591008811 6121 oxamic acid hsa04010 MAPK signaling pathway 3727_5595_5578_4763_4776_5607_8911_9344_3164_5879_7186 11 + 0.0217528491258566 0.223743591008811 6122 oxamic acid hsa04620 Toll-like receptor signaling pathway 3451_3576_5595_5293_5879 5 + 0.0495776983169525 0.409124348458935 6123 oxamic acid hsa04730 Long-term depression 5331_5519_5595_4842_5578 5 + 0.0135850333536182 0.223743591008811 6124 copper sulfate hsa05200 Pathways in cancer 3576_5605_5880_7170_5602_3655_2308_6513_1613_324_7472_7476_3480_4193_7849_8312_1869_3725_4233_4791_5595_5578_6776_1029_7189_7422_5915_54361_7184_2251 30 + 0.0375760897582349 0.705909118139412 6125 copper sulfate hsa04740 Olfactory transduction 26476_2979_3000_157_5566 5 + 1.09421521408383e-05 0.000951967236252932 6126 copper sulfate hsa05219 Bladder cancer 5595_3576_1029_1613_4193_5605_7422_1869 8 + 0.00692900595486629 0.301411759036684 6127 copper sulfate hsa04115 p53 signaling pathway 55367_1647_1029_317_4193_7249_472_51512_651610 9 + 0.0431478777701553 0.705909118139412 6128 copper sulfate hsa05012 Parkinson's disease 317_4712 2 + 0.0249201025451067 0.705909118139412 6129 copper sulfate hsa05010 Alzheimer's disease 22926 1 - 0.0480324688917819 1 6130 copper sulfate hsa04740 Olfactory transduction 8387_5137_10798_409_8388 5 - 0.0264073402809232 1 6131 iloprost hsa05010 Alzheimer's disease 489 1 + 0.0154490110176722 0.625684946215724 6132 iloprost hsa04740 Olfactory transduction 409 1 + 1.20660385873684e-05 0.00097734912557684 6133 iloprost hsa05332 Graft-versus-host disease 3812_3804_3106_3553_3135 5 - 0.023105363382718 0.639248386921865 6134 iloprost hsa04650 Natural killer cell mediated cytotoxicity 3812_3383_3804_3106_3135_7410_6452_9436_8795_4276 10 - 0.0390903882323413 0.811125555821082 6135 iloprost hsa04740 Olfactory transduction 5566_8392_1179 3 - 0.000992293251634676 0.0823603398856781 6136 iloprost hsa04514 Cell adhesion molecules (CAMs) 1272_6403_3383_6404_4099_3106_3135_6693_933_3655_9019_1001 12 - 0.00496284364792504 0.205958011388889 6137 trifluoperazine hsa04916 Melanogenesis 5568_4157_816_7855 4 + 0.0237499907035085 0.295178455886463 6138 trifluoperazine hsa05010 Alzheimer's disease 6390_5532_3708_3709_6868_5534_22926 7 + 0.00196525905897416 0.0284962563551253 6139 trifluoperazine hsa05016 Huntington's disease 6390_27113_3708 3 + 3.09657583399549e-06 0.000134701048778804 6140 trifluoperazine hsa04740 Olfactory transduction 26539_26211_26212_5568_816 5 + 8.02570609516054e-13 6.98236430278967e-11 6141 trifluoperazine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8348_8294_121504_8343_8347_8346_8344_8339_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_3113_8970 34 + 0.000383734715311515 0.00834623005802545 6142 trifluoperazine hsa04062 Chemokine signaling pathway 2309_1234_5568_6655_3576_5290_7852_1399_6362_6093_4793_408 12 + 0.0357454435843509 0.388731698979816 6143 trifluoperazine hsa05012 Parkinson's disease 6390_6531 2 + 9.25927690333823e-05 0.00268519030196809 6144 trifluoperazine hsa03010 Ribosome 6181_6144 2 + 0.00176855293042566 0.0284962563551253 6145 trifluoperazine hsa05214 Glioma 5154 1 - 0.0416465662254318 0.456395387148677 6146 trifluoperazine hsa04080 Neuroactive ligand-receptor interaction 5029_5618_1813_64106_4158_5030_5031_2740_2690 9 - 0.00208677965066479 0.0619077963030554 6147 trifluoperazine hsa04740 Olfactory transduction 109 1 - 1.1712627831399e-13 1.04242387699451e-11 6148 trifluoperazine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_3123_3126_3127_3125_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3014_727 38 - 6.92406821215533e-08 3.08121035440912e-06 6149 trifluoperazine hsa04710 Circadian rhythm - mammal 406_1408_5187_8863 4 - 0.0461523425206527 0.456395387148677 6150 trifluoperazine hsa04012 ErbB signaling pathway 5599 1 - 0.00972337068589578 0.173075998208945 6151 trifluoperazine hsa03022 Basal transcription factors 2967_2969_10629_6875_2957_51616_6872_728198 8 - 0.0291936345417216 0.43303891236887 6152 trifluoperazine hsa04260 Cardiac muscle contraction 27092_6548 2 - 0.0459287713963947 0.456395387148677 6153 trifluoperazine hsa04020 Calcium signaling pathway 5533_5331_109_489_7419_3707 6 - 0.00723274633396178 0.16092860593065 6154 chlorpromazine hsa05010 Alzheimer's disease 5331_351_3709_841_2776 5 + 0.0249500019538815 0.444110034779091 6155 chlorpromazine hsa04740 Olfactory transduction 1179_816 2 + 8.24109034098234e-10 7.33457040347428e-08 6156 chlorpromazine hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8360_8368_8362_8294_8366_8370_718_8359_554313_121504_2215_2214_83740_3111_720_721 23 + 0.00155940466614979 0.0478842408889932 6157 chlorpromazine hsa04062 Chemokine signaling pathway 7852_5331_6366_6772_112 5 + 0.0101894838354513 0.226716015338791 6158 chlorpromazine hsa05012 Parkinson's disease 6531 1 + 0.00161407553558404 0.0478842408889932 6159 chlorpromazine hsa04912 GnRH signaling pathway 1432_3709_1081_5599_5602_2776_5331_2798_1956_5320_112_3725_6714_816 14 + 0.0464110696738389 0.68843086682861 6160 chlorpromazine hsa04080 Neuroactive ligand-receptor interaction 2903_1269_4157_2557_6752_1132_2908_2570_7434_57105_3351_4160_5733_4988_8484 15 - 5.92574082240759e-06 0.000269621207419545 6161 chlorpromazine hsa04742 Taste transduction 3710 1 - 0.00332888482922 0.0504880865765033 6162 chlorpromazine hsa04740 Olfactory transduction 219464_5593_56656_26333_1179_808_818_109_4991_801_805 11 - 7.4195620721299e-15 6.75180148563821e-13 6163 chlorpromazine hsa05322 Systemic lupus erythematosus 2903_8361_8363_8362_8365_8364_8367_8360_8368_6738_8348_8294_121504_8343_8347_8346_8344_8339_8366_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3017_720_721 36 - 0.0309711016106777 0.281837024657167 6164 chlorpromazine hsa04630 Jak-STAT signaling pathway 3717_2057_3594_3588_1154_6654_3601_3559_5291_10379_5296_51561_9180_9655_10254 15 - 0.0456685424185406 0.346319780007266 6165 chlorpromazine hsa04062 Chemokine signaling pathway 5590_3717_3551_5829_6654_7410_5291_5331_5296_10451_109_5058_1398_23236_8976_408 16 - 0.00488943164095551 0.0635626113324216 6166 chlorpromazine hsa05012 Parkinson's disease 836_4698_6390_1347_51465_7381_517 7 - 0.00062869177964117 0.0143027379868366 6167 chlorpromazine hsa04260 Cardiac muscle contraction 784_27092_7168_7381_1347 5 - 0.0202763517236016 0.205016445205305 6168 chlorpromazine hsa04060 Cytokine-cytokine receptor interaction 3601_3554_3553_3552_2057_3594_3588_23765_5155_3624_3559_4254_355_655_51561_9180_91_90 18 - 5.83629152042492e-05 0.00177034176119556 6169 chlorpromazine hsa03010 Ribosome 6187_6168_440589_6189_439992 5 - 0.0030516633824114 0.0504880865765033 6170 chlorpromazine hsa03050 Proteasome 5717_5690 2 - 0.03981811423117 0.32940439954877 6171 chlorpromazine hsa02010 ABC transporters 10257 1 - 0.0165020945769041 0.187711325812284 6172 cyclobenzaprine hsa04740 Olfactory transduction 5613_5616 2 + 0.0190378111418069 0.393448096930676 6173 cyclobenzaprine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3111_3014_8359_8294_8367_554313_121504 16 + 3.86573200497309e-07 2.39675384308332e-05 6174 cyclobenzaprine hsa04710 Circadian rhythm - mammal 8553_5187 2 + 0.0412702859214802 0.511751545426354 6175 cyclobenzaprine hsa04340 Hedgehog signaling pathway 5613_5616_7480_650_4036 5 + 0.0111502239296139 0.345656941818031 6176 cyclobenzaprine hsa04010 MAPK signaling pathway 783_6788_50487_5616_1846_8912_6722_5613_91_3310_3164_2250 12 + 0.0351542351039191 0.511751545426354 6177 cyclobenzaprine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_8294_720_721_121504_8367 16 - 2.32651574187088e-06 0.000116325787093544 6178 cyclobenzaprine hsa04060 Cytokine-cytokine receptor interaction 659 1 - 0.0156349486123104 0.39087371530776 6179 cyclobenzaprine hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0447828608337697 0.663765897388307 6180 quinpirole hsa05214 Glioma 1021_207_5296_6464_5605_5925_1956_7039 8 + 0.0297264700203627 0.480495657395201 6181 quinpirole hsa04120 Ubiquitin mediated proteolysis 23759_4281 2 + 0.0495402114157969 0.493930791692627 6182 quinpirole hsa04080 Neuroactive ligand-receptor interaction 7434_7252 2 + 0.000257020555933582 0.00642551389833955 6183 quinpirole hsa04740 Olfactory transduction 109_393046_409 3 + 4.57613299968353e-06 0.000343209974976265 6184 quinpirole hsa05322 Systemic lupus erythematosus 8358_85235_8968_3013_8351_8330_8332_8969_8331_8329_720_721_8350_8336_8352_8353_8354_8355_8356_8357 20 + 0.000211291789001315 0.00642551389833955 6185 quinpirole hsa05223 Non-small cell lung cancer 1021_207_5296_5605_5925_1956_7039 7 + 0.0327173491763504 0.480495657395201 6186 quinpirole hsa04940 Type I diabetes mellitus 3593_3553_3105_3106_3135_649853 6 + 0.0384396525916161 0.480495657395201 6187 quinpirole hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3725_6714_3576_6868_3579 5 - 0.0293281446373135 0.595992198222594 6188 quinpirole hsa04540 Gap junction 7278_113457_115_108_3709_6714_1902 7 - 0.00773053607296045 0.51794591688835 6189 quinpirole hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0355816237744832 0.595992198222594 6190 quinpirole hsa04912 GnRH signaling pathway 50487_115_108_3709_3725_6714 6 - 0.0457304015851839 0.612787381241464 6191 quinpirole hsa05210 Colorectal cancer 581_3480_5900_324_91_3725 6 - 0.0166267587944338 0.556996419613532 6192 prochlorperazine hsa05332 Graft-versus-host disease 3569_3119_3105_3106_3107_3126_3127_3125_3135_3123_3113_649853 12 + 0.000494031330601938 0.0144915856976568 6193 prochlorperazine hsa05010 Alzheimer's disease 6392_1329_651820_4137_3708_5534 6 + 0.0315127145947645 0.314701637921065 6194 prochlorperazine hsa05320 Autoimmune thyroid disease 1081_3119_3105_3106_3107_3126_3127_3125_3135_3123_3113_649853 12 + 0.00272823098720566 0.0400140544790163 6195 prochlorperazine hsa04612 Antigen processing and presentation 6891_3119_3123_3106_3107_3126_3127_3125_3135_6890_3105_3310_3113_649853 14 + 0.0231822275978476 0.291433718372941 6196 prochlorperazine hsa04740 Olfactory transduction 5566_816 2 + 4.49613667897491e-11 3.95660027749792e-09 6197 prochlorperazine hsa04514 Cell adhesion molecules (CAMs) 9076_214_3383_3119_3123_3106_3107_3126_3127_3685_3125_3135_23308_3105_649853_25945_3113_1462 18 + 0.0429138597165088 0.314701637921065 6198 prochlorperazine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8348_8294_8343_8341_8347_8346_8344_3123_3126_3127_3125_92815_8370_718_717_8359_554313_121504_8339_3119_3113_8970 32 + 2.94895879010599e-06 0.000129754186764664 6199 prochlorperazine hsa05310 Asthma 3119_3123_3113_3127_3126_3125 6 + 0.0477220410131971 0.323041508397027 6200 prochlorperazine hsa05012 Parkinson's disease 6392_1329_651820_9246 4 + 0.034069527251966 0.314701637921065 6201 prochlorperazine hsa04060 Cytokine-cytokine receptor interaction 8744_8743_8742_8741_7852_9180_2323_3556_27242_10850_3576_3570_3572_970_4982_3976_8718_6362_3604_3953_3589_3624_3626_1956_5618_3566_1271_3569_6358_6359_7422 31 + 0.0421551284372565 0.314701637921065 6202 prochlorperazine hsa04912 GnRH signaling pathway 4214_1081_5578_5598_6655_1839_3708_108_1956_8681_5600_5603_3725_100137049_5566_816 16 + 0.0360978208164325 0.314701637921065 6203 prochlorperazine hsa05330 Allograft rejection 3119_3105_3106_3107_3126_3127_3125_3135_3123_3113_649853 11 + 0.00076769774928237 0.0168893504842121 6204 prochlorperazine hsa04940 Type I diabetes mellitus 3119_3105_3106_3107_3126_3127_3125_3135_3123_3113_649853 11 + 0.0020944221858189 0.0368618304704126 6205 prochlorperazine hsa04640 Hematopoietic cell lineage 3123_3554_3126_3127_3125 5 - 0.0387946885051656 0.38451690402786 6206 prochlorperazine hsa04080 Neuroactive ligand-receptor interaction 5029_4889_5618_152_64106_4886_5031_3351_9568_56288_2690_9170 12 - 9.37848485301536e-06 0.000436099545665214 6207 prochlorperazine hsa04742 Taste transduction 5613_5566 2 - 0.0413459036589097 0.38451690402786 6208 prochlorperazine hsa04740 Olfactory transduction 818_5613_5566_4991 4 - 4.5122010204958e-18 4.19634694906109e-16 6209 prochlorperazine hsa05322 Systemic lupus erythematosus 3123_3126_3127_3021_3125_8336_3014_3013_8351_3020 10 - 0.019586396603927 0.227691860520651 6210 prochlorperazine hsa05012 Parkinson's disease 7332_4712_7054_509_7419_539_291 7 - 0.00324140163277615 0.0502417253080303 6211 prochlorperazine hsa04260 Cardiac muscle contraction 4635_27092 2 - 0.00155541478879681 0.0361633938395258 6212 prochlorperazine hsa04060 Cytokine-cytokine receptor interaction 5618_3554_3597_3454_5155_8741_7852_657_355_7042_8792_4233_8795_2690 14 - 3.16661566390333e-05 0.000981650855810032 6213 prochlorperazine hsa03010 Ribosome 6129_6189_439992_6203 4 - 0.00300057413788618 0.0502417253080303 6214 prochlorperazine hsa04610 Complement and coagulation cascades 2161_7035 2 - 0.00683190180950414 0.0907666954691264 6215 phenformin hsa05016 Huntington's disease 4899_4713_7052_1639_581_163 6 + 0.0415726892713244 0.791440901949376 6216 phenformin hsa04740 Olfactory transduction 5566_1179_26476_8392_4991_810_816 7 + 7.49933508339158e-06 0.000622444811921501 6217 phenformin hsa04512 ECM-receptor interaction 1284_960_1301_2812_3691_2335_3679_3685_6383_1292_1291_3674_1280 13 + 0.0140299984315305 0.582244934908516 6218 phenformin hsa04010 MAPK signaling pathway 6722_4763_8681_3164_5609_11221_4908_5566_23162_2260_2247_100137049_776_2258_998_5532_7046_5534_7048_782_5599_1649_4137_7189_355_5871_27092_2257_7186 29 + 0.0476771627680347 0.791440901949376 6219 phenformin hsa05012 Parkinson's disease 2861_4713_5413 3 + 0.0255358178906574 0.706490961641521 6220 phenformin hsa04080 Neuroactive ligand-receptor interaction 151_2902_5618_64106_1241_7067_185_9568_5645 9 - 0.0420294603820271 0.73625945568804 6221 phenformin hsa04740 Olfactory transduction 26333_26212_26716 3 - 2.27944763760764e-08 2.07429735022295e-06 6222 phenformin hsa04062 Chemokine signaling pathway 5296_208_3576_6773_6363_4793 6 - 0.0414995287117465 0.73625945568804 6223 phenformin hsa05012 Parkinson's disease 1329_6622_291 3 - 0.0355952736815024 0.73625945568804 6224 phenformin hsa04260 Cardiac muscle contraction 1329 1 - 0.0434299839693696 0.73625945568804 6225 phenformin hsa04912 GnRH signaling pathway 5599_3725 2 - 0.0485445794959147 0.73625945568804 6226 Prestwick-967 hsa04080 Neuroactive ligand-receptor interaction 1081 1 + 0.0469392719776771 0.844906895598188 6227 Prestwick-967 hsa04740 Olfactory transduction 135948_157 2 + 0.0187247833201441 0.674092199525188 6228 Prestwick-967 hsa03450 Non-homologous end-joining 5591_27434 2 + 0.0457685390914507 0.844906895598188 6229 Prestwick-967 hsa04010 MAPK signaling pathway 1326_9064_783_5599_2317_5154_4791_8912_1616_5607_8986_5600_3304_5871_3303_4763 16 + 0.000532348130935253 0.0383290654273382 6230 Prestwick-967 hsa03020 RNA polymerase 246721_5439_548644 3 - 0.00411823661471148 0.156492991359036 6231 letrozole hsa05211 Renal cell carcinoma 2271_5594_6655_405_3845_7422_1398 7 + 0.0281388945474457 0.229767774616761 6232 letrozole hsa05200 Pathways in cancer 4089_9618_3326_3655_8324_5888_5925_405_5468_598_1017_9134_1398_999_5899_2956_2271_5594_6774_6655_6772_355_3845_7422_7184 25 + 0.00251733992651708 0.100277495668896 6233 letrozole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_6737_8359_8294_8367_554313_121504 15 + 0.000905437934796014 0.0742459106532731 6234 letrozole hsa05212 Pancreatic cancer 5594_9134_6655_5925_3845_3326_1017_7184 8 + 0.0287411112290508 0.229767774616761 6235 letrozole hsa04110 Cell cycle 995_5591_9134_996_4173_4089_699_5925_7027_7534_1017_4616 12 + 0.00366868886593522 0.100277495668896 6236 letrozole hsa05215 Prostate cancer 5594_9134_6655_5925_3845_3326_1017_7184 8 + 0.0272226801252821 0.229767774616761 6237 letrozole hsa05219 Bladder cancer 5594_999_5925_3845_7422_1890 6 + 0.00860911029259299 0.176486760998156 6238 letrozole hsa05216 Thyroid cancer 5468_3845_999_5594 4 + 0.0336245523829406 0.229767774616761 6239 letrozole hsa04115 p53 signaling pathway 5366_9134_4194_355_1017_8795_4616 7 + 0.023317865869724 0.229767774616761 6240 letrozole hsa04350 TGF-beta signaling pathway 5594_3397_4089_6667_9475_5519_7027_653 8 + 0.0257608579545053 0.229767774616761 6241 letrozole hsa05213 Endometrial cancer 2309_5594_6655_999_2002_3845 6 + 0.0208147221117118 0.229767774616761 6242 letrozole hsa05220 Chronic myeloid leukemia 5594_598_6655_1398_5925_3845_4089 7 + 0.0335945648937371 0.229767774616761 6243 letrozole hsa03010 Ribosome 6205_9045_6181_6157 4 - 0.0390127390293282 1 6244 letrozole hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0065673094738596 0.354634711588418 6245 gibberellic acid hsa05211 Renal cell carcinoma 405_6654_5594_7042 4 + 0.0304725656438334 0.427161868233444 6246 gibberellic acid hsa04910 Insulin signaling pathway 5594_6654_867_8660_23265_5140 6 + 0.024819330152473 0.427161868233444 6247 gibberellic acid hsa04062 Chemokine signaling pathway 7454_5594_156_5829_6654_2788_3718_2931 8 + 0.0131762916947962 0.408465042538682 6248 gibberellic acid hsa04010 MAPK signaling pathway 1432_5594_2318_6654_4763_23162_2249_7042_3164_4791_5536 11 + 0.00477035197420553 0.295761822400743 6249 gibberellic acid hsa05220 Chronic myeloid leukemia 6654_5594_867_7042 4 + 0.0344485377607616 0.427161868233444 6250 gibberellic acid hsa03010 Ribosome 9045_6205_284393_389342_6181 5 - 0.0180076366756275 0.986530062436346 6251 apramycin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504 14 + 2.77809829057715e-12 7.50086538455831e-11 6252 apramycin hsa04540 Gap junction 7278_113457_2776_3708_115_5607_3845 7 - 0.00335821444194825 0.21156750984274 6253 tocainide hsa04080 Neuroactive ligand-receptor interaction 1269_56288 2 + 0.0134748328536113 0.525518481290841 6254 tocainide hsa04740 Olfactory transduction 51806_5616_5613 3 + 0.00144671931698494 0.112844106724825 6255 tocainide hsa03010 Ribosome 140801_6205_9045 3 - 0.0246066096960815 0.393705755137304 6256 tocainide hsa03020 RNA polymerase 246721_5439_548644_661 4 - 4.11109705304503e-05 0.00131555105697441 6257 Prestwick-984 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 6.92239688480881e-10 2.42283890968308e-08 6258 Prestwick-984 hsa04740 Olfactory transduction 109 1 - 0.0318185494865763 1 6259 zuclopenthixol hsa05332 Graft-versus-host disease 3553_3105_3106_3126_3127_3125_3135_355_3123_649853 10 + 0.00159916211687571 0.0496981428140726 6260 zuclopenthixol hsa04640 Hematopoietic cell lineage 966_960_3553_3815_3123_3126_3127_3125_3566_7066_3570_3589_915_3655 14 + 0.00649287019769573 0.0934652162045493 6261 zuclopenthixol hsa04080 Neuroactive ligand-receptor interaction 2911_2555_1081_624_2150_9568_2149 7 + 0.00735446265755562 0.0934652162045493 6262 zuclopenthixol hsa05320 Autoimmune thyroid disease 3448_1081_3105_3106_3126_3127_3125_3135_355_3123_649853 11 + 0.00245353990726023 0.0496981428140726 6263 zuclopenthixol hsa04612 Antigen processing and presentation 4800_3448_3123_3106_3126_3127_3125_3135_6890_3326_3105_567_649853 13 + 0.0226923382045433 0.201961810020435 6264 zuclopenthixol hsa05131 Shigellosis 7454_7280_347733_5578_999_9475_7430_9181_6093_2534 10 + 0.00945153871731397 0.0934652162045493 6265 zuclopenthixol hsa04910 Insulin signaling pathway 8660_2308_5602 3 + 0.0361205896021923 0.292248406781374 6266 zuclopenthixol hsa05130 Pathogenic Escherichia coli infection 7454_7280_347733_5578_999_9475_7430_9181_6093_2534 10 + 0.00945153871731397 0.0934652162045493 6267 zuclopenthixol hsa05012 Parkinson's disease 6622 1 + 0.00233014197049141 0.0496981428140726 6268 zuclopenthixol hsa04260 Cardiac muscle contraction 4635 1 + 0.0433886969743432 0.321799502559712 6269 zuclopenthixol hsa05330 Allograft rejection 3105_3106_3126_3127_3125_3135_355_3123_649853 9 + 0.00279203049517262 0.0496981428140726 6270 zuclopenthixol hsa04940 Type I diabetes mellitus 3382_3105_3106_3126_3127_3125_3135_355_3123_3553_649853 11 + 0.000670707514293372 0.0496981428140726 6271 zuclopenthixol hsa05131 Shigellosis 7278_7430_113457 3 - 0.00761324880546874 0.0456794928328124 6272 zuclopenthixol hsa05130 Pathogenic Escherichia coli infection 7278_7430_113457 3 - 0.00761324880546874 0.0456794928328124 6273 zuclopenthixol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504 14 - 2.25560339090219e-12 5.41344813816526e-11 6274 zuclopenthixol hsa03010 Ribosome 6181_6169_6205_9045_439992_6157_6189 7 - 8.91489605525038e-06 0.000106978752663005 6275 fursultiamine hsa04062 Chemokine signaling pathway 2931 1 + 0.0466265287661826 1 6276 fursultiamine hsa04740 Olfactory transduction 157 1 - 0.0155732280236746 0.451944340129336 6277 fursultiamine hsa04010 MAPK signaling pathway 784_2122_4149_6655_50487_8681_7042_7786_2260_100137049 10 - 0.0324942944255668 0.53762905376263 6278 fursultiamine hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0177233074560524 0.451944340129336 6279 tracazolate hsa04740 Olfactory transduction 816 1 + 0.0110987502387991 0.732517515760741 6280 tracazolate hsa04080 Neuroactive ligand-receptor interaction 4886 1 - 0.000116171157408057 0.00964220606486873 6281 tracazolate hsa05012 Parkinson's disease 4712 1 - 0.021934576259444 0.874814788284091 6282 pinacidil hsa04740 Olfactory transduction 810_219464_26529_135948_8392 5 + 0.000884886158753171 0.0654815757477347 6283 pinacidil hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_8294_8367_554313_121504 15 + 0.00440750023694511 0.163077508766969 6284 pinacidil hsa04080 Neuroactive ligand-receptor interaction 1241 1 - 0.0476055344379078 0.690280249349663 6285 pinacidil hsa05200 Pathways in cancer 5599_6932 2 - 0.0359874682214292 0.690280249349663 6286 pinacidil hsa04664 Fc epsilon RI signaling pathway 50487_5599_5163_5608_9846 5 - 0.0369267639576787 0.690280249349663 6287 pinacidil hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0322715987469276 0.690280249349663 6288 azapropazone hsa04740 Olfactory transduction 5566_26212_409 3 + 0.0371610148554953 1 6289 azapropazone hsa04270 Vascular smooth muscle contraction 2983_5566_9475_5605_3709_1909_800 7 + 0.0259843304251539 1 6290 azapropazone hsa04110 Cell cycle 472_4089_9134_8556_4173 5 - 0.0315741160410999 0.655261661598294 6291 azapropazone hsa04920 Adipocytokine signaling pathway 3953_8660_5105_8717 4 - 0.0181704834100123 0.655261661598294 6292 azapropazone hsa04350 TGF-beta signaling pathway 4089_9372_7059_3624 4 - 0.040323794559895 0.655261661598294 6293 azapropazone hsa04512 ECM-receptor interaction 3655_7059_1605_3675 4 - 0.0363287495699973 0.655261661598294 6294 isocarboxazid hsa05322 Systemic lupus erythematosus 55506_85235_8969_8332_8330_8331_8336_8329 8 - 0.000243578195916204 0.0138839571672236 6295 dicoumarol hsa05010 Alzheimer's disease 3553_3710_489 3 + 0.0192404026536677 0.399238355063605 6296 dicoumarol hsa05016 Huntington's disease 6667 1 + 0.000523049791578421 0.0144710442336696 6297 dicoumarol hsa04740 Olfactory transduction 26476_5616_5593 3 + 1.05116829532679e-06 4.36234842560618e-05 6298 dicoumarol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_88_8294_121504_8968_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113 28 + 1.81819577297085e-07 1.50910249156581e-05 6299 dicoumarol hsa04070 Phosphatidylinositol signaling system 5331_810_5333_8394_5578 5 - 0.0495810977112577 0.343849897688237 6300 dicoumarol hsa04740 Olfactory transduction 810 1 - 0.00117446506855832 0.0369956496595871 6301 dicoumarol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 3.50389406939767e-05 0.00220745326372053 6302 dicoumarol hsa04210 Apoptosis 3556_581_472_5534_8837_823 6 - 0.0298740121609408 0.271505851204046 6303 dicoumarol hsa04720 Long-term potentiation 5578_2776_5331_5534_810_814 6 - 0.0147853629423162 0.23286946634148 6304 dicoumarol hsa04020 Calcium signaling pathway 5331_5578_56848_5534_2776_115_5333_1909_810_814 10 - 0.0295048353338982 0.271505851204046 6305 dicoumarol hsa04912 GnRH signaling pathway 5331_2002_5578_5599_998_2776_115_810_10746 9 - 0.00239342956695644 0.0502620209060852 6306 dicoumarol hsa02010 ABC transporters 8714_20_5243_5244 4 - 0.0301673168004496 0.271505851204046 6307 H-7 hsa04740 Olfactory transduction 8392_801_808_805_816 5 + 9.1947712520733e-07 7.63166013922084e-05 6308 H-7 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8290_8329_8294_8969_8370_8332_8359_8330_8331_8336_8335_121504_85235_3119_941 25 + 9.69064630142666e-05 0.00402161821509206 6309 H-7 hsa04360 Axon guidance 64221_9037_5063 3 + 0.0491960784493808 0.931385185356822 6310 H-7 hsa05219 Bladder cancer 23604_7157_3576_7057_4193_5605_1956 7 + 0.0372423374553499 0.931385185356822 6311 H-7 hsa04916 Melanogenesis 112_115_5330_7855_1906_8324_8321_8322_818_1856_1857_10488_2033_7475_816_7477_3815_51384_2932_11211_6934_107_5605_5594_3845_1385_1387_2535 28 - 0.0108086231779606 0.0483814561299189 6312 H-7 hsa04650 Natural killer cell mediated cytotoxicity 8503_2185_5296_5294_5295_5533_5290_5291_5605_10451_6452_5335_5336_836_3105_11261_3459_4776_7410_80328_4277_4276_10725_673_3135_4775_4772_3133_8795_5777_1437_5594_3460_6655_6654_6464_27040_5881_356_355_3845_7409_3106 43 - 0.0292220522277188 0.0915624303135189 6313 H-7 hsa04640 Hematopoietic cell lineage 3570_3655_3675_3554_3553_3552_2057_3690_3123_3126_3127_3125_3581_3815_3589_960_1437_1435_3566_1604_2209_925 22 - 0.0124841757584227 0.0510222835344232 6314 H-7 hsa03320 PPAR signaling pathway 79966_2710_5170_7316_11001_2182_2181_1375_9415_5467_6257_6256_8309 13 - 0.00129586903600975 0.00716539349323038 6315 H-7 hsa05010 Alzheimer's disease 55851_2597_3710_317_9451_5663_5330_7132_1327_3553_4728_4698_11261_509_776_8772_2932_5533_3708_3709_6868_489_836_4714_5594_841_4713_642502_6391_355_351_8851 32 - 1.07934646529904e-07 2.0291713547622e-06 6316 H-7 hsa04080 Neuroactive ligand-receptor interaction 5029_2901_152_2908_2925_5030_5031_56288_136_135_134_6870_1813_5724_7434_2150_2151_4987_7433_9568_4988_7068_1909_4889_2917_3953_1131_4886_6915_146_5732_8001_9170_5618_7442_3354_7067_2897_6751_2893_6755_1241_2798_728_2690 45 - 5.83610993089602e-11 2.74297166752113e-09 6317 H-7 hsa04742 Taste transduction 6340_3710_5330_51764_112_6338 6 - 0.00013178279883383 0.00112614391730727 6318 H-7 hsa04612 Antigen processing and presentation 3326_8625_6891_3308_3306_3304_3305_3303_4800_4801_4802_3123_3106_3126_3127_3125_811_3135_3133_3312_3119_3111_3105_1385_925_649853 26 - 0.0435161059633759 0.123954968501737 6319 H-7 hsa04670 Leukocyte transendothelial migration 8503_5296_2909_394_5290_9475_7852_6387_5335_5336_26285_24146_87_7410_7430_5294_5295_5747_9080_1495_2185_6093_5291_60_1432_10451_27035_1536_1364_1365_7409_88 32 - 0.00386220225654774 0.0201692784508604 6320 H-7 hsa04614 Renin-angiotensin system 1215 1 - 0.0192654685984751 0.0646769302948807 6321 H-7 hsa05016 Huntington's disease 4899_1327_317_246721_5330_23186_3064_6874_10126_6908_5432_5433_5430_836_4728_5434_7052_1639_5439_10488_2033_509_1213_581_55567_3708_548644_161_5481_163_4714_27113_841_4713_642502_6391_7157_5978_4698_1385_1387_9519 42 - 7.77272695752243e-06 8.11818148896787e-05 6322 H-7 hsa04740 Olfactory transduction 818_7932_157_816 4 - 1.07348904236821e-57 1.00907969982612e-55 6323 H-7 hsa04514 Cell adhesion molecules (CAMs) 2734_214_23308_3655_9019_24146_3123_3106_3126_3127_3696_3125_5817_25945_9080_3135_3133_26285_6402_965_4685_3119_3111_1364_1365_5792_3105_6693_923_925_26047_649853 32 - 0.000530527617947989 0.00383612277593161 6324 H-7 hsa04510 Focal adhesion 8503_5170_10000_10298_1302_596_5296_2909_394_5155_5154_5290_9475_60_5881_5747_7791_3655_4659_6714_22798_5728_7059_5063_3690_7057_3696_56924_7410_23396_331_1399_1398_1293_55742_3675_5294_87_5295_3912_896_3910_3480_29780_2932_329_3909_1956_3725_6093_5291_1290_5228_5594_1729_2316_2317_6655_6654_6464_10451_7409_7422_88_673_3911_83660 67 - 0.0146964438601639 0.0552586289142163 6325 H-7 hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8360_8368_6737_88_8362_8294_121504_87_8345_3123_8366_3126_3127_3125_8968_55766_8370_718_717_8358_8359_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_3119_83740_3013_3014_2209_8970_3111_729 46 - 0.0334470673898322 0.101420139827233 6326 H-7 hsa05340 Primary immunodeficiency 64421_8625_925_6891_100_29760 6 - 0.0183902363896227 0.0640252674305383 6327 H-7 hsa04140 Regulation of autophagy 5289_64422_9474_8408_5562_23710 6 - 0.0183902363896227 0.0640252674305383 6328 H-7 hsa04530 Tight junction 10000_93643_6709_88_64398_56288_9223_87_24146_5728_5583_5580_5581_5515_2036_51776_5865_2017_55844_8777_9080_5518_4624_1495_4628_6714_26285_60_5520_7082_8189_10207_1364_1457_3845_7525_6237_1459_27134_1365 40 - 0.0113428638335432 0.0484649636524119 6329 H-7 hsa04720 Long-term potentiation 5533_3710_814_11261_673_818_5330_3708_3709_2033_5594_3845_5605_1387_4659_107_816_468 18 - 0.0131631962044074 0.0515558518005956 6330 H-7 hsa05110 Vibrio cholerae infection 60_7082_8992_5336_115_526_5335_523_23545 9 - 0.000897589148187905 0.00602666999497593 6331 H-7 hsa04512 ECM-receptor interaction 7059_960_22798_1302_3910_3690_3912_3911_3909_3696_7057_961_1293_3655_1290_3339_3675 17 - 0.0011545796111032 0.0067831552152313 6332 H-7 hsa04062 Chemokine signaling pathway 3717_6777_10000_157_156_5296_5294_5747_8503_5290_9475_115_5330_10451_56288_10235_112_2309_7454_3551_7410_1399_1398_5580_5295_2932_673_729230_2185_6093_5291_107_4792_4793_7852_5594_6655_6654_6464_6387_6772_2783_51764_3845_7409_5970_8976 47 - 4.34723209594352e-05 0.000408639817018691 6333 H-7 hsa04810 Regulation of actin cytoskeleton 8503_10298_5296_10672_2909_5295_5155_5154_5290_9475_5605_5881_23396_5747_3655_10458_4659_87_3675_7454_3985_3690_1445_3696_56924_8396_7410_8826_7430_1399_1398_2245_2260_28964_5294_2264_10152_200576_324_5063_8394_1131_673_3984_1956_23191_2263_4628_6093_5291_5962_8874_10093_60_10451_5594_1729_6655_6654_5305_8817_8936_3845_54434_88_2257_7409_6237_8976_2250 70 - 0.00853975671194651 0.0422493226801564 6334 H-7 hsa04540 Gap junction 7280_3710_983_5155_113457_5605_5330_5607_10381_112_347733_1813_2767_5154_3708_1956_6714_107_115_7082_5594_5598_7278_6654_3709_3845_1453_6655 28 - 0.0495197296650335 0.134587863743062 6335 H-7 hsa05012 Parkinson's disease 4714_2861_7326_4698_836_1327_4713_7314_6391_317_7054_4728_509_5481_642502 15 - 4.99868319724922e-10 1.56625406847142e-08 6336 H-7 hsa04260 Cardiac muscle contraction 776_1327_782_783_7139_4624_4635_7171_481 9 - 1.33051591767568e-06 2.0552770196598e-05 6337 H-7 hsa04060 Cytokine-cytokine receptor interaction 3594_8744_5155_5154_7852_6387_9180_1896_7132_3556_3554_3553_3552_2057_3459_3953_3570_3572_657_655_3977_7040_23529_3581_3601_3815_3588_3589_23765_8771_3625_4055_1956_729230_91_90_8792_92_7048_3467_1437_5618_1435_3566_3460_356_355_50616_7422_8795_83729_51330_2690 53 - 3.94160862526241e-09 9.26278026936666e-08 6338 H-7 hsa03010 Ribosome 6204_440589_6139_6165_6137_6187_6168_6141_6234_9349_6158_6160_6129_6233 14 - 1.60052137409896e-06 2.0552770196598e-05 6339 H-7 hsa04020 Calcium signaling pathway 3710_5336_2925_489_115_7220_5333_5335_136_135_1909_9630_490_491_6870_11261_5724_3707_818_493_814_56848_816_146_776_1131_2767_5533_6915_3708_1956_2185_107_5481_8877_5330_8912_3709 38 - 1.74917193162536e-06 2.0552770196598e-05 6340 H-7 hsa03050 Proteasome 23198_5719_5689_5709_5702 5 - 0.000276776287418959 0.00216808091811518 6341 H-7 hsa04730 Long-term depression 5515_5319_2781_3710_5518_10672_50487_2767_673_5605_5330_3708_3709_8681_3845_3480_8398_100137049_5594 19 - 0.0396687387960494 0.116526920213395 6342 H-7 hsa04270 Vascular smooth muscle contraction 3710_10672_50487_9475_115_5330_8681_4637_136_135_112_4659_5319_5583_5580_5581_100137049_146_776_8398_4882_2767_673_3708_9826_6093_107_5605_5594_27094_3709_800_1909 33 - 0.0104764970244287 0.0483814561299189 6343 H-7 hsa02010 ABC transporters 6833_23461_5826_19_5244_5243_9619_6891_10057 9 - 0.0253087547120401 0.0820352738941989 6344 H-7 hsa04610 Complement and coagulation cascades 718_717_629_7056_1604_2_7035_2152_2153_729_728_5329 12 - 0.00103742408080326 0.0065011909063671 6345 PF-00539745-00 hsa04740 Olfactory transduction 26212 1 + 1.11326742453151e-06 8.68348591134578e-05 6346 PF-00539745-00 hsa05120 Epithelial cell signaling in Helicobacter pylori infection 3579_535_525_10392_5781_102_3725 7 + 0.0479462111713006 1 6347 PF-00539745-00 hsa04740 Olfactory transduction 5568_442194_4991 3 - 0.000505802460267366 0.0197262959504273 6348 PF-00539745-00 hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8370_83740_8368_8366_3111_8360_8359_88_8362_8294_8367_554313_121504_6737 20 - 2.75894016256874e-06 0.000215197332680362 6349 PF-00875133-00 hsa05211 Renal cell carcinoma 10000 1 + 0.0289850382990122 0.425113895052179 6350 PF-00875133-00 hsa05010 Alzheimer's disease 779_355_836_348_4698 5 + 0.00532822534009475 0.234441914964169 6351 PF-00875133-00 hsa04670 Leukocyte transendothelial migration 7412_1364_3688 3 + 0.0180807736444354 0.397777020177579 6352 PF-00875133-00 hsa05016 Huntington's disease 246721_1211_836_7052_4698_9001_1385_5468 8 + 0.0443657538687127 0.453109317370181 6353 PF-00875133-00 hsa04740 Olfactory transduction 5137_109_7932_816 4 + 7.03926335948907e-10 6.19455175635038e-08 6354 PF-00875133-00 hsa04350 TGF-beta signaling pathway 10637_4088 2 + 0.0463407256401321 0.453109317370181 6355 PF-00875133-00 hsa04062 Chemokine signaling pathway 2785_10000_156_3577_2931_51764_109_10235 8 + 0.0343053723195194 0.431267537731101 6356 PF-00875133-00 hsa05012 Parkinson's disease 4698_7327_836_5413 4 + 0.0254176405702272 0.425113895052179 6357 PF-00875133-00 hsa03010 Ribosome 6165_9045 2 + 0.0165515115132361 0.397777020177579 6358 PF-00875133-00 hsa04612 Antigen processing and presentation 3106 1 - 0.00200330577115526 0.0607669417250429 6359 PF-00875133-00 hsa04740 Olfactory transduction 51806_157_5616_818_2978_9635_816 7 - 8.82744078745099e-11 8.0329711165804e-09 6360 PF-00875133-00 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8342_81_8347_8346_8345_8344_8969_55766_8370_718_8332_8359_8330_8331_8336_554313_121504_8339_85235_3017_729 33 - 0.0003252445765157 0.0147986282314644 6361 PF-00875133-00 hsa04710 Circadian rhythm - mammal 8864_5187_406_1408_4862_8863 6 - 0.00820059952924672 0.186563639290363 6362 PF-00875133-00 hsa05012 Parkinson's disease 4714_2861_4713_4698_317_6622 6 - 0.022412264083952 0.339919338606605 6363 PF-00875133-00 hsa04260 Cardiac muscle contraction 7139_782_4635 3 - 0.044756742779055 0.577559620890942 6364 PF-00875133-00 hsa03010 Ribosome 6234_6141_6203 3 - 0.0124627279423336 0.226821648550472 6365 pioglitazone hsa03320 PPAR signaling pathway 5465_1593 2 + 0.00685165453276205 0.127440774309374 6366 pioglitazone hsa05010 Alzheimer's disease 836_842_11261_2081_317_2776_5533_3708_3709_351_4842 11 + 0.00362891137034239 0.0843721893604606 6367 pioglitazone hsa04080 Neuroactive ligand-receptor interaction 1269_22953_1813_64106_3360_1131_5032_6915_56288_7067_135_7433 12 + 9.28710592877295e-06 0.000431850425687942 6368 pioglitazone hsa05016 Huntington's disease 5432_7419_6648_842_836_317_6667_2776_3708_5978_55567_1385_1387_161 14 + 0.0132648792524788 0.205605628413421 6369 pioglitazone hsa04740 Olfactory transduction 818_157_1258_816_390892 5 + 7.35910565190317e-17 6.84396825626995e-15 6370 pioglitazone hsa05012 Parkinson's disease 836_7419_317_842 4 + 9.19033727561207e-05 0.00284900455543974 6371 pioglitazone hsa04260 Cardiac muscle contraction 782_6262_781_4635 4 + 0.0217350170033492 0.288765225901639 6372 pioglitazone hsa03010 Ribosome 440589_140801_6187_6181_6234_6165 6 + 0.0272060365873384 0.316270175327809 6373 pioglitazone hsa05016 Huntington's disease 1175_7802_627_5434_581_6392_651820_6390_317_2776_5331_3708_7416_163 14 - 0.00359550704590305 0.0826966620557701 6374 pioglitazone hsa03420 Nucleotide excision repair 5887 1 - 0.0260322394734321 0.399161005259292 6375 pioglitazone hsa04740 Olfactory transduction 26211_5568_157_393046_442194_26716_2978_808_805_4991_801_26529_9635_816 14 - 6.437277891602e-12 5.92229566027384e-10 6376 pioglitazone hsa05322 Systemic lupus erythematosus 2903_8361_8363_8362_8365_8364_8367_8360_8368_554313_88_8294_121504_958_6737_8366_8968_8370_8358_8359_8337_8335_8350_8351_8352_8353_8354_8355_8356_8357_3012_3013_3111_8970 34 - 0.0367246080579785 0.482666277333432 6377 pioglitazone hsa05012 Parkinson's disease 6392_651820_6390_317_7416_6531_9627 7 - 0.000870485278732473 0.0400423228216938 6378 pioglitazone hsa04260 Cardiac muscle contraction 784_6262_10368 3 - 0.00256680999008135 0.0787155063624947 6379 pioglitazone hsa03050 Proteasome 5702 1 - 0.0112005746695179 0.206090573919129 6380 proxyphylline hsa04740 Olfactory transduction 5137_81797 2 + 0.000184127996681809 0.0139937277478175 6381 proxyphylline hsa04080 Neuroactive ligand-receptor interaction 7067_2901_2150 3 - 0.00273739115359918 0.110864341720767 6382 proxyphylline hsa04740 Olfactory transduction 109 1 - 1.53469045410092e-07 1.24309926782175e-05 6383 proxyphylline hsa05322 Systemic lupus erythematosus 8351_3013 2 - 0.0492041810367769 0.878717000571125 6384 proxyphylline hsa04020 Calcium signaling pathway 109_6262_5534 3 - 0.0364893051660468 0.878717000571125 6385 homochlorcyclizine hsa04740 Olfactory transduction 815_442194 2 + 0.0022865164297535 0.0846011079008795 6386 homochlorcyclizine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3113_8359_8294_8367_554313_8970_121504 16 + 7.81551209366443e-06 0.000578347894931168 6387 homochlorcyclizine hsa04010 MAPK signaling pathway 785_2318_6655_4915_1846_4791_8912_8913_5322_5534_3310_5971_2247_9020 14 + 0.0400694168811504 0.988378949735043 6388 homochlorcyclizine hsa04740 Olfactory transduction 818_5613 2 - 0.00112123119871375 0.0863348023009587 6389 homochlorcyclizine hsa05322 Systemic lupus erythematosus 85235_3013_8330_8332_8969_8331_8329_8351_8336 9 - 0.0467033363632939 0.599359483328938 6390 homochlorcyclizine hsa05221 Acute myeloid leukemia 1050_2475_6777_6199_6934 5 - 0.0396262494095866 0.599359483328938 6391 homochlorcyclizine hsa04540 Gap junction 5613_7278_2767_113457_5331_2697_107 7 - 0.0277952105727837 0.535057803526086 6392 homochlorcyclizine hsa04060 Cytokine-cytokine receptor interaction 3556 1 - 0.00800501143625471 0.308192940295806 6393 homochlorcyclizine hsa04912 GnRH signaling pathway 5331_2002_5613_2767_5608_818_5603_107 8 - 0.0209426731134805 0.535057803526086 6394 chlorogenic acid hsa04740 Olfactory transduction 157 1 - 0.0455978363991259 1 6395 betulinic acid hsa04120 Ubiquitin mediated proteolysis 4193 1 + 0.00494730395816855 0.13687540950933 6396 betulinic acid hsa05010 Alzheimer's disease 6868_4695_3708_6622 4 + 0.0352944525845467 0.585887912903475 6397 betulinic acid hsa04740 Olfactory transduction 26211_5593_8390_5566_26692 5 + 1.09081826008282e-05 0.000905379155868741 6398 betulinic acid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8341_3126_8370_8359_554313_121504_3119_2215_2214_3117_3113_8970 22 + 0.000234327314345428 0.00972458354533526 6399 betulinic acid hsa05310 Asthma 3117_3113_3126_3119_3565 5 + 0.0465215815925046 0.64354854536298 6400 betulinic acid hsa05012 Parkinson's disease 4695_6622 2 + 0.024863188378644 0.515911158856863 6401 betulinic acid hsa05332 Graft-versus-host disease 3107_5551 2 - 0.0273294007171093 0.248594488189693 6402 betulinic acid hsa05320 Autoimmune thyroid disease 3107_5551 2 - 0.0411842353236052 0.258872336319804 6403 betulinic acid hsa04930 Type II diabetes mellitus 5581_5602 2 - 0.030883011872681 0.248594488189693 6404 betulinic acid hsa04912 GnRH signaling pathway 3708_23236_5602 3 - 0.0271984077686005 0.248594488189693 6405 betulinic acid hsa05330 Allograft rejection 3107_5551 2 - 0.0228719552036909 0.248594488189693 6406 betulinic acid hsa04270 Vascular smooth muscle contraction 3708_23236_5581 3 - 0.0338992483895036 0.248594488189693 6407 betulinic acid hsa04940 Type I diabetes mellitus 3107_5551 2 - 0.0296789557373416 0.248594488189693 6408 amantadine hsa04740 Olfactory transduction 818_393046_1179_157 4 + 0.00118063170230003 0.0956311678863024 6409 amantadine hsa05322 Systemic lupus erythematosus 3119_3013_940_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 13 + 0.0105118256658506 0.425728939466949 6410 amantadine hsa03450 Non-homologous end-joining 27343_2547_3981 3 + 0.027010519777622 0.729284033995794 6411 amantadine hsa04930 Type II diabetes mellitus 8651_8660 2 - 0.0487972948957775 1 6412 primaquine hsa05332 Graft-versus-host disease 3123_355_3126_3127_3125 5 + 0.0281358782532307 0.317270914457963 6413 primaquine hsa04640 Hematopoietic cell lineage 960_2812_3690_3123_3568_3126_3127_3125 8 + 0.0231969273203208 0.317270914457963 6414 primaquine hsa05010 Alzheimer's disease 355 1 + 0.0236012620406186 0.317270914457963 6415 primaquine hsa05016 Huntington's disease 1212_246721 2 + 0.0499901759588151 0.367502099870577 6416 primaquine hsa04740 Olfactory transduction 23538_1179 2 + 8.79938194105053e-05 0.00321177440848344 6417 primaquine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3123_8335_3126_3127_3125_8359_8294_8367_554313_8368_121504_8354 20 + 2.27628347175736e-06 0.000166168693438287 6418 primaquine hsa05310 Asthma 3123_3126_3127_3125 4 + 0.0347694152830644 0.317270914457963 6419 primaquine hsa05330 Allograft rejection 3123_355_3126_3127_3125 5 + 0.0198693069303086 0.317270914457963 6420 primaquine hsa04940 Type I diabetes mellitus 3123_355_3126_3127_3125 5 + 0.0329777162281873 0.317270914457963 6421 primaquine hsa04640 Hematopoietic cell lineage 3673_960_3566_3552 4 - 0.000869637937004286 0.0114295271720563 6422 primaquine hsa05010 Alzheimer's disease 776_5594_842_351_2776_4137_5663_3709_23385_489_509_5332_22926_801_23236_808_805_3710 18 - 0.00762720967266499 0.0701703289885179 6423 primaquine hsa04080 Neuroactive ligand-receptor interaction 5029_5618_7442_4157_7068_7067_1131_5025_4886_3354_1909_2690_9170 13 - 1.69443985166631e-08 5.19628221177668e-07 6424 primaquine hsa05016 Huntington's disease 4899_6874_842_5978_1639_64764_5439_246721_2776_3092_1387_2033_23186_509_5332_1385_548644_23236 18 - 0.00285121346098587 0.0327889548013375 6425 primaquine hsa04740 Olfactory transduction 157_5613_5616_808_409_801_805 7 - 2.78982725892291e-21 2.56664107820908e-19 6426 primaquine hsa04514 Cell adhesion molecules (CAMs) 2734_4685_3108_999_3106_3107_4897_4756_3135_5819_1365_5792_3105_9019_5817 15 - 0.0434125514871747 0.330692729252221 6427 primaquine hsa05310 Asthma 3108 1 - 0.0497571377928726 0.330692729252221 6428 primaquine hsa05012 Parkinson's disease 2861_7327_51465_842_509 5 - 4.38088867144119e-06 0.000100760439443147 6429 primaquine hsa04260 Cardiac muscle contraction 476_7171_776_10479_27092 5 - 0.00516611397369862 0.0528091650644748 6430 primaquine hsa04060 Cytokine-cytokine receptor interaction 5618_3566_3552_3460_3459_5154_3572_6387_4982_90_2690_659 12 - 1.79159500773087e-09 8.241337035562e-08 6431 primaquine hsa03010 Ribosome 6187_6234_440589 3 - 2.44865270625133e-05 0.000450552097950245 6432 primaquine hsa04020 Calcium signaling pathway 3709_776_3710_5025_5613_1131_5336_5616_2776_115_808_489_1909_5332_801_23236_490_3707_805_493 20 - 0.0122115847343869 0.102133254142145 6433 primaquine hsa04610 Complement and coagulation cascades 7035 1 - 0.000113857849118892 0.00174582035315634 6434 naringenin hsa05010 Alzheimer's disease 3708_776_355_489 4 + 0.00732478267754308 0.123056348982724 6435 naringenin hsa04660 T cell receptor signaling pathway 5163_4772 2 + 0.0239928223502155 0.287913868202586 6436 naringenin hsa05016 Huntington's disease 7052_246721_3708 3 + 0.00127435839950524 0.0356820351861467 6437 naringenin hsa04740 Olfactory transduction 26211_7932_5613_5566_5616_4991_816 7 + 3.68956995328964e-06 0.00030992387607633 6438 naringenin hsa04510 Focal adhesion 596_5829_2317_2324_3685_1277_3690 7 + 0.0387184099340358 0.325234643445901 6439 naringenin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3109_8969_8370_8332_8359_8330_8331_8336_554313_6738_121504_85235_3113 24 + 0.000571884188637661 0.0240191359227818 6440 naringenin hsa05212 Pancreatic cancer 596 1 + 0.0205936799688781 0.287913868202586 6441 naringenin hsa05215 Prostate cancer 596 1 + 0.031497061770906 0.293972576528456 6442 naringenin hsa05012 Parkinson's disease 6570_9627 2 + 0.0060387952410377 0.123056348982724 6443 naringenin hsa04620 Toll-like receptor signaling pathway 9641_7187 2 + 0.0482289063324061 0.368293466538374 6444 naringenin hsa04260 Cardiac muscle contraction 776 1 + 0.0297557247883734 0.293972576528456 6445 naringenin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 1.8595933224075e-09 9.85584460875975e-08 6446 naringenin hsa04210 Apoptosis 472_8837_651610_5534 4 - 0.0195982866465268 0.25967729806648 6447 naringenin hsa04115 p53 signaling pathway 472_651610_3732_4193 4 - 0.00863813824129745 0.152607108929588 6448 naringenin hsa03020 RNA polymerase 246721_5439_548644 3 - 0.00519340254704827 0.137625167496779 6449 meclocycline hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8359_8370_8294_554313_121504 14 + 1.87013249748801e-11 6.91949024070564e-10 6450 carteolol hsa04740 Olfactory transduction 26211_7932_23538_816_810_409 6 + 2.04684599984071e-08 1.82169293985823e-06 6451 carteolol hsa04110 Cell cycle 472_8555 2 + 0.00601741927226086 0.198905773409263 6452 carteolol hsa04370 VEGF signaling pathway 5880 1 + 0.0199618269947896 0.355320520507255 6453 carteolol hsa05012 Parkinson's disease 6392_1339_651820 3 + 0.00670468899132346 0.198905773409263 6454 carteolol hsa03010 Ribosome 140801_6165 2 + 0.016697471952337 0.355320520507255 6455 carteolol hsa05211 Renal cell carcinoma 2271_5594_208_6655_405_5781_4233 7 - 0.00531009881532923 0.392947312334363 6456 carteolol hsa04660 T cell receptor signaling pathway 5594_208_6655_867_5534_925_4793 7 - 0.0386734357973202 0.698911651056091 6457 carteolol hsa04210 Apoptosis 3556_3553_841_208_5534_598 6 - 0.0430519042128922 0.698911651056091 6458 carteolol hsa05220 Chronic myeloid leukemia 5594_598_6655_867_5781_208 6 - 0.0218547360500231 0.698911651056091 6459 digitoxigenin hsa05211 Renal cell carcinoma 8503_6654_2271_5594_208_6655_7042_201163_405_2033_1398_10000_1387_3725_3082 15 + 0.00444453547139469 0.0782238242965465 6460 digitoxigenin hsa04080 Neuroactive ligand-receptor interaction 1081_7068_2908_4886_2150_5644 6 + 0.000121455753919716 0.00356270211497834 6461 digitoxigenin hsa05016 Huntington's disease 1213_4713_1639_3708_2033_23186_509_1387 8 + 0.034192976295469 0.334331323777919 6462 digitoxigenin hsa04740 Olfactory transduction 26212_5568 2 + 3.74157373450308e-12 3.29258488636271e-10 6463 digitoxigenin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8349_8329_8294_121504_8343_8347_8346_8345_8344_8339_723790_8969_8968_8370_92815_8358_8359_8330_8331_8336_8337_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3012_3013 44 + 6.38946433179418e-11 2.81136430598944e-09 6464 digitoxigenin hsa04350 TGF-beta signaling pathway 4092_4088_92_1634_5594_3397_3399_3398_7057_5519_3400_4090_2033_7042_6198_1387_5515 17 + 0.00536064709610478 0.0786228240762034 6465 digitoxigenin hsa04010 MAPK signaling pathway 10000_8649_5534_6722_4763_5494_5495_3164_5609_11221_4616_5568_1850_6788_1398_10746_23118_4214_208_6789_7042_3725_3727_5594_1843_6655_6654_1649_1846_1845_8912_11072_2005_2353_1386 35 + 0.0426395898202947 0.375228390418593 6466 digitoxigenin hsa04260 Cardiac muscle contraction 481 1 + 0.0139308202794596 0.153239023074056 6467 digitoxigenin hsa03010 Ribosome 140801 1 + 0.0030507919090035 0.067117421998077 6468 digitoxigenin hsa04020 Calcium signaling pathway 5568_8912_3708_5534_490_2065 6 + 0.00986057015143317 0.123961453332303 6469 digitoxigenin hsa04650 Natural killer cell mediated cytotoxicity 10451_6452_5295_355_5336 5 - 0.00942333200265744 0.0559117698824341 6470 digitoxigenin hsa04640 Hematopoietic cell lineage 960_3566_2057 3 - 0.045752854750619 0.197283147704903 6471 digitoxigenin hsa05010 Alzheimer's disease 841_8772_317_355_3709_5664_810_7132 8 - 0.011295239748049 0.0628297710985226 6472 digitoxigenin hsa04080 Neuroactive ligand-receptor interaction 56288_5618_7442_2150_4157 5 - 6.94539288097724e-07 3.09069983203487e-05 6473 digitoxigenin hsa04670 Leukocyte transendothelial migration 10451_5295_7430_5336 4 - 0.0091918896839118 0.0559117698824341 6474 digitoxigenin hsa05016 Huntington's disease 5432_246721_841_5439_317_5978_548644_5481 8 - 0.00479720272325074 0.0388137311244833 6475 digitoxigenin hsa04740 Olfactory transduction 810_5613_5616_409 4 - 1.15414438718224e-12 1.02718850459219e-10 6476 digitoxigenin hsa04514 Cell adhesion molecules (CAMs) 214 1 - 2.62575679748842e-05 0.000778974516588231 6477 digitoxigenin hsa04510 Focal adhesion 10451_5295_4233_5154_2324 5 - 4.82744009996098e-05 0.00107410542224132 6478 digitoxigenin hsa05322 Systemic lupus erythematosus 55766_3014 2 - 9.59088779404142e-05 0.00170717802733937 6479 digitoxigenin hsa05212 Pancreatic cancer 5295_5154_3551 3 - 0.0325581937077759 0.168214856555812 6480 digitoxigenin hsa05215 Prostate cancer 5295_5154_3551 3 - 0.0465499562000333 0.197283147704903 6481 digitoxigenin hsa03410 Base excision repair 55247_143_4968_7515_27301_10038_4595_8930_23583 9 - 0.0359110367928137 0.168214856555812 6482 digitoxigenin hsa04530 Tight junction 5519_2036_9223_51776_56288 5 - 0.0093322944864179 0.0559117698824341 6483 digitoxigenin hsa04512 ECM-receptor interaction 960 1 - 0.00282744948443332 0.0251643004114565 6484 digitoxigenin hsa04810 Regulation of actin cytoskeleton 7454_5295_10451_5154_1445_7430_3985_200576 8 - 0.000599318670748422 0.00598180747792784 6485 digitoxigenin hsa05012 Parkinson's disease 317_5481 2 - 0.000204619557188602 0.0030351900982976 6486 digitoxigenin hsa04060 Cytokine-cytokine receptor interaction 5618_7132_3566_2057_2324_5154_355_27242_4233_7048 10 - 0.000243560220591533 0.00309669423323521 6487 digitoxigenin hsa03010 Ribosome 6137 1 - 0.000604901879790456 0.00598180747792784 6488 digitoxigenin hsa03020 RNA polymerase 5432_64425_246721_548644_5439_55703_10621_10622_10623 9 - 0.00859176049443221 0.0559117698824341 6489 digitoxigenin hsa04020 Calcium signaling pathway 5613_5616_7220_3709_113_5336_810_3707_5481_9630 10 - 0.0356339691199522 0.168214856555812 6490 buflomedil hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 + 0.012725668694589 0.194286022775918 6491 buflomedil hsa04640 Hematopoietic cell lineage 3123_1378_3126_3127_3125 5 + 0.0356604300277015 0.336226911689757 6492 buflomedil hsa05320 Autoimmune thyroid disease 3123_3126_3127_3125 4 + 0.0260659432917528 0.286725376209281 6493 buflomedil hsa05322 Systemic lupus erythematosus 8329_3123_3126_3127_3125_8969_8968_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013 22 + 1.28603656320112e-12 8.48784131712739e-11 6494 buflomedil hsa05310 Asthma 3123_3126_3127_3125 4 + 0.00434576915544892 0.143410382129814 6495 buflomedil hsa05330 Allograft rejection 3123_3126_3127_3125 4 + 0.0092782205251874 0.194286022775918 6496 buflomedil hsa04940 Type I diabetes mellitus 3123_3126_3127_3125 4 + 0.0147186380890847 0.194286022775918 6497 buflomedil hsa05332 Graft-versus-host disease 3123_3107_3126_3127_3125 5 - 0.048912689389978 0.433744935291633 6498 buflomedil hsa04662 B cell receptor signaling pathway 10725_10892_5605_4775_3845_3725_27071_4793 8 - 0.0249661265916887 0.39368389155192 6499 buflomedil hsa05010 Alzheimer's disease 5663_517 2 - 0.036932652520056 0.39368389155192 6500 buflomedil hsa04080 Neuroactive ligand-receptor interaction 1131_4886 2 - 0.00159008461492931 0.0445223692180207 6501 buflomedil hsa04740 Olfactory transduction 219464_5567 2 - 9.35564050301184e-06 0.000392936901126497 6502 buflomedil hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_8970_9555 27 - 3.30619784370139e-09 2.77720618870917e-07 6503 buflomedil hsa04210 Apoptosis 3554_581_5567_331_472_51135_8737_8837_651610 9 - 0.0374937039573257 0.39368389155192 6504 buflomedil hsa04060 Cytokine-cytokine receptor interaction 23765_3554_5154 3 - 0.00528554229321688 0.110996388157554 6505 buflomedil hsa05330 Allograft rejection 3123_3107_3126_3127_3125 5 - 0.035195623303488 0.39368389155192 6506 bacampicillin hsa05332 Graft-versus-host disease 3812_3122_3123_3126_3127_3125 6 + 0.0039065903612239 0.114642511972281 6507 bacampicillin hsa05320 Autoimmune thyroid disease 3122_3123_3126_3127_3125 5 + 0.0364360914176381 0.449378460817537 6508 bacampicillin hsa04740 Olfactory transduction 1179_816 2 + 0.000550856349552911 0.0407633698669154 6509 bacampicillin hsa05310 Asthma 3122_3123_3126_3127_3125 5 + 0.00464766940428165 0.114642511972281 6510 bacampicillin hsa05330 Allograft rejection 3122_3123_3126_3127_3125 5 + 0.0112164349644569 0.207504046842453 6511 bacampicillin hsa04940 Type I diabetes mellitus 3122_3123_3126_3127_3125 5 + 0.0190579369846034 0.28205746737213 6512 bacampicillin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 5.1340886813644e-09 1.89961281210483e-07 6513 bacampicillin hsa04115 p53 signaling pathway 472_651610_10912_581 4 - 0.0112240742890257 0.207645374346975 6514 Prestwick-983 hsa04740 Olfactory transduction 219464_442194 2 + 8.79207006818856e-05 0.00676989395250519 6515 Prestwick-983 hsa04070 Phosphatidylinositol signaling system 5331_51763_3631 3 - 0.0352700880837763 0.809353430388836 6516 Prestwick-983 hsa04512 ECM-receptor interaction 3914_1605_3675 3 - 0.0449054215733425 0.809353430388836 6517 nizatidine hsa04740 Olfactory transduction 5593 1 + 0.000257068222455344 0.00925445600839239 6518 nizatidine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_717_8368_8359_8294_8367_554313_121504 15 + 5.00517140571459e-05 0.0036037234121145 6519 nizatidine hsa05131 Shigellosis 7100_7278_113457 3 - 0.028724241178117 0.416501497082697 6520 nizatidine hsa05130 Pathogenic Escherichia coli infection 7100_7278_113457 3 - 0.028724241178117 0.416501497082697 6521 spaglumic acid hsa05219 Bladder cancer 7423_7422 2 + 0.0474795730227216 0.788495068707251 6522 epiandrosterone hsa04740 Olfactory transduction 818_810_9635_8387_8388 5 + 0.000896750843914966 0.0717400675131973 6523 epiandrosterone hsa03440 Homologous recombination 7517_5893_25788_10111 4 - 0.0464580411345532 0.702855830218344 6524 epiandrosterone hsa04080 Neuroactive ligand-receptor interaction 3354_1812 2 - 0.00159312873685171 0.0387661325967249 6525 epiandrosterone hsa04740 Olfactory transduction 810_109 2 - 9.35893006712594e-06 0.000683201894900194 6526 epiandrosterone hsa05322 Systemic lupus erythematosus 8358_85235_8968_3013_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357 18 - 0.000196274459204755 0.00716401776097356 6527 dicloxacillin hsa05211 Renal cell carcinoma 6655_405_7422_5781_1399_7042_3082 7 + 0.0151597318886909 0.128015513726723 6528 dicloxacillin hsa05200 Pathways in cancer 6502_4088_1488_2335_3551_5599_331_6655_999_4193_4254_27006_405_7046_7422_1399_7042_2260_1017_7475_3082 21 + 0.00893728533686305 0.0970333836573703 6529 dicloxacillin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 0.000721506058259534 0.0182781534759082 6530 dicloxacillin hsa04110 Cell cycle 1017_5111_4088_6502_699_4193_472_7027_7042_8556_651610 11 + 0.00374976248977137 0.047496991537104 6531 dicloxacillin hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_3551_5599_1839_6868_5781_5603_102_528 9 + 0.00122305534062777 0.0232380514719276 6532 dicloxacillin hsa04115 p53 signaling pathway 1017_4194_7057_4193_472_651610 6 + 0.0369377855516225 0.255206518356665 6533 dicloxacillin hsa04920 Adipocytokine signaling pathway 3551_948_5599_10645_5781_4793 6 + 0.032956614210076 0.250470267996578 6534 dicloxacillin hsa04350 TGF-beta signaling pathway 656_4088_3624_6667_7057_5519_7046_7027_353500_7042_268 11 + 0.000367673658455171 0.0182781534759082 6535 dicloxacillin hsa04912 GnRH signaling pathway 2778_4214_1432_5599_6655_1839_2776_8681_5603_5338_100137049_23236 12 + 0.000586746639053894 0.0182781534759082 6536 dicloxacillin hsa04730 Long-term depression 2778_10672_2776_5519_8681_100137049_23236 7 + 0.014204614576691 0.128015513726723 6537 dicloxacillin hsa05220 Chronic myeloid leukemia 3551_4088_6655_4193_7046_5781_1399_7042_1488 9 + 0.00173059681383803 0.0263050715703381 6538 ergocalciferol hsa05016 Huntington's disease 5439_246721_548644_842_55567 5 - 0.0301314875036288 0.679590191576512 6539 ergocalciferol hsa03020 RNA polymerase 246721_5439_548644 3 - 0.00291231818059744 0.163089818113457 6540 cisapride hsa05214 Glioma 4193_5290 2 + 0.0421274226273044 0.300416213840127 6541 cisapride hsa05200 Pathways in cancer 3576_1613_5290_4193_8817_7480_2950 7 + 0.00118470803526124 0.0334709230093548 6542 cisapride hsa05212 Pancreatic cancer 2950_4193_5290 3 + 0.0100965432972462 0.100965432972462 6543 cisapride hsa05215 Prostate cancer 2950_4193_5290 3 + 0.0098004869454681 0.100965432972462 6544 cisapride hsa03410 Base excision repair 27343_5111 2 + 0.0146429725511733 0.122024771259778 6545 cisapride hsa05219 Bladder cancer 3576_1613_4193 3 + 0.00133883692037419 0.0334709230093548 6546 cisapride hsa05218 Melanoma 8817_4193_5290 3 + 0.00554034802296921 0.0923391337161535 6547 cisapride hsa03022 Basal transcription factors 2967_51616_728198 3 - 0.0216992108754495 1 6548 puromycin hsa05010 Alzheimer's disease 836_9451_5663_22926_56901_1339_7124 7 + 0.0374069963923949 0.364136200747305 6549 puromycin hsa04080 Neuroactive ligand-receptor interaction 5618_2846_2908_2901_5030_2561_2798_7067_7433 9 + 0.00498742947159795 0.149622884147939 6550 puromycin hsa04740 Olfactory transduction 816 1 + 6.47581800326093e-13 5.82823620293484e-11 6551 puromycin hsa04710 Circadian rhythm - mammal 8864_5187_9572_406_79365_8553 6 + 0.00248025090829257 0.111611290873166 6552 puromycin hsa04062 Chemokine signaling pathway 2309_8503_5579_3718_113_4792_4793 7 + 0.0224050813257459 0.364136200747305 6553 puromycin hsa04010 MAPK signaling pathway 1326_7042_6722_5607_3725_3304_3305_3303_11221_4616_836_4791_8911_10912_10125_4214_468_773_1956_4609_3310_7124_9020_1647_1848_5579_1843_1649_1844_8817_23162_5971_9693_7186 34 + 0.0392502729551183 0.364136200747305 6554 puromycin hsa04260 Cardiac muscle contraction 1339 1 + 0.01383507894741 0.311289276316725 6555 puromycin hsa04270 Vascular smooth muscle contraction 4659_5579_113 3 + 0.0250294070349024 0.364136200747305 6556 puromycin hsa05131 Shigellosis 10092_7280_347733_7278_113457_203068_10383_10381 8 - 0.00992587540972552 0.104221691802118 6557 puromycin hsa05130 Pathogenic Escherichia coli infection 10092_7280_347733_7278_113457_203068_10383_10381 8 - 0.00992587540972552 0.104221691802118 6558 puromycin hsa04740 Olfactory transduction 5613_5616 2 - 2.05153538598288e-06 0.000172328972422562 6559 puromycin hsa04510 Focal adhesion 5295_3912_3911 3 - 0.0195175293401453 0.182163607174689 6560 puromycin hsa04210 Apoptosis 5295_598_839_317_23052_5616_355_5613_8717 9 - 0.0495696666677013 0.346987666673909 6561 puromycin hsa03410 Base excision repair 10357_5111_5425_5427_2237_7374_3146_4968_3978_100130561 10 - 4.30050341900479e-05 0.00180621143598201 6562 puromycin hsa03030 DNA replication 5111_4172_5425_5427_6117_2237_1763_3978 8 - 0.000902310405300378 0.0252646913484106 6563 puromycin hsa04540 Gap junction 7280_347733_5613_7278_5616_113457_203068_10383_10381_2697_23236 11 - 0.00962435351925341 0.104221691802118 6564 puromycin hsa03430 Mismatch repair 5425_3978_2956_6117_5111 5 - 0.00906284914707943 0.104221691802118 6565 puromycin hsa04060 Cytokine-cytokine receptor interaction 355_23765_6387_4254 4 - 0.00776864142218607 0.104221691802118 6566 puromycin hsa04020 Calcium signaling pathway 5613_5616_23236 3 - 0.0364130804052255 0.305869875403894 6567 puromycin hsa05222 Small cell lung cancer 3912_3911_9134_898_598_5295_317_8554_6502 9 - 0.0445247071046182 0.340006854253448 6568 serotonin hsa05332 Graft-versus-host disease 3123_941_3126_3127_3125 5 + 0.0252919480590874 0.363478897599833 6569 serotonin hsa04740 Olfactory transduction 81797 1 + 1.73563979496164e-05 0.000694255917984656 6570 serotonin hsa04514 Cell adhesion molecules (CAMs) 965_3123_3126_3127_3125_5818_23308_4359_9672_941 10 + 0.0384223741193085 0.384223741193085 6571 serotonin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_941_2209 31 + 8.86140953465464e-14 7.08912762772371e-12 6572 serotonin hsa04115 p53 signaling pathway 581_4194_317_4193_7057_472_651610 7 + 0.0184346801969661 0.363478897599833 6573 serotonin hsa05310 Asthma 3123_3126_3127_3125 4 + 0.0318044035399854 0.363478897599833 6574 serotonin hsa05330 Allograft rejection 3123_941_3126_3127_3125 5 + 0.0178034441164596 0.363478897599833 6575 serotonin hsa04940 Type I diabetes mellitus 3123_941_3126_3127_3125 5 + 0.029691825466915 0.363478897599833 6576 serotonin hsa04740 Olfactory transduction 26212 1 - 0.000175878773742148 0.0126632717094347 6577 serotonin hsa04060 Cytokine-cytokine receptor interaction 5155_4233 2 - 0.0259445726634191 0.934004615883088 6578 dinoprost hsa05016 Huntington's disease 23236 1 + 0.0465994222969066 0.827139745770092 6579 dinoprost hsa04740 Olfactory transduction 818_26212 2 + 0.00170123695221489 0.0603939118036286 6580 dinoprost hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3119 15 + 6.25545203109216e-05 0.00444137094207543 6581 dinoprost hsa04060 Cytokine-cytokine receptor interaction 3589_3572 2 + 0.025840628751862 0.611561547127401 6582 dinoprost hsa05322 Systemic lupus erythematosus 85235_8969_8332_8330_8331_8329_8336 7 - 0.00072808155509795 0.0218424466529385 6583 dinoprost hsa04360 Axon guidance 55558_1949_2048_2049 4 - 0.0448087345870319 0.672131018805478 6584 vinblastine hsa04640 Hematopoietic cell lineage 933_3673_925_1604 4 + 0.0423584724020781 0.532506510197553 6585 vinblastine hsa04080 Neuroactive ligand-receptor interaction 1241_1269_5733_5618_7434_2150_2901_56288_9170 9 + 9.39590565480472e-06 0.000413419848811408 6586 vinblastine hsa04740 Olfactory transduction 219464_5613_5566_5616_109_5137 6 + 2.35652272892799e-13 2.07374000145663e-11 6587 vinblastine hsa04260 Cardiac muscle contraction 27092_9167_488 3 + 0.0229160004321343 0.403321607605564 6588 vinblastine hsa04060 Cytokine-cytokine receptor interaction 5618_3459_3460_3576_5154_3627_3572_355_655_7422_8718_1896_268_51330_6376 15 + 0.00173964782331911 0.0510296694840272 6589 vinblastine hsa03010 Ribosome 6125_9349_6141 3 + 0.00421858219685637 0.0928088083308401 6590 vinblastine hsa04020 Calcium signaling pathway 5613_5566_5616_3709_5533_3708_109_5733_488_5137_23236_493 12 + 0.0279279883699087 0.409610496091994 6591 vinblastine hsa05332 Graft-versus-host disease 3123_3107_3126_3127_3125_355 6 - 0.0435650565686503 0.340844888473793 6592 vinblastine hsa04080 Neuroactive ligand-receptor interaction 4889_1081_3354_7067_6915_728 6 - 0.0183911447583801 0.22882297866584 6593 vinblastine hsa05320 Autoimmune thyroid disease 1081_3123_3107_3126_3127_3125_355 7 - 0.0422183258780629 0.340844888473793 6594 vinblastine hsa05131 Shigellosis 7280_7277_347733_7278_3688_113457_203068_10383_10381 9 - 0.00793068311026732 0.134821612874544 6595 vinblastine hsa05130 Pathogenic Escherichia coli infection 7280_7277_347733_7278_3688_113457_203068_10383_10381 9 - 0.00793068311026732 0.134821612874544 6596 vinblastine hsa04740 Olfactory transduction 818_219464_26212_157 4 - 6.13410410113315e-06 0.000260699424298159 6597 vinblastine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8294_121504_8343_8347_8346_8344_8339_3123_3126_3127_3125_8968_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_3012_3013 36 - 5.44536330628189e-12 4.62855881033961e-10 6598 vinblastine hsa04540 Gap junction 7280_7277_347733_6655_113457_3709_203068_1956_10383_10381_6714_7278_23236 13 - 0.00728544669778411 0.134821612874544 6599 vinblastine hsa04620 Toll-like receptor signaling pathway 6772 1 - 0.0451279921208915 0.340844888473793 6600 vinblastine hsa04060 Cytokine-cytokine receptor interaction 2057_8771_3572_7852_355_1956 6 - 0.0188442453018927 0.22882297866584 6601 vinblastine hsa05330 Allograft rejection 3123_3107_3126_3127_3125_355 6 - 0.0299880354954742 0.318622877139413 6602 metixene hsa04740 Olfactory transduction 5137 1 + 6.08159613691952e-09 4.98690883227401e-07 6603 metixene hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_8970 26 + 2.37468267742335e-06 9.73619897743574e-05 6604 metixene hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8336_8329 7 - 0.000160050343960375 0.0083226178859395 6605 metixene hsa04620 Toll-like receptor signaling pathway 148022_8503_5603 3 - 0.0476716223866124 0.67280321120142 6606 fluoxetine hsa04710 Circadian rhythm - mammal 8553_9572 2 + 0.0280682538713914 0.661472220490438 6607 fluoxetine hsa04920 Adipocytokine signaling pathway 32_6257_1375_4793 4 + 0.0367484566939132 0.661472220490438 6608 fluoxetine hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0185130580400191 0.661472220490438 6609 fluoxetine hsa05214 Glioma 5296_5155_5154 3 - 0.00803560164851381 0.168850665460302 6610 fluoxetine hsa05131 Shigellosis 7278_113457 2 - 0.048122416114372 0.24061208057186 6611 fluoxetine hsa04670 Leukocyte transendothelial migration 5296_7409_50848 3 - 0.0400053984841733 0.24061208057186 6612 fluoxetine hsa05130 Pathogenic Escherichia coli infection 7278_113457 2 - 0.048122416114372 0.24061208057186 6613 fluoxetine hsa04510 Focal adhesion 5296_7409_5155_5154 4 - 0.0382206374247885 0.24061208057186 6614 fluoxetine hsa05212 Pancreatic cancer 5296_5155_5154 3 - 0.0181787762293745 0.181787762293745 6615 fluoxetine hsa05215 Prostate cancer 5296_5155_5154 3 - 0.0176608458842933 0.181787762293745 6616 fluoxetine hsa05218 Melanoma 5296_5155_5154 3 - 0.0101310399276181 0.168850665460302 6617 fluoxetine hsa04810 Regulation of actin cytoskeleton 5296_7409_5155_5154 4 - 0.0459677376710033 0.24061208057186 6618 fluoxetine hsa04540 Gap junction 113457_7278_5155_5154_23236 5 - 0.000305768407661441 0.0152884203830721 6619 Trolox C hsa04740 Olfactory transduction 26211 1 + 0.00371544187378938 0.115178698087471 6620 Trolox C hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_6737_9103_8359_8330_8294_8367_554313_121504 17 + 7.92965727290184e-08 4.91638750919914e-06 6621 Trolox C hsa04810 Regulation of actin cytoskeleton 10298_624_2934_5155_5880_10552_8976_2335_2149_3675 10 + 0.0351628408128696 0.726698710132638 6622 Trolox C hsa05010 Alzheimer's disease 3708_5534 2 - 0.00309572012438966 0.110938382516845 6623 Trolox C hsa04080 Neuroactive ligand-receptor interaction 7434_56288_1812_4886_7068 5 - 0.00421284996899411 0.110938382516845 6624 Trolox C hsa04910 Insulin signaling pathway 8660_2475_3551_2872_5599_5613_9470_8503_5140_6009_23433_5834_3845_51763_1399_5566 16 - 0.0208618323945795 0.247673031284863 6625 Trolox C hsa05016 Huntington's disease 5432_3708_7419 3 - 0.00711013137160555 0.14042509458921 6626 Trolox C hsa04740 Olfactory transduction 219464_5613_5566 3 - 3.27721492747913e-07 2.58899979270851e-05 6627 Trolox C hsa04360 Axon guidance 2050_2042_5364_1808_10725_54910_9475_6387_3845_64218_5534_6092_4233_5998_7869_3983 16 - 0.0114876553998642 0.181504955317854 6628 Trolox C hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_4067_3551_5599_8992_5335_5781_5603_3725_4233 10 - 0.0250808132946697 0.247673031284863 6629 Trolox C hsa04664 Fc epsilon RI signaling pathway 8503_1432_8399_5581_5599_3845_5603_5335_81579_4067 10 - 0.03550486551478 0.311653819518624 6630 Trolox C hsa05012 Parkinson's disease 7419_5413 2 - 0.0249529356436522 0.247673031284863 6631 Trolox C hsa04060 Cytokine-cytokine receptor interaction 2057_8742_8741_6387_9180_7042_93_4233 8 - 0.0460306518397504 0.363642149534028 6632 clorsulon hsa04070 Phosphatidylinositol signaling system 23533_51806_3709_8821_5290_3707 6 + 0.00785059943958117 0.525990162451938 6633 clorsulon hsa04012 ErbB signaling pathway 1839_27_56924_5290_23533 5 + 0.0459242098973917 0.713652767228801 6634 clorsulon hsa04930 Type II diabetes mellitus 23533_776_5290_5581 4 + 0.0199000976944394 0.66665327276372 6635 clorsulon hsa04912 GnRH signaling pathway 51806_776_4323_1839_3709_5566 6 + 0.0344019478255983 0.713652767228801 6636 etamivan hsa05211 Renal cell carcinoma 7422_7423_5293_7042 4 + 0.0163229121956932 0.376226108153916 6637 etamivan hsa05219 Bladder cancer 1956_7423_7422 3 + 0.019801374113364 0.376226108153916 6638 etamivan hsa04150 mTOR signaling pathway 7423_5293_5562_7422 4 + 0.00568194214840451 0.323870702459057 6639 etamivan hsa05332 Graft-versus-host disease 3123_3107_3126_3127_3125 5 - 0.00194391243542625 0.0410074527283694 6640 etamivan hsa04640 Hematopoietic cell lineage 3123_4254_3126_3127_3125 5 - 0.0314005112793662 0.297585106519565 6641 etamivan hsa05320 Autoimmune thyroid disease 3123_3107_3126_3127_3125 5 - 0.00490411634774659 0.0572146907237102 6642 etamivan hsa04612 Antigen processing and presentation 3123_3107_3126_3127_3125 5 - 0.0340097264593788 0.297585106519565 6643 etamivan hsa05322 Systemic lupus erythematosus 55506_85235_3012_3123_3126_3127_3125_8332_8969_8331_8336_8335_8329_8330 14 - 1.88634038882923e-06 0.000132043827218046 6644 etamivan hsa05310 Asthma 3123_3126_3127_3125 4 - 0.0038416575584957 0.0537832058189398 6645 etamivan hsa05330 Allograft rejection 3123_3107_3126_3127_3125 5 - 0.00129743517150091 0.0410074527283694 6646 etamivan hsa04940 Type I diabetes mellitus 3123_3107_3126_3127_3125 5 - 0.00234328301304968 0.0410074527283694 6647 cyclizine hsa05332 Graft-versus-host disease 3105_3106_3126_3127_3125_3135_3123_649853 8 + 2.21208614902924e-05 0.000604896116792687 6648 cyclizine hsa04640 Hematopoietic cell lineage 2057_3123_3126_3127_3125_920_931 7 + 0.00734919439228175 0.0651303868850586 6649 cyclizine hsa05320 Autoimmune thyroid disease 3105_3106_3126_3127_3125_3135_3123_649853 8 + 9.66464586739156e-05 0.00147385849477721 6650 cyclizine hsa04612 Antigen processing and presentation 3123_3106_3126_3127_3125_3135_3105_920_649853 9 + 0.000561232887182906 0.00684704122363145 6651 cyclizine hsa04740 Olfactory transduction 26539_5613 2 + 0.00973812372536636 0.0660028385830387 6652 cyclizine hsa04514 Cell adhesion molecules (CAMs) 3123_3106_3126_3127_3125_3135_3105_920_649853 9 + 0.0075085032619318 0.0651303868850586 6653 cyclizine hsa05310 Asthma 3123_3126_3127_3125 4 + 0.00854169008328638 0.0651303868850586 6654 cyclizine hsa05330 Allograft rejection 3105_3106_3126_3127_3125_3135_3123_649853 8 + 1.16800086455718e-05 0.000604896116792687 6655 cyclizine hsa04940 Type I diabetes mellitus 3105_3106_3126_3127_3125_3135_3123_649853 8 + 2.974898935046e-05 0.000604896116792687 6656 cyclizine hsa05214 Glioma 5578_6464_5155_5154_5290_5925_1956_5335 8 - 0.000403258578349183 0.0130175884813326 6657 cyclizine hsa04070 Phosphatidylinositol signaling system 8871_5578_8394_5290_5333_5335 6 - 0.0153654259934209 0.0710195277262971 6658 cyclizine hsa05211 Renal cell carcinoma 2271_6513_5155_5290_3725 5 - 0.0407564574536343 0.124041392250191 6659 cyclizine hsa04662 B cell receptor signaling pathway 6850_5290_8519_5533_5881_933_3725_27071_4793 9 - 0.000209482328153277 0.0130175884813326 6660 cyclizine hsa04080 Neuroactive ligand-receptor interaction 7067 1 - 0.0226931992911724 0.0857265291526409 6661 cyclizine hsa05200 Pathways in cancer 23604_2308_4149_2335_3911_5578_5599_6513_5155_5154_5290_5925_5881_1956_5335_2271_3725_898_8324_2260 20 - 0.000557896649199967 0.0130175884813326 6662 cyclizine hsa04520 Adherens junction 7454_5881_1956_6714_25945_2260 6 - 0.019037784812114 0.0783908786381165 6663 cyclizine hsa04740 Olfactory transduction 157 1 - 0.00116602335056337 0.0163243269078872 6664 cyclizine hsa04510 Focal adhesion 2335_3911_5578_5599_6464_5155_5154_5290_5881_1956_394_3725_6714 13 - 0.00293657321971784 0.0228400139311388 6665 cyclizine hsa04710 Circadian rhythm - mammal 1454_9572_5187 3 - 0.00648369134818733 0.0412598540339194 6666 cyclizine hsa05212 Pancreatic cancer 2308_898_5155_5154_5290_5925_1956_2260 8 - 0.0026176320106339 0.0228400139311388 6667 cyclizine hsa05215 Prostate cancer 2308_898_5155_5154_5290_5925_1956_2260 8 - 0.00245260251343141 0.0228400139311388 6668 cyclizine hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5599_1956_5335_3725_6714_50848 6 - 0.0115060794075121 0.0619558121942959 6669 cyclizine hsa04664 Fc epsilon RI signaling pathway 6850_5578_5599_5290_5881_5606_5335 7 - 0.00514699674124729 0.036028977188731 6670 cyclizine hsa04370 VEGF signaling pathway 5578_5290_5533_5881_5335_6714 6 - 0.0162330349088679 0.0710195277262971 6671 cyclizine hsa05218 Melanoma 5155_5154_5290_5925_1956_2260 6 - 0.0115060794075121 0.0619558121942959 6672 cyclizine hsa04920 Adipocytokine signaling pathway 5599_6794_6513_1375_4793 5 - 0.0318087004729006 0.106029001576335 6673 cyclizine hsa04012 ErbB signaling pathway 5578_5599_6464_5290_1956_5335_3725_6714 8 - 0.00229584016933528 0.0228400139311388 6674 cyclizine hsa05223 Non-small cell lung cancer 5925_1956_5335_5290_5578 5 - 0.0146791207465232 0.0710195277262971 6675 cyclizine hsa04010 MAPK signaling pathway 57551_4149_5578_5599_1847_5155_5154_5881_4137_5533_5607_1956_5606_5536_3725_2260_4763 17 - 0.000807494063177503 0.0141311461056063 6676 cyclizine hsa04540 Gap junction 5578_5155_5154_5607_1956_6714 6 - 0.0349872104915402 0.111322942473082 6677 cyclizine hsa05210 Colorectal cancer 5599_5290_5881_1956_3725_8324 6 - 0.0232686293414311 0.0857265291526409 6678 cyclizine hsa05222 Small cell lung cancer 4149_2335_3911_898_5290_5925 6 - 0.0256035376977765 0.0896123819422177 6679 tubocurarine chloride hsa04740 Olfactory transduction 26212 1 + 0.000257068222455344 0.0185089120167848 6680 tubocurarine chloride hsa05322 Systemic lupus erythematosus 3013_3014_8358_88_8968_8350_8351_8352_8353_8354_8355_8356_8357 13 + 0.00056981763197135 0.0205134347509686 6681 tubocurarine chloride hsa04512 ECM-receptor interaction 7148_961_3910_5649_1290_1291 6 + 0.0442236640854262 0.787646927165741 6682 tubocurarine chloride hsa04080 Neuroactive ligand-receptor interaction 56288 1 - 0.03359651606225 1 6683 tubocurarine chloride hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_8970_121504 15 - 5.09677477804422e-06 0.000321096811016786 6684 tetracaine hsa04740 Olfactory transduction 1179 1 + 0.00520657650434988 0.270741978226194 6685 tetracaine hsa05014 Amyotrophic lateral sclerosis (ALS) 5600_834_5608 3 - 0.0232808720351943 0.504381682024688 6686 tetracaine hsa04010 MAPK signaling pathway 57551_2122_3552_4763_5600_3164_5608 7 - 0.0264668530011274 0.504381682024688 6687 tetracaine hsa04912 GnRH signaling pathway 3708_6714_5608_5600 4 - 0.029098943193732 0.504381682024688 6688 parthenolide hsa04080 Neuroactive ligand-receptor interaction 2912_2908_2150_680_728 5 + 0.00223120900466313 0.045092316395035 6689 parthenolide hsa04612 Antigen processing and presentation 3448_3117_3804_3106_3135_6892_3133_3310_1385_3304_3305_3303 12 + 0.0201781317539473 0.181603185785526 6690 parthenolide hsa05016 Huntington's disease 1385_27113_4695_842_4728 5 + 0.045442178750042 0.357432177610098 6691 parthenolide hsa04740 Olfactory transduction 810_26539_7932_8390 4 + 6.8466186693867e-07 5.54576112220323e-05 6692 parthenolide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_723790_8364_8370_8366_3117_3013_8365_554313_8368_8359_8348_8337_8367_8351_8970_121504_8294 21 + 0.00131053636647228 0.0417152451590847 6693 parthenolide hsa04530 Tight junction 24146 1 + 0.00334017158481741 0.045092316395035 6694 parthenolide hsa05219 Bladder cancer 2277_1026_1029_1613_4193_5228_1950_1890_7422 9 + 0.00313689469497909 0.045092316395035 6695 parthenolide hsa04115 p53 signaling pathway 1647_27113_5366_2810_1029_4193_3732_842_1026_8795_4616 11 + 0.00836062770501792 0.0967444063009216 6696 parthenolide hsa04062 Chemokine signaling pathway 6359_6358_10235_6773 4 + 0.0144444888400044 0.146250449505045 6697 parthenolide hsa05012 Parkinson's disease 4695_842_4728 3 + 0.048540172268038 0.357432177610098 6698 parthenolide hsa04020 Calcium signaling pathway 810_8877 2 + 0.0015450090799661 0.0417152451590847 6699 parthenolide hsa03440 Homologous recombination 10714_5425_7156_6742_5890_7516_5424 7 - 0.0366378673785175 0.404385668468135 6700 parthenolide hsa04080 Neuroactive ligand-receptor interaction 5029_1269_4157_4886_3354_136_2149 7 - 4.80862978517475e-05 0.00142656016960184 6701 parthenolide hsa05016 Huntington's disease 5432_4714_6875_3708_509 5 - 0.000554825676356102 0.0123448712989233 6702 parthenolide hsa04740 Olfactory transduction 801_109_805_808 4 - 5.74819463266329e-12 5.11589322307033e-10 6703 parthenolide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_6632_8344_8339_3123_3126_3127_3125_8968_55766_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113 37 - 2.77190600320763e-06 0.00012334981714274 6704 parthenolide hsa05110 Vibrio cholerae infection 109 1 - 0.0408929327664406 0.404385668468135 6705 parthenolide hsa04062 Chemokine signaling pathway 5295_4067_5580_6777_6387_7852_10451_109_107_8976 10 - 0.0357772028674162 0.404385668468135 6706 parthenolide hsa05012 Parkinson's disease 4714_2861_509 3 - 0.0016124802176302 0.0287021478738176 6707 parthenolide hsa04260 Cardiac muscle contraction 776_4635 2 - 0.0225196901491234 0.33404207054533 6708 prenylamine hsa04070 Phosphatidylinositol signaling system 8871_1608_3710_5579_8394_8396_3631_5331_27124 9 + 0.0442010068806365 0.626278460047916 6709 prenylamine hsa04080 Neuroactive ligand-receptor interaction 3269_2358_5030_1081_1812 5 + 0.0107165751144972 0.307208486615586 6710 prenylamine hsa05200 Pathways in cancer 598_5602_330_3725_3673_652671_4149_5371_5900_650_7472_23604_11186_6469_51384_4609_836_4791_4792_1436_1284_1026_5579_861_8817_7189_7422_2353 28 + 0.0399841123039462 0.626278460047916 6711 prenylamine hsa04740 Olfactory transduction 81697_26212_157_409 4 + 1.31059177140974e-05 0.000563554461706188 6712 prenylamine hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8360_8368_8335_8349_8348_8329_8294_121504_8343_8347_8352_8345_8344_959_8339_723790_8366_8346_8969_8968_3108_8370_8362_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_7124_8353_8354_8355_8356_8357_8332_85235_83740_3012_3013_8970 52 + 3.38920925074447e-23 2.91471995564024e-21 6713 prenylamine hsa04010 MAPK signaling pathway 4763_5602_3725_3164_11221_4616_836_4149_10912_409_5607_4609_3310_7124_4791_1647_1848_5579_1843_1649_1846_8817_7189_2353_5971 25 + 0.0239658422129397 0.515265607578204 6714 prenylamine hsa04080 Neuroactive ligand-receptor interaction 2561_136_9170 3 - 0.019847019571494 0.387016881644133 6715 prenylamine hsa04740 Olfactory transduction 219464_5613_157 3 - 0.000353028317690486 0.013768104389929 6716 prenylamine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_8359_88_8294_720_721_121504_8367 17 - 0.000133484559324025 0.0104117956272739 6717 prenylamine hsa04060 Cytokine-cytokine receptor interaction 3554 1 - 0.000823380570163293 0.0214078948242456 6718 mesalazine hsa04740 Olfactory transduction 26211_817_390892 3 + 1.41562847492413e-05 0.000594563959468135 6719 mesalazine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_8343_8342_8347_8346_8344_3109_8370_718_8359_8337_554313_121504_8339_3119 24 + 1.24560745303648e-06 0.000104631026055064 6720 mesalazine hsa04540 Gap junction 2911_1813_6655_113457_3709_5607_1956_113_7278_23236 10 + 0.0307891597088373 0.862096471847444 6721 mesalazine hsa04070 Phosphatidylinositol signaling system 8871_1040_8394_8396_3633_3631_808_801_5286_8527_805_23236 12 - 0.0418697855786664 0.253268084515637 6722 mesalazine hsa04080 Neuroactive ligand-receptor interaction 2550_5029_152_4889_4158_2925_1909 7 - 0.000883750091335149 0.0397687541100817 6723 mesalazine hsa04612 Antigen processing and presentation 3106 1 - 0.0144274049565604 0.162308305761305 6724 mesalazine hsa05016 Huntington's disease 5435_7157_3064_513_9519_517_23236 7 - 0.0287481896459656 0.199025928318223 6725 mesalazine hsa04740 Olfactory transduction 801_2979_805_808 4 - 2.30193591509887e-09 2.07174232358898e-07 6726 mesalazine hsa05322 Systemic lupus erythematosus 3014_87_94239_6634 4 - 0.0184185495521414 0.163341792097465 6727 mesalazine hsa04110 Cell cycle 5591_890_8243_5347_4085_4087_7157_699_472_1869_10926_7043_7042_7529_51343_651610_4999_9978 18 - 0.0217789056129954 0.163341792097465 6728 mesalazine hsa03022 Basal transcription factors 2966_2961_9519_6880_6877_51616_6872_728198 8 - 0.0190205467934062 0.163341792097465 6729 mesalazine hsa04630 Jak-STAT signaling pathway 3601_3459_3596_3572 4 - 0.00984703566128756 0.156339862311667 6730 mesalazine hsa04010 MAPK signaling pathway 5595_5062_7157_2002_5532_3845_2249_7043_7042_5058_9693 11 - 0.0123858310943706 0.159246399784765 6731 mesalazine hsa05012 Parkinson's disease 513_51465_517 3 - 0.0093507119973032 0.156339862311667 6732 mesalazine hsa04620 Toll-like receptor signaling pathway 5595 1 - 0.00451816774996881 0.135545032499064 6733 mesalazine hsa04260 Cardiac muscle contraction 6548 1 - 0.020633298658015 0.163341792097465 6734 mesalazine hsa04060 Cytokine-cytokine receptor interaction 3601_3596_2324_3459_27242_3572_657_7043_7042_8795 10 - 0.0104226574874445 0.156339862311667 6735 mesalazine hsa04610 Complement and coagulation cascades 5054 1 - 0.0422113474192729 0.253268084515637 6736 hydrastine hydrochloride hsa05332 Graft-versus-host disease 3105_3106_3111_941_3135_649853 6 + 0.00289110834546155 0.0520052655236775 6737 hydrastine hydrochloride hsa05320 Autoimmune thyroid disease 1081_3105_3106_3111_941_3135_649853 7 + 0.00197297999435057 0.0480091798625305 6738 hydrastine hydrochloride hsa05016 Huntington's disease 4899 1 + 0.0476582300995481 0.386561199696335 6739 hydrastine hydrochloride hsa04740 Olfactory transduction 51806_5566_816 3 + 0.00549729624427448 0.0668837709720062 6740 hydrastine hydrochloride hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_9103_3111_941_8359_8294_8367_554313_121504 17 + 6.09095711372556e-06 0.000444639869301966 6741 hydrastine hydrochloride hsa04020 Calcium signaling pathway 51806_3710_5566_51196_2925_5724_8913_1956_113_5733_1910_816 12 + 0.0170880374121042 0.17820381872623 6742 hydrastine hydrochloride hsa04912 GnRH signaling pathway 51806_3710_1081_5566_2002_1956_113_816 8 + 0.0227791773768317 0.207859993563589 6743 hydrastine hydrochloride hsa05330 Allograft rejection 3105_3106_3111_941_3135_649853 6 + 0.00183746755892674 0.0480091798625305 6744 hydrastine hydrochloride hsa04940 Type I diabetes mellitus 3105_3106_3111_941_3135_649853 6 + 0.00356200448792312 0.0520052655236775 6745 hydrastine hydrochloride hsa05120 Epithelial cell signaling in Helicobacter pylori infection 836_4067_5599_1432_102_3725_6714_5781 8 - 0.00430647465640221 0.163646036943284 6746 hydrastine hydrochloride hsa04912 GnRH signaling pathway 1432_5599_5613_50487_5616_808_109_3725_6714_801_805 11 - 0.0018318383743929 0.13921971645386 6747 laudanosine hsa04540 Gap junction 1813_7278_113457_5156_5331_2977 6 + 0.00330866710267579 0.211754694571251 6748 laudanosine hsa04740 Olfactory transduction 818 1 - 2.72187150779305e-05 0.00209584106100065 6749 laudanosine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 0.00135893385658413 0.052318953478489 6750 laudanosine hsa05212 Pancreatic cancer 5170_596_5296_208_4193_5154_2033_6934 8 - 0.020841770627682 0.320963267666303 6751 laudanosine hsa05215 Prostate cancer 5170_596_5296_208_4193_5154_2033_6934 8 - 0.0197042947885533 0.320963267666303 6752 laudanosine hsa04150 mTOR signaling pathway 6794_5170_5296_208_6009_9706 6 - 0.0158561406468576 0.320963267666303 6753 laudanosine hsa04060 Cytokine-cytokine receptor interaction 355_5154_8795 3 - 0.0270497578212051 0.347138558705466 6754 thioridazine hsa05332 Graft-versus-host disease 3811_3552_3821_3117_3123_3107_3126_3127_3111_3802_3135_3133_3125_3569 14 + 0.0330217783706319 0.295578507914529 6755 thioridazine hsa04120 Ubiquitin mediated proteolysis 10277_4214_7318_7322_868_5371_330_4193_83737_9820_8651_23221 12 + 0.0254757552150918 0.292971184973556 6756 thioridazine hsa04640 Hematopoietic cell lineage 3570_3676_3675_3554_3552_2057_3123_3126_3127_3125_931_3581_2812_960_1436_966_1435_3566_947_3569_1604_3684_920_924 24 + 0.0396612576343191 0.304069641863113 6757 thioridazine hsa05010 Alzheimer's disease 6622_6390_317_9451_4137_5331_5532_3708_3709_489_348_23236 12 + 0.000756434415555256 0.0173979915577709 6758 thioridazine hsa04740 Olfactory transduction 26211_26692_5566_8390_442194_818_5137_816 8 + 2.06480709476629e-17 1.89962252718499e-15 6759 thioridazine hsa04514 Cell adhesion molecules (CAMs) 2734_214_6383_8506_3127_22871_9672_3676_24146_3383_3123_3107_3126_3695_3125_25945_8516_1272_3135_6693_4359_3133_6402_965_4684_3117_947_3111_3684_920_923_1003_26047_5817 34 + 0.034437978167466 0.295578507914529 6760 thioridazine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8349_8348_8329_8294_121504_8343_8342_8341_8347_8346_8345_8344_8353_723790_3123_3126_3127_3125_8969_8968_8370_92815_8358_8359_8330_8331_8336_8337_8334_554313_8350_8351_8352_8339_8354_8355_8356_8357_8332_85235_3012_3013_3111_3117_8970 55 + 1.00382045896987e-06 4.6175741112614e-05 6761 thioridazine hsa04340 Hedgehog signaling pathway 5566_7472 2 + 0.0136818345941239 0.179818397522771 6762 thioridazine hsa03022 Basal transcription factors 2967 1 + 0.035340908554998 0.295578507914529 6763 thioridazine hsa04010 MAPK signaling pathway 9479_1326_2872_1649_50487_5881_6237_4763_10369_5602_9344_3304_3305_5609_3303_3725_4616_10000_4908_3554_4149_3552_1616_5566_4791_5871_2263_2247_408_4214_57551_8398_5598_9254_9252_998_5532_5536_3310_3727_81579_5971_3164_1848_1432_782_2318_5578_1843_1647_6655_1847_1846_4137_8817_6196_23162_2258_2353_1386_2251 61 + 0.0471239927346845 0.308505139412574 6764 thioridazine hsa05012 Parkinson's disease 7318_5413_6390_317_7416_7419_6622 7 + 0.000436275334636691 0.0133791102621919 6765 thioridazine hsa04260 Cardiac muscle contraction 6546_6262_782_9254_10369_4635 6 + 0.0464897549694856 0.308505139412574 6766 thioridazine hsa03010 Ribosome 6187_140801_440589_6224_6144 5 + 0.00208214106324043 0.0383113955636239 6767 thioridazine hsa03050 Proteasome 5689 1 + 0.00732843672418972 0.112369363104242 6768 thioridazine hsa04080 Neuroactive ligand-receptor interaction 5029_151_5733_57105_64106_2925_3269_7434_3354_2798_10203_135_1909_9568_154_2690_2740_2561 18 - 0.000945332826782493 0.0289902066879965 6769 thioridazine hsa05016 Huntington's disease 4899_842_841_6390_1329_317_5430_3092_55567_10126_517 11 - 0.000862768103155645 0.0289902066879965 6770 thioridazine hsa04740 Olfactory transduction 219464_157_26532_5613_5616_2978_26333_5137_26476_109_816_810_409 13 - 2.63143365062522e-11 2.4209189585752e-09 6771 thioridazine hsa04350 TGF-beta signaling pathway 4086_9475_1874_7057_656_655_652_653_353500_4091_9372_5519_3400_7042_91_6093_5308_3398_5934_5933_57154_83729 22 - 0.0298831163487098 0.392749529154472 6772 thioridazine hsa05012 Parkinson's disease 7327_842_5413_6622_6390_1329_317_7345_9627_517_7332 11 - 0.0474664552183671 0.545864235011222 6773 thioridazine hsa04260 Cardiac muscle contraction 27092_7168_1329_488 4 - 0.0155310920190436 0.285772093150402 6774 thioridazine hsa04060 Cytokine-cytokine receptor interaction 5155_5154_9180_27242_3451_3553_3455_3570_655_8718_3601_3589_23765_4254_7042_91_4233_1435_8995_355_6372_83729_2690 23 - 0.0120209513659158 0.276481881416063 6775 thioridazine hsa04610 Complement and coagulation cascades 1675_720_721 3 - 0.0212645569779698 0.32605654032887 6776 methapyrilene hsa04080 Neuroactive ligand-receptor interaction 1131_2908_2555_9170 4 - 0.0147950656177875 0.272273103800116 6777 methapyrilene hsa04740 Olfactory transduction 5566 1 - 3.39026298900368e-07 1.42391045538155e-05 6778 methapyrilene hsa04510 Focal adhesion 5296_3655_5881 3 - 0.0273303092152777 0.382624329013888 6779 methapyrilene hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8342_3123_3126_3127_3125_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235 26 - 4.97951865159117e-08 4.18279566733658e-06 6780 methapyrilene hsa04370 VEGF signaling pathway 5296_11261_5605_10725_5881_4775_3845_5336_6300 9 - 0.0162067323690545 0.272273103800116 6781 methapyrilene hsa04060 Cytokine-cytokine receptor interaction 23529_3601_4254_2057 4 - 0.0106748966634868 0.272273103800116 6782 PHA-00745360 hsa04916 Melanogenesis 5568_7306_2776_816 4 + 0.0327281497805613 0.28557677090261 6783 PHA-00745360 hsa04120 Ubiquitin mediated proteolysis 7337_5371_26091_8453_8450_26272_5071 7 + 0.0356970963628262 0.28557677090261 6784 PHA-00745360 hsa04640 Hematopoietic cell lineage 1378_7850_3552 3 + 0.0323791931134402 0.28557677090261 6785 PHA-00745360 hsa05010 Alzheimer's disease 6392_651820_2081_317_2776_5533_3709_489_824_4842 10 + 0.034967540651308 0.28557677090261 6786 PHA-00745360 hsa05016 Huntington's disease 1213_1211_581_7052_651820_317_2776_6392_7416 9 + 0.010588041635813 0.270008245353286 6787 PHA-00745360 hsa04740 Olfactory transduction 26211_26212_7932_5568_56656_8388_8387_135948_1179_26476_2979_816 12 + 1.8394604015806e-07 1.61872515339093e-05 6788 PHA-00745360 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8294_121504_3586_8968_8370_8358_8359_8335_8350_8351_8352_8353_8354_8355_8356_8357_3119_3013_729 29 + 0.00419582181727967 0.184616159960305 6789 PHA-00745360 hsa04110 Cell cycle 995_1029_1021_1870_7042 5 + 0.0318022446856106 0.28557677090261 6790 PHA-00745360 hsa04630 Jak-STAT signaling pathway 3593_10000_3586_3953_3446_5293_5781_10379 8 + 0.0329584091442898 0.28557677090261 6791 PHA-00745360 hsa05012 Parkinson's disease 6392_651820_317_7345_7416_5071 6 + 0.0221150369931746 0.28557677090261 6792 PHA-00745360 hsa04260 Cardiac muscle contraction 7169_4635_783 3 + 0.0446873475754506 0.30249896820305 6793 PHA-00745360 hsa03010 Ribosome 6129_6181_6144 3 + 0.012273102061513 0.270008245353286 6794 PHA-00745360 hsa05217 Basal cell carcinoma 324 1 + 0.0402432222114454 0.295116962883933 6795 betulin hsa04740 Olfactory transduction 26212_816 2 + 0.0375022123370983 0.937555308427457 6796 betulin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 2.84074347605072e-06 0.000142037173802536 6797 betulin hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 - 0.00670057072886694 0.086940863181653 6798 betulin hsa04640 Hematopoietic cell lineage 3123_1435_3126_3127_3125 5 - 0.0176038000775757 0.107383180473212 6799 betulin hsa05320 Autoimmune thyroid disease 3123_3126_3127_3125 4 - 0.0141191326854297 0.0956963437568013 6800 betulin hsa04520 Adherens junction 4088_6714_10458_4233 4 - 0.0492533172287345 0.231111719304062 6801 betulin hsa04740 Olfactory transduction 818 1 - 0.0224968487047365 0.124755251908084 6802 betulin hsa04514 Cell adhesion molecules (CAMs) 24146_3688_3123_3126_3127_3125_6693 7 - 0.00855156031294948 0.086940863181653 6803 betulin hsa05120 Epithelial cell signaling in Helicobacter pylori infection 5335_6714_4233_5603 4 - 0.0346894989957138 0.176338286561545 6804 betulin hsa04664 Fc epsilon RI signaling pathway 100137049_8681_5335_5608_5603 5 - 0.0122606524088222 0.0934874746172693 6805 betulin hsa04370 VEGF signaling pathway 9261_8681_5335_7422_5603_6714_100137049 7 - 0.000445597428867331 0.0271814431609072 6806 betulin hsa05310 Asthma 3123_3126_3127_3125 4 - 0.00221741389317698 0.0676311237418979 6807 betulin hsa04912 GnRH signaling pathway 818_8681_5603_6714_100137049_5608 6 - 0.0111435403662025 0.0934874746172693 6808 betulin hsa05330 Allograft rejection 3123_3126_3127_3125 4 - 0.00483472143330129 0.086940863181653 6809 betulin hsa04940 Type I diabetes mellitus 3123_3126_3127_3125 4 - 0.00779024418518547 0.086940863181653 6810 pronetalol hsa04660 T cell receptor signaling pathway 5532_29851_5588_4793 4 + 0.033613339015157 0.789913466856189 6811 pronetalol hsa04360 Axon guidance 5532_1949_5880_27289_1944 5 + 0.0151377843553523 0.711475864701558 6812 pronetalol hsa05332 Graft-versus-host disease 3105_3106_3126_3127_3125_3135_3123_649853 8 - 0.00409221978122733 0.0827193534024514 6813 pronetalol hsa04080 Neuroactive ligand-receptor interaction 3953_7067_5030_1081_135 5 - 0.0106285932996465 0.139943145112012 6814 pronetalol hsa05320 Autoimmune thyroid disease 1081_3105_3106_3126_3127_3125_3135_3123_649853 9 - 0.00466710511409341 0.0827193534024514 6815 pronetalol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_121504_3123_3126_3127_3125_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013 36 - 2.02553318879061e-12 1.60017121914458e-10 6816 pronetalol hsa03010 Ribosome 140801 1 - 0.044470325155338 0.439144460908963 6817 pronetalol hsa04020 Calcium signaling pathway 2778_2776_135 3 - 0.0192105922533342 0.216805255430486 6818 pronetalol hsa05330 Allograft rejection 3105_3106_3126_3127_3125_3135_3123_649853 8 - 0.00238847698755796 0.0827193534024514 6819 pronetalol hsa04940 Type I diabetes mellitus 3105_3106_3126_3127_3125_3135_3123_649853 8 - 0.0052354021140792 0.0827193534024514 6820 sulfachlorpyridazine hsa05332 Graft-versus-host disease 3126_3107_3113_3127_3125_3123 6 + 0.026742516163667 0.213940129309336 6821 sulfachlorpyridazine hsa04640 Hematopoietic cell lineage 3123_3568_2993_3126_3127_3559_3125_3589_921_3684_925_3674 12 + 0.00277267536484704 0.0520769325331436 6822 sulfachlorpyridazine hsa05320 Autoimmune thyroid disease 958_7252_3126_3107_3113_3127_3125_3123 8 + 0.0085192743778851 0.0766734694009659 6823 sulfachlorpyridazine hsa04310 Wnt signaling pathway 6093 1 + 0.00722922908188622 0.0743577848422583 6824 sulfachlorpyridazine hsa04740 Olfactory transduction 8392_157 2 + 1.40249863367009e-06 0.000100979901624246 6825 sulfachlorpyridazine hsa04514 Cell adhesion molecules (CAMs) 8516_958_3384_3688_3123_4099_3107_3126_3127_3125_5818_51208_3684_925_3113_5817 16 + 0.00289316291850798 0.0520769325331436 6826 sulfachlorpyridazine hsa05322 Systemic lupus erythematosus 958_85235_718_3123_715_8330_3126_3127_3125_8332_8290_8969_8331_8336_8329_3113 16 + 0.00476853581054457 0.063932837245796 6827 sulfachlorpyridazine hsa05310 Asthma 958_3123_3126_3127_3125_3113_8288 7 + 0.00168411536689211 0.0520769325331436 6828 sulfachlorpyridazine hsa05330 Allograft rejection 958_3113_3107_3126_3127_3125_3123 7 + 0.00532773643714967 0.063932837245796 6829 sulfachlorpyridazine hsa04940 Type I diabetes mellitus 3126_3107_3113_3127_3125_3123 6 + 0.0319724359728335 0.230201539004401 6830 sulfachlorpyridazine hsa05214 Glioma 5578_208_6655_4193_5336_810 6 - 0.036853826423075 0.684658246374358 6831 sulfachlorpyridazine hsa04740 Olfactory transduction 810_26212_4991 3 - 0.000992293251634676 0.0803757533824088 6832 sulfachlorpyridazine hsa05220 Chronic myeloid leukemia 3551_4088_208_6655_4193_1399_91 7 - 0.023916682144829 0.684658246374358 6833 citalopram hsa04740 Olfactory transduction 26212_8390_56656 3 + 8.44565771868327e-05 0.00658761302057295 6834 citalopram hsa04514 Cell adhesion molecules (CAMs) 5797_3107_6404_965_29851_3680_940_23114_23308_57502_933_26285_4099 13 + 0.0107024510729394 0.278263727896424 6835 citalopram hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_940_8359_8294_8367_554313_121504 15 + 0.00385760278719285 0.150446508700521 6836 citalopram hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8329_8294_8969_8370_8332_8359_8330_8331_8336_6737_121504_85235 22 - 2.76030398271082e-11 1.65618238962649e-09 6837 citalopram hsa04370 VEGF signaling pathway 10725_100137049_8681_5335_208 5 - 0.0406787517782198 0.996343808110715 6838 withaferin A hsa05332 Graft-versus-host disease 3553_3123_3107_3126_3127_3111_3125 7 + 0.0078941344057182 0.105255125409576 6839 withaferin A hsa04640 Hematopoietic cell lineage 3553_3690_3123_3126_3570_3125_3589_1604_3127 9 + 0.0473053804824483 0.270316459899705 6840 withaferin A hsa04612 Antigen processing and presentation 3123_3107_3126_3127_3111_3125_6892_3310_3304_3305_3303 11 + 0.00763701728102048 0.105255125409576 6841 withaferin A hsa05016 Huntington's disease 317 1 + 0.00163541300542244 0.0436110134779317 6842 withaferin A hsa04740 Olfactory transduction 81697_26529_816 3 + 1.40289260875621e-05 0.00112231408700497 6843 withaferin A hsa04514 Cell adhesion molecules (CAMs) 965_8506_3123_3107_3126_3127_3685_3125_23308_51208_3111_26285_923_5817 14 + 0.0166190881139396 0.143098835101821 6844 withaferin A hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_2215_8370_8366_3123_3126_3127_3111_3125_8359_8294_8367_554313_8368_121504_8341_8364 21 + 3.38501761705569e-05 0.00135400704682228 6845 withaferin A hsa05219 Bladder cancer 23604_2277_3576_5925_1950_7422 6 + 0.0250485360254935 0.166990240169957 6846 withaferin A hsa04115 p53 signaling pathway 1647_5366_317_3479_7249_5268_5054_8795 8 + 0.0290035544594278 0.178483412058017 6847 withaferin A hsa05310 Asthma 3123_3126_3127_3111_3125 5 + 0.023570801103468 0.166990240169957 6848 withaferin A hsa04150 mTOR signaling pathway 2277_5170_3479_7249_5293_6196_7422_5563 8 + 0.00706458721583423 0.105255125409576 6849 withaferin A hsa04010 MAPK signaling pathway 9479_1326_1847_3310_3304_3305_3303_4908_3553_2263_7046_1950_5534_3725_1647_5579_1843_5598_1649_1846_1845_8912_6196 23 + 0.0178873543877276 0.143098835101821 6850 withaferin A hsa05330 Allograft rejection 3123_3107_3126_3127_3111_3125 6 + 0.0168732659255152 0.143098835101821 6851 withaferin A hsa04940 Type I diabetes mellitus 3553_3123_3107_3126_3127_3111_3125 7 + 0.00981136625246247 0.112129900028143 6852 withaferin A hsa05332 Graft-versus-host disease 5551_3126_3127_3123_3125 5 - 0.0356229428104666 0.40500662005613 6853 withaferin A hsa04740 Olfactory transduction 51806 1 - 5.60600127383518e-06 0.000448480101906814 6854 withaferin A hsa05322 Systemic lupus erythematosus 85235_3123_3126_3127_3125_8332_8969_8331_8336_8329_8330_55766 12 - 0.0211840238394352 0.40500662005613 6855 withaferin A hsa04360 Axon guidance 9353_1949_2042_2043_6405_1944_6387_2048_23365_5534_57556 11 - 0.026702102502854 0.40500662005613 6856 withaferin A hsa04530 Tight junction 9076 1 - 0.0455632447563146 0.40500662005613 6857 withaferin A hsa05310 Asthma 3123_3126_3127_3125 4 - 0.0423792929046818 0.40500662005613 6858 withaferin A hsa05012 Parkinson's disease 2861 1 - 0.0455539346708327 0.40500662005613 6859 withaferin A hsa05330 Allograft rejection 5551_3126_3127_3123_3125 5 - 0.0253476072181581 0.40500662005613 6860 withaferin A hsa04940 Type I diabetes mellitus 5551_3126_3127_3123_3125 5 - 0.0415969880542076 0.40500662005613 6861 CP-320650-01 hsa05200 Pathways in cancer 596_1612_330_1488_3674_4149_3576_5371_2033_2249_4842_581_998_4193_7046_8453_8312_91_3725_1284_5599_6502_1029_3685_1387_2251 26 + 0.0245892461916777 0.221303215725099 6862 CP-320650-01 hsa04910 Insulin signaling pathway 5599_32_57818_8660_10211_810 6 + 0.00651869423868515 0.0977804135802773 6863 CP-320650-01 hsa05016 Huntington's disease 1213_4899_581_6392_651820_246721_5331_7350_3708_2033_1387_163 12 + 0.0217996408271017 0.217996408271017 6864 CP-320650-01 hsa04740 Olfactory transduction 26211_7932_26476_3000_810_816 6 + 5.46950334370951e-13 4.92255300933856e-11 6865 CP-320650-01 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8341_8347_8346_8344_8339_8968_8370_718_717_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3018_2215_3013_720_721_729 38 + 6.01444033206534e-05 0.0027064981494294 6866 CP-320650-01 hsa05221 Acute myeloid leukemia 5371 1 + 0.0191969768468723 0.215965989527313 6867 CP-320650-01 hsa04340 Hedgehog signaling pathway 8945 1 + 0.0183000115413243 0.215965989527313 6868 CP-320650-01 hsa05012 Parkinson's disease 6392_7345_651820_6531 4 + 0.000861118834607709 0.0258335650382313 6869 CP-320650-01 hsa04260 Cardiac muscle contraction 4635 1 + 0.00122526787103464 0.0275685270982794 6870 CP-320650-01 hsa03010 Ribosome 140801_6224_6144 3 + 0.00417535169444791 0.0751563305000624 6871 CP-320650-01 hsa05217 Basal cell carcinoma 8312 1 + 0.0278049125821279 0.227494739308319 6872 CP-320650-01 hsa04640 Hematopoietic cell lineage 3589_2057 2 - 0.0228817355335266 0.503398181737585 6873 CP-320650-01 hsa04080 Neuroactive ligand-receptor interaction 2550_5618_64106_2908_4886_3354_7067_9170 8 - 0.000250579741123977 0.011025508609455 6874 CP-320650-01 hsa04740 Olfactory transduction 818_5613_5616_816 4 - 1.94449235671469e-11 1.71115327390893e-09 6875 CP-320650-01 hsa05322 Systemic lupus erythematosus 94239_718_3014_3020_3021_8342 6 - 0.0298905049485099 0.526072887093774 6876 CP-320650-01 hsa04062 Chemokine signaling pathway 5970_2782_5829_5613_6655_5616_7852_208_10681_8976 10 - 0.045589587670693 0.573126245002998 6877 CP-320650-01 hsa03010 Ribosome 6187_440589 2 - 0.00812606347116824 0.238364528487602 6878 CP-320650-01 hsa04912 GnRH signaling pathway 2002_776_1432_8399_5578_5599_5613_6655_1839_5616_3709_818_3708_1956_2767_3725_6714_816 18 - 0.0389944352684227 0.571918383936866 6879 piribedil hsa04520 Adherens junction 4301_4088_998_5797_5770_6714_2241 7 + 0.0476872632304665 0.870292553956014 6880 piribedil hsa04740 Olfactory transduction 26211_26212_7932_8392_818_26476 6 + 0.0144282608296728 0.526631520283057 6881 piribedil hsa05322 Systemic lupus erythematosus 717_3013_8358_8968_8341_8350_8351_8352_8353_8354_8355_8356_8357 13 + 0.00907734998465825 0.526631520283057 6882 piribedil hsa04630 Jak-STAT signaling pathway 6776 1 + 0.0322573084680917 0.784927839390231 6883 piribedil hsa04080 Neuroactive ligand-receptor interaction 2561_5618 2 - 0.00655521094587426 0.179175765853896 6884 piribedil hsa04740 Olfactory transduction 818_409 2 - 0.000132086858594735 0.00541556120238413 6885 piribedil hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3123_8969_8370_8332_8359_8330_8331_8336_554313_6738_121504_85235 23 - 3.25033716350147e-08 2.66527647407121e-06 6886 fluvoxamine hsa04740 Olfactory transduction 818 1 + 0.0471055774427457 0.644042160248319 6887 fluvoxamine hsa04360 Axon guidance 6091_5532_8829_57556_2048 5 + 0.0486611823873638 0.644042160248319 6888 fluvoxamine hsa05120 Epithelial cell signaling in Helicobacter pylori infection 528_50617_1956_1432 4 + 0.0237635213943009 0.644042160248319 6889 fluvoxamine hsa04940 Type I diabetes mellitus 3135_3107_3382 3 + 0.0308945320225961 0.644042160248319 6890 fluvoxamine hsa05322 Systemic lupus erythematosus 85235_8330_3111_8332_8969_8331_8329_720_721_8336 10 - 0.0293577358943377 0.391405833602597 6891 fluvoxamine hsa05212 Pancreatic cancer 5728_595_6655_5155_6934_1869_2260 7 - 0.0297835199415654 0.391405833602597 6892 fluvoxamine hsa05215 Prostate cancer 5728_595_6655_5155_6934_1869_2260 7 - 0.028336040039125 0.391405833602597 6893 fluvoxamine hsa04350 TGF-beta signaling pathway 4090_4088_9475_655_653_7042_57154 7 - 0.0269370215990315 0.391405833602597 6894 fluvoxamine hsa04020 Calcium signaling pathway 2776 1 - 0.0321703424878847 0.391405833602597 6895 fluvoxamine hsa05213 Endometrial cancer 5728_6655_595_6934_324 5 - 0.0316120819275467 0.391405833602597 6896 fluvoxamine hsa05220 Chronic myeloid leukemia 595_4088_6655_1399_7042_1869 6 - 0.0400164283672262 0.41731418154393 6897 etofenamate hsa05211 Renal cell carcinoma 3725_2549_998 3 + 0.0481494507881519 0.927659059430928 6898 etofenamate hsa04660 T cell receptor signaling pathway 3725_27040_998_2353 4 + 0.0355822481049909 0.927659059430928 6899 etofenamate hsa04740 Olfactory transduction 4991 1 - 0.000401513531624439 0.0122461627145454 6900 etofenamate hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 0.000146456077471123 0.0089338207257385 6901 5186223 hsa03440 Homologous recombination 5890_5892_5888 3 + 0.0425094633198815 0.517198470391892 6902 5186223 hsa03320 PPAR signaling pathway 335_2710_5170_5360_6319 5 + 0.040775367375998 0.517198470391892 6903 5186223 hsa04510 Focal adhesion 5170_3691_3693_1289_3685_9475_7410_3679_208_1291_10627 11 + 0.0254257578193766 0.476385917243537 6904 5186223 hsa04512 ECM-receptor interaction 3691_3693_1289_3685_3679_1291 6 + 0.0261033379311527 0.476385917243537 6905 5186223 hsa04810 Regulation of actin cytoskeleton 9459_3691_8396_3693_3685_9475_7410_3679_2263_2246_2261_2264_10627 13 + 0.00845293632045904 0.476385917243537 6906 5186223 hsa04060 Cytokine-cytokine receptor interaction 3953 1 + 0.0156551408022481 0.476385917243537 6907 5186223 hsa04120 Ubiquitin mediated proteolysis 8453_8554_7322 3 - 0.0151634054902633 0.288104704315003 6908 5186223 hsa04350 TGF-beta signaling pathway 4091_4090 2 - 0.04237117991002 0.385229925867774 6909 celastrol hsa04612 Antigen processing and presentation 3135_3308_3310_3304_3305_3303 6 + 0.0406426660490277 0.489996747899652 6910 celastrol hsa04710 Circadian rhythm - mammal 406_9572_79365_8553 4 + 0.000883350748846814 0.0202875967475756 6911 celastrol hsa05219 Bladder cancer 1026_5228_4193_7422 4 + 0.0332562067373262 0.489996747899652 6912 celastrol hsa04115 p53 signaling pathway 1647_1026_5366_4193_355_10912_5054_8795 8 + 0.000966076035598838 0.0202875967475756 6913 celastrol hsa04010 MAPK signaling pathway 2353_2872_3164_1848_1843_1647_1847_1846_1844_8913_355_10912_1649_2005_3310_3304_3305_3303_8074 19 + 0.000289326826239485 0.0182275900530876 6914 celastrol hsa04610 Complement and coagulation cascades 5054_728_2161_1604_2152 5 + 0.046666356942824 0.489996747899652 6915 celastrol hsa05332 Graft-versus-host disease 3123_3126_3127_3125 4 - 0.0296461203912429 0.251509486213916 6916 celastrol hsa04640 Hematopoietic cell lineage 966_3123_3126_3127_3125_3655 6 - 0.0319960182324512 0.251509486213916 6917 celastrol hsa05322 Systemic lupus erythematosus 3123_3125_3126_3017_3014_3127_8343_8339_8347_8346_8345_8344 12 - 0.000664931285902532 0.0492049151567874 6918 celastrol hsa05212 Pancreatic cancer 207_3551_9134_3480_5295_1869_596 7 - 0.0115181286964837 0.170468304707959 6919 celastrol hsa05215 Prostate cancer 207_3551_9134_3480_5295_1869_596 7 - 0.0109093596382058 0.170468304707959 6920 celastrol hsa05310 Asthma 3123_3126_3127_3125 4 - 0.0106823533395766 0.170468304707959 6921 celastrol hsa04060 Cytokine-cytokine receptor interaction 3455 1 - 0.0158221910627452 0.195140356440524 6922 celastrol hsa05330 Allograft rejection 3123_3126_3127_3125 4 - 0.0220020307975412 0.232592897002578 6923 celastrol hsa05222 Small cell lung cancer 5295_3551_207_9134_6502_596_1869_3655 8 - 0.00277945273298921 0.102839751120601 6924 celastrol hsa04940 Type I diabetes mellitus 3123_3126_3127_3125 4 - 0.033987768407286 0.251509486213916 6925 5286656 hsa05131 Shigellosis 7278_113457 2 + 0.00836880576855953 0.0585816403799167 6926 5286656 hsa05130 Pathogenic Escherichia coli infection 7278_113457 2 + 0.00836880576855953 0.0585816403799167 6927 5286656 hsa04540 Gap junction 7278_113457 2 + 0.0214227309876145 0.0999727446088677 6928 5286656 hsa05200 Pathways in cancer 2260_673_6934_5602 4 - 0.011815678773352 0.0498884214874862 6929 5286656 hsa04910 Insulin signaling pathway 673_5602_5509 3 - 0.00621888157992256 0.0393862500061762 6930 5286656 hsa04520 Adherens junction 2260_6934 2 - 0.0203146998440744 0.0643298828395689 6931 5286656 hsa05212 Pancreatic cancer 2260_6934_673 3 - 0.0018641248381595 0.0236122479500203 6932 5286656 hsa05215 Prostate cancer 2260_6934_673 3 - 0.0018065696916214 0.0236122479500203 6933 5286656 hsa05221 Acute myeloid leukemia 6934_673 2 - 0.0115883897756267 0.0498884214874862 6934 5286656 hsa05218 Melanoma 2260_673 2 - 0.0163155965904636 0.0563629700397833 6935 5286656 hsa05216 Thyroid cancer 6934_673 2 - 0.00309438887668032 0.029396694328463 6936 5286656 hsa04920 Adipocytokine signaling pathway 3717_5602 2 - 0.0146611745767673 0.0557124633917157 6937 5286656 hsa04012 ErbB signaling pathway 673_5602 2 - 0.0236801371359345 0.069218862397347 6938 5286656 hsa04010 MAPK signaling pathway 673_2260_5602_3925 4 - 0.00605921900730022 0.0393862500061762 6939 5286656 hsa05213 Endometrial cancer 6934_673 2 - 0.00916709723470294 0.0497642421312445 6940 5286656 hsa05210 Colorectal cancer 673_6934_5602 3 - 0.00158755215351027 0.0236122479500203 6941 5149715 hsa05216 Thyroid cancer 7849 1 + 0.0382793544930585 0.153117417972234 6942 5149715 hsa04010 MAPK signaling pathway 6789_7786_4137 3 - 0.0370708007911794 0.259495605538256 6943 5162773 hsa05016 Huntington's disease 246721_5439_548644_27113 4 - 0.0245195248836238 0.116467743197213 6944 5162773 hsa04110 Cell cycle 472_651610_5933_2810 4 - 0.00543178222787902 0.0344012874432338 6945 5162773 hsa04115 p53 signaling pathway 472_651610_2810_27113 4 - 0.000805896669784584 0.00765601836295355 6946 5162773 hsa03020 RNA polymerase 246721_5439_548644 3 - 0.000801561152603652 0.00765601836295355 6947 pararosaniline hsa04115 p53 signaling pathway 5366_1647_6477 3 + 0.0131138508792154 0.580217138071817 6948 pararosaniline hsa04350 TGF-beta signaling pathway 7059_83729_3397 3 + 0.0236823321661966 0.580217138071817 6949 pararosaniline hsa05200 Pathways in cancer 112399_9134_6502_5295_1857_652_2261 7 - 0.0128442378531243 0.484400866420423 6950 pararosaniline hsa05222 Small cell lung cancer 6502_5295_9134 3 - 0.0285101249395545 0.484400866420423 6951 5152487 hsa05131 Shigellosis 7278_113457_347733 3 + 4.1183418000021e-05 0.000102958545000052 6952 5152487 hsa05130 Pathogenic Escherichia coli infection 7278_113457_347733 3 + 4.1183418000021e-05 0.000102958545000052 6953 5152487 hsa04540 Gap junction 7278_113457_347733 3 + 0.000176531467367806 0.000294219112279677 6954 5213008 hsa04010 MAPK signaling pathway 4214_355_5606_5922 4 + 0.00456352164380047 0.077579867944608 6955 5213008 hsa04912 GnRH signaling pathway 4214_5606 2 + 0.0303717978679738 0.258160281877777 6956 5213008 hsa04330 Notch signaling pathway 182_1857 2 - 0.0264392232952279 0.511532546266598 6957 5213008 hsa04630 Jak-STAT signaling pathway 3717_3601_2057_10379 4 - 0.00905382353781382 0.371206765050367 6958 5186324 hsa04010 MAPK signaling pathway 57551_355_5922 3 + 0.040689395932479 0.345186098915542 6959 5186324 hsa04062 Chemokine signaling pathway 7074_7409 2 - 0.0219076161548075 0.179879655743178 6960 5186324 hsa04810 Regulation of actin cytoskeleton 7074_7409 2 - 0.0276737931912582 0.179879655743178 6961 5114445 hsa04360 Axon guidance 10725_3985_6092_6091_5534 5 - 0.0199584747393848 0.45904491900585 6962 5114445 hsa03020 RNA polymerase 246721_5439_548644 3 - 0.00571995866419287 0.263118098552872 6963 nicotinic acid hsa05332 Graft-versus-host disease 3113_3119 2 + 0.0402966914964459 0.237140006736681 6964 nicotinic acid hsa04514 Cell adhesion molecules (CAMs) 6402_923_3113_3119 4 + 0.017719976278563 0.212164737777162 6965 nicotinic acid hsa05322 Systemic lupus erythematosus 474382_474381_3119_83740_3113_8342 6 + 0.000738892073278967 0.0280778987846007 6966 nicotinic acid hsa04360 Axon guidance 64221_4233_998_9901 4 + 0.0164761108954453 0.212164737777162 6967 nicotinic acid hsa05310 Asthma 3113_3119 2 + 0.0223331302923328 0.212164737777162 6968 nicotinic acid hsa05330 Allograft rejection 3113_3119 2 + 0.0338442544261615 0.237140006736681 6969 nicotinic acid hsa04940 Type I diabetes mellitus 3113_3119 2 + 0.0436836854514939 0.237140006736681 6970 nicotinic acid hsa05211 Renal cell carcinoma 3725_405_5290 3 - 0.0344000434083385 0.37209965170932 6971 nicotinic acid hsa05322 Systemic lupus erythematosus 85235_718_8969_8332_8330_8331_8329_8336 8 - 9.49976381547742e-05 0.00522487009851258 6972 nicotinic acid hsa04620 Toll-like receptor signaling pathway 7100_3725_5290_5602 4 - 0.0182469272275819 0.334526999172335 6973 nicotinic acid hsa04930 Type II diabetes mellitus 8660_5290_5602 3 - 0.0105782063332278 0.290900674163764 6974 nicotinic acid hsa05210 Colorectal cancer 3725_5290_5602 3 - 0.0498215804023981 0.37209965170932 6975 nicotinic acid hsa04610 Complement and coagulation cascades 5265_2152_718 3 - 0.0310029701959639 0.37209965170932 6976 proscillaridin hsa04080 Neuroactive ligand-receptor interaction 2550_2912_1081_1813_2563_2908_3360_5030_2692 9 + 0.0328752827275644 0.441031095837449 6977 proscillaridin hsa05016 Huntington's disease 1212_3708_1387_2033_509 5 + 0.0187918387997066 0.389930655093912 6978 proscillaridin hsa04740 Olfactory transduction 26212_9635_8392_5566 4 + 7.29033137555902e-08 3.02548752085699e-06 6979 proscillaridin hsa04514 Cell adhesion molecules (CAMs) 9076_4950_3107 3 + 0.0361441380693443 0.441031095837449 6980 proscillaridin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8349_8329_8294_121504_8343_8342_8347_8346_8344_8339_723790_8969_8968_8370_92815_8358_8359_8330_8331_8336_8337_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_2215_2214_3012_3013 46 + 7.28663896718922e-15 6.04791034276705e-13 6981 proscillaridin hsa04664 Fc epsilon RI signaling pathway 27040 1 + 0.0431212049314491 0.441031095837449 6982 proscillaridin hsa05012 Parkinson's disease 6622_509 2 + 0.00881875325100683 0.243985506611189 6983 proscillaridin hsa04260 Cardiac muscle contraction 481 1 + 0.0442645730376372 0.441031095837449 6984 proscillaridin hsa04060 Cytokine-cytokine receptor interaction 1436_3589_3569_8795_7046_3977_7042_1489_92_51330 10 + 0.0478226489462294 0.441031095837449 6985 proscillaridin hsa04650 Natural killer cell mediated cytotoxicity 836_5295_355_5290_10451_6452_7409_5336_2534 9 - 0.0284364645531753 0.145341929938452 6986 proscillaridin hsa05010 Alzheimer's disease 836_841_8772_317_8883_5331_355_351_7132_23236 10 - 0.00399505869596825 0.0334132181844617 6987 proscillaridin hsa04080 Neuroactive ligand-receptor interaction 7442_136 2 - 6.59262206526058e-12 3.03260615001987e-10 6988 proscillaridin hsa05320 Autoimmune thyroid disease 355 1 - 0.0179018282462908 0.109797879910584 6989 proscillaridin hsa05016 Huntington's disease 836_841_317_5331_9001_5481_23236 7 - 7.31856883234949e-05 0.00168327083144038 6990 proscillaridin hsa04740 Olfactory transduction 818_5613_5616_157 4 - 1.52543804008185e-16 1.4034029968753e-14 6991 proscillaridin hsa04514 Cell adhesion molecules (CAMs) 933_214_1365_57863_4099 5 - 0.00127169301316905 0.0149489262439607 6992 proscillaridin hsa04510 Focal adhesion 5295_7409_596_83660_2324_5155_5154_5290_9475_10451_23396_3673_55742_4233_2534 15 - 0.0198514125475087 0.114145622148175 6993 proscillaridin hsa05322 Systemic lupus erythematosus 55506_721_3021_3020_720_6737 6 - 0.00129990662990963 0.0149489262439607 6994 proscillaridin hsa03410 Base excision repair 55247_143_5425_5427_4968_4913_10714_7515_27301_10038_4595_8930_23583 13 - 0.00568151091935268 0.0400320930043888 6995 proscillaridin hsa04530 Tight junction 93643_50855_51776_1019_9223_27134_1365 7 - 0.0060918402397983 0.0400320930043888 6996 proscillaridin hsa04512 ECM-receptor interaction 3673_960 2 - 0.00357831261393597 0.0329204760482109 6997 proscillaridin hsa04630 Jak-STAT signaling pathway 3717_5295_3566_2057_598_6777_5290_6772_10379_4609_8835 11 - 0.0384761048731829 0.186305349912254 6998 proscillaridin hsa05012 Parkinson's disease 836_317_5481 3 - 5.29249380756442e-05 0.00162303143431976 6999 proscillaridin hsa04260 Cardiac muscle contraction 784 1 - 0.000526225949962934 0.00968255747931798 7000 proscillaridin hsa04060 Cytokine-cytokine receptor interaction 1436_27242_3566_2057_2324_5155_5154_8741_8742_657_355_8718_8792_7132_4233_7048 16 - 0.000907089232460396 0.0139087015643927 7001 proscillaridin hsa03010 Ribosome 6168_6137_9349 3 - 0.00200945299132784 0.0205410750224624 7002 proscillaridin hsa04020 Calcium signaling pathway 5331_5256_5613_5616_818_136_113_5336_3707_5481_23236 11 - 0.00490872021672055 0.0376335216615242 7003 proscillaridin hsa03050 Proteasome 23198 1 - 0.0258991600841858 0.140160160455594 7004 isoflupredone hsa03450 Non-homologous end-joining 7518_3981_10111 3 + 0.0094830380088921 0.635363546595771 7005 sanguinarine hsa05010 Alzheimer's disease 5532_3708 2 + 0.0181143121787415 0.24528468886739 7006 sanguinarine hsa04080 Neuroactive ligand-receptor interaction 886_64106_5644_2568_2742_2688_1442_9568_2689_2914_2918_4887_3357_3351_6869_5733_7442_2555_2897_2892_8484_680 22 + 0.0127762186438684 0.24528468886739 7007 sanguinarine hsa05016 Huntington's disease 3708 1 + 0.00240987830979817 0.0626568360547524 7008 sanguinarine hsa04740 Olfactory transduction 26211_81797_8590_81696 4 + 0.000105471384170974 0.00411338398266799 7009 sanguinarine hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8360_8368_554313_8362_8329_8294_121504_8366_8969_8968_8370_717_8358_8359_8330_8331_8336_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_83740_3117_3013 38 + 1.9320513607816e-15 1.50700006140965e-13 7010 sanguinarine hsa04110 Cell cycle 7042 1 + 0.0455133262630222 0.394448827612859 7011 sanguinarine hsa05012 Parkinson's disease 5413 1 + 0.0220127284880991 0.24528468886739 7012 sanguinarine hsa04060 Cytokine-cytokine receptor interaction 8743_7852_7850_2829_2323_3554_3579_3574_3576_3558_2688_2689_650_6362_6367_3082_8771_3624_7042_3456_6357_3448 22 + 0.0201695428198794 0.24528468886739 7013 sanguinarine hsa04950 Maturity onset diabetes of the young 5313_3170_3375_5080 4 + 0.0379228418510527 0.369747708047764 7014 sanguinarine hsa04640 Hematopoietic cell lineage 960_2057_2993_4254_1604_3655 6 - 0.00980801075268838 0.0900916784071918 7015 sanguinarine hsa05010 Alzheimer's disease 776_5594_841_5534_6390_509_2776_808_5663_51107_355_3709_6868_489_488_102_801_23236_805_3710 20 - 0.023748933356441 0.167060463730097 7016 sanguinarine hsa04080 Neuroactive ligand-receptor interaction 1241_5618_3355_4157_7068_134_2908_2925_7434_3953_56288_7433_2690 13 - 1.67361153121087e-08 7.61493246700946e-07 7017 sanguinarine hsa04612 Antigen processing and presentation 4801_3451_5993_3119_6890_3133 6 - 0.00710094618817402 0.0900916784071918 7018 sanguinarine hsa04670 Leukocyte transendothelial migration 9076_8503_5578_5296_394_998_9475_1500_5781_5747_6093_5600 12 - 0.023865780532871 0.167060463730097 7019 sanguinarine hsa05016 Huntington's disease 4899_51164_841_6390_3064_2776_23186_509_6874_23236 10 - 3.07325693227138e-06 9.32221269455652e-05 7020 sanguinarine hsa04740 Olfactory transduction 26212_157_5613_5567_5616_808_818_109_801_805 10 - 1.20292601816661e-18 1.09466267653162e-16 7021 sanguinarine hsa04514 Cell adhesion molecules (CAMs) 9076_2734_214_3119_4897_3685_23308_5792_3133_3655_25945_9019_5817 13 - 0.0167951982078188 0.138942094264683 7022 sanguinarine hsa05310 Asthma 3119 1 - 0.0498370628585881 0.323940908580823 7023 sanguinarine hsa05012 Parkinson's disease 7327_7332_6390_7345_51465_509_9627 7 - 7.35043229184841e-05 0.00133777867711641 7024 sanguinarine hsa04260 Cardiac muscle contraction 776_6548_481_488 4 - 0.00177651853885292 0.026943864505936 7025 sanguinarine hsa04060 Cytokine-cytokine receptor interaction 8792_5618_3451_2057_3454_3953_27242_6358_3572_91_355_7422_7042_8718_90_4254_6359_4233_7048_2690 20 - 1.0767002389397e-05 0.000244949304358782 7026 sanguinarine hsa03010 Ribosome 9349_6137_6125_6168_439992_6160_6189_6171 8 - 0.008797933843906 0.0900916784071918 7027 sanguinarine hsa04610 Complement and coagulation cascades 727_1604_4179_7035 4 - 0.00990018444035075 0.0900916784071918 7028 sulfamethizole hsa05332 Graft-versus-host disease 3812_3824_3113_3107_3119 5 + 0.0165109252605139 0.586137846748244 7029 sulfamethizole hsa04080 Neuroactive ligand-receptor interaction 2911_2901_7442_5540_11255_2890_4142_3355_2740_1268_9002_7433_680_6755_5644 15 + 0.0343421336994133 0.609572873164586 7030 sulfamethizole hsa04612 Antigen processing and presentation 3812_3824_3809_3119_3805_3107_3113 7 + 0.0337402213380085 0.609572873164586 7031 sulfamethizole hsa04740 Olfactory transduction 810 1 + 8.36278484608592e-05 0.005937577240721 7032 sulfamethizole hsa03440 Homologous recombination 5890_8940_5893_25788 4 - 0.0181643750751535 0.460164168570555 7033 sulfamethizole hsa04080 Neuroactive ligand-receptor interaction 7068 1 - 0.00357193614612691 0.135733573552823 7034 sulfamethizole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_94239_8366_8368_8294_121504_8367_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013 26 - 2.46173547383915e-11 1.87091896011775e-09 7035 decamethonium bromide hsa04120 Ubiquitin mediated proteolysis 7320 1 + 0.0480915972365668 0.949809045422194 7036 decamethonium bromide hsa04740 Olfactory transduction 7932 1 + 2.50334864603717e-06 9.88822715184682e-05 7037 decamethonium bromide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_3018_85235_3119_1511 24 + 8.16218405030965e-08 6.44812539974462e-06 7038 decamethonium bromide hsa05012 Parkinson's disease 4695 1 + 0.0465845473413447 0.949809045422194 7039 decamethonium bromide hsa03440 Homologous recombination 5890_5425 2 - 0.0405160119399457 0.641975820116637 7040 decamethonium bromide hsa04640 Hematopoietic cell lineage 3589_2993_3553_925_3675 5 - 0.00298722445748239 0.128450651671743 7041 noscapine hsa04660 T cell receptor signaling pathway 6655_1432_5293_4793 4 + 0.0441069738331619 0.50163626326602 7042 noscapine hsa05223 Non-small cell lung cancer 6789_6655_5293 3 + 0.0286799937218934 0.50163626326602 7043 noscapine hsa04010 MAPK signaling pathway 2872_1432_3552_6789_6655_1843_5536_408 8 + 0.0168850273166836 0.50163626326602 7044 noscapine hsa04620 Toll-like receptor signaling pathway 7097_3929_1432_5293_958 5 + 0.00819515068050539 0.50163626326602 7045 noscapine hsa04080 Neuroactive ligand-receptor interaction 2908 1 - 0.0323288297744208 1 7046 noscapine hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0352056766874895 1 7047 tomatidine hsa05322 Systemic lupus erythematosus 3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 11 + 3.11585392213201e-11 1.02823179430356e-09 7048 tomatidine hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1956_836 2 + 0.0388519094615818 0.523549210936163 7049 tomatidine hsa05010 Alzheimer's disease 776_5594_4712_5664_5533_355_5534 7 - 0.0121738301505082 0.159998910549536 7050 tomatidine hsa04080 Neuroactive ligand-receptor interaction 5618_4886 2 - 2.16437523956836e-08 9.95612610201445e-07 7051 tomatidine hsa04740 Olfactory transduction 5566_157 2 - 1.97134732548433e-13 1.81363953944558e-11 7052 tomatidine hsa05322 Systemic lupus erythematosus 55506_6738_8348_8329_8343_8347_8346_8344_8339_3123_8969_8968_8358_8330_8331_8336_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3017_3014 29 - 0.000644844889943161 0.015583744777559 7053 tomatidine hsa04512 ECM-receptor interaction 7059_960 2 - 0.0329654629932592 0.303282259537985 7054 tomatidine hsa04062 Chemokine signaling pathway 5594_157_6655_6772_9475_5747_5566 7 - 0.00518737822037321 0.0954477592548671 7055 tomatidine hsa05012 Parkinson's disease 2861_4712 2 - 0.000677554120763435 0.015583744777559 7056 tomatidine hsa04260 Cardiac muscle contraction 776_481 2 - 0.0324685104535887 0.303282259537985 7057 tomatidine hsa04060 Cytokine-cytokine receptor interaction 5618_5154_8741_3572_657_355_50616_8742_7040_7042_4254_4233 12 - 0.00666364560477377 0.102175899273198 7058 tomatidine hsa03010 Ribosome 6204_6234_6203 3 - 0.0240670574959803 0.276771161203773 7059 tomatidine hsa04020 Calcium signaling pathway 776_5256_5578_5566_5534_2767_5533_5336_493 9 - 0.039637572551102 0.331514243154671 7060 papaverine hsa04130 SNARE interactions in vesicular transport 8417_10228_6844 3 + 0.00590438961893103 0.171227298949 7061 papaverine hsa04080 Neuroactive ligand-receptor interaction 5618 1 - 0.000541265217796184 0.0405948913347138 7062 papaverine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3014_8359_8294_8367_554313_121504 15 - 0.00160943298268781 0.0603537368507929 7063 papaverine hsa03020 RNA polymerase 246721_5439_548644_5441 4 - 0.0402623499454073 0.754919061476387 7064 papaverine hsa04020 Calcium signaling pathway 5331 1 - 0.0113794390033726 0.284485975084315 7065 tetrahydroalstonine hsa05332 Graft-versus-host disease 3135_3105_3106_3119_649853 5 + 4.38701805965504e-05 0.000753489993083024 7066 tetrahydroalstonine hsa04650 Natural killer cell mediated cytotoxicity 3135_3105_3106_5534 4 + 0.0317438454872526 0.190463072923516 7067 tetrahydroalstonine hsa05320 Autoimmune thyroid disease 3135_3105_3106_3119_649853 5 + 0.000121869717954726 0.00127963203852462 7068 tetrahydroalstonine hsa04612 Antigen processing and presentation 3135_3105_3106_3119_649853 5 + 0.00115197823131576 0.00967661714305238 7069 tetrahydroalstonine hsa04514 Cell adhesion molecules (CAMs) 3135_3105_3106_3119_649853 5 + 0.00628581952778077 0.0440007366944654 7070 tetrahydroalstonine hsa04210 Apoptosis 472_651610_5534 3 + 0.0424579227294816 0.222904094329778 7071 tetrahydroalstonine hsa05330 Allograft rejection 3135_3105_3106_3119_649853 5 + 2.82671951068531e-05 0.000753489993083024 7072 tetrahydroalstonine hsa04940 Type I diabetes mellitus 3135_3105_3106_3119_649853 5 + 5.38207137916446e-05 0.000753489993083024 7073 tetrahydroalstonine hsa04070 Phosphatidylinositol signaling system 5331_8394_51763_3707 4 - 0.0331137236083492 0.858888714318034 7074 tetrahydroalstonine hsa04210 Apoptosis 472_5575_1677_651610_8837 5 - 0.0140087273137687 0.798497456884816 7075 arecoline hsa04740 Olfactory transduction 818_5137 2 + 8.90276280290637e-05 0.00685512735823791 7076 arecoline hsa04912 GnRH signaling pathway 5331_8398_3710_6655_3709_818_108_5337_5320_3725 10 + 0.0119581587794511 0.460389113008867 7077 arecoline hsa04730 Long-term depression 2911_8398_3710_3480_5331_3709_5320 7 + 0.0249363134385589 0.640032044923012 7078 arecoline hsa05131 Shigellosis 7278_6093_7430_113457 4 - 0.0167854504753102 0.341304159664641 7079 arecoline hsa05130 Pathogenic Escherichia coli infection 7278_6093_7430_113457 4 - 0.0167854504753102 0.341304159664641 7080 arecoline hsa03450 Non-homologous end-joining 27343_7518 2 - 0.0276741250073019 0.422030406361354 7081 arecoline hsa04540 Gap junction 7278_113457_2776_3709_10746_6714 6 - 0.00571874819434468 0.341304159664641 7082 anisomycin hsa04916 Melanogenesis 23236_4286_1856_10488_5332_2033_6934_8324_1906_1499_1387_1385_8323_7306 14 + 0.0353464910035824 0.14138596401433 7083 anisomycin hsa04640 Hematopoietic cell lineage 1435_2057_3589_3569_3570_3684_3678_915_7124_1604_3675 11 + 0.0398173758501511 0.152633274092246 7084 anisomycin hsa03320 PPAR signaling pathway 51703_7316_51_2170_5465_1376_1375_6257 8 + 0.0433348376595286 0.159472202587065 7085 anisomycin hsa05010 Alzheimer's disease 22926_5533_4698_836_6622_6390_2081_9451_5663_5532_3708_3709_23385_5534_5332_6868_7124_348_4842_23236 20 + 0.000521039849582576 0.00684795230879957 7086 anisomycin hsa04080 Neuroactive ligand-receptor interaction 2550_1241_7442_3355_1081_2917_3953_1131_2908_5025_799_7434_5021_7067_2741_5030_7433_624_7068_1909_623 21 + 3.55179290462639e-08 1.20469544571068e-06 7087 anisomycin hsa05016 Huntington's disease 4899_246721_5332_23186_6875_10126_6908_5430_836_1639_5439_6667_10488_2033_55567_3708_548644_23236_51164_6390_4698_1385_1387 23 + 0.00109519419171486 0.0111953184041963 7088 anisomycin hsa04740 Olfactory transduction 26212_1179_4991 3 + 2.45399105777822e-32 2.25767177315596e-30 7089 anisomycin hsa04514 Cell adhesion molecules (CAMs) 9076_6385_3688_3383_23308_3105_3106_3107_3685_9080_3135_3134_1364_5817_22871_3133_3684_50848_649853 19 + 0.0301493139377239 0.137733336386167 7090 anisomycin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8335_8349_8348_8329_8294_8351_8343_8342_8341_8347_87_8345_8344_8353_723790_3021_3020_92815_8969_8968_8346_55766_8370_8352_8358_8359_8330_8331_8336_8337_8334_554313_8350_121504_7124_8339_8354_8355_8356_8357_8332_85235_85236_3012_3013_3017_3014_720_721_8970 59 + 0.000866228684478739 0.0099616298715055 7091 anisomycin hsa04710 Circadian rhythm - mammal 8864_5187_8553_406_1408_1453_79365_1407_9572_8863 10 + 0.00715311894568445 0.05062207253869 7092 anisomycin hsa03410 Base excision repair 27343_4595 2 + 0.0230270751447816 0.12461711254823 7093 anisomycin hsa03030 DNA replication 1763 1 + 0.00579396425813183 0.0444203926456774 7094 anisomycin hsa05110 Vibrio cholerae infection 535_7082_9414_55176_51606 5 + 0.0165793451299545 0.101686650130388 7095 anisomycin hsa05310 Asthma 7124 1 + 0.0204079031325745 0.117345443012303 7096 anisomycin hsa04062 Chemokine signaling pathway 8503_1147_5293_5290_7852_5332_2309_7454_4067_3551_3576_6363_4793_6364_3627_673_6093_4790_4792_23236_6352_6347_6774_6655_6654_6464_6358_6359_7409_5970_8976 31 + 0.0329362326140835 0.137733336386167 7097 anisomycin hsa04810 Regulation of actin cytoskeleton 623_8503_6548_624_5155_5293_5290_3678_4636_23365_10458_4659_87_3675_7454_93408_7430_2249_7414_2263_2260_8394_1131_673_22800_6093_10093_3688_6655_6654_3685_3684_8817_7409_3985_8976 36 + 0.0306099257834703 0.137733336386167 7098 anisomycin hsa05012 Parkinson's disease 7314_6390_836_6622_4698 5 + 3.92835471427396e-08 1.20469544571068e-06 7099 anisomycin hsa04260 Cardiac muscle contraction 7171_481_6548 3 + 2.5851196689478e-05 0.000475662019086395 7100 anisomycin hsa04060 Cytokine-cytokine receptor interaction 3459_5155_7852_4050_53832_3456_2057_3576_3570_3572_3953_3976_6363_27242_6364_3604_23529_3589_3624_3627_51561_7042_7124_92_8795_1435_6352_6347_3460_3569_1271_6358_6359_7424_7422_51330_7040 37 + 0.0014046734486708 0.0129229957277714 7101 anisomycin hsa03010 Ribosome 6233_6203 2 + 1.21549228669298e-07 2.79563225939385e-06 7102 anisomycin hsa04020 Calcium signaling pathway 623_5532_5261_624_5021_814_1131_5534_5025_3709_8911_5533_7220_3708_5332_1909_490_4842_23236 19 + 0.000107436445160442 0.00164735882579344 7103 anisomycin hsa03050 Proteasome 5713_23198 2 + 0.00341999853381562 0.0286036241010034 7104 anisomycin hsa04270 Vascular smooth muscle contraction 8398_100137049_4660_3709_673_27094_3708_8681_23365_1909_5332_6093_4659_23236 14 + 0.00781738075422485 0.051371359242049 7105 anisomycin hsa05217 Basal cell carcinoma 6934_8324_1856_8323_1499 5 + 0.0318349742182974 0.137733336386167 7106 anisomycin hsa02010 ABC transporters 23461_1244_6890 3 + 0.0245974556563443 0.125720328910204 7107 anisomycin hsa04080 Neuroactive ligand-receptor interaction 5026_136_5031 3 - 0.0145114134371145 0.422810506736867 7108 anisomycin hsa04740 Olfactory transduction 5613_5616 2 - 2.90104206906813e-05 0.0023208336552545 7109 anisomycin hsa05322 Systemic lupus erythematosus 3123 1 - 0.0317473817462515 0.422810506736867 7110 anisomycin hsa04210 Apoptosis 3554_596_5613_5295_317_23052_5616_355_8717 9 - 0.0162199286430325 0.422810506736867 7111 anisomycin hsa04630 Jak-STAT signaling pathway 5295 1 - 0.0221318476406353 0.422810506736867 7112 anisomycin hsa04810 Regulation of actin cytoskeleton 5881_5295_5154 3 - 0.0367915323963346 0.422810506736867 7113 anisomycin hsa04060 Cytokine-cytokine receptor interaction 355_3554_3625_5154 4 - 0.0369959193394759 0.422810506736867 7114 stachydrine hsa04740 Olfactory transduction 818_109_816 3 + 0.00140928702008936 0.105696526506702 7115 stachydrine hsa04520 Adherens junction 4233_7454_56288_2241 4 - 0.0216096754531006 0.497022535421314 7116 stachydrine hsa05322 Systemic lupus erythematosus 85235_8969_8332_8330_8331_8329_6737_8336 8 - 0.000669538504712226 0.0307987712167624 7117 dipivefrine hsa05332 Graft-versus-host disease 3135_3105_3106_3107_649853 5 - 0.00516443201882265 0.129521681268324 7118 dipivefrine hsa04662 B cell receptor signaling pathway 933_3725_4793_3551_8519 5 - 0.0430255418211149 0.296876238565693 7119 dipivefrine hsa04080 Neuroactive ligand-receptor interaction 1269 1 - 0.0224963290339683 0.229386803331033 7120 dipivefrine hsa05320 Autoimmune thyroid disease 3135_3105_3106_3107_649853 5 - 0.0124776211363817 0.172191171682067 7121 dipivefrine hsa04612 Antigen processing and presentation 3105_3106_3107_3135_811_649853 6 - 0.0265955714006995 0.229386803331033 7122 dipivefrine hsa04514 Cell adhesion molecules (CAMs) 9076_24146_3105_4099_3107_3135_933_3106_649853 9 - 0.0075085032619318 0.129521681268324 7123 dipivefrine hsa04210 Apoptosis 3551_598_472_5576_651610_8795 6 - 0.0265955714006995 0.229386803331033 7124 dipivefrine hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0406527468892159 0.296876238565693 7125 dipivefrine hsa05330 Allograft rejection 3135_3105_3106_3107_649853 5 - 0.00350207794987258 0.129521681268324 7126 dipivefrine hsa04940 Type I diabetes mellitus 3135_3105_3106_3107_649853 5 - 0.00617641767397965 0.129521681268324 7127 piretanide hsa04670 Leukocyte transendothelial migration 2909_3688_1432_5600_5880 5 + 0.0380636540946127 0.710597511051695 7128 piretanide hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0201495787732418 1 7129 betahistine hsa04070 Phosphatidylinositol signaling system 8394_27124_23236 3 + 0.0297535454848283 0.404788254053682 7130 betahistine hsa04512 ECM-receptor interaction 3693_1291_2335 3 + 0.038007615965987 0.404788254053682 7131 betahistine hsa04540 Gap junction 7278_113457_23236 3 + 0.0485438960382854 0.404788254053682 7132 betahistine hsa05330 Allograft rejection 5551_3119 2 + 0.0454776234979186 0.404788254053682 7133 betahistine hsa04940 Type I diabetes mellitus 5551_3119_2571 3 + 0.00740673746504644 0.33330318592709 7134 betahistine hsa05332 Graft-versus-host disease 3552_3123_3126_3127_3125_3135 6 - 0.0315375913812549 0.576145094313182 7135 betahistine hsa04080 Neuroactive ligand-receptor interaction 4886 1 - 5.72704328339255e-05 0.00486798679088367 7136 betahistine hsa04510 Focal adhesion 5296_3691_5595 3 - 0.0100655818156386 0.427787227164641 7137 betahistine hsa05012 Parkinson's disease 7327_4728 2 - 0.0489101234118574 0.576145094313182 7138 betahistine hsa05210 Colorectal cancer 5595_8312_4088_4089_1855_5296_5900_3845_7040_6934 10 - 0.0266928595516598 0.576145094313182 7139 betahistine hsa04940 Type I diabetes mellitus 3552_3123_3126_3127_3125_3135 6 - 0.037590062779761 0.576145094313182 7140 tropine hsa04612 Antigen processing and presentation 5994_3806_6892_3107_3111 5 + 0.00443712433257829 0.195233470633445 7141 chloropyrazine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_2215_729 23 + 1.40859964463988e-14 6.76127829427142e-13 7142 chloropyrazine hsa03020 RNA polymerase 246721_5439_548644_661 4 - 0.00144382112293826 0.0563090237945921 7143 monocrotaline hsa04640 Hematopoietic cell lineage 3553_3570_3815 3 + 0.0367520252714041 0.822186175193801 7144 monocrotaline hsa05014 Amyotrophic lateral sclerosis (ALS) 4217_581_11261_5868_5534_5608 6 - 0.00707806279686642 0.460074081796317 7145 monocrotaline hsa04350 TGF-beta signaling pathway 4092_7059_6667_1874_655_6093 6 - 0.043544018814762 1 7146 harmine hsa04740 Olfactory transduction 2979 1 + 0.015410601018595 0.24656961629752 7147 harmine hsa05322 Systemic lupus erythematosus 8358_3108_85235_8968_958_3013_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357 20 + 4.45557992198528e-12 2.13867836255293e-10 7148 harmine hsa04115 p53 signaling pathway 55367_1647_1026_5366_64393_4193_7249_355_8795 9 + 6.7404073361556e-06 0.000161769776067734 7149 harmine hsa05330 Allograft rejection 958_355_3108 3 + 0.0326029858532293 0.391235830238752 7150 harmine hsa05332 Graft-versus-host disease 3105_3106_3119_3133_3123 5 - 0.00544172184954697 0.0300895208151421 7151 harmine hsa04650 Natural killer cell mediated cytotoxicity 8503_5296_5295_5290_5291_5604_10451_5058_5336_836_3455_3105_3106_3459_5781_3845_4277_4276_637_673_5533_5532_5530_4772_3133_5534_5578_6655_3460_6464_2885_80328_2534 33 - 0.00999926812244725 0.040589875240411 7152 harmine hsa04640 Hematopoietic cell lineage 3554_960_2057_3123_4254_1604_3678_3655 8 - 3.03932442816148e-06 4.76160827078632e-05 7153 harmine hsa03320 PPAR signaling pathway 79966_2710_51_11001_1962_34_2181_2171_1375_8310_2180_6257_6256 13 - 0.00991047309109185 0.040589875240411 7154 harmine hsa05010 Alzheimer's disease 3710_1340_5534_2776_1020_5663_5332_5664_4694_1327_836_4728_4701_4698_808_776_637_8772_2932_5533_5532_3709_374291_489_488_102_8851_23236_3416_842_841_840_4719_4137_5530_805_801_823 38 - 0.000415634404501527 0.00279068814451025 7155 harmine hsa04080 Neuroactive ligand-receptor interaction 5029_4889_1269_7068_64106_5025_5618_4886_5031_2150_136_56288_2690_2149_9170 15 - 1.66867866518787e-21 7.84278972638299e-20 7156 harmine hsa04742 Taste transduction 2778_3710_2782_5613_5566_5567_5616_6337_112 9 - 0.0160216373580857 0.0529944243866172 7157 harmine hsa05320 Autoimmune thyroid disease 3105_3106_3133_3119_3123 5 - 0.000377118673395647 0.00272685809993776 7158 harmine hsa04612 Antigen processing and presentation 4800_10197_4802_5993_3119_4801_8625_2923_3309_3105_3106_5641_3133_3123_3306_1385_3304_3312_3303_1514 20 - 0.0242105655698279 0.0758597721187941 7159 harmine hsa04670 Leukocyte transendothelial migration 9076_8503_5296_2771_2909_5747_5290_9475_7852_6387_5600_5336_87_5829_1500_7430_5781_50848_6300_5295_998_9080_1499_6093_5291_1432_5578_10451_1366_1364_1365 31 - 0.0298850836346043 0.0877874331766501 7160 harmine hsa05016 Huntington's disease 4899_1327_1340_64764_246721_2776_5332_23186_6874_6908_5432_5433_5430_6648_4694_4701_5435_1639_5439_6667_2033_1213_1211_581_374291_836_548644_161_5481_23236_27113_842_841_5441_4719_3092_4728_4698_1385_1387_291 41 - 0.000358386723397879 0.00272685809993776 7161 harmine hsa04740 Olfactory transduction 219464_157_5613_5566_5567_5616_818_808_805_801_409 11 - 8.11520966204155e-42 7.62829708231906e-40 7162 harmine hsa04514 Cell adhesion molecules (CAMs) 9076_965_4685_3119_3123_3106_4897_1364_3685_9080_1366_2734_1365_5792_3133_3105_3655_50848_9019_1001_5817 21 - 2.01115578221261e-05 0.000236310804409982 7163 harmine hsa04510 Focal adhesion 8503_595_10298_5296_2909_5295_5154_5290_9475_5604_3678_5601_5747_7791_3655_5063_6093_3725_5501_5728_857_207_2885_5829_3691_3693_858_7057_87_23396_3912_896_5062_3480_2932_998_673_4659_1499_6714_5291_4233_2335_1729_2317_6655_5578_6464_10451_3685_2002_7422_5058_2064_2534 55 - 0.0100462098898886 0.040589875240411 7164 harmine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_94239_8366_8368_8294_8343_8347_8346_8344_8339_8367_3123_3021_3020_87_8370_92815_8359_554313_6738_121504_6632_3119_3014 29 - 0.000619280213543645 0.00388082267154018 7165 harmine hsa05340 Primary immunodeficiency 8625_100_64421_5993 4 - 0.0115968726607623 0.0419271550042945 7166 harmine hsa04140 Regulation of autophagy 5289_9474_23192_5562_64422 5 - 0.0328159873086806 0.0907265531475287 7167 harmine hsa05218 Melanoma 673_8503_595_207_5296_3480_5295_5154_5290_5728_5604_3845_2260_5291_4233 15 - 0.0296697920417119 0.0877874331766501 7168 harmine hsa05310 Asthma 3123_3119 2 - 0.00475008748414446 0.0279067639693487 7169 harmine hsa04512 ECM-receptor interaction 375790_960_3912_3691_3693_1605_7057_3685_3678_3655_2335_3161 12 - 0.000357953324164409 0.00272685809993776 7170 harmine hsa04630 Jak-STAT signaling pathway 8503_6777_595_5296_5295_5292_5290_5291_6772_9655_3597_10254_896_2057_3455_3459_3572_2033_5781_10401_9063_207_7297_3588_8554_4609_8027_868_5618_6778_3460_6655_2885_867_50616_8835_1387_2690 38 - 0.0077504914353235 0.0383445365747584 7171 harmine hsa04062 Chemokine signaling pathway 8503_6777_1147_157_5296_2771_112_5290_9475_115_5604_10451_5332_56288_113_5747_4067_3551_2782_5829_5566_5567_6464_5291_409_408_5295_207_2932_998_673_6093_10681_4790_107_23236_5590_5580_5613_6655_2885_5616_6387_6772_7074_55970_3845_5058_5970_7852 50 - 0.00766868186643152 0.0383445365747584 7172 harmine hsa04810 Regulation of actin cytoskeleton 8503_10298_5296_2909_5295_5154_5290_9475_5604_10451_55970_10109_54961_23365_5747_3655_10458_4659_87_5501_23396_3678_5829_3691_3693_23191_1445_50649_7430_324_55740_2245_2260_2261_8396_2264_10152_79784_2768_5063_5062_2934_998_673_22800_10787_2263_4628_6093_5291_5962_2335_8874_1729_6655_5305_3685_7074_8936_3845_54434_5058_2149 63 - 0.0320147502192396 0.0907265531475287 7173 harmine hsa05012 Parkinson's disease 2861_7326_7327_836_1327_4701_1340_4698_4694_4719_4728_842_374291_65018_27429_51465_5481_291 18 - 1.26343773680862e-06 2.37526294520021e-05 7174 harmine hsa04260 Cardiac muscle contraction 784_776_1327_1340_27092_488_10479_481 8 - 9.93583735534457e-06 0.000133424101628913 7175 harmine hsa04060 Cytokine-cytokine receptor interaction 3597_55540_5154_8741_7852_6387_90_3556_27242_3554_2057_3455_3459_3572_657_4982_659_3588_3625_4254_7042_91_655_92_4233_5618_3460_50616_7422_51330_2690 31 - 2.11858177028398e-13 6.63822288022314e-12 7176 harmine hsa03010 Ribosome 6187_440589_9349_6137_6125_6168_439992_51187_6189 9 - 3.37875752460577e-07 7.94008018282356e-06 7177 harmine hsa04020 Calcium signaling pathway 2778_3710_5534_2776_115_5332_136_113_5336_490_493_5256_5566_5567_818_776_5025_2767_5533_5532_5530_489_488_107_5481_23236_5578_5613_3709_5616_808_805_801_2064_2065_2149_291 37 - 8.21940753237528e-05 0.000772624308043276 7178 harmine hsa03050 Proteasome 10197_5719_5706_5707_5690_23198_7979 7 - 0.00998540625527263 0.040589875240411 7179 harmine hsa05330 Allograft rejection 3105_3106_3119_3133_3123 5 - 0.0162214495485023 0.0529944243866172 7180 harmine hsa04950 Maturity onset diabetes of the young 3087_3280 2 - 0.0163493436937436 0.0529944243866172 7181 harmine hsa04940 Type I diabetes mellitus 3382_3119_3105_3106_3133_3123 6 - 0.0107951795852157 0.040589875240411 7182 harmine hsa02010 ABC transporters 23461_4363_10057_9619_368_10257 6 - 0.0107951795852157 0.040589875240411 7183 harmine hsa04610 Complement and coagulation cascades 1604_7035_1675_2161_2149_5329 6 - 2.59610953498338e-05 0.000271149218098264 7184 thioperamide hsa05332 Graft-versus-host disease 3105_3106_3107_3111_3135_649853 6 + 0.0111308316605608 0.151616116056534 7185 thioperamide hsa04640 Hematopoietic cell lineage 948_3690_3589_2993_915_947_920_3674_3675 9 + 0.0135469661959707 0.151616116056534 7186 thioperamide hsa05320 Autoimmune thyroid disease 3105_3106_3107_3111_3135_649853 6 + 0.028498077341354 0.204668009996997 7187 thioperamide hsa04612 Antigen processing and presentation 3105_3106_3107_3111_3135_6892_1520_920_649853 9 + 0.0153535307399022 0.151616116056534 7188 thioperamide hsa04910 Insulin signaling pathway 7249 1 + 0.0458572600340064 0.301893628557209 7189 thioperamide hsa04740 Olfactory transduction 818_5593 2 + 2.8890336242459e-05 0.00228233656315426 7190 thioperamide hsa04514 Cell adhesion molecules (CAMs) 1272_3105_29851_3107_3685_3135_6693_51208_9672_947_920_3111_26285_923_3106_649853 16 + 0.000285981833556329 0.0101724587042997 7191 thioperamide hsa05340 Primary immunodeficiency 23495_915_29851_920_3718 5 + 0.0199341741285722 0.174977750684134 7192 thioperamide hsa04512 ECM-receptor interaction 1280_948_3690_9672_1289_3685_1277_2335_1290_3918_3674_3675 12 + 0.000386295900163278 0.0101724587042997 7193 thioperamide hsa04062 Chemokine signaling pathway 108_3718 2 + 0.025575629647788 0.202047474217525 7194 thioperamide hsa05330 Allograft rejection 3105_3106_3107_3111_3135_649853 6 + 0.00730651422089587 0.144303655862693 7195 thioperamide hsa04940 Type I diabetes mellitus 3105_3106_3107_3111_3135_649853 6 + 0.0134953108715839 0.151616116056534 7196 thioperamide hsa04350 TGF-beta signaling pathway 4088_6093_3624_7042 4 - 0.0308371345107995 1 7197 benperidol hsa05332 Graft-versus-host disease 3123_3107_3126_3127_3125 5 + 0.0297675984754834 0.286513135326528 7198 benperidol hsa04640 Hematopoietic cell lineage 2323_3581_1435_3690_3123_3126_3127_3125_7850_4254 10 + 0.00321581386116963 0.123808833655031 7199 benperidol hsa05320 Autoimmune thyroid disease 3449_3123_3107_3126_3127_3443_3125 7 + 0.00665327188385881 0.137096141364861 7200 benperidol hsa04612 Antigen processing and presentation 4261_3449_3123_3107_3126_3127_3443_3125_6891 9 + 0.0106828162102489 0.137096141364861 7201 benperidol hsa04740 Olfactory transduction 26211_135948_442194_1179 4 + 0.00156357994192492 0.120395655528219 7202 benperidol hsa05310 Asthma 3123_3126_3127_8288_3125 5 + 0.00903989708635428 0.137096141364861 7203 benperidol hsa05330 Allograft rejection 3123_3107_3126_3127_3125 5 + 0.0210584921206735 0.231643413327409 7204 benperidol hsa04940 Type I diabetes mellitus 3126_3107_2572_3127_3125_3123 6 + 0.0102365264039756 0.137096141364861 7205 benperidol hsa04080 Neuroactive ligand-receptor interaction 3953_5025_5618_2150_2690 5 - 2.89915493111351e-09 1.33361126831221e-07 7206 benperidol hsa04742 Taste transduction 5567 1 - 0.0186102646072285 0.214018042983128 7207 benperidol hsa04740 Olfactory transduction 801_808_5567_805 4 - 9.88023316151914e-17 9.08981450859761e-15 7208 benperidol hsa04514 Cell adhesion molecules (CAMs) 3135_965_2734_4685_6383 5 - 0.000882458496085396 0.0202965454099641 7209 benperidol hsa04110 Cell cycle 5111_4085_4087_4088_983_11200_9184_1022_7157_8881_4089_7534_1031_7531_7533_9133_902_5001_5000_10393_8556_8243_5591_1017_4173_6500_472_5934_7465 29 - 0.00661867436533362 0.101486340268449 7210 benperidol hsa04530 Tight junction 2773_22800_7525_4627_60_51776_1457_387_5516 9 - 0.0283832580683301 0.290139971365152 7211 benperidol hsa05218 Melanoma 7157_5154 2 - 0.010134760409985 0.133199708245517 7212 benperidol hsa04060 Cytokine-cytokine receptor interaction 3556_5618_3566_2057_3460_3953_23765_5154_8741_355_6387_7424_91_3597_55540_2690 16 - 0.000688040976073725 0.0202965454099641 7213 benperidol hsa03010 Ribosome 6168_6138_51187_6203 4 - 0.00607840073664296 0.101486340268449 7214 oxolinic acid hsa05332 Graft-versus-host disease 3824_3119_3804_3107_3126_3127_3802_3811_3123_3125_3113 11 + 1.33969518929065e-07 9.51183584396361e-06 7215 oxolinic acid hsa04640 Hematopoietic cell lineage 1435_3123_3126_3127_3125_1378 6 + 0.0405902840531518 0.288191016777378 7216 oxolinic acid hsa05320 Autoimmune thyroid disease 3119_3126_3107_3113_3127_3125_3123 7 + 0.00113578976985717 0.0115201533799799 7217 oxolinic acid hsa04612 Antigen processing and presentation 3824_3119_3123_3107_3126_3127_3125_3811_3804_6892_3802_3113 12 + 1.74817666897152e-05 0.00062060271748489 7218 oxolinic acid hsa04740 Olfactory transduction 810_26692 2 + 0.00344261284437124 0.0305531889937948 7219 oxolinic acid hsa04514 Cell adhesion molecules (CAMs) 965_3119_3683_3123_1272_3107_3126_3127_3125_5797_23308_3113 12 + 0.000611468267573307 0.0072357078329508 7220 oxolinic acid hsa04360 Axon guidance 9353_2047_57715_57556_56920_56924_4776_8482_8829 9 + 0.0139720164007273 0.110223684939071 7221 oxolinic acid hsa05310 Asthma 3119_3123_3113_3127_3126_3125 6 + 0.000371748398117197 0.00595015224218528 7222 oxolinic acid hsa05330 Allograft rejection 3119_3113_3107_3126_3127_3125_3123 7 + 0.00018869297362064 0.00446573370902181 7223 oxolinic acid hsa04940 Type I diabetes mellitus 3119_3126_3107_3113_3127_3125_3123 7 + 0.000419024805787696 0.00595015224218528 7224 oxolinic acid hsa05010 Alzheimer's disease 5533_823_5664 3 - 0.0363050364497341 0.762405765444416 7225 oxolinic acid hsa04740 Olfactory transduction 409 1 - 1.03302078968363e-07 4.33868731667125e-06 7226 oxolinic acid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_6737_8329_8294_8343_81_8347_8346_8344_8969_8370_8332_8359_8330_8331_8336_8337_554313_121504_8339_85235_3113_3017 31 - 3.24442201148193e-10 2.72531448964482e-08 7227 oxolinic acid hsa05012 Parkinson's disease 65018 1 - 0.0151508442612752 0.424223639315706 7228 oxolinic acid hsa05210 Colorectal cancer 324_596_4088_6655_6932_5599_5881_8312_3725 9 - 0.046909106180769 0.788072983836919 7229 pargyline hsa04740 Olfactory transduction 5593_9635 2 + 0.00922881517078771 0.627559431613564 7230 pargyline hsa04080 Neuroactive ligand-receptor interaction 2570 1 - 0.0115627336376421 0.265942873665768 7231 pargyline hsa04740 Olfactory transduction 409 1 - 0.000255603592996059 0.00881832395836404 7232 pargyline hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_3108_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235 22 - 1.72649690593557e-09 1.19128286509554e-07 7233 STOCK1N-28457 hsa05214 Glioma 23533_2475_6464_5154_808_810_801_805 8 + 0.0263024943722081 0.410318912206446 7234 STOCK1N-28457 hsa04080 Neuroactive ligand-receptor interaction 2488_1813_3953_56288_134_5644 6 + 0.0425239959495214 0.552811947343778 7235 STOCK1N-28457 hsa04740 Olfactory transduction 157_8392_808_810_801_805 6 + 0.000494031226020843 0.0385344356296258 7236 STOCK1N-28457 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_88_8294_8367_554313_121504 15 + 0.0144620359377112 0.410318912206446 7237 STOCK1N-28457 hsa04150 mTOR signaling pathway 23533_2475_5170_6794_7249_6196_7422 7 + 0.0248839356852834 0.410318912206446 7238 STOCK1N-28457 hsa04912 GnRH signaling pathway 801_4313_2488_3709_808_4216_5600_810_3725_6714_6300_805 12 + 0.0170884145179326 0.410318912206446 7239 STOCK1N-28457 hsa05214 Glioma 818_6654_5594_7157_208_6655_5295_6464_4193_5605_808_5335_3480_801_369_805 16 - 0.0218605034123408 0.198930581052301 7240 STOCK1N-28457 hsa04640 Hematopoietic cell lineage 3554_960_2057_1435 4 - 0.0307659686073377 0.248443163349045 7241 STOCK1N-28457 hsa04080 Neuroactive ligand-receptor interaction 1269_7068_5025_5618_6915_2150_3269_9170 8 - 1.06310566700336e-06 4.83713078486529e-05 7242 STOCK1N-28457 hsa04740 Olfactory transduction 818_5137_801_808_805 5 - 8.28636916130947e-15 7.54059593679162e-13 7243 STOCK1N-28457 hsa05212 Pancreatic cancer 6934_5970_5170_5594_5295_9134_7157_3480_6655_6654_4193_4790_5605_208_10488_3326_369_1385_1017_572_842 21 - 0.0147625004861266 0.16792344302969 7244 STOCK1N-28457 hsa04110 Cell cycle 983_4616_7157_699_51433_1017_7534_1031_995_4174_5001_9134_4193_8454_7027_7040_8243_5591_4176_5347_4173_6502_472_7529_7465 25 - 0.0327617358262477 0.248443163349045 7245 STOCK1N-28457 hsa05215 Prostate cancer 6934_5970_5170_5594_5295_9134_7157_3480_6655_6654_4193_4790_5605_208_10488_3326_369_1385_1017_572_842 21 - 0.0140170469594533 0.16792344302969 7246 STOCK1N-28457 hsa05223 Non-small cell lung cancer 2309_5170_11186_842_2272_6789_572_6655_5295_5605_7157_6654_5335_208_369_5594 16 - 0.00654332086957422 0.0992403665218757 7247 STOCK1N-28457 hsa04260 Cardiac muscle contraction 1537_776_7171_27092 4 - 0.0419161817263902 0.293413272084731 7248 STOCK1N-28457 hsa04060 Cytokine-cytokine receptor interaction 50616_5618_3554_3597_2057_2324_23765_53832_3572_7852_1435_7040_655_51330_659 15 - 0.00100604763404644 0.0228875836745565 7249 STOCK1N-28457 hsa05213 Endometrial cancer 2309_3611_5170_6934_7157_572_6655_5295_999_2002_5605_208_842_1495_324_369_6654_5594 18 - 0.000823987774304287 0.0228875836745565 7250 STOCK1N-28457 hsa05220 Chronic myeloid leukemia 5295_5594_7157_613_6655_6654_6464_4193_5605_208_572_5781_1398_598_5970_4790_369_7040 18 - 0.0203841484491185 0.198930581052301 7251 STOCK1N-28457 hsa04610 Complement and coagulation cascades 718 1 - 0.0038522038378049 0.0701101098480492 7252 pyrantel hsa04130 SNARE interactions in vesicular transport 8773_6804_662_6616_8417_51272 6 + 0.00102574962919595 0.0263275738160294 7253 pyrantel hsa04740 Olfactory transduction 5613 1 + 0.000550860749115784 0.0212081388409577 7254 pyrantel hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 8.15456665491719e-05 0.00627901632428624 7255 pyrantel hsa04740 Olfactory transduction 818_51806 2 - 0.000269889886014316 0.0107955954405726 7256 pyrantel hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8969_8370_8332_8359_8330_8331_8336_554313_121504_85235_3113 22 - 4.23888619869e-08 3.391108958952e-06 7257 pyrantel hsa05223 Non-small cell lung cancer 6789_1869_6654_6257_842 5 - 0.0495748086548794 0.755961339436086 7258 pyrantel hsa04010 MAPK signaling pathway 8912_6654_4149_3552_6789_50487_1846_2002_5606_5536_5922_7042_3306_9020_776_27092 16 - 0.047952582937391 0.755961339436086 7259 pyrantel hsa05222 Small cell lung cancer 4149_842_3909_1869_3655_1017_6257 7 - 0.0387723295493346 0.755961339436086 7260 tiratricol hsa04740 Olfactory transduction 5593 1 + 0.00175603490987794 0.117654338961822 7261 tiratricol hsa04360 Axon guidance 2047_1949_80031_6405_8482_5534_7869 7 + 0.0476311677288806 1 7262 tiratricol hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0402506240657491 1 7263 tiratricol hsa05332 Graft-versus-host disease 3123_3126_3127_3111_3125 5 - 0.00811092001594831 0.120718012153416 7264 tiratricol hsa05320 Autoimmune thyroid disease 3123_3126_3127_3111_3125 5 - 0.0191287610406475 0.204951011149795 7265 tiratricol hsa04612 Antigen processing and presentation 3123_3126_3127_3111_3125_6892 6 - 0.0418364883647686 0.392217078419706 7266 tiratricol hsa04740 Olfactory transduction 818_109 2 - 0.00331297633894781 0.0828244084736953 7267 tiratricol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3123_3111_3126_3127_3014_3125_8359_8294_8367_554313_8368_121504 20 - 1.36709043368569e-08 1.02531782526427e-06 7268 tiratricol hsa05310 Asthma 3123_3126_3127_3111_3125 5 - 0.00222616166608088 0.0828244084736953 7269 tiratricol hsa05330 Allograft rejection 3123_3126_3127_3111_3125 5 - 0.00554927536458604 0.104048913085988 7270 tiratricol hsa04940 Type I diabetes mellitus 3123_3126_3127_3111_3125 5 - 0.00965744097227326 0.120718012153416 7271 levamisole hsa05332 Graft-versus-host disease 3109_3123_3126_3127_3111_3125 6 + 0.000989923211895551 0.0140569096089168 7272 levamisole hsa04070 Phosphatidylinositol signaling system 8394_23533_3708_8821_5293 5 + 0.0462798684471036 0.273822554978696 7273 levamisole hsa04640 Hematopoietic cell lineage 1436_3690_3123_3126_3127_3125_7173_915_1378 9 + 0.000510442990206659 0.0109559357744423 7274 levamisole hsa05320 Autoimmune thyroid disease 3109_3123_3126_3127_3111_3125_7173 7 + 0.000577830616335367 0.0109559357744423 7275 levamisole hsa04612 Antigen processing and presentation 3109_3123_3126_3127_3111_3125 6 + 0.0275069444853965 0.236156620791619 7276 levamisole hsa04514 Cell adhesion molecules (CAMs) 3109_3123_3126_3127_3111_3125_6383_6693_26047 9 + 0.00789001060459135 0.080027250417998 7277 levamisole hsa05322 Systemic lupus erythematosus 3109_3123_3126_3127_3111_3125_720_721 8 + 0.0313058530244275 0.236156620791619 7278 levamisole hsa05310 Asthma 3109_3123_3126_3127_3111_3125 6 + 0.000200183764394304 0.0109559357744423 7279 levamisole hsa05213 Endometrial cancer 23533_1956_5293_1495 4 + 0.0461669305401993 0.273822554978696 7280 levamisole hsa05330 Allograft rejection 3109_3123_3126_3127_3111_3125 6 + 0.00061723581827844 0.0109559357744423 7281 levamisole hsa04940 Type I diabetes mellitus 3109_3123_3126_3127_3111_3125 6 + 0.00123131366689396 0.0145705450582452 7282 levamisole hsa04610 Complement and coagulation cascades 2155_721_720_2149_1378 5 + 0.0332614958861435 0.236156620791619 7283 levamisole hsa04740 Olfactory transduction 818_816 2 - 0.00160167797179698 0.113719135997586 7284 levamisole hsa05222 Small cell lung cancer 3551_6502_3909_7189_8554_3673 6 - 0.0464635238892765 1 7285 etofylline hsa04520 Adherens junction 5770_2260_3643_5792_7414 5 + 0.0436338907021905 0.530879003543318 7286 etofylline hsa04740 Olfactory transduction 1179 1 + 0.00249030857659602 0.181792526091509 7287 etofylline hsa04370 VEGF signaling pathway 8398_4772_5293_5320_5534 5 + 0.0382942363953235 0.530879003543318 7288 etofylline hsa05218 Melanoma 1029_2260_1021_5293_2249 5 + 0.0288718918391558 0.530879003543318 7289 etofylline hsa04010 MAPK signaling pathway 786_3554_8398_782_5534_6722_6196_9479_2249_5320_7042_22808_2260 13 + 0.0146710803301016 0.530879003543318 7290 etofylline hsa05220 Chronic myeloid leukemia 1021_7042_1029_5293_5781 5 + 0.0349688555685794 0.530879003543318 7291 etofylline hsa04740 Olfactory transduction 818_157 2 - 0.000135340278320961 0.0108272222656769 7292 tranylcypromine hsa05332 Graft-versus-host disease 3135_3105_3106_649853_3002 5 + 0.00474610739222106 0.0840711571014892 7293 tranylcypromine hsa04650 Natural killer cell mediated cytotoxicity 3448_962_3105_6655_3135_3002_8794_3106_3383 9 + 0.00788119540652642 0.0972014100138259 7294 tranylcypromine hsa04742 Taste transduction 5330_5568_50834_40 4 + 0.0472391881831362 0.317790902322916 7295 tranylcypromine hsa05320 Autoimmune thyroid disease 3448_3105_3106_3135_3002_649853 6 + 0.00253554532439416 0.0792649186347865 7296 tranylcypromine hsa04740 Olfactory transduction 26211_5568 2 + 0.00934304970867563 0.0987693826345709 7297 tranylcypromine hsa04514 Cell adhesion molecules (CAMs) 5797_3383_9369_3105_3106_3135_4359_649853 8 + 0.0189121837677853 0.174937699852014 7298 tranylcypromine hsa05322 Systemic lupus erythematosus 3013_8358_8968_8350_8351_8352_8353_8354_8355_8356_8357 11 + 0.00107236379763365 0.0792649186347865 7299 tranylcypromine hsa05223 Non-small cell lung cancer 6655_5170_1950_2272 4 + 0.0472391881831362 0.317790902322916 7300 tranylcypromine hsa04540 Gap junction 7082_5568_6655_5330_1950_10382 6 + 0.0291483847670262 0.239664496973327 7301 tranylcypromine hsa05330 Allograft rejection 3135_3105_3106_649853_3002 5 + 0.00321344264735621 0.0792649186347865 7302 tranylcypromine hsa04940 Type I diabetes mellitus 3135_3105_3106_649853_3002 5 + 0.00568048358793846 0.0840711571014892 7303 tranylcypromine hsa04740 Olfactory transduction 818 1 - 2.64608924139954e-05 0.00211687139311963 7304 tranylcypromine hsa04510 Focal adhesion 7059_1302_5599_2909_3914_9475_5296_7410_5170_4636_5602_6714_1291_83660 14 - 0.0378992474045853 0.627904912919263 7305 tranylcypromine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_9555 15 - 0.000454784736308834 0.0181913894523534 7306 tranylcypromine hsa04810 Regulation of actin cytoskeleton 3985_5296_2909_9138_8074_9475_7410_7430_2149_2263_2245_1131_2264_4636 14 - 0.0452155163256153 0.627904912919263 7307 chlorzoxazone hsa05332 Graft-versus-host disease 3812_3123_3126_3127_3125 5 + 0.0157625034079357 0.239590051800623 7308 chlorzoxazone hsa04640 Hematopoietic cell lineage 1436_3123_3126_3127_3125_3589_3684 7 + 0.0289105619699676 0.31388610138822 7309 chlorzoxazone hsa05320 Autoimmune thyroid disease 3123_3451_3126_3127_3125 5 + 0.0356550006484153 0.338722506159945 7310 chlorzoxazone hsa05131 Shigellosis 347688_7278_113457_7430_56604_8976 6 + 0.0131747313740816 0.239590051800623 7311 chlorzoxazone hsa05130 Pathogenic Escherichia coli infection 347688_7278_113457_7430_56604_8976 6 + 0.0131747313740816 0.239590051800623 7312 chlorzoxazone hsa04740 Olfactory transduction 8392_1179 2 + 0.000547079401824291 0.0415780345386461 7313 chlorzoxazone hsa05310 Asthma 3123_3126_3127_3125 4 + 0.0214507143102493 0.271709047929824 7314 chlorzoxazone hsa04540 Gap junction 347688_7082_1813_2982_7278_113457_56604_6714_6655 9 + 0.0048632212700278 0.184802408261056 7315 chlorzoxazone hsa05330 Allograft rejection 3123_3126_3127_3125 4 + 0.04261252578828 0.359839106656587 7316 chlorzoxazone hsa04080 Neuroactive ligand-receptor interaction 5031_7433 2 - 0.00663534409961168 0.204850251175663 7317 chlorzoxazone hsa05014 Amyotrophic lateral sclerosis (ALS) 1432_834_1616_5606_9973_5534_5608 7 - 0.00833556184570955 0.204850251175663 7318 chlorzoxazone hsa04740 Olfactory transduction 51806 1 - 1.20660385873684e-05 0.00090495289405263 7319 chlorzoxazone hsa05120 Epithelial cell signaling in Helicobacter pylori infection 1432_5599_535_5335_3725_6714_28964 7 - 0.0249363134385589 0.374044701578383 7320 chlorzoxazone hsa04062 Chemokine signaling pathway 7454 1 - 0.0109253467293687 0.204850251175663 7321 scopolamine N-oxide hsa04740 Olfactory transduction 442194_390892 2 + 0.0359033542161109 0.748925818466511 7322 scopolamine N-oxide hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0227468549338936 0.748925818466511 7323 scopolamine N-oxide hsa04070 Phosphatidylinositol signaling system 8871_8394_5333_23236_27124_3705 6 - 0.0447306438399565 1 7324 antimycin A hsa05016 Huntington's disease 2776 1 + 0.0464130493831311 1 7325 antimycin A hsa04740 Olfactory transduction 1179 1 + 0.00026763111453094 0.0190018091316967 7326 antimycin A hsa04062 Chemokine signaling pathway 2793 1 + 0.047527455646003 1 7327 antimycin A hsa04740 Olfactory transduction 5613 1 - 5.20027147614742e-07 4.00420903663351e-05 7328 antimycin A hsa05322 Systemic lupus erythematosus 55506_3013_3014_8358_8968_55766_720_721_8350_8351_8352_8353_8354_8355_8356_8357 16 - 0.00289238922395576 0.111356985122297 7329 antimycin A hsa04630 Jak-STAT signaling pathway 8835_3717 2 - 0.0498463908124451 0.726113172006677 7330 antimycin A hsa04010 MAPK signaling pathway 9261_9344_3925_5155_3306_5494_3304_3305_3303_2002_4149_11261_2263_408_9064_6885_5534_5613_4137_8912_6195_5970_7186 23 - 0.00995216736932161 0.255438962479255 7331 antimycin A hsa04060 Cytokine-cytokine receptor interaction 7852_5155_4254_6358_6359 5 - 0.034858865609244 0.671033162977947 7332 H-89 hsa05222 Small cell lung cancer 3673_51588_3688_5295_3675 5 + 0.0361119474530301 1 7333 H-89 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 4.25520187845174e-07 2.08504892044135e-05 7334 cefmetazole hsa05332 Graft-versus-host disease 3123_3126_3127_3803_3125_3558 6 + 0.00148881235833602 0.0352352258139525 7335 cefmetazole hsa04640 Hematopoietic cell lineage 1435_947_3123_3126_3127_1438_3125_7850_3589_914_4254 11 + 4.8357927596996e-05 0.00171670642969336 7336 cefmetazole hsa05320 Autoimmune thyroid disease 3123_3558_3126_3127_3125 5 + 0.0175977869563404 0.156180359237521 7337 cefmetazole hsa04612 Antigen processing and presentation 3123_3126_3127_3803_3125_3305 6 + 0.0383195173091815 0.302298414327987 7338 cefmetazole hsa04740 Olfactory transduction 23538_1179_816 3 + 0.014251982382119 0.14455582130435 7339 cefmetazole hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504_8341_8340 20 + 9.48318244519932e-09 6.73305953609152e-07 7340 cefmetazole hsa05310 Asthma 3123_3126_3127_3125 4 + 0.0115121783786528 0.136227444147391 7341 cefmetazole hsa05330 Allograft rejection 3123_3558_3126_3127_3125 5 + 0.00507051322523611 0.0900016097479409 7342 cefmetazole hsa04940 Type I diabetes mellitus 3123_3558_3126_3127_3125 5 + 0.00884849337964686 0.125648605990985 7343 cefmetazole hsa05014 Amyotrophic lateral sclerosis (ALS) 5630_5606_1432_834_5534 5 - 0.029388470385454 1 7344 cefmetazole hsa04740 Olfactory transduction 109 1 - 0.000254596725577247 0.0193493511438708 7345 cefmetazole hsa04010 MAPK signaling pathway 57551_9479_1432_9252_5534_5155_4763_4137_6196_5606_10454_8398_2247_2264 14 - 0.0455231386815794 1 7346 asiaticoside hsa05322 Systemic lupus erythematosus 3013_8358_8968_720_721_8350_8351_8352_8353_8354_8355_8356_8357 13 + 1.98282470703499e-06 0.000126900781250239 7347 asiaticoside hsa05220 Chronic myeloid leukemia 91_861_1021_3551 4 + 0.0422992885477458 0.998330529427862 7348 asiaticoside hsa04080 Neuroactive ligand-receptor interaction 5618_2908 2 - 0.0266604424971321 1 7349 asiaticoside hsa04740 Olfactory transduction 818_409 2 - 0.000814310419506536 0.0618875918824967 7350 oxprenolol hsa05332 Graft-versus-host disease 3135_3105_3106_649853_941 5 + 0.0092198568036638 0.153480140621917 7351 oxprenolol hsa04650 Natural killer cell mediated cytotoxicity 3105_6655_5880_7410_3135_27040_6452_5781_3106_2534 10 + 0.00789154219591178 0.153480140621917 7352 oxprenolol hsa05320 Autoimmune thyroid disease 3135_3105_3106_649853_941 5 + 0.0215830150567362 0.251801842328589 7353 oxprenolol hsa04520 Adherens junction 7454_5880_7525_91_5770_2534 6 + 0.0314250635282312 0.274969305872023 7354 oxprenolol hsa04740 Olfactory transduction 818_810_3000_1179 4 + 0.0268806008011456 0.268806008011456 7355 oxprenolol hsa04514 Cell adhesion molecules (CAMs) 8174_8506_3105_3106_941_3135_23308_6383_923_649853 10 + 0.006544757400624 0.153480140621917 7356 oxprenolol hsa05330 Allograft rejection 3135_3105_3106_649853_941 5 + 0.00632529232637098 0.153480140621917 7357 oxprenolol hsa04940 Type I diabetes mellitus 3135_3105_3106_649853_941 5 + 0.0109628671872798 0.153480140621917 7358 oxprenolol hsa04740 Olfactory transduction 5566 1 - 0.00012388037542307 0.00879550665503797 7359 oxprenolol hsa04060 Cytokine-cytokine receptor interaction 5618 1 - 0.00357461228009228 0.126898735943276 7360 oxprenolol hsa04020 Calcium signaling pathway 5566 1 - 0.048772510771545 1 7361 bumetanide hsa04080 Neuroactive ligand-receptor interaction 7434_2563_56288_2570_4886 5 + 0.0459830892833617 0.790909135673821 7362 bumetanide hsa04520 Adherens junction 51701_117178_7048_5797_5880_56288_6714_10458_2260 9 + 0.0164459618025859 0.390013641240004 7363 bumetanide hsa04740 Olfactory transduction 8392_1179 2 + 6.48435075131569e-06 0.000557654164613149 7364 bumetanide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_3017_3014_8359_8336_8294_8367_554313_121504_8341_8340 19 + 0.000101633712523223 0.00437024963849859 7365 bumetanide hsa04020 Calcium signaling pathway 8911_23236 2 + 0.0181401693600002 0.390013641240004 7366 bumetanide hsa05322 Systemic lupus erythematosus 3113_8343_8339_8347_8346_8344 6 - 0.0145116838830335 0.379042345998672 7367 bumetanide hsa04664 Fc epsilon RI signaling pathway 100137049_8681_5335_1432 4 - 0.0240661806983284 0.379042345998672 7368 bumetanide hsa04370 VEGF signaling pathway 100137049_8681_5335_1432 4 - 0.022229237650279 0.379042345998672 7369 bumetanide hsa04912 GnRH signaling pathway 10746_8681_1432_776_100137049 5 - 0.0168978368076828 0.379042345998672 7370 sulfaquinoxaline hsa04740 Olfactory transduction 51806 1 + 5.64421303468359e-05 0.00378162273323801 7371 sulfaquinoxaline hsa05131 Shigellosis 7278_6093_7430_113457_9181 5 - 0.0113836474364523 0.205601481559582 7372 sulfaquinoxaline hsa04910 Insulin signaling pathway 5613_5575_5616_5290_8660_23265_32_6655 8 - 0.0164099417892732 0.206765266544842 7373 sulfaquinoxaline hsa05130 Pathogenic Escherichia coli infection 7278_6093_7430_113457_9181 5 - 0.0113836474364523 0.205601481559582 7374 sulfaquinoxaline hsa04740 Olfactory transduction 5613_5616 2 - 0.0130540623212433 0.205601481559582 7375 sulfaquinoxaline hsa05322 Systemic lupus erythematosus 85235_8330_8332_8969_8331_8329_720_721_8336 9 - 0.00721980431827067 0.205601481559582 7376 sulfaquinoxaline hsa04060 Cytokine-cytokine receptor interaction 8744 1 - 0.0323925514516584 0.340121790242413 7377 L-methionine sulfoximine hsa04740 Olfactory transduction 26212_26532_7932_5566_816 5 + 7.2094084399485e-08 6.34427942715468e-06 7378 L-methionine sulfoximine hsa05322 Systemic lupus erythematosus 8970_2215_720_721 4 + 0.0354723702574032 1 7379 L-methionine sulfoximine hsa04350 TGF-beta signaling pathway 6093 1 + 0.0207246397640934 0.91188414962011 7380 L-methionine sulfoximine hsa04070 Phosphatidylinositol signaling system 8394_8867_3633_1606 4 - 0.047160786627165 1 7381 L-methionine sulfoximine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 4.56306595078074e-07 2.05337967785133e-05 7382 altretamine hsa05332 Graft-versus-host disease 3123_3107_3126_3127_3111_3125 6 + 0.00566333650478123 0.0764550428145466 7383 altretamine hsa04640 Hematopoietic cell lineage 3581_3554_960_3123_3126_3127_3125_933 8 + 0.0160954637090117 0.162966570053743 7384 altretamine hsa05320 Autoimmune thyroid disease 959_3123_3107_3126_3127_3111_3125 7 + 0.00424611974846734 0.0687871399251709 7385 altretamine hsa04740 Olfactory transduction 26539_135948 2 + 0.000278064652115934 0.0112616184106953 7386 altretamine hsa04514 Cell adhesion molecules (CAMs) 24146_959_3695_3683_3123_3107_3126_3127_3111_3125_5818_23308_57863_933_25945_1462 16 + 5.4293910459866e-05 0.00439780674724915 7387 altretamine hsa05310 Asthma 959_3123_3126_3127_3111_3125 6 + 0.00126839246949719 0.0256849475073181 7388 altretamine hsa05330 Allograft rejection 959_3123_3107_3126_3127_3111_3125 7 + 0.000773584129956548 0.0208867715088268 7389 altretamine hsa04940 Type I diabetes mellitus 3123_3107_3126_3127_3111_3125 6 + 0.00692658361535989 0.0801504675491644 7390 altretamine hsa05211 Renal cell carcinoma 7424_8503_5296_6655_5155_405_2034_8453_7040_7042_7039_4233 12 - 0.0136460250750968 0.303624057920904 7391 altretamine hsa04080 Neuroactive ligand-receptor interaction 3354_5618_1081 3 - 2.61595426640793e-05 0.00116409964855153 7392 altretamine hsa04740 Olfactory transduction 5566_157 2 - 8.13071778782178e-10 7.23633883116138e-08 7393 altretamine hsa05322 Systemic lupus erythematosus 3113_8330_55766 3 - 0.0190978633636747 0.33994196787341 7394 altretamine hsa04020 Calcium signaling pathway 115_11261_5256_5566 4 - 0.00763970299603615 0.226644522215739 7395 zomepirac hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_8341 15 + 2.48462194968094e-08 1.09323365785961e-06 7396 zomepirac hsa04740 Olfactory transduction 157 1 - 0.0320685237337246 0.843132410054544 7397 zomepirac hsa04370 VEGF signaling pathway 5829_6714_8681_100137049 4 - 0.035130517085606 0.843132410054544 7398 drofenine hsa04070 Phosphatidylinositol signaling system 8394_8871_23396_5305_23236 5 - 0.0377431651459572 1 7399 drofenine hsa04060 Cytokine-cytokine receptor interaction 4233 1 - 0.0331195685944744 1 7400 methacholine chloride hsa05332 Graft-versus-host disease 5551_3113 2 + 0.0423041340631832 0.33626392641615 7401 methacholine chloride hsa04514 Cell adhesion molecules (CAMs) 26285_923_3113_26047_5817 5 + 0.00370445805245139 0.118542657678444 7402 methacholine chloride hsa05330 Allograft rejection 5551_3113 2 + 0.0355481655853266 0.33626392641615 7403 methacholine chloride hsa04940 Type I diabetes mellitus 3113_5551 2 + 0.0458483483889308 0.33626392641615 7404 methacholine chloride hsa04070 Phosphatidylinositol signaling system 5298_8394_8396_3632_200576_23236 6 - 0.04746395480207 0.508542372879321 7405 methacholine chloride hsa04740 Olfactory transduction 818_109_409 3 - 0.00283358890735424 0.0923640035213425 7406 methacholine chloride hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3123_3126_3127_3125_8359_8294_8367_554313_8368_121504 18 - 4.16428116433598e-06 0.000312321087325199 7407 methacholine chloride hsa05310 Asthma 3123_3126_3127_3125 4 - 0.0225069366043516 0.422005061331593 7408 methacholine chloride hsa04060 Cytokine-cytokine receptor interaction 8795 1 - 0.0036945601408537 0.0923640035213425 7409 methacholine chloride hsa04912 GnRH signaling pathway 5595_6654_818_109_8681_3725_100137049_23236 8 - 0.032677568363995 0.490163525459925 7410 methacholine chloride hsa05330 Allograft rejection 3123_3126_3127_3125 4 - 0.0445845210398521 0.508542372879321 7411 phenacetin hsa04520 Adherens junction 4301_7046_2260_8976 4 + 0.0334492832821649 0.361252259447381 7412 phenacetin hsa04710 Circadian rhythm - mammal 1408_5187 2 + 0.0193438907526448 0.349679225149522 7413 phenacetin hsa04920 Adipocytokine signaling pathway 3953_8660_181_4793 4 + 0.0194266236194179 0.349679225149522 7414 phenacetin hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0108660628994169 0.349679225149522 7415 phenacetin hsa05220 Chronic myeloid leukemia 5925_7046_1488_867 4 + 0.0275128203459517 0.361252259447381 7416 phenacetin hsa04080 Neuroactive ligand-receptor interaction 146_1812 2 - 0.013714387034456 0.528003900826556 7417 phenacetin hsa04740 Olfactory transduction 818_4991 2 - 0.000183529606098064 0.0141317796695509 7418 mevalolactone hsa05131 Shigellosis 7278_113457 2 + 0.0112847988455147 0.0940399903792892 7419 mevalolactone hsa05130 Pathogenic Escherichia coli infection 7278_113457 2 + 0.0112847988455147 0.0940399903792892 7420 mevalolactone hsa04540 Gap junction 7278_1956_113457 3 + 0.00234157610639841 0.0585394026599603 7421 mevalolactone hsa04360 Axon guidance 10725_6092_64218 3 - 0.0160272827235329 0.352600219917724 7422 pridinol hsa03020 RNA polymerase 246721_5439_548644 3 + 0.00971912832011388 0.660900725767744 7423 pridinol hsa05332 Graft-versus-host disease 3135_3105_3106_3133_649853 5 - 0.00753622017210579 0.209532847405063 7424 pridinol hsa04080 Neuroactive ligand-receptor interaction 5021 1 - 0.0158663822551475 0.249860591363046 7425 pridinol hsa05320 Autoimmune thyroid disease 3135_3105_3106_3133_649853 5 - 0.0178471850973604 0.249860591363046 7426 pridinol hsa04612 Antigen processing and presentation 3105_3106_3135_6890_3133_649853 6 - 0.0388922662562935 0.388922662562935 7427 pridinol hsa04350 TGF-beta signaling pathway 4090_3399_6667_5933_7040_7042 6 - 0.035596669442669 0.388922662562935 7428 pridinol hsa05330 Allograft rejection 3135_3105_3106_3133_649853 5 - 0.00514821546903359 0.209532847405063 7429 pridinol hsa04940 Type I diabetes mellitus 3135_3105_3106_3133_649853 5 - 0.00897997917450272 0.209532847405063 7430 hecogenin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 4.20232581421347e-06 0.000252139548852808 7431 hecogenin hsa03450 Non-homologous end-joining 5591_27343 2 + 0.0414573591909282 0.924743534940724 7432 hecogenin hsa04060 Cytokine-cytokine receptor interaction 5618 1 + 0.0462371767470362 0.924743534940724 7433 hecogenin hsa05332 Graft-versus-host disease 3123_3106_355 3 - 0.0498572679633788 0.567324904360877 7434 hecogenin hsa04115 p53 signaling pathway 836_355_6477_841 4 - 0.045682035316687 0.567324904360877 7435 hecogenin hsa05330 Allograft rejection 3123_3106_355 3 - 0.0394889224638975 0.567324904360877 7436 pipenzolate bromide hsa04640 Hematopoietic cell lineage 3589_3553_2057_3684 4 + 0.0210209154267953 0.651648378230654 7437 pipenzolate bromide hsa04664 Fc epsilon RI signaling pathway 208_27040_5880_5581 4 + 0.0154990244655421 0.651648378230654 7438 pipenzolate bromide hsa04010 MAPK signaling pathway 3553_1850_208_5880_7042_5971_3164 7 + 0.0435662206884184 0.680964286778673 7439 pipenzolate bromide hsa04916 Melanogenesis 5331_6932_808_112_801_805 6 - 0.00996637832778833 0.122325475673662 7440 pipenzolate bromide hsa05214 Glioma 1869_801_808_805 4 - 0.0276024456715908 0.228705978421752 7441 pipenzolate bromide hsa04070 Phosphatidylinositol signaling system 8394_3633_5331_808_801_805 6 - 0.00238016500456005 0.0582461393255833 7442 pipenzolate bromide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 3.44010701225683e-07 1.99526206710896e-05 7443 pipenzolate bromide hsa04720 Long-term potentiation 5331_6196_808_801_805 5 - 0.0105452996270398 0.122325475673662 7444 pipenzolate bromide hsa04912 GnRH signaling pathway 2002_5331_808_112_6714_801_805 7 - 0.00301273134442672 0.0582461393255833 7445 pipenzolate bromide hsa04270 Vascular smooth muscle contraction 5331_808_112_801_27345_805 6 - 0.0172130763357337 0.166393071245426 7446 isopropamide iodide hsa05214 Glioma 1869_6655_5154_5290 4 - 0.0251091352117856 0.263645919723749 7447 isopropamide iodide hsa04662 B cell receptor signaling pathway 7410_6655_4067_5290_4793 5 - 0.00935512257029235 0.196457573976139 7448 isopropamide iodide hsa04510 Focal adhesion 7059_6655_1289_5154_5290_7410_29780_83660 8 - 0.0225795359011535 0.263645919723749 7449 isopropamide iodide hsa04664 Fc epsilon RI signaling pathway 7410_6655_4067_5290 4 - 0.0449852364044118 0.339759151722458 7450 isopropamide iodide hsa05223 Non-small cell lung cancer 1869_6655_6256_5290 4 - 0.0141084432742851 0.22220798156999 7451 isopropamide iodide hsa04062 Chemokine signaling pathway 4067_6655_6777_5290_7852_7410_4793_23236_408 9 - 0.00541478948068691 0.170565868641638 7452 isopropamide iodide hsa04010 MAPK signaling pathway 9344_3925_6655_1649_5154_4137_5607_4616_408 9 - 0.0485370216746369 0.339759151722458 7453 isopropamide iodide hsa04540 Gap junction 7278_113457_5154_5607_6655_23236 6 - 0.00524851732092394 0.170565868641638 7454 isopropamide iodide hsa05220 Chronic myeloid leukemia 1869_6655_6777_5290 4 - 0.0386171289321214 0.339759151722458 7455 glycopyrronium bromide hsa04670 Leukocyte transendothelial migration 5829_93408_399_1432_3383 5 + 0.0287453126394953 0.881682851489241 7456 glycopyrronium bromide hsa04740 Olfactory transduction 157 1 - 0.0320685237337246 0.83378161707684 7457 glycopyrronium bromide hsa04710 Circadian rhythm - mammal 79365_1408 2 - 0.0213369669767314 0.83378161707684 7458 aminohippuric acid hsa05332 Graft-versus-host disease 3105_3106_3107_3113_3135_649853 6 + 0.00431713774568821 0.0673473488327361 7459 aminohippuric acid hsa05320 Autoimmune thyroid disease 958_3105_3106_3107_3113_3135_649853 7 + 0.00311748153070094 0.0607908898486683 7460 aminohippuric acid hsa05016 Huntington's disease 7052 1 + 0.0339524481776207 0.24075372344131 7461 aminohippuric acid hsa04740 Olfactory transduction 818_23538 2 + 0.000380470720614807 0.0216236904139341 7462 aminohippuric acid hsa04514 Cell adhesion molecules (CAMs) 2734_958_3107_3105_3106_3680_3113_3135_57863_947_923_649853 12 + 0.0027797335856582 0.0607908898486683 7463 aminohippuric acid hsa04510 Focal adhesion 5599_858_3680_1289_5602_1277_3690_7410_5880_29780_1292_6093_4233_3674 14 + 0.0179822372383217 0.175326813073637 7464 aminohippuric acid hsa04360 Axon guidance 1949_80031_22885_2048_5880_4772_6093_4233_57556 9 + 0.0478694434700986 0.311151382555641 7465 aminohippuric acid hsa04512 ECM-receptor interaction 960_3690_3680_1289_1277_1292_3674 7 + 0.0280406364716359 0.21871696447876 7466 aminohippuric acid hsa04020 Calcium signaling pathway 2769_776_8913_56848_5333_818_6915_108_8911_6869_489_9630_491 13 + 0.013255021213826 0.147698807811204 7467 aminohippuric acid hsa04930 Type II diabetes mellitus 8651_5599_776_8913_5602 5 + 0.0223282726495717 0.193511696296288 7468 aminohippuric acid hsa05330 Allograft rejection 958_3105_3106_3107_3113_3135_649853 7 + 0.000554453600357285 0.0216236904139341 7469 aminohippuric acid hsa04940 Type I diabetes mellitus 3105_3106_3107_3113_3135_649853 6 + 0.0052965248277045 0.0688548227601585 7470 phenyl biguanide hsa05332 Graft-versus-host disease 3135_3134_355_3107_3133 5 + 0.00987849043215533 0.205400113367505 7471 phenyl biguanide hsa05320 Autoimmune thyroid disease 3135_3134_355_3107_3133 5 + 0.0230298139487884 0.322417395283038 7472 phenyl biguanide hsa04740 Olfactory transduction 26476 1 + 0.00039538288714154 0.0276768020999078 7473 phenyl biguanide hsa05330 Allograft rejection 3135_3134_355_3107_3133 5 + 0.0067874478346152 0.205400113367505 7474 phenyl biguanide hsa04940 Type I diabetes mellitus 3135_3134_355_3107_3133 5 + 0.011737149335286 0.205400113367505 7475 phenyl biguanide hsa04740 Olfactory transduction 5137_26716 2 - 0.0357622234054987 1 7476 reserpine hsa04080 Neuroactive ligand-receptor interaction 3953_3351_9038_5645_624 5 + 0.0312545541732194 0.718854745984046 7477 reserpine hsa04080 Neuroactive ligand-receptor interaction 4886 1 - 0.0326176796437991 0.569185518640934 7478 reserpine hsa04740 Olfactory transduction 219464 1 - 0.00260858237279785 0.161732107113467 7479 reserpine hsa05322 Systemic lupus erythematosus 85235_3119_8330_8332_8969_8331_8329_8337_8336 9 - 0.00891407914643825 0.276336453539586 7480 reserpine hsa03020 RNA polymerase 246721_5439_548644 3 - 0.0367216463639312 0.569185518640934 7481 lomustine hsa05219 Bladder cancer 4193_1956_7422_1613_1871 5 + 0.0133197836252826 0.959024421020347 7482 lomustine hsa05010 Alzheimer's disease 5331_4698_5594 3 - 0.0497552506323472 0.70230181149029 7483 lomustine hsa04080 Neuroactive ligand-receptor interaction 1241_5029_2149_7433 4 - 0.0108006846213062 0.295218712982369 7484 lomustine hsa04740 Olfactory transduction 5137_219464_157 3 - 1.37692007171045e-05 0.00112907445880257 7485 lomustine hsa05322 Systemic lupus erythematosus 89_85235_942_3123_55766_8330_3126_3127_3125_8332_8969_8331_8336_8343_8329_8339_8347_8346_8344 19 - 0.000238400879718131 0.00977443606844337 7486 orphenadrine hsa05211 Renal cell carcinoma 5879_2271_56924_2034_8453_3725_1387 7 + 0.0493386609213554 0.464728294460475 7487 orphenadrine hsa04080 Neuroactive ligand-receptor interaction 7067_1395_3356_2917 4 + 0.0272393826270423 0.42493436898186 7488 orphenadrine hsa05200 Pathways in cancer 5371_331_1387_5337_5888_51176_3576_1612_2034_7471_2247_3918_8453_5467_91_3725_4791_2261_2271_5599_8817_355_5879_2064 24 + 0.0222043521130685 0.42493436898186 7489 orphenadrine hsa05016 Huntington's disease 1387 1 + 0.00520789360413845 0.2031078505614 7490 orphenadrine hsa04510 Focal adhesion 1280_93408_5829_858_331_56924_3918_5649_5599_7060_29780_3725_55742_5879_2064_10627 16 + 0.0402136269289492 0.464728294460475 7491 orphenadrine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_554313_9103_8359_8294_720_721_121504_8367 17 + 0.000461278937688395 0.0359797571396948 7492 orphenadrine hsa05219 Bladder cancer 1612_2064_3576_1890_2261 5 + 0.0474348866172392 0.464728294460475 7493 orphenadrine hsa04010 MAPK signaling pathway 9479_9344_5607_8681_3164_2261_100137049_4776_2247_91_3725_4791_1848_5599_5598_4915_4137_8817_355_8911_5971_5879 22 + 0.0114255792587852 0.297065060728415 7494 orphenadrine hsa04070 Phosphatidylinositol signaling system 8394_3708_5333_808_801_805_23236 7 - 0.0367881197069919 0.472114202906396 7495 orphenadrine hsa04080 Neuroactive ligand-receptor interaction 2911_1081_7433 3 - 0.0196681938038295 0.470410607512026 7496 orphenadrine hsa04740 Olfactory transduction 801_808_157_805 4 - 0.00158548574592459 0.122082402436193 7497 orphenadrine hsa04720 Long-term potentiation 2911_3708_808_5534_801_805_23236 7 - 0.0347634501785031 0.472114202906396 7498 orphenadrine hsa03450 Non-homologous end-joining 5591_27343_27434 3 - 0.0244369146759494 0.470410607512026 7499 orphenadrine hsa04912 GnRH signaling pathway 4313_1081_5598_998_3708_808_3725_801_805_23236 10 - 0.0135952839437304 0.470410607512026 7500 phenelzine hsa04910 Insulin signaling pathway 25759 1 + 0.0219056681868703 0.799556888820766 7501 phenelzine hsa05016 Huntington's disease 1387_317_9001 3 + 0.0499454351963792 1 7502 phenelzine hsa04740 Olfactory transduction 26211_8383_3000_4991 4 + 0.000218683396056784 0.0159638879121452 7503 phenelzine hsa03440 Homologous recombination 57804_8940_8438_5890_5892_5893_7156_5888 8 - 0.0198164058192415 0.363293478312658 7504 phenelzine hsa04080 Neuroactive ligand-receptor interaction 5618_7442_1081_2561_706_5025_1241_152_2150_7433_56288_5644_9170 13 - 0.00461460334502627 0.143052703695814 7505 phenelzine hsa04740 Olfactory transduction 818_219464_109 3 - 7.7613548787084e-14 7.21806003719881e-12 7506 phenelzine hsa05012 Parkinson's disease 4712_7054_65018_27429_513_291 6 - 0.0219855198285768 0.363293478312658 7507 phenelzine hsa04060 Cytokine-cytokine receptor interaction 1436_5618_8744_3597_50616_3589_3594_5154_8741_8742_4982_91_655_4254_51330_8795 16 - 0.0234382889233973 0.363293478312658 7508 phenelzine hsa03010 Ribosome 140801 1 - 0.000610553242789629 0.0283907257897177 7509 ketoprofen hsa05332 Graft-versus-host disease 3824_3109_3119_3117_3804_3107_3126_3127_3125_356_3123_941 12 + 0.00094661881375068 0.0125005526663875 7510 ketoprofen hsa04120 Ubiquitin mediated proteolysis 23327_326_7329 3 + 0.00471012093755311 0.0318838955772826 7511 ketoprofen hsa04640 Hematopoietic cell lineage 1435_948_3690_3123_4254_3126_3127_1438_3125_947_915_931_3676_925 14 + 0.0401824088426981 0.196447332119857 7512 ketoprofen hsa04662 B cell receptor signaling pathway 10000 1 + 0.0301953391960643 0.166074365578354 7513 ketoprofen hsa05010 Alzheimer's disease 2903_776_1339_317_487_3709_810 7 + 0.0381660009615226 0.196447332119857 7514 ketoprofen hsa04080 Neuroactive ligand-receptor interaction 151_2903_2901_624_2908_2925_185_117_135_2488_3360_5724_7434_2740_4987_4986_1395_5028_719_2917_2642_7433_4887_3356_3351_3350_3352_3269_5340_2555_2558_5617_6752_2692 34 + 0.0273258349000154 0.160311564746757 7515 ketoprofen hsa05320 Autoimmune thyroid disease 3439_3449_3109_3119_3117_3123_3447_3107_3126_3127_3125_356_941_3448 14 + 0.000709450397632979 0.0124863269983404 7516 ketoprofen hsa04612 Antigen processing and presentation 3439_3824_3449_972_3119_3805_3123_3447_3107_3126_3127_3125_3117_8302_3804_3109_925_3448 18 + 0.00328359316210711 0.0288956198265426 7517 ketoprofen hsa05016 Huntington's disease 1339_4899_317_246721 4 + 0.000703134258100367 0.0124863269983404 7518 ketoprofen hsa04740 Olfactory transduction 5593_8390_1179_818_5137_810_26659_9635_816 9 + 1.64822736965771e-06 0.000145044008529878 7519 ketoprofen hsa04514 Cell adhesion molecules (CAMs) 23308_57863_22871_3676_3383_3123_3107_3126_3127_3125_25945_1462_4099_4359_3109_965_4684_3688_3119_6404_3117_947_3685_941_5797_57502_6693_925_26047_1000 30 + 1.54787273211128e-05 0.000681064002128963 7520 ketoprofen hsa05322 Systemic lupus erythematosus 2903_8361_8363_8362_8365_8364_8367_8360_8368_9103_8290_8294_3109_3123_8366_3126_3127_3125_8370_718_8359_8330_554313_121504_8354_3119_3117_941_720_721 30 + 5.39342679847717e-05 0.00158207186088664 7521 ketoprofen hsa04110 Cell cycle 699 1 + 0.000994362143917184 0.0125005526663875 7522 ketoprofen hsa05310 Asthma 3109_3119_3117_3123_3126_3127_3125_8288 8 + 0.00920016476563788 0.0578296070982952 7523 ketoprofen hsa05012 Parkinson's disease 1339_317 2 + 0.00137507378834176 0.0151258116717594 7524 ketoprofen hsa03010 Ribosome 6165 1 + 0.00304420960595099 0.0288956198265426 7525 ketoprofen hsa05330 Allograft rejection 3109_3119_3117_3123_3107_3126_3127_3125_356_941 10 + 0.00407730894123574 0.0299002655690621 7526 ketoprofen hsa04940 Type I diabetes mellitus 3109_3119_3117_2572_3107_3126_3127_3125_356_3123_941 11 + 0.00369905262351077 0.0295924209880862 7527 ketoprofen hsa04080 Neuroactive ligand-receptor interaction 64106_7067_2901_2149 4 - 0.0277685587584446 0.873678070808026 7528 ketoprofen hsa04514 Cell adhesion molecules (CAMs) 214 1 - 0.0315787254508925 0.873678070808026 7529 ketoprofen hsa05322 Systemic lupus erythematosus 6738 1 - 0.0219866634645818 0.873678070808026 7530 nefopam hsa05016 Huntington's disease 4899_54205 2 + 0.00934271235758522 0.383051206660994 7531 nefopam hsa04740 Olfactory transduction 51806_8388_8387_5566_8390_3000_81797 7 + 0.00175321616375842 0.14376372542819 7532 nefopam hsa05012 Parkinson's disease 54205 1 + 0.0151064105793025 0.412908555834268 7533 nefopam hsa05322 Systemic lupus erythematosus 85235_8330_8969_8332_88_8331_8336_6737_8970_8329 10 - 0.044062789774344 1 7534 prilocaine hsa05211 Renal cell carcinoma 10298_2549_5155_3845_7042_7039 6 + 0.0470513549039355 0.611667613751162 7535 prilocaine hsa05016 Huntington's disease 4695 1 + 0.0226761715028004 0.58958045907281 7536 prilocaine hsa04740 Olfactory transduction 26212_5566 2 + 0.00026469355062814 0.0206460969489949 7537 prilocaine hsa04540 Gap junction 5578_5566_56034_5155_3709_3356_3845_1902 8 + 0.0202854515683381 0.58958045907281 7538 prilocaine hsa04730 Long-term depression 5578_3480_3709_8681_3845_100137049 6 + 0.0446377178902309 0.611667613751162 7539 prilocaine hsa04270 Vascular smooth muscle contraction 5578_4882_3778_3709_8681_6093_4638_100137049_5566 9 + 0.0399526043772686 0.611667613751162 7540 prilocaine hsa04080 Neuroactive ligand-receptor interaction 146_1813_3953_3354_7433_2149 6 - 0.00227143896063194 0.0666288761785369 7541 prilocaine hsa05200 Pathways in cancer 4088_598_331_9618_5291_5881_6772_652671_3675_4149_7157_5371_1613_1856_405_1398_1017_581_208_999_4193_4254_5467_91_4286_3918_4233_4791_1021_5594_841_5599_867_6789_2258_5914 36 - 0.0182012070621105 0.400426555366431 7542 prilocaine hsa04740 Olfactory transduction 818_51806 2 - 1.86186637940208e-09 1.63844241387383e-07 7543 prilocaine hsa04210 Apoptosis 841_581_7157_598_11261_331_5291_208_5576_8737_8794_5575 12 - 0.0419947626956735 0.583237037654616 7544 prilocaine hsa04370 VEGF signaling pathway 9261_1432_5594_5829_208_11261_5291_7867_5881_8398_6714 11 - 0.0471837233180179 0.583237037654616 7545 prilocaine hsa05012 Parkinson's disease 7327 1 - 0.00152194351539649 0.0666288761785369 7546 prilocaine hsa05220 Chronic myeloid leukemia 1021_5594_4088_208_4193_867_5291_7157_1398_91_598 11 - 0.028455777215682 0.500821678996003 7547 metoclopramide hsa04740 Olfactory transduction 442194_9635_816_1258 4 + 0.00217049980141495 0.160616985304706 7548 metoclopramide hsa04514 Cell adhesion molecules (CAMs) 6402_965_3688_3119_3685_941_5818_57863_51208_6383 10 + 0.0406748810381988 0.888046127787246 7549 metoclopramide hsa04920 Adipocytokine signaling pathway 51703_10000_10645_5465_5602_4852 6 + 0.0480024933939052 0.888046127787246 7550 metoclopramide hsa02010 ABC transporters 11194_5244_64137_5243_8714_10347 6 + 0.00888763137452364 0.328842360857375 7551 metoclopramide hsa04740 Olfactory transduction 51806_26212_26529 3 - 0.0143554376892119 0.976169762866409 7552 metoclopramide hsa04115 p53 signaling pathway 355_25898_4193_841_4616 5 - 0.045493433403756 1 7553 hydralazine hsa04662 B cell receptor signaling pathway 10000_6655_5532_7410_5880_933_4793 7 + 0.0209785192462521 0.440548904171294 7554 hydralazine hsa04740 Olfactory transduction 810_26476_7932 3 + 0.00140928702008936 0.0591900548437531 7555 hydralazine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_716_3113_8359_8294_8367_554313_8368_121504_8354 17 + 3.16096956042277e-05 0.00265521443075513 7556 hydralazine hsa04062 Chemokine signaling pathway 2785_4283_10000_2185_6655_2788_3718_7852_7410_5880_10235_6363_6093_4793 14 + 0.0170550302216293 0.440548904171294 7557 hydralazine hsa04080 Neuroactive ligand-receptor interaction 1909_1813_3953_2917_3354_7067_7433_64106 8 - 0.0361732547050368 0.799777666545456 7558 hydralazine hsa04740 Olfactory transduction 26212_5566_157 3 - 7.10074021932403e-08 5.96462178423218e-06 7559 hydralazine hsa05012 Parkinson's disease 2861_7419 2 - 0.0180998625507301 0.760194227130664 7560 6-benzylaminopurine hsa05332 Graft-versus-host disease 3119_3126_3107_3113_3127_3125_3123_941 8 + 0.0129086279152258 0.138767750088677 7561 6-benzylaminopurine hsa04120 Ubiquitin mediated proteolysis 7320_5371 2 + 0.00866044483794801 0.106399750866218 7562 6-benzylaminopurine hsa04640 Hematopoietic cell lineage 1435_947_3690_3123_3126_3127_3125_7850_3589_1378_290_3675 12 + 0.0342163811913074 0.245217398537703 7563 6-benzylaminopurine hsa05010 Alzheimer's disease 775_487_4695_4137 4 + 0.0196480610346809 0.168973324898256 7564 6-benzylaminopurine hsa05320 Autoimmune thyroid disease 3119_3113_3107_3126_3127_3125_3123_7038_941 9 + 0.0159479415609006 0.152391441581939 7565 6-benzylaminopurine hsa05016 Huntington's disease 7350_4695 2 + 0.000754109317335296 0.0216178004302785 7566 6-benzylaminopurine hsa04740 Olfactory transduction 5593_56656 2 + 3.9449331099457e-09 3.3926424745533e-07 7567 6-benzylaminopurine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_88_8294_3123_3126_3127_3125_8370_717_8359_554313_121504_3119_3113_941 23 + 0.000560914625241076 0.0216178004302785 7568 6-benzylaminopurine hsa05310 Asthma 3119_3123_3113_3127_3126_3125 6 + 0.0246949002810761 0.193069220379322 7569 6-benzylaminopurine hsa05012 Parkinson's disease 4695 1 + 0.00226004020119371 0.0429732105095585 7570 6-benzylaminopurine hsa05330 Allograft rejection 3592_3119_3113_3107_3126_3127_3125_3123_941 9 + 0.00249844247148596 0.0429732105095585 7571 6-benzylaminopurine hsa04940 Type I diabetes mellitus 3592_3119_3113_3107_3126_3127_3125_3123_941 9 + 0.0057829211235433 0.0828885361041206 7572 6-benzylaminopurine hsa04916 Melanogenesis 107 1 - 0.045569594775994 0.663883832387624 7573 6-benzylaminopurine hsa05010 Alzheimer's disease 3708 1 - 0.00111194045285329 0.0461455287934115 7574 6-benzylaminopurine hsa04080 Neuroactive ligand-receptor interaction 7067_3354 2 - 0.00012215651263267 0.0101389905485116 7575 6-benzylaminopurine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_6737_8359_8294_8367_554313_6738_121504 16 - 0.0189864149132808 0.393968109450577 7576 6-benzylaminopurine hsa05012 Parkinson's disease 7419 1 - 0.0109419188088315 0.302726420377672 7577 6-benzylaminopurine hsa04020 Calcium signaling pathway 3708_7419_814_107 4 - 0.047991602341274 0.663883832387624 7578 tropicamide hsa04120 Ubiquitin mediated proteolysis 4214 1 + 0.0219157694854773 0.560463851052929 7579 tropicamide hsa05016 Huntington's disease 1213_7802_7350 3 + 0.049897974756834 0.560463851052929 7580 tropicamide hsa04740 Olfactory transduction 51806_5566_8383_5132 4 + 0.000214530906783734 0.016947941635915 7581 tropicamide hsa05012 Parkinson's disease 9627 1 + 0.0327129104651748 0.560463851052929 7582 tropicamide hsa04740 Olfactory transduction 26212_157_816 3 - 6.68333019860111e-06 0.000561399736682493 7583 tropicamide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_88_8294_8367_554313_121504 15 - 0.0148984269339157 0.31286696561223 7584 tropicamide hsa05221 Acute myeloid leukemia 8503_6934_3551_208_6655_5371_3845_5467_652671 9 - 0.00600638612682333 0.25226821732658 7585 tropicamide hsa04664 Fc epsilon RI signaling pathway 8503_208_6655_8681_5335_5603_3845_100137049_5606 9 - 0.0407212547546559 0.423108936152728 7586 tropicamide hsa04370 VEGF signaling pathway 8503_5829_208_9261_8681_3845_5603_5335_6714_100137049 10 - 0.0104534550088365 0.292696740247422 7587 tropicamide hsa05223 Non-small cell lung cancer 8503_5170_208_6655_5335_3845_6257 7 - 0.0300541835089082 0.423108936152728 7588 lomefloxacin hsa04120 Ubiquitin mediated proteolysis 6502_9063_867 3 + 0.0494223208638813 0.849198870067477 7589 lomefloxacin hsa05016 Huntington's disease 5330_1211_7416_4695_581 5 + 0.0461634532092102 0.849198870067477 7590 lomefloxacin hsa04740 Olfactory transduction 810_4991_1179_816_390892 5 + 2.64593368793205e-06 0.00021961249609836 7591 lomefloxacin hsa05012 Parkinson's disease 4695_7416 2 + 0.0179558162098714 0.745166372709663 7592 lomefloxacin hsa04740 Olfactory transduction 818_5613_26212_5566_4991 5 - 0.00316069935844155 0.256016648033766 7593 lomefloxacin hsa04710 Circadian rhythm - mammal 9572_5187_8863 3 - 0.0223327227737794 0.904475272338066 7594 famprofazone hsa05332 Graft-versus-host disease 3553_3126_3113_3127_3111_3125_5551_3123 8 + 0.00444390467804229 0.0773239413979358 7595 famprofazone hsa05320 Autoimmune thyroid disease 3441_3126_3127_3111_3125_5551_3123_3113 8 + 0.0146776716370339 0.159619679052744 7596 famprofazone hsa04740 Olfactory transduction 8392_26476_7932_23538_816 5 + 4.40238658745773e-05 0.00191503816554411 7597 famprofazone hsa04514 Cell adhesion molecules (CAMs) 4684_8174_3383_9369_3123_1272_3126_3127_3111_3125_23308_51208_3113_923_25945_3897_26047_5817 18 + 0.00136514469941195 0.0296918972122099 7598 famprofazone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_9103_8294_8341_8340_3123_3126_3127_3125_8370_8359_554313_121504_3113_3111 23 + 2.33913167700386e-05 0.00191503816554411 7599 famprofazone hsa05310 Asthma 3123_3126_3127_3111_3125_3113 6 + 0.0108295686557672 0.134596067578821 7600 famprofazone hsa05330 Allograft rejection 3113_3126_3127_3111_3125_5551_3123 7 + 0.00890538354038763 0.129128061335621 7601 famprofazone hsa04940 Type I diabetes mellitus 3382_3113_3126_3127_3111_2571_5551_3123_3553_3125 10 + 0.000468599120033784 0.0135893744809797 7602 famprofazone hsa05332 Graft-versus-host disease 3553_3126_3107_3113_3127_3125_355_5551_3123 9 - 0.00887460270674311 0.179951732598306 7603 famprofazone hsa04080 Neuroactive ligand-receptor interaction 5618_4157_1081_1813_7067_134_6754_3354_7433_2740 10 - 0.0290299669492919 0.280623013843155 7604 famprofazone hsa05320 Autoimmune thyroid disease 3451_1081_3113_3107_3126_3127_3125_355_5551_3123 10 - 0.012547450992757 0.179951732598306 7605 famprofazone hsa04310 Wnt signaling pathway 5566_23236_6934_5578 4 - 0.0259758143842097 0.280623013843155 7606 famprofazone hsa05016 Huntington's disease 7419_2776_23236 3 - 0.000891920270586204 0.0258656878469999 7607 famprofazone hsa04740 Olfactory transduction 810_51806_26212_5566_157 5 - 1.00363543018868e-07 4.36581412132076e-06 7608 famprofazone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8343_8347_8346_8344_8339_3123_3126_3127_3125_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3113_727_720_721 38 - 1.07121191347704e-09 9.31954364725025e-08 7609 famprofazone hsa05012 Parkinson's disease 2861_7419_7054_5413 4 - 0.046211688218365 0.402041687499775 7610 famprofazone hsa05330 Allograft rejection 3113_3107_3126_3127_3125_355_5551_3123 8 - 0.0144788750366453 0.179951732598306 7611 famprofazone hsa04940 Type I diabetes mellitus 3553_3113_3107_3126_3127_3125_355_5551_3123 9 - 0.0113972137453669 0.179951732598306 7612 Prestwick-689 hsa04740 Olfactory transduction 26333_23538 2 + 0.00922799044995205 0.29068169917349 7613 Prestwick-689 hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 1.64384544462594e-05 0.00103562263011434 7614 Prestwick-689 hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0367216463639312 0.771154573642555 7615 Prestwick-689 hsa04080 Neuroactive ligand-receptor interaction 3953_56288 2 - 0.013714387034456 0.236573176344366 7616 Prestwick-689 hsa04740 Olfactory transduction 5566 1 - 2.53984994896457e-05 0.000876248232392777 7617 Prestwick-689 hsa05322 Systemic lupus erythematosus 8358_85235_8968_3013_8330_8332_8969_8331_8329_8351_8350_8336_8352_8353_8354_8355_8356_8357 18 - 1.14450882666075e-05 0.000789711090395918 7618 Prestwick-689 hsa04060 Cytokine-cytokine receptor interaction 3953_5155 2 - 0.00935570012362533 0.215181102843383 7619 rotenone hsa05332 Graft-versus-host disease 3812_3824_3125_3107_3126_3127_3558_356_3811_3123_3802 11 + 0.00714125337650736 0.157107574283162 7620 rotenone hsa05131 Shigellosis 51807_347688_3688_7278_113457_9475_56604_10382_9181_7430_6093_2534 12 + 0.0302393301960993 0.281028648324627 7621 rotenone hsa05016 Huntington's disease 2902_246721_627_1639_317_7350_5978_7416_6875 9 + 0.0236685493059472 0.281028648324627 7622 rotenone hsa05130 Pathogenic Escherichia coli infection 51807_347688_3688_7278_113457_9475_56604_10382_9181_7430_6093_2534 12 + 0.0302393301960993 0.281028648324627 7623 rotenone hsa04740 Olfactory transduction 26211_4993_390892_5137_816_81797 6 + 4.71170096857391e-10 4.14629685234504e-08 7624 rotenone hsa04510 Focal adhesion 23533_1301_1302_2909_5155_5154_9475_5649_5602_87_3674_2321_5063_3690_2889_3695_93408_1399_29780_55742_1291_29895_8515_1311_331_3908_1950_3725_6093_2335_1284_3688_7148_2318_5579_1282_5599_6655_7422_824_6696_2534 42 + 7.21132146484916e-05 0.00317298144453363 7625 rotenone hsa04360 Axon guidance 9475_7852_9037_23365_27289_1949_57715_5063_1944_10154_5533_4772_10501_6093_10505_64218_1969_5362_3688_9901_6405_2534 22 + 0.0319350736732531 0.281028648324627 7626 rotenone hsa04512 ECM-receptor interaction 1284_8515_7148_1302_1311_1282_3690_3908_3695_5649_3688_2335_961_1291_6696_3674_1301 17 + 0.0131051455938834 0.230650562452348 7627 rotenone hsa05012 Parkinson's disease 9627_7416_6622_317_7054 5 + 0.0174459988650815 0.255874650021195 7628 rotenone hsa03010 Ribosome 140801_6141 2 + 0.00552166988572273 0.157107574283162 7629 rotenone hsa05016 Huntington's disease 4899_6648_841_6390_3708_9001_7419_161 8 - 0.0443601495060281 0.767681020265841 7630 rotenone hsa04740 Olfactory transduction 26529_9635 2 - 8.57966991014288e-12 7.20692272452002e-10 7631 rotenone hsa05322 Systemic lupus erythematosus 8348_8329_8343_8347_8346_8344_8339_8969_8968_8358_8330_8331_8336_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_3013_942_3017_3014_720_721 31 - 2.33773508566645e-05 0.000981848735979909 7632 betonicine hsa04640 Hematopoietic cell lineage 2814_1435_3553_2057_3815_3690_3574_2812_952_920_7850_926_914_933_1378_3589_3676_925_3674_960 20 + 0.00461170228703138 0.136813834515264 7633 betonicine hsa05010 Alzheimer's disease 4713_3553_2904_54205_509_487_348 7 + 0.00368329275959955 0.136813834515264 7634 betonicine hsa05016 Huntington's disease 246721_5439_4713_2904_54205_64446_10540_509_548644_291 10 + 0.0212617008987103 0.378458275997043 7635 betonicine hsa04740 Olfactory transduction 26211_5593_5592_5566_26664_9635_815_1258 8 + 7.58143155998648e-10 6.74747408838797e-08 7636 betonicine hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_2904_8368_6737_8360_8362_8294_8341_8340_8366_8370_8359_554313_121504_8354_83740_3113_3111_729 25 + 0.0357226628079994 0.397414623738993 7637 betonicine hsa04110 Cell cycle 6502_699_1029_4193_8556 5 + 0.0315766539824693 0.397414623738993 7638 betonicine hsa03450 Non-homologous end-joining 27343_27434_2547_3981_10111 5 + 0.0323197133889227 0.397414623738993 7639 betonicine hsa04512 ECM-receptor interaction 8516_2814_1291_1281_22798_1311_2812_3690_3695_3685_7060_5649_1284_7148_960_1277_3676_6696_3674 19 + 0.0066400258503945 0.147740575171278 7640 betonicine hsa05012 Parkinson's disease 4713_5413_54205_6531_7345_509_291 7 + 0.0467198240750485 0.462007149186591 7641 betonicine hsa05211 Renal cell carcinoma 2271_208_6655_6513_405_3845_7422_7042_3725_4233 10 - 0.0125594898519884 0.33765785143136 7642 betonicine hsa05200 Pathways in cancer 8030_4088_9618_5881_10342_5888_8321_7184_3675_6513_5371_405_208_4193_3918_1956_7042_91_3725_4233_1436_2271_6502_6655_7189_355_3845_7422_6257 29 - 0.0319972017914979 0.359287933394523 7643 betonicine hsa04740 Olfactory transduction 219464 1 - 1.38558781337719e-08 1.1361820069693e-06 7644 betonicine hsa04514 Cell adhesion molecules (CAMs) 3135_5817 2 - 0.034820237342931 0.359287933394523 7645 betonicine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8367_554313_3017_8359_55766_8337_720_721_121504_8294 19 - 0.00135906525730052 0.0557216755493213 7646 betonicine hsa04350 TGF-beta signaling pathway 7059_4086_4088_7057_9475_91_7027_653_7042_10637_57154 11 - 0.020588893379961 0.33765785143136 7647 betonicine hsa05012 Parkinson's disease 2861_7419 2 - 0.0350524813067827 0.359287933394523 7648 betonicine hsa05210 Colorectal cancer 4088_208_6655_4233_5881_1956_3845_7042_91_3725_8321 11 - 0.0181702240632858 0.33765785143136 7649 BAS-012416453 hsa04080 Neuroactive ligand-receptor interaction 3354 1 + 0.0011580126140762 0.0503735487123147 7650 BAS-012416453 hsa04740 Olfactory transduction 5567 1 + 1.16979404802778e-05 0.00101772082178417 7651 BAS-012416453 hsa05214 Glioma 818_5728_5155_5154_673_5605_1869 7 - 0.0217971142280249 0.25222375035286 7652 BAS-012416453 hsa04080 Neuroactive ligand-receptor interaction 5025_5031 2 - 0.00479259060311773 0.0835214557057366 7653 BAS-012416453 hsa05014 Amyotrophic lateral sclerosis (ALS) 842_572_5630_5606_5534_6300 6 - 0.0332481601095482 0.299233440985934 7654 BAS-012416453 hsa04740 Olfactory transduction 818 1 - 5.53817030050105e-06 0.000224295897170293 7655 BAS-012416453 hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8360_8368_8362_8294_121504_8366_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_83740_3013_3014 29 - 2.2444992027469e-11 1.81804435422499e-09 7656 BAS-012416453 hsa05212 Pancreatic cancer 5728_842_3551_572_4824_5155_5154_673_5605_1869 10 - 0.00515564541393436 0.0835214557057366 7657 BAS-012416453 hsa05215 Prostate cancer 5728_842_3551_572_4824_5155_5154_673_5605_1869 10 - 0.00479665498388312 0.0835214557057366 7658 BAS-012416453 hsa05218 Melanoma 5728_572_5155_5154_673_5605_1869 7 - 0.0321191121173106 0.299233440985934 7659 BAS-012416453 hsa05223 Non-small cell lung cancer 842_6789_572_673_5605_1869_6257 7 - 0.00927611476609693 0.125227549342309 7660 BAS-012416453 hsa03020 RNA polymerase 246721_5439_548644_5434 4 - 0.0382566549173084 0.309878904830198 7661 BAS-012416453 hsa04912 GnRH signaling pathway 4215_115_3709_5598_2776_818_5606_5605_6300 9 - 0.0483888143982501 0.345601940969411 7662 iopanoic acid hsa05332 Graft-versus-host disease 3107_3119_3811_3802 4 + 0.0416223800195423 0.717986055337105 7663 iopanoic acid hsa04740 Olfactory transduction 810 1 + 0.000255603592996059 0.00881832395836404 7664 iopanoic acid hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_718_8368_8366_8359_3119_8294_8367_554313_121504_8341 17 + 3.32188141662011e-06 0.000229209817746788 7665 iopanoic acid hsa04912 GnRH signaling pathway 8398_3710_6655_3709_1956_5337_810_10746_6714 9 + 0.00624826828562504 0.143710170569376 7666 iopanoic acid hsa04710 Circadian rhythm - mammal 9572_5187 2 - 0.0373935813470889 1 7667 iopanoic acid hsa04010 MAPK signaling pathway 57551_4149_3925_5154_5607_5606_5600_7043_5534_7786_8398_4763_408 13 - 0.008754411631624 0.534019109529064 7668 SB-202190 hsa04740 Olfactory transduction 818_219464_8390_56656_157 5 + 0.00168058600624962 0.13276629449372 7669 SB-202190 hsa04912 GnRH signaling pathway 50487_1081_5578_5598_1839_818_5600_3725_6714_5609 10 + 0.0302281773156623 1 7670 SB-202190 hsa04640 Hematopoietic cell lineage 960 1 - 0.0212586757921918 0.369900958784137 7671 SB-202190 hsa04080 Neuroactive ligand-receptor interaction 9568_1241_2908_5025_4886 5 - 0.000159247727024222 0.00461818408370244 7672 SB-202190 hsa04740 Olfactory transduction 818_26212_157 3 - 6.42105956196653e-10 2.79316090945544e-08 7673 SB-202190 hsa04514 Cell adhesion molecules (CAMs) 3135_3106_1365_4267 4 - 0.0467879150867866 0.428850529559301 7674 SB-202190 hsa05322 Systemic lupus erythematosus 55506_8361_8363_8362_8365_8364_8367_8360_8368_8329_8294_121504_8343_8347_8346_8344_8339_8366_8969_8968_8370_8358_8359_8330_8331_8336_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3013_3014_727 40 - 3.48127837295041e-10 2.79316090945544e-08 7675 SB-202190 hsa04010 MAPK signaling pathway 8399_7157_6655_2005_5605_5607_1956_5606_5536_10454_5970_2264 12 - 0.0379824407021978 0.428850529559301 7676 SB-202190 hsa04060 Cytokine-cytokine receptor interaction 3597_23529_7852_1956_9180_8718_93_4233_51330 9 - 0.00653436941606093 0.142122534799325 7677 SB-202190 hsa03010 Ribosome 6234_6165 2 - 0.0348272299021716 0.428850529559301 7678 SB-202190 hsa04020 Calcium signaling pathway 6262_5025_818_3708_1956_7416_5335 7 - 0.049293164317161 0.428850529559301 7679 SB-202190 hsa05213 Endometrial cancer 3611_8503_842_7157_572_6655_5605_1956_324 9 - 0.0428940919002331 0.428850529559301 7680 naftidrofuryl hsa04740 Olfactory transduction 810_51806_81697_8392_5137 5 + 2.25283519937858e-05 0.00189238156747801 7681 naftidrofuryl hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_3117_8368_941_8359_8294_8367_554313_121504_3119 17 + 0.0132833331879238 0.415186226209807 7682 naftidrofuryl hsa04110 Cell cycle 1017 1 + 0.0148280795074931 0.415186226209807 7683 naftidrofuryl hsa04130 SNARE interactions in vesicular transport 9570_662_6844 3 - 0.0442670963237931 0.435293113850632 7684 naftidrofuryl hsa05131 Shigellosis 7278_7280_113457_347733 4 - 0.0284449811948861 0.435293113850632 7685 naftidrofuryl hsa05130 Pathogenic Escherichia coli infection 7278_7280_113457_347733 4 - 0.0284449811948861 0.435293113850632 7686 naftidrofuryl hsa05322 Systemic lupus erythematosus 3013_8343_8351_8339_8347_8346_8344 7 - 0.027094970572618 0.435293113850632 7687 naftidrofuryl hsa03450 Non-homologous end-joining 27343_7518 2 - 0.0373051800847943 0.435293113850632 7688 naftidrofuryl hsa04540 Gap junction 7278_7280_113457_2776_347733 5 - 0.0410789484152188 0.435293113850632 7689 pentoxyverine hsa05010 Alzheimer's disease 6390 1 + 0.00761087523036492 0.300629571599414 7690 pentoxyverine hsa04740 Olfactory transduction 816 1 + 1.13791519568266e-06 8.98953004589301e-05 7691 pentoxyverine hsa05218 Melanoma 1021_5154_5290_8817_1956_2258_2260 7 + 0.049801887977372 1 7692 pentoxyverine hsa04080 Neuroactive ligand-receptor interaction 1269_2925_1812 3 - 0.00277832106916355 0.0777929899365794 7693 pentoxyverine hsa04740 Olfactory transduction 5567_157 2 - 1.39718033015293e-06 5.86815738664231e-05 7694 pentoxyverine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_8969_8370_8332_8359_8330_8331_8336_554313_121504_8339_85235 26 - 1.41455818072148e-07 1.18822887180604e-05 7695 pentoxyverine hsa05221 Acute myeloid leukemia 2475_3551_5371_8503_6932_3845_5914 7 - 0.0383892281698721 0.644939033253851 7696 pentoxyverine hsa04060 Cytokine-cytokine receptor interaction 23529_5155_8742_8741 4 - 0.00804802795322955 0.169008587017821 7697 clomifene hsa04740 Olfactory transduction 2979_816_390892 3 + 4.79041264288215e-07 1.94011712036727e-05 7698 clomifene hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8348_8294_121504_8343_8347_8352_8344_8339_8346_8968_8370_8358_8359_8335_8350_8351_7124_8353_8354_8355_8356_8357_2215_3012_3013_8970 36 + 1.60411689217754e-11 1.29933468266381e-09 7699 clomifene hsa04062 Chemokine signaling pathway 115_5290_5293_4792 4 + 0.0268655435653199 0.544027257197728 7700 clomifene hsa05012 Parkinson's disease 4698 1 + 0.00742412070784412 0.200451259111791 7701 clomifene hsa04080 Neuroactive ligand-receptor interaction 4889_5618_4886 3 - 0.00033360267202364 0.0138445108889811 7702 clomifene hsa04740 Olfactory transduction 157 1 - 4.07005848949882e-09 3.37814854628402e-07 7703 clomifene hsa03450 Non-homologous end-joining 5591_27343_3981_7518 4 - 0.0168217907864372 0.349052158818572 7704 clomifene hsa04060 Cytokine-cytokine receptor interaction 5618_2057_8742_8741_6387_4233 6 - 0.0104439363037223 0.288948904402984 7705 clomifene hsa04020 Calcium signaling pathway 115_7419_5335_2776 4 - 0.0366160890985552 0.607827079036016 7706 zoxazolamine hsa05332 Graft-versus-host disease 3105_3106_3126_3127_3111_3125_3135_3123_3002_649853 10 + 3.45047562220787e-05 0.000483066587109102 7707 zoxazolamine hsa05320 Autoimmune thyroid disease 3449_3105_3106_3126_3127_3111_3125_3135_3123_3002_649853 11 + 4.23131571105572e-05 0.000493653499623167 7708 zoxazolamine hsa04612 Antigen processing and presentation 3449_972_3123_3106_3126_3127_3111_3125_3135_6892_3105_649853 12 + 0.000711867507046804 0.00711867507046804 7709 zoxazolamine hsa05016 Huntington's disease 64446_7416 2 + 0.0370554572184784 0.235807455026681 7710 zoxazolamine hsa04740 Olfactory transduction 23538_4991 2 + 2.95861919977306e-05 0.000483066587109102 7711 zoxazolamine hsa04514 Cell adhesion molecules (CAMs) 8174_3123_3106_3126_3127_3696_3125_3135_3111_3105_7122_649853 12 + 0.0170155190287548 0.132342925779204 7712 zoxazolamine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8290_8294_3123_3126_3127_3125_8370_8359_554313_121504_8354_2215_3111 22 + 7.82939893524359e-07 5.48057925467051e-05 7713 zoxazolamine hsa05310 Asthma 3123_3126_3127_3111_3125 5 + 0.0123213403777058 0.107811728304926 7714 zoxazolamine hsa04512 ECM-receptor interaction 1281_1302_3910_3691_3696_1277_3371_3918 8 + 0.0314728147402357 0.22030970318165 7715 zoxazolamine hsa05012 Parkinson's disease 7416 1 + 0.0458603339482676 0.267518614698228 7716 zoxazolamine hsa05330 Allograft rejection 3105_3106_3126_3127_3111_3125_3135_3123_3002_649853 10 + 1.64752962380288e-05 0.000384423578887339 7717 zoxazolamine hsa04940 Type I diabetes mellitus 2572_3105_3106_3126_3127_3111_3125_3135_3123_3002_649853 11 + 9.43297264644258e-06 0.00033015404262549 7718 zoxazolamine hsa04080 Neuroactive ligand-receptor interaction 7067 1 - 0.00750359501760403 0.273881218142547 7719 zoxazolamine hsa04740 Olfactory transduction 157 1 - 0.000261394934177306 0.0190818301949433 7720 zoxazolamine hsa03010 Ribosome 440589_6187_284393_439992_6129_389342_6189 7 - 0.0380402574106284 0.847796512303492 7721 N6-methyladenosine hsa04740 Olfactory transduction 26476 1 + 5.95646130584261e-05 0.00452691059244038 7722 N6-methyladenosine hsa04912 GnRH signaling pathway 8399_1081_6655_115_3708_5603_3725_5338_23236 9 + 0.0159079505819345 0.604502122113511 7723 N6-methyladenosine hsa04730 Long-term depression 8399_2775_5519_3708_4842_23236 6 + 0.0426609562112888 1 7724 N6-methyladenosine hsa05131 Shigellosis 7278_7280_113457_347733 4 - 0.0117784090347648 0.164136751368885 7725 N6-methyladenosine hsa05130 Pathogenic Escherichia coli infection 7278_7280_113457_347733 4 - 0.0117784090347648 0.164136751368885 7726 N6-methyladenosine hsa05322 Systemic lupus erythematosus 85235_3013_8330_3014_8332_8969_8331_8329_8351_8343_8336_8339_8347_8346_8344 15 - 1.13497837548145e-08 4.99390485211838e-07 7727 N6-methyladenosine hsa04540 Gap junction 7278_7280_113457_2776_347733 5 - 0.0149215228517168 0.164136751368885 7728 chlorprothixene hsa04740 Olfactory transduction 1179 1 + 1.65156179288403e-06 6.27593481295931e-05 7729 chlorprothixene hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8329_8294_121504_8343_8347_8346_8344_8339_8969_8968_8370_8358_8359_8330_8331_8336_8335_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3012_3013_942_940_8970 42 + 5.99520898357204e-20 4.55635882751475e-18 7730 cefalexin hsa04662 B cell receptor signaling pathway 3551_5880_5293_8519_4776_7410_4775_3725_4793 9 + 0.00163176883803979 0.041338143897008 7731 cefalexin hsa05010 Alzheimer's disease 4714 1 + 0.0321274349346442 0.348812150718994 7732 cefalexin hsa04660 T cell receptor signaling pathway 3551_5293_867_3558_4776_7410_4775_3725_4793 9 + 0.0159210350070232 0.282146655755364 7733 cefalexin hsa04740 Olfactory transduction 7932 1 + 5.55331539843723e-05 0.0042205197028123 7734 cefalexin hsa04510 Focal adhesion 3679_22798_93408_5599_3691_2909_5880_5293_3690_7410_1956_3725_3082_2335 14 + 0.0185622799839055 0.282146655755364 7735 cefalexin hsa05322 Systemic lupus erythematosus 718_3013_3113_8358_8968_8335_8350_8351_8352_8353_8354_8355_8356_8357 14 + 0.000663446535568897 0.0252109683516181 7736 cefalexin hsa05210 Colorectal cancer 4088_5880_5293_5599_1956_3725_8326 7 + 0.0292035299415723 0.348812150718994 7737 cefalexin hsa04080 Neuroactive ligand-receptor interaction 1269_4157_1081_1813_64106_2908 6 - 0.0183911447583801 0.754036935093584 7738 cefalexin hsa04740 Olfactory transduction 4991 1 - 1.39663966856222e-08 1.14524452822102e-06 7739 cefalexin hsa05012 Parkinson's disease 7419_517 2 - 0.0350918422312719 0.959177020988099 7740 bepridil hsa05010 Alzheimer's disease 4695_3553_4842_23236 4 + 0.0193139884760702 0.488465594293595 7741 bepridil hsa04740 Olfactory transduction 26211_8392_390892 3 + 5.02469627739154e-08 4.47197968687847e-06 7742 bepridil hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8290_3013_554313_8366_3111_8359_8294_8367_121504_8368_8351 18 + 0.0205671829204005 0.488465594293595 7743 bepridil hsa03010 Ribosome 6234 1 + 0.0219535098558919 0.488465594293595 7744 bepridil hsa04070 Phosphatidylinositol signaling system 3628_5296_8396_3631_8394_8821_23396_810_8526_3705 10 - 0.0143137153196583 0.29700959288291 7745 bepridil hsa04080 Neuroactive ligand-receptor interaction 64106_2690 2 - 0.000178819052100177 0.00742099066215735 7746 bepridil hsa04740 Olfactory transduction 810_5567_157 3 - 2.18849259402296e-06 0.000181644885303906 7747 bepridil hsa04530 Tight junction 5521_5581 2 - 0.0349233556339879 0.483106419603499 7748 bepridil hsa05310 Asthma 3123_3126_3127_3113_3125 5 - 0.0345267349525765 0.483106419603499 7749 bepridil hsa04350 TGF-beta signaling pathway 5308_4090_3624_9475_654_655_652_7040_5933_6093_268_6199 12 - 0.00552904529307958 0.152970253108535 7750 bepridil hsa04940 Type I diabetes mellitus 3126_3113_3127_3125_1363_3123 6 - 0.0456658295131653 0.525952955053763 7751 bezafibrate hsa04740 Olfactory transduction 816 1 + 0.00249030857659602 0.154399131748953 7752 bezafibrate hsa04080 Neuroactive ligand-receptor interaction 3953_1081 2 - 0.00159064046941066 0.0652162592458371 7753 bezafibrate hsa04740 Olfactory transduction 5613_801_808_157_805 5 - 0.0012299570047335 0.0652162592458371 7754 dequalinium chloride hsa04740 Olfactory transduction 26212_815_3000 3 + 4.21735102723658e-05 0.00341605433206163 7755 dequalinium chloride hsa05322 Systemic lupus erythematosus 8341 1 + 0.0226543836166797 0.917502536475528 7756 dequalinium chloride hsa04630 Jak-STAT signaling pathway 6655_59067 2 + 0.0494673291047655 1 7757 dequalinium chloride hsa05332 Graft-versus-host disease 3119_3105_3106_3135_3134_649853 6 - 0.0373818837307162 0.988081921030725 7758 dequalinium chloride hsa04612 Antigen processing and presentation 4800_3119_6890_3105_3106_3135_3134_3306_811_3304_821_3303_649853 13 - 0.00239511473477496 0.213165211394971 7759 dequalinium chloride hsa05330 Allograft rejection 3119_3105_3106_3135_3134_649853 6 - 0.0255685042567317 0.988081921030725 7760 dequalinium chloride hsa04940 Type I diabetes mellitus 3119_3105_3106_3135_3134_649853 6 - 0.0444081762261 0.988081921030725 7761 xamoterol hsa04740 Olfactory transduction 5566 1 + 0.00167611688428247 0.0511215649706153 7762 xamoterol hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 1.72212601254469e-05 0.00105049686765226 7763 xamoterol hsa03020 RNA polymerase 246721_5439_548644 3 + 0.0371057043389605 0.754482654892197 7764 xamoterol hsa04010 MAPK signaling pathway 3725_10912_5154 3 - 0.0484363145595233 0.347343816301533 7765 xamoterol hsa04540 Gap junction 5154_1813 2 - 0.0325158073413366 0.347343816301533 7766 primidone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 + 1.56870994526924e-05 0.000800042072087312 7767 primidone hsa04710 Circadian rhythm - mammal 1454_9572 2 - 0.0078249377102088 0.25822294443689 7768 medrysone hsa05332 Graft-versus-host disease 57292_3119_3804_3126_3127_3125_3123 7 + 0.00442966350729018 0.354373080583214 7769 medrysone hsa04612 Antigen processing and presentation 57292_3119_3123_3126_3127_3125_6891_3804_3310 9 + 0.0373326700659111 0.426659086467555 7770 medrysone hsa05016 Huntington's disease 5331_1211 2 + 0.0267560191454203 0.426659086467555 7771 medrysone hsa04740 Olfactory transduction 51806_8388_8387_135948_8392_26211_81797_81696 8 + 0.021564594810248 0.426659086467555 7772 medrysone hsa05310 Asthma 3123_3126_3127_3119_3125 5 + 0.0155086074279707 0.426659086467555 7773 medrysone hsa05012 Parkinson's disease 6622 1 + 0.0316427814952008 0.426659086467555 7774 medrysone hsa05330 Allograft rejection 3123_3126_3127_3119_3125 5 + 0.0349180707471171 0.426659086467555 7775 medrysone hsa05010 Alzheimer's disease 842_4137_5331_3708_5534_102 6 - 0.0129778483717027 0.183852851932455 7776 medrysone hsa04080 Neuroactive ligand-receptor interaction 1909_5618_7442_7433 4 - 7.6521262949133e-06 0.000325215367533815 7777 medrysone hsa04612 Antigen processing and presentation 3135_4802 2 - 0.0327414060038907 0.347877438791339 7778 medrysone hsa05016 Huntington's disease 5331_246721_27113_842_3708 5 - 0.00289792488749296 0.0492647230873803 7779 medrysone hsa04740 Olfactory transduction 818_219464_4991 3 - 5.79182544925187e-11 4.92305163186409e-09 7780 medrysone hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8294_121504_8968_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_3013_3017_3014 27 - 0.000577715093758327 0.0122764457423644 7781 medrysone hsa05012 Parkinson's disease 842 1 - 0.000207939841202626 0.0058916288340744 7782 medrysone hsa04060 Cytokine-cytokine receptor interaction 5154_5618_8771_2057_3594_3455_8742_8741_3572_7852_655_4254 12 - 0.0235770558901895 0.28629282152373 7783 demeclocycline hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504_3119 15 + 5.91206400407432e-07 3.25163520224088e-05 7784 demeclocycline hsa04080 Neuroactive ligand-receptor interaction 7067_2740_5618_152_1909 5 - 0.00781435139070493 0.312574055628197 7785 demeclocycline hsa04740 Olfactory transduction 818 1 - 1.36908885209737e-08 1.0952710816779e-06 7786 digoxigenin hsa05332 Graft-versus-host disease 3569_3553_3119_3821_942_3107_3126_3127_3111_3125_3135_3133_3123 13 + 0.00792045760493938 0.102965948864212 7787 digoxigenin hsa05010 Alzheimer's disease 3553_3710_6390_5534_9451_5330_509_487_4695_348 10 + 0.00943361346711858 0.107307353188474 7788 digoxigenin hsa05016 Huntington's disease 1213_4695_6390_55567_6667_5330_7416_509_2033_1387 10 + 0.00412534452551124 0.0921240641069017 7789 digoxigenin hsa04740 Olfactory transduction 26212_5566_81797 3 + 1.87275356956813e-16 1.704205748307e-14 7790 digoxigenin hsa05322 Systemic lupus erythematosus 474382_8361_8363_474381_8365_8364_8367_8360_8368_8335_8349_8362_8329_8294_121504_8343_8342_8341_8347_8346_8345_8344_8339_723790_3123_8366_3126_3127_3125_8969_8968_8370_92815_8358_8359_8330_8331_8336_8337_554313_8350_8351_8352_8353_8354_8355_8356_8357_8332_85235_3119_83740_3012_3013_942_3017_3111 57 + 1.25743222980488e-11 5.7213166456122e-10 7791 digoxigenin hsa04664 Fc epsilon RI signaling pathway 5293_2207 2 + 0.00725508192074376 0.102965948864212 7792 digoxigenin hsa05012 Parkinson's disease 4695_5413_6390_7345_7416_509 6 + 0.00471601354343355 0.0921240641069017 7793 digoxigenin hsa04260 Cardiac muscle contraction 782_4635 2 + 0.00506176176411548 0.0921240641069017 7794 digoxigenin hsa04270 Vascular smooth muscle contraction 59_3710_5566_5330_108_135_6093 7 + 0.0452161714900039 0.36613211646442 7795 digoxigenin hsa04940 Type I diabetes mellitus 3553_2572_3119_942_3107_3126_3127_3111_3125_3135_3133_3123 12 + 0.0293935955084177 0.297201910140668 7796 digoxigenin hsa04650 Natural killer cell mediated cytotoxicity 836_6850_6655_5295_355_10451_3845_5336 8 - 0.0319305164045284 0.169043910376915 7797 digoxigenin hsa03440 Homologous recombination 10714_5888_675_80198_641_7516_5892_5893_25788_10111 10 - 0.00606658195121576 0.0454993646341182 7798 digoxigenin hsa04640 Hematopoietic cell lineage 3678_2057 2 - 0.00528982097644883 0.0432803534436722 7799 digoxigenin hsa05010 Alzheimer's disease 836_841_8772_355_3709_7132_23236 7 - 0.000747736786610752 0.00950003585305375 7800 digoxigenin hsa04080 Neuroactive ligand-receptor interaction 5618_4157_1813_2561_5021_56288_136_7433_2149 9 - 1.32137117157322e-05 0.000546779724705 7801 digoxigenin hsa05200 Pathways in cancer 5295_5155_5154_5336_5888_8321_8322_1488_4149_3551_652_2260_9134_8772_675_836_9915_841_6502_6655_6777_6772_7188_355_3845_2535 26 - 0.0245914383611344 0.147548630166806 7802 digoxigenin hsa05320 Autoimmune thyroid disease 355 1 - 0.0267045979727686 0.150213363596823 7803 digoxigenin hsa04670 Leukocyte transendothelial migration 10451_5336_5295_1500_9080 5 - 0.00904038437586306 0.0625872764482827 7804 digoxigenin hsa05016 Huntington's disease 246721_836_841_5439_548644_5481_23236 7 - 0.00041514385874992 0.0062271578812488 7805 digoxigenin hsa04740 Olfactory transduction 818_5613_5616_157 4 - 7.44648451020384e-15 6.70183605918346e-13 7806 digoxigenin hsa04514 Cell adhesion molecules (CAMs) 5818_214_5792_9080 4 - 0.000844447631382556 0.00950003585305375 7807 digoxigenin hsa04510 Focal adhesion 6655_5295_5155_3678_5154_10451 6 - 1.82259908235e-05 0.000546779724705 7808 digoxigenin hsa05322 Systemic lupus erythematosus 55506_718_3021_3020_727_55766_6737 7 - 0.0115638857697359 0.0743392656625879 7809 digoxigenin hsa04530 Tight junction 5583_5581_9080_51776_56288_3845_9223_27134 8 - 0.0423668149265732 0.200710920856691 7810 digoxigenin hsa04370 VEGF signaling pathway 5295_3845_5336 3 - 0.0446024268570424 0.200710920856691 7811 digoxigenin hsa04512 ECM-receptor interaction 3678 1 - 0.00125030314873952 0.0125030314873952 7812 digoxigenin hsa04810 Regulation of actin cytoskeleton 3678_6655_5295_5155_5154_10451_50649_3845_54434_23365_3984_3985_2260_8396_2149_1445 16 - 0.0436829177383564 0.200710920856691 7813 digoxigenin hsa05012 Parkinson's disease 836_5481 2 - 4.21847534686248e-05 0.000949156953044058 7814 digoxigenin hsa04060 Cytokine-cytokine receptor interaction 5618_7132_2057_3594_5155_8742_8741_5154_657_355_27242 11 - 6.82398333491392e-05 0.00122831700028451 7815 digoxigenin hsa03010 Ribosome 6168_6137_6181 3 - 0.0041748883671096 0.0375739953039864 7816 felbinac hsa05010 Alzheimer's disease 51806_3553_2905_355_4137_3708_3709_5534_4695_801_348_808_805 13 + 0.0114801875153618 0.170289448144533 7817 felbinac hsa05016 Huntington's disease 4899_4695_3708 3 + 2.21694003007194e-08 1.63967283631845e-06 7818 felbinac hsa04740 Olfactory transduction 51806_26212_7932_8390_56656_26211_8386_8385_2774_5616_5593_808_26532_805_81696_801_26189_816_81797 19 + 3.68465805914258e-08 1.63967283631845e-06 7819 felbinac hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8290_8294_121504_959_3108_3126_8968_6738_8370_8358_8359_554313_8350_8351_8352_8353_8354_8355_8356_8357_2212_3119_3013_3113_3014_941_727 36 + 0.00673566360198828 0.148101299110124 7820 felbinac hsa04110 Cell cycle 995_993_4088_8881_1028_1032_8243_10744_4616 9 + 0.046201339490069 0.551625406527277 7821 felbinac hsa05012 Parkinson's disease 4695_5413 2 + 2.21645128244596e-06 6.57547213792301e-05 7822 felbinac hsa03010 Ribosome 6187_440589_6137_6192_6171 5 + 0.00832029770281597 0.148101299110124 7823 diloxanide hsa05214 Glioma 10000_208_6655_4193_5925_1956_810_816 8 + 0.0270674132410623 0.766910041830098 7824 diloxanide hsa04740 Olfactory transduction 157_8388_8387_5566_810_816 6 + 0.000496453438020607 0.0421985422317516 7825 diloxanide hsa04920 Adipocytokine signaling pathway 6794_51703_10000_948_3953_208_5781_9370_9021 9 + 0.0122785808452898 0.521839685924817 7826 diloxanide hsa05131 Shigellosis 7278_7454_113457 3 - 0.0216025829604057 0.26643185651167 7827 diloxanide hsa05016 Huntington's disease 5439_4899_548644_246721_1213 5 - 0.0455738782256726 0.421558373587472 7828 diloxanide hsa05130 Pathogenic Escherichia coli infection 7278_7454_113457 3 - 0.0216025829604057 0.26643185651167 7829 diloxanide hsa03020 RNA polymerase 246721_5439_548644 3 - 0.00400796245413915 0.148294610803149 7830 2-aminobenzenesulfonamide hsa04740 Olfactory transduction 5566_26476_816_4991 4 + 0.0199740989292596 0.426114110490871 7831 2-aminobenzenesulfonamide hsa05322 Systemic lupus erythematosus 3119_3013_8358_8968_8342_8350_8351_8352_8353_8354_8355_8356_8357 13 + 0.000644245178212084 0.0412316914055734 7832 2-aminobenzenesulfonamide hsa04270 Vascular smooth muscle contraction 9138_3779_3778_5331_3708_72_5320_1909_81579_5566 10 + 0.00405523191620412 0.129767421318532 7833 meclofenoxate hsa04512 ECM-receptor interaction 3690_3688_1290_3910_22987 5 + 0.0197244607574255 0.650907204995042 7834 meclofenoxate hsa04540 Gap junction 5593_7082_5598_5331_57369_1902 6 + 0.00770609940468427 0.508602560709162 7835 meclofenoxate hsa04912 GnRH signaling pathway 5331_5598_776_816_51806 5 + 0.0479771398853618 0.9668268692089 7836 meclofenoxate hsa04080 Neuroactive ligand-receptor interaction 64106_5618 2 - 0.000538797796627095 0.0220907096617109 7837 meclofenoxate hsa04740 Olfactory transduction 157 1 - 1.52967427741796e-07 1.25433290748273e-05 7838 meclofenoxate hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 0.0225245331391516 0.615670572470144 7839 levonorgestrel hsa04740 Olfactory transduction 51806 1 + 0.0156721489551127 0.641044974616329 7840 levonorgestrel hsa04512 ECM-receptor interaction 1292_960_3908_22798_2812 5 + 0.0197244607574255 0.641044974616329 7841 levonorgestrel hsa04080 Neuroactive ligand-receptor interaction 7067_5618_1131 3 - 7.82207682699843e-05 0.00328527226733934 7842 levonorgestrel hsa04612 Antigen processing and presentation 3305 1 - 0.0452349385575318 0.474966854854084 7843 levonorgestrel hsa04740 Olfactory transduction 818_26212 2 - 6.11769793426312e-09 5.13886626478102e-07 7844 levonorgestrel hsa04210 Apoptosis 8503_3554_842_841_581_7157_5295_8795_472_8737_8837_651610_9020 13 - 0.0127199007404386 0.265206855205853 7845 levonorgestrel hsa04115 p53 signaling pathway 27113_842_841_581_7157_4194_4193_472_25898_651610_8795 11 - 0.0166081147255964 0.265206855205853 7846 levonorgestrel hsa04020 Calcium signaling pathway 818_8912_1131_7419_489 5 - 0.0335582963127083 0.4026995557525 7847 levonorgestrel hsa05210 Colorectal cancer 8503_6934_581_7157_6655_5295_5599_5881_324_7042_91_842 12 - 0.0189433468004181 0.265206855205853 7848 levonorgestrel hsa04270 Vascular smooth muscle contraction 5581 1 - 0.00693560378943415 0.194196906104156 7849 tetrandrine hsa03320 PPAR signaling pathway 4199_2182_2180_4023_6319_5105 6 + 0.0488011157790551 0.346044275524209 7850 tetrandrine hsa05200 Pathways in cancer 23533_1021_324_868_27006_6655_331_330_1950_1857_4088_11211_2249_5290_5602_91_8324_4233_861_7422 20 + 0.0362764508157535 0.314395907069864 7851 tetrandrine hsa05016 Huntington's disease 2904 1 + 0.0155041714459522 0.182132847591603 7852 tetrandrine hsa04740 Olfactory transduction 442194 1 + 2.59097952592214e-05 0.00202096403021927 7853 tetrandrine hsa04510 Focal adhesion 23533_29895_1302_1311_3690_331_6655_3791_7057_5290_330_88_1950_5602_55742_4233_7422 17 + 0.00238034498942389 0.0618889697250211 7854 tetrandrine hsa05218 Melanoma 23533_1021_27006_5290_2249_4233_1950 7 + 0.0186802920606772 0.182132847591603 7855 tetrandrine hsa04012 ErbB signaling pathway 868_23533_6655_5290_1950_5602_3084 7 + 0.0454411533386828 0.346044275524209 7856 tetrandrine hsa05223 Non-small cell lung cancer 2309_23533_1021_6655_5290_1950 6 + 0.0176516506354497 0.182132847591603 7857 tetrandrine hsa05213 Endometrial cancer 2309_23533_6655_5290_1950_324 6 + 0.0151166636710962 0.182132847591603 7858 tetrandrine hsa05210 Colorectal cancer 23533_4088_6655_5290_1857_11211_324_5602_91_8324_4233 11 + 0.000447211362411854 0.0174412431340623 7859 tetrandrine hsa05220 Chronic myeloid leukemia 23533_1021_868_4088_6655_5290_861_91 8 + 0.0081509648616152 0.158943814801496 7860 tetrandrine hsa04080 Neuroactive ligand-receptor interaction 7434_2740_56288 3 - 0.01974246077047 0.261408045255216 7861 tetrandrine hsa05200 Pathways in cancer 4089_5154_1488_1613_2263_2260_2261_3912_998_3918_6932_8453_8554_367_1436_2247_6502_6655_867_2257_5914_7186 22 - 0.0222448521162634 0.261408045255216 7862 tetrandrine hsa05016 Huntington's disease 5331 1 - 0.0108855946454936 0.261408045255216 7863 tetrandrine hsa04740 Olfactory transduction 818 1 - 8.09662283683236e-06 0.000319816602054878 7864 tetrandrine hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_554313_8329_8294_8969_8370_8332_8359_8330_8331_8336_6737_6738_121504_85235_3111 24 - 1.86931109970295e-08 1.47675576876533e-06 7865 tetrandrine hsa04512 ECM-receptor interaction 960_3912_2812_3691_3693_1289_3918_9672 8 - 0.023162738187171 0.261408045255216 7866 tetrandrine hsa04810 Regulation of actin cytoskeleton 2261_3984_9138_3691_6655_3693_998_5154_8394_7409_54434_2257_2263_2260_2247_2909_2264 17 - 0.0138739954784788 0.261408045255216 7867 tetrandrine hsa04010 MAPK signaling pathway 5154_784_9479_1432_6655_27092_998_7186_4137_5607_776_2261_10454_2257_2263_2260_2247_2264 18 - 0.040849128334124 0.403385142299474 7868 tetrandrine hsa04060 Cytokine-cytokine receptor interaction 1436_5154_3454_3448 4 - 0.0490435782231476 0.430493631069851 7869 ozagrel hsa05332 Graft-versus-host disease 3123_3107_3126_3127_941_3125 6 + 0.0094349241184239 0.135862907305304 7870 ozagrel hsa05320 Autoimmune thyroid disease 7253_3123_3107_3126_3127_941_3125 7 + 0.00757823824147848 0.135862907305304 7871 ozagrel hsa04740 Olfactory transduction 810_26529_4992_2979_4991 5 + 0.00433647417983894 0.135862907305304 7872 ozagrel hsa04514 Cell adhesion molecules (CAMs) 965_3689_3123_3107_3126_3127_3125_5797_23308_941_5817_1462 12 + 0.0132717911377854 0.159261493653425 7873 ozagrel hsa05310 Asthma 3123_3126_3127_3125 4 + 0.0393524616886236 0.4047681773687 7874 ozagrel hsa05330 Allograft rejection 3123_3107_3126_3127_941_3125 6 + 0.00616491826917325 0.135862907305304 7875 ozagrel hsa04940 Type I diabetes mellitus 3382_3123_3107_3126_3127_941_3125 7 + 0.00304402320861622 0.135862907305304 7876 ozagrel hsa04650 Natural killer cell mediated cytotoxicity 5336 1 - 0.0468014130865665 0.723899765890316 7877 ozagrel hsa04740 Olfactory transduction 157 1 - 2.44566445481421e-06 0.000205435814204394 7878 ozagrel hsa05322 Systemic lupus erythematosus 3119 1 - 0.0318465370407523 0.723899765890316 7879 ozagrel hsa04530 Tight junction 4619 1 - 0.0464091675189432 0.723899765890316 7880 ozagrel hsa04062 Chemokine signaling pathway 5331_157 2 - 0.0258064428587739 0.723899765890316 7881 pergolide hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8370_8366_8368_8359_8294_8367_554313_121504 14 - 3.56082431514584e-10 1.10385553769521e-08 7882 streptozocin hsa05332 Graft-versus-host disease 57292_3108_3123_3126_3127_3125_3134 7 + 0.00379004099757116 0.0960143719384694 7883 streptozocin hsa05010 Alzheimer's disease 836 1 + 0.00735607939023908 0.137604184447969 7884 streptozocin hsa05320 Autoimmune thyroid disease 3108_3123_3126_3127_3125_3134 6 + 0.0345235208557894 0.290041693499051 7885 streptozocin hsa04740 Olfactory transduction 5566_442194 2 + 2.07469253104918e-05 0.000788383161798688 7886 streptozocin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_8365_8364_8367_8366_8368_8329_8294_8343_8347_8346_8344_3108_3123_3126_3127_3125_8969_8370_717_8332_8359_8330_8331_8336_554313_6738_121504_8339_85235 33 + 2.09174364400373e-13 1.58972516944283e-11 7887 streptozocin hsa05219 Bladder cancer 1029_11186_3576_3845_7057 5 + 0.0438553035446854 0.299222109672243 7888 streptozocin hsa04115 p53 signaling pathway 836_1029_7057_3486_472_5054_8795 7 + 0.0374402449629794 0.290041693499051 7889 streptozocin hsa05310 Asthma 3123_3125_3108_3127_3126 5 + 0.0138544517220618 0.175489721812783 7890 streptozocin hsa04810 Regulation of actin cytoskeleton 6655_3845_2335 3 + 0.0381633807235594 0.290041693499051 7891 streptozocin hsa05012 Parkinson's disease 836 1 + 0.0472455962640384 0.299222109672243 7892 streptozocin hsa05330 Allograft rejection 3108_3123_3126_3127_3125_3134 6 + 0.00905290687157691 0.137604184447969 7893 streptozocin hsa04940 Type I diabetes mellitus 3108_3123_3126_3127_3125_3134 6 + 0.0165693749778323 0.179896071187894 7894 streptozocin hsa05322 Systemic lupus erythematosus 8361_8360_8363_8362_85235_8364_8370_8366_8368_8365_8330_8332_8359_8969_8331_8329_8336_8367_554313_121504_8294 21 - 8.34758122331482e-13 5.42592779515463e-11 7895 streptozocin hsa04664 Fc epsilon RI signaling pathway 208_8681_100137049_5600_5578 5 - 0.0157203908040792 0.170304233710858 7896 streptozocin hsa04370 VEGF signaling pathway 208_8681_100137049_5600_5578 5 - 0.0142841885468594 0.170304233710858 7897 streptozocin hsa04010 MAPK signaling pathway 1326_5578_5598_1852_208_8681_5600_7042_2257_3725_2260_100137049 12 - 0.00428472473634855 0.0928357026208853 7898 streptozocin hsa04620 Toll-like receptor signaling pathway 1326_3448_208_148022_5600_3725_9641 7 - 0.00296371703164004 0.0928357026208853 7899 streptozocin hsa04912 GnRH signaling pathway 5578_5598_8681_5600_3725_100137049 6 - 0.0148227726133444 0.170304233710858 7900 5155877 hsa04080 Neuroactive ligand-recept